PATENTS AND DESIGNS JOURNAL
Transcript of PATENTS AND DESIGNS JOURNAL
![Page 1: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/1.jpg)
05/2009ื"ืืชืฉืก/ื"ื
ืจืฉืืืืชISRAEL STATE RECORDS
Decemberืข"ืืชืฉ ืืืกืื'ื 24, 2009
ืืื๏ฟฝ ืืคืื ืื๏ฟฝ ืืืืืืื๏ฟฝPATENTS AND DESIGNS JOURNAL
PATENTSืขืืืืคืื ืื๏ฟฝPage
3Applicationsืืงืฉืืช ืฉืืืืฉื filed310Applicationsืืงืฉืืช ืฉืงืืืื accepted496Patentsืคืื ืื๏ฟฝ ืฉื ืืชื ื granted497Patentsืคืื ืื๏ฟฝ ืฉืืืืฉื renewed
499Patentsืคืื ืื๏ฟฝ ืฉืชืืงืค๏ฟฝ ืคืงืขื not in force500Patentsืคืื ืื๏ฟฝ ืฉืืืืฉื ืืขืฉืจื๏ฟฝ ืฉื ื renewed for 20 years
501Extensionืฆืืื ืืืจืื ืฉืืืืฉื orders renewed502Noticesืขืืชืืื
507Corrigendaืชืืงืื ื ืืขืืืืช508Countryืงืืื๏ฟฝ ืืืืื ืืช codes
iIndicesืืคืชืืืช ืืืงืฉืืช ืฉืงืืืื of applications accepted
DESIGNSืืืืื๏ฟฝ510Designsืืืืื๏ฟฝ ืฉื ืจืฉืื registered517Designsืืืืื๏ฟฝ ืฉืืืืฉื renewed518Designsืืืืื๏ฟฝ ืฉืืืืื void
![Page 2: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/2.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 2
ืืืืขืืช ืืืืืืช
ืื' ืืื, ืืกืืืื, ืืืชืืื :ืืขื ืืื ื ืคืื ืืื ืืืืืืื ืืฉ ืืฉืืื ืืจืืฉืืื, ืืืื,5ืื ืื, ืืจืืฉืืื, ืื ืื ืืื ืืืืืืื, ืจืฉื ืืคืื ืืื ืืืืืืืื
ืคืชืืื ืืจืืฉืืื ืืืื, ืืืื,5ืื ืื, ืืฉืืช ืืคืื ืืื ื ืืฆืืช ืืื ืื ืืื ืืืืืืื ืืจืืฉืืื.12:30-ื 8:30ืืฆืืืืจ ืืืื ืืื ืฉืืื ื ืขืจืื ืฉืืช ืื ืืืขื ืืื ืืฉืขืืช
ืื 2.50ืืฉืืช ืืคืื ืืื ืืกืคืงืช ืชืฆืืืืื ืฉื ืคืืจืืืื ืืฉืจืืืืื ืืืืืจ ืฉื ืฉืงืืื ืืขื.ืขืืื ืื ืืืง ืืื ื
' ืืืจืืช ืืืฉืืช ืืคืื ืืื ืืชืงืืืืช ืื ืืจืง ืขื ืืื ืชืฉืืื ืืืฉืืื ืืืฉืื ืืื ืง ืืืืืจ ืืกื ืงืืืช ืื ืง ืืืืืจ ืืืฉืื ืืื ืขื ืืืงืฉื ืืคืขืืื ืฉืขืืืจื ืืืืจื ืืฉ ืืืฆื. 0-24145-2
.ืฉืืืื
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:The Commissioner of Patents and Designs, Jerusalem Technology Park, Building 5, Malcha,Jerusalem
The Patent Office is located at Jerusalem Technology Park, Building 5, Malcha, Jerusalem andis open to the public on weekdays, except on Fridays or on the eves of holydays, from 08:30 to12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of theOffice, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office togetherwith the application for the action for which the fee has been paid.
ืืืืช ืืืืฆืจืื ืืชืงืฆืืจืื ืืื ืฉืืืจืืืช, ืืืืื ืช ืืฉืจืื ืืื ืืืขืชืืง
ืงืฆืืจืื.ืืื ืืื ืืจืฉืืช ืืฉืืช ืืคืื ืืื
Copyright by the State of Israel. NoExtracts may be published except with thepermission of the Patent Office.
ื(ืืื ืืืืจืช ืืืืืช: ืืืืจ Price.96โช.)ื.ืข.ืืืื per single issue (incl. VAT) : NIS 96.
ื(ืืื ืืชืืื ืืฉื ื Annual.โช 1,152.)ื.ืข.ืืืื subscription (incl. VAT):NIS 1,152.
:ืืคืฉืจ ืืืฉืื ืืฆืื, ืฉืจืืช ืืืคืฆื ืฉื ืคืจืกืืื ืืืืฉืื ' ืจืืื
.ืืืื-ืชื, ืืงืจืื,29' ืืก
Available at the Distribution Service ofGovernment Publications, 29 B-Street,Hakirya, Tel-Aviv.
![Page 3: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/3.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 20093
ืืืืง ืืคืื ืืื16ืืืืขื ืืคื ืกืขืืฃ 1967-ื"ืชืฉื
NOTICE UNDER SECTION 16 OF THEPATENTS LAW, 5727-1967
ืืืื ืจืฉืืืช ืืงืฉืืช ืืืฉืืช ืืืจ ืืืจืืฉืืช ืฉื ืงืืขืืืืืืืืช
,ืืชืงื ืืช ืืคืื ืืื)ื(32ืืชืงื ื:1968โื"ืชืฉื
In the following there are listed newApplications complying with theProvisions of rule 32(a) of the PatentRegulations, 5728-1968
ืคืจืื ืืืงืฉืืช ืืืืืื ืืคื:ืกืืจ ืื
Particulars of the applications aregiven in the following order:
ืืชืืจืื ืืืฉืชืโ ืืกืคืจ ืืืงืฉื ืืืจืืขื ืืกืื ืื ืืจืืฉืื ืื ืฉื
ืืกืืืื ืืืื ืืืืื
Number and date of applicationAnd the first four symbols of theInternational Classification
ืข( ืฉื ืืืืฆืื ื"ืืคื ืฉืืืฆืข)ืืืืงืฉ
Title of invention(as proposed by applicant)
Applicant ืืืืงืฉ
โืืืื ืช ืืืืืื: ืืื ืงืืืื ืชืืจืื ืืืกืคืจ ืืงืฉืช ืืืืฅ
Priority right: Convention country โNumber and date ofForeign application
International ืืกืคืจ ืืงืฉื ืืื ืืืืืืช Application Number
International ืืื ืืืืืืคืจืกืื' ืืก Publication Number
![Page 4: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/4.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 4
)2009.01 (G09B19092717/04/2008
ืฉืืื ืืืจืืื ืืคืฆืื ืืืื ืืืืจ ืืืฆืืจืชืืฉืคืขื ืจืืฉืืช ืืื ืืืืืช ืืขืจืื
ืืืืืืช ืืืืืจืื ืืืืฉืื ืืฉืืื ืืืืืจื
METHOD OF ARRANGING OBJECTSIN A ROOM TO CREATE EMOTIONALAND MENTAL EFFECTS AND KIT OFACCESSORIES FOR IMPLEMENTINGTHE METHOD
MICHAL ืืืื ืืืจ OR
)2009.01 (F41H19289417/07/2008
ARMOR ืืื ืืืืื PANELPLASANื"ืคืืกื ืกืืกื ืืข SASA LTD.
)2009.01(G08B19291720/07/2008
METHOD ืืขืจืืช ืืฉืืื ืืืงืจืช ืืืืืืช AND SYSTEM FORBORDER CONTROL
VERINTื"ืืจืื ื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (G08C19291820/07/2008
ืืขืจืืืช ืืฉืืืืช ืืืืืื ืืกืืคื ืชืงืฉืืจืชืืืืืืืื ืขื ืืื ืืื ืจืื ืืขืืจืช ืืืืข
ืขื ืืจืฅ ืืืงืืจ
SYSTEMS AND METHODS FORVERIFICATION OF WIRELESSTERMINALS ON BOARD VEHICLESUSING CONTRY-OF-ORIGININFORMATION
VERINTื"ืืจืื ื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (G01S19320403/08/2008
LASERื ืืืืืจ"ืืขืจื ืื RADAR ARRAYืืืคืืืงื-ืืืืื ืืขืจืืืช ืืืงืืจื
ื"ืืืืืค ืืขELBIT SYSTEMS ELECTRO-OPTICALELOP LTD.
![Page 5: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/5.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 20095
)2009.01 (G08B19344013/08/2008
ืืขืจืืืช ืืฉืืื ืืืืืืช ืืืืจ ืขืืื ืืืืืก
SYSTEM AND METHOD FORBOARDING AREA SECURITY
VERINTื"ืืจืื ื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (G02F19389704/09/2008
ืกืืืืจืืช ืืืฉืืืืขืจืืช ืืืืจืช ืงืจืื ืA SYSTEM FOR CONVERTINGSOLAR RADIATION INTOELECTRICITY
TENEื"ืื ื ืกืืืืจ ืืข SOLAR LTD
)2009.01 (F41B19466412/10/2008
ืืขืจืืช ืืืจืื ืืืืื ืืกืคืจ ืืืืจืืื ืงืื ืื
AN INTERCEPTION SYSTEM THATEMPLOYS MINIATURE KILLVEHICLE
ืืขืืชืขืฉืืื ืืืืืจืืช ืื ISRAELื"ืฉืจืื AEROSPACE INDUSTRIESLTD.
)2009.01 (C07K19494022/05/2008
PROTEIN ืืืืงืช ืืืืื ASSAYOMRIX BIOPHARMACEUTICALS INCDELAWARE CORPORATION OF
PCT/US/2008/064514
)2009.01 (F41B19517109/11/2008
ืืจืืื ืืขืจืืช ืืืจืื ืืืืื ืืกืคืจ ืื ืงืื ืื
AN INTERCEPTION SYSTEM THATEMPLOYS MINIATURE KILLVEHICLES
ISRAELื"ืืชืขืฉืืื ืืืืืจืืช ืืืฉืจืื ืืข AEROSPACE INDUSTRIESLTD.
12/10/2008194664IL
![Page 6: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/6.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 6
)2009.01 (C07K19517514/12/2007
ืชืืืื ืืืืฆืืจ ื ืชืจื ืืืคืจืชื ืืืื ืืืื ืืืืจืืงืกืืื
PROCESS TO PRODUCE SODIUMSULFATE AND MAGNESIUMHYDROXIDESERVICIOS INDUSTRIALES PENOLESS.A. DE C.V.
PCT/MX/2007/000153WO/2009/078690
)2009.01 (C12N19532406/12/2007
ืคืืกืื ืืฉืืืืฉ/ื ืืกืจืื"ืจื โืืืงืจื ืืื
SERUM/PLASMA MICRORNAS ANDUSES THEREOF
JIANGSU MINGMA BIOTECH CO, LTD02/11/2007200710134620.4CN
PCT/CN/2007/003463
)2009.01 (G01R19538919/11/2008
A ืืขืจืืช ืืฉืืื ืืืืคืื ืฉืื ืืื ืื SYSTEM AND A METHOD FORMAPPING A MAGNETIC FIELD
ELBITื"ืืืืื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (H04L19588411/12/2008
ืืื ืืืืืื ืืืงืืช ืชืขืืืช ืชืงืฉืืจืช ืืืื ืืช ืืจืฉืช ืชืงืฉืืจืช ืฆืืืืจืืช ืืื ืืืื
TECHNIQUE FOR PROVIDINGSECURED TUNNELS IN A PUBLICNETWORK FORTELECOMMUNICATIONSUBSCRIBERS
ืืข. ืืื.ืกื. ืื ECIื"ืืืงืื TELECOM LTD.
![Page 7: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/7.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 20097
)2009.01 (B64C19597716/12/2008
ืืื ืืืืืจื ืื ืืืืืฉ ืืขื ืชืฆืืจื ืืืจืืืื ืืืืช ืืฉืืคืจืช
UNMANNED AERIAL VEHICLEHAVING AN IMPROVEDAERODYNAMIC CONFIGURATION
ISRAELื"ืืชืขืฉืืื ืืืืืจืืช ืืืฉืจืื ืืข AEROSPACE INDUSTRIESLTD.
)2009.01 (H01S19610222/12/2008
LASER ืืืืื ืืืืืืช ืืืืืจ BEAM UNIFICATION
RAFAELื"ืจืคืื ืืขืจืืืช ืืืืื ืืชืงืืืืช ืืข ADVANCED DEFENSESYSTEMS LTD.
)2009.01 (H04B19614623/12/2008
โืืขืจืืช ืชืงืฉืืจืช ืืืืืืืืช ืจืืจื ืืืจืงืืืืืช ืืฉืืื ืืื
DIGITAL RETRO-DIRECTIVECOMMUNICATION SYSTEM ANDMETHOD THEREOF
ELTAื"ืืืชื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (H04Q19615024/07/2007
ืขืจืืฅ ืฉืืืื ืืฉืชื ื ืขืืืจ ืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
VARIABLE CONTROL CHANNEL FORA WIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED
24/07/200660/832487US24/07/200660/633054US
PCT/US/2007/074246WO/2008/014275
)2009.01 (C02F19623128/12/2008
ืฉืืืืช ืืืชืงื ืื ืขืืืจ ืืฆืืจืช ืื ืจืืื ืขื ืืืืื ื ืืื
METHODS AND DEVICES FOR LOWCONTAMINATION ENERGYGENERATIONCLEAN MARINE
![Page 8: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/8.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 8
)2009.01 (G06F19627630/12/2008
ืืขืจืืช ืืฉืืื ืื ืืืื ืขืฆืืื ืืคืืืคืืจืื ืชืืจืืืืจืช
AUTONOMOUS NAVIGATIONSYSTEM AND METHOD FOR AMANEUVERABLE PLATFORM
ELBITื"ืืืืื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (H01H19637307/01/2009
DEFENSE ืืืืช ืืื ื ืืคื ื ืืจื ืืืชืจืื ืงืฆืจื WALL AGAINST SHORTNOTICE SHOOTING
BARAM ืืจืขื ืขืื AMI
)2009.01 (A61K19637507/01/2009
ืชืืฉืืจืื ืืืืืืจ ืืืืจืื ืืืืืืืฉืืืืฉ ืืชืืฉืืจืื ืืื, ืืืืืืืืืื
ืืืืฉืืจ ืืืื ืชื ืืืฉืืืืฉ ืืื
COMPOSITIONS FORDECONTAMINATING HAZARDOUSCHEMICAL AND BIOLOGICALCOMPOUNDS, METHODSEMPLOYING SAME AND SYSTEMSFOR PREPARING SAME
ISRAEL ืงืจ ืืืืืืื ืืืฉืจืืืืืืื ืืื INSTITUTE FORBIOLOGICAL RESEARCH
)2009.01 (H04B19639808/01/2009
UWB(ULTRA(ืจืื ืกืจืโืืงืื ืืืืืจื WIDEBAND RECEIVERELBITื"ืืืืื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (H04Q19640608/01/2009
A ืฉืืื ืื ืืืืจ ืจืฉืชืืช ืืืฉื METHOD FOR MONITORINGACCESS NETWORKS
ืืข. ืืื.ืกื. ืื ECIื"ืืืงืื TELECOM LTD.
![Page 9: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/9.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 20099
)2009.01 (C07K19642324/07/2007
ื IAPDIMERICืื ืืืื ืืกืืื ืืืืจืืื IAP ANTAGONISTSTETRALOGIC PHARMACEUTICALSCORPORATION
24/07/200660/820156USPCT/US/2007/074225WO/2008/014263
)2009.01 (A61K19642918/07/2007
ืืื ืืืืืื ืชืืืืืืช ืืืืืจืช ืคืืืืืจืืืกืืืจื ืื ืฉืขืืจื ืืจืืืื ืฆืื ืืชืขืจืืืืช
ื ืื ืืืคืืืช/ืืจืืืงืฆืืืช ืืื ื ืืฆืจื ืืจืืจืื ืื ืื ืืืืืืช, ืืชืขืจืืืืช ืืืืืืืช
PROCESS TECHNOLOGY FORRECOVERING BROMINATEDSTYRENIC POLYMERS FROMREACTION MIXTURES IN WHICHTHEY ARE FORMED AND/ORCONVERTING SUCH MIXTURESINTO PELLETS OR INTO GRANULESOR PASTILLESALBEMARLE CORPORATION
20/07/200660/832184US28/11/200660/867548US
PCT/US/2007/073805WO/2008/011477
)2009.01 (F41H19645612/01/2009
UDERBELLY ืืืื ืืจืื ืืฉืืจืื OF ARMORD VEHICLEPLASANื"ืคืืกื ืกืืกื ืืข SASA LTD.
)2009.01 (H01L19645910/07/2007
ืฉืืื ืืืชืงื ืืืงืจื ืขื ืืืืจืืช ืกืืืืื ืฉื ืจืืืืจ ืฉื ืื ืืข ืคืืืืืืืงืืจื
METHOD AND CONTROL DEVICEFOR THE SPEED OF ROTATION OF APIEZOELECTRIC MOTOR ROTORSAGEM DEFENSE SECURITE
13/07/20060606438FRPCT/FR/2007/051635WO/2008/007017
![Page 10: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/10.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 10
)2009.01 (G06F19646312/01/2009
WORKSTATION ืชืื ืช ืขืืืื ืืืงืจืช ืคืืืคืืจืื ืืจืืืงืช FOR REMOTEPLATFORM CONTROL
ELBITื"ืืืืื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (A61K19647412/07/2007
IMPROVED ืชืืืื ืืฉืืคืจ ืืืื ืช ืืืจืืงืื ืืืื PROCESS FOR THEPREPARATION OF VORICONAZOLEMEDICHEM, S.A.
13/07/200660/807275USPCT/IB/2007/004408WO/2008/075205
)2009.01 (H05B19650615/06/2007
THERMAL ืื ืืจืืืื ื ืชืจืืืช ืขืืืจ ืืืืฆืื PROTECTION FOR LAMPBALLASTSLUTRON ELECTRONICS CO., INC.
18/07/200611/489145USPCT/US/2007/071330WO/2008/011238
)2009.01 (E02D19657719/01/2009
UNDERGROUND ืืืกืื ืื ืืจืืช ืชืช ืงืจืงืขื TUNNEL BARRIEROFER ืขืืคืจ ืคืืจืช PORAT
![Page 11: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/11.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200911
)2009.01 (A61K19682520/07/2007
ืชืืฉืืจืื ืืืืฆืจืื ืืฉืืคืืจ ืืืคืื, ืฉืืืืช ืืกืจืื
METHODS, COMPOSITIONS ANDARTICLES OF MANUFACTURE FORCONTRIBUTING TO THETREATMENT OF CANCERSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,
02/08/200611/461961USPCT/US/2007/074036WO/2008/016793
)2009.01 (B60N19683702/02/2009
RASSENGER ืชื ื ืืกืขืื ืืจืื ืืฉืืจืื CABIN FOR ANARMORED VEHICLE
PLASANื"ืคืืกื ืกืืกื ืืข SASA LTD.29/05/2008191807IL
)2009.01 (A61K19684431/07/2007
โืจืขื ืืชืคืงืื ืชืจืืืฉืืื ืืืืคืื ืืืค ืจืืืืืืจื ืืืืฆืขืืช ืคืืจืืงืกืืื
METHOD OF TREATINGTHERMOREGULATORYDYSFUNCTION WITH PAROXETINENOVEN THERAPEUTICS, LLC
04/08/200611/499586USPCT/US/2007/017062WO/2008/019010
)2009.01 (G06F19685502/02/2009
ืืฉืชืืฉ ืืคืืจืื ืืขืจืืช ืืืกืคืงืช ืืืืข20 โSCTEืืืจืืืช ืืืืื ืืืืืืช ืจืง
SCTEโ21ืืืืข ืืฉืชืืฉ ืืคืืจืื
SYSTEM FOR PROVIDING SCTE - 20CLOSED CAPTION WITHIN A VIDEOSTREAM CONTAINING ONLY SCTE -21 CLOSED CAPTION
HARMONICื"ืืจืืื ืืง ืืืืืื ื ืืืืจืงืก ืืข VIDEO NETWORKS LTD.
![Page 12: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/12.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 12
)2009.01 (H04L19685602/02/2009
ืืขืจืืช ืืืกืคืงืช ืชืงืฉืืจืช ืจืืืช ืกืจื ืืื ืชืื ืืช ืงืจืงืขืืืช ืืืืืกืื
SYSTEM PROVIDING BROADBANDCOMMUNICATION BETWEENTERRESTRIAL STATIONS ANDAIRPLANES
ืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืืDEUTSCHE ืืืืงืจ ืืคืืชืื TELEKOM AG
)2009.01 (F42B19688003/02/2009
GRENADE ืื ืื ืื ืจืืืื MECHANISMISRAELื"ืืชืขืฉืืื ืืฆืืืืช ืืืฉืจืื ืืข MILITARY INDUSTRIES LTD.
)2009.01 (B41J19689904/02/2009
ืืืฉืืจ ืืืขืจืืช ืืืืืื ืคืจืืืื, ืฉืืื ืืืกืื ืืืืคืก ืืงืฉืืจืื ืืืืืืงืื ืืืื
METHOD, APPARATUS AND SYSTEMFOR IDENTIFYING ITEMS IN APRINTED DOCUMENT ASSOCIATEDWITH MEDIA OBJECTS
XSIGHTSื"ืืงืกืืืืก ืืืื ืืข MEDIA LTD
)2009.01 (B60J19691605/02/2009
QUICK ืืฆืืื ืืืืจื ืืจืื CAR SUNSHADEOFIR ืืืคืืจ ืืืืจ MAZOR
)2009.01 (G06F19692305/02/2009
ืชืงืฉืืจืช ื ืืืื ืืชืงื ืืืืืช ืืขืจืืฅ ืืืฉืื
CONTROLLING AN IMAGINGAPPARATUS OVER A DELAYEDCOMMUNICATION LINK
ELBITื"ืืืืื ืืขืจืืืช ืืข SYSTEMS LTD.
![Page 13: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/13.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200913
)2009.01 (G08B19693408/02/2009
ืฉืืื ืืืขืจืืช ืืืืืืื ืื ืื ืืืคื ืืข ืืืจืืืจ ืื ืืืฉ ืืืืืชโืืืืื, ืืืคื ืืื
ืืืืืื ืืืืฆืื
METHOD AND SYSTEM FOR SAFETYOF CYCLIST, ROLLER-SKATER OFEMERGENCY SERVICES PRRSON
MINUTIN ืืื ืืืื ืืืื ืื D. LEONID
)2009.01 (F24H19693508/02/2009
MAGNETIC ืืืฃ ืืืืื ืืื ืื ืืฉืืืช ืืืืฆืืจ HEATING ELEMENT &METHOD TO PRODUCE SAME
ืืข.ื .ื.ื D.T.N.Rื"ืจ LTD
)2009.01 (B62K19693608/02/2009
ืืืคื ืืื ืืืืืืื ืืืฉื ืฉื ืืฆืจ ืืืงืืืง ืื ืืชื ืืฉืืืืจ
TOY CYCLE HAVING A SEATFORMED OF A RECYCLABLEBOTTLETOYMONSTER INTELLECTUALPROPERTY LIMITED
06/11/2008195145IL
)2009.01 (F41J19694708/02/2009
ืจื ืขื ืกืื ื ืฉื ืืื ืืขืจืืช ืืฉืืื ืืืื ืืกืืืโืืืื
SYSTEM AND METHOD FORWARNING OF RISK FROM A HIGH -TRAJECTORY PROJECTILE
RAFAELื"ืจืคืื ืืขืจืืืช ืืืืื ืืชืงืืืืช ืืข ADVANCED DEFENSESYSTEMS LTD.
)2009.01 (H01H19695409/02/2009
A ืืืืจ ืืื ืืืข NON-CONTACT CONNECTORCHUBU NIHON MARUKO CO. LTD.
13/08/20082008-208422
JP
![Page 14: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/14.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 14
)2009.01 (G08B19697509/02/2009
POSITION ืืืฉืืจ ืืืืืื ืืืงืื ืืฉืืื ืืืืืื ืืืงืื DETECTING DEVICE ANDPOSITION DETECTING METHODWACOM CO., LTD.
13/02/2008P2008-031857
JP
)2009.01 (H01L19701112/02/2009
A ืงืืจืืช ืืกื ืืขื ืืื ื ืืืคืื ืืืืืื METHOD AND APPARATUS ASTRUCTURED SOLAR SCREEN WALL
SOLARORื"ืกืืืจืืืจ ืืข LTD
)2009.01 (H01H19701212/02/2009
INPUT ืืืฉืืจ ืงืื ืขื ืคืื ืงืฆืืช ืชืฆืืื DEVICE WITH DISPLAYFUNCTIONWACOM CO., LTD.
25/02/2008P2008-043581
JP
)2009.01 (H01H19702912/02/2009
ืืืืฉืช ืคืฆืขืื ืืืืฆืขืืช ืืืคืื ืืคืฆืขืื ืืืืงืื ืขื ืืืืืจื ืืืฆืืข ืืฉืชื ืื
VACUUM WOUND THERAPYWOUND DRESSING WITH VARIABLEPERFORMANCE ZONESTYCO HEALTHCARE GROUP LP
13/03/200812/047910US
)2009.01 (H01H19703012/02/2009
ืคืชืื ืืชืืืืฉืช ืืชืืืืฉืช ืืืชืืืื ืืื
WOUND DRESSING PORT ANDASSOCIATED WOUND DRESSING
TYCO HEALTHCARE GROUP LP07/03/200812/044051US
![Page 15: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/15.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200915
)2009.01 (G02B19703612/02/2009
โืืืื ืืืคืื ืืืืืจ ืืืืื ื ืื ืืจืืืงืืงืื ืืฉืืืช ืืืฆื
AMPLIFIER OPTICAL FIBERCOMPRISING NANOPARTICLES ANDPRODUCTION METHODDRAKA COMTEQ B.V.
12/02/200808/00742FR
)2009.01 (G01S19704415/02/2009
ืฉืืื ืืืืืืช ืืืืจืืช ืจืืืืืืช ืฉื ืืืจื ืขื ืจืืืจ ืืืคืืจ
A METHOD FOR MEASURING THERADIAL VELOCITY OF A TARGETWITH A DOPPLER RADARTHALES NEDERLAND B.V.
22/02/20081035066NL
)2009.01 (A61B19705516/02/2009
AN ืืืฉืืจ ืืืืืื ืฉืชื ืื ืืืื APPARATUS FOR DETECTING ADENTAL IMPLANT
.DRืจ ืจืื ืคืืจืจื"ื REMI PETRARU
)2009.01 (H01H19706416/02/2009
FLOATING ืฆืืืช ืืจืืคืช PLATEYITZHAK ืืฆืืง ืืจืง MARK
![Page 16: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/16.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 16
)2009.01 (H01H19706516/02/2009
ืืืฆืขืื ืืืืืจืช ืฆืืจืช ืืืืื ืฉื ืืฉืืืืขืืืื ื ืืชืื ืืืจืื ืืื ืื ืืืืคืฆืื
ืชืืืื ืืืืฆืืจื ืืืฉืืืืฉ ืืื, ืืืืืืืืืืคืื ืืื ืืขื ืฉื ืืคืจืขืืช ืคืชืืืืืืืช
ืช โืืื ืืช ืืืืืืคืกืืืืืืืืืช ืืืฉืืคืืจ ืคืืืืงืืืืช
MEANS FOR INSERTION OFEXPRESSION OF HIGHERSUPERVISION INTO LIVINGORGANISM AND INANIMATEOBJECTS, A PROCESS FOR THEMANUFACTURE THEREOF ANDTHEIR USE IN THE TREATMENT ANDPROPHYLAXIS OF PATHOLOGICALAND PSYCHOLOGICAL DISORDERSAND IMPROVEMENT OF CHEMO-PHYICAL PROPERTIES
ADI ืขืื ืืืื LAVIT
)2009.01 (E02B19706616/02/2009
SYSTEM ืืขืจืืช ืืฉืืื ืืืืืืจ ืืื AND METHOD FORRECYCLING WATER
YUVAL ืืืื ืื YAM
)2009.01 (B62J19707717/02/2009
ืขืืื ืขืืืจ ืฉืขืจ ืชืืืื ืฉื ืืชื ืืืืืงื ืขืืืจ ืืฆืืจืืืชืืืื
TROLLEY FOR A SLIDABLECANTILEVER GATE AND PROCESSFOR ITS MANUFACTUREFRATELLI COMUNELLO S.P.A.
12/06/200808425418.4EP
)2009.01 (B32B19708117/02/2009
, ืฆืืคืื ืกืืคื ืงืจืื ื ืืืืคื ืืจืจื ื ืฉืคืืคืจืช ืกืืคืืช ืืชืืืื ืืืื ืชื
RADIATION-SELECTIVE ABSORBERCOATING, ABSORBER TUBE ANDPROCESS FOR PRODUCTION THEREOFSCHOTT AG
20/02/2008102008010199.0DE
![Page 17: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/17.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200917
)2009.01 (H01H19708617/02/2009
ืืคืื ืืืืืื ืืขื ืชืืืืช, ืืืืฃ ืคืจืื ืืืืช ืืืืื
FILLED BAKED CRISPY SNACKHAVING A HIGH MOISTURECONTENTKRAFT FOODS GLOBAL BRANDSLLC
29/02/200812/040428US
)2009.01 (G06F19709223/08/2007
ืฉืืืืช ืืืขืจืืืช ืื ืืืื ืืขืจืืืช ืืืืขMETHODS AND APPARATUS FORINFORMATION MANAGEMENTSYSTEMSRAYTHEON COMPANY
24/08/200660/823439US22/08/200711/843266US
PCT/US/2007/076621WO/2008/024900
)2009.01 (H04Q19713420/08/2007
ืชืืืื ืืกืืืื ืขืืืจ, ืืงืฆืืช ืืฉืื ืืื ืืื LTEโืงืฆื ืฉืืจืืช ืืืืข ืืฉืชื ื
DYNAMIC RESOURCE ALLOCATION,SCHEDULING AND SIGNALING FORVARIABLE DATA RATE SERVICE INLTEINTERDIGITAL TECHNOLOGYCORPORATION
21/08/200660/839110USPCT/US/2007/018440WO/2008/024321
![Page 18: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/18.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 18
)2009.01 (G01H19713616/08/2007
ืฉืืื ืืืขืจืืช ืืื ืืขืช ืืกืืืช ืฉืืืืจHSUPAืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
METHOD AND APPARATUS FORPREVENTING TRANSMISSIONBLOCKING IN AN HSUPA WIRELESSCOMMUNICATION SYSTEMINTERDIGITAL TECHNOLOGYCORPORATION
21/08/200660/839198USPCT/US/2007/018314WO/2008/024289
)2009.01 (H01H19714219/02/2009
ืืืโืืืฉืืจ ืืฉืืืืช ืืืืืื ืืืืจื ื ืคืฅ ืขื ืืืื ืืืื
APPARATUS AND METHODS FORDETECTION OF EXPLOSIVES BY USEOF VAPOUR MARKERSICTS EUROPE HOLDINGS B.V.
)2009.01 (A61K19716015/09/2007
ืงืื ืืืืืื ืคืืืืืจืืื ืืืืืืื ืืืง ืขื ืืืขื ืืืืื
POLYMERIC CONJUGATESCONTAINING A POSITIVELY-CHARGED MOIETYENZON PHARMACEUTICALS, INC.
15/09/200660/844944US15/09/200660/844945US27/11/200660/861349US27/11/200660/861350US13/04/200760/911734US20/08/200760/956814US
PCT/US/2007/078598WO/2008/034123
![Page 19: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/19.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200919
)2009.01 (A61K19716122/08/2007
ืื ืืืืืื)ืืืืฆืืงืืืืืงืืโN(โ4ื ืืืจืืช ืืชืืฉืืจืื ืืืืืืื ืืืชื
DERIVATIVES OF 4-(N-AZACYCLOALKYL)ANILIDES ANDCOMPOSITIONS CONTAINING THESAMEVALEANT PHARMACEUTICALSINTERNATIONAL
23/08/200660/839941USPCT/US/2007/018571WO/2008/024398
)2009.01 (B01D19716222/08/2007
ืคืืจืืง ืชืจืื ืฉื ืฉืชื ื ืืืจื ืฆืืื ืฉื ืืืืขืืจื ืืืจืืื ืืืืฆืขืืช ืืืืืฃ ืืื
ืืืืฉ
THERMAL DECOMPOSITION OFUREA IN A SIDESTREAM OFCOMBUSTION FLUE GAS USING AREGENERATIVE HEAT EXCHANGERBABCOCK POWER, INC.
22/08/200660/839364USPCT/US/2007/018515WO/2008/024367
)2009.01 (E02D19716324/08/2007
SYSTEM ืืขืจืืช ืฉื ืืื ื ืขื ืืื ืืืืืืง ืงืืจ OF BRICK WITH ROD FORRATAINING WALLMARTINEZ NARANJO, JHON JAIRO
24/08/200606083678COPCT/IB/2007/002520WO/2008/023262
)2009.01 (A45D19716523/08/2007
A ืืกืจืง ื ืื ืืื ืื LICE COMBSCHWARTZ, DAVID JACOB
23/08/20062006904564AUPCT/AU/2007/001202WO/2008/022387
![Page 20: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/20.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 20
)2009.01 (G02C19716723/08/2007
SYSTEM ืืขืจืืช ืืฉืืื ืืืืืื ืืืจ ืืจืจื ื AND METHOD FORSELECTIVE LIGHT INHIBITIONHIGH PERFORMANCE OPTICS, INC.
23/08/200660/839432US01/09/200660/841502US28/11/200660/861247US
PCT/US/2007/018593WO/2008/024414
)2009.01 (G06F19716822/02/2009
ืืขืจืืช ืืฉืืื ืืืืืื ืคืืืฉืืช ืขืชืืืืืช ืืื ืืฉืชืืฉืื ืืชืงืฉืืจืช ืืืืืืืช
SYSTEM AND METHOD FORPREDICTING FUTURE MEETINGS OFWIRELESS USERS
VERINTื"ืืจืื ื ืืขืจืืืช ืืข SYSTEMS LTD.
)2009.01 (A61K19716924/08/2007
ื ืืืืฆืืจ ืฉื ืชืจืืคืFGFโ18ืฉืืืืฉ ืืืืคืื ืืืคืจืขืืช ืกืืืก
USE OF FGF-18 IN THEMANUFACTURE OF A MEDICAMENTFOR TREATMENT OF CARTILAGEDISORDERSARES TRADING S.A.
25/08/200606119557.4EP28/08/200660/840600US
PCT/EP/2007/058830WO/2008/023063
)2009.01 (B67C19717021/08/2007
DEVICE ืืชืงื ืืืคืืื ืฉื ืืืืืื FOR OVERTURNINGCONTAINERSARES TRADING S.A.
23/08/2006P200602238ISPCT/EP/2007/058664WO/2008/023010
![Page 21: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/21.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200921
)2009.01 (G02B19717122/02/2009
APPARATUS ืืชืงื ืืคืืฆืื ืงืจื ืืืจ FOR SPLITTING A LIGHTBEAMLIMO PATENTVERWALTUNG GMBH&CO. KG
21/02/2008102008010382.9DE
)2009.01 (H04L19717220/08/2007
ืฉืืื ืืืขืจืืช ืืืงืฆืื ืืืืคื ืืื ืื ืฉื ืืงืฉืจ ืขื ืืืืืืHARQืชืืืืื
METHOD AND APPARATUS FORDYNAMICALLY ALLOCATING HARQPROCESSES IN THE UPLINKINTERDIGITAL TECHNOLOGYCORPORATION
21/08/200660/839172US13/10/200660/829457US30/10/200660/863543US01/12/200660/868185US
PCT/US/2007/018474WO/2008/024340
)2009.01 (H04W19717309/08/2007
โืชืืื ืืฉืืจืืชืื ืจืืโืงืืืืจืืื ืฆืื ืจืืชืืขื ืฉื ืฉืืืืจื ืืืืืืืืื ืืืขืจืืช
ืชืงืฉืืจืช ืืืืืืืช
MULTI-CELL COORDINATION FORMULTIMEDIA BROADCASTMULTICAST SERVICES IN AWIRELESS COMMUNICATIONSYSTEMINTERDIGITAL TECHNOLOGYCORPORATION
21/08/200660/839196US08/08/200760/954620US
PCT/US/2007/017712WO/2008/024214
![Page 22: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/22.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 22
)2009.01 (B64C19717424/08/2007
HTAL(HIGH(ืืขืืืช ืืืืืจืืช ืืคืืชืื ืืืื TORQUE AERIAL LIFT (HTAL)AMERICAN DYNAMICS FLIGHTSYSTEMS, INC.
24/08/200660/839774US08/08/200760/954684US08/08/200760/954685US
PCT/US/2007/076754WO/2008/105923
)2009.01 (C02F19717511/07/2007
ืฆ ืืื ืคืืจืืืืฆืืช ืืื ืขื ืงืืฆืืฅ ืืชืืืื ืืืื ืชื
WATER FORMULATION WITH HERBALHINT AND A PROCESS THEREFORCENTURY BIOLOGICALS PRIVATELIMITED
23/08/20061495/CHE/2006INPCT/IN/2007/000287WO/2008/023387
)2009.01 (G01N19717623/02/2009
NEW ืืขืจืืช ืืืืืช ืืจื ืืื ืืืฉื HEAT FLOW MEASURINGSYSTEM
.DRืจ ืืืื ืืืืื ืกืงื"ื YULI LOZINSKI
)2009.01 (G01N19717723/02/2009
HEAT ืืืืฉื ืืจื ืืื FLOW SENSOR.DRืจ ืืืื ืืืืื ืกืงื"ื YULI LOZINSKI
)2009.01 (A61C19717823/02/2009
DENTAL ืฉืชื ืื ืืื IMPLANT.DRืจ ืืืื ืืืืื ืกืงื"ื YULI LOZINSKI
![Page 23: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/23.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200923
)2009.01 (G02B19717924/07/2007
ืืืคืืโืืืฃ ืชืืืจื ืืืืื ืืชื ืืืงืืจื"ืคืืืื ื"ืืืจืจ
LIGHT INCLUDING AN ELECTRO-OPTICAL "PHOTONIC" SELECTORSWITCHSTREAMLIGHT, INC.
23/08/200611/508383USPCT/US/2007/074158WO/2008/024582
)2009.01 (F41H19718023/02/2009
GUNNER ืืืช ืืืจืื PLATFORMPLASANื"ืคืืกื ืกืืกื ืืข SASA LTD.
)2009.01 (C10B19718129/08/2007
ืกืืืจืืช ืืืืจื ืฉื ืืกืโืืืจื ืชืจืืืช ืืืืืืืืช ืืื
RAPID SOLAR-THERMALCONVERSION OF BIOMASS TOSYNGASTHE REGENTS OF THE UNIVERSITYOF COLORADO A BODYCORPORATE
29/08/200660/823872USPCT/US/2007/077134WO/2008/027980
)2009.01 (H04L19718223/08/2007
ืืชืืืื ืืชืงืฉืืจืชMIMOืืฉืืจ ืืืงืื ืืืืื ืืช ืฉื ืืืืืช ืงืืืื ืืขืจืืฅ ืืื
MIMO TRANSMITTER ANDRECEIVER FOR SUPPORTINGDOWNLINK COMMUNICATION OFSINGLE CHANNEL CODEWORDSINTERDIGITAL TECHNOLOGYCORPORATION
24/08/200660/823484USPCT/US/2007/018727WO/2008/024462
![Page 24: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/24.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 24
)2009.01 (G08B19718323/02/2009
ืืืืืโืฉืืื ืืืชืงื ืืชืื ืื ื ืชืื ืชืืชืืื ืืขืช ืืืฉืืืื ืืืฉืชืืฉืื ืืืืฉืืจืื
ืืจืืืื
METHOD AND DEVICE FOR THREE-DIMENSIONAL PATH PLANNING TOAVOID OBSTACLES USINGMULTIPLE PLANESHONEYWELL INTERNATIONAL INC.
10/03/200812/045449US
)2009.01 (B32B19718410/09/2007
ืืืืจืื ืืจืืืืื ืืืืกืืืื ืืขืื ืืืฆืืข ืืจืืืืื ืืืืืฉืืช ืืฉืืคืจืช ืืฉืืื ืืืฆ
HIGH PERFORMANCE BALLISTICCOMPOSITIES HAVING IMPROVEDFLEXIBILITY AND METHOD OFMAKING THE SAMEHONEYWELL INTERNATIONAL INC.
12/09/200660/843868US28/06/200711/823570US
PCT/US/2007/078012WO/2008/097355
)2009.01 (A61K19718524/08/2007
ืื ืืืืืื ืืืชืืจืื ืืฉืืืืชโืืฆืื ืืฉืืืืฉื
SUBSTITUTED ACYLANILIDES ANDMETHODS OF USE THEREOFUNIVERSITY OF TENNESSEE RESEARCHFOUNDATION
24/08/200660/839665US28/08/2006PCT/US2006/033490US28/08/200611/510844US16/04/200760/907749US
PCT/US/2007/018686WO/2008/024456
![Page 25: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/25.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200925
)2009.01 (A21D19718614/08/2007
ืฉืืื ืืืื ืช ืขืืื ืชืื ืฉืืืืฉ ืืชืกืก ืฉืืื ืืจืื ื
METHOD OF PREPARING A CAKEUSING PHOSPHOLIPASE
PURATOS NV28/08/200606119649.9EP
PCT/EP/2007/058418WO/2008/025674
)2009.01 (C01D19718721/08/2007
ืืชืงื ืื ืืฉืืืืช ืืืืจืืช ืจืืืื ืคืืื ืื ืืืฆื ื ืื ืืื
METHODS AND APPARATUSES FORDECREASING THE CO2CONCENTRATION OF A FLUID
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
29/08/200660/840708USPCT/IL/2007/001039WO/2008/026201
)2009.01 (A61K19718814/08/2007
ืืืคืื ืืืืืืืื ืืืงืืืงืืจืืืืืื ืืืืฆืขืืช ืฆืืงืืืคืืกืืื ืื
TREATING MYCOBACTERIALINFECTIONS WITH CYCLIPOSTINS
SANOFI AVENTIS29/08/200606017963.7EP
PCT/EP/2007/007159WO/2008/025449
)2009.01 (A61K19718914/08/2007
METHODS ืฉืืืืช ืืืืจืืช ืจืืืช ืืืืืงืื OF LOWERING GLUCOSELEVELSSANOFI-AVENTIS DEUTSCHLANDGMBH
28/08/200660/840850USPCT/EP/2007/007160WO/2008/025450
![Page 26: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/26.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 26
)2009.01 (A61K19719024/08/2007
ื ืจืืงืืืช ืืฉืืืืช ืืขืืช ืคืืจืืืืฆืืฉืืจืืจ ืืืืงืจ ืืืืืื ืืืืืืจืืคืืจืืืืืืืืกืื ืชืขืืืช ืกืืื ืืืขืืื ืจืืืงืืื
COAโHMG
COMBINED PHARMACEUTICALFORMULATION WITHCONTROLLED-RELEASECOMPRISING DIHYDROPYRIDINECALCIUM CHANNEL BLOCKERSAND HMG-COA REDUCTASEINHIBITORSHANALL PHARMACUETICAL CO.,LTD
24/08/200610-2006-0080694
KR
24/08/2007 10#2007#0085480 KR
PCT/KR/2007/004079WO/2008/023958
)2009.01 (F24F19719127/08/2007
ืืขืจืืช ืืฉืืื ืืฉืืืื ืืืืืช ืืื ืื ืืืSYSTEM AND METHOD FORMANAGING WATER CONTENT IN AFLUIDADIR SEGAL, LTD
25/08/200660/840312USPCT/IB/2007/004333WO/2008/053367
)2009.01 (C07C19719217/08/2007
PREPARATION ืืื ืช ืืงืืืืืืคื ืื ืืชืื OFDECAHALODIPHENYL ETHANEALBEMARLE CORPORATION
29/08/200660/823862USPCT/US/2007/076166WO/2008/027737
![Page 27: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/27.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200927
)2009.01 (A45D19719323/08/2007
A ืืกืจืง ื ืื ืืื ืื LICE COMBSCHWARTZ, DAVID JACOB
24/08/20062006904605AUPCT/AU/2007/001201WO/2008/022386
)2009.01 (A01N19719415/08/2007
METHOD ืฉืืื ืืืคืืชืช ื ืืง ืืชืื ืขืฆื OF REDUCING NEURONALCELL DAMAGETHE UNIVERSITY OF MONTANA
23/08/200660/839974USPCT/US/2007/076034WO/2008/024660
)2009.01 (A61K19719523/08/2007
ืชืฆืืืืื ืฉื ืคืคืืืืื ืืืืืืื ืจืฆืฃRGDืืืืจืืคืื) ืืงืืจืื(ืืคืืจืคืืจืื ืื
ืคืืืืกืื ืชืกืืืืจืื ืืฉืืืืฉื
CONJUGATES OF RGD PEPTIDESAND PORPHYRIN OR (BACTERIO)CHLOROPHYLLPHOTOSYNTHESIZERS AND THEIRUSES
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
23/08/200660/839409USPCT/IL/2007/001055WO/2008/023378
)2009.01 (G08B19719623/02/2009
ืืืืื ืืืื ืืช ืืืืฆืขืืช ืฉืืืืฉ ืืืืืื ืืจืงืื ื ืกืชืจืื ืืืคืจืืคืื ืืฉืชืืฉ
INTENTION PREDICTION USINGHIDDEN MARKOV MODELS ANDUSER PROFILE
ืืื ืืืจืกืืืช ืื ืืืจืืื ืื ืื ืืจืฉืืช ืืืืงืจ ืืคืืชืื
BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
![Page 28: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/28.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 28
)2009.01 (A61K19719711/09/2007
โืชืืืืืช ืืืงืกืื ืืื ืืกืืื ืื ืื ืื ืกืจืื ืืื
OXINDOLE DERIVATIVES ASANTICANCER AGENTS
F. HOFFMANN-LA ROCHE AG21/09/200660/846201US
PCT/EP/2007/059489WO/2008/034736
)2009.01 (A61F19719822/08/2007
DEVICES ืืช ืืฉืื ืื ืืชื ืืืืช ืืืืืืืืฉืืจืื ืืฉืื AND METHODS FORALTERING EATING BEHAVIORSVIP 2 LLC
23/08/200660/839413US24/11/200660/860806US04/06/200760/924867US
PCT/IL/2007/001047WO/2008/023374
)2009.01 (C07K19719905/09/2007
ื ื ืื ืืืืื ืื ืืืจืคืืื ืืืื ืฉื ื ืืืื ืืืืขืฆื ืืงืืืื ืื ืฉืืื ืืฉืืืืช ืืฉืืืืฉ
ืืื
ANTIBODIES TO BONEMORPHOGENIC PROTEINS ANDRECEPTORS THEREFOR ANDMETHODS FOR THEIR USEMEDAREX, INC.
05/09/200660/824596USPCT/US/2007/019652WO/2008/030611
)2009.01 (A01G19720112/09/2007
ืืืืฉื ืืฆื ืขืืืจ ืฉืชืืืื ืืืขืจืืช ืฉืชืืื ืืืืืืช ืืืืฉื ืืฆื ืืกืื ืื
STATE SENSOR FOR PLANTS AND AWATERING SYSTEM COMPRISING ASTATE SENSOR OF THIS TYPERAUMEDIC AG
14/09/2006102006043058.1DEPCT/EP/2007/007947WO/2008/031579
![Page 29: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/29.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200929
)2009.01 (B32B19720224/02/2009
EASY ืฆืืคืื ืงื COATINGSHAY ืฉื ืืืจืืื LURIA
25/06/2008SL001US
)2009.01 (A61B19720303/10/2007
LOCKABLE ืืืืืจ ืื ืืชื ืื ืขืืื JOINTHELMUT FRICKE
06/10/200660/850090US29/05/200760/932127US29/06/200760/963699US
PCT/EP/2007/008582WO/2008/040537
)2009.01 (A61K19720429/08/2007
ืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืชืจืืคื ืืขืืชืืกืืกืืืช ืืืฉื ืืฆืืคืื ืืขื ืฉืืจืืจ ืคืืขื
ืืชืืืื
PHARMACEUTICAL COMPOSITIONSCONTAINING A WEAKLY BASICDRUG AND A TIMED PULSATILERELEASE COATINGEURAND, INC.
31/08/200660/841760US31/08/200660/841893US
PCT/US/2007/077153WO/2008/027993
)2009.01 (B23C19720524/02/2009
CUTTING ืืื ืืืชืื ืืขื ืื ืื ืื ืืืื ืื TOOL HAVINGADJUSTMENT MECHANISM
ISCARื"ืืฉืงืจ ืืข LTD.
![Page 30: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/30.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 30
)2009.01 (E01F19720624/02/2009
ืืืืืจ ืืืจ ืืกืื ืขืื ื ืืชืื ืืืืชืืSERVICEABLE ืืชืืืืงืช ืืืืฉ ROAD STUD
LIRAN ืืืจื ืืืจืื MIZRAHI
)2009.01 (A61K19720722/08/2007
ื, ืืืืจื ืืืืื ืื/ืืืืจืื ื ืื ืืืืืืืืืขืื, ืืชืืืกืืช ืืืืืืืช, ืืืืจืื ืืขืงืจืื
ืืืงืกืืืืชืืืื ื ืืืื ืฉื ืคืจ
AQUEOUS SANITIZERS,DISINFECTANTS, AND/ORSTERILANTS WITH LOWPEROXYGEN CONTENTSOLUTIONS BIOMED, LLC
24/08/200611/510516USPCT/US/2007/018606WO/2008/033206
)2009.01 (A46B19720817/08/2007
ืืืจืฉืช ืฉืื ืืื ืขื ืืืคืื ืืฉืืคืขืื ืืืืคืื ืืืืืืื
TOOTHBRUSH WITH INCLINEDBRISTLED AND POINTES BRISTLES
GABA INTERNATIONAL AG25/08/20061364/06CH
PCT/CH/2007/000405WO/2008/022480
)2009.01 (G07B19720924/02/2009
A ืืืฉืืจ ืืืืจืื ืฉื ืืืฆืจ PRODUCT RATING APPARATUSAND METHOD
LIORืจืืืืืจ ื ื NENER
)2009.01 (G09B19721024/02/2009
CARDBOARD ืืื ืืืืขืืช ืืงืจืืื MADE BULLETINBOARD
,KLEINERื"ืงืืืื ืจ ืืจืืื ืืฆื ืืื ืืืื ืคืืง ืืข MORDECHAI
![Page 31: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/31.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200931
)2009.01 (A61K19721123/08/2007
METHODS ืฉืืืืช ืืืจืืืื ืืืืคืื ืืกืจืื AND COMPOSITIONS FORTREATING CANCERCOUGAR BIOTECHNOLOGY, INC.
25/08/200660/921506USPCT/US/2007/018769WO/2008/024484
)2009.01 (A61K19721223/08/2007
ืฉืืืืช ืืืืคืื ืืกืจืื ืืืืืืืช ืืชืืืืจืืืื, ืืืืืจ ืชืจืืคืชื ื ืืกืฃDืืืืืื
ืืืืืืื ืืืชื
METHODS FOR TREATING CANCERCOMPRISING THE ADMINISTRATIONOF A VITAMIN D COMPOUND ANDAN ADDITIONAL THERAPEUTICAGENT, AND COMPOSITIONSCONTAINING THE SAMECOUGAR BIOTECHNOLOGY, INC.
25/08/200660/934924USPCT/US/2007/018770WO/2008/024485
)2009.01 (C12P19721307/09/2007
13INTERLEUKIN-13โืืืืื ืื ืงืืฉืจื ืืื ืืจืืืืงืื BINDINGPROTEINSABBOTT LABORATORIES
08/09/200660/843249USPCT/US/2007/019660WO/2008/127271
![Page 32: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/32.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 32
)2009.01 (A61K19721424/08/2007
ืฆืืจืืช ืืื ืื ืขืืืืืช ืืฉืืืืฉ ืื ืืืจืฉื ืืืคืืืืืืืืืชื ืคืืื ืืืืืืืช ืืืืืฉ
TAMPER RESISTANT ORALPHARMACEUTICAL DOSAGE FORMSCOMPRISING AN OPIOIDANALGESICPURDUE PHARMA L.P.
25/08/200660/840244USPCT/IB/2007/002515WO/2008/023261
)2009.01 (G09F19721524/02/2009
ืขืโืกืืืืืืฆืื ืฉื ืกืืืื ืื ืจื ื ืงืืืชืืืื ืืฆืืขื ืืืืืืชืง
SIMULATION OF MULTI-POINTGESTURES WITH A SINGLEPOINTING DEVICEAPPLE INC.
26/02/200812/037848US
)2009.01 (H03M19721631/08/2007
ืฉืืื ืืืขืจืืช ืืืขืืจืช ืงืืืฅ ื ืชืื ืื ืืจืฉืช ื ืชืื ืื
METHOD AND SYSTEM FORTRANSMITTING A DATA FILE OVERA DATA NETWORKPACBYTE SOFTWARE PTY LIMITED
01/09/200660/824391USPCT/IB/2007/053509WO/2008/026186
)2009.01 (C07K19721716/10/2007
NOVELืืืืคืื ืืกืจืื38CDื ืืืื ืื ืืืฉืื ืื ืื ANTI-CD38 ANTIBODIES FORTHE TREATMENT OF CANCERSANOFI-AVENTIS
19/10/200606291628.3EPPCT/IB/2007/004172WO/2008/047242
![Page 33: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/33.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200933
)2009.01 (A01N19721830/08/2007
ืคืืจืืืืฆืืืช ืืืืืืืช ืืื ืืืงืกืืงืืจื ืืืืืื ืืกืืจืฆืื ืืงืืืืช ืืขืืจ
LOCAL TOPICAL ADMINISTRATIONFORMULATIONS CONTAININGINDOXACARBE.I. DUPONT DE NEMOURS ANDCOMPANY
01/09/200660/841846USPCT/US/2007/019096WO/2008/030385
)2009.01 (A61K19721924/08/2007
ืืืื ืืื ืขื ืคืืืืืจ ืืืืื ืื ืืจืฆืคืืืจืื ืคืจืืคืจืืืื ืฉื ืื ืืืืืืืคืื
FLUORINATED LIGANDS FORTARGETING PERIPHERALBENZODIAZEPINE RECEPTORSAUSTRALIAN NUCLEAR SCIENCEAND TECHNOLOGY ORGANISATION
24/08/20062006904617AU22/12/20062006907288AU
PCT/AU/2007/001216WO/2008/022396
)2009.01 (C07K19722027/08/2007
PROTEIN ื ืืงืื ืืืืื ืื PURIFICATIONARES TRADING S.A.
28/08/200606119611.9EP06/09/200660/842542US
PCT/EP/2007/058887WO/2008/025748
![Page 34: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/34.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 34
)2009.01 (C07K19722127/08/2007
PROTEIN ื ืืงืื ืืืืื ืื PURIFICATIONARES TRADING S.A.
28/08/200606119610.1EP06/09/200660/842682US
PCT/EP/2007/058886WO/2008/025747
)2009.01 (A61L19722223/08/2007
ืคืืกืคืื ืืคืืืื ื ืงืืืื ืืขืโืืืง ืกืืื ืกืคืืื ืืืืจืช ืืืืื
MACROPOROUS AND HIGHLYRESORBABLE APATITIC CALCIUM-PHOSPHATE CEMENTUNIVERSITE DE NANTES OF
24/08/200606291352.0EP24/08/200660/839697US
PCT/IB/2007/002422WO/2008/023254
)2009.01 (H04L19722328/08/2007
ืืืืืืื ืืฉืืืืืIMSืฉืืจืืชื ืืืชืืช ืืืขืื ืืืืืืช ืืจืืืื
UNIFIED IMS SUPPLEMENTARYSERVICES SIGNALING ACROSSCIRCUIT AND PACKET DOMAINSLUCENT TECHNOLOGIES INC.
31/08/200611/513922USPCT/US/2007/018956WO/2008/027407
)2009.01 (A01N19722423/08/2007
ืชืจืืืืืช ืืฉืืคืจืืช ืืืืื ื ืคืืจืืืงืืงืื ืืืช
PHARMACOKINETICALLYIMPROVED COMPOUNDS
SURFACE LOGIX, INC.24/08/200660/840306US
PCT/US/2007/018784WO/2008/024494
![Page 35: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/35.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200935
)2009.01 (A61K19722523/08/2007
ืืืื ืฆืืืจืื ืืืจืืจืื ืืืฆืงืื ืฉืIVโDPPืืขืืื
SOLID CITRATE AND TARTRATESALTS OF DPP-IV INHIBITORS
PHENOMIX CORPORATION30/08/200660/841097US
PCT/US/2007/018629WO/2008/027273
)2009.01 (A61K19722604/09/2007
ืคืขืื ืขื ืื ืื ืืโืืชืงื ืืื ืคืืืื ืื ืฉืืจืืจ ื ืขืืื ืืืืืืื
DISPOSABLE INFUSION DEVICEWITH AUTOMATIC UNLOCKINGMECHANISMCALIBRA MEDICAL, INC.
06/09/200611/516812USPCT/US/2007/019343WO/2008/030462
)2009.01 (A61M19722704/09/2007
ืืืืชืงื ืื ืคืขืื ืขื ืืืืจ ืืืืจโื ืคืืืื ืืชืงืคื
DISPOSABLE INFUSION DEVICEWITH AIR TRAPPING COLLAPSIBLERESERVOIRCALIBRA MEDICAL, INC.
06/09/200611/516467USPCT/US/2007/019342WO/2008/030461
)2009.01 (B25D19722801/08/2007
WALLBOARDืจืืกืืื ืืืคืืื ืขื ืคืืืฉ ืคืืืื TAPING KNIFE WITHPOLYMERIC HAMMERUNITED STATES GYPSUM COMPANY
25/08/200611/510452USPCT/US/2007/017183WO/2008/027149
![Page 36: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/36.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 36
)2009.01 (B32B19722926/09/2006
MOLDABLE ืืืืื ืืืโืืจืื ืื ืืชื ืืขืืฆืื ืขื ืืืืื ืื FABRIC WITHUNIDIRECTIONAL YARNSMILLIKEN & COMPANY
11/09/200611/519134USPCT/US/2006/037572WO/2008/054372
)2009.01 (C07D19723011/09/2007
ืฉืืื, ืืืืืื ืืืชืืจืื ืืกืืืืืื ืืืื ืชื ืืฉืืื ืืฉืืืืฉ ืืื
CERTAIN SUBSTITUTED AMIDES,METHOD OF MAKING, AND METHODOF USE THEREOFCGI PHARMACEUTICALS, INC.
11/09/200660/843959USPCT/US/2007/078181WO/2008/033854
)2009.01 (C07D19723111/09/2007
ืชืืืืืช ืคืืจืืืืืื ืืืช ืืฉืืืืฉื ืืืขืืื ืงืื ืื
PYRIMIDINES DERIVATIVES ANDTHEIR USE AS KINASE INHIBITORS
CGI PHARMACEUTICALS, INC.11/09/200660/843836US
PCT/US/2007/078154WO/2008/033834
![Page 37: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/37.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200937
)2009.01 (C07D19723220/09/2007
ืชืืืืืช ืกืืืคืื ืืืคืืจืืืืืืกืืืคืื ืืืคืืจืืืืืื ืงืจืืืงืกืืืืืื
ื 6Hโืืืื ืืืื ืืกืืื Tโ5
SULFONYLPYRAZOLE ANDSULFONYLPYRAZOLINECARBOXAMIDINE DERIVATIVES AS5-HT6 ANTAGONISTSSOLVAY PHARMACEUTICALS B.V.
22/09/200660/846406US22/09/200606121087.8EP23/02/200760/902865US23/02/200707102965.6EP
PCT/EP/2007/059944WO/2008/034863
)2009.01 (C07C19723328/09/2007
SOLUBLE ืืขืืื ืืคืืงืกืื ืืืืจืืืื ืืกืืกืื EPOXIDE HYDROLASEINHIBITORSARETE THERAPEUTICS, INC.
28/09/200660/848107USPCT/US/2007/079943WO/2008/039999
)2009.01 (G01S19723427/08/2007
POSITION ืฉืืื ืืืืืื ืืืงืื ืืืชืงื ืงืฉืืจ ESTIMATION METHODAND RELATED DEVICEHARRIS CORPORATION
30/08/200611/512535USPCT/US/2007/076866WO/2008/027822
)2009.01 (A61K19723528/08/2007
THERAPEUTIC ืชืืฉืืจืื ืจืคืืืืื COMPOSITIONSACTELION PHARMACEUTICALS LTD.
29/08/2006PCT/IB2006/052999WO19/10/2006PCT/IB2006/053857WO
PCT/IB/2007/053448WO/2008/026156
![Page 38: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/38.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 38
)2009.01 (A61K19723611/09/2007
H1โCAMPATHTREATMENTืืืคืื ืืืจืฉืช ื ืคืืฆื ืขื OF MULTIPLESCLEROSIS (MS)WITH CAMPATH-1HGENZYME CORPORATION
13/09/200660/844251US14/09/200606090169.1US
PCT/EP/2007/008084WO/2008/031626
)2009.01 (A61K19723731/08/2007
ืืื ืืขื ืืืืคืื7Cืฉืืืืฉ ืืกืืืจืื ืืคืืจืช
USE OF C7 SUGARS IN PREVENTIONAND TREATMENT OF MYCOSES
LABORATOIRES EXPANSCIENCE31/08/20060607651FR
PCT/EP/2007/059136WO/2008/025847
)2009.01 (E02D19723817/12/2007
GABION ืคืจืืกืช ืืืืื ืขืคืจ DEPLOYMENTHESCO BASTION LIMITED
02/01/20070700001.1GBPCT/GB/2007/050760WO/2008/081177
)2009.01 (C07C19723906/07/2007
PHENYLOXYANILINE ืชืืืืืช ืคื ืื ืืืงืกืืื ืืืื DERIVATIVESBAYER SCHERING PHARMA AG
04/09/200606018455.3EPPCT/EP/2007/006148WO/2008/028533
![Page 39: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/39.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200939
)2009.01 (A61K19724007/09/2007
ื ืืฉืืืืฉื ืืืืืืWNTโืื ืืืื ืืกืืืWNTืกืืจืื ืืชืืืืโืืืืคืื ืืื
WNT ANTAGONISTS AND THEIR USEIN THE DIAGNOSIS ANDTREATMENT OF WNT-MEDIATEDDISORDERSGENENTECH, INC.
08/09/200660/825063US20/07/200760/951175US
PCT/US/2007/077845WO/2008/031009
)2009.01 (C07K19724119/09/2007
ืชืืฉืืจืื ืืฉืืืืช ืืงืฉืืจืืช ืื ืืืื ืื ืืงืืืื ืืืืงืืืื
COMPOSITIONS AND METHODSRELATING TO GLUCAGONRECEPTOR ANTIBODIESAMGEN INC.
20/09/200660/846202US30/08/200760/968977US
PCT/US/2007/020349WO/2008/036341
)2009.01 (C07D19724227/08/2007
โ)ืืืืืื ืโ2โืคืืจืืืื(โ2ืกื ืชืืื ืฉื ืืื ืืโ7โืืืืคืืจืืื]Dโ3,2[ืคืืจืืื
SYNTHESIS OF 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONESPFIZER PRODUCTS INC.
08/09/200660/843051US05/06/200760/942104US
PCT/IB/2007/002524WO/2008/032157
![Page 40: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/40.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 40
)2009.01 (C07D19724303/09/2007
ืคืืจืืืืืื ืื)Dโ3,2(ืชืจืืืืืช ืคืืจืืื3PIืืฉืืืืฉื ืืืขืืื
PYRIDO (2,3-D)PYRIMIDINONECOMPOUNDS AND THEIR USE AS PI3INHIBITORSPFIZER PRODUCTS INC.
15/09/200660/845065US03/07/200760/947852US30/07/200760/952628US
PCT/IB/2007/002578WO/2008/032162
)2009.01 (C07D19724421/09/2007
ืชืืืืืช ืกืืืคืื ืืืื ืืืืื ืืกืืื ืืืจื ืจืืืื ืืื ืืืื ืืกืืื ืืืกืงืจื ืืื
SULFONAMIDE DERIVATIVES ASADRENERGIC AGONISTS ANDMUSCARINIC ANTAGONISTSPFIZER LIMITED
04/10/200660/828099USPCT/IB/2007/002896WO/2008/041095
)2009.01 (A61B19724504/09/2007
ืฉืืื ืืืขืจืืช ืืืืืื ืื ืคืืืฉื ืืช ืฉื ืคืจืืืจืื ืืืืืื
METHOD AND SYSTEM FOR NON-INVASIVE MEASUREMENT OFCARDIAC PARAMETERS
ืืข. ืืื.ืื .N.Iื"ืืืืงื MEDICAL LTD.05/09/200660/842035US
PCT/IL/2007/001088WO/2008/029396
)2009.01 (A61B19724604/09/2007
MEDICAL ืืืฉืืจ ืจืคืืื INSTRUMENTืืข. ืืื.ืื .N.Iื"ืืืืงื MEDICAL LTD.
05/09/200660/842159USPCT/IL/2007/001087WO/2008/029395
![Page 41: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/41.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200941
)2009.01 (H03M19724712/09/2007
ืืคืขื ื ืฆืืคื ืืืืืืืฆืืช ืคืืื ืจืฆืืคื ืืฉืืืืช ืงืฉืืจืืช ืื ืืชื ืืชืื ืืช
PROGRAMMABLE CONTINUOUSPHASE MODULATION (CPM)DECODER AND ASSOCIATEDMETHODSHARRIS CORPORATION
13/09/200611/531447USPCT/US/2007/078249WO/2008/033906
)2009.01 (H04L19724812/09/2007
ืืคืขื ื ืฆืืคื ืจืฉืช ืื ืืชื ืืชืื ืืช ืืฉืืืืช ืืจืืชืงืฉ
PROGRAMMABLE TRELLISDECODER AND ASSOCIATEDMETHODSHARRIS CORPORATION
13/09/200611/531462USPCT/US/2007/078261WO/2008/033915
)2009.01 (H04N19725027/08/2007
ืืฆืืื ืืืืืืืืืช ืืฉืืืืืช ืืขืืช ืจืืืืืฆืืืช ืืืืช ืฉืืื ื ืืืืื
IMPROVED DIGITAL CAMERA WITHNON-UNIFORM IMAGE RESOLUTION
ITZHAK ืืฆืืง ืคืืืจื ืฅ POMERANTZ25/08/200660/823508US27/08/200711/845658US
PCT/US/2007/076914WO/2008/085553
)2009.01 (B23G19725106/03/2007
TAP ืืืืืง ืืื ืืืจืื HOLDERDAISHOWA SEIKI CO,LTD.
31/10/2006PCT/JP2006/321755JPPCT/JP/2007/054309WO/2008/053606
![Page 42: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/42.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 42
)2009.01 (B23G19725223/02/2007
TAP ืืืืืง ืืื ืืืจืื HOLDERDAISHOWA SEIKI CO,LTD.
PCT/JP/2007/053410WO/2008/105043
)2009.01 (B23B19725313/09/2007
ืฉ ืืืืืง,ื ืืืืืง ืืื ืงืื ืืืจืืื ืงืื ื ืืืื ืืืืง ืืืืืืง ืืื ืงืื ื
CONSTITUENT MEMBER OF COLLETCHUCK, COLLET AND FASTENING NUTAND COLLET CHUCKDAISHOWA SEIKI CO,LTD.
31/10/2006PCT/JP2006/321756JPPCT/JP/2007/067853WO/2008/053638
)2009.01 (C23C19725405/09/2007
ืืงืื ืืืืืื ื ืขื ืฆืืคืื ืจื ืฉืืืชื ืืฉืืื ืืืื ืชื
A TWIST DRILL WITH A MULTI-LAYERCOATING AND METHOD FOR MAKINGTHE SAMESANDVIK INTELLECTUAL PROPERTYAB
06/09/2006102006042226.0DEPCT/SE/2007/050621WO/2008/030177
)2009.01 (B32B19725525/02/2009
INSULATED ืืืืืช ืืืืืืื PANELSPOLYURETHANE LTD.
25/02/200861/064259US
![Page 43: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/43.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200943
)2009.01 (F03G19725625/02/2009
POWER ืืชืงื ืืืืื ืืื GENERATION APPARATUSBIRAN ืืืจื ืื ืืื DANIEL
)2009.01 (C09K19725729/08/2007
ืฉ ื ื ืืื ืืืื ืขืืืจ ืชืจืืืฃ ืชืจืืืืืชืฉืืืืช ืืืืฆืืจื ืืฉืืืืช ืืฉืืืืฉ, ืฉืืืงื
ืืื
AQUEOUS FLUID COMPOSITIONSFOR ABRASIVE SLURRIES,METHODS OF PRODUCTION, ANDMETHODS OF USE THEREOFSAINT-GOBAIN CERAMICS &PLASTICS, INC.
30/08/200660/841580USPCT/US/2007/018911WO/2008/027374
)2009.01 (C09K19725829/08/2007
, ืชืจืืืืืช ืืจืืืืืช ืฉื ืชืจืืืฃ ืฉืืืงื ืฉืืืืช ืืืืฆืืจื ืืฉืืืืช ืืฉืืืืฉ ืืื
CONCENTRATED ABRASIVESLURRY COMPOSITIONS, METHODSOF PRODUCTION, AND METHODS OFUSE THEREOFSAINT-GOBAIN CERAMICS &PLASTICS, INC.
30/08/200660/841423USPCT/US/2007/018910WO/2008/027373
)2009.01 (F04C19725917/07/2008
FLUID ืืืื ื ืื ืืื MACHINEKABUSHIKI KAISHA TOYOTAJIDOSHOKKI
19/07/20072007188312JPPCT/JP/2008/062940WO/2009/011395
![Page 44: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/44.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 44
)2009.01 (G06Q19726025/02/2009
ORGANIZATION ืืืคืืืืืืฆืืืช ืืจืืื OPTIMIZATIONSARA ืฉืจื ืคืื ืกืงื PINSKY
)2009.01 (G06F19726131/08/2007
ืืชืืื ื ืืืจืืืืงืืืจื, ืฉืืื, ืืขืจืืช ืืืืืข ืฉืืืืืจ ืขื ืืื ืฆืจืื
SYSTEM, METHOD, AND COMPUTERPROGRAM FOR A CONSUMERDEFINED INFORMATIONARCHITECTUREPETER SWEENEY
31/08/200611/469258US18/10/200611/550457US22/01/200711/625452US
PCT/CA/2007/001546WO/2008/025167
)2009.01 (A61K19726220/08/2007
ืฉืืืืฉ ื ืื ืืกืจืื ืฉื ืืืืฆื ืงืคืืืืช ืื ืืืจืืชืื
ANTI CANCER USE OF CAFFEICACID AND ITS DERIVATIVES
PIRAMAL LIFE SCIENCES LIMITED01/09/200660/842060US
PCT/IB/2007/053308WO/2008/026125
)2009.01 (E21D19726309/11/2007
IMPROVED ืขืืื ืืืืืง ืืฉืืคืจ SLIDING ANCHORATLAS COPCO MAI GMBH
10/11/2006102006053141.8DEPCT/EP/2007/009733WO/2008/055696
![Page 45: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/45.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200945
)2009.01 (C07D19726411/09/2007
ืฉืืื, ืืืืืื ืืืชืืจืื ืืกืืืืืื ืืืื ืชื ืืฉืืื ืืฉืืืืฉ ืืื
CERTAIN SUBSTITUTED AMIDES,METHOD OF MAKING, AND METHODOF USE THEREOFCGI PHARMACEUTICALS, INC.
11/09/200660/843833USPCT/US/2007/078185WO/2008/033857
)2009.01 (G07B19726529/08/2006
APPARATUS ืืขืจืืช ืืคืจืก ืืฆืืืจ ืืืืจื FOR PROGRESSIVEJACKPOTVIDEOB HOLDINGS LIMITED
PCT/IB/2006/052997WO/2008/029197
)2009.01 (A61B19726606/09/2007
ืื ืืืืจ ืืืฅ ืืขืจืืช ืืืจืื ื ืชืื ืืชืงืืืฉืืื ืืืขืจืืช ืืืฉืืช, ืืืชืื ืืืื
ืืชืืฆืจืื, ืชืจืืคื ืืชื ืืืืช ืืจืืคืื
APPARATUS FOR MONITORING ASYSTEM PRESSURE IN SPACE WITHTIME AND METHOD FOR ASSESSINGDRUG DELIVERY AND RESISTANCETO THERAPY AND PRODUCT
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
06/09/200660/824655USPCT/IL/2007/001102WO/2008/029407
![Page 46: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/46.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 46
)2009.01 (A61K19726731/08/2007
ืฉืืืืช ืืชืืฉืืจืื ืืืืืจืช ืกืืืืืช ืืืืื ืืืืื ืฉืืืืช ืืืืืืืช ืฉืจืืจ ืืื
METHODS AND COMPOSITIONS FORINCREASING PATIENTTOLERABILITY DURINGMYOCARDIAL IMAGING METHODSCV THERAPEUTICS, INC.
01/09/200660/841842USPCT/US/2007/077410WO/2008/028140
)2009.01 (H01H19726926/02/2009
MULTI-PIN ืคืื ืืโืืืืจ ืืฉืืื ืจื ELECTRICALCONNECTORHARRIS CORPORATION
28/02/200812/038969US
)2009.01 (G01S19727008/09/2006
ืชืืืืืื ืืฉืืคืจืื ืืงืฉืืจืื ืืืื ืืืจืฆืื ืื ืงืืืจื ืืืช ืืืงืื
IMPROCED PROCESSES INVOLVINGNON-COHERENT INTEGRATION IN ARECEIVERNOKIA CORPORATION
PCT/IB/2006/003862WO/2008/029195
)2009.01 (G01N19727107/09/2007
BIOMARKERS ืกืื ืื ืืืืืืืืื ืืืขืจืืช ืชืคืงืื ืืื FOR ASSESSINGLIVER FUNCTIONUCL BUSINESS PLC
07/09/20060617581.4GBPCT/GB/2007/003362WO/2008/029145
![Page 47: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/47.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200947
)2009.01 (A61K19727207/09/2007
VACCINE ืืืกืืGLAXOSMITHKLINE BIOLOGICALSS.A.
07/09/20060617602.8GB21/12/20060625593.9GB
PCT/EP/2007/059390WO/2008/028956
)2009.01 (A61K19727330/08/2007
โืชืืฉืืจื ืจืืงืืืช ืืฉืืืืฃ ืืืืืืื ืงืกืคืื14
PHARMACEUTICAL ANDSUNSCREEN COMPOSITIONSCOMPRISING CASPASE-14VIB VZW
01/09/200606119971.7EP18/12/200606126387.7EP
PCT/EP/2007/059069WO/2008/025830
)2009.01 (C07D19727407/09/2007
ืชืืืืืช ืืื ืืืืื ืืืืคื ื ืื ืฉื ืงืืืื ืงืฉืืจ ืืงืื ืื1โืืื ืืจืืืงืื
INDAZOLE DERIVATIVES ASMODULATORS OF INTERLEUKIN-1RECEPTOR-ASSOCIATED KINASEBIOGEN IDEC MA INC.
07/09/200660/842801USPCT/US/2007/019588WO/2008/030584
)2009.01 (A61K19727527/08/2007
ืชืืฉืืจื ืจืืงืืืช ืฉื ืงืืื ืืืคื ืืฉืืืืช ืืฉืืืืฉ ืืื
PHARMACEUTICAL COMPOSITIONSOF CLONAZEPAM AND METHODSOF USE THEREOFJAZZ PHARMACEUTICALS, INC.
28/08/200660/840568USPCT/US/2007/018877WO/2008/027357
![Page 48: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/48.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 48
)2009.01 (A61K19727631/08/2006
ืื ืืืืคืืโืฉืืืืช ืืขืืืื ืืืืืฆืจืืช ืืืืืโืืืืืืช ืืงืฉืืจืืช ืืืืืืฆืจืืช ืืื
METHODS OF INHIBITINGANGIOGENESIS AND TREATINGANGIOGENESIS ASSOCIATEDDISEASESABRAXIS BIOSCIENCE, LLC
PCT/US/2006/034365WO/2008/027055
)2009.01 (B65D19727826/02/2009
ืฉืงืืช ืื ืคืขืืืช ืืงืืืื ืืฉืืจื ืฉื ืฆืจืืื ืฉื ืืื
DISPOSALE BAG FOR DIRECTLYRECEIVING FAECES DOG
ELYAHU ืืืืื ืืืืจ MAZOR
)2009.01 (A47J19727926/02/2009
ื HOLDER.ืค.ืืืืืง ืืืขืื ืืืก AND STAND FORDISPOSABLE CUP
MOSHE ืืฉื ืฉืืืื SHTEIN
)2009.01 (G02B19728228/08/2006
ืฉืืื ืืืฆืืช ืชืืื ื ืืฉืืืฉื ืืืืืื ืืืืฆืจืช ืืื
METHOD OF DISPLAYING AN IMAGEIN THREE DIMENSIONS AND PANELTHUS PRODUCEDLIRONE
PCT/FR/2006/001998WO/2008/025888
![Page 49: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/49.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200949
)2009.01 (A01N19728422/08/2007
DISINFECTANT ืืขืจืืืช ืืฉืืืืช ืืืืืื SYSTEMS ANDMETHODSSOLUTIONS BIOMED, LLC
31/08/200611/514721USPCT/US/2007/018603WO/2008/027264
)2009.01 (G07F19728526/02/2009
SHOPPING ืืขืจืืช ืืฉืืื ืืขืจืืืช ืงื ืืืช SYSTEM AND METHODTHEREFOR
YANIV ืื ืื ืฉืื SEGEV25/02/200861/031034US
)2009.01 (H01H19728626/02/2009
WATERING ืฉืืืช ืืฉืงืืื ืืฉืืื ืืืืฉืืื SYSTEM AND METHODOF IMPLEMENTING IT
YITZHAK ืืฆืืง ืืื ืืจ ZINGER
)2009.01 (B65D19728710/04/2007
DRINK ืืงืืืง ืืฉืชืื ืขื ืืคืฅ ืคืจืกืืื BOTTLE WITH APROMOTIONAL OBJECTDLOUHY, PAVEL
31/08/2006PUV2006-18046
CZ
PCT/CZ/2007/000026WO/2008/025301
)2009.01 (A47J19728826/02/2009
FRUIT ืืืชื ืคืจืืช ืืืจืงืืช AND VEGETABLE SLICERITAI ืืืชื ืขืืจื ื ืืจื EZRA NURI
![Page 50: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/50.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 50
)2009.01 (G01N19728931/08/2007
ืืืฆืขืื ืืฉืืืืช ืืืืืื ืืื ืืจืืงืฆืืืช ืคืคืืืโืืืืื
METHODS FOR DETECTINGPROTEIN-PEPTIDE INTERACTIONS
NEXIGEN GMBH31/08/200606018277.1EP16/08/200707016137.7EP
PCT/EP/2007/007633WO/2008/025564
)2009.01 (F16L19729029/08/2007
ืืชืงื ืฉืจืืื ืืืคืื ืจื ืคืขืื ืขืืืจ ืืืคืื ืฉื ืืืกืืืื ืืืืงืฉืื ืืืงืืื
REUSABLE INVERSION SLEEVEASSEMBLY FOR INVERSION OFCURED IN PLACE LINERSINA ACQUISITION CORP.
29/08/200660/840818USPCT/US/2007/077123WO/2008/027973
)2009.01 (C12N19729115/08/2007
ืฉืืืืช ืืืฆืืจืช ืชืื ืขืฆื ืืืืื ืืฉืืืืฉืืืืืคืื ืืืฆืืื ืจืคืืืืื ืฉื ืืขืจืืช
ืืขืฆืืื ืืืจืืืืช
METHODS OF GENERATING GLIALAND NEURONAL CELLS AND USE OFSAME FOR THE TREATMENT OFMEDICAL CONDITIONS OF THE CNS
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
28/08/200660/840426USPCT/IL/2007/001026WO/2008/026198
![Page 51: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/51.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200951
)2009.01 (F41H19729218/09/2007
ื ืงืจืื ืืฉืืื ืืืืฆืืจ ืฉื ืฉืจืืื ืฉืจืื ืงืจืื
CERAMIC ARMORING AND METHODFOR THE PRODUCTION OF CERAMICARMORINGDEUTSCHES ZENTRUM FUR LUFT-UNDRAUMFAHRT E.V.
27/09/2006102006047110.5DEPCT/EP/2007/059832WO/2008/037623
)2009.01 (C07D19729327/09/2007
โD[ืชืืืืืื]3,1[ืชืืืืืช ืืืฉืืช ืฉืืืโ)H3(2โืคืืจืืืืืื ]5,4 ืืืชืืจืืชโืืื
ืืฉืืืืฉื ืืืืคืื7โื5ืืขืืืืช
NOVEL 5,7-DISUBSTITUTED[1,3]THIAZOLO [4,5-D] PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIRUSE IN THERAPYASTRAZENECA AB
29/09/200660/827460US04/10/200660/828125US
PCT/SE/2007/000857WO/2008/039138
)2009.01 (C07D19729417/10/2007
โ1โืืืื ืโ2(โ4ืชืืืืืช ืฉืืฉื)ืืืืจืืงืกืืืชืื ืคื ืื ืืืืื ืืกืืื
ื ืืืจื ืจืื?2โืืจืฆืคืืืจ
DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL ASAGONISTS OF THE ?2 ADRENERGICRECEPTORLABORATORIOS ALMIRALL, S.A.
20/10/2006P200602676ESPCT/EP/2007/008992WO/2008/046598
![Page 52: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/52.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 52
)2009.01 (A61K19729510/09/2007
โืชืืฉืืจ ืจืคืืื ืืืืื ืืืืื ืฉื ืืื ืXAืืืืืืช ืืืืืืืช ืืขืื ืืคืงืืืจ
PHARMACEUTICAL COMPOSITIONCOMPRISING A PLURALITY OF MINI-TABLETS COMPRISING A FACTORXA INHIBITORGLAXO GROUP LIMITED
12/09/200660/825314USPCT/EP/2007/059443WO/2008/031782
)2009.01 (A61K19729620/09/2007
ืฉืืื ืืืืขืื ืืืืคืื ืืืืงืืื ืืืืืืชืืคืืืืืคืื ืืืืฆืขืืช ืืขืืื ืืืจืืืื ืงืื ื
ABL
METHOD OF OPTIMIZING THETREATMENT OF PHILADELPHIA-POSITIVE LEUKEMIA WITH ABLTYRO-SINE KINASE INHIBITORSNOVARTIS AG
22/09/200660/826622US05/10/200660/828278US
PCT/US/2007/078978WO/2008/036792
)2009.01 (C07D19729707/09/2007
ืฉืืช ืจืืืืืช ืืืืืืฆืืงืืืืช ืืืขืืืืช ืกืคืืื ืืืืฉ ืฉื ืืื ืืืืื ืื
AZABICYCLIC COMPOUNDS ASINHIBITORS OF MONOAMINESREUPTAKEGLAXO GROUP LIMITED
11/09/20060617863.6GB11/09/20060617868.5GB22/08/20070716371.0GB
PCT/EP/2007/059381WO/2008/031772
![Page 53: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/53.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200953
)2009.01 (C07D19729827/09/2007
]Dโ4,5[ืชืืืืืื)3,1(ืชืืืืืช ืืืฉืืช ืฉืืืโ)H3(2โืคืืจืืืืืื ืืืชืืจืืชโืืืื ืืฉืืืืฉื ืืืืคืื7โื5ืืืืฆืืช
NOVEL 5,7-DISUBSTITUTED(1,3)THIAZOLO [4,5-D]PYRIMIDIN-2(3H)-AMINE DERIVATIVES ANDTHEIR USE IN THERAPYASTRAZENECA AB
29/09/200660/827442US04/10/200660/828122US
PCT/SE/2007/000858WO/2008/039139
)2009.01 (C07K19729904/10/2007
PTHืฉืขืืจื ืคืืืืฆืื ืืืืคื ื ืื ืฉืื ืืฉืืืืฉืPTHโืจืฆืคืืืจ
PEGYLATED PTH AS PTH RECEPTORMODULATORS AND USES THEREOF
ELI LILLY & CO.13/10/200660/829383US
PCT/US/2007/080367WO/2008/048784
)2009.01 (C07K19730012/09/2007
ื ืืืื ืื ืืืืงื ื ืืืื ืืืื ืืื ืื ืื ืจืฆืคืืืจืคืืืื ืืืืคืื ืจืืืืืืืื ืโืืืคื ืืื ืื
ืืงืจืฆืื ืืื ืฉื ืืฉืืื
HUMAN ANTI-FOLATE RECEPTORALPHA ANTIBODIES ANDANTIBODY FRAGMENTS FOR THERADIOIMMUNOTHERAPY OFOVARIAN CARCINOMAISTITUTO NAZIONALE PER LOSTUDIO E LA CURA DEI TUMORI
15/09/200606019399.2EPPCT/EP/2007/007944WO/2008/031577
![Page 54: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/54.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 54
)2009.01 (C07D19730118/09/2007
HTโ5QUINOLINEืืื ืขื ืชืืื ืืช ืงืืฉืืจ ืชืืืืืช ืงืืืื ื DERIVATIVES WITH 5-HT-BINDING PROPERTIESF. HOFFMANN-LA ROCHE AG
28/09/200606121449.0EPPCT/EP/2007/059840WO/2008/037626
)2009.01 (F24H19730226/02/2009
ืฉืืื ืืืขืจืืช ืื ืืืื ืืื ืืขืืจืช ืืื ืื ืืืืืืื ืืืขืจืืช ืืื
METHOD AND SYSTEM FORPREDICTING HOT WATER FLOWDURATION IN A WATER HEATINGSYSTEM
GALื"ืื ืืืืื ืืื ืืข WATER PREDICTIONS LTD.
)2009.01 (A61K19730513/09/2006
METHODSืฉืืืืช ืืืืคืื ืืืืงืช ืืืขื ืืืก ืืืืืืืช OF TREATMENT FORULCERATIVE COLITISTHE PROCTER & GAMBLECOMPANY
PCT/US/2006/035427WO/2008/033124
)2009.01 (G01S19730626/02/2009
ืฉืืื ืืืขืจืืช ืืืืืืช ืืืืืจืืกืืื ื ืืืืืืชืืช
METHOD AND APPARATUS FORULTRASOUND SYNTHETIC IMAGING
SUPER SONIC IMAGINE13/03/200812/047645US
![Page 55: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/55.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200955
)2009.01 (C22C19730721/09/2007
METAL ืืืงืช ืืชืืช POWDERH. C. STARCK GMBH
22/09/2006102006045339.5DEPCT/EP/2007/060060WO/2008/034903
)2009.01 (H04M19730807/11/2006
RESILIENT ืื ืืฃ ืืืืฉ ืขืืืจ ืืชืงื ืฉืืชืจืืื LEVER FOR A FLIP TOPDEVICENOKIA CORPORATION
PCT/FI/2006/000355WO/2008/056019
)2009.01 (A61K19730930/08/2007
ืชืืฉืืจ ืืืืืคืจืืคื ืชืืกืก ืืขื ืงืฆื ืืชืคืจืงืืช ืืืื ืืฉืืื ืืืืฆืืจื
IBUPROFEN-EFFERVESCENTPREPARATION HAVING A HIGHDISSOLUTION RATE AND METHODFOR THE PRODUCTION THEREOFLOSAN PHARMA GMBH
26/09/200606121278.3EPPCT/EP/2007/059043WO/2008/037555
)2009.01 (A61K19731007/09/2007
VACCINE ืืืกืืGLAXOSMITHKLINE BIOLOGICALSS.A.
07/09/20060617602.8GB21/12/20060625593.9GB
PCT/EP/2007/059391WO/2008/028957
![Page 56: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/56.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 56
)2009.01 (G01N19731127/07/2007
ืฉืืืืช ืืขืจืืืช ืืืืืื ื ืืื ืฉืงืฉืืจ ืืืื ืืืืื ืืฉืืจื ืืืืืื
METHODS AND KITS FORDETECTING CEREBROSPINAL ALUIDIN A SAMPLESTONY BROOKANESTHESIOLOGISTS U.F.P.C.
06/09/200611/516385USPCT/US/2007/016907WO/2008/030305
)2009.01 (G06F19731424/08/2007
ืขืจืืืช ืคืขืืืืช ืืืืื ืขื ืืื ืืชืงื ืจื ืืขืืืื ืืกืืืืจื
PERFORMING DIAGNOSTICOPERATIONS UPON ANASYMMETRIC MULTIPROCESSORAPPARATUSARM LIMITED
24/10/200660/853756US11/05/20070709182.0GB
PCT/GB/2007/003223WO/2008/050076
)2009.01 (C07C19731505/09/2007
TREATMENT ืืืคืื ืืกืจืื OF CANCERBIPAR SCIENCES, INC.
05/09/200660/842474USPCT/US/2007/077651WO/2008/030883
)2009.01 (A61K19731629/08/2007
BUPRENOPHINE-WAFER ืืืคืจื ืืคืื ืขืืืจ ืืืคืื ืชืืืืคื ืืกืืืโืืคื FOR DRUGSUBSTITUTION THERAPYEURO-CELTIQUE S.A.
30/08/200606119839.6EPPCT/EP/2007/058978WO/2008/025791
![Page 57: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/57.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200957
)2009.01 (A61M19731728/08/2007
ืชืืื ืช ืขืจืืื ืขืืืจ ืืขืจืืช ืืฉืืจืืจ ืชืจืืคืืช
VORTEX FEATURE FOR DRUGDELIVERY SYSTEMMERIDIAN MEDICALTECHNOLOGIES, INC.
31/08/200660/841709USPCT/US/2007/018920WO/2008/027382
)2009.01 (G08B19731826/02/2009
LOCATION ืืขืจืืช ืืืงืื ืขื ืืกื ืืืข ืืืจืืืืื SYSTEM WITH VIRTUALTOUCH SCREENBIOSENSE WEBSTER, INC.
29/02/200812/039779US
)2009.01 (E04C19731926/02/2009
RETAINING ืืขืจืืช ืืืฆืื ืงืืจ ืชืื WALL STABILIZATIONSYSTEMACKERSTEIN INDUSTRIES
)2009.01 (F16K19732026/02/2009
PRESSURE ืฉืกืชืื ืืงืจื ืืืืจืืืื ืืฉืืืื ืืืืฅ MANAGEMENTHYDRAULIC CONTROL VALVEBERMAD LIMITED PARTNERSHIP
)2009.01 (G08B19732129/10/2007
ืืขืจืืช ืืืชืืจ ืคืจืืฆื ืืืงืคืืช ืืืืคืขืืช ืืืืืืช ืขืฆืื
SELF-OPERATED PERIMETERINTRUSION DETECTION SYSTEM
INTELGUARD LTD.01/01/200711/618919US
PCT/IL/2007/001310WO/2008/081421
![Page 58: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/58.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 58
)2009.01 (B01D19732226/02/2009
ืืชืงื ืกืื ืื ืืฉืืื ืืืืคืื ืืืืืืช ืกืื ืื ืืจืืจืืช
A FILTRATION APPARATUS ANDMETHOD FOR TREATINGGRANULAR FILTRATION MEDIUM
LIQUIDื"ืืข) 2001(ืงืกืืจ ืืืื ื ืืืื ืืคืืชืื AUTOMATION LTD
)2009.01 (A61B19732326/02/2009
ืฉืืื ืืืฉื ืืช ืืืจืื ืืื ืืขื ืื ืืืืคืื ืืืืืืงืืื ืืืืชืจ ืืืฅ ืชืื ืขืื ื
NOVEL METHOD ANDCOMPOSITIONS FOR PREVENTIONOR TREATMENT OF GLAUCOMAAND OCULAR HYPERTENSION
MUHAMMAD ืืืืื ืขืืืืจืืืง ABDULRAZIK
)2009.01 (A61B19732426/02/2009
ื ืจืืืกืืืื ืฉื ืชืจืืคืืช ืืื ืืขื ืฆืืจืืคืื ืกืืื ืืืืคืื ืืืืืืงืืื ืืืืชืจ ืืืฅ ืชืื
ืขืื ื
SYNERGISTIC DRUGCOMBINATIONS FOR PREVENTIONOR TREATMENT OF GLAUCOMAAND OCULAR HYPERTENSION
MUHAMMAD ืืืืื ืขืืืืจืืืง ABDULRAZIK
)2009.01 (A61K19732504/09/2007
IMATINIB ืชืจืืืืืช ืฉื ืืืืืื ืื COMPOSITIONS
TEVAื"ืืืข ืชืขืฉืืืช ืคืจืืฆืืืืืช ืืข PHARMACEUTICALINDUSTRIES LTD.
01/09/200660/841707USPCT/US/2007/019338WO/2008/027600
![Page 59: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/59.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200959
)2009.01 (A61K19732630/08/2007
SOLID ืชืจืืืืืช ืืืฆืงืืช ืฉื ืงืืืื ืกืืื ืคืขืื COMPOSITES OF A CALCIUMRECEPTOR-ACTIVE COMPOUND
TEVAื"ืืืข ืชืขืฉืืืช ืคืจืืฆืืืืืช ืืข PHARMACEUTICALINDUSTRIES LTD.
01/09/200660/841689USPCT/US/2007/019151WO/2008/027522
)2009.01 (C07D19732718/09/2007
CRYSTALLINE ืจืืืืืกืืืื ืงืืฆืืื ืงืจืืกืืืื ื ROSUVASTATINCALCIUM
TEVAื"ืืืข ืชืขืฉืืืช ืคืจืืฆืืืืืช ืืข PHARMACEUTICALINDUSTRIES LTD.
18/09/200660/845584USPCT/US/2007/020247WO/2008/036286
)2009.01 (A01N19732828/08/2007
ืชืืืื ืืืืฆืืจ ืชืืืกื ืฉื ืืืืจ ืืืื ืืฉืืืืฉ ืืชืืจ ืงืืื ืืืืืงืื
PROCESS FOR PRODUCINGAQUEOUS CHLOROUS FOR USE ASBACTERICIDEHONBU SANKEI CO. LTD.
28/08/20062006-231280
JP
PCT/JP/2007/066691WO/2008/026607
)2009.01 (G02B19732901/03/2009
ืืืงืจืืกืงืืค ืืืืฉื ืกืืจืง ืืืืืืื ืขื ืืืืฉืืืืื ืื ืืืืฉื ืื ืืจืืืื ืืื ืืืืืฅ
ืฆืื ืืืคืืืช ืืืืืืจื ืืืื ืืื ืืจืคืจื ืืคืขืืื ืืืืืืจ ืื ืื ืืื
A SCANNED PROBE MICROSCOPEWITHOUT INTERFERENCE ORGEOMETRIC CONSTRAINT FORSINGLE OR MULTIPLE PROBEOPERATION IN AIR OR LIQUID
DAVIDืจ ืืื ืืืืืก"ื LEWIS
![Page 60: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/60.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 60
)2009.01 (A61M19733001/03/2009
ืข ืฆืืืช ืืชืงื ืชืื ืืคื ืื ืืชื ืืืชืืืืืืืคืฉืจืช ืืืฅ ืืืืื ืชืื ืืจืื ืื ืฉืืื
ืืฉืืื ืืฉืืืืฉื
AN INTRA-ORAL SELF-ADAPTABLECONTINUOUS POSITIVE AIRWAYPRESSURE (CPAP) INTERFACE ANDNETHOD
DISCOVERื"ืืืกืงืืืจ ืืืืงื ืืืืืืกื ืืข MEDICAL DEVICES LTD.
)2009.01 (A47C19733128/08/2007
ื ืืืคืฉืจ ืืฉืืื ืืชื ืืืืช ืืกื ืืชืืืื ื ืืจืืืืช ืืฉืืืืช ืืฉืืืืฉื
ADJUSTABLE CHAIR FORACCOMMODATING MULTIPLEBODY POSITIONS AND METHODS OFUSE THEREOF
GAYOื"ืืืื ืืืืืื ืืข DESIGN LTD28/08/200660/840425US03/01/200760/878045US03/01/200760/878092US
PCT/IL/2007/001067WO/2008/026209
)2009.01 (A61F19733230/08/2007
BLOOD ืชืืชืืช ืืื ืื ืืืขืจืืช ืื ืชืื ื VESSEL PROSTHESIS ANDDELIVERY APPARATUSBARTS AND THE LONDON NHSTRUST
31/08/20060617219.1GBPCT/GB/2007/003274WO/2008/025983
)2009.01 (C11B19733330/08/2007
ืืขืจืืช ืกืื ืื ืืชื ืื ืืช ืืฉืืื ืืฉืืืืฉืืืืชื ืืืืจ ืขืืืจ ืขืืืื ื ืืืืื ืืืื
ืฉืื ืื
STAGGERED FILTRATION SYSTEMAND METHOD FOR USING THESAME FOR PROCESSING FLUIDSSUCH AS OILSGRACE GMBH & CO. KG
01/09/200660/842067USPCT/EP/2007/007595WO/2008/025552
![Page 61: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/61.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200961
)2009.01 (A61K19733430/08/2007
ืฉืืืืฉ ืืืืืืืืืืจืื ืืืืกืืจืืื ืฉื ืืขืืืื ืฉื ืืืืื ื ืฉืืืชืAMPAืงืืืื
METHOD OF INHIBITION OFRESPIRATORY DEPRESSION USINGPOSITIVE ALLOSTERIC AMPARECEPTOR MODULATORSTHE GOVERNORS OF THEUNIVERSITY OF ALBERTA
31/08/200660/824245USPCT/CA/2007/001517WO/2008/025148
)2009.01 (A61K19733527/08/2007
ืกื ืกืืืืืฆืื ืฉื ืชืืื ืกืจืื ืืื ืืืืคืืืข ื ืืืื ืืกืืื ืฉื ืื ืืืชืืื"ืจืืืืืงืืืื
SENSITIZATION OF TUMOR CELLSTO RADIATION THERAPY THROUGHTHE ADMINISTRATION OFENDOTHELIN AGONISTSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,
31/08/200660/824197USPCT/US/2007/076903WO/2008/027839
)2009.01 (G02B19733601/03/2009
ืืขืื ืืจืืงื ืืขืื ื ืขืืืจ ืืืฆื ืืืื ืืืคืื
CHARGE DEPLETING CIRCUIT FOROPTICAL RANGE FINDERS
RAFAELื"ืจืคืื ืืขืจืืืช ืืืืื ืืชืงืืืืช ืืข ADVANCED DEFENSESYSTEMS LTD.
)2009.01 (A22B19733730/08/2007
MEAT ืขืืืื ืืฉืจ PROCESSINGMPSC, INC
31/08/200611/513519USPCT/US/2007/019174WO/2008/027538
![Page 62: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/62.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 62
)2009.01 (A61B19733830/08/2007
ืืขืจืืช ืืืืื ืจืขืฉ ืืืืคืขืืช ืืืืคืืืืืืืืื ืืืืืื ืืืชืืช ืืงืฉืืจืืช
ืืืคืจืขืืช ืืงืฆื ืืื
AUTOMATED NOISE REDUCTIONSYSTEM FOR PREDICTINGARRHYTHMIC DEATHS
NONLINEAR MEDICINE, INC.31/08/200660/824170US
PCT/US/2007/077175WO/2008/028004
)2009.01 (H01M19734019/09/2007
ืกืืืื ืืขืืช ืืืงืืจืืืช ืืืืจ ืืืื ืื ืืฃ ืืืื
BATTERY HAVING AIR ELECTRODEAND BIASED LEVER GASKETEVEREADY BATTERY COMPANY,INC.
22/09/200611/525261USPCT/US/2007/020324WO/2008/039344
)2009.01 (A01P19734113/09/2007
PESTICIDE ืชืืฉืืจ ืงืืื ืืืืงืื COMPOSITIONBASF SE
14/09/200660/844469USPCT/EP/2007/059657WO/2008/031870
)2009.01 (B23C19734207/12/2007
CUTTING ืืืืืง ืืืื ืืฉืืื ืงืฉืืจื, ืฉืืืช ืืืชืื INSERT, TOOL HOLDER,AND RELATED METHODTDY INDUSTRIES, INC.
16/01/200760/885053US03/05/200711/743803US
PCT/US/2007/086717WO/2008/088621
![Page 63: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/63.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200963
)2009.01 (D02J19734315/09/2007
ืชืืืื ืืืื ืช ืืืืื ืืขืื ืืืืง ืืืื ืืืื ืืืจืืขืืช ืกืืืืืช
PROCESS FOR MAKING UNIFORMHIGH STRENGTH YARNS ANDFIBROUS SHEETSHONEYWELL INTERNATIONAL INC.
25/09/200611/526350USPCT/US/2007/078589WO/2008/039650
)2009.01 (B65D19734417/09/2007
ืชืืฉืืจื ืืืชืงื ืืืืืฉืื ืฉืืื ื ืืืจืืื ืืืืคืฉืืืช ืืืืืืื ืืืจื ืืืืืง
COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING A GLUING AGENTMCNEIL NUTRITIONALS, LLC
18/09/200611/532667USPCT/US/2007/020120WO/2008/036229
)2009.01 (A47J19734502/03/2009
A ืืืฉืืจ ืืฉืืื ืืืืืืช ืกืืจ DEVICE AND METHOD FORSEALING A POT
ROMEO ืจืืืื ืืืืืืืจ GOLDHAMMER12/11/200861113604US
)2009.01 (G06F19734602/03/2009
ืฉืืื ืืืขืจืืช ืืืชื ืฉืืจืืชืื ืืืืฆืขืืช ืืืืจ ืืืงืืจืื ื
A METHOD AND A SYSTEM FORPROVIDING SERVICES VIA E-MAIL
BEN-DANIEL ืื ืื ืืื ืจืื ื RONEN
)2009.01 (E04D19734702/03/2009
ROOF ืืฉืืืืืจืฆืคืช ืืืืื ืืื INSULATION TILE ANDMETHOD
MANOR ืื ืืจ ืขืืื UZI
![Page 64: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/64.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 64
)2008.04 (A61K19734830/04/2002
THERAPEUTIC ืชืืฉืืจืื ืจืคืืืืื ืืืืืื ื ืืืืืืืืืื COMPOSITIONS FORTARGETING LYSOSOMESZYSTOR THERAPEUTICS, INC.
30/04/200160/287531US10/07/200160/304609US15/10/200160/329461US23/01/200260/351276US
PCT/US/2002/013835WO/2002/087510
)2009.01 (H01R19734902/03/2009
A ืืขืจืืช ืืฉืืื ืืชืืงืื ืืขืืืื ืืฉืืืืื METHOD AND SYSTEM FORELECTRICAL CIRCUIT REPAIR
ORBOTECHื"ืืืจืืืืง ืืข LTD.
)2009.01 (A61K19735005/09/2007
ืืืืื ืกืื ืชืื ืฉื ืืืืฆื ืฉืืื ืืช ืขื ืืื ืืฉืืืืช ืืืคืื ืืืPARPืืขืืื
INHIBITION OF FATTY ACIDSYNTHESIS BY PARP INHIBITORSAND METHODS OF TREATMENTTHEREOFBIPAR SCIENCES, INC.
05/09/200660/842479USPCT/US/2007/077662WO/2008/030891
)2009.01 (H04L19735104/09/2007
ืฉืืื ืืืชืงื ืขืืืจ ืืืืข ืืฉืืืื ืืฉืืืืจ ืืจืืื
METHOD AND APPARATUS FORDATA AND CONTROLMULTIPLEXINGQUALCOMM INCORPORATED
05/09/200660/842619US29/08/200711/847307US
PCT/US/2007/077516WO/2008/030798
![Page 65: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/65.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200965
)2009.01 (C07D19735219/09/2007
โ2,1[ืคื ืืืืืืืืืืโ6โืืจืืโ2ื ืืืจืืช ืฉื]aืืื ืชื ืืฉืืืืฉืืื ืืจืคืืืืื, ืคืืจืืืื
2-ARYL-6-PHENYLIMIDAZO[1,2-A]PYRIDINE DERIVATIVES,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS
22/09/20060608350FRPCT/FR/2007/001517WO/2008/034974
)2009.01 (G01N19735305/09/2007
PARPืฉืืืืช ืขืืืจ ืชืื ืื ืืขืืื ืืฉืืืืฉืื ืืื
METHODS FOR DESIGNING PARPINHIBITORS AND USES THEREOF
BIPAR SCIENCES, INC.05/09/200660/842470US
PCT/US/2007/077655WO/2008/030887
)2009.01 (H04L19735427/09/2007
ืฉืืืืช ืืืชืงื ืืขืืฆืื ืกืื ื ืืกืืื ื ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
METHODS AND APPARATUS FORCONFIGURING A PILOT SYMBOL INA WIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED
27/09/200611/535940USPCT/US/2007/079787WO/2008/039952
![Page 66: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/66.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 66
)2009.01 (H04L19735527/09/2007
ืฉืืืืช ืืืชืงื ืขืืืจ ืฉืืืืจ ืฉืื ืืื ื ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
METHODS AND APPARATUS FORTRANSMITTING A FRAMESTRUTURE IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED
27/09/200611/535947USPCT/US/2007/079785WO/2008/039951
)2009.01 (B05B19735602/03/2009
ืชืืืืชื ืื ืืชื ืืืืฉืงโืืืืื ืืืกื ืจื ืขื ืืงืื ืจืืกืืก ืืฆืืข
MULTI-PURPOSE LID ASSEMBLYINTERFACEABLE WITH A PAINTSPRAY GUN
EREZ ืืจื ื ืืกืื ืืื NISIM LEVI
)2009.01 (A61K19735702/03/2009
ืฉื, ืืขืจืืช ืืืฉืชืื ืฉืคืขืื ืืชืคืขืื ืกืืืื ืืืฉืชืืช
A SYSTEM FOR IMPLANTING,ACTIVATING, AND OPERATING ANIMPLANTABLE BATTERY
,ORTHO-IONื"ืืืจืชืืืื ืืข LTD.
)2009.01 (A61M19735824/07/2007
AUTOMATIC ืฉืกืชืื ืขืฆืืจื ืงืืง ืืืืืืื STOP COCK VALVEALCON, INC.
18/09/200611/522648USPCT/US/2007/074172WO/2008/036462
![Page 67: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/67.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200967
)2009.01 (G06F19736001/11/2007
ืืืืืช ืืขืืจืช ืืฉืืืื ืืืืข ืืืืืงืืSECURING DISTRIBUTEDAPPLICATION INFORMATIONDELIVERYMICROSOFT CORPORATION
01/11/200611/555610USPCT/US/2007/083390WO/2008/057970
)2009.01 (G06F19736116/10/2007
ืืืจืืืืืืืฆืื ืขืืืจ ืืืืื ืฉื ืขืืืืืช ืืืชืขืจืืืช
VIRTUALIZATION FOR DIVERSIFIEDTAMPER RESISTANCE
MICROSOFT CORPORATION27/10/200611/553841US
PCT/US/2007/081485WO/2008/115279
)2009.01 (A61K19736207/09/2007
ืฉืืื ืืืคืืชืช ืื ืืืจืืขืช ืืืงืช ืืืขืจืืช ืืขืืืื
METHOD FOR REDUCING ORALLEVIATING INFLAMMATION INTHE DIGESTIVE TRACTORE PHARMACEUTICALS, INC.
08/09/200660/825075US02/10/200660/827807US
PCT/US/2007/077857WO/2008/031014
)2009.01 (A61K19736307/09/2007
ืชืจืืืืืช ืืฉืืืืช ืขืืืจ ืืืจืืื ืืืกืืื ืืF18ืขื
COMPOUNDS AND METHODS FOR18F LABELED AGENTS
BAYER SCHERING PHARMA AG08/09/200606090166.7EP23/04/200707090079.0EP
PCT/EP/2007/008042WO/2008/028688
![Page 68: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/68.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 68
)2009.01 (F41H19736415/09/2007
ืืืืจืื ืืจืืืืื ืืืืืืื ืขื ืืจืงืืืืืืื ืืขืื ืืืฆืืขืื ืืืืื ืขื ืืื ืฉืื ืื
ืชืืืืช ืืฉืจืฃ ืืืื
HIGH PERFORMANCE SAME FIBERCOMPOSITE HYBRIDS BY VARYINGRESIN CONTENT ONLY
HONEYWELL INTERNATIONAL INC.26/09/200611/527924US
PCT/US/2007/078590WO/2008/108882
)2009.01 (C07D19736526/09/2007
ืืืคื ื ื ืงืืืื ืคืจืืืกืืจืื ืคืืจืืืืืืงืกืืืคืื ืื
PYRIDOOXAZEPINE PROGESTERONRECEPTOR MODULATORS
N.V. ORGANON27/09/200606121372.4EP
PCT/EP/2007/060225WO/2008/037746
)2009.01 (B01F19736617/09/2007
DEVICE ืืชืงื ืืืืกืคืช ืื ืื ืืื FOR GASSING A LIQUIDKOCH MEMBRANE SYSTEMS GMBH
19/09/2006102006044624.0DEPCT/EP/2007/008063WO/2008/034570
)2009.01 (F04B19736718/10/2007
VIBRATION ืื ืืืืจืฆืืืชืืื ISOLATOREDWARDS LIMITED
19/10/20060620723.7GBPCT/GB/2007/050645WO/2008/047168
![Page 69: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/69.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200969
)2009.01 (C22C19736821/09/2007
METAL ืืืงืช ืืชืืช POWDERH. C. STARCK GMBH
22/09/2006102006045481.2DEPCT/EP/2007/060058WO/2008/034902
)2009.01 (C07D19736929/09/2007
โ3โืืืืจืโ4[{(โ4[โ4โ)ืืืื ื}ืงืจืืืืื)]ืคื ืื)ืืจืืคืืืืืจืืืชืื(โ2โืืชืืืคืืจืืืืโNโ]ืคืืืืืจืืคื ืืงืกืโ3
ืงืจืืืงืกืืืื ืืื ืืืืืจืื
4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDEMONOHYDRATEBAYER SCHERING PHARMAAKTIENGESELLSCHAFT
11/10/200606021296.6EPPCT/EP/2007/008503WO/2008/043446
)2009.01 (H01H19737003/03/2009
COMPRESSION ืืชืงื ืืืืกื ืขื ืกืืืื DEVICE WITH SOLETYCO HEALTHCARE GROUP LP
04/03/200812/041816US
)2009.01 (A61F19737104/09/2007
ืชืืชืืช ืคื ืืืืช ืืฉืืื ืืืืฆืืจ ืชืืชืืช ืคื ืืืืช
ENDOPROSTHESIS, AND METHODFOR PRODUCING ANENDOPROSTHESISUNIVERSITE PIERRE ET MARIECURIE ( PARIS 6 )
04/09/20060607733FRPCT/FR/2007/001431WO/2008/029020
![Page 70: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/70.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 70
)2009.01 (A23L19737217/09/2007
ืงืืืจืืืช ืืืืืฉืืโืชืืฉืืจื ืืืชืงื ืืืืฉืืื ื ืืืจืืื ืืืืคืฉืืืช ืขื ื ืคื ืืฆืืืฆื
LOW-CALORIE COHESIVE NON-FREEFLOWING SWEETENERCOMPOSITIONS WITH DECREASEDVOLUMEMCNEIL NUTRITIONALS, LLC
18/09/200611/532681USPCT/US/2007/020119WO/2008/036228
)2009.01 (A23L19737317/09/2007
ืชืืฉืืจื ืืืชืงื ืืืืืฉืื ืฉืืื ื ืืืจืืื ืืืืคืฉืืืช ืืืืืืื ืืืืจ ืืชืคืืจืจ
COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING DISINTEGRANTMCNEIL NUTRITIONALS, LLC
18/09/200611/532687USPCT/US/2007/020136WO/2008/036233
)2009.01 (G01N19737403/10/2007
ELISAืขืืืจVEGFELISA FOR VEGFGENENTECH, INC.
04/10/200660/828203USPCT/US/2007/080310WO/2008/060777
)2009.01 (C07D19737520/09/2007
PYRIDINE ืื ืคืืจืืืื ืืืจืืืชืฆืื BORANE COMPLEXESBASF SE
21/09/200660/846144USPCT/EP/2007/060003WO/2008/034886
![Page 71: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/71.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200971
)2009.01 (A61K19737613/09/2006
ืฉืืื ืืืืคืื ืืืืงืช ืืขื ืืืก ืืืืืืืช ืืืืฆืขืืช ืืืื ืืกืืืฆืืืื
METHODS OF TREATMENT FORULCERATIVE COLITIS USINGAMINOSALICYLATETHE PROCTER & GAMBLECOMPANY
PCT/US/2006/035428WO/2008/033125
)2009.01 (B65D19737803/03/2009
A ืืขืจืืช ืืฉืืื ืืงืืจืืจ ืืงืืืง SYSTEM AND METHOD FORCOOLING A BOTTLE
DUDU ืืืื ืืืื HAIM
)2009.01 (B01D19737903/03/2009
ืชืืืื ืืืคืงืช ืืืืฆื ืืืืจืืืืืจืืชืืชืืืกื ืืืืืืช ืฉืื ืืชืืฉืืจ ืืืฆืื
ืืฉืืืืฉ ืื
A PROCESS FOR THE RECOVERY OFHCL FROM A DILUTE SOLUTIONTHEREOF AND EXTRACTANTCOMPOSITION FOR USE THEREIN
ืก ืืข' ืืืืฅ HCLื"ืื ืงืืื ืื CLEANTECH LTD.
)2009.01 (A61K19738004/09/2007
ืืืขืืืชโืชืืฉืืจืื ืืืืืืื ืืืงืจื ืืืคืืคืืืืืช ืืืืืืืืช ืืื
COMPOSITIONS CONTAININGAMPHIPHILLIC GAS-FILLEDMICROVESICLESBRACCO RESEARCH S.A.
05/09/200606120109.1EPPCT/EP/2007/059256WO/2008/028917
![Page 72: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/72.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 72
)2009.01 (C07D19738111/09/2007
KINASE ืืขืื ืงืื ืื INHIBITORSANOFI AVENTIS
11/09/200660/825168USPCT/US/2007/078103WO/2008/033798
)2009.01 (F41H19738201/07/2004
ANTIBALLISTIC ืืืืกืืืื ืืชืืืืโืืืืจืื ืื ืื MATERIALS ANDPROCESSANTIBALLISTIC SECURITY ANDPROTECTION INC.
01/07/200360/483630US02/04/200460/521336US05/05/200460/567795US
PCT/US/2004/020989WO/2005/043071
)2009.01 (H04N19738330/08/2007
DISPLAYING ืืฆืืช ืืืืื VIDEONDS LIMITED
04/09/20060617385.0GB05/09/200660/842222GB
PCT/GB/2007/003264WO/2008/029086
)2009.01 (E06B19738403/09/2007
RAIL ืืขืจืืช ืืกืืืืช ืืืืชืืช ืืืืื ืืช ืืืื SYSTEM FOR SLIDING DOORSAND WINDOWSSTARGET CONCEPT LTD.
03/09/200660/824441USPCT/IL/2007/001086WO/2008/029394
![Page 73: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/73.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200973
)2009.01 (G06F19738505/09/2007
ืฉืืืืช ืืงืืืขืช ืืืงืื ืกืื ืืืืข ืืฆืืข ืขื ืืกื ืืืข
METHODS FOR DETERMINING ACURSOR POSITION FROM A FINGERCONTACT WITH A TOUCH SCREENDISPLAYAPPLE INC.
06/09/200660/824769US07/01/200760/879253US08/01/200760/879469US27/06/200760/946716US29/06/200760/937993US04/09/200711/850015US
PCT/US/2007/077645WO/2008/030880
)2009.01 (G09B19738603/03/2009
TOUCH ืืืื ื ืืืื ืืืจืืข ืืืข EVENT MODELAPPLE INC.
04/03/200812/042318US
)2009.01 (F02B19738703/03/2009
ืืขืจืืช ืืฉืืื ืืื ืขื ืชืื ืฉืืืืฉ ืืชื ืฉืจืืคื ืืคืืื ืืกื ืืจืืืืช
PROPULSION SYSTEM AND METHODUSING A COMBUSTION CHAMBERDISCHARGING A CONCENTRATEDMASS
TECHNIONื"ืืืกื ืืืื ืืื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT FOUNDATION LTD.
![Page 74: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/74.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 74
)2009.01 (G08B19738803/03/2009
ืฉืืื ืืืฉืชืืฉืช ืืจืืืจ ืืืืืื ืืืจืืืืชื ืืืืขื ืืขืฉืืื ืืืืืช ืืืืงืืช
ืืื ืืืจืืช ืืืจืืช, ืืืืื ื ืชืื ืืงืืจืื ืืืืืงืืืช ืืืืชื ืืืื ืืงืืจืื
METHOD USING RADAR TO DETECTA KNOWN TARGET LIKELY TO BEPOSITIONED AT APPROXIMATELY AGIVEN HEIGHT, NEAR OTHERTARGETS POSTIONED ATAPPAOXIMATELY THE SAMEHEIGHTTHALES
01/04/20080801787FR
)2009.01 (C07K19738904/10/2007
ืืืืจ ืคืจืืคืืืงืื ืื ืชืจืคืืืื ืืกืจืื
PROPHYLACTIC OR THERAPEUTICAGENT FOR CANCERTAKEDA PHARMACEUTICAL COMPANYLIMITED
06/10/2006PCT/JP2006/320429JP04/04/2007P-070101453AR06/04/20072007#100876JP
PCT/JP/2007/069908WO/2008/044754
)2009.01 (C07K19739006/09/2007
ืืืืงืืืืช ืงืืฉืจืืช ืื ืืฉืืืช ืืืกืืืืืช ืฉืืื ืืฉืืืืฉืื1N5Hืื ืืจื ื ืืืฃ ืฉืคืขืช
HUMAN BINDING MOLECULESCAPABLE OF NEUTRALIZINGINFLUENZA VIRUS H5N1 AND USESTHEREOFCRUCELL HOLLAND B.V.
07/09/200606120316.2EP07/09/200660/842930US14/09/200606120644.7EP30/11/200606125107.0EP28/06/200707111235.3EP
PCT/EP/2007/059356WO/2008/028946
![Page 75: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/75.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200975
)2009.01 (D06M19739104/09/2007
ืืืฆืจื ืืงืกืืื ืืขืืื ืืขืจื ืืฉืืื ืืืืฆืืจื
FLAME RETARDED TEXTILEPRODUCTS AND A METHOD OFMAKING THE SAMEALBEMARLE CORPORATION
08/09/200660/824935USPCT/US/2007/077508WO/2008/030792
)2009.01 (C12Q19739205/09/2007
GENOMIC ืฆืืคื ืืืจืก ืื ืืื MORSE CODEINSTITUT PASTEUR
07/09/200611/516673USPCT/EP/2007/059299WO/2008/028931
)2009.01 (C07D19739306/09/2007
ืืื ืืืืจืืืโ4โืชืืืืืช ืคืืจืืืืืช ืืืืกืืืืืคื ื ื ืืขืจื
PYRIDIN-4-YL DERIVATIVES ASIMMUNOMODULATING AGENTS
ACTELION PHARMACEUTICALS LTD.07/09/2006PCT/IB06/053147IB
PCT/IB/2007/053594WO/2008/029371
)2009.01 (C07D19739406/09/2007
ืื ืืืืจืืื ืืืคื ื ืโ3โืชืืืืืช ืคืืจืืืื ืืืกืื
PYRIDIN-3-YL DERIVATIVES AMIMMUNOMODULATING AGENTS
ACTELION PHARMACEUTICALS LTD.08/09/2006PCT/IB06/053187IB
PCT/IB/2007/053593WO/2008/029370
![Page 76: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/76.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 76
)2009.01 (C07D19739510/07/2007
ืชืืืืืช ืชืืืคื ืืืืื ืืกืืื ืืงืืืื1EDG/1P1S
THIOPHENE DERIVATIVES ASS1P1/EDG1 RECEPTOR AGONISTS
ACTELION PHARMACEUTICALS LTD.07/09/2006PCT/IB06/053150IB
PCT/IB/2007/052742WO/2008/029306
)2009.01 (C07D19739724/10/2007
ืชืจืืืืืช ืืืงืกืืืืืืื ืืชืืืืืืืืืืฉืืืืฉ ืืื ืืืืคื ื ื ืงืืืื ืืฆืืืืืืืื
ื ืืงืืืื ื
OXADIAZOLE AND THIADIAZOLECOMPOUNDS AND THEIR USE ASNICOTINIC ACETYLCHOLINERECEPTOR MODULATORSNEUROSEARCH A/S
25/10/2006PA200601380DK25/10/200660/854078US
PCT/EP/2007/061433WO/2008/049864
)2009.01 (G01N19739804/03/2009
LONG-LASTING ืจืื ืขืืื ืืืืจื ืืืื ืืฆืืง ืืืืงืืจืืคื'ื PRECASTELECTROPHORESIS GEL
GENEื"ืื ืืืฉืืืื ืืืืืืืืื ืืข BIO-APPLICATION LTD.
)2009.01 (A47J19739906/09/2007
PREPARING ืืืฉืืจ ืืื ื DEVICEBRAVILOR HOLDING B.V.
07/09/20062000218NLPCT/NL/2007/050436WO/2008/030095
![Page 77: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/77.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200977
)2009.01 (C22C19740012/09/2007
MAGNESIUM ืกืืกืืืืช ืืื ืืืื ืืืืืื GADOLINIUM ALLOYSMAGNESIUM ELEKTRON LIMITED
13/09/20060617970.9GBPCT/GB/2007/003491WO/2008/032087
)2009.01 (H01Q19740131/07/2007
ืขืืืื ืืืื ืืงืืช ืชืช ืืขืจื ืืจืืฆืฃ ืื ืงืฉืืจืืช
TILE SUB-ARRAY AND RELATEDCIRCUITS AND TECHNIQUES
RAYTHEON COMPANY21/09/200611/533848US09/11/200611/558126US
PCT/US/2007/074795WO/2008/036469
)2009.01 (C07D19740219/09/2007
ืื ืืืงโNืชืืืื ืืืื ื ืฉื ืืืืืืื ืฉื ื ืืืจืงืกืื
PROCESS FOR PREPARING N-ALKYLNALTREXONE HALIDES
SANOFI-AVENTIS21/09/20060608286FR
PCT/FR/2007/001516WO/2008/034973
)2009.01 (E21B19740304/03/2009
ืืชืงื ืืฉืืื ืขืืืจ ืคืจืืฆื ืืืืงืจืช ืฉื ืืืื ืืืืืง
DEVICE AND METHOD FORCONTROLLED BREACHING OFREINFORCED CONCRETERAYTHEON UTD INC.
![Page 78: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/78.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 78
)2009.01 (A61M19740407/09/2007
COLLAPSIBLE ืืืื ืืชืงืคื ืืืืกืืฃ ื ืืื ืจืคืืื CANISTER LINER FORMEDICAL FLUID COLLECTIONALLEGIANCE CORPORATION
07/09/200611/517125USPCT/US/2007/019615WO/2008/030597
)2009.01 (H04N19740507/10/2007
ืืืฉืง ืืฉืชืืฉ ืืื ืืจืืงืืืื ืชืืช ืืืืื ืืืขืงื ืืงืื
INTERACTIVE 3D SHORTAGETRACKING USER INTERFACE
MICROSOFT CORPORATION01/11/200611/591689US
PCT/US/2007/080662WO/2008/054953
)2009.01 (C07D19740827/09/2007
PROCESS ืชืืืื ืืืื ืช ืืืืงืืืจ FOR THE PREPARATIONOF ABACAVIRESTEVE QUIMICA, S.A.
28/09/200606121459.9EP28/09/200660/847979US
PCT/EP/2007/060249WO/2008/037760
)2009.01 (B65D19740916/07/2007
ืืกืืืจ ืขื ืืขืื ืืจืืื ืืืืืืช ืืืืRFID
CLOSURE AND CONTAINERPACKAGE WITH RFID CIRCUITREXAM HEALTHCARE PACKAGINGINC.
07/09/200611/517000USPCT/US/2007/016115WO/2008/030295
![Page 79: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/79.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200979
)2009.01 (G06K19741017/10/2007
ืฉืืื ืืงืืืช ืชืืื ืืช ืืจืืืืืช ืืืืฆืขืืชMRIืืช ืืืจืืืืืช ืืขืืืื ืืชืืื
ืืืชืงืืืืช ืืชืืฆืจ
METHOD FOR OBTAINING SPATIALIMAGES THROUGH MRI ANDPROCESSING THE RESULTINGSPATIAL IMAGES AND PRODUCT
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
17/10/200660/829705USPCT/US/2007/081580WO/2008/048982
)2009.01 (C25D19741105/09/2007
ืชืืกืฃ ืืืฉ ืขืืืจ ืืืงืืจืืืืืื ืฉื ืืจืื
A NOVEL ADDITIVE FOR CHROMIUMELECTROLYTES
TIB CHEMICALS AG05/09/2006102006042076.4DE
PCT/EP/2007/059308WO/2008/028932
)2009.01 (B01J19741205/03/2009
ืืืืืื ื ืืฉืืืโืืืจืืื ื ืืืจCOMBINATORIALHETEROGENEOUS-HOMOGENEOUSREACTORBABCOCK & WILCOX TECHNICALSERVICES GROUP, INC.
07/03/200861/034534US03/03/200912/397070US
![Page 80: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/80.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 80
)2009.01 (A61K19741306/09/2007
ืชืืฉืืจืื ืืืืืืื ืคืคืืืืื ืงืืื ืืืืงืื ืืืืืื ืื ืืืจืจื ืืชื
COMPOSITIONS COMPRISINGSELECTIVELY TARGETEDANTIMICROBIAL PEPTIDESTHE REGENTS OF THE UNIVERSITYOF CALIFORNIA
06/09/200660/842871USPCT/US/2007/077795WO/2008/030988
)2009.01 (H01H19741405/03/2009
ื ืืคืงื ืืืืืจ ืฉื ืืืืืฉ ืืชืงื ืจืคืืื ืืข ืชืืื ืืืฉืืื ืืฉืืืืฉื
A MEDICAL DEVICE WITHENHANCED EFFECT OF CELLREGENERATION AND THE METHODTHEREOFHAN, WAN-SEOK
)2009.01 (A01N19741511/09/2007
ืืืื ื ืืงืืืืกืืืื ืืฉืืืืฉ ืืืขืืื ืคืืืืืจืืืื ืืืจืืืืืื ืฉื ืจื ื ืืื ื
AZOLE NUCLEOSIDES AND USE ASINHIBITORS OF RNA AND DNAVARIAL POLYMERASESSOUTHERN RESEARCH INSTITUTE
11/09/200660/843398USPCT/US/2007/078139WO/2008/067002
)2009.01 (G07B19741605/03/2009
ืืฉืืื ืืืืืืืช ืืฉืคืขืช ืคืจืกืื ืขื ืชืคืืกืช ืืืืชื
A METHOD FOR MEASURING THEIMPACT OF ADVERTISING ONBRAND PERCEPTION
RUTHIE ืจืืชื ืืจื ืืื BRANDMAN07/03/200861/064479US
![Page 81: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/81.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200981
)2009.01 (G02B19741705/03/2009
ืืชืงื ืืืคืื ืืฉืืื ืืชืืงืื ืืืจืฆืืืช ืืจืืืืืืช
OPTICAL DEVICE AND METHOD FORCORRECTING CHROMATICABERRATIONS
ืืืคืืืงื-ืื ืืขืจืืืช ืืืงืืจืืืืื"ืืืืืค ืืข
ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD
)2009.01 (G01C19741905/03/2009
INERTIAL ืชืฆืืจืช ืืืืื ืืืืฉื ืืื ืจืฆืืืื SENSOR ASSEMBLYCONFIGURATION
ืืืคืืืงื-ืืืืื ืืขืจืืืช ืืืงืืจืื"ืืืืืค ืืข
ELBIT SYSTEMS ELECTRO-OPTICSELOP LTD
)2009.01 (C07D19742015/10/2007
โ4(โ3[โ4ืฆืืจื ืคืืืืืืจืคืืช ืฉืโ1โืคืืคืจืืืืโืฆืืงืืืคืจืืคืื ืงืืจืืื ืื
โH2โ]ืื ืืืโืคืืืืืจืโ4โ)ืงืืจืืื ืื ืืืโ1โืคืชืืืืืื
POLYMORPHIC FORM OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1- CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONEKUDOS PHARMACEUTICALSLIMITED
17/10/200660/829694USPCT/GB/2007/003888WO/2008/047082
)2009.01 (H04B19742109/09/2007
ACCESS ืืืื ืืื ืืชืื ืื ื ืงืืืช ืืืฉื POINT PLANNINGMECHANISM
DESIGNARTื"ืืืืื ืืจื ื ืืืืจืงืก ืืข NETWORKS LTD08/09/200660/843183US15/01/200711/623110US
PCT/IL/2007/001108WO/2008/029411
![Page 82: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/82.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 82
)2009.01 (H04B19742209/09/2007
POINT-TO-POINT ืฉืืืช ืชืงืฉืืจืช ืื ืงืืื ืื ืงืืื COMMUNICATIONMETHOD
DESIGNARTื"ืืืืื ืืจื ื ืืืืจืงืก ืืข NETWORKS LTD08/09/200660/843079US18/01/200711/624232US
PCT/IL/2007/001109WO/2008/029412
)2009.01 (H03C19742309/09/2006
ืฉืืืช ืชืงืฉืืจืช ืื ืงืืื ืื ืงืืื ืขื ืฉืืืื ืืคืจืขื
POINT-TO-POINT COMMUNICATIONMETHOD WITH INTERFERENCEMITIGATION
DESIGNARTื"ืืืืื ืืจื ื ืืืืจืงืก ืืข NETWORKS LTD08/09/200660/843079US17/01/200711/623774US
PCT/IL/2007/001110WO/2008/029413
)2009.01 (G01N19742405/03/2009
SPRืืืืื ืฉืืืจืื ืขื ืืืDETECTION OF ANALYTES BYSURFACE PLASMON RESONANCESPECTROSCOPY
ืืืฉืื ืืืจื ืืคืืชืื ืืืืงืจ ืฉื ืจืกืืื ืืขืืจืืช ืืืจืืฉืืืืืืื ืื
YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM
)2009.01 (G06F19742501/11/2007
HEALTH ืืืฉืืืช ืืจืืืืชAPIืชืืื ืืช INTEGRATION PLATFORMAPIMICROSOFT CORPORATION
01/11/200660/863897US08/05/200711/745902US
PCT/US/2007/083395WO/2008/057973
![Page 83: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/83.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200983
)2009.01 (A61K19742611/09/2007
ืืขืืื ืืืกืืื ืืืฆืืืืื ืขื ืคืขืืืืชIืืฉืืืืช ืขื ืืืกืืื ืืืฆืืืืืืื ืืกืื
ืืฉืืืื ืขื ืืขืืื ืคืจืืืืืืืIIBืืืกืื
HISTONE DEACETYLASEINHIBITORS WITH COMBINEDACTIVITY ON CLASS-I AND CLASS-IIB HISTONE DEACETYLASES INCOMBINATION WITH PROTEASOMEINHIBITORSJANSSEN PHARMACEUTICA, N.V.
15/09/200606120726.2EP03/05/200760/915895US
PCT/EP/2007/059518WO/2008/031817
)2009.01 (B26B19742706/09/2007
ืื ืจืืื ืืืืืื ืกืืืข ืืืืื ืืขืจืืช ืืืื ืืืฆืืคื ืืฉืื ืืื ืจืื
WET SHAVING SYSTEM INCLUDINGA MINERAL OIL COATED SHAVINGAIDTHE GILLETTE COMPANY
13/09/200611/520388USPCT/IB/2007/053598WO/2008/032242
)2009.01 (B26B19742806/09/2007
BLADE ืืืช ืืืืืืชืืืื ืืื ืืฉืืืืฉ ืืืขืจ SUPPORTS FOR USE INSHAVING SYSTEMS
THE GILLETTE COMPANY15/09/200611/521819US
PCT/IB/2007/053599WO/2008/032243
)2009.01 (B64D19742924/09/2007
DETECTING ืืืืื ืืืงืืงื ืงืจื ICE PARTICLESROSEMOUNT AEROSPACE INC.
25/09/200660/826827USPCT/US/2007/079328WO/2008/051673
![Page 84: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/84.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 84
)2009.01 (B24C19743011/09/2007
METHOD ืฉืืื ืืืืื ืืฉืืืื OF DOPING SURFACESENBIO LIMITED
11/09/20062006/0669IE06/04/200760/910464US
PCT/US/2007/078197WO/2008/033867
)2009.01 (A23L19743106/09/2007
FOOD ืชืืฉืืจ ืืืื COMPOSITIONKRAFT FOODS GLOBAL BRANDSLLC
11/09/20060607937FRPCT/FR/2007/051884WO/2008/031970
)2009.01 (C07K19743207/09/2007
ืคืืืืคืคืืืืื ืืืืจืืื ืืืคืจืฉืช ืืืืืช ืืืคืจืฉืช ื ืชืจื ืืจื ืืฉืชื ืืื ืคืขืื
ืืืจืืืช ืืื ืืื
AQUARETIC AND NATRIURETICPOLYPEPTIDES LACKINGVASODILATORY ACTIVITY
MAYO FOUNDATION FOR MEDICALEDUCATION AND RESEARCH
08/09/200660/825028USPCT/US/2007/077900WO/2008/031045
)2009.01 (A23L19743306/09/2007
FILLINGS ืืืืืืืKRAFT FOODS GLOBAL BRANDSLLC
11/09/20060607936FRPCT/FR/2007/051886WO/2008/031972
![Page 85: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/85.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200985
)2009.01 (H04N19743401/08/2007
ืฉืืื ืืืขืจืืช ืืฉืืืืจ ืชืืื ืืช ืืืืืืจ ื ืืืง
METHOD AND SYSTEM FORTRASMISSION OF IMAGES FROM AMONITORED AREA
MTEYEืืขืืืื MTEYEื"ื SECURITY LTD07/09/200611/516614US
PCT/IL/2007/000963WO/2008/029385
)2009.01 (A61L19743503/09/2007
ืืืืฉ ืืืืืจืื ืจืคืืืืื ืืืืจืืจืืืืืืืฉืืืืื ืขื ื ืืืืื ืืขืืืื ืืืื ืขืื
ืืืืจื
SURGICAL AND MEDICALGARMENTS AND MATERIALSINCORPORATING SHEARTHICKENING FLUIDSREGENT MEDICAL LIMITED
05/09/2006GB0617452.8
GB
PCT/GB/2007/003310WO/2008/029101
)2009.01 (G01J19743605/09/2007
PHOTODETECTOR ืืืื ืืืจHAMAMATSU PHOTONICS K.K.
06/09/20062006-241797
JP
PCT/JP/2007/067297WO/2008/029840
)2009.01 (H03M19743705/09/2007
AD ืืืืืืื ืืืืืฉื ืืืคืืโืืขืื ืืืืจ ืื ืืืื CONVERTER CIRCUIT ANDOPTICAL SENSORHAMAMATSU PHOTONICS K.K.
06/09/20062006-241818
JP
PCT/JP/2007/067302WO/2008/029841
![Page 86: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/86.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 86
)2009.01 (B32B19743801/03/2007
ืฉืืืชืืชโืืขืจืืช ืืืืืืช ืชืืืช ืจืUVืขืฉืืื ืืืืืจ ืขืืื ื ืื
UV RESISTANT MULTILAYEREDCELLULAR CONFINEMENT SYSTEM
ืืข.ืืก.ืืจ.ืคื .P.R.Sื"ืืืืืจื ืืื MEDITERRANEAN LTD.
PCT/US/2007/063081WO/2008/105876
)2009.01 (C08L19743901/03/2007
ืืคืฅ ืืืืืกืื ืืื ืืขื ืืืฆืืขืื ืืจืื ืืืืื
HIGH PERFORMANCEGEOSYNTHETIC ARTICLE
ืืข.ืืก.ืืจ.ืคื .P.R.Sื"ืืืืืจื ืืื MEDITERRANEAN LTD.
PCT/US/2007/063084WO/2008/105878
)2009.01 (C07D19744010/09/2007
ืคืื ืงืฆืืื ืืืืืชโืืืืงืืืืช ืงืื ืืช ืืืืืื ื ืื ืืชืจืืืชืืกืืื ื
MULTI-FUNCTIONAL SMALLMOLECULES AS ANTI-PROLIFERATIVE AGENTSCURIS, INC.
11/09/200660/843590US20/03/200760/895889US
PCT/US/2007/077971WO/2008/033747
)2009.01 (A61K19744114/09/2007
1HMGBโืAโBOXืชืืืืื ืคืืืืืจ ืฉืืฉืื AโBOXืืจืืื ืืื Nโ 1HMGB
POLYMER CONJUGATES OF BOX-AOF HMGB1 AND BOX-A VARIANTSOF HMGB1CREABILIS THERAPEUTICS S.P.A.
15/09/200606019362.0EP05/03/200760/904776US
PCT/EP/2007/008029WO/2008/031612
![Page 87: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/87.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200987
)2009.01 (C12P19744206/09/2007
FUSION ืืจืืืื ืชืจืคืืืืืื ืฉื ืืืืื ื ืืืืื PEPTIDE THERAPEUTICCOMPOSITIONSPHASEBIO PHARMACEUTICALS,INC.
06/09/200660/842464USPCT/US/2007/077767WO/2008/030968
)2009.01 (A61F19744307/09/2007
THERMAL ืืืกืื ืชืจืื COVERINGWYETH
08/09/200660/843119USPCT/IB/2007/053620WO/2008/029378
)2009.01 (C12N19744413/09/2007
CELL ืฉืืคืืจืื ืืชืจืืืช ืชืืื CULTURE IMPROVEMENTSABBOTT LABORATORIES
13/09/200660/845158US21/12/200660/876374US
PCT/US/2007/020027WO/2008/033517
)2009.01 (C07D19744506/09/2007
,1,2ืชืืืืืื ืืืื ืช ืืืืฆืืช ืื ืืืืืืช ืืืงืกืืืืืืโ4
PROCESSES FOR THE PREPARATIONOF 1,2,4-OXADIAZOLE BENZOICACIDSPTC THERAPEUTICS, INC
08/09/200660/843595USPCT/US/2007/019561WO/2008/030570
![Page 88: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/88.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 88
)2009.01 (A61F19744626/07/2007
ืขืืฆืื ืืืืืืจื ืฉื ืืืฉืืจ ืืืืงื ื ืืชืืื ืฉื ืืขืื ืืื
MODULAR DESIGN FOROPHTHALMIC SURGICAL PROBE
ALCON, INC.31/10/200611/554812US
PCT/US/2007/074433WO/2008/054900
)2009.01 (A61K19744710/09/2007
ืง ืื ืื ืืืืืืื ืืชืจ ืงืืฉืจ ืืขืืื ืืืจืืืื ืืืฅ
TYROSINE KINASE INHIBITORSCONTAINING A ZINC BINDINGMOIETYCURIS, INC.
11/09/200660/843730US20/03/200760/895901US
PCT/US/2007/077970WO/2008/033746
)2009.01 (A61K19744812/09/2007
ืืืงืืืื ืฉืืืืช ืืืชื ืกืืื ืื ืืืคื ืืืืฉืืื
METHODS FOR ADMINISTERINGLONG-LASTING HYPOGLYCEMICAGENTSSMITHKLINE BEECHAMCORPORATION
13/09/200660/825472US04/12/200660/868391US
PCT/US/2007/078226WO/2008/033888
![Page 89: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/89.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200989
)2009.01 (B65D19744906/09/2007
ื ืคืืืืื ืืืืืืื ืืืืจ ืคืขืื ืืจืืื ืืฉืืื ืืืื ืชื
PACKAGING FOR ACTIVE SUBSTANCE-CONTAINING FILMS AND METHOD FORPRODUCING THEMLTS LOHMANN THERAPIE-SYSTEMEAG
07/09/2006102006041921.9DEPCT/EP/2007/007333WO/2008/028560
)2009.01 (C12Q19745019/09/2007
, ืกืื ืื ืืืืืืืืื ืฉื ืืืคื ื ื ืืืจืื, ืืขืืืืช RAFืื ื ืืืื ืืืขืืื/ืืืื ื
BIOMARKERS OF TARGETMODULATION, EFFICACY,DIAGNOSIS AND/OR PROGNOSISFOR RAF INHIBITORSNOVARTIS AG
19/09/200660/845601USPCT/US/2007/078946WO/2008/082730
)2009.01 (C07D19745110/09/2007
ืืืืกืกื ืงืืืื ืืืืืืEGFRืืขืืื ืืืืืืื ืืชืจ ืืงืืฉืจ ืืืฅ
QUINAZOLINE BASED EGFRINHIBITORS CONTAINING A ZINCBINDING MOIETYCURIS, INC.
11/09/200660/843644US20/03/200760/895873US
PCT/US/2007/077977WO/2008/033749
![Page 90: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/90.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 90
)2009.01 (C07D19745210/10/2007
ืืื ืชื, ื ืืืจืืช ืืืืืืืืืืื ืืืฉืืชืืจืืืื ืคืจืืฆืืืืื ืืฉืืืืฉ, ืืชืจืืคืืช
ืืืืืื, ืืื ืืืขืืื ืคืจืืืืื ืงืื ืื7CDC
NEW IMIDAZOLONE DERIVATIVES,PREPARATION THEREOF AS DRUGS,PHARMACEUTICAL COMPOSITIONS,AND USE THEREOF AS PROTEINKINASE INHIBITORS, INPARTICULAR CDC7SANOFI-AVENTIS
12/10/20060608924FRPCT/FR/2007/001651WO/2008/046982
)2009.01 (A47J19745308/03/2009
ืืืฉืืจ ืืืจืืช ืืืฉื ืืกืื ืืื ืืืข ืื ืืื
A HANDS-FREE TOILET SEATLIFTING DEVICE
EREZ ืืจื ืืืจืืืื BOROCHOV14/07/200861/080280US
)2009.01 (B65D19745408/03/2009
A ืคืขืื ืืืืกืืช ืืงืืืโืืืกื ืื SINGLE-USE COVER FOR SHOT-GLASS
HAGAI ืืื ืคืืืืฉืืง POLISHUK
)2009.01 (G08B19745509/10/2006
ืืื ืชืื ืื, ืฉืืื ืืงืืืขืช ืืืกืื ืืืืืืืฉืชืืฉืื ืืืขืจืืช ืืื ืช ืืืืืืช
ืืฉืืื
METHOD FOR DETERMININGSENSOR COVERAGE, A DESIGNTOOL AND A BORDER PROTECTIONSYSTEM USING THE METHODTELEFONAKTIEBOLAGET LMERICSSON (PUBL)
PCT/NO/2006/000349WO/2008/044933
![Page 91: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/91.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200991
)2009.01 (G08B19745609/10/2006
ื ืงืืืขืช ืืืื ื ืื ืืืืืฉืืื ืืืขืจืืชMETHOD AND SYSTEM FORDETERMINING A THREAT AGAINSTA BORDERTELEFONAKTIEBOLAGET LMERICSSON (PUBL)
PCT/NO/2006/000350WO/2008/044934
)2009.01 (G03B19745721/09/2007
MIRROR ืื ืืข ืืจืื ืขืืืจ ืืฆืืื DRIVE FOR A CAMERAROLLEI GMBH
21/09/2006102006045599.1DEPCT/DE/2007/001732WO/2008/034439
)2009.01 (A01N19745810/09/2007
A ืืืืจ ืืืืืจืช ืืืืงืื ืืฆืืจืช ืชืจืืืฃ PEST CONTROL AGENT IN THEFORM OF A SUSPENSIONNIPPON SODA COMPANY LTD.
12/09/20062006-246658
JP
PCT/JP/2007/067584WO/2008/032671
![Page 92: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/92.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 92
)2009.01 (A61K19745910/09/2007
ืืฉืืืืช, ืืืื ื ืืืื ืื, ืืืืื ืื ืืืื ืฉืื ืืืื ืชื
HUMANIZED PROTEINS, INCLUDINGANTIBODIES AND METHODS FORPRODUCING THE SAMEGLYCOTOPE GMBH
10/09/200606090162.6EP18/09/200606090171.7EP13/10/200606090190.7EP04/05/200707090094.9EP
PCT/EP/2007/007877WO/2008/028686
)2009.01 (H04L19746025/10/2007
ืืขืงื ืืืจ ื ืชืื ื ืืฆื ืืฉืชื ืื ืืกืืืข ืืืืืืช ืจืฉืช ืืืฉื
TRACKING CHANGING STATE DATATO ASSIST IN COMPUTER NETWORKSECURITYARCSIGHT, INC.
25/10/200660/862932US24/10/200711/923502US
PCT/US/2007/082560WO/2008/052133
)2009.01 (G06F19746125/10/2007
ืืืืื ืืืื ืืืช ืฉื ืืืื ื ืืก ืืกืืืื ืฉื ื ืืก ืืกืืืข ืืืืืืช ืจืฉืช ืืืฉืืื
REAL-TIME IDENTIFICATION OF ANASSET MODEL ANDCATEGORIZATION OF AN ASSET TOASSIST IN COMPUTER NETWORKSECURITYARCSIGHT, INC.
25/10/200660/862930US24/10/200711/923513US
PCT/US/2007/082562WO/2008/052135
![Page 93: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/93.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200993
)2009.01 (A46B19746204/07/2007
ื ืืงืื ืืฆืืจืช ืคืก ืฉืืืชื ืงืืืคืชื ืืืืืชืขืืืจ ืืืฆืืจ ืืืจืฉืืช ืกืืืืืืืช
ืืืขืจืืืช ืฉืืืคืช ืืืื ืืืช
VELVETY LAMINAR STRIP CLEANINGELEMENT FOR MAKING ROTARYBRUSHES FOR MOTOR VEHICLEWASHING SYSTEMSFAVAGROSSA EDOARDO S.R.L.
12/09/2006MI2006A001742ITPCT/IT/2007/000481WO/2008/032344
)2009.01 (B82B19746308/03/2009
THIN-LAYERED ืืื ื ืขื ืฉืืืืช ืืงืืช STRUCTUREACKTARื"ืืงืืจ ืืข LTD.
)2009.01 (A61K19746408/03/2009
FOAMABLE ืชืืฉืืจ ืืืคืืงืื ืืืงืฆืฃ TOPICAL COMPOSITIONืชืจืืื ืชืืฆืจื ืจืคืืื ืืฉืจืืืืื ืืขืืจืืช
ื"ืืขTRIMA ISRAEL PHARMACEUTICALPRODUCTS MAABAROT LTD.
)2009.01 (A61F19746505/09/2007
PELVIC ืืชืงื ืชืืืื ืืืื ANCHOR BRACEKOALAื"ืงืืืื ืืืืืจื ืืจืืืืช ืืข HEALTH ACCESSORIES LTD
07/09/200660/842663US20/02/200760/902047US
PCT/IL/2007/001099WO/2008/029404
![Page 94: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/94.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 94
)2009.01 (F02B19746610/09/2007
ืืขืจืืช ืืืชืืืืืืืื ืืืืฆืืจ ืืฉืื ืขื ืืืืฉืืืืฉ ืืื ืืข ืืื ืืืื ืืืืืจ
ืคืืืืืืืงืืจื
SYSTEM AND METHODOLOGY FORGENERATING ELECTRICITY USINGA CHEMICAL HEAT ENGINE ANDPIEZOELECTRIC MATERIALPEACOCK, KIMBERLY
08/09/200611/530147USPCT/US/2007/078031WO/2008/031096
)2009.01 (G02C19746712/09/2007
MECHANICAL ืฆืืจ ืืื ื ืืื ืืืจืกืื UNIVERSAL HINGECHIC OPTIC, INC.
12/09/200611/531180USPCT/CA/2007/001594WO/2008/031204
)2009.01(A61K19746810/09/2007
ืชืืฉืืจื ืงืฆืฃ ืืืคืืงืืืื ืฆืืืขืื ืื ืืชื ืื ืืฆืืืขื
COLORED OR COLORABLEFOAMABLE COMPOSITION ANDFOAM
FOAMIXื"ืคืืืืืงืก ืืข LTD08/09/200660/843144US
PCT/IB/2007/003351WO/2008/032212
)2009.01 (F16F19746913/09/2007
ืืืืชืงื ืื ืืืฉืื, ืืื ืืฉืืืื ืขื ืืืืื ืืืืื ืืช ืืืชืงื
FRICTION DEVICE FORCONTROLLING FORCE, AND AFRICTION DAMPER COMPRISINGSUCH A DEVICEMESSIER-DOWTY SA
14/09/20060653744FRPCT/FR/2007/051931WO/2008/031998
![Page 95: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/95.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200995
)2009.01 (A61K19747011/09/2007
ืืืืฆืืจ ืืื ืกืืืื ืืฆืืจืช ืฉื ืชืืฉืืจ ืฉืืื ืืืจืื
METHOD FOR PRODUCING INSULININ THE FORM OF AN ORALPREPARATIONCONCERN 03" COMPANY LIMITED
13/09/20062006132763RUPCT/RU/2007/000483WO/2008/033058
)2009.01 (A61F19747103/11/2002
NON-PENETRATINGืจื ืืชืื ืกืื ืื ืื ืืื FILTRATIONSURGERY
Iื"ืืื ืืืคืืืื ืืข OPTIMA LTD.15/11/200160/331402US
PCT/IL/2002/000872WO/2003/041623
)2009.01 (C01B19747213/09/2007
ืฉืืื ืืืชืงื ืืงืืืช ืกืืืืงืื ืืืืจPROCESS AND APPARATUS FORPURIFYING LOW-GRADE SILICONMATERIALSILICIUM BECANCOUR INC.
14/09/200660/844372USPCT/CA/2007/001646WO/2008/031229
)2009.01 (A61K19747308/03/2009
ืืกืืจืื ืคืจืืืจืืื ืืืืงืืจืื ืืืื ืฉืืจืืฆืืงืืื ืื ืืฉืืื ืืืื ื ืืฉืืืืฉ'ืื ืช
ืืืืืืชืจืคืื ืฉื ืืืืื ืกืืงืืืื
ESTERS OF GLUCURONIDEPRODRUGS OF ANTHRACYCLINESAND METHOD OF PREPARATIONAND USE IN TUMOR-SELECTIVECHEMOTHERAPYPHARMACHEMIE B.V.
07/03/200808004249.2EP
![Page 96: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/96.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 96
)2009.01 (A61K19747417/10/2007
LONG-TERM ืืื ื ืืืืื ืืจืื ืฉื ืืืขื ืขืืืจ ืชืืืืงื ENTERAL FEED FORMAINTENANCENESTEC S.A.
19/10/200660/862168USPCT/EP/2007/061086WO/2008/046857
)2009.01 (A23L19747517/10/2007
LONG-TERM ืืื ื ืืืืื ืืจืื ืฉื ืงืฉืืฉืื FEED-ELDERLYNESTEC S.A.
19/10/200660/862156USPCT/EP/2007/061098WO/2008/046865
)2009.01 (A23L19747617/10/2007
LONG-TERM ืืื ื ืืืืื ืืจืื ืฉื ืงืฉืืฉืื FEED-CANCERPATIENTNESTEC S.A.
19/10/200660/862159USPCT/EP/2007/061108WO/2008/046870
)2009.01 (G06F19747708/03/2009
, ืืขืจืืช ืืฉืืื ืืืืืื ืงืืฆืื ืืืืงืืืืื ืื ืืืืจ ืจืฆืคืื ืืืืืกืกืืช ืขื ืื
ืืืคืืื ืืื ืฉื ืงืจืืืืช ืืขืจืืช ืืคืขืื
SYSTEM AND METHOD FORDETECTING NEW MALICIOUSEXECUTABLES, BASED ONDISCOVERING AND MONITORINGOF CHARACTERISTIC SYSTEM CALLSEQUENCES
ืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืื ืืืืงืจ ืืคืืชืื
BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
![Page 97: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/97.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200997
)2009.01 (G06F19747807/09/2007
ืืขืจืืช ืืฉืืื ืืฉืื ืจืืืง, ืืืืืช ืืืฉืง ืืืืฉื
COMPUTER REMOTE CONTROLMODULE, INTERFACE, SYSTEM ANDMETHODPOWERDESK LTD.
07/09/20060617583.0GB07/09/200660/843285US
PCT/GB/2007/003413WO/2008/029174
)2009.01 (C07K19747902/10/2007
ื ืืืื ืื ืืืื ืฉืื ืืขืื ืืืงื ืืืืื ืืืื ืฉILโ4ืืงืืืื
HIGH AFFINITY HUMANANTIBODIES TO HUMAN IL-4RECEPTORREGENERON PHARMACEUTICALS,INC.
02/10/200660/848694US24/08/200760/957738US
PCT/US/2007/021210WO/2008/054606
)2009.01 (H04W19748003/10/2007
ืฉืืืืจ ืืืชืืช ืืืฉื ืืงืจืืืช ืืืืชืช ืขืืืจ ืืืฉืช ืืขืจืืช ืืชืงืฉืืจืช ืืืืืืืช
RANDOM ACCESS SIGNALINGTRANSMISSION FOR SYSTEMACCESS IN WIRELESSCOMMUNICATIONQUALCOMM INCORPORATED
03/10/200660/828058USPCT/US/2007/080319WO/2008/042967
![Page 98: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/98.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 98
)2009.01 (H04B19748101/10/2007
ืกื ืืจืื ืฉืืืืจืื ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
SYNCHRONIZATIONTRANSMISSIONS IN A WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED
03/10/200660/828051USPCT/US/2007/080111WO/2008/042865
)2009.01 (H04L19748229/11/2001
ืฉืืื ืืืขืจืืช ืืชืืงืืฃ ืืงืฆื ืืืืืื ืฉืืืกืืจืืช ืืืืืจ ื ืื ืกืืช ืืขืืืช ืงืฆื
ืืฉืชื ื
METHOD AND SYSTEM FORVALIDATING DETECTED RATES OFRECEIVED VARIABLE RATE SPEECHFRAMESQUALCOMM INCORPORATED
04/12/200009/730147USPCT/US/2001/044574WO/2002/047316
)2009.01 (G01V19748310/10/2007
ืฉืืื ืืืชืงื ืืฉืืืืจ ืกืืจืชื ืืืื ืฉืืืืชืืช ืงืืืื ืฉื ืืชืืจืื
ืืืงืืจืืืงืืกืืื
METHOD AND DEVICE FOR THE TIMESERIAL TRANSMISSION OF RECEPTIONSIGNALS OF ELECTROACOUSTICTRANSDUCERSATLAS ELEKTRONIK GMBH
30/10/2008102006051065.8DEPCT/EP/2007/008798WO/2008/052641
![Page 99: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/99.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 200999
)2009.01 (C07D19748407/01/2003
โ 3,1โ)ืืืโ2โืืื ืืืโ1H(โ7โืืืื ืโ5ืโ2โืคืืจืืืื]Bโ5,4ืืืืืืืโืืืืืืจื โืืื
7โ)1Hโ3โืืชืืโ2โ)ืืืโ2โืืื ืืืHโ ืืืืืืื
]5,4โB[ืืืืืืื ืืฉืจ ืื ืืืืืโ5โืคืืจืืืืืืชืืฉืืจืBOCืืื ืงื ืืืื ืื ืืงืืืฆืืช ืจืืงืืืช ืืืืืืื ืืืชื
5-AMINO-7-(1H-INDOL-2-YL)-1,3-DIHYDRO-IMIDAZOL[4,5-b]PYRIDIN-2-ONE AND ITS N- BOC PROTECTED-7-(1H-INDOL-2-YL)-2-METHYL-3H-IMIDAZO[4,5-b]PYRIDIN-5-YLAMINEAND PHARMACEUTICALCOMPOSITIONS COMPRISING THEM
EISAI R&D MANAGEMENT CO., LTD.07/01/200260/346598US
PCT/US/2003/000366WO/2003/057696
)2009.01 (A61K19748521/09/2007
ืืื ืืขืชDืฉืืืืฉ ืืชืจืืืืืช ืฉื ืืืืืื ืืืืืงืืืืช
USE OF VITAMIN D COMPOUNDSFOR THE PREVENTION OFADHESIONSBIOXELL SPA
22/09/20060618700.9GB22/09/200660/846832IL
PCT/EP/2007/060068WO/2008/034908
)2009.01 (A61K19748612/10/2007
NOVEL ืฉืืื ืืืฉื ืืืืคืื ืืืื ืืื ืืช ืืืจืืช METHOD OF TREATMENT OFMALE SUB-FERTILITYBIOXELL SPA
13/10/20060620284.0GB13/10/200660/851683US
PCT/EP/2007/060923WO/2008/043857
![Page 100: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/100.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 100
)2009.01 (G01N19748712/09/2007
IMPROVED ืฉืืืช ืชืืืื ืืืืื ื ืืฉืืคืจืืช IMMUNOASSAYMETHODSONCIMMUNE LIMITED
13/09/200660/844158US13/09/20060618055.8GB
PCT/GB/2007/003486WO/2008/032084
)2009.01 (A23L19748817/09/2007
ืืืืื ืืืืื ืฉื ืชืืืกื ืืชืืฉืืจื ืืืชืงื ืฉืืื ื ืืืจืืื ืืืืคืฉืืืช
BALANCING HEAT OF SOLUTION INNON-FREE FLOWING SWEETENERCOMPOSITIONSMCNEIL NUTRITIONALS, LLC
18/09/200611/532880USPCT/US/2007/020229WO/2008/036276
)2009.01 (C01F19748922/08/2007
ืืื ืงืืจืืช?โื? ืชืืืื ืืืฆืืจ ืชืขืจืืืช ืืขื ืขืงืืืืช ื ืืืื
PROCESS FOR MANUFACTURINGULTRA LOW CONSISTENCY ? AND?-BLEND STUCCOUNITED STATES GYPSUM COMPANY
20/09/200611/533604USPCT/US/2007/018558WO/2008/036160
)2009.01 (A23L19749017/09/2007
ืชืืฉืืจื ืืืชืงื ืืืืืฉืื ืฉืืื ื ืืืจืืื ืงืืืจืืืชโืืืืคืฉืืืช ืืืืืืื ืจืืืืื ืืื
COHESIVE NON-FREE FLOWINGSWEETENER COMPOSITIONSINCLUDING LOW-CALORIEINGREDIENTSMCNEIL NUTRITIONALS, LLC
18/09/200611/532885USPCT/US/2007/020220WO/2008/036270
![Page 101: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/101.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009101
)2009.01 (A23L19749117/09/2007
SOLID ืืืืืช ืืื ืื ืืืฆืงื ืฉื ืชืืฉืืจื ืืืชืงื UNIT DOSE, SWEETENINGCOMPOSITIONSMCNEIL NUTRITIONALS, LLC
18/09/200611/532887USPCT/US/2007/020137WO/2008/036234
)2009.01 (A61B19749220/09/2007
ืืชืงื ืืืชื ืืืืจ ืื ืืชื ืืขืืฆืื ืืืืื ืืืง ืืกืชืืื ืืืกืคืงืช ืืืืืจ
CURABLE MATERIAL DELIVERYDEVICE WITH A ROTATABLESUPPLY SECTIONALLEGIANCE CORPORATION
22/09/200611/526164USPCT/US/2007/020421WO/2008/039355
)2009.01 (A61B19749325/09/2007
HEAT ืงืื ืื ืขืืืจ ืืืืื ืชืจืกืืก ืงืคืืืจื CAPACITOR FOR CAPILLARYAEROSOL GENERATORPHILIP MORRIS PRODUCTS S.A.
25/09/200611/526123USPCT/IB/2007/003701WO/2008/038144
)2008.04 (H04J19749419/05/2000
โืงืืืืืช ืืืงืจืช ืืจืืื ืฉื ืขืจืืฅ ืจื ืืฉืชืืฉืื
PRIORITIZATION AND FLOWCONTROL OF A SPREADSPERCTRUM MULTIUSER CHANNELINTERDIGITAL TECHNOLOGYCORPORATION
20/05/199960/135073USPCT/US/2000/013918WO/2000/072608
![Page 102: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/102.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 102
)2009.01 (C12N19749510/09/2007
ื ืืขืืืืsiRNAsโืชืืฉืืจื ืจืืงืืืชEBP?/C
COMPOSITIONS AND siRNAs FORINHIBITING C/EBP?
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
10/09/2006177989ILPCT/IL/2007/001112WO/2008/029414
)2009.01 (A61K19749625/09/2007
ืชืืฉืืจืื ืจืคืืืืื ืืืืืืื ื ืืืืืื ืื ืื ืืื ืฉืื
PHARMACEUTICAL COMPOSITIONSCOMPRISING NILOTINIB OR ITSSALTNOVARTIS AG
27/09/200606121371.6EPPCT/EP/2007/060165WO/2008/037716
)2009.01 (A61K19749714/09/2007
ืืขืจืืืช ืืืืื ืฉื ืืืืืืื ืงืืืืืื ืื ืืืจืืื
OLIGONUCLEOTIDE NON-VIRALDELIVERY SYSTEMS
FMC BIOPOLYMER AS15/09/200660/844729US
PCT/EP/2007/059740WO/2008/031899
)2009.01 (C08B19749805/09/2007
ืืืืืืจืื ืืช ืืืืฉืืช ืชืืืืืช ืืืืฆื"ืืืืืืช ื ืงืืฉื"ืืจื ืงืืฉืืจ ืืฆืืื ืฉื
HYALURONIC ACID DERIVATIVESOBTAINED VIA CLICK CHEMISTRY'CROSSLINKINGFIDIA FARMACEUTICI S.P.A.
11/09/2006MI2006A001726ITPCT/EP/2007/007758WO/2008/031525
![Page 103: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/103.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009103
)2009.01 (G07B19749909/03/2009
ืฉืืื ืืืขืจืืช ืืืืฆืืข ืขืืกืงืืช ืืฉืจืื ืืื ืฆืืจื ืืืจืืืก
METHOD AND SYSTEM FORPERFORMING CREDITTRANSACTIONS WITH NO CARD
YUVAL ืืืื ืืืกืงืืืืฅ MOSCOVICH
)2009.01 (A61K19750021/09/2007
ืืื ืืืืืืื, ื ืืืจืืช ืฉื ืคืืจืืืืืืืืืืื ืชื ืืฉืืืืฉืืื ืืจืคืืื, ืืงืืืื ืืืืืื
DERIVATIVES OF PYRROLIZINE,INDOLIZINE AND QUINOLIZINE,PREPARATION THEREOF ANDTHERAPEUTIC USE THEREOFSANOFI-AVENTIS
22/09/20060608348FRPCT/FR/2007/001545WO/2008/037881
)2009.01 (A61K19750111/09/2007
ื ืืืืืคืืงืฆืืืช ืฉื ืคืคืืืืื ื ืืืจื ืืงืืคืจืืืงืกืื ืืฉืืืืช ืืฉืืืืฉ ืืื
MODIFICATIONS OF CUPREDOXINDERIVED PEPTIDES AND METHODSOF USE THEREOFTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS
11/09/200660/843388USPCT/US/2007/078136WO/2008/033820
![Page 104: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/104.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 104
)2009.01 (A61K19750211/09/2007
ื โืคืืคืจืืืืโืืืื ืโ3ืโ(โ6โ2ืฉืืืืฉโ3,4โืืืืืงืกืโ2,4โืืชืื3โ)ืืืโ1
โ1โืคืืจืืืืืืโH2โืืืืืืจืโ4โืืืืืชืื ืื ืืื ืืืจืืโืคืืืืืจื
USE OF 2-6-(3-AMINO-PIPERIDIN-1-YL)-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMET HYL-4-FLUORO-BENZONITRILE
TAKEDA PHARMACEUTICAL COMPANYLIMITED
13/09/2006PCT/US2006/035958US13/03/200760/894628US
PCT/US/2007/078177WO/2008/033851
)2009.01 (F41B19750309/03/2009
GUIDED ืืื ืืื ืื MISSILEDIEHL BGT DEFENCE GMBH & CO. KG
13/03/2008102008014257.3DE
)2009.01 (C07C19750431/08/2007
ื ืืืจืืช ืืืืืกืจืื ืืืขืืื ืคืงืืืจ ืงืจืืฉืIXa
ISOSERINE DERIVATIVES ASINHIBITORS OF COAGULATIONFACTOR IXaSANOFI AVENTIS
13/09/2006102006042926.5DEPCT/EP/2007/007613WO/2008/031509
)2009.01 (C07C19750531/08/2007
ื ืืืจืืช ืืจืืจื ืืฉืืืืฉ ืืืขืืื ืคืงืืืจIXaืงืจืืฉื
TARTRATE DERIVATIVES FOR USE ASCOAGULATION FACTOR IXaINHIBITORSSANOFI AVENTIS
13/09/2006102006042927.3DEPCT/EP/2007/007612WO/2008/031508
![Page 105: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/105.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009105
)2009.01 (C07D19750610/09/2007
NOVELืช ืืืฉื ืฉื ืืืืฆื ืคื ืืืืฆืืืชื ืืืจ PHENYLACETIC ACIDDERIVATIVEFUJI YAKUHIN CO., LTD.
11/09/20062006-245194
JP
PCT/JP/2007/067568WO/2008/032665
)2009.01 (C07D19750710/09/2007
โ4ืชืืืืืช ืืืื ืืืคืืจืื ืืืช ืืืขืืืPDE10โืโPDE
DIBENZOFURAN DERIVATIVES ASINHIBITORS OF PDE-4 AND PDE-10
MATRIX LABORATORIES LIMITED11/09/20061647/CHE/2006IN
PCT/IB/2007/002596WO/2008/032171
)2009.01 (A01N19750801/09/2007
OIL-BASED ืชืจืืืื ืชืจืืืคืื ืืืืกืกื ืฉืื SUSPENSIONCONCENTRATESBAYER CROPSCIENCE AG
15/09/2006102006043444.7DEPCT/EP/2007/007655WO/2008/031512
)2009.01 (A61K19750905/10/2007
ื ืื ืฉืืคืืจ ืฉื ืงืจืืฉื ืชืื/ืืืจื ืืืืคืื ืขืืจืงืืช ืืชืคืฉืืช
THERAPEUTIC AND/ORAMELIORATING AGENT FORDISSEMINATED INTRAVASCULARCOAGULATIONASAHI KASEI PHARMACORPORATION
06/10/20062006-274573
JP
PCT/JP/2007/069560WO/2008/044631
![Page 106: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/106.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 106
)2009.01 (C07D19751002/10/2007
PROCESS ืชืืืื ืืืื ืช ื ืืืืืืื FOR PREPARING NEBIVOLOLZACH SYSTEM S.P.A.
03/10/2006MI2006A001889ITPCT/EP/2007/008549WO/2008/040528
)2009.01 (A61F19751119/09/2007
ืฉืโืคืจืื ืื ืคืขืื ืืืืื ืคืกืืืช ืืฉืืืื ืืื ืืชโืฉื ื ืคืจืืืื ืื ืืืฉืื ืื
A DISPOSABLE WASTECONTAINMENT ARTICLE AND ACOMBINATION OF TWO ARTICLESWORN SIMULTANEOUSLYTISTERON, LTD.
20/09/200660/845771US17/09/200711/901635US
PCT/US/2007/020264WO/2008/036296
)2009.01 (A61K19751210/10/2007
ืืืกืื ืืืืื ืชืืกืฃ ืฉืื ื ืืืืืกืืืช ืฉืื ืืืื
VACCINE COMPRISING AN OIL INWATER EMULSION ADJUVANT
GLAXOSMITHKLINE BIOLOGICALS S.A.12/10/20060620336.8GB12/10/20060620337.6GB19/10/20060620815.1GB19/10/20060620816.9GB20/12/2006PCT/EP06/069977EP20/12/2006PCT/EP06/069979EP20/04/20070707697.9GB12/06/20070711357.4GB21/06/20070712062.9GB
PCT/EP/2007/060743WO/2008/043774
![Page 107: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/107.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009107
)2009.01 (C07D19751314/09/2007
ืชืืืืืช ืคืืจืืืืืคืืจืืืืืื ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื
PYRAZOLOPYRIMIDINEDERIVATIVES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAMEDAIICHI SANKYO COMPANY,LIMITED
19/09/20062006-253465
JP
PCT/JP/2007/067933WO/2008/035629
)2009.01 (C23C19751407/09/2007
ืืืฉืืจ ืืืชืื ืืฆืืคื ืืฉืืื ืืืื ืชืCOATED CUTTING TOOL ANDMETHOD FOR THE PRODUCTIONTHEREOFSANDVIK INTELLECTUALPROPERTY AB
15/09/20060601950-9SEPCT/EP/2007/059376WO/2008/031768
)2009.01 (A61K19751515/09/2007
ืืกืคืงื ืคืืืืืจืืืช ืืืืืืืช ืืขืจืืืช ืคืืืืืืงืืื ืืืงืกืืืื
POLYMERIC DELIVERY SYSTEMSCONTAINING POLYALKYLENEOXIDESENZON PHARMACEUTICALS, INC.
15/09/200660/844942USPCT/US/2007/078593WO/2008/034119
![Page 108: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/108.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 108
)2009.01 (A01N19751615/09/2007
ืคืืืืืจืืืช ืขื ืืกืืก ืืขืจืืืช ืืกืคืงื ืืกืืจ
ESTER-BASED POLYMERICDELIVERY SYSTEMS
ENZON PHARMACEUTICALS, INC.15/09/200660/845028US
PCT/US/2007/078597WO/2008/034122
)2009.01 (A61K19751715/09/2007
ืชืจืืคืืช ืคืืืืืจืืืช ืืืืื ืืช ืืืืืืืโืคืจืืืฉโืืงืฉืจืื ืจื ืืืืช ืืืื ืชืืชืืืืชืืื
TARGETED POLYMERIC PRODRUGSCONTAINING MULTIFUNCTIONALLINKERS AND METHODS OF USETHEREOFENZON PHARMACEUTICALS, INC.
15/09/200660/844943USPCT/US/2007/078600WO/2008/034124
)2009.01 (A61K19751812/10/2007
ืืืื ืืืืืกืจืื ืฆืืจืช ืืื ืื ืืืฆืงืช ืื ืืืืงืกืืืื ืืืืืืืืคืื
SOLID DOSAGE FORM OFOLMESARTAN MEDOXOMIL ANDAMLODIPINEDAIICHI SANKYO COMPANY,LIMITED
15/09/200660/845090USPCT/GB/2007/003933WO/2008/032107
![Page 109: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/109.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009109
)2009.01 (A61K19751915/09/2007
ืืจืืืช ืขื ืืกืืก ืืขืจืืืช ืืกืคืงื ืคืืื ืืฉืืืืช ืืืื ืชื, ืืืกืื
LYSINE-BASED POLYMERICDELIVERY SYSTEMS AND METHODSOF PRODUCING THE SAMEENZON PHARMACEUTICALS, INC.
15/09/200660/844945US27/11/200660/861349US13/04/200760/911734US
PCT/US/2007/078594WO/2008/034120
)2009.01 (A47J19752010/03/2009
ืืชืงื ืืืืืื ื ืืืจ ืืืืื ืืืืจืื ืืชืืช ืืืืืจ ืขื ืฆืื ืืจ ืื ืืงืื
A TOILET PAPER ROLL DEVICEASSEMBLED UNDERNETH THE SINKON THE DRAINAGE PIPE
COHEN ืืืื ืืื MALKA04/02/200961/147764US
)2009.01 (B01F19752112/09/2007
ืฆืืคืื ืงืฆื ืืขื ืขืืืืืช ืืืฆื ืืฉืืื ืืืื ืชื
ALGAE RESISTANT EDGE COATINGAND METHOD OF FORMING SAME
MUNTERS CORPORATION12/09/200611/518959US
PCT/US/2007/019750WO/2008/033354
![Page 110: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/110.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 110
)2009.01 (B01J19752316/09/2007
ืืืจืื ืื ืืืชืงืืืื ืืืงืืงืืโื ื ื ืืืืืกืืืช ืขื ืืื ืืืืื ืืืืกโืืืืงืจื
ORGANIC NANOPARTICLESOBTAINED FROMMICROEMULSIONS BY SOLVENTEVAPORATION
ืืืฉืื ืืืจื ืืคืืชืื ืืืืงืจ ืฉืื"ืืืื ืืืจืกืืื ืืขืืจืืช ืืืจืืฉืืื ืืข
YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
14/09/200660/844365USPCT/IL/2007/001136WO/2008/032327
)2009.01 (A01N19752416/09/2007
ืืืงืืงืื ืฉื ืงืืืื ืขืฉืืืโื ื ืโืืืืืกืืืช ืื ื ืโืืืชืงืืืื ืืืืงืจื
ืืืืืกืืืช
PESTICIDE NANOPARTICLESOBTAINED FROMMICROEMULSIONS ANDNANOEMULSIONS
ืืขืืืชืฉื ื"ื ืืคืขืืื ืืืืืืYISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
14/09/200660/844366USPCT/IL/2007/001137WO/2008/032328
)2009.01 (A61B19752511/03/2009
ืฉืืื ืืืชื ืคืืืฉื ืืช ืืืืฉืืจ ืื ืืืืืขืชืืืืื ืืืืืืช ืืคืื ืื ืืืื ืืืงืืืช
ืืืจืืช ืืฆื ื ืฉ ืื ืืกืืืคืืืืืืืช ืืืืืช ืืฉืง ืืืืืืื ืฉืื ืื
A NON INVASIVE METHOD ANDDEVICE FOR PREDICTION OFFUTURE ABORTION OR PRETERMDELIVERY AND OTHER MEDICALDISORDERS IN ASYMPTOMATICWOMEN AND DOMESTIC ANIMALSOF VARIOUS AGES
ABRAHAM ืืืจืื ืงืกืืจ KESSLER
![Page 111: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/111.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009111
)2009.01 (A61M19752611/09/2007
ืืชืงื ืืืื ื ืืคื ื ืชืกืืืฃ ืื ืืฉืืื ืืฉืืืืฉ
EMBOLIC PROTECTION DEVICE ANDMETHOD OF USEEMBRELLA CARDIOVASCULAR ,INC.
11/09/200611/518865USPCT/US/2007/078170WO/2008/033845
)2009.01 (C07C19752711/09/2007
ืชืืืื ืืืืืจื ืืื ืืื ืืืื ืช ืืขืืื ืืื ืืืจืื
PROCESS AND INTERMEDIATES FORPREPARING INTEGRASE INHIBITORS
GILEAD SCIENCES, INC.12/09/200660/844020US07/03/200760/905365US
PCT/US/2007/078157WO/2008/033836
)2009.01 (A61K19752817/09/2007
ืฉื, ืฉืืืืช ืืฉืืืืฉ, ืกืื ืชืืื ืืชืืฉืืจืื ืฆืืงืืืืืงืืืืชืืืืืื ืื
SYNTHESIS, METHODS OF USING,AND COMPOSITIONS OFCYCLOALKYLMETHYLAMINESREVIVA PHARMACEUTICALS, INC
15/09/200660/825868USPCT/US/2007/078682WO/2008/034142
)2009.01 (C12N19752901/10/2007
ืชืืฉืืจืื ืืฉืืืืช ืืืืฆืืจ ืกืืืื ืื ืืืืจืืืืืืคื ืกืืจืืืืืืืืืจื ืืืืืจื ืืื ืืื
ืกืื ืชืืืื ืขืืืจื
COMPOSITIONS AND METHODS FORPRODUCING STEREOISOMERICALLYPURE STATINS AND SYNTHETICINTERMEDIATES THEREFORCODEXIS, INC
02/10/200660/848951USPCT/US/2007/080125WO/2008/042876
![Page 112: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/112.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 112
)2009.01 (C07D19753010/09/2007
ืชืืืืืช ืงืืืื ืืืืืื ืื ืืืืืืงืืืื ืืืื ืื ืืฆืืืืื
QUINAZOLINONE ANDISOQUINOLINONE ACETAMIDEDERIVATIVESPHARMASCOPEIA, LLC
11/09/200660/843718USPCT/US/2007/078022WO/2008/033764
)2009.01 (C07H19753120/09/2007
ืืืืื ืืชืืื ืช ืื ืืืช ืฉื ืืืืื ืืืืืืชืืจืื ืืกืืืคืื ืืืืคื ืืจืจื ื
ืืืืืืงืืจืื
GENETICALLY PROGRAMMEDEXPRESSION OF SELECTIVELYSULFATED PROTEINS INEUBACTERIATHE SCRIPPS RESEARCH INSTITUTE
21/09/200660/846519US28/10/200660/855210US
PCT/US/2007/020459WO/2008/036392
)2009.01 (A61K19753211/03/2009
ANALYTE ืฉืืื ืืืขืจืืช ืืืืืงืช ืืืืจ TESTING METHOD ANDSYSTEMLIFESCAN SCOTLAND LTD.
21/03/200861/038624US
)2009.01 (A01N19753324/09/2007
ื ืืฉ/ืชืืฉืืจ ืืืืคืื COMPOSITION ืื ืื ืืขืช ืคืืืขืช FOR THE TREATMENTAND/OR PREVENTION OF FIRE BLIGHTLANXESS DISTRIBUTION GMBH
27/09/2006102006045505.3DEPCT/EP/2007/060078WO/2008/037677
![Page 113: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/113.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009113
)2009.01 (H01G19753427/09/2007
ENERGY ืืกืื ืื ืจืืืืืืืื ืื STORAGE MODULESIEMENS AKTIENGESELLSCHAFT
28/09/2006102006046042.1DEPCT/EP/2007/060253WO/2008/037763
)2009.01 (A61F19753510/09/2007
ืกื ืื ืืชื ืื ืืคืื ืืืฉืืฉ ืืงืืืืข ืืืืจINFLATABLE ืคืืืข SPLINT
ORTHO-FLEXื"ืืืจืชืืคืืงืก ืืข LTD14/09/200660/844383US
PCT/IL/2007/001111WO/2008/032309
)2009.01 (C07D19753626/09/2007
H3(4โืคืืจืืืืืื]Dโ4,3[ืชืืืืืช ืคืืจืืื ืืื ืืื ืืืื ืืกืืื ืฉื ืงืืืื ืกืืืโ)
PYRIDO [4,3-D]PYRIMIDIN-4(3H)-ONEDERIVATIVES AS CALCIUMRECEPTOR ANTAGONISTSPFIZER PRODUCTS INC.
04/10/200660/828162US30/08/200760/969083US
PCT/IB/2007/002976WO/2008/041118
)2009.01 (F03G19753720/09/2007
ืืืืฉ ืืืฉืื ืืงืืืขโืืืืจ ืชื ืืขืช ืจืื ืืชืื ืคืก ืืืื
VEHICULAR MOVEMENTELECTRICITY CONVERTEREMBEDDED WITHIN A ROAD BUMP
INNOVATIVEื"ืืื ืืืืื ืคืื ืืื ืืข PATENTS LTD.20/09/200660/845772US
PCT/IL/2007/001165WO/2008/035348
![Page 114: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/114.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 114
)2009.01 (E04F19753811/09/2007
ืคื ื ืืืกืื ืขื ืงืฆืืืช ืืฉืืคืขืื ืืขื ืืชื ืืฉืชื ื ืืืขืจืืช ืืฉืืื ืืืืฆืืจื
COVERING PANEL WITH BEVELLEDEDGES HAVING VARYING CROSS-SECTION, AND APPARATUS ANDMETHOD OF MAKING THE SAMESPANOLUX N.V. -DIV. BALTERIO
11/09/200606120427.7EP20/02/200707102710.6EP
PCT/EP/2007/059544WO/2008/031829
)2009.01 (C07K19753927/08/2002
ืื ืืืืฆืืช ืขื8.ืื.ืืจืขืื ืืคืืืืคืคืืืืื ืคืขืืืืช ืืืืืื ืืช
BV8 NUCLEIC ACIDS ANDPOLYPEPTIDES WITH MITOGENICACTIVITYGENENTECH, INC.
29/08/200160/316184USPCT/US/2002/027571WO/2003/020892
)2009.01 (A61K19754010/09/2007
ื ืชืืฉืืจืื ืืืืืืื ืืืืจืืื ืืืช ืืืคืืงืื
TOPICAL FORMULATIONS OFTELLURIUM-CONTAININGCOMPOUNDS
BIOMASื"ืืืืืืก ืืข LTD.11/09/200660/843402US
PCT/IB/2007/004220WO/2008/032227
)2009.01 (E04B19754108/03/2007
SPACE ืกืืืืจ ืืืืืช ืืืืืจ ืืกืืจืช ืืจืืืืช FRAME CONNECTION NODEARRANGEMENTGOSSAMER SPACE FRAMES
22/09/200611/525721USPCT/US/2007/005761WO/2008/039233
![Page 115: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/115.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009115
)2008.04 (A61B19754219/06/2003
ืฉืโืฉืืื ืืืชืงื ืืืืคืื ืคืืื ืชืจืื ืจืงืื ืืขืืืง
METHOD AND APPARATUS FORPHOTOTHERMAL TREATMENT OFTISSUE AT DEPTH
THE GENERAL HOSPITALCORPORATION
19/06/200260/389871USPCT/US/2003/019474WO/2004/000150
)2009.01 (C12Q19754305/10/2007
ืืคืกืงืื ืืืืงืืืจืื ืืฉืืืืช ืขืืืจ ืฉืืืืฉืื ืฉืืื
MOLECULAR SWITCHES ANDMETHODS FOR THEIR USEJOHNSON & JOHNSON RESEARCHPTY LIMITED
06/10/200660/828451USPCT/AU/2007/001517WO/2008/040095
)2009.01 (H04N19754417/09/2007
ืืืืฉื ืชืืื ื ื ืขื ืืืืฆืขืืช ืืืืื ืืืืืืจ ืืงืืืืืืCMOSืจืฆืืคืื ืขื ืคืืงืกืื
MOVING IMAGE SENSOR BYSUCCESSIVE INTEGRATION ANDSUMMATION, WITH ACTIVE CMOSPIXELSE2V SEMICONDUCTORS
19/09/20060608187FRPCT/EP/2007/059777WO/2008/034794
)2009.01 (F03G19754512/03/2009
ืืชืงื ืืืืกืืฃ ืืื ืจืืื ืฉื ืืื ืจืื ืื ืข ืขื ืืืืืฉ
A DEVICE FOR THE TAKING OFENETGY FROM THE MOTION OFVEHICLES, TRAVELING ON A ROAD
MICHAEL ืืืืื ืืจื ืืจ GRENADER
![Page 116: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/116.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 116
)2009.01 (A61N19754612/03/2009
A ืฉืืื ืืืชืงื ืืืืคืื ืจืคืืื ืืืืจ METHOD AND A DEVICE FORTREATMENT BY LIGHT
YOHAI ืจืืฉื ืืืจืืงื ืืื TAHOR
)2009.01 (F24F19754712/03/2009
PERSONAL ืืืืจ ืืื ืืืฉื WATER PURIFIERFREE-OXื"ืืข ืคืจืืืืงืก LTD
)2009.01 (G11B19754803/11/2007
TIMING ืืืืืื ืชืืืื ืืื ืฉื ืืืฉืช ืชืืื ืฉืืืืจ ASPECTS OF MEDIACONTENT RENDERINGMICROSOFT CORPORATION
07/11/200611/594352USPCT/US/2007/083553WO/2008/058041
)2009.01 (C12N19754925/09/2007
ื ืืืืืืื ืืงืืืืืืืCPGโืื ืืืืืืขืTืืืืืืื ืื ืืืืื ืืืืืจืืคืืืืง
ืคืขืืืืช ืืืืืจืช ืืืืจืฆืช ืืืขืจืืช ืืืืกืื ืืช
CPG OLIGONUCLEOTIDE ANALOGSCONTAINING HYDROPHOBIC TANALOGS WITH ENHANCEDIMMUNOSTIMULATORY ACTIVITY
COLEY PHARMACEUTICAL GMBH27/09/200660/847811US
PCT/IB/2007/004389WO/2008/068638
![Page 117: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/117.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009117
)2009.01 (A01N19755028/12/2006
INHIBITORS ืืขืืืื ืฉื ืืจืืืื ืืืจืืกืื ืงืื ืื OF BRUTON'STYROSINE KINASEPHARMACYCLICS, INC.
22/09/200660/826720US06/10/200660/828590US
PCT/US/2006/049626WO/2008/039218
)2009.01 (G06F19755121/04/2007
ืืขืจืืช ืืฉืืื ืืืืืื ื ืชืื ืื ืืืืื ืืืื
SYSTEM AND METHOD FOROBFUSCATION OF DATA ACROSSAN ENTERPRISEDIRECT COMPUTER RESOURCES,INC.
27/09/200660/848015USPCT/US/2007/067164WO/2008/039565
)2009.01 (A61M19755228/09/2007
FLASHBACK ืฉืืคืืจ ืืืืชื ืฉื ืชื ืคืืฉืืง CHAMBER VISUALENHANCEMENTTYCO HEALTHCARE GROUP LP
29/09/200660/848250USPCT/US/2007/020997WO/2008/042293
)2009.01 (A61K19755304/10/2007
USE ืจืืืช ืืืืคืืชืจืืืืฉืืืืฉ ืืชืจืืคืืช ืืื OF HYPOTHERMIA INDUCINGDRUGSNEUROKEY A/S
04/10/2006PA200601289DK06/03/2007PA200700335DK
PCT/DK/2007/050137WO/2008/040360
![Page 118: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/118.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 118
)2009.01 (C09K19755414/09/2007
PHOSPHORESCENT ืชืืฉืืจืื ืคืืกืคืืจืฆื ืืืื ืืืืืื COMPOSITIONSFOR IDENTIFICATIONPERFORMANCE INDICATOR L.L.C
15/09/200660/844647US07/06/200711/808266US
PCT/US/2007/019950WO/2008/105830
)2009.01 (B05D19755514/09/2007
ืชืืฉืืจืื ืคืืกืคืืจืฆื ืืืื ืืฉืืืืช ืืืืืื ืืขืืจืชื
PHOSPHORESCENT COMPOSITIONSAND METHODS FORIDENTIFICATION USING THE SAMEPERFORMANCE INDICATOR L.L.C
15/09/200660/844647US07/06/200711/808262US
PCT/US/2007/019949WO/2009/002329
)2009.01 (G06F19755613/09/2007
ืืชืงื ืืฉืืคืืจ ืืืฆืืข ืฉื ืคืจืืืืงืืื ืืืืืชืืขืืจื ืืกืืืื ืจื ืืก
DEVICE FOR IMPROVINGPERFORMANCE OF TRANSPORTPROTOCOLS IN A MULTI-PATHENVIRONMENTASANKYA NETWORKS, INC.
13/09/200660/844226USPCT/US/2007/078395WO/2008/034000
)2009.01 (A61K19755712/09/2007
LONG ืชืจืืคืืช ืจืืงืืืืช ืขืืืืืช LASTING DRUGFORMULATIONS
ืืข'ืืื MEDGENICSื"ื ืืงืก LTD.14/09/200660/844351US
PCT/US/2007/019774WO/2008/033375
![Page 119: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/119.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009119
)2009.01 (H04M19755812/09/2007
ืฉืืจืืชื ืืืคืื ืืืงืจ ืืืืืืืืื ื ืืชื ืืชืื ืืช
TELEPHONY SERVICES FORPROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC
12/09/200611/519981USPCT/US/2007/019795WO/2008/033387
)2009.01 (H04N19755913/09/2007
ืชืื ืืช ืกืืืื ืื ืืืื ืืืืข ืืืืืช ื ืชืื ืื ืืืงืจ ืืืืืืืืื ืื ืืชื ืืชืื ืืช
PROGRAMMING ENVIRONMENTAND METADATA MANAGEMENTFOR PROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC
13/09/200611/520215USPCT/US/2007/019912WO/2008/033453
)2009.01 (G08C19756013/09/2007
ืฉืื ืจืืืง ืืืงืจ ืืืืืืืืื ืื ืืชื ืืชืื ืืช
REMOTE CONTROL UNIT FOR APROGRAMMABLE MULTIMEDIACONTROLLERSAVANT SYSTEMS LLC
13/09/200611/520328USPCT/US/2007/019842WO/2008/033414
)2009.01 (G10L19756101/10/2007
ENCODING ืงืืืื ืืืช ืืืืข AN INFORMATION SIGNALFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
18/10/2006102006049154.8DEPCT/EP/2007/008527WO/2008/046505
![Page 120: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/120.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 120
)2009.01 (A61K19756211/09/2007
SELECTIVE ืืคื ืื ืกืืงืืืื ืฉื ืืืืงืื CHEMOKINEMODULATIONPROPHY MED AB
12/09/200660/843760USPCT/SE/2007/000785WO/2008/033069
)2009.01 (H01H19756318/09/2006
ืฉื, ืงื ืืืืืงืช ืืืืืืช ืืฉืืืืฉืื ืืืืชืงื
A RETROFITTING POWERDISTRIBUTION DEVICE AND USESTHEREOFHINBIT DEVELOPMENT
PCT/IL/2006/001091WO/2008/035322
)2009.01 (H01G19756417/09/2007
METAL ืืขืจืืืช ืืืจ ืืชืืชืืืช GETTER SYSTEMSSAES GETTERS S.P.A.
15/09/200660/844879USPCT/US/2007/020172WO/2008/033560
)2009.01 (A61J19756517/10/2007
METHODS ืฉืืืืช ืืืกืคืงืช ืชืืื ื ืืืืื ืืจืื OF PROVIDING LONG-TERM NUTRITIONNESTEC S.A.
19/10/200660/862165USPCT/EP/2007/061112WO/2008/046871
![Page 121: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/121.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009121
)2009.01 (A61K19756614/09/2007
โNืชืจืืืืืช ืืืจืืืื ืฉืืืชืืืืืื ืืืชืื ืืืืืืื ืืื ืืฉืืืืช
ืืฉืืืืฉ ืืื
N-METHYLAMINOMETHYLISOINDOLE COMPOUNDS ANDCOMPOSITIONS COMPRISING ANDMETHODS OF USING THE SAMECELGENE CORPORATION
15/09/200660/845227USPCT/US/2007/020201WO/2008/033567
)2009.01 (C07D19756713/09/2007
ื ืืืจืืช ืืืืืืื ืืืืืืืื ืืขืืืืช ืืืืคืื ืืืื ืืืืคืจืขืืช ืฉื ืืืืืืืื ืฉื ืฉืืื
AZETIDINE AND AZETIDONEDERIVATIVES USEFUL IN TREATINGPAIN AND DISORDERS OF LIPIDMETABOLISMSCHERING CORPORATION
15/09/200660/845076USPCT/US/2007/019934WO/2008/033468
)2009.01 (A61K19756813/09/2007
ืฉื, ืืกืืืจืช, ืืืคืื ืืืื ืืืืคืจืขืืช ืืืืืืืื ืฉื ืฉืืื
TREATING PAIN, DIABETES, ANDDISORDERS OF LIPID METABOLISM
SCHERING CORPORATION15/09/200660/844810US
PCT/US/2007/019925WO/2008/033460
)2009.01 (G01S19756912/03/2009
ืืืฆืขื ืชืืืื ืืืืืืจ ืงืจืื ื ืกืืืจืืช ืืกืื ืฉืืงืช ืคืจืืืืืช
SUPPORTING MEANS FORPARABOLIC TROUGH SOLARREFLECTOR
ืืข- ืืื ZIV-AVื"ืื ืื ืืกื ENHINEERING LTD
![Page 122: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/122.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 122
)2009.01(A61B19757012/03/2009
ืคืขืื ืขื ืืขืจืืช ืืฉืืืืชโืืืชืื ืื ืืกืืืืง ืืืฉืคื
DISPOSABLE DIAPER WITHINTEGRAL DISPOSAL SYSTEM
SAMUEL ืฉืืืื ืงืจืกื ืื KARSENTI
)2009.01 (G03B19757112/03/2009
DIGITAL ืืฆืืื ืืืืืืืืืช ืืฉืืคืจืช CAMERACOHEN ืืืืจ ืืืื MAOR
)2009.01 (C07D19757213/03/2008
PROCESS ืชืืืื ืืืืฆืืจ ืืืจืชืืืืคืื FOR PRODUCTION OFMIRTAZAPINESUMITOMO CHEMICAL COMPANY,LIMITED
22/03/20072007-075573
JP
PCT/JP/2008/054628WO/2008/114691
)2009.01 (A61M19757327/09/2007
DIRECTIONAL ืฉืืืืฉ ืืืืื ื USENICONOVUM AB
27/09/2006PA200601246DK24/07/200760/951619US
PCT/EP/2007/008420WO/2008/037470
)2009.01 (A61K19757426/09/2007
PHARMACEUTICAL ืชืืฉืืจืื ืจืคืืืืื COMPOSITIONSZYSIS LIMITED
26/09/20060618879.1GBPCT/GB/2007/003677WO/2008/038003
![Page 123: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/123.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009123
)2009.01 (C12N19757511/09/2007
ืฉืืืช ืืจืืื ืืชืื ืื ืืืืจืืืืฉืืืืฉ, ืืืืืื ืื ืคืจืืคืจื, ืืืื
ืงืฉืืจ ืืชืืื ืืจืคืืื
EXPANSION METHOD FOR ADULT STEMCELLS FROM BLOOD, PARTICULARLYPERIPHERAL BLOOD, AND RELATIVEAPPLICATION IN MEDICAL FIELDSALES ENGINEERING AG
20/09/2006RM2006A000498ITPCT/EP/2007/059531WO/2008/034740
)2009.01 (H04M19757612/03/2009
ืฉืืื ืืืื ืืืฆืืจืช ืืืื ืฉื ืืฉืืืืช ืืืืฉืืืื ืืืืฉืืจ ื ืืื
A METHOD AND TOOL FOR TASKMODELING OF MOBILE PHONEAPPLICATIONS
ืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืื ืืืืงืจ ืืคืืชืื
BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
)2009.01 (C07D19757724/09/2007
ืคืืจืืืื ืงืจืืืงืกืืืื ืืฉืโ3ืชืืืืืช ืฉืืคืืจืืืื ืงืจืืืงืกืืืื ืืกืืื ืื ืืืขืืืโ2
HDLืืืืกืืจืื
3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDEDERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTSF. HOFFMANN-LA ROCHE AG
04/10/200606121755.0EPPCT/EP/2007/060094WO/2008/040651
)2009.01 (A61K19757912/03/2009
ืืืืื ืืขืื ืจื ืืืืื ืฉื ืื ืื ืืืืืชKืืืจืื
EFFICIENT MULTI-DIMENSIONALSUPPRESSION FOR K-ANONYMITY
ืืื ืืืจืกืืืช ืื ืืืจืืื ืื ืื ืืจืฉืืช ืืืืงืจ ืืคืืชืื
BEN-GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
![Page 124: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/124.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 124
)2009.01 (A61K19758013/09/2007
ALBUMIN ืืืืื ื ืืืืืืื ืืืืืื FUSION PROTEINSHUMAN GENOME SCIENCES, INC.
14/09/200660/844349US13/11/200660/858410US20/02/200760/902039US07/06/200760/942647US12/09/200760/960039US
PCT/US/2007/019841WO/2008/033413
)2009.01 (G06F19758114/09/2006
MATCHINGื ืืฆืจืื ืืืืชืืืช ืืืืช ืืืื THE FIT OF GARMENTSTO CONSUMERSMYSHAPE, INC.
PCT/US/2006/035965WO/2008/033138
)2009.01 (A61K19758204/03/2003
ืชืืฉืืจืื ืืืืืืื ืฆืืจื ืงืจืืกืืืื ืืช ืฉืืืืืฆื ืืืืจืืงืกืืืช ืฉื ืกืืจืืืืืื ืืืื
)SAHA(ืืฉืืืืช ืืืื ืชSAHA
COMPOSITIONS COMPRISING ACRYSTALLINE FORM OFSUBEROYLANILIDE HYDROXAMICACID (SAHA) AND METHODS FORSAHA PREPARATIONSLOAN-KETTERING INSTITUTE FORCANCER RESEARCH
04/03/200260/361759USPCT/US/2003/006451WO/2003/075839
![Page 125: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/125.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009125
)2009.01 (G06F19758303/04/2008
ืืขืจืืช ืืืฉื ืืืชืืืช ืืืืฉ ืืืืกืกืชืขื ืืืืื ืืกืื ืื ืืืืืกืก ืขื ืืืื ืืืคื ื
ืืืชืืื
COMPUTER SYSTEM FOR RULE-BASED CLOTHING MATCHING ANDFILTERING CONSIDERING FIT RULESAND FASHION RULESMYSHAPE, INC.
06/04/200711/697688USPCT/US/2008/059278WO/2008/124511
)2009.01 (C07D19758527/10/2007
ืชืืืืืช ืื ืืืืืืืืช ืืืฉืืช ืืื ืืืื ืืกืืื ืืืจืืืงืื ืื
NEW BENZAMIDE DERIVATIVES ASBRADYKININ ANTAGONISTS
RICHTER GEDEON NYRT.27/10/2006P0600808HU
PCT/HU/2007/000102WO/2008/068540
)2009.01 (C07C19758627/10/2007
ืชืืืืืช ืคื ืืืกืืืคืืืืื ืื ืืืืื ืืืฉืืช ืืื ืืืื ืืกืืื ืืืจืืืืงืื ืื
NEW PHENYLSULFAMOYLBENZAMIDE DERIVATIVES ASBRADYKININ ANTAGONISTSRICHTER GEDEON NYRT.
27/10/2006P0600809HUPCT/HU/2007/000103WO/2008/050167
![Page 126: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/126.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 126
)2009.01 (A61F19758813/09/2007
ืืื ืื ืกืคืืืืื ืืืืจืืคืืืืื ืคืืืืืจืืื ืืฉืืืืช ืืืื ืชื
HYDROPHILLIC POLYMER SPONGESTRUCTURES AND METHODS OFPRODUCING THE SAMEHEMCON, MEDICAL TECHNOLOGIESINC.
13/09/200611/520230US13/09/200611/520357US02/10/200611/541988US02/10/200611/541991US13/09/200711/900854US
PCT/US/2007/019927WO/2008/033462
)2009.01 (A61B19758910/09/2007
THREE ืืขืจืืช ืืืฉืืจ ืืืคืืืช ืืช ืฉืืืฉ ืืืืืืช DIODA OPTICAL BRIDGESYSTEMGROVE INSTRUMENTS, INC.
25/09/200611/526564USPCT/US/2007/019635WO/2008/039299
)2009.01 (H04L19759005/10/2007
METHOD ืฉืืื ืืืชืงื ืขืืืจ ืืืืืช ืืืื AND APPARATUS FORMUTUAL AUTHENTICATIONQUALCOMM INCORPORATED
10/10/200660/850882US03/10/200711/866946US
PCT/US/2007/080525WO/2008/045773
)2009.01 (H01H19759115/03/2009
ืืืขืช ืืืืืงืช ืืคืชืืืช ืขื ืืืฆืขืืืืืืคืฉืจืื ืืื ืกื ืงืื ืืืืฆืื ืงืื ืฉื
ืืืคืชืืืช ืืืืืืช
KEYS RING WITH MEANS, THETALLOW EASY INSERTION ANDTAKING OUT OF THE KEYS IN ANDFROM THE RING RESPECTIVELY
.DR ืขืืจื ืื ืฉืืืืืจ ืืืื"ื HAIM AMRAM BEN-SIMHON
![Page 127: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/127.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009127
)2009.01 (F41H19759215/03/2009
,ืฉ ืื ืจืื"ื ืื, ืฉืจืืื ืจืืืงืืืื ืืื ืงืื(ืื ืื ืคืืืื ืื ืืืืื ืืขืื ืืืขื ืืืื
)ืืืืจ ืฉืจืืื
REACTIVE ARMOR FOR A TANK,APC(ARMOURED PERSONNELCARRIER) OR A VEHICLE, AGAINSTSHELLS OR MISSILES WITHHOLLOW EXPLOSIVE CHARGE(ARMOR PENETRATINGAMUNITION).
.DRืจ ืืืื ืขืืจื ืื ืฉืืืื"ื HAIM AMRAM BEN-SIMHON
)2009.01 (G06F19759317/09/2007
ืืขืจืืช ืืฉืืื ืืืืืืืฆืื ืฉื ืืขืืจืช ื ืชืื ืื ืืืืฉืง ืืื ืืจื ืื ืืืืฉืง ืืืจ
SYSTEM AND METHOD FORAUTOMATING THE TRANSFER OFDATA FROM A WEB INTERFACE TOANOTHERJOBDIVA, INCORPORATED
15/09/200660/844646US17/09/200711/856586US
PCT/US/2007/078677WO/2008/034139
)2009.01 (C07K19759417/09/2007
ืชืืฉืืจืื ืืืืืืื ืืืืื ืื ืืืืืคืืืืช ืืืื ืชืืืืืฅ ืืืื ืืฉืืื
COMPOSITIONS COMPRISING HIGHPRESSURE-TREATED PROTEINS ANDMETHODS OF PREPARING THESAMEBAROFOLD, INC.
15/09/200660/844996USPCT/US/2007/020128WO/2008/033556
![Page 128: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/128.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 128
)2009.01 (H04Q19759511/09/2007
ืฉืืื ืืชืงืฉืืจืช ืืืืืืืช ืืืขืจืืช ืืงืฆืืช ืืืืงืื ืืชื ืืืฉืืื
WIRELESS COMMUNICATIONMETHOD AND APPARATUS FORASSIGNING CELL AND RESOURCEBLOCKSINTERDIGITAL TECHNOLOGYCORPORATION
14/09/200660/844428USPCT/US/2007/019768WO/2008/033369
)2009.01 (H04Q19759613/09/2007
ืขืจืืช ืืขืืืื ืื ืืื ืืืืื ืฉื ืฉืืื ืื ืคืจืืืจื ืืืฉื ืืงืจืืืื
METHOD AND APPARATUS FORDYNAMIC UPDATES OF RANDOMACCESS PARAMETERSINTERDIGITAL TECHNOLOGYCORPORATION
15/09/200660/825759USPCT/US/2007/019928WO/2008/033463
)2009.01 (C03B19759712/09/2007
ืืืืฆืืจ ืืืืืืช ืงืืืืจืฅ2SIOืชืขืจืืืช ืืืืฉืื ืืชืขืจืืืช
SIO2 SLURRY FOR THE PRODUCTIONOF QUARTZ GLASS AS WELL AS THEAPPLICATION OF THE SLURRYHERAEUS QUARZGLAS GMBH & CO.KG
29/09/2006102006046619.5DEPCT/EP/2007/059565WO/2008/040615
![Page 129: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/129.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009129
)2009.01 (B62B19759814/09/2007
ืืชืงื ืขืืืจ ืขืืืช ืชืื ืืง ืืฉืืืืฉ ืืืื ืืืืคื ืฉืื
DEVICE FOR A PRAM AND USE OF APUSH BAR
MUTSY B.V.14/09/20061032494NL
PCT/NL/2007/000227WO/2008/033014
)2009.01 (A61C19759914/09/2007
ืืช ืฉืืื ืืืขืจืืช ืืืืฆืืจ ืชืืชื ืื ืืืืืช
METHOD AND SYSTEM FORPRODUCING A DENTAL PROSTHESISDENTAL CONSULTING MONKMEYERS.L.
14/09/2006102006043284.3DEPCT/EP/2007/008031WO/2008/031614
)2009.01 (H04N19760017/08/2007
ืืื ืืืจื ืืคืืขืCMOSืืืฉื ืชืืื ื ืืืืฆืขืืช ืืขืืจืช ืืืขื
CMOS LINEAR IMAGE SENSOROPERATING BY CHARGE TRANSFER
E2V SEMICONDUCTORS19/09/20060608188FR
PCT/EP/2007/058549WO/2008/034677
![Page 130: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/130.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 130
)2009.01 (C12N19760118/09/2007
ืคืืืืื ืื ืืืืืฆืืช ืฉืืื ืฉื ืืฆืืช ืืืืจื ืฉืจืฉืจืช ืืื ืื ื
ALGAL MEDIUM CHAIN LENGTHFATTY ACIDS ANDHYDROCARBONSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
18/09/200660/825946USPCT/US/2007/078760WO/2008/036654
)2009.01 (C07K19760213/09/2007
ืชืจืืืืืช ืืฉืืืืช ืืื ืืขืช ืกืจืื ืขื ืงืืคืจืืืงืกืื ืื
COMPOSITIONS AND METHODS TOPREVENT CANCER WITHCUPREDOXINSTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ILLINOIS,
14/09/200660/844358USPCT/US/2007/078371WO/2008/033987
)2009.01 (H04L19760310/10/2007
ืชืืขืื ืืืืงืช ืืจืื ืืจืืืช ืื ืืกืืช ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
SPACE DIVISION MULTIPLE ACCESSCHANNELIZATION IN WIRELESSCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED
10/10/200660/828821US09/10/200711/869589US
PCT/US/2007/081013WO/2008/045980
![Page 131: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/131.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009131
)2009.01 (A61K19760514/09/2007
ืฉืืื ืืืืคืื ืืกืจืื ืืืืคืืช ืืืืฆืืืชEGFRโื
METHOD FOR TREATING CANCERHARBORING EGFR MUTATIONSBOEHRINGER INGELHEIMINTERNATIONAL GMBH
18/09/200606120856.7EP31/01/200707101505.1EP
PCT/EP/2007/059735WO/2008/034776
)2009.01 (H04B19760620/09/2007
ืฉืืืืจ ืืจืกืืืจืฆืื ืฉื ืฉืื ืืืช ืืืคืืRECONSTRUCTION ANDRESTORATION OF AN OPTICALSIGNAL FIELDLUCENT TECHNOLOGIES INC.
22/09/200611/525786USPCT/US/2007/020367WO/2008/036356
)2009.01 (A23L19760717/09/2007
ืชืืฉืืจื ืืืชืงื ืืืืืฉืื ืฉืืื ื ืืืจืืืืืืืคืฉืืืช ืืืืืืื ืืืจื ืืืืงื
ืืืืจืืกืงืืคื ืืืืืจ ืืืืืฉ
COHESIVE NON- FREE FLOWINGSWEETENER COMPOSITIONSCONTAINING A HYGROSCOPICGLUING AGENT AND A DESICCANTMCNEIL NUTRITIONALS, LLC
18/09/200611/532709USPCT/US/2007/020122WO/2008/036230
![Page 132: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/132.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 132
)2009.01 (A23G19760808/08/2007
ืฉืืื ืืืชืงื ืืืฆืืจ ืงืื ืคืืืืจื ืืืกืคืจ ืืจืืืืื
METHOD AND APPARATUS FORPRODUCING A CONFECTIONARYPRODUCT FROM MULTIPLECOMPONENTSKRAFT FOODS R&D, INC.
20/09/200606019675.5EPPCT/US/2007/075435WO/2008/036476
)2009.01 (C07K19760920/09/2007
PROTEASE ืื ืืืืื ืืืื ืกืืืื ืขืืืืื ืืคืจืืืืื RESISTANT INSULINANALOGUESNOVO NORDISK A/S
22/09/200606121113.2EPPCT/EP/2007/059990WO/2008/034881
)2009.01 (B05D19761010/10/2007
RADIATION ืืื ืื ืืชื ืืขืืฆืื ืืงืจืื ื CURABLE INKSHEXION SPECIALTY CHEMICALS,INC.
11/10/200660/851036USPCT/US/2007/021670WO/2008/045480
)2009.01 (C08J19761111/10/2007
ืืช ืชืืฉืืจื ืืื ืื ืืชื ืื ืืืืจืงื ืกืืืื ืืืขืืฆืื ืืืงืจื ื
RADIATION CURABLE ANDJETTABLE INK COMPOSITIONSHEXION SPECIALTY CHEMICALS,INC.
11/10/200660/851023USPCT/US/2007/021754WO/2008/045517
![Page 133: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/133.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009133
)2009.01 (A01N19761215/09/2007
ืืืฆืจืื ืืฉืืืืช ืืืฉืชืืฉืื ืืคืคืืืืืื ืืืืืืช ืืจืืช ืฉื ืกืืื ืืืืจืืช ืืจื
LDLืฉื ืืืืกืืจืื
PRODUCTS AND METHODS USINGSOY PEPTIDES TO LOWER TOTALAND LDL CHOLESTEROL LEVELS
SOY LABS LLC16/09/200660/966529US17/07/200761/007925US
PCT/US/2007/078584WO/2008/034116
)2009.01 (C07K19761321/11/2003
ืชืืฉืืจืื ืืคืืจืืืืฆืืืช ืฉื ืืกืืจืื ืืฉืืืืช ืืฉืืืืฉ ืืืื ื
GASTRIN COMPOSITIONS ANDFORMULATIONS, AND METHODS OFUSE AND PREPARATIONWARATAH PHARMACEUTICALS,INC.
21/11/200260/428100US22/11/200260/428562US03/12/200260/430590US14/11/200360/519933US
PCT/CA/2003/001778WO/2004/045640
)2009.01 (C07D19761417/09/2007
THIAZOLE ืชืจืืืืืช ืชืืืืื ืคืืจืืืืืืคืืจืืืืืื PYRAZOLOPYRIMIDINECOMPOUNDSELI LILLY & CO.
20/09/200660/826264USPCT/US/2007/078605WO/2008/036579
![Page 134: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/134.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 134
)2009.01 (C07K19761530/04/2004
SECRETED ืืฉืคืืช ืืืืื ืืืคืจืฉ PROTEIN FAMILYARES TRADING S.A.
30/04/20030309916.5GBPCT/GB/2004/001890WO/2004/096856
)2009.01 (G06F19761616/03/2009
ืืขืจืืช ืชืงืฉืืจืช ืืืืฆืขืืช ืืืืืช ืงืืSMSืืืืืขืืช) ืืืืืื ืื(
COMMUNICATION SYSTEM VIA SMSDOMAIN NAME
ARI ืืจื ืืืืขื ELIAZ16/03/200961036965US
)2009.01 (H04Q19761712/10/2007
ืืขืืจืช ืืฉืืืื ืืงืืฉืืจ ืืคืื ืืืงืจืชืืื ืืงืืฉืืจ ืืคืื ืขืืืจ ืืขืจืืช ืชืงืฉืืจืช
ืืืืืืืช
REVERSE LINK RESOURCEASSIGNMENT AND REVERSE LINKPOWER CONTROL FOR WIRELESSCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED
13/10/200660/829388US11/10/200711/870962US
PCT/US/2007/081238WO/2008/048894
)2009.01 (C07D19761801/11/2007
ืกืื ืืืื ืกืืงืืืื ืงืืื ื ืืงืืืื ืืงืืืืื ืืืืฆืืืืืืืื ืฉื ืืืืืืืก
NICOTINIC ACETYLCHOLINERECEPTOR SUB-TYPE SELECTIVEAMIDES OFDIAZABICYCLOALKANESTARGACEPT, INC.
02/11/200660/856079USPCT/US/2007/083330WO/2008/057938
![Page 135: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/135.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009135
)2009.01 (B01L19761926/09/2007
CARTRIDGE ืืขืจืืช ืืืกื ืืืช SYSTEMITI SCOTLAND LIMITED
26/09/20060618966.6GBPCT/GB/2007/003666WO/2008/037995
)2009.01 (E04G19762016/03/2009
STRUCTURE ืืืืืง ืืืื ื REINFORCEMENTAHARON ืืืจืื ืจืืืฅ RAVITZ
)2009.01 (C12N19762104/09/2003
ืฉืืืืฉ ืืืืื ืืื ืืกืื ืกืืจืืืืกืืกืืืืืื ืฉื ื ืฉืื ืืืืงืื4ERGื ืกืจืืืื
ืืืื ืงืื
USE OF SACCHAROMYCESCEREVISIAE ERG4 MUTANTS FORTHE EXPRESSION OF GLUCOSETRANSPORTERS FROM MAMMALSSANOFI-AVENTIS DEUTSCHLANDGMBH
14/09/200210242763.1DEPCT/EP/2003/009812WO/2004/026907
)2009.01 (A01G19762215/10/2007
ืืืืืื ืขืืืจ ืืืืืช, ืืกื ืืืืืื ืชืจืื ืฉื ืื ื ืืช ืืืื ืื
THERMAL INSULATION SCREEN,ESPECIALLY FOR HORTICULTURALAND MARKET GARDENINGGREENHOUSESMDB TEXINOV SA
26/10/20060654538FRPCT/FR/2007/052143WO/2008/050029
![Page 136: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/136.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 136
)2009.01 (H01L19762323/10/2007
IMPROVED ืืืื ืืฉืืืื ืฉื ืจืืืื ืืืืคื ืืืฆืข CALIBRATION OF ASUBSTRATE HANDLING ROBOTCYBEROPTICS SEMICONDUCTOR,INC.
23/10/200660/853660USPCT/US/2007/022490WO/2008/051544
)2009.01 (B65B19762403/09/2003
A ืืืฆืืจ ืืืืืื ืฉื ืืืื ืืืืืฉืืื METHODS OF MAKING ANDFILLING SEALED CONTAINERSMEDICAL INSTILL TECHNOLOGIES,INC.
03/09/200260/408068USPCT/US/2003/027545WO/2004/026695
)2009.01 (B01D19762531/07/2007
ืืืืจื ืืช ืกืื ืื ืขื ืืกืืก ืคืืืืืจื ืืื ืชืืืฉืืืืช
POLYMER-BASED FILTRATIONMEMBRANES AND METHODS OFPRODUCING THE SAMEGKSS-FORSCHUNGSZENTRUMGEESTHACHT GMBH
22/09/2006102006045282.8DEPCT/EP/2007/006759WO/2008/034487
)2009.01 (G07G19762618/03/2008
A ืงืืคื ืจืืฉืืช CASH REGISTER MACHINESIMCHA ืฉืืื ืืฉืจืื ืกืืืืืก ISRAEL SAMUELS
20/03/200760/895745US18/03/2008PCT/IL/000372WO
PCT/IL/2008/000372WO/2008/114251
![Page 137: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/137.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009137
)2009.01 (H04M19762817/03/2009
A ืืขืจืืช ืืฉืืื ืืืืคืื ืื TELEPHONY SYSTEM ANDMETHOD
SHAI ืฉื ืืืื HAKIM
)2009.01 (H04M19762917/03/2009
ืฉืืื ืื ืืืื ืฉืืืืช ื ืื ืกืืช ืืืืฆืืืชMETHOD OF INBOUND ANDOUTBOUND CALL WITHTRANSPARENT HAND-OFF
DAN ื ืงื'ืื ืคืจืืืฆ FROMCHENKO
)2009.01 (A47J19763020/09/2007
ืืขืจืืช ืกืืืื ืขืืืจ ืืื ืช ืืฉืงื ืืืืกื ืืช
EXTRACTION SYSTEM FOR THEPREPARATION OF A BEVERAGEFROM A CARTRIDGENESTEC S.A.
26/09/200606121239.5EPPCT/EP/2007/059930WO/2008/037642
)2009.01 (A23P19763101/10/2007
CO-EXTRUDED ืืืฆืจ ืืืืฆื ืืื PRODUCTNESTEC S.A.
05/10/2006PCT/EP2006/067110EPPCT/EP/2007/060394WO/2008/040705
![Page 138: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/138.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 138
)2009.01 (A61K19763228/09/2007
CโJAMUSEืฉืืืืฉ ืืชืจืืืืืช ืืงืืฉืจืืช OF JAM-C BINDINGCOMPOUNDSMERCK SERONO S.A.
28/09/200660/827389USPCT/IB/2007/002861WO/2008/038127
)2009.01 (A01N19763402/10/2007
ืชืืฉืืจ ื ืืืื ืืงืืืืช ืืืืงืื ืืืืืโNืชืจืืืืืช ืงืืืืืช ืืืืงืื
ืคื ืืืกืืืงืจืืืืื ืืืช
LIQUID PESTICIDE COMPOSITIONCONTAINING N-PHENYLSEMICARBAZONEPESTICIDE COMPOUNDSBASF SE
03/10/200660/849145US08/11/200606123698.0EP
PCT/EP/2007/060449WO/2008/040727
)2009.01 (A61M19763528/09/2007
SURGICAL ืืขืจืืช ืืืจืืจืืืช ืืืขืืจืช ื ืืื FLUID TRANSFERAPPARATUSTYCO HEALTHCARE GROUP LP
29/09/200660/848519USPCT/US/2007/020987WO/2008/042285
)2009.01 (C07K19763601/10/2007
ืง Aืืฉืจื ืื ืืืื ืืงืืืื ืืืืื ืื 17โILIL-17 RECEPTOR A ANTIGENBINDING PROTEINSAMGEN INC.
02/10/200660/827882US05/12/200660/873072US04/09/200760/969895US
PCT/US/2007/021174WO/2008/054603
![Page 139: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/139.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009139
)2009.01 (C07K19763716/10/2007
BBืืืื ื 4-1 ืืืืช ืืืงืชืืืชืื 4โ1 BB LIGAND IN INFLAMMATORYDISEASESTHE SCRIPPS RESEARCH INSTITUTE
16/10/200660/852022US11/05/200760/917561US
PCT/US/2007/022103WO/2008/057171
)2009.01 (C07D19763817/03/2009
ืชืืืื, ืชืจืืืืืช ืืืืืกืืชืื ืืืฉืืช ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชืืืืื ืชื
NEW DIOSMETIN COMPOUNDS, APROCESS FOR THEIR PREPARATIONAND PHARMACEUTICALCOMPOSITIONS CONTAINING THEMLES LABORATOIRES SERVIER
01/04/200808/01779FR
)2009.01 (C07D19763924/09/2007
ืชืืืื ืืืื ืช ืชืืืืืช ืคื ืืงืกื ืื ืืคืืจืืืืืืืืืื
PROCESS FOR SYNTHESIS OFPHENOXY DIAMINOPYRIMIDINEDERIVATIVESF. HOFFMANN-LA ROCHE AG
04/10/200660/849203USPCT/EP/2007/060095WO/2008/040652
)2009.01 (C07D19764020/09/2007
, ืชืืืืืช ืงืืจืื ืืื ืืืชืืจืืช ืืคืืืืืจืจืงืจืกืืจืื ืืืื ืงื ืืื ืชื ืืฉืืืืฉื ืืค ืืืงืืืืื ืืืืจื
FLUORINATED CATHARANTHINEDERIVATIVES, THEIR PREPARATIONAND THEIR UTILISATION AS VINCADIMERIC ALKALOID PRECURSORSPIERRE FABRE MEDICAMENT
20/09/200660/826245US20/09/200606/08226FR
PCT/EP/2007/059991WO/2008/034882
![Page 140: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/140.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 140
)2009.01 (C07D19764128/09/2007
FIRE-RESISTANTืืฉโืืื ืืืก ืืกืื GYPSUM PANELUNITED STATES GYPSUM COMPANY
12/10/200611/546736USPCT/US/2007/020906WO/2008/045217
)2009.01 (C07D19764217/04/2003
ื ืฉื ื ืืืจืืช ืืืจืืฆืืงืืืืช ืืืืืืืืืจื ืืืคืืืืื
HETEROCYCLIC DERIVATIVES ASOPIOID MODULATORS
JANSSEN PHARMACEUTICA N.V.29/04/200260/376,406US26/03/200310/400,006US
PCT/US/2003/011872WO/2003/092688
)2009.01 (B29B19764317/09/2007
ืืขืจืืช ืืฉืืื ืืฉืืืืฉ ืืืืจ ืืคืกืืืชืฉืื ืชืืืื ืืืฆืืจ ืืืชืืืื ืขืืืจ ืืืคืงื
ืืืืื ืคืกืืืช ืจืคืืืืช
SYSTEM AND METHOD FORRECLAIMING WASTE FROM DIAPERMANUFACTURE FOR THEPRODUCTION OF MEDICAL WASTECONTAINERSTYCO HEALTHCARE GROUP LP
21/09/200660/846292USPCT/US/2007/020104WO/2008/036223
)2009.01 (G06F19764424/01/2007
ืฉืืื ืืืขืจืืช ืืืืืื ืืจืืขืื ืืืขืจืืช ืืืขืจืืช ืืืืืฉืืช
A METHOD AND APPARATUS FOREVENT DIAGNOSIS IN ACOMPUTERIZED SYSTEMCORRELSENSE LTD.
PCT/IL/2007/000089WO/2008/900536
![Page 141: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/141.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009141
)2009.01 (A01G19764521/09/2007
ืืืืจ ืืขืืื ืืงืืืคืช ืืืจื ืืืฆืข ืื ืืืื ืืฆืืืื
PROCESSED RICE HULL MATERIALAS GERMINATION AND PLANTGROWTH MEDIUMBENTLE PRODUCTS AG
22/09/2006PA200601222DK21/12/200660/876136US
PCT/IB/2007/004352WO/2008/059387
)2009.01 (A61B19764619/09/2007
ืืขืจืืช ืืืืคืื ืืืืฅ ืืืคืืช ืืขื ืคืชืืืช ืืืืจืืชโืืกืืื ืืืืืืืช ืืื ืช ืืืฅ ืื
REDUCED PRESSURE TREATMENTSYSTEM HAVING BLOCKAGECLEARING AND DUAL-ZONEPRESSURE PROTECTIONCAPABILITIESKCI LICENSING, INC.
19/09/200660/845993US02/10/200660/849138US19/09/200711/903165US
PCT/US/2007/020375WO/2008/036361
)2009.01 (A61F19764719/09/2007
ืืขืจืืช ืืฉืืื ืืงืืืขืช ืกืืืืก ืืืืื ืฉื ืืืื ื ืืื ืืืขืจืืช ืืืคืื ืืืืฅ ืืืคืืช
SYSTEM AND METHOD FORDETERMINING A FILL STATUS OF ACANISTER OF FLUID IN A REDUCEDPRESSURE TREATMENT SYSTEMKCI LICENSING, INC.
19/09/200660/845993US18/09/200711/901664US
PCT/US/2007/020374WO/2008/036360
![Page 142: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/142.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 142
)2009.01 (G06F19764819/09/2007
ืืขืจืืช ืืฉืืื ืื ืืืื ืืืื ืืืื ืฉื ืืืื ืืืืคืื ืืจืืคืื ืคืฆืขืื
SYSTEM AND METHOD FORMANAGING HISTORY OF PATIENTAND WOUND THERAPYTREATMENTKCI LICENSING, INC.
19/09/200660/845993US18/09/200711/901601US
PCT/US/2007/020355WO/2008/036345
)2009.01 (A61B19764919/09/2007
ืืขืจืืช ืืฉืืื ืืืขืงื ืืืจ ืืชืงืืืืช ืืืืืื ืฉื ืจืงืื
SYSTEM AND METHOD FORTRACKING HEALING PROGRESS OFTISSUEKCI LICENSING, INC.
19/09/200660/845993US18/09/200711/901663US
PCT/US/2007/020353WO/2008/036343
)2009.01 (C12Q19765021/09/2007
A ืฉืืื ืืืืืืช ืงืืืื ืืจืงืื METHOD FOR QUANTITATION OFCOLLAGEN IN TISSUEKCI LICENSING, INC.
21/09/200660/846250US20/09/200711/858737US
PCT/US/2007/079153WO/2008/036891
![Page 143: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/143.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009143
)2009.01 (A61M19765119/09/2007
ืืืืืช ืจืืื ืืืขืจืืช ืืืคืื ืืืืฅ ืืืคืืชCOMPONENT MODULE FOR AREDUCED PRESSURE TREATMENTSYSTEMKCI LICENSING, INC.
19/09/200660/845993US18/09/200711/901602US
PCT/US/2007/020373WO/2008/036359
)2009.01 (F16M19765219/09/2007
ืืชืงื ืชืืื ืืงืืืืข ืืืฉืืจ ืจืคืืื ืืืื ื ืชืืื ืืืคืงื ืื ืื ืื ืืขืืงืจ
HANGING APPARATUS FOR FIXINGA MEDICAL DEVICE TO ASUBSTANTIALLY HORIZONTAL ORSUBSTANTIALLY VERTICALSUPPORT STRUCTUREKCI LICENSING, INC.
19/09/200660/845993USPCT/US/2007/020354WO/2008/036344
)2009.01 (G01N19765322/04/2003
ืื ืื ืื ืืืืจืืืืช ืฉื ืืืืื ื ืืื ืืืืฆ ืงืคืกืื
ANTIVIRAL INHIBITION OF CAPSIDPROTEINSUNIVERSITY OF MARYLAND,BALTIMORE COUNTY
22/04/200260/374,557US25/04/200260/375,852US16/08/200260/404,043US
PCT/US/2003/012260WO/2003/089615
![Page 144: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/144.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 144
)2009.01 (H04L19765425/07/2007
SECURE ืืขืจืืช ืืืืืืืช ืืืืฆืืข ืืขืืจืืช UNIVERSAL TRANSACTIONSYSTEMFRANCHI, JOHN FRANCO
18/09/200611/532580US19/12/200606256440.6US19/12/20060625304.1US
PCT/US/2007/074327WO/2008/060725
)2009.01 (A61K19765517/03/2009
EMULSIONS ืชืจืืืคืื ืืฉืืืืช ืืืื ืชื AND METHODS OFTHEIR PRODUCTION
ืืข-ืืืื -AHAVAื"ืืขืืืืช ืื ืืืื DEAD SEA LABORATORIESLTD.
17/03/200861/064617US
)2009.01 (A61M19765618/09/2007
BIOLOGICAL ืืื ืงืืืื ืื ืืื ืืืืืืื FLUID RECEPTACLELOTUS BIO INC.
18/09/200660/845173USPCT/IL/2007/001144WO/2008/035333
)2009.01 (A61M19765718/09/2007
ืฆืื ืืจืืช ืืืฉืงืื ืืืคืืืฃ ืืกืื ืืืืืืจืืืืื ืืืงืจืช ืืจืืื ืืืืฆืืจ ืฆืื ืืจืืช
ืืืื
DRIP IRRIGATION HOSES OF THELABYRINTH TYPE AND FLOW-CONTROL ELEMENTS FORPRODUCING SUCH HOSES
AMIR ืืืืจ ืืื COHEN18/09/200611/522445US
PCT/IL/2007/001146WO/2008/035335
![Page 145: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/145.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009145
)2009.01 (A62D19765821/09/2007
GASIFIER ืืืื ืืชื ืืจ ืืืฉืืืช ืคืกืืืช ืืืืืืืืช AND INCINERATOR FORBIOMASS SLUDGE DESTRUCTIONBROOKES, DAVID, R.
22/09/200611/534452USPCT/CA/2007/001701WO/2008/034263
)2009.01 (C02F19765924/09/2007
METHOD ืงืืืืืโืฉืืื ืืืชืงื ืืืืคืื ืืื AND APPARATUS FORTREATMENT OF WASTEWATERWILLIAM G. SMITH
25/09/200611/534770US15/02/200711/675113US
PCT/US/2007/079274WO/2008/039711
)2009.01 (H04L19766006/11/2007
ืฉืืืืช ืืืชืงื ืื ืืืขืืจืช ืืืืขืืชMETHODS AND APPARATUS FORCOMMUNICATION OFNOTIFICATIONSQUALCOMM INCORPORATED
06/11/200660/864567US12/04/200711/734640US
PCT/US/2007/083808WO/2008/058140
)2009.01 (B65D19766117/03/2009
CONTAINERS ืืืืื ืืืขืจืืช ืืืืื AND CONTAINERSYSTEM
THEื"ืื ืกืื ืื ืืืจืงืก ืืฉืจืื ืืข STANLEY WORKS ISRAEL LTD15/04/200812/081369US
![Page 146: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/146.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 146
)2009.01 (A61B19766221/10/2003
ืืชืงื ืืืืฆืืข ืื ืืืืคืืกืืื ืืืืกืกืช ืขื ืฆื ืชืจ ืืืืฆืขืืช ืงืืคืืืื ืืงืืืืื
APPARATUS FOR PERFORMINGCATHETER-BASED ANNULOPLASTYUSING LOCAL PLICATIONSMITRALIGN, INC.
21/10/200260/420095USPCT/US/2003/033382WO/2004/037317
)2009.01 (C07K19766317/07/2003
ืืืคืื ืืืฉื ืืืืืชื ืืืืฆืขืืช ืืื ืืจืคืจืื?
THERAPIES FOR RENAL FAILUREUSING INTERFERON ?
BIOGEN IDEC MA INC.17/07/200260/396393US
PCT/US/2003/022440WO/2004/006756
)2009.01 (C07D19766405/10/2007
BIARYL ืชืจืืืืืช ืืืืจืื ืืชืจ ืืืจืืื ETHER UREA COMPOUNDSPFIZER PRODUCTS INC.
18/10/200660/829966US17/08/200760/965210US
PCT/IB/2007/003202WO/2008/047229
)2009.01 (B05D19766518/09/2007
ืฉืืื ืืืืฆืขืื ืืืฆืืจ ืืื ืืืงืฆืื ืืืฉืจืช ืืื ืืืช ืืฆืืคืื ืืืืื ืืืงืืงืื ืืื ืืืื
METHOD AND MEANS FORPRODUCING A MAGNETICALLYINDUCED INDICIA IN A COATINGCONTAINING MAGNETICPARTICLESSICPA HOLDING S.A.
17/10/200606122467.1EPPCT/EP/2007/059818WO/2008/046702
![Page 147: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/147.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009147
)2009.01 (B61C19766618/09/2007
ืจืื ืื ืข ืขื ืืกืืื ืขื ืืืืืชโืืืRAIL ื ืืืื VEHICLE WITH A DRIVE UNIT
BOMBARDIER TRANSPORTATIONGMBH
18/09/2006102006044396.9DEPCT/EP/2007/059860WO/2008/034830
)2009.01 (A23L19766718/10/2007
POLYPHENOL-RICE ืชืืฆืืช ืขืฉืืจื ืืคืืืืคื ืื ืืืืืจ ืฆืืื EXTRACT FROMPLANT MATERIALKRAFT FOODS R&D, INC.
20/10/200606022029.0EPPCT/US/2007/081801WO/2008/051799
)2009.01 (C12N19766809/10/2007
ื ืืืคื ืืRNAโืชืจืืืืืช ืื ืืืื ืืกืืืืช9PCSK
RNA ANTAGONIST COMPOUNDSFOR THE MODULATION OF PCSK9
SANTARIS PHARMA A/S09/10/200660/828735US17/09/200760/972932US04/10/200760/977409US
PCT/EP/2007/060703WO/2008/043753
)2009.01 (B32B19766909/10/2007
ืฉืืืชืืื ืืืืืืืโืืืืจืื ืจืืงืืคืืืืืจืื ืชืจืืืคืืกืืื ืฉื
ืคืืืืกืืืืงืกืื ืืืจืืื
LAMINATES COMPRISINGTHERMOPLASTIC POLYSILOXANEUREA COPOLYMERS
WACKER CHEMIE AG11/10/2006102006048216.6DE
PCT/EP/2007/060693WO/2008/043749
![Page 148: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/148.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 148
)2009.01 (A61F19767025/09/2007
ืฉืืื ืืืขืจืืช ืืฉืืคืืจ ืืชืคืงืื ืืืืืกืืืื ืฉื ืืื
METHOD AND SYSTEM FORIMPROVING DIASTOLIC FUNCTIONOF THE HEART
CORASSISTื"ืงืืจืืกืืกื ืงืจืืืืืกืงืืืจ ืืข CARDIOVASCULAR LTD.25/09/200660/846748US
PCT/IL/2007/001180WO/2008/038276
)2009.01 (G08G19767119/09/2007
METHOD ืฉืืื ืืืขืจืืช ืืื ืืขืช ืชืืื ืืช AND SYSTEM FORPREVENTING ACCIDENTSUNIFIED MESSAGING SYSTEMS AS
19/09/200620064234NO19/09/200660/826090US
PCT/NO/2007/000329WO/2008/035981
)2009.01 (G01J19767218/09/2007
DEVICE ืืืฉืืจ ืืฉืืื ืืืืื ืช ืืืืืช ืฉืืขืจ AND METHOD FORINSPECTING A HAIR SAMPLE
ืืข'ืกืืช SEETHROUGHื"ืจื LTD19/09/200611/523009US
PCT/IL/2007/001147WO/2008/035336
)2009.01 (G06F19767318/09/2007
ืฉืืื ืืืขืจืืช ืขืืืจ ืืื ืคืืืื ืืืืงืจืช ืฉื ืืืืจืื ืืืคืืืืื
METHOD AND SYSTEM FORCONTROLLED INFUSION OFTHERAPEUTIC SUBSTANCESBAXTER INTERNATIONAL INC.
18/09/200611/523794USPCT/US/2007/078765WO/2008/036658
![Page 149: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/149.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009149
)2009.01 (H04Q19767418/09/2007
ืืืืคืช ืืฉืืืื ืืจืืื ืงืืฉืืจ ืฉืืืชื ืชืืืื ืฉื ืืืืโืขืืืจ ืืขืืจื ืืืชื
SWITCHING MULTIPLE LINK LAYERRESOURCES FOR MEDIAINDEPENDENT HANDOVERINTERDIGITAL TECHNOLOGYCORPORATION
18/09/200660/826024US12/03/200760/894370US
PCT/US/2007/020232WO/2008/036278
)2009.01 (C07K19767520/09/2007
PEPTIDES ืคืคืืืืืLEXCICON LIMITED
20/09/20060618512.8GB19/04/20070707626.8GB
PCT/GB/2007/003592WO/2008/035093
)2009.01 (A47D19767618/03/2009
ืฉืืืื ืืืชืงืคื ืืืืฆื ืขื ืืจืืื ืขื ืื ืื ืขื ืชืืืืืช ืืืืงืื, ืฆืืจ
FOLD OUT SAWHORSE WITHPIVOTABLE, CANTILEVEREDSUPPORT MEMBERSDARRYL W. HULS
20/03/200812/052685US
)2009.01 (C07K19767724/10/2007
ืชืืจืื ืืฉืืืืช ืืืืืื ืืืืืงืืคืจืืืืื ืื ืืฉืืคืจืื
MATERIALS AND METHODS FORIMPROVEDIMMUNOGLYCOPROTEINSTRUBION PHARMACEUTICALS, INC.
24/10/200660/853944USPCT/US/2007/082343WO/2008/052030
![Page 150: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/150.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 150
)2009.01 (G01N19767810/07/2002
ืืืืขืืืืื ืืืืR2Tืืขื ืฉืืืืฉ ืืงืืืื ื ืชืจืืืืืช ืืืืกืืืช ืืขื ืืจ
USE OF SPECIFIC T2R TASTERECEPTORS TO IDENTIFYCOMPOUNDS THAT BLOCK BITTERTASTESENOMYX, INC.
10/07/200160/303811US15/04/200260/372089US
PCT/US/2002/021602WO/2003/006482
)2009.01 (A23N19767919/09/2007
ืืืื ื ืืืืืืืืช ืืืืฆืื ืืืฅ ืืคืจืืืืจ ืขื ืืืื ืืื ืคืื ืงืฆืืื ืืืื
ืืืืคืฉืจืื ื ืืงืื ืงื ืืืชืจ
AUTOMATIC MACHINE FOR CITRUSFRUIT JUICE EXTRACTION WITHFUNCTIONAL ELEMENTS ALLOWINGEASIER CLEANINGA.A.T.-AGROINDUSTRY ADVANCEDTECHNOLOGIES S.P.A
19/09/2006BO2006A000640ITPCT/IT/2007/000650WO/2008/035388
)2009.01 (A61K19768024/09/2007
ืชืืฉืืจืื ืืฉืืืืช ืืืชื ืชืจืืคืืช ืืืืื ืืชpH
COMPOSITIONS AND METHODS FORpH TARGETED DRUG DELIVERYLABOPHARM, INC.
22/09/200660/846355USPCT/IB/2007/004171WO/2008/035229
![Page 151: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/151.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009151
)2009.01 (C08B19768126/09/2007
ืืงืกืืจืื ืืืฉืืคืขื ืขื ืืืืฆืืช ืืืื ื ืืืืจืืคืืืืืช
DEXTRAN FUNCTIONALIZED WITHHYDROPHOBIC AMINO ACIDS
ADOCIA26/09/2006PCT/IB06/002666WO29/03/20070702316FR
PCT/IB/2007/002807WO/2008/038111
)2009.01 (A63B19768219/09/2007
EXERCISE ืืืฉืืจ ืืชืขืืืืช APPARATUSHARRY MOK,
20/09/200611/523293USPCT/US/2007/078925WO/2008/036758
)2009.01 (C07K19768327/02/1998
ืืืืงืืื ืฉื ืคื ื ืฉืื ืืชื ืืืชืืืืชื ืืืขืืจืช ืืืชืืชืฆืืืื ืชื
CELL SURFACE MOLECULEMEDIATING CELL ADHESION ANDSIGNAL TRANSMISSIONJAPAN TOBACCO INC.
27/02/19979/62290JP26/02/199810/62217JP
PCT/JP/1998/000837WO/1998/038216
)2009.01 (C12N19768424/09/2007
ืื ืืืืื ืชืจืืืช ืืชืื ืืืข STEM ืืฉืืืืฉืื CELL CULTURE MEDIUM ANDMETHODS OF USE THEREOFRIKEN
22/09/20062006257780JP27/04/20072007118183JP25/05/20070710095.1JP
PCT/GB/2007/003636WO/2008/035110
![Page 152: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/152.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 152
)2008.04 (C07D19768511/05/1999
ื ืชืืฉืืจื ืจืืงืืืช ืชืจืืืืืช ืืืจืืฆืืงืืืืช ืืืืืืื ืืืชื
HETEROCYCLIC COMPOUNDS ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAMEVERTEX PHARMACEUTICALSINCORPORATED
11/05/199860/085053US01/04/199960/127626US13/04/199960/129099US
PCT/US/1999/010291WO/1999/058502
)2009.01 (H04L19768726/08/2007
REMOTE ืืขืจืืช ืืฉืืืืจ ืืจืืืง TRANSMISSION SYSTEMLIVEUื"ืืืืืื ืืข LTD
26/09/200660/847148USPCT/IL/2007/001057WO/2008/038261
)2009.01 (B01J19768824/09/2007
ืฆืืจืื ืคืืจืืืืืืื ืฉื ืืืงืช ืืกืฃ ืืืืืงืืืืชืืืืฆืช ืืืจืงืื ืืื ืืฉืืืืฉ ืืืจื ืืืืงืืจืืืืช ืขื ืืกืืก ืืืคืืืืืช ืื
POROUS CLUSTERS OF SILVERPOWDER PROMOTED BYZIRCONIUM OXIDE FOR USE AS ACATALYST IN GAS DIFFUSIONELECTRODES, AND METHOD FORTHE PRODUCTION THEREOF
BAR-ILAN ืืืื-ืืื ืืืจืกืืืช ืืจ UNIVERSITY22/09/200660/846346US
PCT/US/2007/079261WO/2008/036962
![Page 153: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/153.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009153
)2009.01 (C12N19768919/09/2007
ืืืืกืชืื ืืืขืืจืืMIRโ 200ืื ืื ืืืืจืืช ืืืชืขืจืืืช ืจืคืืืืช
MIR-200 REGULATED GENES ANDPATHWAYS AS TARGETS FORTHERAPEUCTIC INTERENTIONASURAGEN INC.
19/09/200660/826173US21/05/200760/939309US
PCT/US/2007/078894WO/2008/036741
)2009.01 (C12N19769019/09/2007
ืืืงืจื ืจื ื ืืืชืืืืื ืืฆืืจืืช ืฉืื ืืช ืืืืืืช ืฉื ืืืืื ืืฉืืืืฉืื ืฉืืื
MICRORNAS DIFFERENTIALLYEXPRESSED IN PANCREATICDISEASES AND USES THEREOFASURAGEN INC.
19/09/200660/826173USPCT/US/2007/078936WO/2008/036765
)2009.01 (C12N19769119/09/2007
ืืืืกืชืื ืืืขืืจืืMIRโ 143ืื ืื ืืืืจืืช ืืืชืขืจืืืช ืจืคืืืืช
MIR-143 REGULATED GENES ANDPATHWAYS AS TARGETS FORTHERAPEUTIC INTERVENTIONASURAGEN INC.
19/09/200660/826173US22/05/200760/939573US
PCT/US/2007/078859WO/2008/036718
)2009.01 (C07D19769310/07/2007
ืชืืืืืช ืคื ืืืืืช ืืืฉืืืืฉ ืืื ืืืกืืโืืืืคื ื ื
PHENYL DERIVATIVES AND THEIR USEAS IMMUNOMODULATORS
ACTELION PHARMACEUTICALS LTD.21/09/2006PCT/IB06/053426WO
PCT/IB/2007/052746WO/2008/035239
![Page 154: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/154.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 154
)2009.01 (C07D19769420/09/2007
ืกืืจืืโืชืืืืืช ืคืืจืืืื ืืืืคืื ืืืืืืืืืืืื ืืงืฉืืจืื ืืขืืืืืช ืืืื ืกืืืื
ืื ืืืืคืจืืืืงืืื
PYRIDINE DERIVATIVES FOR THETREATMENT OF METABOLICDISORDERS RELATED TO INSULINRESISTANCE OR HYPERGLYCEMIAPIRAMAL LIFE SCIENCES LIMITED
21/09/200660/846194US18/12/200660/875672US
PCT/IB/2007/053811WO/2008/035305
)2009.01 (C07D19769520/09/2007
โืื ืืืืคืื ืืืืคืืจืืโืืืื ืโ3ืชืืืืืช ืกืืจืื ืืืืืืืืื
3-AMINO-PYRIDINE DERIVATIVESFOR THE TREATMENT OFMETABOLIC DISORDERSPIRAMAL LIFE SCIENCES LIMITED
21/09/200660/846194US18/12/200660/875672US
PCT/IB/2007/053812WO/2008/035306
)2009.01 (B01D19769620/09/2007
ืฉืืื ืืืขืจืืช ืืืขืฉืจืช ืืืืืืืคืื ืฉื ืืืฆื ืืื
METHOD AND EQUIPMENT FOR THEENRICHMENT OF HEAVY OXYGENISOTOPESTAIYO NIPPON SANSOCORPORATION
26/09/20062006-260894
JP
PCT/JP/2007/068253WO/2008/038561
![Page 155: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/155.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009155
)2009.01 (H04Q19769718/09/2007
ืืืื ืืืื ืืืคืขื ืฉื ืงืืฉืืจ ืืืืฉืืจ ืืฉืชืืฉ
USER PLANE UPLINK TIMEDIFFERENCE OF ARRIVAL (U-TDOA)
TRUEPOSITION, INC19/09/200611/533310US
PCT/US/2007/078783WO/2008/036673
)2009.01 (H04Q19769818/09/2007
LOCATION ืืืืืช ืืืงืื ืฉื ืืืื ืฉืืจืืช QUALITY OF SERVICEINDICATORTRUEPOSITION, INC
21/09/200611/534137USPCT/US/2007/078786WO/2008/036676
)2009.01 (A01K19769928/09/2007
ืฉืืื ืืืขืจืืช ืืงืจื ืืืงืื ืช ืืขืืืก ืืชืจืื ืขื ืืืืช
A METHOD AND CONTROL SYSTEMFOR DECREASING THE THERMALLOAD ON ANIMALSDELAVAL HOLDING AB
29/09/20060602048-1SEPCT/SE/2007/050690WO/2008/039150
)2009.01 (E02D19770024/09/2007
CELLULAR ืืขืจืืืช ืฉื ืชืืื ืืืืืืื CONFINEMENTSYSTEMSTERRAM LIMITED OF
25/09/20060618868.4GB27/06/20070712510.7GB
PCT/GB/2007/003630WO/2008/037972
![Page 156: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/156.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 156
)2009.01 (A61K19770119/10/2007
MICELLAR ื ื ืืืืงืืงืื ืืืฆืืื ืฉื ืืืืจืื ืืืืืื NANOPARTICLES OFCHEMICAL SUBSTANCESSOLVAY PHARMACEUTICALS B.V.
20/10/200606122648.6EP20/10/200660/853023US
PCT/EP/2007/061194WO/2008/046905
)2009.01 (C07K19770219/11/2007
ืชืฆืืื ื ืืื ืืืืืืืค ืืฉืืืืฉ ืื ืืกืื ืืจื ืืืืื ืืืกืื
ANTI-IDIOTYPE CONJUGATE ANDITS USE AS A STANDARD IN ANIMMUNASSAYF. HOFFMANN-LA ROCHE AG
21/11/200606024133.8EPPCT/EP/2007/009980WO/2008/061684
)2009.01 (A01N19770317/09/2007
ืืืืจ ืืืืคืื ืืืืืืืื ืืชืืช ืืฆืืคืืจื ืืื ืืฉืืื ืืืืคืื ืืืืืืืื ืคืืจืืชืืื
SUBUNGUICIDE, AND METHOD FORTREATING ONYCHOMYCOSIS
JAY E. BIRNBAUM19/09/200611/523508US
PCT/US/2007/078632WO/2008/036595
![Page 157: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/157.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009157
)2008.04 (H04J19770402/04/2003
ืืขืจืืช ืืฉืืืจืืจ ืืขืื ืฉื ืืืืข ืืขืงืืืชื HSโDSCHโืฉืื ืื
SYSTEM FOR EFFICIENT RECOVERYOF NODE B BUFFERED DATAFOLLOWING SERVING HIGH SPEEDDOWNLINK SHARED CHANNELCELL CHANGEINTERDIGITAL TECHNOLOGYCORPORATION
05/04/200260/370740US30/12/200210/334489US
PCT/US/2003/000100WO/2003/087978
)2009.01 (A61K19770512/11/2002
ืฉืืื ืืืฆืืจ,Apo2ืืจืื ืืฆืื ืืืื ืืืืืฉื ืืืฉืืืืฉ ืืื ืืืื ืช2Apoืืืื ื
ืชืจืืคืืช
STABLE FORMULATION OF Apo2LIGNAD, A METHOD OF MAKINGCRYSTALIZED Apo2 LIGNAD ANDUSE THEREOF IN THEMANUFACTURE OF MEDICAMENTSGENENTECH, INC.
13/11/200160/338249USPCT/US/2002/036251WO/2003/042344
)2009.01 (G01V19770619/09/2007
ืืชืงื ืืฉืืื ืืืืืื ืืืืื ืฉื, ืืืขืืคื, ืงืืื ื ืกืชืจืืืืืืื
ื ืืืโืื ืชื ืืขืช ืื ื/ืืืืืืืงื
ARRANGEMENT AND METHOD FORRECOGNISING AND CLASSIFYINGPREFERABLY HIDDEN OBJECTS INOBJECT AND/OR HUMAN TRAFFICDISPLAYCOM TRACK TECHNOLOGIESGMBH
19/09/2006102006044398.5DEPCT/DE/2007/001704WO/2008/034434
![Page 158: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/158.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 158
)2009.01 (A61F19770720/09/2007
INTRAUTERINE ืจืืื ืืื ืืขืช ืืจืืืโืืชืงื ืชืื CONTRACEPTIVEDEVICEKARPATI, MELINDA-KINGA
20/09/200606019697.9EPPCT/EP/2007/008202WO/2008/034619
)2009.01 (C01F19770803/04/2007
ืฆืืจ ืืืงืืงืื ื ื ืืืืจืืื ืชืืืื ืืืืืืืืื ืืืฆืืืื ืฉื ืืื ืืืื
ืืืืืฆืจ ืืืชืงืื, ืืืืจืืงืกืื ืืืชืืืื
PROCESS FOR THE FABRICATION OFMANOMETRIC, ZONODISPERSED ANDSTABLE MAGNESIUM HYDROXIDE ANDPRODUCT OBTAINED
SERVICIOS INDUSTRIALES PENOLES S.A.DE C.V.
10/10/2006NL/A/2006/000070MXPCT/MX/2007/000045WO/2008/041833
)2009.01 (F24F19770919/03/2009
SUPPORT ืืขืจืืช ืชืืืื ืืืืืืช ืืืื SYSTEM FOR AN AIRCONDITIONER
COOOLื"ืงืื ืขืืฆืื ืืืืืจ ืืข AIR DESIGN LTD
)2009.01 (C02F19771021/09/2007
ืืื ืชืืื, ืืขืจืืืช ืืฉืืคืจืืช ืืืชืืืืืืืืืช ืืืืฆืืจ ืืื ื ืงืืื ืืชืืฆืจืืื
NOVEL ENHANCED SYSTEMS,PROCESSES AND METHODLOGIESFOR PRODUCING CLEAN WATERAND PRODUCTS THEREBYALTELA INC.
22/09/200660/826730USPCT/US/2007/079197WO/2008/036925
![Page 159: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/159.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009159
)2009.01 (B60R19771123/09/2007
ืืขืจืืช ืฉืืืื ืืจืืืง ืืจืื ืฉืืืืืช ืจืืื ืืืืคื ืืืชืื
VEHICLE REMOTE CONTROLSYSTEM WITH ADJUSTABLEREPLACEMENT DEVICE
GOREN ื ืืจ ืืืจื NIR21/09/200660/846112US
PCT/IL/2007/001171WO/2008/035351
)2009.01 (C07C19771218/09/2007
SULFONAMIDE ืืืืชืืืืืช ืกืืืคืื ื DERIVATIVESF. HOFFMANN-LA ROCHE AG
29/09/200606121544.8EPPCT/EP/2007/059842WO/2008/037628
)2009.01 (C12N19771321/09/2007
ืืจื ืกืคืืจืืฆืื ืืืืฃ ืืื ืฉื ืชืื ืืงืื ืจ ืฉื ืืืืื ืืชืืื ืืืืฆืจื ืืื ืกืืืื
IN VIVO TRANSFORMATION OFPANCREATIC ACINAR CELLS INTOINSULIN-PRODUCING CELLSBAYLOR RESEARCH INSTITUTE
22/09/200660/846465USPCT/US/2007/079242WO/2008/036953
)2009.01 (C07D19771405/10/2007
ืคืืจืืืื ืงืจืืืงืกืืืื ืืขืืชโ2ื ืืืจืช ืฉืGKืคืขืืืืช ืฉืคืขืื ืฉื
2-PYRIDINECARBOXAMIDEDERIVATIVE HAVING GK-ACTIVATING ACTIVITYBANYU PHARMACEUTICAL CO.,LTD.
06/10/20062006-275824
JP
PCT/JP/2007/070014WO/2008/044777
![Page 160: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/160.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 160
)2009.01 (E01F19771519/09/2007
ENHANCED ืืขืจืืช ืืฉืืคืจืช ืืืกืืืช ืืื ืจืื VEHICLE BARRIERSYSTEMUNIVERSAL SAFETY RESPONSE,INC.
22/09/200611/525479US14/05/200711/803445US
PCT/US/2007/020270WO/2008/039336
)2009.01 (C07D19771625/09/2007
5ื ืืืจืืช ืงืืืื ืืืืื ืื ืืืืชืืจืืช ืืขืืื ืกืจืื ืืืโืืืืืจืื ืื ืื
5-SUBSTITUTED QUINAZOLINONEDERIVATIVES AS ANTITUMORAGENTSCELGENE CORPORATION
26/09/200660/847471USPCT/US/2007/020765WO/2008/039489
)2009.01 (C07D19771724/09/2007
โ5[โ3โืฆืืจืืช ืืืืฉืืืช ืฉื ืืืืฆื ืื ืืืืืช]4,2,1[โ)ืคืืืืืจืืคื ืืโ2(
]ืืืโ3โืืืงืกืืืืืื
CRYSTALLINE FORMS OF 3-[5-(2-FLUOROPHENYL)-[1,2,4]OXADIAZOL-3-YL]-BENZOICACIDPTC THERAPEUTICS, INC.
25/09/200660/847326USPCT/US/2007/020633WO/2008/039431
![Page 161: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/161.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009161
)2009.01 (A61K19771824/09/2007
HDACืชืืฉืืจืื ืจืืงืืืื ืฉื ืืขืืืืืชืจืืืืืช ืืชืืช ืื ืืชื ืืช ืืงืืืฆืื
ืืขืืโืื ืืชืืชืืงืืืคืืงืกืื ืฉื ืงืHDAC
PHARMACEUTICAL COMPOSITIONSOF HDAC INHIBITORS ANDCHELATABLE METAL COMPOUNDS,AND METAL-HDAC INHIBITORSCHELATE COMPLEXESMERCK & CO., INC.
28/09/200660/848300USPCT/US/2007/020609WO/2008/039421
)2009.01 (E04H19771919/09/2007
REMOVABLE ืืขืจืืช ืืจืืงืื ืฉื ืืชื ืช ืืืืื BARRICADE SYSTEMUNIVERSAL SAFETY RESPONSE,INC.
22/09/200611/525478USPCT/US/2007/020280WO/2008/039338
)2009.01 (C07D19772027/09/2007
โ3โืืื ืืืโ1Hโืคืืืจืโ6(โ2[ืื]ืื ืืื)ืืืืกืืืคื ืื ืืคืื ืืชืื ืืืื ืืืคืจืขืืช
[2-(6-FLOURO-1H-INDOL-3-YLSULFANYL)BENZYL]METHYL AMINE FOR THETREATMENT OFAFFECTIVE DISORDERSH. LUNDBECK A/S
28/09/2006PA200601251DK20/03/2007PA200700432DK
PCT/DK/2007/000419WO/2008/037258
![Page 162: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/162.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 162
)2009.01 (C07K19772128/09/2007
ืชืจืืืืืช ืืฉืืืืช ืืืืืื ืืืืคืื ืืกืจืืCOMPOSITIONS AND METHODS FORDIAGNOSING AND TREATINGCANCERONCOMED PHARMACEUTICALS,INC.
29/09/200660/847904US23/01/200760/886260US07/06/200760/942542US
PCT/US/2007/020889WO/2008/042236
)2009.01 (C07D19772225/09/2007
5MGLURMGLUR5ืืืคื ื ืื ืฉื MODULATORSASTRAZENECA AB
05/10/200660/828325USPCT/IB/2007/002784WO/2008/041075
)2009.01 (C07D19772302/10/2007
3/5STATSTAT3/5ืืขืื ืฉืคืขืื ืฉื ACTIVATION INHIBITOROTSUKA PHARMACEUTICAL CO.,LTD.
02/10/20062006-271172
JP
PCT/JP/2007/069645WO/2008/044667
)2009.01 (C07D19772424/09/2007
ืชืจืืืืืช ืืชืืฉืืจืื ืืืขืืื ืคืจืืืืื ืงืื ืื
COMPOUNDS AND COMPOSITIONSAS PROTEIN KINASE INHIBITORS
NOVARTIS AG02/10/200660/827873US
PCT/US/2007/079340WO/2008/042639
![Page 163: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/163.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009163
)2009.01 (A61K19772526/09/2007
NUTRIENT ืืืืฉื ืฉื ืืืืจ ืืืื SENSORBAYLOR RESEARCH INSTITUTE
26/09/200660/847252USPCT/US/2007/079570WO/2008/039855
)2009.01 (A61K19772620/09/2007
ืืืจืืฆืืงืืื ืืืชืืจืื ืืืืืืื ืื ืงื ืืืกืืชADPืืืขืืื ืจืฆืคืืืจ
NITROGEN CONTAININGSUBSTITUTED HETEROCYCLES ASPLATELET ADP RECEPTORINHIBITORSPORTOLA PHARMACEUTICALS, INC.
20/09/200660/846328US17/09/200711/856616US
PCT/US/2007/079076WO/2008/036843
)2009.01 (A61K19772726/09/2007
38CDCOMBINATIONืืืคืื ืืฉืืื ืืืืืืืื ืืืืืืื TREATMENT OFCD38-EXPRESSING TUMORSGENMAB A/S
26/09/2006PA200601232DK26/09/200660/847329US
PCT/DK/2007/000418WO/2008/037257
)2009.01 (H02M19772822/09/2006
VACUUMืชืืฆืืช ืื ืจืืื QUANTUMQUANTUM VACUUM ENERGYEXTRACTIONJOVION CORPORATION
PCT/US/2006/037096WO/2008/039176
![Page 164: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/164.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 164
)2009.01 (B29B19772903/10/2007
IMPROVED ืชืื ืืืช ืคืืกืืืง ืืฉืืคืจืืช PLASTIC PREFORMCONCORDIA DEVELOPMENT S.R.L
06/10/2006MI2006A001922ITPCT/IB/2007/054015WO/2008/041186
)2009.01 (G01N19773020/09/2007
ื ืืืื ืืืืืื ืืชืืจืืโืืขืจืืื ืืืืกืกื ืืจืืื ืืืช ืืชืืื ื ืขืื ื ืืืจืื
ANTIBODY-BASED ARRAYS FORDETECTING MULTIPLE SIGNALTRANSDUCERS IN RARECIRCULATING CELLSPROMETHEUS LABORATORIES, INC.
21/09/200611/525598US20/04/200760/913087US
PCT/US/2007/079002WO/2008/036802
)2009.01 (A47K19773122/03/2009
ืืืฉืืจ ืืืืืืช ืืืืื ืื ืืขืช ืืฉืืืืฉDEVICE FOR HOLDING A PRE-MOISTENED TOWELLETTE DURINGUSE
ื GALIA ืืืื ืืื'ืืืื GULYA LEVY
)2009.01 (A61J19773228/09/2007
ืืขืจืืช ืืืจืืืช ืชืืฉืืจืื ืจืืงืืืืืืจืืื ืืขืจืืืช ืืืืืืืชโืืืชื ืชืื
ืืืชื
PACKAGING SYSTEM FORPHARMACEUTICAL COMPOSITIONSFOR INTRAVENOUS ADMINISTRATIONAND KITS COMPRISING THE SAMEINFA S.A.
29/09/2006MI2006A001881IT29/03/2007MI2007A000635IT
PCT/IB/2007/002857WO/2008/038126
![Page 165: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/165.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009165
)2009.01 (H04M19773329/10/2007
, ืืืืขืื, ืืชืืืื, ืฉืืืืช ืืืขืจืืืช ืืงืืืขืืืืืชืืื ืฉื ืชืงืฉืืจืช ืืืฉืืช ืืืงืืืข
ืงื ืชืงืฉืืจืช ืกืืจ ืขืืืคืืืืช ืขืืืจ ืืคื ืืืชืงื ื ืชืงืฉืืจืช
METHODS AND SYSTEMS FORSETTING, SCHEDULING,OPTIMIZING, AND INITIATINGPERSONAL COMMUNICATION ANDPRIORITIZING COMMUNICATIONCHANNELS AND DEVICESNEATCALL LTD.
29/10/200660/863368USPCT/IL/2007/001309WO/2008/053467
)2009.01 (G06K19773407/08/2008
ืฉืืื ืืืขืจืืช ืืืืฆืืข ืืืชืืจ ืืืขืงื ืชื ืืขื ืืืคืืืช ืฉื ืืคืฅ ืขื ืคื ื ืฉืื ืจืื
METHOD AND SYSTEM TOPERFORM OPTICAL MOVINGOBJECT DETECTION AND TRACKINGOVER A WIDE AREAVISIONMAP LTD.
07/08/200760/954366USPCT/IL/2008/001085WO/2009/019695
)2009.01 (G06K19773524/09/2007
ืชืงืฉืืจืช ืืืืืืืช ืขื ืืื ืจืฉืช ืืืคืืืชPON(WIRELESS(ืกืืืื OVER PON
PASSOVER, INC.22/09/200660/826679US
PCT/US/2007/079322WO/2008/036976
![Page 166: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/166.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 166
)2009.01 (C07H19773624/09/2007
ืฉืืืืช, ืืงืืืจืื, ื ืืงืืืืืืืืืคืืืื"ืืขืจืืืช ืืืืงืืืืฆืื ืฉื ืจื ืื/ื
ืืืืื ืื ืืชืืื ืืืื
ISOLATED POLYNUCLEOTIDES,NUCLEIC ACID CONSTRUCTS,METHODS AND KITS FORLOCALIZATION OF RNA AND/ORPOLYPEPTIDES WITHIN LIVINGCELLS
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
28/09/200660/847664USPCT/IL/2007/001175WO/2008/038272
)2009.01 (C07K19773723/09/2007
ANTIGEN ืืืกืื ืื ืจืื ืืคืืืืคืื ืืื ืืืื ืืกืืื SPECIFIC MULTI EPITOPEVACCINES
VAXIL ืืืืืจ ืืจืืื BIO TERAPEUTICS LTD.21/09/200660/846087US
PCT/IL/2007/001168WO/2008/035350
)2009.01 (A61L19773814/09/2007
ืฉืืืช ืฉืื ืืืืจืจืช ืื ืกืคืืช ืืืืฃ ืืฉืืืืช ืืืื ืชื
PERFORATED BIOABSORBABLE OILFILM AND METHODS FOR MAKINGTHE SAMEATRIUM MEDICAL CORPORATION
22/09/200611/525390USPCT/US/2007/019978WO/2008/039308
![Page 167: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/167.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009167
)2009.01 (A61K19773914/01/2004
ืืื ืกืืืื ืืจืื ืืืื ืืืืจืืช ืืชืืืืืืืงืจืืืืืืกืงืืืจืืช ืืืชืืืชื ืืืืืื ืงืื
2ืกืืจืชืืื ืืืืืืื ืขื ืกืืจืช ืืกืื
LONG ACTING INSULIN FORREDUCING CARDIOVASCULARMORBIDITY AND MORTALITY INPREDIABETIC PATIENTS ANDPATIENTSWITH TYPE 2 DIABETESAVENTIS PHARMACEUTICALS INC.
14/01/200360/439941USPCT/US/2004/000879WO/2004/064862
)2009.01 (E04B19774020/09/2007
ืืื ื ืืืืจืื ืืืืื ื ืืจืืื ืืืื ืื ืืASSEMBLY COMPOSED OF ACONSTRUCTION ELEMENT AND AMASONRY TOOLDI TRAPANI, AGOSTINO
22/09/200606121158.7EPPCT/EP/2007/060008WO/2008/034888
)2009.01 (H02K19774114/06/2007
MAGNETIC ืืืกื ืืื ืื BEARINGTREUBERT, KIRK
22/09/200611/525398USPCT/US/2007/014090WO/2008/039256
)2009.01 (G02C19774222/03/2009
ืฉืืคืืจืื ืืืขืจืืืช ืขืืฉื ืืกืชืืืช ืชืื)AIOL(ืขืื ืืช
IMPROVEMENTS INACCOMMODATING INTRAOCULARLENS (AIOL) ASSEMBLIES
NULENSื"ื ืืืื ืก ืืข LTD.
![Page 168: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/168.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 168
)2009.01 (H04L19774323/10/2007
ืืืืื ื ืืกืืจืช ืขืืืจ ืืขืจ โืืืช ืชืงืฉืืจืช ืืืืืช
FRAME STRUCTURES FORWIRELESS COMMUNICATIONSYSTEMSQUALCOMM INCORPORATED
24/10/200660/862641US24/10/200660/862744US
PCT/US/2007/082209WO/2008/070316
)2009.01 (H04L19774416/10/2007
ืช ืงืฉืืจืช ืืืืจืืช ืืืกืืื ืื ืจืืื ืขืืืจ ืืืืืชโืื
POWER SAVE ENHANCEMENTS FORWIRELESS COMMUNICATION
QUALCOMM INCORPORATED19/10/200660/862146US12/10/200711/871874US
PCT/US/2007/081562WO/2008/115282
)2009.01 (A61K19774520/11/2003
ืฉืืืืช ืืขืฉืืืช ืคืืจืืืืฆืืืช ืจืงืืืืชืืืงืืงืื ืฉื ืืคืืโืืืืืช ืืืงืจืืื
ืืืืฉืื
METHODS FOR MAKINGPHARMACEUTICAL FORMULATIONSCOMPRISING DEAGGLOMERATEDMICROPARTICLESACUSPHERE, INC.
19/12/200210/324558USPCT/US/2003/037100WO/2004/060344
![Page 169: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/169.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009169
)2009.01 (C07C19774613/09/2007
2CBCOMPOUNDSืืืืช ืืืืคื ื ืืช ืืช ืืงืืืื ืชืจื WHICH MODULATETHE CB2 RECEPTORBOEHRINGER INGELHEIMINTERNATIONAL GMBH
25/09/200660/826819USPCT/US/2007/078341WO/2008/039645
)2009.01 (C09B19774724/09/2007
PIGMENT ืชืจืืื ืฆืืขื CONCENTRATEAKZO NOBEL COATINGSINTERANTIONAL B.V.
26/09/2006981/ KOL/2006
IN
09/11/200606123764.0EP10/11/200660/858290US
PCT/EP/2007/060079WO/2008/037678
)2009.01 (B64F19774824/09/2007
SYSTEM ืชื ืืขืช ืืืืกืื ืืฉืืืช ืชืขืืคื AND METHOD FORTRANSFERRING AIRPLANES
ISRAELื"ืืชืขืฉืืื ืืืืืจืืช ืืืฉืจืื ืืข AEROSPACE INDUSTRIESLTD.
28/09/200611/528647US16/05/200711/798777US
PCT/IL/2007/001172WO/2008/038270
)2009.01 (B64F19774926/09/2007
CYTOKINE ืกืืืื ืฆืืืืงืื ื SIGNALINGCASE WESTERN RESERVEUNIVERSITY
26/09/200660/847656USPCT/US/2007/079602WO/2008/039876
![Page 170: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/170.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 170
)2009.01 (C07D19775004/10/2007
ืคืืจืืืืืื ืชืืื ืืคืืจืืืื ืื ืืืืฆืขืื ืืืคืืืืื
THERAPEUTIC PYRAZOLYLTHIENOPYRIDINES
PFIZER PRODUCTS INC.16/10/200660/851982US
PCT/IB/2007/002994WO/2008/047198
)2009.01 (C25B19775109/10/2007
CATHODE ืงืชืืื ืขืืืจ ืชืืืืืื ืืืงืืจืืืืืื FOR ELECTROLYTICPROCESSESINDUSTRIE DE NORA S.P.A
11/10/2006MI2006A001947ITPCT/EP/2007/060728WO/2008/043766
)2009.01 (C07C19775214/09/2007
HDACHDACืืขืืื INHIBITORSCHROMA THERAPEUTICS LTD.
06/10/20060619753.7GBPCT/GB/2007/003504WO/2008/040934
)2009.01 (C07C19775306/09/2007
TOILET ืืืฉืืจ ืืืกืื DEVICEGILLIAN PAULA WRIGHT
29/09/20060619171.2GBPCT/GB/2007/050526WO/2008/038036
![Page 171: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/171.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009171
)2009.01 (G10K19775423/03/2009
CROSSLINKED ืืฆืืืืืชPANืืืก ืฉื ืคืืืจืืืืช PAN FIBERSCOMPACT
ืืืฉืื ืืืจื ืืคืืชืื ืืืืงืจ ืฉื ืืืื ืืืจืกืืื ืืขืืจืืช ืืืจืืฉืืื
YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM
)2009.01 (A61K19775501/10/2007
โืฉื ืจืื ื)NIMIV(ืืืืื ืืื ืื ืืจื ืืืฉืืืจืืก ืืืฉืืืืฉ ืื ืืืืฉืืืื ืฉื ืชืจืืืื
ืืืกืื
NOVEL NEUTRALIZINGIMMUNOGEN (NIMIV) OFRHINOVIRUS AND ITS USE FORVACCINE APPLICATIONSSANOFI PASTEUR BIOLOGICS CO.
29/09/200660/848451USPCT/US/2007/021053WO/2008/057158
)2009.01 (C12N19775601/10/2007
RECOMBINANT ืืืจืืก ืืฆืจืคืโืืงืืืจืื ืฉื ืจืื ื RHINOVIRUSVECTORSSANOFI PASTEUR BIOLOGICS CO.
29/09/200660/848308US15/01/200760/880664US
PCT/US/2007/021102WO/2008/100290
![Page 172: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/172.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 172
)2009.01 (G10L19775729/08/2007
ืืขืจื, ืืขืจืืช ืฉื ืืขืจื ืืกื ื ืื ืื ืืชืืืืขืจืื,ืืคืขื ื, ืืงืื, ืืกื ื ืื ืืกืื ืชืื ืื ืืืื ืืขืืืืช
ANALYSIS FILTERBANK, SYNTHESISFILTERBANK, ENCODER, DECODER,MIXER AND CONFERENCINGSYSTEMFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
18/10/200660/862032US04/05/200711/744641US
PCT/EP/2007/007553WO/2008/046468
)2009.01 (C07D19775802/10/2007
ืชืืฉืืจ, ื ืืืจืืช ืืืฉืืช ืืกืื ืื ืืืคืืจืืื ืืืืื ืืช ืืืืืจ ืืฆืืจื ืืืคืื
ืืฉืืืืฉ, ืื ืืขืช ืชืคืงืื ืงืืื ืืืืื ืืงืื ืืืื
NOVEL BENZOFURAN TYPEDERIVATIVES, A COMPOSITIONCOMPRISING THE SAME FORTREATING OR PREVENTINGCOGNITIVE DYSFUNCTION AND THEUSE THEREOFDIGITAL BIOTECH CO. LTD
02/10/20061020060097388KRPCT/KR/2007/004833WO/2008/041826
)2009.01 (B05B19775923/03/2009
ULTRASONIC ืืจืกืก ืืืืืจืืกืื ื ืืขืจืืช ืืฉืืื SPRAYER SYSTEMAND METHOD
.U.Sื"ืืืืืฉ ืืืืืจืกืื ื ืืข DRYER LTD
)2009.01 (A61K19776027/09/2007
FORMULATIONS ืชืืฉืืจืื ืืืืืืื ืืืืจืื ืฆืืงืืืื COMPRISINGCYCLIC COMPOUNDSPAOLO BOTTI
27/09/200606020286.8EPPCT/EP/2007/008442WO/2008/037484
![Page 173: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/173.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009173
)2009.01 (A61C19776123/03/2009
ืืืืกื ืืขืจืืื ืืื ืืืืจื ืฉืืฃ ืืขืจืืืชืืืืืื, ืืืืืืืช ืืืืกืืช ืฉืืืื ืืฉืืืืฉ ืืจืืคืื ืฉืื ืืื
CAPSULE FOR MIXING TOGETHERTWO FLOWABLE MATERIALS, ANDKITS INCLUDING SUCH CAPSULES,PARTICULARLY USEFUL INDENTISTRY
MOSHE ืืฉื ืืืฆืื ZALSMAN
)2009.01 (A61K19776223/03/2009
ืืฉืืืืฉ ืืืืคืื ืืชืืืG6ืจืืืืื ืกืจืื ืืื
RHODAMINE 6G FOR USE INTREATING CANCEROUS CELLS
ANISOPHARM INC.
)2009.01 (C07D19776324/09/2007
PYRAZINE-2-CARBOXAMIDE ืงืจืืืงืกืืืืโ2โืชืืืืืช ืคืืจืืืื DERIVATIVESF. HOFFMANN-LA ROCHE AG
04/10/200606121749.3EPPCT/EP/2007/060090WO/2008/040649
)2009.01 (C07D19776404/10/2007
VINYLOGOUSืืืืืช ืืืขืืื ืืืืืืชืืืืืช ืืืืฆืืช ืืื ืื ACIDS DERIVATIVESAS CHYMASE INHIBITORSF. HOFFMANN-LA ROCHE AG
13/10/200606122239.4EPPCT/EP/2007/060528WO/2008/043698
![Page 174: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/174.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 174
)2009.01 (C07K19776503/10/2007
METHODS ืฉืืืืช ืืืืืืจ ืชืืืืืื ืฉื ืคืืืืคืคืืืืื FOR PURIFICATION OFPOLYPEPTIDE CONJUGATESNOVO NORDISK A/S
03/10/200660/848969US02/11/200660/864117US30/11/200660/868057US31/01/200760/887517US20/07/200760/951159US09/08/200760/955001US17/08/200760/956468US
PCT/US/2007/080353WO/2008/057683
)2009.01 (A61K19776624/09/2007
ืฉืืืืฉ ืืืืจืืืืืืื ืฆืื ืืื ืืขื ืืืืืคืื ืืื ืชืจืงืก
USE OF ORITAVANCIN FOR THEPREVENTION AND TREATMENT OFANTHRAXTARGANTA THERAPEUTICS CORP
25/09/200660/847397USPCT/US/2007/079277WO/2008/097364
)2009.01 (A61K19776726/09/2007
CAPECITABINE ืคืืืืืจืืืช ืืืืืืช ืงืคืฆืืืืื PEDIATRIC TABLETSF. HOFFMANN-LA ROCHE AG
06/10/200660/850174US24/07/200760/951557US
PCT/EP/2007/060186WO/2008/040665
![Page 175: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/175.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009175
)2009.01 (A61K19776802/10/2007
IMMUNISATION ืกืจืืืืคืื ืฉื ืื ืื4ืฉืืื ืืืืกืื ืื ืื METHOD AGAINSTTHE 4 DENGUE SEROTYPESSANOFI PASTEUR
04/10/200606/08660FRPCT/FR/2007/052054WO/2008/047023
)2009.01 (C07H19776911/10/2007
NOVEL ืชืืืืืช ืืืจืคืื ืืืฉืืช MORPHINE DERIVATIVESNEORPHYS
12/10/20060654247FRPCT/FR/2007/052122WO/2008/043962
)2009.01 (A61K19777004/10/2007
ืกืืืจืื ืฉืขืืจื ืคืืืืฆืื ืืืืืงืืคืคืืืืื ืืงืฉืืจืื ืืืืืฆืจืื
GLYCEROL LINKED PEGYLATEDSUGARS AND GLYCOPEPTIDES
NOVO NORDISK A/S04/10/200660/828208US
PCT/US/2007/080471WO/2008/060780
)2009.01 (A61B19777123/03/2009
GLUCOSE ืืืืฉื ืืืืืงืื DETECTORIRINA ืื ื ืืื ื ONUFRIEVICH,
![Page 176: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/176.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 176
)2009.01 (C25D19777207/10/2007
ื ืืฉืืื'ืโืจืืืืฅ ืฉื ืฉืืืืช ืกืื ืืืงืืจืืืืืืช
ELECTROCHEMICAL CO-DEPOSITION OF SOL-GEL FILMS
ืฉ ื ืืืฉืื ืืืจื ืืคืืชืื ืืืืงืจื"ืืืื ืืืจืกืืื ืืขืืจืืช ืืืจืืฉืืื ืืข
YISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
27/09/200660/847378USPCT/IL/2007/001216WO/2008/038293
)2009.01 (C07D19777310/10/2007
A ืืืโ4โืชืืืื ืืืืฆืืจ ืชืืืืช ืคืืคืืจืืืื PROCESS FOR THE PRODUCTIONOF A PIPERIDIN -4-ONE DERIVATIVENIPPON SODA COMPANY LTD.
11/10/20062006-277086
JP
PCT/JP/2007/069741WO/2008/044701
)2009.01 (C12N19777416/01/2003
ืืืื ืืกืืื ืฉื ืงืืืื ืืฉืืจืจ2ืงืืจืืืงืืืจืืคืื ืืืืคืืก
CORTICOTROPIN RELEASINGFACTOR 2 RECEPTOR AGONISTSTHE PROCTER & GAMBLECOMPANY
16/01/200260/349117US29/04/200260/376337US14/06/200260/388895US19/09/200260/411988US
PCT/US/2003/001461WO/2003/062269
![Page 177: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/177.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009177
)2009.01 (G06F19777519/11/2007
ืืืืื ืืฆื ืืืคืฉื ืื ืขืืื ืืคืชืจืื ืืขืืืช ืืื ืืืืืืช ืืงืืืืืช
LOCK-FREE STATE MERGING INPARALLELIZED CONSTRAINTSATISFACTION PROBLEM SOLVERSMICROSOFT CORPORATION
20/11/200611/602092USPCT/US/2007/085149WO/2008/064185
)2009.01 (A61K19777620/11/2007
F/Aืคืืืืคืคืืืืื ืืืจืืืืืจืื ืฉื 17โIL ืืฉืืืืฉืืื ืืจืคืืืืื
IL-17A/F HETERODIMERICPOLYPEPTIDES AND THERAPEUTICUSES THEREOFGENENTECH, INC.
29/11/200611/606192USPCT/US/2007/085269WO/2008/067223
)2009.01 (C07F19777728/09/2007
ืืื ืืืืื ืืืืจืื ืืืืื ื ืคืืกืคืHIVืื ื ืืืืืจืืช ืืืขืืื
ENANTIOMERICALLY PUREPHOSPHOINDOLES AS HIVINHIBITORSIDENIX PHARMACEUTICALS, INC.
29/09/200660/848584US09/11/200660/857980US23/02/200760/903115US
PCT/US/2007/020900WO/2008/042240
![Page 178: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/178.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 178
)2009.01 (A61K19777812/10/2007
ืฉืื ืื ืืืืง ืืื ื ืืชืืืกืืช ืฉื ื ืืืื ืื ืืืฉืื/ืืืงืื ืช ืืืืงื
MODIFICATION FOR IONICSTRENGTH IN ANTIBODY-SOLUTIONS TO REDUCEOPALESCENCE/AGGREGATESWYETH
12/10/200660/851651USPCT/US/2007/021904WO/2008/045563
)2009.01 (F41H19777915/09/2007
POLYOLEFIN ืืืื ืืืืืง ืืกืื ืคืืืืืืืคืื FIBER REINFORCEDHONEYWELL INTERNATIONAL INC.
25/09/200611/526353USPCT/US/2007/078592WO/2008/097363
)2009.01 (H01Q19778024/03/2009
ืืชื ืื ืืื ืืืชื ืืขืจืืช ืื ืื ื ืืืืื ืืช ืฉื ืขืืืจ ืชืงืฉืืจืช ืืืืื ืืืืช ืฉื ืืื ืจืื
ืืืืืจืืื
STEERABLE DIRECTIONALANTENNA SYSTEM FORAUTONOMOUS AIR VEHICLECOMMUNICATIONHONEYWELL INTERNATIONAL INC.
03/06/200812/132474US
)2009.01 (F26B19778103/10/2007
LYOPHILIZATION ืืฆืืืฉืืืืช ืืืชืงื ืื ืืืืืืคืืื METHODS ANDAPPARATUSESWYETH
03/10/200660/849040USPCT/US/2007/021240WO/2008/042408
![Page 179: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/179.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009179
)2009.01 (C12P19778209/10/2007
ืืืืืจ ืฉื ืคืืืืกืืืืจืืืื ืฉืPNEUMONIAE STREPTOCOCCUS
3ืืืืคืืก
PURIFICATION OF STREPTOCOCCUSPNEUMONIAE TYPE 3POLYSACCHARIDES
WYETH10/10/200660/850665US
PCT/US/2007/080768WO/2008/045852
)2009.01 (C07D19778326/09/2007
ืืืจืืื ืคืืืืฆืืงืืืื ืืืืคืื ืื ืฉืืื ืกืื ืกืืฆืืืืืช ืืืืืื ืืืจืืื
POLYCYCLIC AGENTS FOR THETREATMENT OF RESPIRATORYSYNCYTIAL VIRUS INFECTIONSBIOTA SCIENTIFIC MANAGEMENTPTY LTD.
28/09/200660/848073USPCT/AU/2007/001429WO/2008/037011
)2009.01 (A63F19778424/03/2009
A ืืฉืืง ืืื ืืฉืืืช ืืฉืืง ืขืืืจื DICE BOARD GAME AND PLAYINGMETHOD THEREOF
YAN ืืื ืคืืฉืืืื FISHGOLD
)2009.01 (F25J19778524/03/2009
POWER-POINT ืชืื ืช ืืื ืขื ืืื ืืฉืืฉ FROM THE HEAT OFFTHE SUN
BOAZ ืืขื ืืื MELET
![Page 180: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/180.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 180
)2009.01 (F21S19778605/10/2007
DIRECTIONAL ืกืคืื ืืืืื ื DOWNLIGHTFRANCIS WILLIAM AUSTIN
06/10/2006550427NZPCT/NZ/2007/000291WO/2008/041870
)2009.01 (C23C19778730/08/2007
WORKPIECE ืืื ืขืืืื ืขื ืฆืืคืื ืงืฉื WITH HARD COATINGOERLIKON TRADING AG,TRUBBACH
26/09/200660/826943US02/04/200760/909559US
PCT/EP/2007/059070WO/2008/037556
)2009.01 (C07D19778827/09/2007
ืชืจืืืืืช ืื ืืืื ืืกืืืืช ืืจืฆืคืืืจืืจืืืื ืืืืืืื ืชืจืืืืืช ืืื, ืืืืืงืืื
ืืฉืืืืช ืฉืืืืฉ
GLUCAGON RECEPTORANTAGONIST COMPOUNDS,COMPOSITIONS CONTAINING SUCHCOMPOUNDS AND METHODS OFUSEMERCK & CO., INC.
03/10/200660/848967USPCT/US/2007/020858WO/2008/042223
)2009.01 (H04L19778918/12/2001
TELEVISION ืืงืื ืืืืืืื ืืฉืืื ืืืคืขืืช ืฉืจืช RECEIVER ANDMETHOD OF OPERATING A SERVERWAPTV LIMITEd
12/01/20010100912.5GBPCT/GB/2001/005599WO/2002/056590
![Page 181: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/181.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009181
)2009.01 (A61K19779027/09/2007
ืฉืืื ืืืืฆืืจ ื ืืืื ืื ืคืขืืืื ื ืื ืื ืืืืื ืืืื ืื ืฉืืืฆืจื ืขื ืืื ืืฉืืื, ืขืืืืืช
ืืฉืืืืฉืื ืืื
METHOD FOR GENERATING ACTIVEANTIBODIES AGANIST ARESISTANCE ANTIGEN, ANTIBODIESOBTAINED BY SAID METHOD ANDTHEIR USESPIERRE FABRE MEDICAMENT
28/09/200606/08514FRPCT/EP/2007/060243WO/2008/046724
)2009.01 (C11D19779101/10/2007
ืชืืืกื ืื ืืงืื ืืชืืืช ืงืืจ ืืืืืื ืชืจืืื ืื ืืืื ืืชืืืกื ืืืืืช ืืืืื
GRAFFITI CLEANING SOLUTIONINCLUDING A NON-AQUEOUSCONCENTRATE AND DILUTEDAQUEOUS SOLUTIONECO HOLDINGS LLC
29/09/200611/540330USPCT/US/2007/080060WO/2008/042840
)2009.01 (C08J19779226/09/2007
ืืจืืืื ืืขืืื ืืขืจื ืืืืกืกื ืงืฆืฃ ืคืืืืกืืืจื ื ืฉืขืืจ ืืงืกืืจืืืื
FLAME RETARDANT EXTRUDEDPOLYSTYRENE FOAMCOMPOSITIONSALBEMARLE CORPORATION
26/09/200660/827020USPCT/US/2007/079520WO/2008/039836
![Page 182: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/182.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 182
)2009.01 (G06Q19779314/09/2007
ืืขืจืืช ืืฉืืื ืืืืืืช ืืืืช ืืืฉืชืืฉ ืืืจื ืืงืฆืืืช ืืืงืืจืื ืืืช
A SYSTEM AND METHOD FORVERIFYING A USER'S IDENTITY INELECTRONIC TRANSACTIONSSCAMMELL DAN
29/09/200611/537461USPCT/CA/2007/001639WO/2008/037062
)2009.01 (C02F19779428/08/2007
LIQUID ืืชืงื ืืฉืืื ืืืืืืจ ื ืืืืื PURIFICATION DEVICE ANDMETHOD
H2Q WATER INDUSTRIES LTDH2Q WATER INDUSTRIES LTD.28/08/200660/823664US09/07/200760/929668US
PCT/IL/2007/001066WO/2008/026208
)2009.01 (H04B19779507/01/2005
ืชืฆืจืืคืื ืืืืืจืช ืคืืจืืื ืืืขืืจื ืงืืืื ืืืืืืืช/ืืืืืืช ืฉืืืืจ
TRANSPORT FORMATCOMBINATION SELECTION IN AWIRELESS TRANSMIT/RECEIVEUNITINTERDIGITAL TECHNOLOGYCORPORATION
09/01/200460/535426US22/12/200411/019489US
PCT/US/2005/000571WO/2005/067659
![Page 183: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/183.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009183
)2009.01 (A61K19779624/09/2007
ื โNโืื ืืืืื ืฉื ืืจืืื ืืืืชืืจืื ืืงืฆื ืืจืืื ืื
ANALOGS OF GHRELINSUBSTITUTED AT THE N-TERMINAL
IPSEN PHARMA S.A.S27/09/200660/847423US
PCT/US/2007/020595WO/2008/039415
)2009.01 (A21D19779913/12/2006
ืขืืืืืช ืืืืืืืช ืืื ืืืื ืืขืืืื ืขืืืืืขืืฆืืืช ืืกืืจืืจ ืืืขืืืช ืชืืืืช ืกืืืื
ืืืืื
HIGH FIBER ROTARY MOLDEDCOOKIES CONTAINING INULIN ANDRESISTANT STARCH
KRAFT FOODS GLOBAL BRANDSLLC
12/12/200611/637589USPCT/US/2006/062022WO/2008/073127
)2009.01 (B01D19780025/03/2009
INTERNAL ืืชืงื ืกืื ืื ืคื ืืื FILTERING DEVICESHMUEL ืฉืืืื ืื ืืืืืจ BEN MUVHAR
)2009.01 (A61K19780426/09/2006
ืืฉืืืืชCืชืจืืืืืช ืืืืคืื ืืืคืืืืืกCืืฉืืืืฉ ืืชืจืืืืืช ืืืืคืื ืืืคืืืืืก
COMPOSITIONS FOR THETREARMENT OF HEPATITIS C ANDMETHODS FOR USINGCOMPOSITIONS FOR THETREATMENT OF HEPATITIS CLOTSOF HOWARD L.
PCT/US/2006/037231WO/2008/039179
![Page 184: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/184.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 184
)2009.01 (B60R19780525/03/2009
WEIGHING ืืชืงื ืฉืงืืื SCALEBEN ืื ืฆืืื ืื ZION THEE
)2009.01 (G06F19780620/09/2007
ืฉืืื ืืืชืงื ืืืืืื ืจืืืื ืชืืื ืMETHOD AND SYSTEM FORISOLATING SOFTWARECOMPONENTS
TYPEMOCKื"ืืืืคืืืง ืืข LTD25/09/200660/826749US
PCT/IL/2007/001152WO/2008/038265
)2009.01 (G06T19780725/03/2009
ืืขืจืืช ืืฉืืื ืืืืืื ืกืคืื ืื ืชืื ืื ืฉื ืชืืื ื
SYSTEM AND METHOD FOR SPAMDETECTION IN IMAGE DATA
PINEAPPื"ืคืืื ืืค ืืข LTD26/03/200812/055812US
)2009.01 (A61B19780825/09/2007
EXAMINATION ืืชืงื ืืืืงื DEVICEMEDVISION ืืืืืืืื ืืื ืง INC.
28/09/200660/847648USPCT/IL/2007/001190WO/2008/038281
)2009.01 (A44B19780925/03/2009
SOCKS ืืจืืืืDALITEX ืืืืงืืงืก LTD
![Page 185: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/185.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009185
)2009.01 (B23H19781025/03/2009
INDEXABLE ืชืืชื ืืืจืืชื ืขื ืืจืืฅ INSERT WITH NICKSUMITOMO ELECTRIC HARDMETALCORP.
31/03/20082008-091447
JP
)2009.01 (A61K19781126/09/2007
ืฉืืืืช ืืฉืืคืืจ ืืืืจื ืืืขืจืืืช ืืืืืืืืืช
MEANS AND METHODS OFENHANCING DELIVERY TOBIOLOGICAL SYSTEMSPAOLO BOTTI
27/09/200606020286.8EP05/07/200707013218.8EP
PCT/EP/2007/008396WO/2008/037463
)2009.01 (G06F19781224/09/2007
ืืืฉืืจ ืืฉืืื ืืืืืจ ืืืืข ืืืืืจAN APPARATUS AND METHOD FORA DISTRIBUTED STORAGE GLOBALDATABASE
ืืขืงืกืจืืื ื ืืขืจื XEROUNDื"ืืช SYSTEMS LTD28/09/200660/847613US
PCT/IL/2007/001173WO/2008/038271
)2009.01 (A61B19781307/10/2007
ORTHOPEDIC ืงืืืืข ืขืฆื ืืืจืืืคืื BONE FIXATION
OGENื"ืขืืื ืชืขืฉืืืช ืจืคืืืืืช ืืืฉื ืืืช ืืข INNOVATIVE MEDICALDEVICES LTD
28/09/200660/847681USPCT/IL/2007/001197WO/2008/038286
![Page 186: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/186.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 186
)2009.01 (C07D19781427/09/2007
SUBSTITUTED ืชืืืืืช ืกืืืคืื ืืืื ืืืชืืจืืช SULFONAMIDEDERIVATIVESGRUNENTHAL GMBH
29/09/2006102006046743.4DEPCT/EP/2007/008417WO/2008/040492
)2008.04 (C07D19781505/09/2003
ืชืืืืืช ืืงืกืื ืคืื ืงืฆืืื ืืืืืช ืืขืืื ืืชืืืื ืืืื ืชื 14
TAXANE DERIVATIVESFUNCTIONALIZED AT THE 14-POSITIONAND A PROCESS FOR THEPREPARATION THEREOFINDENA S.P.A.
10/09/2002MI2002A001921ITPCT/EP/2003/009866WO/2004/024706
)2009.01 (F42B19781619/09/2007
DEVICE ืืชืงื ืืืกืจืช ืืจืืืช ืชืืืืฉืช FOR THE DECONFINEMENTOF AN AMMUNITION CASINGNEXTER MUNITIONS
29/09/20060608681FRPCT/FR/2007/001518WO/2008/040860
)2009.01 (C07K19781707/09/2007
PETSILICONื ืขืืืจ ืืืืืืช ืชืืืืืช ืกืืืืงื DERIVATIVES FOR PETIMAGINGBAYER SCHERING PHARMA AG
02/10/200606076823.1EP11/10/200606076869.4EP12/03/200707090043.6EP23/04/200707090079.0EP
PCT/EP/2007/008044WO/2008/040441
![Page 187: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/187.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009187
)2009.01 (A61K19781802/11/2007
MULTIPLE ืชืจืืคื ืืืจืฉืช ื ืคืืฆื SCLEROSIS THERAPYNORTHWESTERN UNIVERSITY
03/11/200660/864295USPCT/US/2007/083525WO/2008/063849
)2009.01 (A47J19781926/03/2009
ืืืชืงื ืืงืืจืืจ ืืืืืื ืฉื ืคืืืืช ืืืงืืืงื ืืฉืงื
APPARATUS FOR COOLING ANDCARBONATION BEVERAGE CANSAND BOTTLES
PAVEL ืคืืื ืืจื ืจ LERNER
)2009.01 (H01R19782026/03/2009
ื ืืื ืืืืื ืชืืืจืช ืืืจืื/ ืฉืงืข ื ืืื ืืืืื ืืืขืจืืืช ืืื ื ืืืชืจืขื
PORTABLE/STATIONARY SOCKETWITH EMERGENCY AND NIGHTLIGHTING AND PROTECTION ANDWARNING SYSTEMS
DAN ืขืฆืืื ืืงื KATZ
)2009.01 (F16L19782103/10/2007
ืคืก ืืืจืื ืืืืืืง ืื ืืชื ืืืืคืืฃ ืืืฆืืจ ืฆืื ืืจ ืกืืืื ืืฉืืื ืขืืืจื
COMPOSITE REINFORCED STRIPWINDABLE TO FORM A HELICALPIPE AND METHOD THEREFORRIB LOC AUSTRALIA PTY LIMITED
04/10/20062006905464AUPCT/AU/2007/001463WO/2008/040052
![Page 188: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/188.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 188
)2009.01 (A45F19782229/10/2007
PROTECTIVE ืืกื ืืื ืืคื ื ืืจืงืื ANTI-INSECT SCREENMDB TEXINOV SA
31/10/20060654680FRPCT/FR/2007/052263WO/2008/053116
)2009.01 (C07H19782330/10/2007
METHODS ืฉืืืืช ืืฉืืคืืจ ืืืฆืืจ ื ืืืื ืื FOR IMPROVINGANTIBODY PRODUCTIONIMMUNOGEN, INC.
31/10/200660/855361USPCT/US/2007/082994WO/2008/073598
)2009.01 (C07D19782410/10/2007
ืฉืืืืช ืืืืฆืืจ ื ืืืจืช ืืืืืืฆืืงืืืืืงื ืืPROCESS FOR THE PRODUCTION OFAN AZABICYCLOALKANOLDERIVATIVENIPPON SODA COMPANY LTD.
11/10/20062006-278150
JP
PCT/JP/2007/069742WO/2008/044702
)2009.01 (C07D19782508/02/2008
ืฆืืจืช ืืืืฉืืืช ืฉื ืชืจืืืืช ืชืืืืืืืืื ืืืื ืืฉืืืืช ืืืื ืชื
CRYSTALLINE FORMS OF ATHIZOLIDINEDIONE COMPOUNDAND MANUFACTURING METHODSTHEREOFDAIICHI SANKYO COMPANY,LIMITED
08/02/200760/900251USPCT/JP/2008/052594WO/2008/099944
![Page 189: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/189.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009189
)2008.04 (C12N19782601/12/1998
ืคืืืืคืคืืืืื ืืืืืฆืืช ืืจืขืื ืืืงืืืืืช ืืืชื
POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME
GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US
PCT/US/1998/025108WO/1999/028462
)2009.01 (A61K19782707/10/2007
ืฉืืืืฉ ืืืืืฆืจืืคืืกืคืืืืคืืืื ืืกืืืื ืคืจืงืื
USE OF GLYCEROPHOSPHOLIPIDSFOR JOINT IUBRICATION
ื"ืืืกื ืืืื ืืื ืืืืงืจ ืืคืชืื ืืขYISSUM RESEARCH DEVELOPMENTCOMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
28/09/200660/847651USPCT/IL/2007/001215WO/2008/038292
![Page 190: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/190.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 190
)2009.01 (C07D19782805/10/2007
ืชืจืืืืืช ืืืจืืฆืืงืืืืช ืืืฆืืงืืืืชืืืืืืืช ืื ืงื ืืฉืืืืฉ ืืืขืืื
ืืกืืืืจืืCoAืกืืืืจืืืื
BICYCLIC NITROGEN-CONTAININGHETEROCYCLIC COMPOUNDS FORUSE AS STEAROYL COADESATURASE INHIBITORSCV THERAPEUTICS, INC.
05/10/200660/849648USPCT/US/2007/080627WO/2008/043087
)2009.01 (H04L19782906/08/2007
ENCRYPTION ืืฆืคื ื ืืืืงืืืื ืืงืฆืื ืืืืืืืช IN A WIRELESSTELECOMMUNICATIONSLUCENT TECHNOLOGIES INC.
03/10/20060619499.7GBPCT/EP/2007/006995WO/2008/040412
)2009.01 (F24J19783028/09/2007
RADIATION ืืืจื ืงืจืื ื COLLECTORALE AIRLIGHT ENERGY SA
27/09/20061562/06CH29/05/2007846/07CH
PCT/CH/2007/000480WO/2008/037108
)2009.01 (A61K19783101/10/2007
4CXCRื ืืืื ืื ืื ืืฉืืื ืืงืืฉืจืื ืืฉืืืืฉืืื
HUMAN ANTIBODIES THAT BINDCXCR4 AND USES THEREOF
MEDAREX, INC.02/10/200660/827851US
PCT/US/2007/021152WO/2008/060367
![Page 191: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/191.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009191
)2009.01 (A61K19783219/10/2007
ืืืืคืืILโ1ืฉืืืืฉ ืืื ืืืื ืืกืืื ืฉืืืืืโืืคืกืืืืืืฉืืืืื
USE OF IL-1 ANTAGONISTS TOTREAT GOUT AND PSEUDOGOUTREGENERON PHARMACEUTICALS,INC.
20/10/200660/853385USPCT/US/2007/022377WO/2008/051496
)2009.01 (A61B19783326/03/2009
ื ืื ืืืืจืืช/ืืชืงื ืื ืชืื ืช ืชืจืืคืืช ืืงืืืืชื ืืืืืื ืฉื ืืืจืืื ืขืืืจ ืืจืืืื
ืืืคืืืืื
DEVICE FOR LOCAL AND/ORREGIONAL DELIVERY EMPLOYINGLIQUID FORMULATIONS OFTHERAPEUTIC AGENTSCORDIS CORPORATION
31/03/200812/059291US
![Page 192: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/192.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 192
)2008.04 (C12N19783401/12/1998
ืืจืขืื ืืืงืืืืืช ืคืืืืคืคืืืืื ืืืืืฆืืช ืืืชื
POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME
GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US
PCT/US/1998/025108WO/1999/028462
![Page 193: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/193.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009193
)2008.04 (C12N19783501/12/1998
ืคืืืืคืคืืืืื ืืืืืฆืืช ืืจืขืื ืืืงืืืืืช ืืืชื
POLYPEPTIDES AND NUCLEICACIDS ENCODING THE SAME
GENENTECH, INC.03/12/199760/067411US11/12/199760/069334US11/12/199760/069335US11/12/199760/069278US12/12/199760/069425US16/12/199760/069696US16/12/199760/069694US16/12/199760/069702US17/12/199760/069870US17/12/199760/069873US18/12/199760/068017US05/01/199860/070440US09/02/199860/074086US09/02/199860/074092US25/02/199860/075945US
PCT/US/1998/025108WO/1999/028462
)2009.01 (C07D19783627/09/2007
ืื ืืืืื ืฉื ืคืืืจืืืื ืืืขืืื ื ืชืจื ืืืืงืืCOโ2ืืจื ืกืคืืจืืจ
PHLORIZIN ANALOGS ASINHIBITORS OF SODIUM GLUCOSECO-TRANSPORTER 2LEXICON PHARMACEUTICALS, INC.
29/09/200660/848156US08/03/200760/905714US10/07/200760/948780US
PCT/US/2007/079654WO/2008/042688
![Page 194: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/194.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 194
)2009.01 (C40B19783728/09/2007
ืชืื ืื ืืื ืื ืฉื ืกืคืจืืืช ืคืคืืื ืืคืืืืคืคืืื ืืืืืจืืช
DESIGN AND CONSTRUCTION OFDIVERSE SYNTHETIC PEPTIDE ANDPOLYPEPTIDE LIBRARIESSEA LANE BIOTECHNOLOGIES, LLC.
02/10/200660/849035USPCT/US/2007/079849WO/2008/042754
)2009.01 (A61K19783804/10/2007
ืืื ืช ืกืื ืกืืคืืจืคืื ืขื ืืจืืช ืืืืืจ ืืืืื ืืงื ื ืืืื ืืืื
HIGH-PURITY LARGE SCALEPREPARATION OF STANNSOPORFININFACARE PHARMACEUTICALCORPORATION
04/10/200660/849641US28/02/200760/904601US
PCT/US/2007/021485WO/2008/045377
)2009.01 (A61K19783904/10/2007
ืืืคืื ืืืชืจ ืืืืืจืืืื ืืื ืืชืื ืืงืืชืืืืฆืขืืช ืฉืืืืฉ ืืืื ืื ืื ื ืืืืื ืฉื
ืกืืื ืกืืคืืจืคืื
TREATMENT OF INFANTHYPERBILIRUBINEMIA USING LOWDOSAGES OF STANNSOPORFIN
INFACARE PHARMACEUTICALCORPORATION
04/10/200660/849509USPCT/US/2007/021486WO/2008/045378
![Page 195: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/195.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009195
)2009.01 (C01G19784026/09/2006
โืฉืืื ืืืืฆืืจ ืชืืืืฆืืช ืืืื ืืื ืชืช ืกืืืืืืืืืจืืืช ืืืืฆืขืืช ืืคืืชืช ืืืื
A METHOD OF PRODUCINGSUBSTOICHIOMETRIC OXIDES OFTITANIUM BY REDUCTION WITHHYDROGENATRANOVA LTD
PCT/GB/2006/003573WO/2008/037941
)2009.01 (A61C19784126/03/2009
INCLINED ืืชืงื ืืืืื ืชืืื ืื ืืื ืืฉืืคืข DENTAL ABUTMENTASSEMBLY DEVICE
ืืข.ืืื.ืื MIS-IMPLANTSื"ืืก ืืื ืืืืืืืช ืฉืชืืื TECHNOLOGIESLTD.
27/05/200812/127227US
)2009.01 (B23B19784218/07/2007
SURFACE ืืื ืืืชืื ืืฆืืคื COATING CUTTING TOOLSUMITOMO ELECTRIC INDUSTRIES,LTD.
02/10/20062006-271066
JP
PCT/JP/2007/064135WO/2008/041402
![Page 196: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/196.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 196
)2009.01 (C07C19784311/06/2002
, ืชืจืืคืืช ืฉื ืื ืืืืื ืฉื ืืืืโืงืื ืชืืฉืืจืื ืืฉืืืืฉืื ืฉืืื
PRODRUGS OF GABA ANALOGS,COMPOSITIONS AND USES THEREOF
XENOPORT, INC.11/06/200160/297521US14/06/200160/298514US19/03/200260/366090US
PCT/US/2002/018689WO/2002/100347
)2009.01 (C12N19784403/10/2006
ืชืืืื ืืฉืืืื ืืจืืืืืืืื ืืืืืคืช ืจืฆืคืDNAืืงืืืกืืจืืืื
PROCESS FOR CHROMOSOMALINTEGRATION AND DNA SEQUENCEREPLACEMENT IN CLOSTRIDIAMETABOLIC EXPLORER
PCT/EP/2006/066997WO/2008/040387
)2009.01 (C12N19784504/10/2007
ืืื ื ืฉื ืชืืื ืืืฆืืืื ืื ืืืื ืืืืืืชืืฉืขืืจื ืืื ืืงืืืืฆืื ืืฉืืืืฉื ืืืืคืืืื
ืชืืืื
PREPARATION OF INACTIVATEDARTIFICIAL ANTIGEN PRESENTINGCELLS AND THEIR USE IN CELLTHERAPIESJANSSEN PHARMACEUTICA, N.V.
04/10/200660/849299USPCT/US/2007/021326WO/2008/045286
)2009.01 (A61K19784610/10/2007
STICK ืืงืืื ืืืืช ืืฉืคืชืืื LIP BALMWYETH
11/10/200660/850724USPCT/US/2007/021667WO/2008/045479
![Page 197: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/197.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009197
)2009.01 (G05B19784714/11/2006
ื ืืืืจืืืืืช ืืืืง ืื ืขื ืืขื ืคืขืืื ืืืืจืช ืจืื ืงืืืืช"ืืฉืืจื ืื ืงืืขืช ืขืค
DIRECT ACTING HYDRAULIC TRIPBLOCK WITH MAJORITY VOTING
ELLIOTT COMPANY16/10/200611/581799US
PCT/US/2006/044255WO/2008/048290
)2009.01 (G07D19784826/09/2007
ืืชืงื ืืฉืืื ืืืืืงื ืืืคืืืช ืฉื ืืื ืืขืื ืขืจืืืกื
APPARATUS AND METHOD FOR THEOPTICAL EXAMINATION OF VALUEDOCUMENTSGIESECKE & DEVRIENT GMBH
27/09/2006102006045626.2DEPCT/EP/2007/008383WO/2008/037457
)2009.01 (A61K19784928/09/2007
2Eืคืจืืกืืืื ืืื (2PGE(ืืืกืืืข ืืืฆืืจืช ืืื ืืื ืืงืืื ืืื ื
PROSTAGLANDIN E2 (PGE2) AS ANADJUVANT IN MONOCLONALANTIBODY GENERATIONCENTOCOR ORTHO BIOTECH INC.
28/09/200660/827229USPCT/US/2007/079968WO/2008/400019
)2009.01 (G01B19785317/04/2008
ืืชืงื ืืืืืจืช ืืกืคืจ ืฉื ืืืง ืฉืกืชืื ืื ืืกืคืจ ืฉื ืืืง ืืคืจืง
JIG FOR SELECTING VALVE PARTNUMBER OR JOINT PART NUMBER
KABUSHIKI KAISHA FUJIKIN
29/06/20072007-173099
JP
PCT/JP/2008/057524WO/2009/004850
![Page 198: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/198.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 198
)2009.01 (A61F19785426/03/2009
ืฉืืื ืืืืฉืืจ ืืืืืงืช ืชืืืืฉืช ืืืืคื ืื ืืชื ืืฉืืืจืืจ
METHOD AND APPARATUS FORRELEASABLY RETAININGBANDAGES
FIRSTื"ืืืฆืจื ืคืืจืกื ืงืืืจ ืืข CARE PRODUCTS LTD.
)2009.01 (C05G19785524/07/2007
NUTRIENT ืชืืืกืช ืืืื FEED SOLUTIONCARBON STIMULATED GROWTH(PROPRIETY) LIMITED
27/09/20062006/08027ZAPCT/IB/2007/052929WO/2008/038165
)2009.01 (H03G19785625/09/2007
ืขืืืื ืืื ืืืงื ืฉืืืขืชืืช ืืืืฆืขืืช ืืืคืืก
AUDIO DYNAMICS PROCESSINGUSING A RESETDOLBY LABORATORIES LICENSINGCORPORATION
20/10/200660/853127USPCT/US/2007/020747WO/2008/051347
)2009.01 (C12N19785714/08/2002
ืืืืฆืืช ืืจืขืื ืืืงืืืืืช ืืคืืืืคืคืืืืืืฉืืฉ ืืื ืืคืืืช ืชืืื ื ืืืช ืฉื ืงืืืื
B83ORืจืื
NUCLEIC ACID MOLECULESENCODING POLYPEPTIDES HAVINGAT LEAST ONE PROPERTY OF ANINSECT 0R83B ODORANT RECEPTORSENTISEARCH, INC.
14/08/200160/312319USPCT/US/2002/025869WO/2003/016477
![Page 199: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/199.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009199
)2009.01 (C12N19785914/08/2002
ืืืืฆืืช ืืจืขืื ืืืงืืืืืช ืืคืืืืคืคืืืืืืฉืืฉ ืืื ืืคืืืช ืชืืื ื ืืืช ืฉื ืงืืืื
ืฉื ืืจืงB83ORืจืื
NUCLEIC ACID MOLECULESENCODING POLYPEPTIDES HAVINGAT LEAST ONE PROPERTY OF ANINSECT 0R83B ODORANT RECEPTORSENTISEARCH, INC.
14/08/200160/312319USPCT/US/2002/025869WO/2003/016477
)2009.01 (A61K19786007/10/2007
ืืจืืื ืืื ืืงืฆื ืืืืื ื ืฉื ืืืจื ืืืืืืคืืืจืืืืกืื ืืขืื ืกืืงืืืืืืช ืืืืืจืช
ืืงืืืื ืืฉืืืืฉืื ืืื
N-TERMINAL FGF VARIANTSHAVING INCREASED RECEPTORSELECTIVITY AND USES THEREOF
HEPACOREื"ืืคืืงืืจ ืืข LTD.28/09/200660/847658US
PCT/IL/2007/001199WO/2008/038287
)2009.01 (G06F19786126/03/2009
IMPROVED ืฉืืืืช ืืฉืืคืจืืช ืืืื ืกืช ื ืชืื ืื DATA ENTRY SYSTEMSBENJAMIN ืื ืืืื ืคืืจืื ืืกืืืื FIROOZ GHASSABIAM
)2009.01 (B23P19786326/03/2009
PIEZO ืืชื ืงืื ืคืืืื CAPACITANCE SWITCH
BARANื"ืืข) 1986(ืืจื ืืื ืืืืืืืช ืืชืงืืืืช ADVANCED TECHNOLOGIES(1986) LTD.
![Page 200: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/200.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 200
)2009.01 (A61K19786427/09/2007
ืงืืืื ืืชืืฉืืจืื ืืืืฆืืจ ืืงืืงื, ืฉืืืืช ืฉืืขืจ ืืืฉืื ืืืืืื ืฉืืขืจ
METHODS, KITS, ANDCOMPOSITIONS FOR GENERATINGNEW HAIR FOLLICLES ANDGROWING HAIRTHE TRUSTEES OF THE UNIVERSITYOF PENNSYLVANIA
28/09/200660/847854USPCT/US/2007/020842WO/2008/042216
)2009.01 (G01C19786504/10/2007
ืฉืืื ืืฉืืืื ืคืื ืงืฆืืื ืืืืช ืฉื ืคืืืคืืจืื ืืื ืจืืืช ืฉื ืืื ื ืข
METHOD OF FUNCTIONALCONTROL OF AN INERTIALPLATFORM OF A MOVING CRAFTMBDA FRANCE
05/10/20060654113FRPCT/FR/2007/052076WO/2008/040917
)2009.01 (F24J19786629/09/2006
ืืจืืืช ืืจืืื ืืืชืงื ืช ืฆื ืจืช ืงืืจืืจืืชืืช ืืคื ื ืืฉืื ืืืขืจืืช ืืืืืฃ ืืฉืืจ
ืงืืจืืจ/ืฉื ืืืืื
ENCASEMENT ASSEMBLY FORINSTALLATION OF SUB-SURFACEREFRIGERANT TUBING IN A DIRECTEXCHANGE HEATING/COOLINGSYSTEMEARTH TO AIR SYSTEMS, LLC
PCT/US/2006/038220WO/2008/039202
![Page 201: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/201.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009201
)2009.01 (A61F19786728/09/2007
ืืืฉืืจ ืืขืืจื ืืืขืืจืช ืชืืชืืช ืืจื ืืขืืจ
DELIVERY TOOL FORPERCUTANEOUS DELIVERY OF APROSTHESISHEART LEAFLET TECHNOLOGIES,INC.
28/09/200660/827373USPCT/US/2007/079978WO/2008/040014
)2009.01 (C07K19786828/09/2007
ืื ืืืื ืื ืื ืืืื ืื ืืืฉืื ืืงืฉืืจืื ืืืื ืืงืจืฆืื ืืื ืฉื ืชืขืืช ืืืืื
NOVEL ANTIGENS AND ANTIBODIESASSOCIATED TO PANCREATICDUCTAL ADENOCARCINOMARIBOVAX BIOTECHNOLOGIES S.A.
29/09/200606121552.1EP20/12/200606126726.6EP
PCT/EP/2007/060305WO/2008/037792
)2009.01 (A61K19786902/10/2007
1CHKCOMPOSITIONSืชืจืืืืืช ืฉื ืืขืืื OF CHK1INHIBITORSICOS CORPORATION
20/10/200660/853056USPCT/US/2007/080150WO/2008/067027
![Page 202: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/202.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 202
)2009.01 (A61L19787012/10/2007
ืขืืฉืืช ืชืื ืขืื ืืืช ืืขืืืช ืืืคืืื ืื ืฉืืกืืื ืืืืื ืืืขืืจืช ืืืจโืฆืืฆืื ืืืื
ืืืื
INTRAOCULAR LENSES WITHUNIQUE BLUE-VIOLET CUTOFF ANDBLUE LIGHT TRANSMISSIONCHARACTERISTICSALCON, INC.
13/10/200660/851666US09/02/200760/889131US
PCT/US/2007/081204WO/2008/048880
)2009.01 (A61K19787104/10/2007
ืฆืืจืืช ืืื ืื ืคืจืืงืืืืืืืช ืืืฆืงืืชืืงืืืขืืช ืืชืืโืืืืืืืช ืชืจืืืืืช ืืืงืจื
ืคืืืืืจืื ืืื ืืื ืืืชื ืืกืืกืื ืืืื
PHARMACEUTICAL SOLID DOSAGEFORMS COMPRISING COMPOUNDSMICRO-EMBEDDED IN IONICWATER-INSOLUBLE POLYMERS
F. HOFFMANN-LA ROCHE AG13/10/200660/851852US07/08/200760/954401US
PCT/EP/2007/060542WO/2008/043701
)2009.01 (C07D19787209/10/2007
ืืืืืืืืืืื ืืขืื ืืคืื ืืืชโ2โืืืื ืืืชืื ืืืืืืจืฆืคืืืจืื ืืงืฉืืจืื ืืฉืืืจ
AMINOMETHYL-2-IMIDAZOLESWITH AFFINITY WITH THE TRACEAMINE ASSOCIATED RECEPTORSF. HOFFMANN-LA ROCHE AG
19/10/200606122553.8EPPCT/EP/2007/060664WO/2008/046756
![Page 203: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/203.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009203
)2009.01 (B01D19787302/10/2007
ืฉืืื ืืืืฉืืจ ืืืืฆืืช ืื ืชืืืืฆืช ืื ืืืืืืจืืคื
METHOD AND APPARATUS FOREXTRACTING CARBON DIOXIDEFROM AIRGLOBAL RESEARCHTECHNOLOGIES, LLC.
02/10/200660/827849US13/10/200660/829376US
PCT/US/2007/080229WO/2008/042919
)2009.01 (A61B19787426/03/2009
RELIGIOUS ืคืจืื ืืืืฉ ืืชื GARMENTMATITYAHU TENENBAUM
)2009.01 (C07D19787516/10/2007
ืโCืืจืืืื ืืฉืืืืช ืืืืืกืืช ืงืืืื ื โืงืืPDGFR
COMPOSITIONS AND METHODS FORMODULATING C-KIT AND PDGFRRECEPTORSIRM LLC
20/10/200660/862430USPCT/US/2007/081538WO/2008/051757
![Page 204: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/204.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 204
)2009.01 (C07D19787619/10/2007
Nโ(2โืืืืจืืงืกืืืชืื(โNโ4โืืชืืโโ4โืชืืืืื(โ1(ืืโ8โืงืืืื ืืืื (
, ืื ืืืืื)ืืชืื)ืืืืืโ4โืคืืคืจืืืื )ืืืืชืื, ืชืืืื ืืืืฆืืจื ืืฉืืืืฉื ืืืืคืื ืืืื
ืืจืื ืืืืืืื
N-(2-HYDROXYETHYL)-N-METHYL-4-(QUINOLIN-8-YL(1-(THIAZOL-4-YLMETHYL)PIPERIDIN-4-YLIDENE)METHYL)BENZAMIDE,THE PROCESS OF MAKING IT ASWELL AS ITS USE FOR THETREATMENT OF PAIN, ANXIETYAND DEPRESSIONASTRAZENECA AB
20/10/200660/862327USPCT/SE/2007/000924WO/2008/048171
)2009.01 (C07D19787709/10/2007
AMINOMETHYL-4-IMIDAZOLES ืืืืืืืืืืืโ4โืืืื ืืืชืืF. HOFFMANN-LA ROCHE AG
19/10/200606122586.8EPPCT/EP/2007/060666WO/2008/046757
)2009.01 (G06F19787827/09/2007
ืคืืชืื ืชืืื ื ืืฉืืจืืชื ืืืืจืืช ืืืืจื ืชืงืืคืช ืืืื
SOFTWARE DEVELOPMENT ANDSALES LIFE-CYCLE SERVICES
BRIGHTHUB, INC.27/09/200660/827203US
PCT/US/2007/079801WO/2008/039958
)2009.01 (B65D19787910/12/2007
CONTAINER ืืืืHAGLEITNER, HANS, GEORG
23/01/200707001378.4ATPCT/AT/2007/000559WO/2008/089500
![Page 205: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/205.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009205
)2009.01 (F16L19788028/09/2007
INSULATED ืืืฆืจื ืืขืจืืช ืชืืขืื ืืืืืืื DUCTWORK PRODUCTSSPECIALIST INSULATION LIMITED
29/09/20060619178.7GB11/06/20070711224.6GB
PCT/GB/2007/003692WO/2008/038013
)2009.01 (A61K19788305/10/2007
COMBINATIONื ืืฉืืืืชืชืจืืค DRUGTAKEDA PHARMACEUTICALCOMPANY LIMITED
06/10/20062006-275841
JP
07/03/20072007#057902JPPCT/JP/2007/070026WO/2008/044782
)2009.01 (H04Q19788430/10/2007
Bืชืืืื ืืขืืจื ENODEโINTERINTER-ENODE B HANDOVERPROCEDUREQUALCOMM INCORPORATED
31/10/200660/863791USPCT/US/2007/083033WO/2008/055169
)2009.01 (A01N19788505/10/2007
STABILIZED ืืืืฆืEืชืจืืืืช ืคืจืืกืืืื ืืื PROSTAGLANDINE ECOMPOSITIONNEXMED HOLDINGS, INC.
11/10/200611/546196USPCT/US/2007/021374WO/2008/045309
![Page 206: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/206.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 206
)2009.01 (H01L19788626/09/2007
FORMED ืืืงืืจื ืืขืืฆืโืืืืื ืขืจืืฅ ืืฉืืื ืคืืื PHOTOVOLTAIC MODULEBUSBARSSUNPOWER CORPORATION
03/10/200611/543440USPCT/US/2007/020801WO/2008/042194
)2009.01 (C07D19788717/10/2007
ืชืจืืืืืช, ื ืืืจืืช ืคืืืืืจื ืืืฉืืชืืืืืืืช ืืืชื ืืืืจ ืืฉืืืืฉ ืืื
90HSPืืืขืืืืช ืฉื ืืืืื ืืืืื
NEW FLUORENE DERIVATIVES,COMPOSITIONS CONTAINING THESAME AND USE THEREOF ASINHIBITORS OF THE PROTEINCHAPERONE HSP 90SANOFI-AVENTIS
24/10/20060609331FRPCT/FR/2007/001703WO/2008/049994
)2009.01 (F23G19788828/09/2007
INTEGRATED ืืขืจืืช ืื ืจืืื ืืืืืกื ืืฉืืืืช BIOMASS ENERGYSYSTEMZILKHA BIOMASS ENERGY LLC
29/09/200660/848466USPCT/US/2007/079895WO/2008/091415
)2009.01 (C07D19788904/03/2004
ืงืืืืืงืื ืืฉืืืืช'ืชืจืืืืืช ืืจืืืืืื ืืืฆ ืืื ืชื ืืฉืืืืฉื
ARYLVINYLAZACYCLOALKANECOMPOUNDS AND METHODS OFPREPARATION AND USE THEREOFTARGACEPT, INC.
05/03/200310/379868USPCT/US/2004/006530WO/2004/078752
![Page 207: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/207.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009207
)2009.01 (C07D19789004/03/2004
ืงืืืืืงืื ืืฉืืืืช'ืชืจืืืืืช ืืจืืืืืื ืืืฆ ืืื ืชื ืืฉืืืืฉื
ARYLVINYLAZACYCLOALKANECOMPOUNDS AND METHODS OFPREPARATION AND USE THEREOFTARGACEPT, INC.
05/03/200310/379868USPCT/US/2004/006530WO/2004/078752
)2009.01 (H04L19789126/10/2007
ืฉืืื ืืืชืงื ืขืื ืืืืืคื ืกืคืจ ืงืื ืืืขืจืืช ืืืืืืืช ืืจืืืช ืืืฉืืช
METHOD AND APPARATUS FORCODEBOOK EXCHANGE IN AMULTIPLE ACCESS WIRELESSCOMMUNICATION SYSTEMQUALCOMM INCORPORATED
26/10/200660/854898US27/10/200660/863313US25/10/200711/923967US
PCT/US/2007/082734WO/2008/052191
)2009.01 (C07D19789216/10/2007
โืืืืืืืืจืื ืืกืื ืืืคื ืื ืกืืืคืื ืื ืืคื ืื3Hืืืจืืืจืื ืกืืืคืื ืื ืฉื ืจืฆืคืืืจ
ืืืืกืืืื ืืฉืืืืฉืืื ืืืืคืื ืืืืืืช ืืงืฉืืจืืช ืืืื
BIPHENYL SULFONYL AND PHENYL-HETEROARYL SULFONYLMODULATORS OF THE HISTAMINEH3-RECEPTOR USEFUL FOR THETREATMENT OF DISORDERSRELATED THERETOARENA PHARMACEUTICALS, INC.
17/10/200660/852610US11/06/200760/934358US
PCT/US/2007/022086WO/2008/048609
![Page 208: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/208.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 208
)2009.01 (C07J19789324/10/2007
ืืจืืืื ืืฉืืืืช ืืขืืืื ืฉื ืฉืืฉืื ืืื ืืืืืจืืื
COMPOSITIONS AND METHODS FORSUPPRESSING ENDOMETRIALPROLIFERATIONREPROS THERAPEUTICS INC.
24/10/200660/862632US17/01/200760/885348US
PCT/US/2007/082432WO/2008/067086
)2009.01 (A01N19789402/10/2007
ืืืฉืืจ ืืฉืืืืช ืืฉืืืืฉ ืืชืจืืืืืช ืกืืืืืืืืืช ืืฉื ืืืืจืช ืืจืงืื
APPARATUS AND SYSTEMS FORUSING SEMIOCHEMICALCOMPOSITIONS FOR INSECT PESTCONTROLSUTERRA LLC
02/10/2006US60/827878USPCT/US/2007/080220WO/2008/063751
)2009.01 (A47J19789705/04/2009
PLACEMENT ืืฉืื ืืื ืืช ืืืื ืืฉืืื ืืืฆืืจื DEVICE AND METHODOFER ืขืืื ืื ืขืื MANOR
07/04/2008GB0806168.1GB
)2009.01 (B23C19789805/04/2009
CUTTING ืฉืืื ืืืื ืืืชืื ืขืืืจื INSERT AND CUTTINGTOOL THEREFOR
ISCARื"ืืฉืงืจ ืืข LTD.
![Page 209: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/209.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009209
)2009.01 (B23C19789905/04/2009
CUTTING ืืื ืืืชืื ืืืืืืง ืืื ืขืืืจื TOOL ASSEMBLY ANDTOOL HOLDER THEREFOR
ISCARื"ืืฉืงืจ ืืข LTD.
)2009.01 (A47C19790105/04/2009
A ืืืืช ืืืงืืืื VACUUM BEDMAYMON ืืืืื ืกืืืจืื SIGRON
)2009.01 (C12N19790318/02/2000
ืจืืืืืืจืืก ืืืืคืื ืืืคืจืขืืช ืืชืจืืืช ืชืืืช
REOVIRUS FOR THE TREATMENTOF CELLULAR PROLIFERATIVEDISORDERSONCOLYTICS BIOTECH INC.
24/02/199909/256824USPCT/CA/2000/000178WO/2000/050051
)2009.01 (H04L19790427/09/2007
ื ืืคืขืืช ืืืืื ืืืืืืืช ืฉืืื ืืืขืจืืชืงืืืื ืืชืื ืฉืืจืืช ืืืืงืืฉืื/ืืฉืืืืจ
ืืขืโืืฉืืืืจื ืืืืืืืืื ืจืื
METHOD AND APPARATUS FORWIRELESS TRANSMIT/RECEIVEUNIT OPERATION IN DEDICATEDMULTIMEDIA BROADCASTMULTICAST SERVICES CELLSINTERDIGITAL TECHNOLOGYCORPORATION
29/09/200660/827551USPCT/US/2007/020861WO/2008/042225
![Page 210: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/210.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 210
)2009.01 (B32B19790529/08/2007
COMPOSITE ืงืืจ ืืืก ืืืืืจ ืืจืืื ืืขื ืืฉืงื ื ืืื LIGHT WEIGHTGYPSUM WALLBOARDUNITED STATES GYPSUM COMPANY
29/09/200611/537395USPCT/US/2007/018978WO/2008/042060
)2009.01 (C07H19790704/10/2007
HCV ื ืืงืืืืืืืืHCVืืขืื NUCLEOSIDE INHIBITORMEDIVIR AB
10/10/200660/850926USPCT/EP/2007/060557WO/2008/043704
)2009.01 (A61K19790817/10/2007
ืชืืฉืืจ ืืฆืืจืช ืชืจืกืืก ืฉืืื ื ืชืืช ืืืฅ ื ืืจืคืื ืืืชื ืืจื ืืจืืจืืชืืืืื ืืืคืจ
BUPRENORPHINE-CONTAININGNON-PRESSURISED SPRAYCOMPOSITION FORTRANSMUCOSAL ADMINISTRATIONPHARMASOL LIMITED,
18/10/20060620661.9GBPCT/GB/2007/050639WO/2008/047163
)2009.01 (A23L19790926/12/2007
REDUCTION ืืจื ืคืืืืคื ืืืืงืื ืช ืงืฉืืืช ืืชืืฉ OF ASTRINGENCY INPOLYPHENOL COMPOSITIONSKRAFT FOODS GLOBAL BRANDSLLC
27/12/200611/616572US18/12/200711/958556US
PCT/US/2007/088814WO/2008/083152
![Page 211: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/211.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009211
)2009.01 (B32B19791029/09/2007
ืื ืืจืืืื ืชืืืื ืืืืฆืืจ ืืืฆืจืื ืืืืจืืืฉื ืจืฆืืขืืช ืคืืืืืจืืืช ืืืกืืืจืืช ืืืืคื
ืืืืื ืโืื
PROCESS FOR PRODUCINGLAMINATES OFUNIDIRECTIONALLY ARRANGEDPOLYMERIC TAPESNOVAMEER B.V.
05/10/200606020909.5EPPCT/EP/2007/008495WO/2008/040506
)2009.01 (B32B19791129/09/2007
ืืื ืืืืฆืืจ ืืืืืช ืืืืฉืื ืืืืืืื ืชืืืืฆืจืื ืืืืจืืืื ืืจืืืื ืฉื ืจืฆืืขืืช
ืืืืื ืโืคืืืืืจืืืช ืืืกืืืจืืช ืืืืคื ืื
PROCESS FOR PRODUCINGFLEXIBLE PANELS COMPRISINGLAMINATES OFUNIDIRECTIONALLY ARRANGEDPOLYMERIC TAPESNOVAMEER B.V.
05/10/200606020902.0EPPCT/EP/2007/008500WO/2008/040511
)2009.01 (B32B19791229/09/2007
ืชืืืื ืืืืฆืืจ ืืจืืืื ืืืืืืื ืจืฆืืขืืช ืืืืื ืโืคืืืืืจืืืช ืืืกืืืจืืช ืืืืคื ืื
PROCESS FOR PRODUCING FABRICSCOMPRISING UNIDIRECTIONALLYARRANGED POLYMERIC TAPESNOVAMEER B.V.
05/10/200606020901.2EPPCT/EP/2007/008499WO/2008/040510
![Page 212: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/212.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 212
)2009.01 (A01N19791320/09/2007
ืืจืืื ืจืืงืืืช ืฉื ืืืจืืื ืชืจืืคืืช ืฉื ืคืจืืคืืคืื ืืืืกืกื ืืื
AQUEOUS BASEDPHARMACEUTICAL FORMULATIONSOF WATER-SOLUBLE PRODRUGS OFPROPOFOLEISAI INC.
05/10/200660/828307USPCT/US/2007/020351WO/2008/045189
)2009.01 (A61K19791412/10/2007
ืืืืื ืืื ืืืืคืื ืืกืจืื ืืืืฆืขืืช ืฉืืืืฉEREGืื ืืืื ืื ืื
DIAGNOSIS AND TREATMENT OFCANCER USING ANTI-EREGANTIBODYTHE UNIVERSITY OF TOKYO
12/10/20062006-278819
JP
PCT/JP/2007/069988WO/2008/047723
)2009.01 (H04R19791525/09/2007
โืืขืจืืช ืืฉืืื ืืฉืคืื ืขืืืืช ืืืจืื ืื ืืื ืืจื ืฉื ืืชืืจ ืืืืื
SYSTEM AND METHOD FORCOMPENSATING MEMORYLESSNON-LINEAR DISTORTION OF ANAUDIO TRANSDUCERDTS, INC.
18/10/200611/583190USPCT/US/2007/020652WO/2008/048413
![Page 213: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/213.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009213
)2009.01 (C07H19791605/10/2007
ืชืืฉืืจืื ืืืืฆืืื ืืฉืืืืช ืืืืฆืื ืืืืฆื ืจืืืื ืืงืืืืืช
STABILIZING COMPOSITIONS ANDMETHODS FOR EXTRACTION OFRIDONUCLEIC ACIDDNA GANOTEK INC
06/10/200660/828563US22/11/200660/866985US13/07/200760/949778US
PCT/CA/2007/001785WO/2008/040126
)2009.01 (C07K19791717/10/2007
ืืืืื ืื ืืืช ืฉื ืืืืฆืืช ืืืื ื ืฉืืื ื ืืืขืืืช ืืชืื ืืืืื ืื ืืชืื ืืื ืงืื
GENETIC INCORPORATION OFUNNATURAL AMINO ACIDS INTOPROTEINS IN MAMMALIAN CELLSTHE SCRIPPS RESEARCH INSTITUTE
18/10/200660/853008US12/04/200760/923458US
PCT/US/2007/022232WO/2008/073184
)2009.01 (H04B19791805/04/2009
ืืขืจืืช ืชืงืฉืืจืช ืืืชืงื ืืืฉืชืืฉืืืคืกโืืคืขืืื ืื ืฆืจโืจืื ืืคืกโืืื ืืช ืฉืBANDโINืืฉืืื ืงืฉืืจื
COMMUNICATIONS SYSTEM ANDDEVICE USING SIMULTANEOUSWIDEBAND AND IN-BANDNARROWBAND OPERATION ANDRELATED METHODHARRIS CORPORATION
04/04/200812/062550US
)2009.01 (A61J19791901/10/2007
INFANT ืืืื ืืืืืืช ืชืื ืืงืืช FEEDING CONTAINERADIRI, INC.
06/10/200611/539572USPCT/US/2007/080123WO/2008/045714
![Page 214: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/214.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 214
)2009.01 (C07K19792003/07/2007
โืคืืืืคืคืืืืื ืขื ืชืืื ืืช ืื ืืืืืงืชืืช ืืืืืจืช ืืฆืืืืืืงืกืืช
ืืืคืืชืช ืืฉืืืืช ืงืฉืืจืืช
POLYPEPTIDES WITH ENHANCEDANTI-INFLAMMATORY ANDDECREASED CYTOTOXIC PROPERTIESAND RELATING METHODSTHE ROCKEFELLER UNIVERSITY
26/10/2006PCT/US06/41791US03/04/2007PCT/US07/08396US
PCT/US/2007/072771WO/2008/057634
)2009.01 (C08F19792104/10/2007
ืคืืืืืจื ืืกืจืง ืืฉืืืืฉืืื ืืืืฆืืจ ืจืืืืื ืคืขืืืื ืื ืืขืืืื ืืจืืืื ืฉื
COMB POLYMERS AND USETHEREOF FOR THE PRODUCTION OFACTIVE OR EFFECTIVE INGREDIENTFORMULATIONSBASF SE
05/10/200606121851.7EPPCT/EP/2007/060553WO/2008/040786
)2009.01 (G06F19792230/10/2007
ืคืืจืืฆืื ืืจืื ืืฉืืชืฃ ืขืืืจ ืืื ืืชืงืฉืืจืช
SHARED SPACE FORCOMMUNICATING INFORMATION
MICROSOFT CORPORATION13/11/200611/599599US
PCT/US/2007/083024WO/2008/063833
)2009.01 (C07K19792312/11/2007
SYNTHETIC ืืืืืื ืคืคืืืืื ืกืื ืชืืืื PEPTIDE AMIDESCARA THERAPEUTICS, INC.
10/11/200660/858109US10/05/200760/928550US
PCT/US/2007/023858WO/2008/057608
![Page 215: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/215.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009215
)2009.01 (C07K19792413/11/2007
ืืืืืื ืคืคืืืืื ืกืื ืชืืืื ืืืืืจืื ืฉืืื
SYNTHETIC PEPTIDE AMIDES ANDDIMERS THEREOF
CARA THERAPEUTICS, INC.10/11/200660/858121US10/11/200660/858120US10/11/200660/858123US10/05/200760/928551US10/05/200760/928527US10/05/200760/928557US
PCT/US/2007/023874WO/2008/060552
)2009.01 (B02C19792530/10/2007
METHOD ืฉืืื ืืืืงืจืื ืืืฆืื OF MICRONIZATION
OMRIXื"ืืืืจืืงืก ืืืืคืืจืืืฆืืืืงื ืืข BIOPHARMACEUTICALSLTD.
02/11/200660/856042USPCT/IL/2007/001318WO/2008/053475
)2009.01 (A61K19792726/10/2007
W/O/WW/O/Wืชืืฉืืจ ืืืืืกืื EMULSION COMPOSITIONCONTROLLED LIPO TECHS, INC.
27/10/20062006-292426
JP
PCT/JP/2007/070896WO/2008/053799
![Page 216: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/216.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 216
)2009.01 (C07K19792826/10/2007
ื ืืืื ืื ืืชืฆืืืืื ืืืกืื ืืื ืืฉืืืืฉืืืANTIBODIES ANDIMMUNOCONJUGATES AND USESTHEREFORGENENTECH, INC.
27/10/200660/863295US05/12/200660/868707US30/03/200760/921300US29/06/200760/937857US
PCT/US/2007/082726WO/2008/052187
)2009.01 (C07K19792919/12/2007
ืฉื ืืืืื ืฉืSHRNAโืขืืืื ืืชืืื ืคืืงืืกืืืืจืื ืกืคืจืืโ6,1โืืืคื
SHRNA-MEDIATED INHIBITION OFEXPRESSION OF ALPHA-1,6-FUCOSYLTRANSFERASEF. HOFFMANN-LA ROCHE AG
22/12/200606026653.3EPPCT/EP/2007/011160WO/2008/077547
)2009.01 (C07D19793012/10/2007
โืืืืืืจืโ6,3[โ5โืืืืจืโ2ืืืืจืืืื ืฉืโืืจืืคืืืืืจื(โ4โืืืืืงืกืโ6,2โืืชืืโ3
โNโืคืืืืืจืโ4โ]ืคืืจืืืืืื ืื)H2(โ1โ)ืืชืืืืืื ืโ)ืืชืืืืชืืโ1(โืืชืื[[
ืื ืืืืื]ืกืืืคืื ืื
HYDRATES OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUORO-METHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYLETHYL)-AMINO]SULPHONY]BENZAMIDEBASF SE
13/10/200606122264.2EPPCT/EP/2007/060880WO/2008/043836
![Page 217: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/217.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009217
)2009.01 (A23F19793118/12/2007
ืฉืืื ืืืื ืช ืืจืืื ืืฉืงื ืืขืื ืชืืื ืืชืืฉืืคืจืืช ืืฉืืจืืจ ืืจืืื ืืืจืืืื
ืืฉืืืืฉ
METHOD FOR PREPARINGBEVERAGE COMPOSITIONS HAVINGIMPROVED AROMA RELEASECHARACTERISTICS ANDCOMPOSITIONS FOR USE THEREINKRAFT FOODS GLOBAL BRANDSLLC
29/12/200660/882743US13/12/200711/955778US
PCT/US/2007/087927WO/2008/082953
)2009.01 (A61K19793210/10/2007
FAAHืืืืฆืืช ืืืกืืจืื ืืืจืื ืื ืืืขืืืBORONIC ACIDS AND ESTERS ASINHIBITORS OF FATTY AMIDEHYDROLASEINFINITY DISCOVERY, INC.
10/10/200660/850520USPCT/US/2007/021626WO/2008/063300
)2009.01 (A61K19793311/10/2007
ืืขืืื ืงื ืื ืืืขืืืื ืืืืคืื ืืืืืืช ืฉืืจืืืื ืืจืืืื ืืื ืืขืฆื ืืืืืืช ืฉืืฉืื
ื ืืกืคืืช
KINASE INHIBITORS USEFUL FORTHE TREATMENT OFMYLEOPROLIFERATIVE DISEASESAND OTHER PROLIFERATIVEDISEASESDECIPHERA PHARMACEUTICALS,LLC
11/10/200660/850834US10/10/200711/870388US
PCT/US/2007/081098WO/2008/046003
![Page 218: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/218.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 218
)2009.01 (C07D19793412/10/2007
90HSPHYDROBENZAMIDEืืืืจืืื ืืืืื ืืืขืืื ืชืืืืืช DERIVATIVESAS INHIBITORS OF HSP90ASTEX THERAPEUTICS LIMITED
12/10/20060620259.2GB12/10/200660/829243GB
PCT/GB/2007/003871WO/2008/044034
)2009.01 (A47J19793530/10/2007
JUGืืืฆื ืฆื ืช ืืกืื ืื ื ืืื FOR FILTERING LIQUIDSLAICA S.P.A.
15/11/2006PD2006A000425ITPCT/EP/2007/009412WO/2008/058632
)2009.01 (A61B19793605/10/2007
IMPLANTABLE ืืชืงื ืื ืืชื ืืืฉืชืื DEVICEPFM PRODUKTE FUR DIE MEDIZINAKTIENGESELLSCHAFT
05/10/2006102006047494.5DE20/10/2006102006050385.6DE
PCT/EP/2007/008656WO/2008/040555
)2009.01 (C07K19793711/10/2007
ANTIBODIES ื ืืืื ืื ืืืืืคืืืืงืกืื ืืืคื TO LYMPHOTOXIN-ALPHAGENENTECH, INC.
12/10/200660/829257US18/05/200760/938999US
PCT/US/2007/081154WO/2008/063776
![Page 219: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/219.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009219
)2009.01 (C07K19793826/10/2007
ืฉื ILIL-21โ21ืืจืืื ืืื VARIANTSNOVO NORDISK A/S
26/10/200606123040.5EPPCT/EP/2007/061543WO/2008/049920
)2009.01 (H04L19793928/09/2007
ืฉื ืฉืืื ืืืขืจืืช ืืงืืืื ืืืื ืืืืืชืงืืืื ืฉื ืืืืื ืฉื ืืืืขโืขืจืืฅ ืืงืื
ืืงืจื
METHOD AND APPARATUS FORENCODING CHANNEL QUALITYINDICATOR AND PRECODINGCONTROL INFORMATION BITSINTERDIGITAL TECHNOLOGYCORPORATION
02/10/200660/827829US30/10/200660/855682US09/01/200760/884116US02/02/200760/887829US05/02/200760/888272US08/02/200760/888867US09/02/200760/889038US15/03/200760/895093US
PCT/US/2007/020924WO/2008/042255
)2009.01 (H04B19794026/09/2007
)CQIืืืืกืก(ืืืื ืืื ืืงืจืช ืื ืฉืืืืจ ืืืืขื/ืืฉืืื ืืืืื ืคืชืืื ืืืืื ืกืืืจื
UTRAโEืืฉืงืืช ืืคืจืขืืช ืขืืืจ
COMBINED OPEN LOOP/CLOSEDLOOP (CQI-BASED) UPLINKTRANSMIT POWER CONTROL WITHINTERFERENCE MITIGATION FOR E-UTRAINTERDIGITAL TECHNOLOGYCORPORATION
03/10/200660/827965US27/10/200660/863188US
PCT/US/2007/020779WO/2008/042187
![Page 220: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/220.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 220
)2009.01 (A61K19794104/10/2007
ืฉืืืืฉ ืืชืืืืืช ืื ืืืื ืืคืืจืืืืืื ืืืืฆืืจืชืืฉืืจื ืจืืงืืืช ืืืืคืื ืืืืืืช ืืื
ืฉืืื ื ืงืฉืืจืืช ืืฉืชืื
USE OF ANILINOPYRIMIDINEDERIVATIVES FOR THEPREPARATION OFPHARMACEUTICAL COMPOSITIONSFOR TREATING NON-ALCOHOLICLIVER DISEASESARES TRADING SA
04/10/200660/849251US28/02/200760/904116US
PCT/EP/2007/008627WO/2008/040548
)2009.01 (H04R19794210/10/2007
ืืขืืจื, ืชืืืื ืืืชืงื ืืืฉืืืขื ืงืื ืขืืืจ ืืืฉืืื ืืืฉืืขื ืฉื ืืืจื
ืชืงืฉืืจืช
PROCESS AND DEVICE FOR THEACQUISITION, TRANSMISSION, ANDREPRODUCTION OF SOUND EVENTSFOR COMMUNICATION APPLICATIONSANDREAS MAX PAVEL
12/10/2006102006048295.6DEPCT/DE/2007/001805WO/2008/043349
)2009.01 (C23C19794306/03/2003
ืฉืืื ืืฉืืืโืืื ืืืชืื ืืฆืืคื ืื ื ื ืืืฆืืจื
NANOLAYERED COATED CUTTINGTOOL AND METHOD FOR MAKINGTHE SAMEKENNAMETAL INC.
14/03/200210/097487USPCT/US/2003/006953WO/2003/078689
![Page 221: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/221.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009221
)2009.01 (B65B19794409/10/2007
ืืคืื ืืืืืื ืืขืืืื ืืืืจ ืฉืืื ืื ืืืืืืื
METHOD FOR HEAT TREATMENTAND PROCESSING OF BIOLOGICALMATERIALSSTEINAR GJERSDAL
09/10/200620064604NOPCT/NO/2007/000354WO/2008/044940
)2009.01 (A61K19794505/10/2007
ืชืืฉืืจื ืฆืืืงืืื ืื ื ืืืืืื ืืฉืืืืชืชืืืืื
LIQUID CHALCOGENIDECOMPOSITIONS AND METHODS OFPRODUCING THE SAMEIKARIA, INC.
05/10/200660/849900US23/03/200760/896727US
PCT/US/2007/080613WO/2008/043081
)2009.01 (A61K19794603/10/2007
ืชืืฉืืจื ืืืืกืื ืืืืจืงื ืืฉืืืืช ืืืื ืชื
INJECTABLE DEPOT COMPOSITIONSAND PROCESS FOR PRODUCING THESAMEPANACEA BIOTEC LTD
05/10/20062195/DEL/2006INPCT/IN/2007/000454WO/2008/041245
)2009.01 (A61K19794703/10/2007
ืชืืฉืืจื ืืืืกืื ืืืืจืงื ืืฉืืืืช ืืืื ืชื
INJECTABLE DEPOT COMPOSITIONSAND PROCESS FOR PRODUCING THESAMEPANACEA BIOTEC LIMITED
05/10/20062195/DEL/2006INPCT/IN/2007/000473WO/2008/041246
![Page 222: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/222.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 222
)2009.01 (B62B19794805/04/2009
A ืขืืืช ืชืื ืืง BABY STROLLERYOHANAN ืฉื ื ืืืื ื SHANI
)2009.01 (B65D19794905/04/2009
ืืชืงื ืขืืืจ ืืคืืชืช ืืืืช ืฉื ืืืืจ ืืืืืืฅ ืืืืื
A DEVICE FOR REDUCING THEAMOUNT OF MATERIALEXTRACTED FROM A CONTAINER
TSUK ืขืจื ืืืืืืจื CHEN
)2009.01 (A61K19795024/10/2007
ืขืืืื ืจืืงืื ืืืื ืืืืื ืจืืืืืืคืื ืืืืื ืืืฆืืจ ืืื
AQUEOUS PHARMACEUTICALSUSPENSIONS CONTAININGREBAMIPIDE ANDMANUFACTURING PROCESSTHEREOFOTSUKA PHARMACEUTICAL CO.,LTD.
26/10/20062006-291535
JP
PCT/JP/2007/071167WO/2008/050896
)2009.01 (A61J19795115/11/2007
ืืืกืื ืืฉืืื ืืืขืจืืืช ืืกืืจื ืขืืืจ ืชืจืืืืืช ืชืืื ืชืืืช
INTEGRATED STORAGE ANDDELIVERY SYSTEMS FORNUTRITIONAL COMPOSITIONSNOVARTIS AG
17/11/200660/866297USPCT/US/2007/084734WO/2008/064046
![Page 223: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/223.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009223
)2009.01 (A61M19795205/11/2007
FLOW ืืงืจ ืืจืืื CONTROLLERNESTEC S.A.
07/11/200606123583.4EPPCT/EP/2007/061889WO/2008/055876
)2009.01 (F24J19795309/10/2006
ืืืื ืขืืืจ ืืืฆืืจ ืคื ืืื ืคืืืืืืืืืืกืืืจืืื ืืฉืืืืื ืืกืื ืชืจืื ืืคื ื ืกืืืจื
ืืงืฉืืจ ืืฉืื ืืื ื
PROCESS FOR MANUFACTURINGCOMBINED SOLAR PANELS OFPHOTOVOLTAIC AND THERMALTYPE AND RELATED SOLAR PANELTECHNICAL FIELDS.I.E.M. S.R.L.
PCT/IT/2006/000712WO/2008/044250
)2009.01 (C07D19795415/11/2007
ืชืืืื ืืืื ืช ืืืืืื ืื ืืชืืฆืจื ืืื ืืื ืฉืื
PROCESS FOR THE PREPARATION OFIMATINIB AND INTERMEDIATESTHEREOFF.I.S. FABBRICA ITALIANA SINTETICIS.p.A.
16/11/2006MI2006A002208IT09/05/2007MI2007A000942IT
PCT/IT/2007/000804WO/2008/059551
![Page 224: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/224.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 224
)2009.01 (C07D19795509/10/2007
ืชืืืืืช ืืืืืืืืืืื ืืืืืืืืืืืืืื ืื ืขืืืจ ืกืืืจืช1HSDโB11ืืืขืืื
IMIDAZOLONE ANDIMIDAZOLIDINONE DERIVATIVESAS 11B-HSD1 INHIBITORS FORDIABETESF. HOFFMANN-LA ROCHE AG
19/10/200606122591.8EPPCT/EP/2007/060667WO/2008/046758
)2009.01 (C07D19795609/11/2007
POLYMORPHS ืคืืืืืืจืคืื ืฉื ืชืืฆืจื ืืื ืืื ื ืืงืืืื ืืื OF NICOTINICINTERMEDIATESPFIZER PRODUCTS, INC.
09/11/200660/865077US05/11/200760/985406US
PCT/US/2007/023683WO/2008/060487
)2009.01 (A61M19795729/10/2007
INFUSION ืขืจืื ืืืื ืคืืืื SETUNOMEDICAL A/S
31/10/200606022674.3EP31/10/200660/855554US
PCT/DK/2007/000459WO/2008/052545
![Page 225: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/225.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009225
)2009.01 (C07D19795818/10/2007
ืืจืืืืืืื ืืืฆืืงืืืื ืืืืคื ื ืื ืฉื ืคืจืืืืื ืงืื ืื
BICYCLIC TRIAZOLES AS PROTEINKINASE MODULATORS
SGX PHARMACEUTICALS, INC.23/10/200660/862552US15/12/200660/870309US24/04/200760/913766US30/07/200760/952840US
PCT/US/2007/081841WO/2008/051808
)2009.01 (A01N19795911/12/2007
ืืจืื ืืืืืจ ืืืืงืื ืืืืื ืชืจืืืืชืกืื ืืืืช ืฉืืืืฉืืช ืืืืืจ ื ืืืืืฆืื ืฉื ืฆืืื ืงืื ืืืช ืืชืจืืืืช ืืืืืจืช ืืจืงืื
PESTICIDAL COMPOSITIONCOMPRISING A SYNTHETICCOMPOUND USEFUL ASNODULATION AGENT OFLEGUMINOUS PLANTS AND ANINSECTICIDE COMPOUNDBAYER CROPSCIENCE SA
12/12/200606356144.3EPPCT/EP/2007/063639WO/2008/071674
)2009.01 (C07D19796012/10/2007
BICYCLIC ืชืจืืืืืช ืืืจืืืจืืืืืืช ืืืฆืืงืืืืช HETEROAROMATICCOMPOUNDSGLAXO GROUP LIMITED
13/10/200660/829328US25/01/200711/626882US
PCT/US/2007/081165WO/2008/048866
)2009.01 (G06F19796105/04/2009
METHODS ืฉืืืืช ืืขืืืื ืืขืื ืฉื ืกืืจืืช ืืื FOR EFFECTIVEPROCESSING OF TIME SERIES
HYPERROLLื"ืืืคืจืจืื ืืฉืจืื ืืข ISRAEL LTD
![Page 226: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/226.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 226
)2009.01 (C07D19796218/10/2007
โ4โ)ืืโ3โืืื ืืืโ1H(โ3โืฉืื ืืื ืืืืฉ ืฉืโืงืืื ืืืืืืโ)ืืโ1โืคืืคืจืืืืโืืชืืโ4(โ2[
ืืืืืโ2,5โืคืืจืืโ]ืืโ4
CRYSTAL MODIFICATIONS OF -3-(1H-INDOL-3-YL)-4-[2-(4-METHYL-PIPERAZIN-1-YL)-QUINAZOLIN-4-YL]-PYRROLE-2,5-DIONENOVARTIS AG
20/10/200660/853384USPCT/US/2007/022241WO/2008/051440
)2009.01 (B60F19796301/10/2007
AMPHIBIOUS ืืื ืจืื ืืืคืืื VEHICLEGIBBS TECHNOLOGIES LIMITED
29/09/20060619244.7GBPCT/GB/2007/003723WO/2008/038029
)2009.01 (A01N19796408/10/2007
PROCESS ืชืืืื ืืืืฆืืจ ืฉื ืืจืืืืื ืื ืื ืืืชืืจืื FOR THE PRODUCTION OFSUBSTITUTED BROMOBENZENESSYNGENTA PARTICIPATIONS AG
25/10/200606022279.1EPPCT/EP/2007/008697WO/2008/049507
)2009.01 (C07C19796503/10/2007
ืคืืืืืจื ืืืขืืืโืชืจืืืืืช ืืืืืืืช ืื ืฆืืกืืืื ืคืจืืืื
DI-FLUORO CONTAININGCOMPOUNDS AS CYSTEINEPROTEASE INHIBITORSVIROBAY, INC.
04/10/200660/849587USPCT/US/2007/080320WO/2008/042968
![Page 227: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/227.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009227
)2009.01 (A61K19796610/10/2007
USE ืฉืืืืฉ ืืฆืืงืืืกืคืืจืื ืฉืขืืจ ืฉืื ืื OF MODIFIED CYCLOSPORINNOVARTIS AG
12/10/200660/829228USPCT/EP/2007/060794WO/2008/043797
)2009.01 (G06F19796710/10/2007
โืืืืขืจืืช ืกืคืจืื ืฆืืืืจืืช ืืืกืคืงืช ืงืจืืืืื ืฉื ืคืจืื ืกืคืจืืช ื ืืืจ ืืฉื ื ืืงืืืืช
ืืจืืืงืื
PUBLIC LIBRARY SYSTEM FORPROVIDING READING-TOGETHERAT TWO REMOTE LOCATIONS OF ASELECTED CHILDREN LITERATUREITEM
DROR ืืจืืจ ืืืืจืื OBERMAN16/10/2006178653IL
PCT/IL/2007/001222WO/2008/047344
)2009.01 (A01N19796811/12/2007
ืืจืื ืืืืืจ ืืืืงืื ืืืืื ืชืจืืืืชืกืื ืืืืช ืฉืืืืฉืืช ืืืืืจ ื ืืืืืฆืื ืฉื ืฆืืื ืงืื ืืืช ืืชืจืืืืช ืงืืืืช ืคืืจืืืช
PESTICIDAL COMPOSITIONCOMPRISING A SYNTHETICCOMPOUND USEFUL ASNODULATION AGENT OFLEGUMINOUS PLANTS AND AFUNGICIDE COMPOUNDBAYER CROPSCIENCE SA
12/12/200606356143.5EPPCT/EP/2007/063637WO/2008/071672
![Page 228: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/228.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 228
)2009.01 (G06Q19796930/07/2007
ืืชืงื ืืชืืฆืจ, ืฉืืื ืืืขืจืืช ืืืืื ืืืฆืขื ืื ืืชื ืืงืจืืื ืขื ืืื ืืืฉื
DIAMOND VALUATION METHOD,APPARATUS AND COMPUTERREADABLE MEDIUM PRODUCTROSY BLUE DMCC
11/10/200660/828981USPCT/US/2007/074726WO/2008/045613
)2009.01 (C07D19797003/10/2007
PROCESS ืชืืืื ืืืื ืช ืคืืืจืืืืืืืื ืื FOR THE PREPARATIONOF PLEUROMUTILINSNABRIVA THERAPEUTICS AG
05/10/200606121852.5EPPCT/AT/2007/000468WO/2008/040043
)2009.01 (C07K19797125/09/2007
โืืงืืจืืืืืื ืืื ืืโืคืคืืืืื ืื ืื ืืืจืืืืื ืืืงืืื ืืืืืจื ื ืืืืืื ืกืืก
ANTIBACTERIAL AND ANTIVIRALPEPTIDES FROM ACTINOMADURANAMIBIENSISSANOFI AVENTIS
06/10/200606020980.6EPPCT/EP/2007/008294WO/2008/040469
)2009.01 (A61K19797202/07/2007
ืกืื ืชืื ืืขืืื ืฉื ืืืืืจืื ืืืืืืืชืืฉืืจืื: ืืจืขืื ืืช ืืจืืืืชืจืืคืื
ืืืคืืืงืฆืืืช
EFFICIENT SYNTHESIS OFCHELATORS FOR NUCLEARIMAGING AND RADIOTHERAPY:COMPOSITIONS AND APPLICATIONSTHE BOARD OF REGENTS OF THEUNIVERSITY OF TEXAS SYSTEM
05/10/200660/828347US28/06/200711/770395US
PCT/US/2007/072669WO/2008/045604
![Page 229: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/229.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009229
)2009.01 (A61M19797326/09/2007
ืืฉืืื ืฉื ื ืืขืช ืืืขืืืโืืืงืจื ืืขืืช ืจืืฉ ืืฉืืื ืื ืืชื ืืืืืคื
PERISTALTIC MICROPUMP WITHEXCHANGEABLE PUMP HEADSANOFI-AVENTIS DEUTSCHLANDGMBH
07/10/2006102006047613.1DEPCT/EP/2007/008361WO/2008/040477
)2009.01 (A61M19797426/09/2007
ืืขืจืืช ืืืืืงืช ืื ืืช ืฉื ืชืจืืคื ืืฉืืืโืืืืคืขืืช ืืืืฆืขืืช ืืืงืจื
MICROPUMP-OPERATED DRUGDOSING SYSTEMSANOFI-AVENTIS DEUTSCHLANDGMBH
07/10/2006102006047538.0DEPCT/EP/2007/008362WO/2008/040478
)2009.01 (A61M19797526/09/2007
ืงืืืขื ืืืคืืืช ืฉื ืืืงืื ืืคืงืง ืืืืกื ืืืช ืืืืืืช
OPTICAL DETERMINATION OF THESTOPPER POSITION IN GLASSCARTRIDGESSANOFI-AVENTIS DEUTSCHLANDGMBH
07/10/2006102006047537.2DEPCT/EP/2007/008363WO/2008/040479
![Page 230: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/230.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 230
)2009.01 (G10L19797623/10/2007
โืืชืงื ืืฉืืื ืืืฆืืจืช ืขืจืื ืฉืืข ืชืชืคืกืืื ืืืชืงื ืืฉืืื ืืืฆืืจืช ืืืืืืืช ืฉืืข
ืืืืโืืืชืื
APPARATUS AND METHOD FORGENERATING AUDIO SUBBANDVALUES, AND APPARATUS ANDMETHOD FOR GENERATING TIME-DOMAIN AUDIO SAMPLESFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
25/10/200660/862954USPCT/EP/2007/009199WO/2008/049589
)2009.01 (G06F19797730/10/2007
PRIVACY-AWARE ืคืจืืืืช ืืืื ืช ืชืืืโืืขืจืืช ืืืืขืช CONTENTPROTECTION SYSTEMNDS LIMITED
02/11/2006179023IL29/03/2007182338IL
PCT/IL/2007/001314WO/2008/053471
)2009.01 (E03B19797805/10/2007
ืืขืจืืช ืืจืื ืืืืื ืืฉ ืืืืืืช ืจืืืื ืขื ืฉืกืชืื ืฉื ื
WET BARREL FIRE HYDRANTSYSTEM WITH SECOND VALVEDAVIDSON HYDRANTTECHNOLOGIES, INC.
06/10/200611/544429USPCT/US/2007/080572WO/2008/045785
![Page 231: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/231.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009231
)2009.01 (C07K19797903/10/2007
METHOD ืฉืืื ืืกืื ืชืืื ืฉื ืคืคืืื FOR PEPTIDE SYNTHESISLONZA AG
05/10/2006EP06020893EPPCT/EP/2007/008581WO/2008/040536
)2008.04 (H04Q19798020/03/2001
ืฉืืื ืืืชืงื ืืืงืจืช ืฉืืืืจืื ืืืขืจืืช ืชืงืฉืืจืืช
METHOD AND APPARATUS FORCONTROLLING TRANSMISSIONS OFA COMMUNICATIONS SYSTEMQUALCOMM INCORPORATED
30/03/2000539157USPCT/US/2001/009325WO/2001/076098
)2009.01 (C07D19798108/10/2007
KINASE ืืขืืื ืงืื ืื INHIBITORSTAKEDA PHARMACEUTICAL COMPANYLIMITED
09/10/200611/539857US10/10/2006PCT/US2006/039667US18/04/200760/912629US
PCT/US/2007/080714WO/2008/054956
)2009.01 (A61K19798210/10/2007
ืชืืฉืืจื ืืฉืืื ืืืืคืื ืืืืืืชืงืจืืืืืกืงืืืจืืืช ืืืืืกืก ืขื ืชืืืืจืื
ืฉื ืืจืื ืืชืจืคืื
COMBINED PREPARATION FOR THETREATMENT OF CARDIOVASCULARDISEASES BASED ONCHRONOTHERAPY THEORYHANALL PHARMACUETICAL CO., LTD
10/10/20061020060098438KR09/10/20071020070101492KR
PCT/KR/2007/004929WO/2008/044862
![Page 232: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/232.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 232
)2009.01 (C07H19798312/10/2007
ื ืืืจืช ืฉื ืชืืืืืืงืืื ืกืคืืจืืงืื ืืฉืืืืฉ ืื ืืชืืฉืืจ ืจืคืืื ืืกืืืจืช
THIOGLUCOSE SPIROKETALDERIVATIVE AND USE THEREOF ASTHERAPEUTIC AGENT FORDIABETESCHUGAI SEIYAKU KABUSHIKIKAISHA
13/10/20062006-280159
JP
PCT/JP/2007/069933WO/2008/044762
)2009.01 (A61M19798415/10/2007
ืืขืจืืช ืืืชื ืืืฅ ืืืคืืช ืืขืืช ืืฉืืืืืืจืืช ืืื ืืช ืืืกืคืงืช ืืืคืื ืืคืฆืขืื
ืืืืจื ื ืืืื
REDUCED PRESSURE DELIVERYSYSTEM HAVING A MANUALLY-ACTIVATED PUMP FOR PROVIDINGTREATMENT TO LOW-SEVERITYWOUNDSKCI LICENSING, INC.
13/10/200660/851494USPCT/US/2007/021947WO/2008/048527
)2009.01 (C07H19798505/10/2007
ANTICOAGULANT ืชืจืืืืืช ืืื ืืขืช ืงืจืืฉื COMPOUNDSENDOTIS PHARMA
05/10/200606291556.6EPPCT/IB/2007/003938WO/2008/041131
![Page 233: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/233.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009233
)2009.01 (A61K19798602/10/2007
ืชืืฉืืจืื ืจืคืืืืื ืืืืืืื ืื ื ืืืืืจ ืฉื ืงืืืงืื ืืืื
KETOCONAZOLE ENANTIOMER INHUMANS
CORTENDO INVEST AB02/10/200660/848963US
PCT/US/2007/080186WO/2008/042898
)2009.01 (B01J19798712/12/2002
ืชืืืื ืืจืื ืืื ื ืืื ืงืจ ืืืืงืจื ืืงืจืื ืชืชืืจ ืจืืื ืืฉืืื ืืกืืกืืช ืืืฆืืจ ืืืงืืงืื
ืืืืื ื ื ื
A THERMAL PROCESS INVOLVINGCOLD RF IRRADIATED LIQUID AS ACORE METHOD FOR PRODUCINGNANO-SIZE PARTICLES
ืืข-ืื DO-COOPื"ืงืืค ืืื ืืืืืืืช TECHNOLOGIES LTD.12/12/2001147049IL
PCT/IL/2002/001004WO/2003/053647
)2009.01 (C07K19798811/08/2000
ืื ืืืื ืืงืืื ืืจื ืกืืืืจื ื ืืืืคืืก ืกืืจืื ืืืืืช ืืขืจืืื ืืช ืืื ื ืืืชืืื ืืก
ืืื ืืืฉืืืืฉ ืื
C-TYPE LECTIN TRANSMEMBRANEANTIGEN EXPRESSED IN HUMANPROSTATE CANCER AND USESTHEREOFAGENSYS, INC.
12/08/199960/148935USPCT/US/2000/022065WO/2001/012811
![Page 234: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/234.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 234
)2009.01 (B44F19798903/10/2007
ืฉืืื ืืืขืจืืช ืืืืฆืืจ ืืื ืืขื ืคื ื ืฉืืืืื ืืขื ืคื ื ืฉืื ืืืืืื, ืืืืืื
ืืืขืจืืช ืฉื ืืืืืช ืืื ืืืืืืืืืื
METHOD OF AND APPARATUS FORMANUFACTURING A LARGESURFACE PANEL, A LARGESURFACE PANEL, AND A SET OFINDIVIDUAL PANELSSPANOLUX N.V. -DIV. BALTERIO
05/10/200606121829.3EP13/04/200707106127.9EP
PCT/EP/2007/060503WO/2008/040760
)2009.01 (G01N19799008/10/2007
ืฉืืื ืืืืฆืืจ ืคืจืืคืื ืจืืืงืืืืืืช ืฉื ืืกืืช ืื ืขืืืจ ืืคืจื
A METHOD OF GENERATING APLATELET REACTIVITY PROFILEFOR AN INDIVIDUALROYAL COLLEGE OF SURGEONS INIRELAND
06/10/200606394020.9EPPCT/IE/2007/000096WO/2008/041220
)2009.01 (B25J19799102/10/2007
ROBOTIC ืืื ืจืื ืจืืืืื VEHICLEIROBOT CORPORATION
06/10/200660/828606US05/01/200760/878877US29/03/200760/908782US07/06/200760/942598US13/06/200711/762458US13/06/200711/762315US06/08/200711/834658US06/08/200760/954227US
PCT/US/2007/080138WO/2008/105948
![Page 235: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/235.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009235
)2009.01 (B25J19799205/10/2007
ืืชโืืื ืืจื ืื ืืขืื ืจืืฉ ืจืื ืจืืืืืืื ืืืืฉื ื ืื ืืชื ืืืืงืื
MANEUVERING ROBOTIC VEHICLESHAVING A POSITIONABLE SENSORHEADIROBOT CORPORATION
06/10/200660/828611US05/01/200760/883731US21/08/200711/842881US21/08/200711/842868US
PCT/US/2007/080541WO/2008/097376
)2009.01 (H04B19799314/05/2002
ืืืืืช ืืืืืช ืืขืจืืฅ ืขืืืจ ืืืืง ืืฉืืืื ืฉื ืืืช ืืฉืืืจ ืืืืืื ืืจืฆื
CHANNEL QUALITYMEASUREMENTS FOR DOWNLINKRESOURCE ALLOCATIONINTERDIGITAL TECHNOLOGYCORPORATION
14/05/200160/290739USPCT/US/2002/015242WO/2002/093757
)2009.01 (C07C19799409/05/2007
INSECTICIDAL ืื ืืืืืืื ืื ืงืืืื ืืจืงืื BENZAMIDINESBAYER CROPSCIENCE AG
16/05/20062006-136726
JP
PCT/EP/2007/004092WO/2007/131680
![Page 236: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/236.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 236
)2009.01 (G09G19799507/10/2007
ืข ืืชืงื ื, ืืชืงื ื ืืฉืืจ,ื ืืืืืืืืืขืจืืช ืืฉืืืืช ืืืฆืืจ ืืฉืืืืฉ ืืื, ืงืืืื
DIGITAL PEN SYSTEM,TRANSMITTER DEVICES, RECEIVINGDEVICES, AND METHODS OFMANUFACTURING AND USING THESAME
PEGASUSื"ืคืืกืืก ืืื ืืืืืืืช ืืข TECHNOLOGIES LTD.05/10/200660/828240US
PCT/IL/2007/001205WO/2008/041234
)2009.01 (A23D19799705/10/2007
โืืงืฆืคื ืื ืืืโืืจ, ืืืฆืจ ืืืื ืืฆืื ืคืจืืืืื
STABLE PROTEIN-FREE WHIPPABLEFOOD PRODUCT
RICH PRODUCTS CORPORATION06/10/200660/850166US
PCT/US/2007/080582WO/2008/045790
)2009.01(H02H19799826/09/2007
ืืชืจโืืืืจื ื ืื ืืจืโืืขืื ืืื ื ืืืืกืก ืขืืืจ ืืขืจืืืช ืืืืงืช ืืื
HARDWARE BASED OVER-CURRENTPROTECTION CIRCUITRY FORPOWER DISTRIBUTION SYSTEMSAVOCENT HUNTSVILLE CORP.
29/09/200611/529214USPCT/US/2007/020716WO/2008/042173
)2009.01 (H01H19799905/04/2009
ืืืืจื ืขื ืืขืื ืฆืืื ืืขื ืืืืืืื ืืชืืืื ืงืฉืืจ
SPRINKLER WITH GEARED VISCOUSHESITATOR AND RELATED METHODNELSON IRRIGATIONCORPORATION
29/04/200812/149264US
![Page 237: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/237.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009237
)2009.01 (H01H19800005/04/2009
SPRINKLER ืืชืืืื ืงืฉืืจ ืืืืจื ืขื ืืขืื ืฆืืื WITH VISCOUSHESITATOR AND RELATED METHODNELSON IRRIGATIONCORPORATION
29/04/200812/149265US
)2009.01 (F03G19800104/10/2007
REACTION ืืืจืืื ื ืกืืืืจืืช SOLAR TURBINEJOSE ANTONIO BARBEROFERRANDIZ
10/10/2006P200602605ES01/10/2007P200702556ES
PCT/ES/2007/000558WO/2008/043867
)2009.01 (C07D19800416/10/2007
โืืืืืืืืืื ืืืชืืจืื ืืืืืืืืืจืื ืืชืช ืฉื ืจืฆืคืืืจ ืืืืืืกืื3ืกืื
SUBSTITUTED IMIDAZOLES ASBOMBESIN RECEPTOR SUBTYPE-3MODULATORSMERCK & CO., INC.
20/10/200660/853193USPCT/US/2007/022087WO/2008/051406
)2009.01 (A61K19800505/10/2007
ื ืขืืืจ ืืืคืื2CCRืื ืืืื ืืกืืื ืืคืืืจืืืืก
CCR2 ANTAGONISTS FORTREATMENT OF FIBROSIS
CENTOCOR ORTHO BIOTECH INC.05/10/200960/828253US
PCT/US/2007/080542WO/2008/060783
![Page 238: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/238.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 238
)2009.01 (H01R19800602/05/2008
ืืืืืืื ืืฆืืจืช ืชืืฃ ืขื ืืืขืืช ืืืขืืจืช ื ืชืื ืื ืืชืืืจืืช ืืืืื
HIGH-FREQUENCY DRUM-STYLESLIP-RING MODULES
MOOG INC15/05/200711/803483US
PCT/US/2008/005669WO/2008/143771
)2009.01 (C07D19800719/10/2007
ืชืจืืืืืช ืืืจืืฆืืงืืืืช ืืฉืืืืฉื ืืืขืืื3ืืืืงืืื ืกืื ืืื ืงืื ืื
HETEROCYCLIC COMPOUNDS ANDTHEIR USE AS GLYCOGENSYNTHASE KINASE 3 INHIBITORSABBOTT LABORATORIES
21/10/200606022094.4EP22/06/200760/936837US
PCT/EP/2007/061231WO/2008/046919
)2009.01 (C12N19800823/10/2007
ืฉืืืืช ืืืจืืืื ืืืืคืื ืืคืืืื ืฉืืืขืฆื ืืืืฆืขืืช ืืืืืืกืืืช ืชืืื
ืฉืืืืชืืื
METHODS AND COMPOSITIONS FORTREATMENT OF BONE DEFECTSWITH PLACENTAL CELLPOPULATIONSANTHROGENESIS CORPORATION
23/10/200660/853971US30/10/200660/855629US28/09/200760/997022US
PCT/US/2007/022545WO/2008/051568
![Page 239: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/239.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009239
)2009.01 (C07D19800902/10/2007
ื ืืืจืืช ืืืฆืืงืืืืช ืืืจืืฆืืงืืืืช ืืื ืืืื ืืกืืื ืืจืฆืคืืืจ ืืืจืืืืื
BICYCLIC AND TRICYCLICDERIVATIVES AS THROMBINRECEPTOR ANTAGONISTSSCHERING CORPORATION
04/10/200660/849354USPCT/US/2007/021277WO/2008/042422
)2009.01 (A61K19801031/10/2007
ืชืจืืืืืช ืคื ืืืคืจืืคืืื ืืืื ืืืฉืืืืฉ ืืืPHENYLPROPIONAMIDECOMPOUNDS AND THE USETHEREOFPURDUE PHARMA L.P.
01/11/200660/855826USPCT/IB/2007/003411WO/2008/053352
)2009.01 (C07D19801102/10/2007
ืื ืืืื ืืกืืื ืืจืฆืคืืืจ ืืืจืืืืืืืืืืกืกืื ืขื ืืืืื ืืจืืฆืืงืืืช ืฉื
ืืืืืฆืื ืฉืขืืจื ืฉืื ืื
THROMBIN RECEPTORANTAGONISTS BASED ON THEMODIFIED TRICYCLIC UNIT OFHIMBACINESCHERING CORPORATION
04/10/200660/849284USPCT/US/2007/021259WO/2008/060372
![Page 240: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/240.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 240
)2009.01 (C07K19801209/10/2007
ืืืืื ืืืืื ืฉื ืืืืืจืื ืจืืืจืกื ืืงืืืืืืืื ืืืงืืืืื, ืืจื ืกืงืจืืคืืื
ืืฉืืืืฉืื ืฉืืื, ืืืชื
TELOMERASE REVERSETRANSCRIPTASE FUSION PROTEIN,NUCLEOTIDES ENCODING IT, ANDUSES THEREOFISTITUTO DI RICERCHE DIBIOLOGIA MOLECOLARE P.ANGELETTI SPA
12/10/200660/851183USPCT/EP/2007/060713WO/2008/043760
)2009.01 (A62C19801312/07/2007
APPLYING ืืืฆื ื ืขื ืืืืจ ืืืจืโืคืืืืจ ืคืืื ืื SOLID CARBON DIOXIDETO A TARGET MATERIALCRYO RESPONSE, INC.
02/10/200611/542324USPCT/US/2007/073365WO/2008/042488
)2009.01 (C07D19801421/09/2007
ืืขืืืื ืืืืืืืคืจืืืืื ืฉืื ืชืืฆืจืื ืืืจืืฆืืงืืืื
HETEROCYCLIC DERIVEDMETALLOPROTEASE INHIBITORS
JANSSEN PHARMACEUTICA, N.V.05/10/200960/828226US
PCT/US/2007/079114WO/2008/045668
)2009.01 (A61K19801509/10/2007
ืืจืืืื ืฉื ืงืืืื ืฉืืืืชื ืืืขื)ืืืืคืคืืื(
NATIVE (TELOPEPTIDE)PLACENTALCOLLAGEN COMPOSITIONS
ANTHROGENESIS CORPORATION06/10/200660/850131US
PCT/US/2007/021677WO/2008/057162
![Page 241: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/241.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009241
)2009.01 (A61K19801605/10/2007
โS)โ(+)โ2โ(2(ืงืจืืกืื ืืืฉ ืฉื ืงืจืืืโืืชืืโืืืืจืืงืกืโ2โ)ืืืืจืืคื ืื
NOVEL CRYSTAL OF (S)-(+)-2-(2-CHLOROPHENYL)-2-HYDROXY-ETHYL CARBAMATEJANSSEN PHARMACEUTICA, N.V.
06/10/200660/828392USPCT/US/2007/021502WO/2008/045391
)2009.01 (C12Q19801813/10/2007
ืฉืืื ืืงืืืขืช ืคืขืืืืช ืื ืืื)ืืคืจืื ืื(ืื ืืืืืืงืืกืืืื
METHOD FOR DETERMININGENDOGLYCOSIDASE(HEPARANASE)ENZYME ACTIVITYHANS-DIETER HAUBECK,
07/11/200606023091.9EPPCT/EP/2007/008905WO/2008/055575
)2009.01 (F42B19801906/04/2009
ืชืืืืฉืช ืืขืืช ืงืืืจ ืืืื ืื ืืขื ืช ืืืืืจ
LARGE CALIBRE AMMUNITIONLOADED FROM THE REAR
NEXTER MUNITIONS09/04/20080801943FR
)2009.01 (C07K19802010/10/2007
ANTI-CD20 ืืฉืืืืช ืืฉืืืืฉ20CDโื ืืืื ืื ืื ืื ANTIBODIES ANDMETHODS OF USEVACCINEX, INC.
10/10/200660/850604US09/10/200711/869170US
PCT/US/2007/080925WO/2008/063771
![Page 242: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/242.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 242
)2009.01 (A61K19802122/10/2007
ืืืื ืืื ืขืืืืื ืืคืจืืืืื ืฉื ืชืืืชืืงืื ืฉื ื ืืง1ืืฉืชืืชื ืื ืืืจ ืืคืงืืืจ
ืืจืงืื
PROTEASE RESISTANT MUTANTS OFSTROMAL CELL DERIVED FACTOR-1IN THE REPAIR OF TISSUE DAMAGE
THE BRIGHAM AND WOMEN'SHOSPITAL, INC.
23/10/200660/853441US22/06/200760/929353US19/10/200711/976032US
PCT/US/2007/022394WO/2008/051505
)2009.01 (C07C19802230/10/2007
ืขืโLืืืืฆื ,18Fืืืืืืืช ืืืกืืื ืช Lโ, ื ืืืจืืชืืื,18Fืืืืืืืื ืืืกืืื ืขื
ืืฉืืืืฉ ืืื ืืชืืืืืื ืืืื ืชื
[F-18]-LABELED L-GLUTAMIC ACID,[F-18]-LABELED-L-GLUTAMINEDERIVATIVES THEREOF AND USETHEREOF AND PROCESSES FORTHEIR PREPARATIONINSTITUTE OF THE HUMAN BRAINRUSSIAN ACADEMY OF SCIENCE(IHB RAS)OF
01/11/20062006138584RU18/11/200606090211.1EP
PCT/EP/2007/009518WO/2008/052788
)2009.01 (D21F19802314/08/2007
ืืืืืืช ืืขืืฆืืืช ืขื ืืื ืืืฅ ืืชื ืืMOLDED ืจืืืืืช WET-PRESSED TISSUE
KIMBERLY-CLARK WORLDWIDE,INC.
27/10/200611/588652USPCT/IB/2007/053230WO/2008/050246
![Page 243: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/243.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009243
)2009.01 (E21B19802419/10/2007
ืืืืื ืฉืืืช ืืืื ืืคืชืืช ืชืื ืืื ืืงืจืช ืืืฅ
HEATING TAR SANDS FORMATIONSWHILE CONTROLLING PRESSURESHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.
20/10/200660/853096US20/04/200760/925685US
PCT/US/2007/081901WO/2008/051827
)2009.01 (C07D19802515/10/2007
NOVEL ืืืจืืืจืื ืงืจืืืงืกืืืืืื ืืืฉืื HETEROARYLCARBOXAMIDESF. HOFFMANN-LA ROCHE AG
25/10/200606122944.9EPPCT/EP/2007/060928WO/2008/049747
)2009.01 (A61K19802617/10/2007
SEQUENTIAL ืืืคืื ืืฉืืื ืจืฆืืฃ COMBINATIONTHERAPYDYAX CORP.
17/10/200660/852263US19/12/200660/875736US
PCT/US/2007/081621WO/2008/048996
)2009.01 (C07K19802705/11/1999
ืจืฆืคื ื ืืงืืืืืืืืื ืืืืืื ืื ืฉื ืืNOGOืืฉืืืืช ืืืืืกืกืืช ืขืืืื
NUCLEOTIDE AND PROTEINSEQUENCES OF NOGO GENES ANDMETHODS BASED THEREONUNIVERSITAT ZURICH
06/11/199860/107446USPCT/US/1999/026160WO/2000/031235
![Page 244: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/244.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 244
)2009.01 (C12Q19802804/10/2007
ืฉืืื ืขืืืจ ืืขืจืืช ืืืืืจ ืชืจืื ืืืืจ ืจืฆืืฃ
METHOD FOR A CONTINUOUSRAPID THERMAL CYCLE SYSTEM
VANDALIA RESEARCH, INC.06/10/200660/850103US
PCT/US/2007/021328WO/2008/045288
)2009.01 (C07B19802906/04/2009
ืชืืืื ืืืคืงืช ืืืืฆื ืืืืจืืืืืจืืชืืชืืืกื ืืืืืืช ืฉืื ืืชืืฉืืจ ืืืฆืื
ืืฉืืืืฉ ืื
A PROCESS FOR THE RECOVERY OFHCL FROM A DILUTE SOLUTIONTHEREOF AND EXTRACTANTCOMPOSITION FOR USE THEREIN
ืก ืืข' ืืืืฅ HCLื"ืื ืงืืื ืื CLEANTECH LTD.
)2009.01 (G06F19803015/10/2007
LOCATING ืืืชืืจ ืคืืืขืืช ืืืืืชืืืช ืืงืื ืืงืืจ SECURITYVULNERABILITIES IN SOURCE CODECHECKMARX LTD
19/10/200660/853349USPCT/IL/2007/001233WO/2008/047351
)2009.01 (E06B19803106/04/2009
ืชืจืืก ืขื ืืจืืืื ืืืจ ืืืืืืืช ืงืืฉืืจ ืืฉืจืข ื ืืคืจืง ืืืืืืช ืงืจืก"ืืืืืจืช
ROLLER SHUTTER WITH AERATIONGAPS APERTURES BETWEEN SLATSBASED ON A COUPLING LINK.COMPRISED BY ARTICULATE JOINTAND A SLIDING HOOK GRIP
ARNON ืืจื ืื ืืจืง BARAK
![Page 245: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/245.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009245
)2009.01 (H04M19803206/04/2009
TELEPHONE ืืขืจืืืช ืืฉืืืืช ืืกืื ืื ืชืืื ืืืคืื ื CONTENT FILTERINGSYSTEMS AND METHODS
ืืข.ื.ืฉ .S.Jื"ืืจืงื ืคืื MARKET PHONE LTD.
)2009.01 (H01H19803306/04/2009
ืืขืจื ืขืฆืืฆืื ืื ืืชื ืืืืื ืขื ืืืืืจ ืืืฉืืื ืฉื ืืื ืืืืืจืื ืืืื ืื
MOVABLE PLANTER ARRAYSYSTEM WITH WATER ANDNUTRIENT RECYCLE ANDREPLENISHMENT
RON ืจืื ืืืืืืกืงื MIDOVSKY
)2009.01 (B65G19803406/04/2009
A ืืชืงื ืืืขืืจืช ื ืืืืื DEVICE FOR THE TRANSFER OFLIQUIDS
YOSEF ืขืืื ืขืืจื ืืืืฉื ORPELI
)2009.01 (B67B19803506/04/2009
ืืขืจืืช ืืฉืืื ืืกืืืจื ืืืืืืื ืฉื ืืื ืคืืกืืืง
A SYSTEM AND METHOD FOR APLASTIC CLOSURE WITH INTEGRALLINER
AMARAZื"ืืืจื ืืข LTD
)2009.01 (A47K19803606/04/2009
A ืืืฉืืจ ืืืืื ืืืืืื ืืืื MACHINE FOR WASHING &STERILIZING DISHES
GIL ืืื ืฉืืฉ SHEMESH
![Page 246: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/246.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 246
)2009.01 (B62B19803706/04/2009
A ืืืคืช ืืืคื ืื ืืฉืืื ืขืืืจื BICYCLE CANOPY AND METHODTHEREFOR
SHLOMO ืฉืืื ืืื MAMAN
)2009.01 (A47B19803806/04/2009
ืชืืง ื ืฉืืื ืืืื ืืคื ื ืื ืืื ืืืืืื ืืืืฉืืื ื ืืฉืืื
THEFT PROTECTABLE CARRYINGBAG IN PARTICULAR FORPORTABLE COMPUTERS
MEIR ืืืืจ ืืืื ืื AVGANIM
)2009.01 (G01C19803906/04/2009
AID ืืืฉืืจ ืขืืจ ืืกืจื ืืืืื DEVICE FOR TAPE MEASURE
MEDVAื"ืืืื ืืืืืืช ืืื ืืกื ืืข SURVEY & ENGINEERINGLTD
)2009.01 (C07D19804002/12/1999
ืืืื ืช ืชืจืืืืืช ืืจืืืืืื ืืืืจื ืืื ืืื)5,4โD(ืคืืจืืืืืื
INTERMEDIATES FOR THEPREPARATION OF TRIAZOLO (4,5-D)PYRIMIDINE COMPOUNDSASTRAZENECA AB
04/12/19989804211-2SE09/04/19999901271#8SE
PCT/SE/1999/002256WO/2000/034283
![Page 247: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/247.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009247
)2009.01 (F24J19804109/10/2007
TWO-AXLE ืกืจื ืโืืฉืฉ ืกืืืจื ืื SOLAR TRACKERCABANILLAS INGENIEROS, S.L.
09/10/2006U200602226ES25/10/2006U200602371ES22/12/2006U200602756ES
PCT/ES/2007/000574WO/2008/043871
)2009.01 (G06F19804207/10/2007
ืขืช ืืฉืชื ื ืืจืืื ืฉื ื ืืื ืืืืจื ืืจื ืงืืืขื ืืื ืฉืืืืฉ, ืงืืืืชโืืขืืจ ืืฆืืจื ืขื
ANALYSIS(ืืื ืืืืช ืฉืื ืืจืืืง FIELDโFAR(
ULTRASONICALLY DETERMININGFLOW PARAMETERS OF A FLUIDFLOWING THROUGH A PASSAGE, BYUSING FAR-FIELD ANALYSIS
YEDAื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD
10/10/200660/850266USPCT/IL/2007/001207WO/2008/044232
)2009.01 (A61K19804315/10/2007
ืืืืคืื151CDโืฉืืืืฉ ืื ืืืื ืื ืื ืืกืจืื
USE OF AN ANTI-CD151 ANTIBODYIN THE TREATMENT OF CANCER
PIERRE FABRE MEDICAMENT18/10/20060609135FR
PCT/FR/2007/001688WO/2008/049990
![Page 248: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/248.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 248
)2009.01 (C23C19804403/09/2007
ืืขืจืืช ืฉืืื ืืขืืช ืืคืืืช ืฉืืื ืืืช ืฉื ืชืขืจืืืช ืงืจืืกืื ืฉื ืคืืืืืืงืกืื
LAYER SYSTEM HAVING AT LEASTONE MIXED CRYSTAL LAYER OF APOLYOXIDEOERLIKON TRADING AG,TRUBBACH
10/10/200601614/06SEPCT/EP/2007/059196WO/2008/043606
)2009.01 (G02B19804506/04/2009
IMAGE ืืขืจืืช ืืืืฉื ืืืืืื SENSOR SYSTEMDIEHL BGT DEFENCE GMBH & CO. KG
07/04/2008102008017585.4DE
)2009.01 (C07K19804624/10/2007
METASTIN ื ืืืจืืช ืฉื ืืืกืืื ืืฉืืืืฉืืื DERIVATIVES AND USETHEREOFTAKEDA PHARMACEUTICALCOMPANY LIMITED
25/10/20062006-290536
JP
31/01/20072007#021387JP28/08/20072007#221911JP
PCT/JP/2007/071169WO/2008/050897
)2009.01 (C07C19804715/10/2007
ื 1SELECTIVEืืืโTRโืืืื ืืกื ืกืืงืืืื TR-BETA 1 AGONISTCADILA HEALTHCARE LIMITED
31/10/20061813/MUM/2006INPCT/IN/2007/000493WO/2008/062469
![Page 249: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/249.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009249
)2009.01 (A61K19804806/09/2001
CARDIAC ืฉืืืืช ืืืืคืื ืจืคืืื ืืืคืจืขืืช ืงืฆื ืืื ARRHYTHMIATREATMENT METHODSJOHNS HOPKINS UNIVERSITY
06/09/200060/230311US05/06/200160/295889US
PCT/US/2001/027623WO/2002/019966
)2009.01 (A61G19804925/10/2007
ืืชืงื ืฉืืคืืข ืืืืื ืืขื ืชืืืืช ืฉืืืจื ืืจืืืืช
PATIENT INCLINE DEVICE HAVINGCENTERLINE SPINAL SUPPORT
PATIENT TRANSFER SYSTEMS, INC.01/11/200660/855874US20/11/200660/860044US03/04/200711/732184US
PCT/US/2007/022621WO/2008/057239
)2009.01 (A61K19805012/10/2007
7CXCRANTIBODIESื ืืืื ืื ืืงืืฉืจืื ืืคืืืืค ืฉื THAT BIND CXCR7EPITOPESCHEMOCENTRYX, INC.
18/10/200660/852745US10/10/200711/869883US
PCT/US/2007/021927WO/2008/048519
![Page 250: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/250.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 250
)2009.01 (H04Q19805119/12/1997
ืฉืืื ืืืชืงื ืืืืฆืืข ืืกืืจื ืงืฉืืื ืจืืืช ืชืงืฉืืจืชืืกืืืืขืช ื ืืืืืช ืืื ืืข
METHOD AND APPARATUS FORPERFORMING MOBILE ASSISTEDHARD HANDOFF BETWEENCOMMUNICATION SYSTEMSQUALCOMM INCORPORATED
15/01/199708/784280USPCT/US/1997/236450WO/1998/032262
)2009.01 (B23C19805207/04/2009
CUTTINGืืฉืืื ืืืื ืืืชืื ืขืืืจ INSERT AND CUTTINGTOOL THEREFOR
ISCARื"ืืฉืงืจ ืืข LTD.
)2009.01 (B23B19805307/04/2009
CUTTING ืืื ืืืชืื ืืฉืืื ืขืืืจื TOOL AND CUTTINGINSERT THEREFOR
ISCARื"ืืฉืงืจ ืืข LTD.
)2009.01 (G06F19805405/12/2007
ืช ืขื ืฆืืจืืฃ ืฉื ืืืืืช ืืขืืืืช ืืืืืกืก ืจืฉืช ืชืงืฉืืจืช
WEB-BASED COLLOCATION ERRORPROOFING
MICROSOFT CORPORATION05/12/200611/633788US
PCT/US/2007/086560WO/2008/070750
![Page 251: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/251.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009251
)2009.01 (G06F19805507/12/2007
OPERATING ืืคืขืืช ืืืฉืงื ืืืข ืืืกื TOUCH SCREENINTERFACESMICROSOFT CORPORATION
07/12/200611/635730USPCT/US/2007/086707WO/2008/070815
)2009.01 (G06Q19805606/12/2007
PATIENT ื ืืืืจ ืืืื ืืืืฆืขืืช ืงืืืช ืชืืื ื MONITORING VIA IMAGECAPTUREMICROSOFT CORPORATION
06/12/200611/567455USPCT/US/2007/086596WO/2008/070759
)2009.01 (G06F19805706/12/2007
ืืกืืจืืืืืช ืืืงืืจืช ืืืืชืื ืคืืืขืืืืช ืื ืืจืืืช ืืจืืืฉืช ืืืชืื ืืืืฆื
STRATEGIES FOR INVESTIGATINGAND MITIGATINGVULNERABILITIES CAUSED BY THEACQUISITION OF CREDENTIALSMICROSOFT CORPORATION
07/12/200611/608126USPCT/US/2007/086694WO/2008/070805
)2009.01 (G06F19805827/11/2007
ืืฆืจืช ืงืื ืืืืฆืืข ืืืชืืืช ืืขืืช ืืืื ืืช ืคืืืชื
COMPILING EXECUTABLE CODEINTO A LESS-TRUSTED ADDRESSSPACEMICROSOFT CORPORATION
28/11/200611/564249USPCT/US/2007/085664WO/2008/067329
![Page 252: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/252.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 252
)2009.01 (C07D19805912/10/2007
AMINOCARBONYL-PYRIDINE-2 ืืืื ื ืงืจืืื ืื ืคืืจืืืืโ2ืชืืืืืชDERIVATIVESACTELION PHARMACEUTICALS LTD.
13/10/2006PCT/IB06/053773WO17/10/2006PCT/IB06/053817WO
PCT/IB/2007/054155WO/2008/044217
)2009.01 (G06K19806010/10/2007
ืฉืืื ืืืืฆืืจ ื ืฉื ืืืืื ืื ืืคืชืืืืงืืจืื ื ืขืืืจ ืื ืขืืืื ืขืืืจ ืื ืขืืืื
ืืืืคืขืืื ืืืงืืจืื ืืช
METHOD FOR THE PRODUCTION OFAN IDENTIFICATION CARRIER ORELECTRONIC KEY FORELECTRONICALLY ACTUATEDLOCKSEVVA-WERK SPEZIALERZEUGUNGVON ZYLINDER-UNDSICHERHEITSSCHLOSSERNGESELLSCHAFT M.B.H. & CO. KG
11/10/2006A1694/2006ATPCT/AT/2007/000474WO/2008/043117
)2009.01 (C07K19806118/10/2007
โืA17โILืืืืงืืืืช ื ืืืื ืื ืืงืืฉืจืืชF17โIL
ANTIBODY MOLECULES WHICEBIND IL-17A AND IL-17FUCB PHARMA S.A.
18/10/20060620729.4GBPCT/GB/2007/003983WO/2008/047134
![Page 253: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/253.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009253
)2009.01 (G06F19806210/10/2007
IMPROVEMENTS ืฉืืคืืจืื ืืงืฉืืจืื ืืืืืื ืชืื ืืืช RELATING TO THEDETECTION OF PATTERNSTHE QUEEN'S UNIVERSITY OFBELFAST
10/10/20060620043.0GBPCT/GB/2007/003833WO/2008/044004
)2009.01 (E21B19806319/10/2007
ืืืืื ืฉืืืช ืืืื ืืืืืื ืคืืืืื ืื ืืชืืืื ืฉืื ืงืืื
HEATING HYDROCARBONCONTAINING FORMATIONS IN ALINE DRIVE STAGED PROCESSSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.
20/10/200660/853096US20/04/200760/925685US
PCT/US/2007/081905WO/2008/051831
)2009.01 (E21B19806419/10/2007
ืืืืื ืฉืืืช ืืืื ืืืืืื ืคืืืืื ืื ืืชืืืื ืฉืืื ืืขื ืฆืืจืช ืืื ืฉืืื
HEATING HYDROCARBONCONTAINING FORMATIONS IN ACHECKERBOARD PATTERN STAGEDPROCESSSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.
20/10/200660/853096US20/04/200760/925685US
PCT/US/2007/081910WO/2008/051833
![Page 254: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/254.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 254
)2009.01 (E21B19806519/10/2007
ืืช ืืืื ืืืืืื ืคืืืืื ืื ืืืืื ืฉื ืืชืืืื ืฉืืื ืกืืืืื
HEATING HYDROCARBONCONTAINING FORMATIONS IN ASPIRAL STARTUP STAGEDSEQUENCESHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.
20/10/200660/853096US20/04/200760/925685US
PCT/US/2007/081915WO/2008/051834
)2009.01 (E21B19806619/10/2007
ืชืืืื ืืืคืื ืืื ืคื ืืื ืืืฉืชืืฉ ืืืขืจืืช ืืืืื ืืืกืืื ืกืืืจ
IN SITU HEAT TREATMENT PROCESSUTILIZING A CLOSED LOOPHEATING SYSTEMSHELL INTERNATIONALERESEARCH MAATSCHAPPIJ B.V.
20/10/200660/853096US20/04/200760/925685US
PCT/US/2007/081918WO/2008/051836
)2009.01 (G06F19806807/04/2009
IMPROVED ืฉืืืืช ืืฉืืคืจืืช ืืืื ืกืช ื ืชืื ืื DATA ENTRY SYSTEMSBENJAMIN ืื ืืืื ืคืืจืื ืืกืืืื FIROOZ GHASSABIAM
)2009.01 (C07H19807025/10/2007
NOVEL ืืืฉืืช ืืฉืืืืฉืsiRNAืืืืงืืืืช siRNAS AND METHODS OFUSE THEREOFQUARK PHARMACEUTICALS, INC.
25/10/200660/854503US15/05/200760/930493US
PCT/IL/2007/001278WO/2008/050329
![Page 255: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/255.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009255
)2009.01 (C07D19807210/10/2007
ืชืืืืืช ืคืืจืืืื ืื ืืืชืืจืืช ืืฉืืืืฉ ืืชืจืืคื
SUBSTITUTED PYRAZINONEDERIVATIVES FOR USE AS AMEDICINEJANSSEN PHARMACEUTICA, N.V.
12/10/200606122173.5EPPCT/EP/2007/060748WO/2008/043775
)2009.01 (C07D19807316/10/2007
ืชืจืืืืืช ืืืจืืืืืจืืคืืจืืืืคืืจืืืืK+ืืืชืืจืืช ืืขืืืช ืืืงื ืืขืจืืฅ 2/3
KCNQืืฉืืืืฉื ืืชืจืืคื
SUBSTITUTEDTETRAHYDROPYRROLOPYRAZINECOMPOUNDS HAVING AFFINITY WITHTHE KCNQ2/3 K+ CHANNEL AND USETHEREOF IN MEDICAMENTSGRUNENTHAL GMBH
17/10/2006102006049452.0DEPCT/EP/2007/008957WO/2008/046582
)2009.01 (C12N19807412/12/2003
IL-21 ืืชืืื ืคืจืืืืงืืืILโ21ืืืฆืืจ ืฉื PRODUCTION INPROKARYOTIC HOSTSZYMOGENETICS INC.
13/12/200260/433448US13/12/200260/433452US
PCT/US/2003/039764WO/2004/055168
)2009.01 (C07K19807528/09/2007
ื ืฉืืืืจืื ืืขืื ืืืืจืื ืคืขืืื ืฉืื ืชืืื ืืช ืืฉืืคืจืืช
RECONSTITUTED SURFACTANTSHAVING IMPROVED PROPERTIES
CHIESI FARMACEUTICI S.P.A.13/10/200606021521.7EP
PCT/IB/2007/002841WO/2008/044109
![Page 256: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/256.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 256
)2009.01 (C12N19807610/10/2000
ื CTSโืcPPTโืืงืืืจ ืืืืืื ืืืืื ืืืืจืืฉื ืจืืจืืืจืืก ืืจืฆืฃ ืืืืฆืชcisื ืืคืืข
ืืจืขืื ืืืจืืืืื
AN HIV - 1 EXPRESSION VECTORCOMPRISING THE cPPT AND CTS cis-ACTING REGIONS OF ARETROVIRUS AND AHETEROLOGOUS NUCLEIC ACIDSEQUENCEINSTITUT PASTEUR
12/10/199960/158387USPCT/EP/2000/010418WO/2001/027304
)2009.01 (A63F19807715/10/2006
METHOD ืฉืืื ืืืชืงื ืืืฉืืง ืืงืืื ืืืกืืคืื AND APPARATUS FORONLINE GAMING ON TERMINALSVIDEOB HOLDINGS LIMITED
PCT/IB/2006/053781WO/2008/047176
)2009.01 (B01D19807819/12/2007
ืืฆืืจ ืื ืจืืื ืืคืืื ืฉืืืืช ืืืขืจืืืช ืื ืืืฆื ืโืื
METHODS AND SYSTEM FORPRODUCING ENERGY FROMCARBON DIOXIDE
ืืข'ืื ื ืืืจื,ื"ืื ืืืืืื ืืืงืจ ืืคืืชืื ืืฉืจืืืืช ืืืืืจ ืืชืขืฉืื ืืืจืืื
ENGINEUITY RESEARCH &DEVELOPMENT LTD
25/10/200660/862827US13/07/200711/818967US
PCT/IL/2007/001576WO/2008/050350
![Page 257: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/257.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009257
)2009.01 (C07K19807918/10/2007
ืืืฉืืืืฉ3NOTCHโื ืืืื ื ืืืื ืืกื ืื ืืื โืืื ืืืืคืื ืืืืืืช ืืงืฉืืจืืช
3NOTCH
ANTI-NOTCH3 AGONISTANTIBODIES AND THEIR USE IN THETREATMENT OF NOTCH3-RELATEDDISEASESGENENTECH, INC.
19/10/200660/852861US06/01/200760/879218US
PCT/US/2007/081797WO/2008/051797
)2009.01 (C07D19808019/10/2007
THETAโPKCPURINESืคืืจืื ืื ืืืขืืื AS PKC-THETAINHIBITORSPHARMACOPEIA, LLC
20/10/200660/853396USPCT/US/2007/081899WO/2008/051826
)2009.01 (C07D19808119/10/2007
ืชืจืืืืืช ืคื ืื ืืืจืืื ืืืขืืื ืืคืืงืกืื ืืืืจืืืื ืืกืืกืื
PHENYLUREA COMPOUNDS ASSOLUBLE EPOXIDE HYDROLASEINHIBITORSARETE THERAPEUTICS, INC.
20/10/200660/853226US13/03/200760/894639US
PCT/US/2007/082009WO/2008/051873
![Page 258: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/258.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 258
)2009.01 (C07D19808219/10/2007
โืชืืืืืช ืคืืจืืืื ืืืขืืื ืงืื ืื ืืืืPOLOืืืฉืืฉืื ืืืืคืื ืืกืจืื
PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFULIN THE TREATMENT OF CANCERCHROMA THERAPEUTICS LTD.
25/10/20060621205.4GB10/08/20070715614.4GB
PCT/GB/2007/003998WO/2008/050096
)2009.01 (B01D19808328/08/2007
FLUID ืืชืงื ืื ืืืืจ ืคืืืืจ ื ืืืืื FILTER MONITORING DEVICEH2Q WATER INDUSTRIES LTDH2Q WATER INDUSTRIES LTD.
08/10/200660/828643US04/12/200660/872489US
PCT/IL/2007/001065WO/2008/044230
)2009.01 (A61K19808406/11/2007
ืฉืืืืช ืืืงืจืช ืืืืืช ืขืืืจ ืืืืืกืืืช ืืืื ืืืืืืืช ืกืงืืืืโืฉืื
QUALITY CONTROL METHODS FOROIL-IN-WATER EMULSIONSCONTAINING SQUALENENOVARTIS AG
08/11/20060622282.2GBPCT/IB/2007/004229WO/2008/056263
)2009.01 (A63B19808510/10/2007
INDIVIDUAL ืืชืงื ืืืืืื ืืืคื ื PHYSICAL TRAININGDEVICE
AMIT ืขืืืช ืืฉืจืืื ISRAELI10/10/200660/850292US
PCT/IL/2007/001224WO/2008/044238
![Page 259: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/259.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009259
)2009.01 (C07H19808605/10/2007
ืืื ืช ื ืืงืืืืืืืืื ืจืืืืคืืจืื ืืืื ืคืืจืืืืืื ืื
PREPARATION OF NUCLEOSIDESRIBOFURANOSYL PYRIMIDINES
PHARMASSET, INC.10/10/200660/850962US
PCT/US/2007/021548WO/2008/045419
)2009.01 (A61K19808709/10/2007
METHODS ืืช ืืืฉืืชืช ืืืจืืกืืืฉืื OF INACTIVATINGVIRUSESRUDYARD LYLE ISTVAN
10/10/200660/851028USPCT/US/2007/080788WO/2008/045860
)2009.01 (A61K19808815/10/2007
ืชืจืืืืืช ืืืจืืฆืืงืืืืช ืืขืืช ืืื ืืกืคืฆืืคื ืืืขืืืช ืืคืืืืฆืื ืฉื ืืชื
ื ื ืืืืช ืืืืืื,ืืืืืืืืืื ืื ืืขืืืช ืืืื ื ื ืืืจืื ืืช
ANTIDEPRESSANT,NEUROPROTECTANT, AMYLOIDBETA DEPOSITION INHIBITOR ORAGE RETARDANT CONTAININGHETEROCYCLIC COMPOUNDHAVING SPECIFIC STRUCTUREZENYAKU KOGYOKABUSHIKIKAISHA
13/10/20062006-280768
JP
PCT/JP/2007/070963WO/2008/047952
![Page 260: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/260.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 260
)2009.01 (A61K19808915/10/2007
ืืขืื ืืชืงืืืืช ืฉื ืืืืช ืืืืฆืืืืืจืืืืื ืชืจืืืืช ืืืจืืฆืืงืืืช ืืขืืช ืืื ื
ืกืคืืฆืืคื
AN ALZHEIMER'S DISEASEPROGRESSION INHIBITORCONTAINING HETEROCYCLICCOMPOUND HAVING SPECIFICSTRUCTUREZENYAKU KOGYOKABUSHIKIKAISHA
13/10/20062006-280768
JP
PCT/JP/2007/070962WO/2008/047951
)2009.01 (A61M19809012/10/2007
ืืืืจืจ ืขืืืจ ืชืืืื ืืืืจื ืืชื ืื ืืืื ื ืฉืืืชืืช
VENTILATOR FOR RAPID RESPONSETO RESPIRATORY DISEASECONDITIONSSPACELABS HEALTHCARE, LLC
13/10/200660/829502USPCT/US/2007/081198WO/2008/048876
)2009.01 (H01M19809130/10/2007
ืงืืืคืืงืกืื ืฉื ืืืงืกืืืื ืืืืืคืืื ืขื ืคืืื ืืฉืืื ืืืื ืชื
CARBONATED COMPLEX OXIDESAND METHOD FOR MAKING THESAMEUNIVERSITE DE MONTREAL
30/10/20062566906CAPCT/FR/2007/001803WO/2008/062111
![Page 261: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/261.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009261
)2009.01 (C07D19809212/10/2007
โ6,3[โ5โืืืืจืโ2ืฆืืจื ืืืืฉืืช ืฉืโ4โืืืืืงืกืโ6,2โืืชืืโ3โืืืืืืจื
โ1โ)ืืจืืคืืืืืจืืืชืื()2H(ืคืืืืืจืโ4โ]ืคืืจืืืืืื ืืโNโโืืชืืโ1(โืืชืื[[
ืื ืืืืื]ืกืืืคืื ืื]ืืืื ื)ืืชืื
CRYSTALLINE FORM OF 2-CHLORO-5-[3,6-DIHYDRO-3-METHYL-2,6-DIOXO-4-(TRIFLUOROMETHYL)-1-(2H)-PYRIMIDINYL]-4-FLUORO-N-[[METHYL-(1-METHYL)ETHYL)AMINO]SULPHONYL]BENZAMIDE
BASF SE13/10/200606122265.9EP
PCT/EP/2007/060879WO/2008/043835
)2009.01 (H04L19809329/10/2007
CDMโFDMืฉืืื ืืืชืงื ืขืืืจ ืืื ืืืืืจืืื ืขืืืจ ืขืจืืฆื ืืงืจื ืืืืกืกื ื ืืฉื
ืืืื
METHOD AND APPARATUS FORHYBRID FDM-CDM STRUCTURE FORSINGLE CARRIER BASED CONTROLCHANNELSQUALCOMM INCORPORATED
01/11/200660/863955USPCT/US/2007/082881WO/2008/057836
)2009.01 (H04B19809431/10/2007
ืขืืฆืื ืกืืื ืืืืืก ืขืืืจ ืืงืืจืช ืชื ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช ืืืจืชืืืื ืืืช
REFERENCE SIGNAL DESIGN FORCELL SEARCH IN AN ORTHOGONALWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED
01/11/200660/863965USPCT/US/2007/083267WO/2008/057899
![Page 262: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/262.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 262
)2009.01 (A63F19809529/06/2003
INTERACTIVE ืืฉืืง ืืื ืขืจืืฆื ืืื ืืจืืงืืืื INTER-CHANNELGAMENDS LIMITED
PCT/IL/2003/000543WO/2005/002697
)2009.01 (G06F19809609/11/2006
ืฉืืืืฉ ืืืืืื ืฉื ืืจืืืกืื ืืืืื ืืช ืืืฉื ืืืืืืชืืืขืจื
REMOTE ADMINISTRATION OFSMART CARDS FOR SECURE ACCESSSYSTEMNDS LIMITED
)2009.01 (H04L19809718/10/2007
ืืฉืืขื ืืืืจืช, ืฉืืืืช ืืืขืจืืืช ืืืงืืืืืืืคืืฉ ืืืืข ืฉื ืคืจืืืืงืื, ืืืื ืืืช
ืฉืืืช ืืฆืื
METHODS AND SYSTEMS FORRECORDING AND REAL-TIMEPLAYBACK AND SEEKING OF APRESENTATION LAYER PROTOCOLDATA STREAMCITRIX SYSTEMS INC.
20/10/200660/862349US01/11/200611/555611US01/11/200611/555615US
PCT/US/2007/081751WO/2008/055005
)2009.01 (A01G19810109/10/2007
ื PORTABLE ืืืืช ืืืงืจืช ืืงืืืืืขืจืืช CLIMATE CONTROLSYSTEM
BABYื"ืืืืื ืงืืืคืืจื ืืข COMFORT LTD10/10/200660/850293US
PCT/IL/2007/001218WO/2008/044234
![Page 263: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/263.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009263
)2009.01 (A61K19810222/03/2004
ืืืืฆืืจILโ21ืฉืืืืฉ ืคืืืืคืคืืื ืฉืืื,10โืชืจืืคื ืืกืืจ ืืืกืจ ืืืื ืืจืืืงืื
ืืืื ืืงืฉืืจื ืืืืชื ืืืกืจ ืืืื ืง
USE OF AN IL-21 POLYPEPTIDE INTHE MANUFACTURE OF AMEDICAMENT FOR MODULATINGAN IL-10 DEFICIENCY, OR ADISORDER ASSOCIATEDTHEREWITH IN A MAMMALWYETH
21/03/200360/456920USPCT/US/2004/008833WO/2004/084835
)2009.01 (F16L19810307/04/2009
ืืื ืืชโืื ืื ืื ืืฉืืื ืืฉืืจืืจ ืื ืขืืื ืื ืฉื ืื ืื ืื ืืื ืข ืื ืืคืจืงืื ืจืืื
METHOD AND SYSTEM FORSIMULTANEOUS LOCKING ANDUNLOCKING OF MECHANISMCOMPRISING A PLURALITY OFJOINTS
MORDEHAI ืืจืืื ืฉืืื SHOLEV
)2009.01 (G09G19810414/05/2007
AUTONOMOUS ืืชื ืืืืืืช ืืืืื ืืืืืช ืืจืื ืืจืืืง BEHAVIROS FOR AREMOTE VEHICLEIROBOT CORPORATION
06/10/200660/828632US13/04/200760/911785US24/04/200711/739590US
PCT/US/2007/068890WO/2008/060689
)2009.01 (B65D19810507/04/2009
ืืขืจืืช ืืืืฆืขื ืืืืืงื ืืคืงืื ืขื ืืืืช ืืืืคืจืืืจืช ื ืืื ืืืืื
SYSTEM AND MEANS FORCONTROLLING AND CHECKING THETEMPERATURE AND QUANITY OFLIQUID IN A CONTAINER
,GROFF ื ืืจ ืืจืืฃ NIR
![Page 264: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/264.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 264
)2009.01 (B03C19810611/10/2007
ืืืจื ืืชืงื ืืฉืืื ืืืคืจืืช ืืืืจ ืืืงืืงื ืื
DEVICE AND METHOD FORSEPARATING PARTICULATEMATERIAL FROM A GAS FLOWVIRUS FREE AIR B.V.
11/10/20061032666NLPCT/NL/2007/000259WO/2008/044922
)2009.01 (G09B19810808/11/2007
ืฉืืื ืืืืืืช ืืืฉื ืืืขืืจืช ืคืจืกืืืืช ืืืืืืืฉืชืืฉืื ืฉื ืืชืงื ืื ื ื
METHOD AND COMPUTERPROGRAM PRODUCT FORPROVIDING ADVERTISEMENTS TO AMOBILE USER DEVICE
MEDIAื"ืืืื ืืืืจืก ืืข LAYERS LTD10/11/200660/865200US25/12/200660/871834US
PCT/IL/2007/001362WO/2008/056358
)2009.01 (A47L19811005/10/2007
VACUUM ืืขืจืืช ืืคืจืื ืื ืืงืื ืฆืื ืืจ ืฉืืื ืืืง LINE CLEAN-OUTSEPARATOR SYSTEMTBW INDUSTRIES, INC.
07/10/200660/849896USPCT/US/2007/021371WO/2008/042444
)2009.01 (G06G19811119/10/2007
ืฉืืื ืืืชืงื ืืืืฆืืข ืืืืืื ืฉื ืืจืฉืช ืขืืจืงืื
METHOD AND APPARATUS FORMODELING ATHEROSCLEROSIS
ENTELOS, INC.19/10/200660/853280US
PCT/US/2007/082024WO/2008/049125
![Page 265: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/265.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009265
)2009.01 (C07D19811227/09/2007
โA[ืืืื ืืืืืืืืืโ3ื ืืืจืืช ืฉืืฉื]1,2 โ1ืคืืจืืืื ืขื ืคืขืืืืช ืืืืื
SGLT2โืโSGLTืืืืคืื ืืกืืืจืช ืืกืื2ืืกืื1
3-AMINOIMIDAZO [1,2-A]PYRIDINEDERIVATIVES HAVING AN SGLT1-ANDSGLT2-INHIBITING ACTION FOR THETREATMENT OF TYPE 1 AND TYPE 2DIABETESMERCK PATENT GMBH
16/10/2006102006048728.1DEPCT/EP/2007/008424WO/2008/046497
)2009.01 (C12M19811310/10/2007
REDUCING ืืคืืชืช ืืคืจืขื ืืืคืืืช ืืืชืงื ืื ืืืืื OPTICAL INTERFERENCEIN A FLUIDIC DEVICETHERANOS, INC.
13/10/200611/549558US13/03/200711/685615US
PCT/US/2007/080917WO/2008/063770
)2009.01 (A01N19811405/10/2007
ืฉื ืงืจืืกืื โS)โ(+)โ2โ(2(ืืืฉ ืงืจืืืโืืชืืโืืืืจืืงืกืโ2โ)ืืืืจืืคื ืื
NOVEL CRYSTAL OF (S)-(+)-2-(2-CHLOROPHENYL)-2-HYDROXY-ETHYL CARBAMATEJANSSEN PHARMACEUTICA, N.V.
10/10/200660/828785USPCT/US/2007/021423WO/2008/063284
![Page 266: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/266.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 266
)2009.01 (C07D19811518/10/2007
ืืจืืืื ืฉืืื, ืชืจืืืืืช ืืืจืืืจืืืืืช ืืฉืืืืฉ ืืื ืืืขืืื ืคืจืืืืื ืงืื ืื
HETEROARYL COMPOUNDS,COMPOSITIONS THEREOF, ANDTHEIR USE AS PROTEIN KINASEINHIBITORSSIGNAL PHARMACEUTICALS, LLC
19/10/200660/853166USPCT/US/2007/022374WO/2008/051493
)2009.01 (C07D19811618/10/2007
ืืจืืืื ืฉืืื, ืชืจืืืืืช ืืืจืืืจืืืืืช ืืฉืืืืฉ ืืื ืืืขืืื ืคืจืืืืื ืงืื ืื
HETEROARYL COMPOUNDS,COMPOSITIONS THEREOF, AND USETHEREOF AS PROTEIN KINASEINHIBITORSSIGNAL PHARMACEUTICALS, LLC
19/10/200660/853135USPCT/US/2007/022375WO/2008/051494
)2009.01 (C07D19811701/11/2007
โืืืงืกืโ5โืชืืืื ืืืื ืช ื ืืืจืืช ืืื ืืื ืงืืืื ืืืืืื ืืืืืจื ืืื ืืื
PROCESS FOR PREPARING INDOL-5-OXY-QUINAZOLINE DERIVATIVESAND INTERMEDIATESASTRAZENECA AB
02/11/200660/864036US22/08/200760/957401US
PCT/GB/2007/004176WO/2008/053221
)2009.01 (H01R19811807/04/2009
MULTIPLE ืฉืงืข ืืฉืืื ืืืจืืโืจื ELECTRICAL SOCKETASSEMBLY
YOAV ืืืื ืจืืื ืืจื ROTTENBERG
![Page 267: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/267.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009267
)2009.01 (A01N19811921/12/2007
ืืืืืื ืืจืื ืืืืืจ ืืืืงืื ืืืืื ืคื ืืชืจืืืืช ืืืืืจืช ืืจืงืื
PESTICIDAL COMPOSITIONCOMPRISING FENAMIDONE AND ANINSECTICIDE COMPOUNDBAYER CROPSCIENCE AG
22/12/200606127142.5EPPCT/EP/2007/064421WO/2008/077922
)2009.01 (C12N19812009/10/2007
ื ืืกืืืก ืืืื ืืื ืฉื ืคืืืืคืคืืื ืืืืคื ืืฉืืืืช ืืฉืืืืฉ ืืื
POLYPEPTIDE LIGANDS FORTARGETING CARTILAGE ANDMETHODS OF USE THEREOFECOLE POLYTECHNIQUE FEDERALEDE LAUSANNE
10/10/200611/545819USPCT/US/2007/021529WO/2008/063291
)2009.01 (A63B19812107/04/2009
PROTECTING ืืกืคืืจื ืืืืืืืคืคืช ืืื ื GLOVE FOR FIGHTINGSPORTS
ELDAN ืืืื ืงืจ KER
)2009.01 (C07D19812222/04/2003
ื ืืืจืืช ืืจืืืืืืื ืืื ืืืื ืืกืืื ืฉื ืงืืืื ืฉื ืืืงืืงืื ืื
TRIAZOLE DERIVATIVES ASTACHYKININ RECEPTORANTAGONISTSELI LILLY & CO.
26/04/200260/376,121USPCT/US/2003/010681WO/2003/091226
![Page 268: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/268.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 268
)2009.01 (F27B19812307/04/2009
A ืชื ืืจ ืืืืคืื ืืืื ืขื ืืืืื ืืื ืืืงืืืื HEAT TREATMENT OVEN WITHINDUCTIVE HEATINGSNECMA PROPULSION SOLIDE
18/04/20080852641FR
)2009.01 (F24F19812516/04/2009
AIR ืืขืจืืช ืืืืื ืืืืจ CONDITIONING SYSTEMLAMOS INC.
)2009.01 (C22B19812616/04/2009
DUCTILE ืกืืกืืืช ืืื ืืืื ืจืงืืข MAGNESIUM ALLOYGKSS-FORSCHUNGSZENTRUMGEESTHACHT GMBH
23/04/2008102008020523.0DE
)2009.01 (C07K19812708/11/2007
)GLPโ2(2โืคืคืืืโืฉืืืโืืืื ืืืืงืืืืื ืกืืงืืืืืื
SELECTIVE GLUCAGON-LIKE-PEPTIDE-2 (GLP-2)ANALOGUES
ZEALAND PHARMA A/S08/11/2006PA2006.01456DK15/11/200660/859313US
PCT/GB/2007/004273WO/2008/056155
)2009.01 (A63B19812816/04/2009
ืช ืืืืืืช ื ืชืื ืื ืืืืฉืืจ ืืืืืื ืืขืจื ืืื
A SYSTEM FOR MEASUREMENTDATA IN GYM EQUIPMENT
ROM ืจืื ืืืื ืืจื EUSENBERG
![Page 269: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/269.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009269
)2009.01 (B05D19812916/04/2009
A ืืืจืฉืช ืืืจืืื ืืืชืืืช ืืฉืคืืคืจืช ืงืจื SPREADING BRUSH SUITABLEFOR TUBE OF CREAM
ILANA ืืืื ื ืืืืื MALIHI
)2009.01 (A61K19813102/04/2001
KBNUCLEARืคืงืืืจ ืืฉืจื ืคืงืืืจ ืืจืขืื FACTOR KB INDUCINGFACTORAVENTIS PHARMACEUTICALS INC.
31/03/200060/193905US26/07/20000018307.9GB
PCT/US/2001/010719WO/2001/074900
)2009.01 (C07K19813202/04/2001
KBNUCLEARืคืงืืืจ ืืฉืจื ืคืงืืืจ ืืจืขืื FACTOR KB INDUCINGFACTORAVENTIS PHARMACEUTICALS INC.
31/03/200060/193905US26/07/20000018307.9GB
PCT/US/2001/010719WO/2001/074900
)2009.01 (A61K19813312/10/2007
ืืืืฆื ืฉื ืื ืื, ืืืืฆื ืฆืื ืืืชืืืจืืช ืฉื ืื ืืืคืืจื ืืฉืืืืฉ ืืืืคืื ืื
ืืืืงืช ืืกืจืื
CINNAMIC ACID, VANILLIC ACID ANDBENZOFURAN DERIVATIVES FOR USEIN THE TREATMENT OFINFLAMMATION AND CANCERRELIANCE LIFE SCIENCES PVT. LTD.
13/10/20061696/MUM/2006INPCT/IN/2007/000488WO/2008/062466
![Page 270: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/270.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 270
)2009.01 (A61K19813418/10/2007
ืฉืืืื ืฉื ืชืจืืคืืช ืื ืืืคืกืืืืืืืชืืืืจืืฆืืงืืื ืื ืืืืคืื ืืืืืืช
ืคืกืืืืืืจืืืช
COMBINED THERAPIES OFANTIPSYCHOTIC DRUGS ANDTETRACYCLINES IN THE TREATMENT OFPSYCHIATRIC DISORDERS
MORื"ืืืจ ืืืงืจืื ืืืฉืืืืื ืืข RESEARCH APPLICATIONS LTD.19/10/200660/852646US29/03/2007PCT/IL2007/000414IL
PCT/IL/2007/001251WO/2008/047365
)2009.01 (A47D19813516/04/2009
SHABAT ื ืจืืช ืืฉืื ืืฉืืช ELECTRICAL CANDLESNISIM ื ืืกืื ืืืื OUZAN
)2009.01 (A47J19813627/07/2007
METHOD ืฉืืื ืืืขืืจืช ืืื ืืืชืงื ืขืืืจ ืื FOR HEAT TRANSFER ANDDEVICE THEREFORJEONG HYUN LEE
11/10/2006200607076-7
SG
PCT/KR/2007/003622WO/2008/044823
)2009.01 (A23L19813710/10/2007
KETOGENIC ืืืืื ืงืืืื ืืช DIETN.V. NUTRICIA
17/10/200611/581749USPCT/NL/2007/050491WO/2008/048094
![Page 271: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/271.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009271
)2009.01 (G06K19813816/10/2007
BIOMETRIC ืืขืจืืืช ืืืืืืจืืงื SYSTEMSืืข.ืงืื.ืื I.Q.Sื"ืืก ืฉืื SHALEV LTD
19/10/200611/583044USPCT/IL/2007/001240WO/2008/047356
)2009.01 (A47D19813923/10/2007
TOILET ืฉืืืคืช ืืกืื ืืื ืฉืืืืฉ ืืืืื ืืกืื FLUSHING WITHOUT USINGA TOILET TANK
BRAVERMAN-ABADI ืขืืืื ืขืืื MICHAL24/10/200660/862615US
PCT/IL/2007/001272WO/2008/050324
)2009.01 (A47D19814020/11/2007
FURNITURE ืกืืืจื ืืจืืืืื CLOSUREFRITZ HAKEMANN
28/11/2006PCT/EP2006/011428EPPCT/EP/2007/010038WO/2008/046666
)2009.01 (C07D19814222/10/2007
ืชืจืืืืืช ืื ืืืื ืืืื ื ืืืจืืฆืืงืืืืืฉืืืืฉืืืช ืืืืคืื ืฉื ืืืื ืืืชืืืืช
GLKืขื ืืื
BENZOYL AMINO HETEROCYCLYLCOMPOUNDS USEFUL IN THETREATMENT OF A DISEASEMEDIATED THROUGH GLKASTRAZENECA AB
23/10/200660/862493US28/02/200760/891993US
PCT/GB/2007/004018WO/2008/050101
![Page 272: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/272.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 272
)2009.01 (C07D19814325/10/2007
ืชืจืืืืืช ืื ืืืื ืืืื ื ืืืจืืฆืืงืืื)GLK(ื ืื ืืืฉืคืขืื ืืืืงืืงื
BENZOYL AMINO HETEROCYCLYLCOMPOUNDS AS GLUCOKINASE(GLK) ACTIVATORSASTRAZENECA AB
26/10/200660/863056US22/08/200760/957370US
PCT/GB/2007/004057WO/2008/050117
)2009.01 (A61K19814408/10/2007
PHENYLALKYL ืืจืืืื ืฉื ืคื ืืืืืงืื ืงืจืืืื CARBAMATECOMPOSITIONSJANSSEN PHARMACEUTICA, N.V.
13/10/200660/829355USPCT/US/2007/080677WO/2008/048802
)2009.01 (A61K19814508/10/2007
PHENYLALKYLAMINO ืืจืืืื ืฉื ืคื ืืืืืงืืืืืื ื ืงืจืืืื CARBAMATECOMPOSITIONSJANSSEN PHARMACEUTICA, N.V.
13/10/200660/829342USPCT/US/2007/080675WO/2008/048801
)2009.01 (A61L19814610/10/2007
ืชืืฉืืจืื ืืืชืงื ืื ืืืืจืืืื ืืกืืืืงืื ืืคืืืืคืืกืคืื ืื ืกืคืฆืืคืืื
COMPOSITIONS AND DEVICESCOMPRISING SILICONE ANDSPECIFIC POLYPHOSPHAZENESCELONOVA BIOSCIENCES, INC.
10/10/200660/828833USPCT/US/2007/080976WO/2008/045953
![Page 273: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/273.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009273
)2009.01 (A61K19814711/10/2007
ืืืงืกืืืืืื ืคืขืืโ4,2,1ืฉืืืืช ืืื ืื ืกื ืกโืืืชื ืคืืื ืืืืืื ืืืืฆืืืช ื ืื
METHODS FOR DOSING AN ORALLYACTIVE 1,2,4-OXADIAZOLE FORNONSENSE MUTATIONSUPPRESSION THERAPYPTC THERAPEUTICS, INC
12/10/200660/851450USPCT/US/2007/021921WO/2008/045566
)2009.01 (A61L19814810/10/2007
BIOPROSTHETIC ืฉืกืชืื ืื ืืืืคืจืืกืชืื ืขื ืคืืืืคืืกืคืื HEART VALVEWITH POLYPHOSPHAZENECELONOVA BIOSCIENCES, INC.
10/10/200660/828840USPCT/US/2007/080969WO/2008/045949
)2009.01 (C07D19814918/10/2007
NOVEL ืืขืืืื ืืืฉืื ืฉื ืงืืื INHIBITORS OF CHYMASEJANSSEN PHARMACEUTICA, N.V.
18/10/200660/852604USPCT/US/2007/022244WO/2008/048668
)2009.01 (C07D19815023/10/2007
4,2ื ืืืจืืช ืืืฆืืงืืืืช ืืืืืืช ืฉืCโMETโืALKืืืืืื ืืคืืจืืืืืื ืืืขืืื
FUSED BICYCLIC DERIVATIVES OF2,4-DIAMINOPYRIMIDINE AS ALKAND C-MET INHIBITORSCEPHALON, INC.
23/10/200660/853562USPCT/US/2007/022496WO/2008/051547
![Page 274: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/274.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 274
)2009.01 (H04Q19815131/10/2007
)UPLINK(ืืงืฉืช ืืฉืื ืขืจืืฅ ืขืืื ืืืืื
RELIABLE UPLINK RESOURCEREQUEST
QUALCOMM INCORPORATED31/10/200660/863794US
PCT/US/2007/083244WO/2008/055239
)2009.01 (H01L19815216/10/2007
ืืืืืืชโืืืจ ืืื ืคืจืโืืขืจืื ืืืืืืชืืืขืจืืืช ืืืืฉื ืื ืขื ืฉืืืช ืคืกืืืฆืื
ืืฉืืคืจืช ืืฉืืืืช ืฉื ืืืฆืืจ
INFRARED PHOTODIODES ANDSENSOR ARRYS WITH IMPROVEDPASSIVATION LAYERS ANDMETHODS OF MANUFACTURERAYTHEON COMPANY
17/10/200611/582937USPCT/US/2007/022003WO/2008/048555
)2009.01 (B01D19815310/10/2007
DESALINATION ืืขืจืืช ืืชืคืื SYSTEMTHE TEXAS A & M UNIVERSITYSYSTEM
10/10/200660/828882USPCT/US/2007/080954WO/2008/045943
)2009.01 (C07D19815418/10/2007
INDOLE ืชืจืืืืช ืืื ืืื COMPOUNDTAKEDA PHARMACEUTICALCOMPANY LIMITED
19/10/20062006-285551
JP
PCT/JP/2007/070772WO/2008/050821
![Page 275: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/275.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009275
)2009.01 (B65B19815516/04/2009
DOUBLE ืืจืืื ืขื ืืืืื ืืคืื SEAL PACKAGE
NAKNIKื"ื ืงื ืืง ื ืืจืื ืืฉืจ ืืืืืืืง ืืข HAHARIYA KASHER,SOGLOWEK LTD.
)2009.01 (C23C19815624/10/2007
METHOD ืฉืืื ืืืืืกืช ืืคืฆืื ื ืงืืืืืื OF DENSIFYING POROUSARTICLESMESSIER-BUGATTI
29/10/200660/863377USPCT/EP/2007/061429WO/2008/052923
)2009.01 (C07D19815722/10/2007
ืืืื ืฉื ืชืืืืืช ืืชืจ ืืืืืืืืจืื ืืคื 3Dโื A2HTโ5โืืงืืืื ืื
ETHER DERIVATIVES DUALMODULATORS OF THE 5-HT2A ANDD3 RECEPTORSF. HOFFMANN-LA ROCHE AG
31/10/200606123274.0EPPCT/EP/2007/061253WO/2008/052899
)2009.01 (H01S19815816/04/2009
ืืืืืืื ืืขืจืื ืืื ืืืืืจ ืืงืืจืจื ื ืืื ื ืืืฉืช ืืืืืจืื ืืชืืืืื/ืืจืืืช ืืืืื
LIQUID COOLED LASER BARARRAYS INCORPORATINGDIAMOND/COPPER EXPANSIONMATCHED MATERIALSLASERTEL, INC.
17/04/200812/105126US
![Page 276: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/276.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 276
)2009.01 (A61M19815925/10/2007
ืฉืืื ืืืืฆืืจ ืืฉืืืืฉ, ืืชืงื ืืคืืืืจ ืืืงืืืจืืืืื ืื ืืชื ืื ืืฉืืืืฉ ืืืชืงื, ืืชืงืื
ืืืืืฉืืจืื ืืืจืื
POWDER DISPERSION APPARATUS,METHOD OF MAKING AND BEUSING THE APPARATUS, ANDCOMPONENTS THAT CAN BE USEDON THE APPARATUS AND OTHERDEVICESNOVARTIS AG
25/10/200660/854601US13/03/200760/906977US
PCT/US/2007/022830WO/2008/051621
)2009.01 (A61K19816012/10/2007
PHARMACEUTICAL ืชืืฉืืจืื ืจืคืืืืื FORMULATIONSFOURNIER LABORATORIESIRELAND LTD
12/10/200660/829255USPCT/US/2007/081267WO/2008/046052
)2009.01 (A61K19816117/10/2007
DICLOFENACื ืืืืืืคื ื'ื GELNUVO RESEARCH
17/10/200660/829756USPCT/US/2007/081674WO/2008/049020
)2009.01 (H04M19816216/04/2009
ืืชืงื ืืืงืืจืื ื ืืฆืืจื ืฉื ืืขืจืืชื ืื ืืชืงื/ืืืคืื ืื ืืื ืฉืืืืฉ ืืื ื
ื ืืืื
ELECTRONIC DEVICE IN THE FORM OFA HANDS-FREE TELEPHONE SYSTEMAND/OR A NAVIGATION DEVICE
BURY SP. Z.O.O.22/04/2008102008020551.6DE
![Page 277: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/277.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009277
)2009.01 (G03B19816302/10/2005
GIMBAL ืืขืจืืช ืืืืื SYSTEMFLIR SYSTEMS, INC
01/10/200410/956738US01/10/200410/956739US
)2009.01 (H04N19816430/01/2003
ืืขืจืืช ืืงืืื ืืขืืืช ืฉืืข ืืืจืื ืืจืืืช ื ืงืืืืช ืืืืืจ
MULTIPOINT AUDIOVISUALCONFERENCING SYSTEM
LARRY E. ROHER30/01/200260/353053US
PCT/US/2003/002759WO/2003/065706
)2009.01 (A61N19816623/10/2007
ELECTROLYTIC ืืืงืืจืืืืกื ืืืืคืื ืืจืงืืืช ืืชืงื ื TISSUETREATMENT DEVICESECPOINT MEDICAL INC.
24/10/200660/853747USPCT/US/2007/082267WO/2008/051993
)2009.01 (G06F19816718/10/2007
METHOD ืฉืืื ืืืขืจืืช ืืืจืืืช ืชืืื AND SYSTEM FORCONTENT COMPOSITION
ืืข. ืืืืื .TABOOLAื"ืงืื COM LTD19/10/200660/852648US10/05/200760/924361US
PCT/IL/2007/001249WO/2008/047363
![Page 278: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/278.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 278
)2009.01 (A61K19816810/10/2006
ROBUST ืืจืืืื ืืฆืืืื ืืฉืืจืืจ ืืืืงืจ SUSTAINED RELEASEFORMULATIONSPENWEST PHARMACEUTICALSCOMPANY
PCT/US/2006/039923WO/2008/045060
)2009.01 (A61K19816910/10/2006
ืืจืืืื ืืฆืืืื ืืฉืืจืืจ ืืืืงืจ ืฉื ืืืงืกืืืืจืคืื
ROBUST SUSTAINED RELEASEFORMULATIONS OFOXYMORPHONEPENWEST PHARMACEUTICALSCOMPANY
PCT/US/2006/039767WO/2008/045046
)2009.01 (A61K19817010/10/2006
ืืจืื ืืฆืื ืืฉืืจืืจ ืืืืงืจ ืฉื ืืืงืกืืืืจืคืื ืืฉืืืืช ืืฉืืืืฉ ืื
ROBUST SUSTAINED RELEASEFORMULATIONS OFOXYMORPHONE AND METHODS OFUSE THEREOFPENWEST PHARMACEUTICALSCOMPANY
PCT/US/2006/039781WO/2008/045047
![Page 279: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/279.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009279
)2009.01 (C07D19817112/12/2007
ืชืืืืืช ืืืืืืจืืคืืจืืืื ืืืฉืืฉืืช ืืืขืืื ืคืจืืืืืื ืงืื ืื
DIHYDROPYRIDINE DERIVATIVESUSEFUL AS PROTEIN KINASEINHIBITORSBAYER SCHERING PHARMA AG
14/12/200660/875124USPCT/EP/2007/011076WO/2008/071451
)2009.01 (H04B19817209/01/2007
ืืขืจืืช ืืชืงืฉืืจืช ืืืคืืืช ืืืื ืืฉืืื ืืชืคืขืืื
SYSTEM FOR FREE SPACE OPTICALCOMMUNICATION AND METHODFOR METHOD FOR OPERATIONTHEREOF
OPTIGOื"ืืืชื ืืขืจืืืช ืืข SYSTEMS LTD07/11/2006179089IL
PCT/IL/2007/000023WO/2008/056347
)2009.01 (C07D19817311/08/2007
PEGืงืืืืืื ืืชืืชืืื ืืขืื ืงืืืฆืชืฉืืื ืืืฆืืจื, ืืืชืืจืช ืืืื ืืคืืืืืจ
ืืฉืืืืฉ ืืื
METAL CHELATES HAVING APERFLUORINATED PEG GROUP,METHOD FOR THE PRODUCTIONTHEREOF, AND USE THEREOFBAYER SCHERING PHARMA AG
18/10/2006102006049821.6DE20/10/200660/852963US15/02/200760/890071US
PCT/EP/2007/007284WO/2008/046463
![Page 280: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/280.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 280
)2009.01 (F16K19817419/10/2007
FLUID ืืขืจืืช ืฉืกืชืืืืช ืืืงืจืช ื ืืื ืืฉืืืืช CONTROL VALVA SYSTEMAND METHODSTYCO FIRE PRODUCTS LP
20/10/200660/862305US29/01/200760/887040US
PCT/US/2007/082006WO/2008/051871
)2009.01 (A61P19817518/10/2007
ืฉืืื ืืชืืฉืืจ ืจืืงืืืช ืืืืคืื ืืชืช ืคืืจืืืช ืืืืจืื
METHOD AND PHARAMCOLOGICALCOMPOSITION FOR THE DIAGNOSISAND TREATMENT OF MALE SUB-FERTILITY
PERINESSื"ืคืจืื ืก ืืข LTD18/10/200660/852402US
PCT/IL/2007/001250WO/2008/047364
)2009.01 (H04Q19817610/10/2007
ืฉืืื ืืืขืจืืช ืืฉืืืืช ืืฉืื ืขืืืจ ืฉืจืืชืืฉืืชืฃ ืืืืืืื ืืืจืฅ ืืืฉืืืจ ืืืกืคืจ
ื ืงืืืื/ืฉืืืืจืจื ืฉื ืืืืืืช ืืืืืืืืช
METHOD AND APPARATUS FORSENDING FEEDBACK FOR ADOWNLINK SHARED SERVICETRANSMITTED TO A PLURALITY OFWIRELESS TRANSMIT/RECEIVEUNITSINTERDIGITAL TECHNOLOGYCORPORATION
10/10/200660/828881US05/01/200760/883594US
PCT/US/2007/021642WO/2008/045471
![Page 281: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/281.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009281
)2009.01 (B67D19817710/10/2007
ืฉืืื ืืืชืงื ืื ืืคืืง ืื ืชื ืฉื ื ืืื ืืืื ืืืืจ ืืฉืืืืช ืืืฆืื
METHOD AND APPARATUS FORDOSED DISPENSING OF GASIFIEDLIQUID AFTER PRESSUREEQUALISATIONDISPENSING TECHNOLOGIES B.V.
10/10/20061032658NLPCT/NL/2007/000256WO/2008/044920
)2009.01 (C01B19817817/10/2007
HYDROGEN ืืืฆืืจ ืืืื ืืืืืฆื ืคืืจืืืช PRODUCTION FROMFORMIC ACIDECOLE POLYTECHNIQUE FEDERALELAUSANNE (EPFL)
18/10/200606122534.8EPPCT/IB/2007/054222WO/2008/047312
)2009.01 (A61N19817916/10/2007
OCULAR ื ืืชืื ืขืื ื ืืืืฆืขืืช ืงืจืื ื RADIOSURGERYORAYA THERAPEUTICS, INC.
16/10/200660/829676US18/10/200660/862044US19/10/200660/862210US13/12/200660/869872US09/04/200760/922741US 04/06/200760/933220US
PCT/US/2007/081569WO/2008/118198
![Page 282: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/282.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 282
)2009.01 (A01N19818016/10/2007
ืฉืโPืืื โ5ืืืืืื ืืืืฆื ืกืืืคืื ืืชโDโ?โืืืืงืกืโ'3โืืฆืืืโ0โ'2(โ3โืืืื ื
โ5,4[ืชืืืืืโ3Hโ)ืจืืืืคืืจืื ืืืืืD[ืืื ืืฉืืืืช ืืืฆืืจืโ2โืคืืจืืืืืื
P-TOLUENE SULFONIC ACID SALTOF 5-AMINO-3-(2'-O-ACETYL-3'-DEOXY-?-D-RIBOFURANOSYL-3H-THIAZOLE[4,5-D]PYRIMIDINE-2-ONEAND METHODS FOR PREPARATIONANADYS PHARMACEUTICALS, INC.
17/10/200660/852002US05/02/200760/899405US02/08/200760/953597US
PCT/US/2007/081526WO/2008/140549
)2009.01 (H01Q19818103/10/2007
RAPIDLY ืืขืจืืช ืื ืื ื ืื ืืชื ืช ืืคืจืืกื ืืืืืจืืช DEPLOYABLE ANTENNASYSTEMHARRIS CORPORATION
17/10/200611/550129USPCT/US/2007/080309WO/2008/115267
)2009.01 (A61K19818229/08/2007
โืฉืืืืฉ ืืฆืืืจืืืื ืืืืคืื ืืชื ืื ืชืช ืชืืื ื
USE OF CITRULLINE FOR TREATINGUNDERNUTRITION CONDITIONSUNIVERSITE RENE DESCARTES(PARIS V) OF
17/10/200606/09077FRPCT/FR/2007/001407WO/2008/049984
![Page 283: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/283.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009283
)2009.01 (A61K19818327/09/2007
ืชืืฉืืจืื ืืืจืืืื ืืืืคืื, ืฉืืืืช ืืืืืช ืขืื ืืื ืชืืจืืืืืืช
METHODS, COMPOSITIONS, ANDFORMULATIONS FOR THETREATMENT OF THYROID EYEDISEASELITHERA, INC.
17/10/200660/852221US29/01/200760/898009US20/03/200760/919011US
PCT/US/2007/079740WO/2008/048770
)2009.01 (A61K19818416/10/2007
ื ืจืงืื ืืืืืื ืชืื ืืจืืืื ืืืืคืืืกืืจืื ืืจืงืืโืจืงืื ืขืืจืืช ืืื, ืฉืืื
ืฉืจืืจืืช
FORMULATIONS FOR TREATMENTOF ADIPOSE TISSUE, CUTANEOUSTISSUE AND DISORDERS, ANDMUSCULAR TISSUELITHERA, INC.
17/10/200660/852221US29/01/200760/898009US20/03/200760/919011US
PCT/US/2007/081568WO/2008/067060
)2009.01 (G01N19818518/10/2007
ืืจื ืฆืืื ืืืจื ืืืขื ืื ืืืง ืืืจืื ืืืื ืืืฉืืืืช, ืืืืืกืก ืขื ืชืื ืืช ืืืื ื ืงืืืืืช
ืืืื ื ืืฉืืืืช ืืฉืืืืฉ
LATERAL FLOW AND FLOW-THROUGH BIOASSAY BASED ONPATTERNED POROUS MEDIA,METHODS OF MAKING SAME, ANDMETHODS OF USING SAMEPRESIDENT AND FELLOWS OFHARVARD COLLEGE
18/10/200660/852751US26/04/200760/914252US
PCT/US/2007/081848WO/2008/049083
![Page 284: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/284.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 284
)2009.01 (C07K19818616/10/2007
ืืืกืื ื ืคืคืืื ืืกืจืื ืื ืืืืืืื1DEPDCืื1MPHOSPHืคืืืืคืคืืืืื
PEPTIDE VACCINES FOR CANCERSEXPRESSING MPHOSPH1 OR DEPDC1POLYPEPTIDESONCOTHERAPY SCIENCE, INC.
17/10/200660/852575USPCT/JP/2007/001122WO/2008/047473
)2009.01 (C08L19818712/10/2007
ืชืืฉืืจ ืคืืืืืจื ืืืืื ืคืืืืืจ ืื ืืชื ืจืืคืืื
CURABLE FLUORINE-CONTAININGPOLYMER COMPOSITION
DOW CORNING CORPORATION
12/10/20062006-279147
JP
PCT/JP/2007/069941WO/2008/044765
)2009.01 (H01H19818818/10/2007
BIFURCATED ืืจืืื ืกืื ืืื ืืคืืืืื STENT ASSEMBLIESืืข.ืืื ืกืคืืืจ ืื INSPIREMDื"ืื LTD.
18/10/200660/852392US18/10/200611/582354US22/11/200660/860485US27/12/200660/877162US01/05/200711/797168US
PCT/IL/2007/001253WO/2008/047367
)2009.01 (B01D19818918/10/2007
FILTER ืืชืงื ื ืืกื ื ืื ASSEMBLIESืืข.ืืื ืกืคืืืจ ืื INSPIREMDื"ืื LTD.
18/10/200660/852392US18/10/200611/582354US
PCT/IL/2007/001254WO/2008/047368
![Page 285: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/285.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009285
)2009.01 (A61B19819018/10/2007
KNITTED ืขืืืคืืช ืกืื ืืื ืกืจืืืื STENT JACKETSืืข.ืืื ืกืคืืืจ ืื INSPIREMDื"ืื LTD.
18/10/200660/852392US22/11/200660/860485US27/12/200660/877162US
PCT/IL/2007/001255WO/2008/047369
)2009.01 (C07K19819124/10/2007
NEURONAL ืคืคืืืืื ืืขืืื ืืงืืืฆืืืืืืก ืื ืืืจืื ืื EXOCYTOSISINHIBITING PEPTIDESLIPOTEC S.A.
25/10/2006200602720ESPCT/ES/2007/000603WO/2008/049945
)2009.01 (G10L19819228/09/2007
ืืชืงื ืืฉืืื ืืขืืืื ื ืืกืฃ ืฉื ืขืจืืืืกืคืงืืจืืื ืืืงืื ืืคืขื ื ืขืืืจ ืืืชืืช
ืืืืื
DEVICE AND METHOD FORPOSTPROCESSING SPECTRAL VALUESAND ENCODER AND DECODER FORAUDIO SIGNALSFRAUNHOFER-GESELLSCHAFT ZURFORDERUNG DER ANGEWANDTENFORSCHUNG E.V.
02/11/2006102006051673.7DEPCT/EP/2007/008477WO/2008/052627
)2009.01 (B60S19819319/04/2009
CHASSIS ืฉืกื ืืขืืื ืื ืืจืื FOR CART OF VEHICLEYARON ืืืื ืื ืืื ืืืื LEVY
![Page 286: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/286.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 286
)2009.01 (B23K19819417/11/2001
ืฉืืื ืืืขืจืืช ืื ืืชืืจ ืืืงืจื ืืืื ืืืชืืืื ืืฉืงืข ืืฉืืืืฉ ืืืื ืืืืืืืช ืฆืืืื
ืืืืช ืืขืืืื ืืืืช ืืฆืคืื ืืืืืืจ ืืืชืืืื ืืืฆืืจ ืืชืืช ืืฉืืจ ืืกืืืข ืืืืืจ
METHOD AND SYSTEM FOR REAL-TIME MONITORING ANDCONTROLLING HEIGHT OF DEPOSITBY USING IMAGE PHOTOGRAPHINGAND IMAGE PROCESSINGTECHNOLOGY IN LASER CLADDINGAND LASER AIDED DIRECT METALMANUFACTURING PROCESSINSSTEK INC
PCT/KR/2001/001970WO/2003/042895
)2009.01 (C03C19819519/10/2007
ื ืืื ืชืืืืืจืื ืืืจืืืื ืืฉืืืืชCOMPOSITE MATERIALS ANDPROCESSES FOR PRODUCING THESAMEMILLENIUM RESEARCH PTY LTD.
19/10/20062006905838AUPCT/AU/2007/001588WO/2008/046152
)2009.01 (A61K19819618/10/2007
TREATMENT ืกืืจืื ืืืืืืื ืืืโืืืคืื ืืื OF DEMYELINATINGDISORDERSTHE UNIVERSITY OF NORTHCAROLINA AT CHAPEL HILL
20/10/200660/862343USPCT/US/2007/081761WO/2008/049053
![Page 287: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/287.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009287
)2009.01 (B32B19819718/10/2007
ืข ื"ืฉืืืืช ืืืขืจืืช ืืืื ืช ืฆืืคืืืื ืฉืืืืฉ ืืชืจืกืืก ืืืงืืจืืกืืืื
METHODS AND APPARATUS FORMAKING COATINGS USINGELECTROSTATIC SPRAYTHE BOARD OF TRUSTEES OF THEUNIVERSITY OF ARKANSAS
19/10/200660/852931USPCT/US/2007/022220WO/2008/051433
)2009.01 (G08B19819819/04/2009
TRACKING ืืขืงื ืขืืืจ ืืขืจืืืช ืืืืื ืืืืืช OF AUTONOMOUSSYSTEMSHONEYWELL INTERNATIONAL INC.
20/06/200812/143055US
)2009.01 (B05D19819918/10/2007
ืข ื"ืฉืืืืช ืืืขืจืืช ืืืื ืช ืฆืืคืืืื ืฉืืืืฉ ืืฉืืงืืข ืชืจืกืืก ืืืืืจืืกืื ื
METHODS AND APPARATUS FORMAKING COATINGS USINGULTRASONIC SPRAY DEPOSITIONNANOMECH, LLC
19/10/200660/852863USPCT/US/2007/022221WO/2008/051434
)2009.01 (A61K19820012/10/2007
โ?17ืฉืืืืฉ ืืืกืืจืืืืืื ืืืืจืื ืืืกื ืืืืคืื'ืืกืืจืืืืืื ืืื ืขื ืืืื ืื
ื ืื ืืืืจืช ืืืืื ื/ืจืคืืื ืคืืื ืืฉืืืจื ื ืฉืืช
USE OF ESTRADIOL VALERATE OR17?-ESTRADIOL IN COMBINATIONWITH DIENOGEST FOR ORALTHERAPY FOR MAINTAININGAND/OR INCREASING THE FEMALELIBIDOBAYER SCHERING PHARMA AG
20/10/200606022091.0EP10/05/200707009373.7EP
PCT/EP/2007/008866WO/2008/046559
![Page 288: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/288.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 288
)2009.01 (A01M19820119/10/2007
A ืืืืช ืืืืืืืื RAT TRAPPAF HOLDING APS
19/10/2006PA200601357DK26/02/200711/678687US
PCT/DK/2007/000449WO/2008/046424
)2009.01 (C07K19820217/10/2007
PEPTIDE-CYTOTOXIC ืฆืืืืืืงืกืืโืชืฆืืืื ืคืคืืื CONJUGATESIPSEN PHARMA S.A.S
20/10/200660/853140US15/03/200760/918133US
PCT/US/2007/022179WO/2008/051421
)2009.01 (C07D19820322/10/2007
โ3,2[ืคืืจืืืโ7Hโืืืงืืโ5ืชืืืื ืืืื ืชD[ืืืืืโ2โืคืืจืืืืืื
PROCESS FOR PREPARING 5-ALKYL-7H-PYRROLO[2,3-D]PYRIMIDINE-2-OLSLEXICON PHARMACEUTICALS, INC.
23/10/200660/853891USPCT/US/2007/082049WO/2008/051887
)2009.01 (C12M19820419/10/2007
ืืขืจืืช ืืฉืืื ืืืืืื ืชืืื ืคืืืืกืื ืชืืืื
SYSTEM AND METHOD FORGROWING PHOTOSYNTHETIC CELLSTHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
20/10/200660/862366USPCT/US/2007/081994WO/2008/051865
![Page 289: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/289.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009289
)2009.01 (C12N19820519/10/2007
MODIFIED ืฆืืื ืืืงืืจืื ืืืชืืืช CYANOBACTERIATHE ARIZONA BOARD OF REGENTS,A BODY CORPORATE OF THE STATEOF ARIZONA ACTING FOR AND ONBEHALF OF ARIZONA STATEUNIVERSITY
20/10/200660/853285USPCT/US/2007/082000WO/2008/130437
)2009.01 (A61M19820616/10/2007
ืฉืืืืช ืืืชืงื ืื ืขืืืจ ืืชืงืืืืช ืฆื ืชืจ ืืืชื ืืืืจืื ืืจืื
METHODS AND DEVICES FORCATHETER ADVANCEMENT ANDDELIVERY OF SUBSTANCESTHERETHROUGHGUIDED DELIVERY SYSTEMS, INC.
18/10/200611/583627USPCT/US/2007/022122WO/2008/048626
)2009.01 (A61L19820719/10/2007
ืื ืืืชื ืชืจืืคืืช ืืฉืืืโืชืืืื ืืชืื ืืื ืืฉืืืืฉ
DRUG-DELIVERY ENDOVASCULARSTENT AND METHOD OF USEBIOSENSORS INTERNATIONALGROUP
20/10/200660/853077US23/03/200711/690768US21/05/200711/751268US
PCT/US/2007/022284WO/2008/051453
![Page 290: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/290.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 290
)2009.01 (A61K19820822/10/2007
โืขืืืื ืคืืจืืง ืืฉืืืื ืฉื ืืืจืืฆื ืืืฅ ืชืืืช
INHIBITION OF DEGRADATION OFEXTRACELLULAR MATRIXTHE AUSTRALIAN NATIONALUNIVERSITY A BODY CORPORATEESTABLISHED BY THE AUSTRALIAN
20/10/20062006905854AUPCT/AU/2007/001603WO/2008/046162
)2009.01 (B65B19821019/04/2009
FILLABLE ืืืืื ืืฉืืืช ืืืืโืืืกื ืืจ LID FOR SEWAGEMANHOLE
ROMOLDื"ืจืืืืื ืืื ืืืืืืืช ืืข TECHNOLOGIES LTD.
)2009.01 (F23R19821118/10/2007
ืขืจืืื ืืื ืืืืง ืืฉืืืืฉโืชืขืจืืืช ืงืื ืืืืจ ืื ืจืืื/ืืื ืขื ืืืฉืืจื ืืฉืืจืจ
PREMIXER FOR GAS AND FUEL USEIN COMBINATION WITH ENERGYRELEASE/CONVERSION DEVICELEAN FLAME INC.
18/10/200660/829993USPCT/US/2007/081803WO/2008/049067
)2009.01 (A61B19821217/10/2007
ืืืืฉืืจ ืืืชื ืืจืืื ืืื ืงืืฆื ื ืืขื ืคืืืฉื ืืช ืืื ืืืืืช
MINIMALLY INVASIVE TOOLINGFOR DELIVERY OF INTERSPINOUSSPACERVERTIFLEX, INC.
18/10/200611/582874USPCT/US/2007/022171WO/2008/048645
![Page 291: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/291.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009291
)2009.01 (G06F19821322/10/2007
ืืขืจืืช ืืฉืืื ืืืคืงืช ืืืืจืืช ืจืื ืืืืจืืื ืช ืจืื ืื ืืืคืขืืช
METHOD AND SYSTEM FORDERIVING WIND SPEED IN A STALLCONTROLLED WIND TURBINESOUTH WEST WINDPOWER, INC
20/10/200660/853036USPCT/US/2007/022400WO/2008/097286
)2009.01 (H04B19821531/10/2007
ืฉืืื ืืืชืงื ืขืืืจ ืืืคืืฉ ืชื ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช ืืืจืชืืืื ืื
METHOD AND APPARATUS FORCELL SEARCH IN AN ORTHOGONALWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED
01/11/200660/863965USPCT/US/2007/083265WO/2007/057898
)2009.01 (A61K19821603/10/2007
ืืืืืืืืื ืืืจืืืจื ืืฆืืื ืฉืขืืื ืืื ืงื ืืืฆื ื
NITRIC OXIDE-BLOCKED CROSSLINKED TETRAMERIC HEMOGLOBIN
IKOR, INC.23/10/200660/853968US24/10/200611/586312US01/03/200711/713195US
PCT/US/2007/080337WO/2008/051689
![Page 292: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/292.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 292
)2009.01 (H04L19821731/10/2007
ืืชืงื ืืฉืืื ืืืืฉื ืืงืจืืืช ืขืืืจ ืชืงืฉืืจืช ืืืืืืืช
APPARATUS AND METHOD OFRANDOM ACCESS FOR WIRELESSCOMMUNICATIONQUALCOMM INCORPORATED
31/10/200660/855903USPCT/US/2007/083239WO/2008/055235
)2009.01 (G01J19821823/10/2007
ืกืืจืง ืคืก ืืคืื ืขื ืืืืื ื ืจืืื ืืขืื ืืืืLWIR ืืฉืืืืื ืขื ืืืืSWIRืืืื
ืืงืืจืจืื
DUAL BAND IMAGER EITH VISIBLEOR SWIR DETECTORS COMBINEDWITH UNCOOLED LWIR DETECTORS
RAYTHEON COMPANY24/10/200611/586323US
PCT/US/2007/022461WO/2008/127297
)2009.01 (H04L19821901/11/2007
SUB-BAND ืคืก ื ืชืืโื ืืืื ืืฉืื ืชืช DEPENDENT RESOURCEMANAGEMENTQUALCOMM INCORPORATED
01/11/200660/863889US06/11/200660/864579US
PCT/US/2007/083393WO/2008/057971
)2009.01 (A61K19822009/08/2004
ENTRAPPED ืชืื ืืืข ืืืืืื ืืฉืืืืฉื STEM CELLS AND USESTHEREOFTHE ROGOSIN INSTITUTE
04/09/200310/655275USPCT/US/2004/025713WO/2005/026320
![Page 293: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/293.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009293
)2009.01 (H04L19822130/10/2007
ืืงืจืช ืฉืืืืจ ืืจืืื ืืืืืข ืขื ืขืืฆืืชFDMAโSCืงืืืื ืืฉืชื ื ืืืขืจืืช
MULTIPLEXING OF CONTROL ANDDATA WITH VARYING POWEROFFSETS IN A SC-FDMA SYSTEMQUALCOMM INCORPORATED
01/11/200660/863960USPCT/US/2007/082931WO/2008/057843
)2009.01 (H04B19822206/11/2007
)UPLINK(ื ืืืื ืืืขื ืช ืขืจืืฅ ืชืืกืืจืชืคืกโืชืืื ืชืช
SUB-BAND DEPENDENT UPLINKLOAD MANAGEMENT
QUALCOMM INCORPORATED06/11/200660/864576US
PCT/US/2007/083840WO/2008/058162
)2009.01 (C07K19822325/10/2007
CRYSTALLINE ืืืคื TNFโhโื ืืืื ืื ืืืืฉืืื ืฉื ืื ืื ANTI-HTNFALPHAANTIBODIESABBOTT BIOTECHNOLOGY LTD.
27/10/200660/855104USPCT/US/2007/022622WO/2008/057240
)2009.01 (A01N19822419/10/2007
ืฆืืจืืช ืืื ืฉื ืชืจืืืืืช ืื ืืืชืืื ืื ืืืชืืจืืช
SALT FORMS OF SUBSTITUTEDBENZOTHIENYL COMPOUNDS
JANSSEN PHARMACEUTICA, N.V.20/10/200660/853407US
PCT/US/2007/022370WO/2008/051489
![Page 294: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/294.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 294
)2009.01 (A61K19822519/10/2007
ืงืคืกืืืืช ืจืืืช ืืืืืืืช ืคืืื ืืกืืจืืืืืืจืืืืืจืื ืืขืืืช ืืฆืืืืช ืืืืื ืืช
ืืืืืืืืช ืืฉืืคืจืืช
SOFT CAPSULES COMPRISINGPALONOSETRON HYDROCHLORIDEHAVING IMPROVED STABILITY ANDBIOAVAILABILITYHELSINN HEALTHCARE S.A.
24/10/200660/854342USPCT/EP/2007/009098WO/2008/049552
)2009.01 (C07D19822623/10/2007
โืืืืจืืงืกืโ5โืคื ืืโL[โ2ื ืืืจืืช ืฉืโืืชืืโืืืคื4
โ5โืืื ืืืื]F[ืืงืกืืืืืจืืฆืืงืืืคื ืืืฉื]ืืื ืืชืื ืคื ืื ืืืืื ืืื
ืจืฆืคืืืจ ืืืืืงืืงืืจืืืงืืืื
2-[L-PHENYL-5-HYDROXY-4ALPHA-METHYL-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES ASGLUCOCORTICOID RECEPTOR LIGANDS
MERCK & CO, INC.23/10/200660/853655US13/04/200760/923337US
PCT/US/2007/022449WO/2008/060391
)2009.01 (C07D19822726/10/2007
โ9[โ4ืฆืืจืืช ืืืฆืงืืช ืืืืืืืชโ6,4,2(โ8โ)ืืืโ3โืคืืจืืโืืืืจืืืืืจ(
โ2โืคืืจืืโ9Hโ)ืคื ืืืืืื ืโืืจืืคืืืืืจืืืจืืืื, ืืืโ1โืฆืืงืืืืงืกืโ]ืืืืืืื ื
ืฉืืื ืืฉืืืืฉ ืืืชื
SOLID FORMS COMPRISING 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL, COMPOSITIONSTHEREOF, AND USE THEREWITHSIGNAL PHARMACEUTICALS, LLC
27/10/200660/854757USPCT/US/2007/022648WO/2008/057252
![Page 295: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/295.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009295
)2009.01 (A47K19822820/04/2009
VENTILATOR ืงืืื ืจืืืืช ืืืกืื SMELLS TO THETOILET
JOUL ืืื ืกืจืืื SRHAN
)2009.01 (F24J19822920/04/2009
HEATING ืืืฃ ืืืืื ืืคืจืฉื ืืงืืื ELEMEN SECRETION TOTHE SOLAR COLLECTOR
JOUL ืืื ืกืจืืื SRHAN
)2009.01 (B41M19823016/11/2007
ืืฉืืขื ืืืืืจืื ืืืืโืฉืืื ืืกืืืื ืื ืืืืฆืืข ืืืชื ืืคืขืืื
METHOD FOR THE UNIVOCALMARKING OF MATERIALS, AND INKFOR CARRYING OUT THE SAMECLAUDIO SELVA
16/11/2006BI2006A000010IT04/12/2006BI2006A000013IT21/02/2007BI2007A000002IT
PCT/IT/2007/000809WO/2008/059552
)2009.01 (C07D19823131/10/2007
1HSDืคืืจืืืื ืงืจืืืงืกืืืืืื ืืืขืืื?11
PYRIDINE CARBOXAMIDES AS11?HSD1 INHIBITORSASTRAZENECA AB
03/11/200660/864303US03/11/200660/864247US
PCT/GB/2007/004131WO/2008/053194
![Page 296: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/296.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 296
)2009.01 (H04L19823206/11/2007
ืจืืช ืขืจืืื ืืืืช ืฆืืคื ืขืืืจ ืฉืืืืจMIMO
CODEWORD LEVEL SCRAMBLINGFOR MIMO TRANSMISSIONQUALCOMM INCORPORATED
06/11/200660/864582USPCT/US/2007/083730WO/2008/058109
)2009.01 (H04B19823306/11/2007
ื ืื/ืฉืืืืช ืืืชืงื ืื ืขืืืจ ืืงืฆืืช ืืืSIMO/MIMOืืืืจืช ืฉืืขืืจ ืขืื ืคืขืืืืช
ULืขื ืฉืืงืืืPAR
METHODS AND APPARATUS FORPOWER ALLOCATION AND/OR RATESELECTION FOR UL MIMO/SIMOOPERATIONS WITH PARCONSIDERATIONSQUALCOMM INCORPORATED
06/11/200660/864573USPCT/US/2007/083814WO/2008/058143
)2009.01 (H04B19823406/11/2007
ืขื ืฉืืืช ืคืจืืืืฆืืMIMOืฉืืืืจื ืืืืืืชืืืขืจืืช ืชืงืฉืืจืช
MIMO TRANSMISSION WITH LAYERLAYER PERMUTATION IN AWIRELESS COMMUNICATIONSYSTEMQUALCOMM INCORPORATED
06/11/200660/864581USPCT/US/2007/083739WO/2008/058112
![Page 297: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/297.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009297
)2009.01 (C07C19823601/11/2007
โืืืืืคืืจืืืื ืื ืืืจ, ื ืืืจืืช ืืืืจืื ืคืจืืืื ืื ืืฉืืืืฉืื ืฉืืื
DIARYL, DIPYRIDINYL AND ARYL-PYRIDINYL DERIVATIVES AND USESTHEREOFPFIZER PRODUCTS INC.
13/11/200660/865479USPCT/IB/2007/003393WO/2008/059335
)2009.01 (H04Q19823707/05/2002
ืฉืืื ืืืชืงื ืืืฆืืจืช ืืืืข ืืงืจื ืืืืจื ื ืชืื ืื
METHOD AND APPARATUS FORGENERATING CONTROLINFORMATION FOR PACKET DATAQUALCOMM INCORPORATED
07/05/200160/289450US30/05/200160/294674US11/04/200210/121648US
PCT/US/2002/014530WO/2002/091767
)2009.01 (G01S19823806/11/2007
ืกืืืืจ ืืชืคืขืื ืืขืจื ืืชืืจ ืขืืืจ ืืืฉืืืSODAR
TRANSDUCER ARRAYARRANGEMENT AND OPERATIONFOR SODAR APPLICATIONSSECOND WIND, INC.
06/11/200660/864429US01/06/200760/941302US05/11/200711/934915US
PCT/US/2007/083690WO/2008/108894
![Page 298: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/298.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 298
)2009.01 (C07D19823906/11/2007
โ2โืคืืคืจืืืื ืืโ8ื ืืืจืืช ืืืชืืจืืช ืฉืโ6โืคืืจืืืืืื]Aโ1,2[ืคืืจืืืืืโืคืืจืืืื ืื
ื โืคืืจืืืืืื ืืโ2โืคืืคืจืืืื ืืโ8โืืื ืืืโ6โืคืืจืืืืืื]Aโ1,2[ืคืืจืืืืื
SUBSTITUTED 8-PIPERIDINYL-2-PYRIDINYL-PYRIMIDO [1,2-A]PYRIMIDIN -6- ONE AND 8-PIPERIDINYL-2- PYRIMIDINYL [1,2-A] PYRIMIDIN -6- ONE DERIVATIVESSANOFI-AVENTIS
07/11/200606291725.7EPPCT/IB/2007/004272WO/2008/056266
)2009.01 (H04B19824010/11/2007
ืืขืจืืืช ืืฉืืืืช ืขืืืจ ืืืืื ืื ืืืืืช ืฉื ืืืืืืช ืฉืืืืจ ืืขืจืืฅ ืืื
SYSTEMS AND METHODS FORDETECTING THE PRESENCE OF ATRANSMISSION SIGNAL IN AWIRELESS CHANNELQUALCOMM INCORPORATED
10/11/200660/865348US06/11/200711/935911US
PCT/US/2007/084369WO/2008/061044
)2009.01 (C07D19824117/10/2007
ืชืจืืืืืช ืคืืจืืืืืื ืืื ืืืื ืืกืืื ืืงืืืื ืืืื ืจืืืงืืจืืืงืืืื
PYRAZOLINE COMPOUNDS ASMINERALOCORTICOID RECEPTORANTAGONISTSPFIZER PRODUCTS INC.
31/10/200660/863606USPCT/IB/2007/003207WO/2008/053300
![Page 299: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/299.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009299
)2009.01 (A01N19824225/10/2007
HERBICIDAL ืืืื ืงืืืื ืขืฉืืืืืจ COMPOSITIONSSYNGENTA PARTICIPATIONS AG
27/10/20060621440.7GBPCT/EP/2007/009276WO/2008/049618
)2008.04 (C07D19824310/01/2003
โ3,2[ืคืืจืืืโ)ืืืืื ืโ2โืคืืจืืืื(โ2D[ืืื ืืโ7โืคืืจืืืืืื
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONES
WARNER-LAMBERT COMPANY LLC22/01/200260/350877US
PCT/IB/2003/000059WO/2003/062236
)2009.01 (C07D19824423/10/2007
PYRIDAZINE ืชืืืืืช ืคืืจืืืืื DERIVATIVESSYNGENTA PARTICIPATIONS AG
25/10/200606022285.8EPPCT/EP/2007/009189WO/2008/049585
)2009.01 (C09D19824525/10/2007
ืืืืื ืืืคื ื ืืคืจืืืื ืืืจืื ืืขืืฆืื ืขืฆืื
SELF DESIGNED FASHION WEARAND OTHER ARTICLES
MY DESIGN LTD25/10/200660/862775US05/11/200660/864402US
PCT/IL/2007/001292WO/2008/050338
![Page 300: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/300.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 300
)2009.01 (C07D19824722/10/2007
ืชืืืืืช ืืื ืืืืื ืืืฉืืฉืืช ืืืขืืื1CPTโL
INDAZOLE DERIVATIVES USEFULAS L-CPT1 INHIBITORS
F. HOFFMANN-LA ROCHE AG01/11/200606123321.9EP
PCT/EP/2007/061251WO/2008/052898
)2009.01 (C07D19824808/11/2007
ืืชืืฉืืจืืCืืืืื ืืืจืืก ืืคืืืืืก ืืืืืืื ืืืชื
HEPATITIS C VIRUS INHIBITORSAND COMPOSITIONS COMPRISINGTHE SAMEBRISTOL-MYERS SQUIBB COMPANY
09/11/200660/865034US05/11/200711/934840US
PCT/US/2007/084012WO/2008/060927
)2009.01 (A61K19824907/11/2007
ืชืืฉืืจืื ืืืืืืื ืืืื ืืกื ืืืคืืืื ืืื ืืืืื ืืกื ืืืคืืืื
COMPOSITIONS COMPRISING ANOPIOID AGONIST AND AN OPIOIDANTAGONISTNEKTAR THERAPEUTICS AL,CORPORATION
07/11/200660/857610USPCT/US/2007/023534WO/2008/057579
![Page 301: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/301.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009301
)2009.01 (C07D19825008/11/2007
โืืืืืืืงืกืโ10,9โืืืืืืืืืโ3ืชืจืืืืืช11,7,6,4,3,1BโืืงืกืืืืจืโH2โ1,2[ืคืืจืืืโ
A[ืชืืฉืืจืื, ืืื ืืืชืืจืืชโ2โืืืืืืื ืืืื ืื ืืฆืืื, ืืืืืืื ืืืชื
SUBSTITUTED 3-ISOBUTYL-9,10-DIMETHOXY-1,3,4,6,7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-OL COMPOUNDS,COMPOSITIONS COMPRISING THE
SAME AND USES THEREOFNEUROCRINE BIOSCIENCES, INC.
08/11/200660/864944USPCT/US/2007/084176WO/2008/058261
)2009.01 (C12N19825106/11/2007
ืคืกืืืืืืื ืก ืจืืืืกืื ืื ืืชื ืืืืกืืช ืืืืืช ืฆืืืื
PSEUDOMONAS RHODESIAECAPABLE OF CONTROLLING PLANTDISEASESNIPPON SODA COMPANY LTD.
08/11/20062006-302263
JP
PCT/JP/2007/071531WO/2008/056653
)2009.01 (C04B19825217/12/2007
ืชืืืื ืืืคืื ืืงืืฆืืื ืกืืืคืื ืืืืืืืจืื
CALCIUM SULFATE HEMIHYDRATETREATMENT PROCESS
THE NUGYP CORP.20/12/200660/871039US
PCT/CA/2007/002300WO/2008/074137
![Page 302: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/302.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 302
)2009.01 (G06F19825320/11/2007
ืืฆืืจืช ืืืืข ืืืืกืื ืืืืข ืชืื ืฉืืืืฉ ืืืื ืชืืืืืื ืืื ืืืืช
CREATING DATA IN A DATA STOREUSING A DYNAMIC ONTOLOGY
PALANTIR TECHNOLOGIES, INC.20/11/200611/602626US
PCT/US/2007/085202WO/2008/064207
)2009.01 (C07D19825422/10/2007
MAPK/ERKMAPK/ERKืืขืืื ืงืื ืื KINASE INHIBITORSTAKEDA PHARMACEUTICALCOMPANY LIMITED
23/10/200660/862569USPCT/US/2007/082138WO/2008/140553
)2009.01 (G01N19825514/09/2007
ืฉืืื ืืืชืงื ืืืืฆืืจ ืื ืืืืื ืฉื ืืื ืื ืฉืืืืืช ืขืืืจ ืื ืืืืช/ืืืื ื ืืืืืืช
ืื
METHOD AND DEVICE FORPRODUCING POSITIVELY AND/ORNEGATIVELY IONIZED GAS ANALYTESFOR GAS ANALYSISGESELLSCHAFT ZUR FORDERUNG DERANALYTISCHEN WISSENSCHAFTENE.V.
25/10/2006102006050136.5DEPCT/EP/2007/007999WO/2008/049488
)2009.01 (C07F19825609/06/2006
ืชืืืื ืืืื ืช ืืืงืกืืืืืจืืืืืื ืื ืืืจืื ืืื
PROCESS FOR SYNTHESIS OFORGANO OXAZABOROLOLDINES
BASF SE13/06/200560/690113US
PCT/EP/2006/063044WO/2006/134074
![Page 303: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/303.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009303
)2009.01 (G10K19825725/10/2007
ืฉืืื ืืืฆืืจ ืืืื ืืืื ืืื ืืืืฆืขืืช ืืฆืืจืช ืืื ืงืจืื ื ืืงืืกืืืช ืืืฉืงืืช
METHOD FOR GENERATINGMECHANICAL WAVES BYCREATING AN INTERFACIALACOUSTIC RADIATION FORCESUPER SONIC IMAGINE
25/10/20060654502FR03/01/200760/883233US
PCT/FR/2007/052247WO/2008/050072
)2009.01 (C07F19825805/11/2007
DIALKYLBORANE ืงืืืคืืงืกืื ืฉื ืืืืืงืืืืืจืื ืืืื AMINECOMPLEXESBASF SE
09/11/200660/865100USPCT/EP/2007/061859WO/2008/055859
)2009.01 (C07D19825905/11/2007
ืชืืืื ืขืืืจ ืกืืืคืื ืืืืฆืื ืฉื ื ืืืจืช ืคืืจืืืื
PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE
BASF SE10/11/200660/865178US24/04/200760/913617US
PCT/EP/2007/061891WO/2008/055877
)2009.01 (C07D19826005/11/2007
ืชืืืื ืขืืืจ ืกืืืคืื ืืืืฆืื ืฉื ื ืืืจืช ืคืืจืืืื
PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE
BASF SE10/11/200660/865178US24/04/200760/913638US
PCT/EP/2007/061893WO/2008/055879
![Page 304: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/304.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 304
)2009.01 (C07D19826105/11/2007
ืชืืืื ืขืืืจ ืกืืืคืื ืืืืฆืื ืฉื ื ืืืจืช ืคืืจืืืื
PROCESS FOR THE SULFINYLATIONOF A PYRAZOLE DERIVATIVE
BASF SE10/11/200660/865178US24/04/200760/913646US
PCT/EP/2007/061894WO/2008/055880
)2009.01 (A01N19826205/11/2007
CRYSTALLINE ืฉืื ืื ืืืืฉื ืฉื ืคืืคืจืื ืื MODIFICATION OFFIPRONILBASF SE
10/11/200606023438.2EPPCT/EP/2007/061895WO/2008/055881
)2009.01 (C07D19826330/10/2006
ืืืืจืืงืกืืืืื ืืืขืืื ืืืกืืื ืืืฆืืืืื
HYDROXAMATES AS INHIBITORS OFHISTONE DEACETYLASE
CHROMA THERAPEUTICS LTD.
PCT/GB/2006/004034WO/2008/053131
)2009.01 (A01N19826405/11/2007
CRYSTALLINE ืฉืื ืื ืืืืฉื ืฉื ืคืืคืจืื ืื MODIFICATION OFFIPRONILBASF SE
10/11/200606023437.4EPPCT/EP/2007/061896WO/2008/055882
![Page 305: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/305.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009305
)2009.01 (A01N19826505/11/2007
CRYSTALLINE ืฉืื ืื ืืืืฉื ืฉื ืคืืคืจืื ืื MODIFICATION OFFIPRONILBASF SE
10/11/200606023436.6EPPCT/EP/2007/061897WO/2008/055883
)2009.01 (A01N19826605/11/2007
CRYSTALLINE ืฉืื ืื ืืืืฉื ืฉื ืคืืคืจืื ืื MODIFICATION OFFIPRONILBASF SE
10/11/200606023435.8EPPCT/EP/2007/061898WO/2008/055884
)2009.01 (C07D19826729/10/2007
ืชืจืืื ืื ืคืจืืืืืโืกืจืื?โIKKืืขืืื ืงืื ืื
IKK-? SERINE-THREONINE PROTEINKINASE INHIBITORS
CHROMA THERAPEUTICS LTD.01/11/20060621720.2GB09/08/20070715470.1GB
PCT/GB/2007/004114WO/2008/053182
)2009.01 (C23C19826812/10/2007
METHOD ืฉืืื ืืฆืืคืื ืืฆืข ืืชืืฆืจ ืืฆืืคื FOR COATING ASUBSTRATE AND COATED PRODUCTH. C. STARCK GMBH
07/11/200660/864729USPCT/US/2007/081200WO/2008/057710
![Page 306: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/306.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 306
)2009.01 (G01N19826907/11/2007
ืฉืืื ืืืืืืจ ืฉื ืืคืืืช ืืืืจ ืืืจื ืืื ืืฉืจ ืืฉ ืืืืืชื
METHOD FOR THE PURIFICATION OFAT LEAST ONE TARGET SUBSTANCETHAT IS TO BE IDENTIFIEDJOCHEN PETER
08/11/2006102006052923.5DE21/12/2006102006060717.1DE
PCT/EP/2007/009648WO/2008/055671
)2009.01 (C07D19827009/11/2007
โ3,2[ืฉืืืืช ืืืื ืช ืืงืกืืืืืจืืคืืจืB[ืืืโ3โืคืืจืื
METHODS FOR THE PREPARATIONOF HEXAHYDROFURO[2,3-B]FURAN-3-OLTIBOTEC PHARMACEUTICALS LTD.
09/11/200606123752.5EPPCT/EP/2007/062119WO/2008/055970
)2009.01 (C07K19827108/11/2007
ืืฉืชื ืื ืืฉืืืืช ืืฉืืืืฉ ืืืืจื ืืืืืBETAโ9ืืชืืืจ
VARIANTS AND METHODS OFUSING TRANSFORMING GROWTHFACTOR BETA-9ZYMOGENETICS INC.
08/11/200660/864873USPCT/US/2007/084145WO/2008/058251
![Page 307: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/307.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009307
)2009.01 (A43B19827220/11/2007
ืกืืืื ืื ืขืืืื ืืขืืืื ืืืื ืืืืืจืื ืขืืืื ืืืฉืชืืฉืืช, ืืืื ืืื
ืืกืืืื ืื ืืฉืืื ืืืฆืืจ ืกืืืื ืื ืขืืืื ืืื
VAPOR-PERMEABLE WATERPROOFSOLE FOR SHOES, SHOE WHICH USESSAID SOLE, AND METHOD FORMANUFACTURING SAID SOLE ANDSAID SHOEGEOX S.P.A.
23/11/2006PD2006A000437ITPCT/EP/2007/010045WO/2008/061710
)2009.01 (A01N19827305/12/2007
โ3,2ืชืืืืืช ืืืชืืจืืช ืฉืืงืืืื ืืืืืื]Cโ2,1[ืืืื ืืืืืืจืืืืื
ืืืขืืืื ืืืืคืื ืืื ืกืืจืื ืื ืืืขืื ืขืโืืฉืืฉืื ืืชืจ ืืืืืืช ืืงืฉืืจืืช
ืืชืคืชืืืช ืืื ืื ืืืฉืื
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVESUSEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS ANDDISEASES ASSOCIATED WITHANGIOGENESISBAYER SCHERING PHARMA AG
05/12/200660/873090USPCT/US/2007/024985WO/2008/070150
)2009.01 (C07D19827431/10/2007
ืชืืืื ืืืื ืช ืืืืฆืืช ืืืืื ืืืช ืืชืืืืืชืืื
PROCESS OF PREPARATION OFALDONIC ACIDS AND DERIVATIVESTHEROFC.B. FLEET COMPANY,INCORPORATED VIRGINIACORPORATION,
31/10/20060621669.1GBPCT/GB/2007/004149WO/2008/053206
![Page 308: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/308.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 308
)2009.01 (A47D19827521/04/2009
BED ืืืื ืืขืืช ืืืง ืขืืืื ืืชืจืืื WITH RAISABLE PORTIONKACTELื"ืงืกืื ืืืจืืืื ืืืืงืืช ืืข BOROCHOV HOLDINGS LTD
)2009.01 (G06F19827621/04/2009
A ืขืจืื ืืื ืืขืช ืฉืืืช ืืืืื ืืจืื KIT TO PREVEN FORGETTING ACHILD IN A CAR
YAMIT ืขืืื ื ืืื ื ATTIAS
)2009.01 (B65D19827719/10/2007
ืืืกื ืืืืื ืืืืืขื ืืขืืงืจ ืืืฉืงืืืชAN END CLOSURE OF A CONTAINERPRIMARILY INTENDED FORBEVERAGESINVENTO SP. Z O.O.
23/10/2006P-380896PLPCT/PL/2007/000070WO/2008/051099
)2009.01 (G01S19827922/11/2007
ืฉืืื ืืืชืงื ืืืืืื ืืืืืืงื ืืืืื ืืืืืืจ ืืืจ ืืืืคื ืจืืจื
METHOD AND DEVICE FORDETECTING AN OBJECT THAT CANRETROREFLECT LIGHTCOMPAGNIE INDUSTRIELLE DESLASERS CILAS
28/11/200606/10392FRPCT/FR/2007/001919WO/2008/071866
![Page 309: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/309.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009309
)2009.01 (F41G19828015/11/2007
AIMING ืืขืจืืช ืืืืื ื ืขื ืืื ืกืืืื ืืืืื SYSTEM WITH INTEGRATEDDEVIATION METERMBDA FRANCE
21/11/200606/10165FRPCT/FR/2007/001876WO/2008/062114
)2009.01 (G06F19828121/04/2009
ืืื ืืืจืืืืืืช ืืฉืืื ืช ืืืชืงื ืืืืจืื ื ืืื
AN EXTERNAL-MEMORY DEVICERESIDENT VITUAL ANIMAL
NOAM ื ืขื ืืืก HADAS
)2009.01 (F03B19828221/04/2009
ื ืืคืงืช ืื ืจืืืืช ืืฉืื ืืืืฆืขืืช ืืชืงื ืืืืืืโื ืืฆืื ืืจืืื ืชืช
A DEVICE FOR OBTAININGELECTRIC ENERGY USINGUNDERWATER CURRENTS
VLADIMIR ืืืืืืืจ ืกืืจืื SAKHAROV
![Page 310: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/310.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 310
-ื"ืืืืง ืืคืื ืืื ืชืฉื26ืืืืขื ืืคื ืกืขืืฃ1976
NOTICE UNDER SECTION 26 OF THEPATENTS LAW, 5727-1967
ืืืงืฉืืช ืฉืคืจืืืื ืืชืคืจืกืืื ืืืื ืงืืืืืื ืืืขืื ืื. ืืืืง ืืคืื ืืื17ืืคื ืกืขืืฃ
ืืืชื ืื ืืืชื ืคืื ื ืขื ืคื ืืงืฉื ืืืืงืฉืืช ืชืื ืฉืืืฉื ืืืฉืื, ืืืชืคืจืกืืืช ืจืฉืื
ืืืืืฉ ืืจืฉื ืืคืื ืืื, ืืชืืจืื ืืืื ืืืืืืง ืืคืื ืืื30ืืืืขืช ืืชื ืืืืช ืืคื ืกืขืืฃ
ืืชืงื ืืช ืืืืื57ืืืจื ืืงืืืขื ืืชืงื ื .1968โื"ืชืฉื, ืืคืื ืืื
The applications, particulars of which are setout below, have been accepted pursuant toSection 17 of the Patents Law. Any personwishing to oppose the grant of a patent on anyof the applications published here, may,within three months from the date of thisjournal, give to the Commissioner of Patentsnotice under Section 30 of the Patents Law, inthe manner prescribed in regulations 57 et seqof the Patents Regulations, 5728-1968
ืคืจืื ืืืงืฉืืช ืืืืื ืืืืฉืืืื ืืืืืื ืืคืืืืก :ืืจ
Particulars of the applications, whereapplicable, are given in the following order:
[11] ืืกืคืจ ืืืงืฉื [21] Number of application[54] ืฉื ืืืืฆืื Title of invention
[22] ืชืืจืื ืืืงืฉื Application dateืืืื ืชโืืกืคืจ ืืชืืจืื ืฉื ืืงืฉืืช ืืืืฅ
ืืืืื[31] [32] [33] Number and date of foreignapplication โ convention country.
[51]* ืืืืืจื ืฉืืืขืืชโืกืืืื ืืื ืืืืื* Int.Cl.[61] ืืงืฉื ืืคืื ื ืืืกืฃ Application for patent of addition
[62] ืืงืฉืช ืืืืงื Divisional application[71] ืืืืงืฉ Applicant[72] ืืืืฆืื Inventor
[87] ืคืจืกืื ืฉื ืืงืฉื ืืืื ืืืืืืช' ืืก International Publication Number[74] ืืขื ืืืกืืจืช ืืกืืืื Address for service
[57])ืืฉืคื ืื ืขืจืื ืืคืืจืื(ืชืงืฆืืจ ืืืืฆืื Abridgement of invention (in thelanguage in which the specification is drawnup)
ืืกืืื ืืืื: ืืขืจื* 'ื ืืคืื ืืื ืืืืืืืืื ืืชื ืฆืืื ืืืงืฉืืช ืคืื ืืื ืืกืืืื ืืคื 1/06
ืืืืืืจื ืืฉืืื ืืช ืฉื ืืกืืืื ืืืื ืืืืื )2006ืืฉื ื(ืฉื ืคืื ืืื
*Note: As from Patents and Designs JournalNo.1/06, patent applications are classifiedaccording to the Eighth Edition of theInternational Patent Classification (2006)
![Page 311: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/311.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009311
124636]21][11[
ืืงืืืจืื ื ืืืจืื ืื ืืืฃ ืฉืฉืืคืืื ืืืชื ื ืืฉืืืืฉื
CONDITIONALLY REPLICATINGVIRAL VECTORS AND THEIRUSE
]54[
27.11.1996]22[US]33[28.11.1995]32[08/563459]31[
Int. Cl.(2008.04) A61K 48/00, C12N 15/11, 15/40, 15/48, 15/63, 15/69, 15/86, 5/10]51[THE JOHNS HOPKINS UNIVERSITYSCHOOL OF MEDICINE, U.S.A.
]71[
WO/1997/020060]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The present invention provides a conditionally replicating viral vector, methods ofmaking, modifying, propagating and selectively packaging, and using such a vector,isolated molecules of specified nucleotide and amino acid sequences relevant to suchvectors, a pharmaceutical composition and a host cell comprising such a vector, theuse of such a host cell to screen drugs. The methods include the prophylactic andtherapeutic treatment of viral infection, in particular HIV infection, and, thus, are alsodirected to viral vaccines and the treatment of cancer, in particular cancer of viraletiology. Other methods include the use of such conditionally replicating viral vectors ingene therapy and other applications.
]57[
__________
![Page 312: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/312.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 312
126626]21][11[
ืคืคืืืืื ืืืฉืื ืืืขืืืื ืืืืืช ืืืืคืืืื ืืงืืืืืืืืื ืืืงืืืื ืืืชื, ืื
ืืฉืืืืช ืืขืืืื ืืืืืช ืืื ืื
NOVEL ANTIANGIOGENICPEPTIDES, POLYNUCLEOTIDESENCODING SAME ANDMETHODS FOR INHIBITINGANGIOGENESIS
]54[
05.05.1997]22[US]33[03.05.1996]32[08/643219]31[US03.04.1997 08/832087
Int. Cl.(2009.01) A61K 38//43, 48//00, A61P 19//02, 27//02, 35//00, C07K 14//47,14//515, 19//00, C12N 09//68, 15//57, C12P 21//06
]51[
ABBOTT LABORATORIES, U.S.A.THE CHILDREN'S MEDICALCENTER CORPORATION, U.S.A.
]71[
WO/1997/041824]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
Mammalian kringle (5) fragments of plasminogen and kringle (5) fusion proteins aredisclosed as compounds for treating angiogenic diseases. Methods and compositionsfor inhibiting angiogenic diseases are also disclosed.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
195827,The applications for divisionfrom this application havenot yet been published
__________
![Page 313: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/313.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009313
126728]21][11[
ื ืืืจืืช ืืชืืื ืืชืืฉืืจืื ืืืจืืืืืืืืืืืืืื ืืช ืื ืืืจืืช ืืืืืจืืช ืืืจืืื
ืคืขืื
ETHYLENE DERIVATIVES ANDAGROCHEMICALCOMPOSITIONS CONTAININGSAID DERIVATIVES AS ANACTIVE INGREDIENT
]54[
24.04.1997]22[JP]33[25.04.1996]32[8-104878]31[JP07.06.1996 8-145802 JP20.06.19968-159346JP13.02.19979-28916
Int. Cl.(2008.04) A01N 43/56, 43/78, C07D 207/30, 215/12, 217/12, 231/06, 231/10,231/56, 233/54, 233/70, 233/72, 235/06, 237/08, 237/14, 237/28, 237/30, 239/26,239/72, 241/10, 241/40, 249/04, 251/14, 2530/65, 257/04, 257/08, 261/04, 261/06,263/08, 263/30, 263/54, 271/06, 271/10, 275/02, 277/08, 277/30, 277/64, 285/06,285/08, 285/12, 307/10, 333/06, 401/06, 401/14, 403/06, 403/14, 405/06, 409/06,409/14, 413/06, 413/14, 417/06, 417/14, 521/00, C07F 7/08, 9/28
]51[
NISSAN CHEMICAL INDUSTRIESLTD., JAPAN
]71[
WO/1997/040009]87[',ืืืจืืืืฅ ืืฉืืช.ืฉ
ืชื, 41-45ืฉืืจืืช ืจืืืฉืืื, ืืืช ืฆืืื ืืืื
S. HOROWITZ & CO.,ZION HOUSE,
41-45 ROTHSCHILD BLVD.,TEL AVIV 65784
]74[
Ethylene derivatives of general formula (I) and pesticides or aquatics adhesioninhibitors characterized by containing at least one of the derivatives, wherein Q isoptionally substituted phenyl or a hetero-cyclic group (particularly, 4-thiazolyl, 1- or 3-pyrazolyl, 1,3-oxazol-4-yl, phenyl or pyridyl); E is cyano or the like; A is 4-pyrrazolyl,thiazolyl or the like; and B is alkylcarbonyl or the like.
]57[
__________
![Page 314: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/314.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 314
129966]21][11[
ืืืคืืคืื ืขืืืจืืื ืฉืืงืืจื ืืชืื ืืงืืจ ืขืืืจืืื ืฉื ืืื
ISOLATED HUMAN EMBRYOIDBODIES (HEB) DERIVED FROMHUMAN EMBRYONIC STEMCELLS
]54[
14.05.1999]22[Int. Cl.(2008.04) A61K 35/54, 48/00, C12N 5/08]51[
ืืืคื,ื"ืืืกื ืืืื ืืื ืืืืงืจ ืืคืืชืื ืืขืชืื ืืืืงืจ ืฉื ืืืฉืื ืืืจื ืืคื
,ื"ืืืื ืืืจืกืืื ืืขืืจืืช ืืืจืืฉืืื ืืข ืืจืืฉืืื
TECHNION RESEARCH ANDDEVELOPMENT FOUNDATIONLTD.YISSUM RESEARCHDEVELOPMENT COMPANY OFTHE HEBREW UNIVERSITY OFJERUSALEM LTD
]71[
NISSIM ืืืืืจ-ืืืกืฃ ืืืฆืงืืืืฅ, ื ืกืื ืื ืื ืืกืื BENVENISTY, JOSEPHITSKOVITZ-ELDOR
]72[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An isolated human embryoid body (hEB) derived from human embryonic stem cells andcontaining mesoderm, ectroderm and endoderm cell lineages.
]57[
__________
131197]21][11[
APPARATUS ืืชืงื ืืืืคืืืื ืืขืืื ืืฉืืจื FOR SPINALPROCEDURES
]54[
01.08.1999]22[Int. Cl.(2009.01) A61B 17//00]51[KYPHON SARL, SWITZERLAND]71[
ASSAF ืืกืฃ ืืงื DEKEL]72[,ื"ืืข) 1995(ืืจืืื.ืื.ื'ื
,11ืจืืื ืื ืื ืืืื,15ืงืืื, ืืืื ืืืืื ืจืืช ืื
G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,RAMAT GAN 52521
]74[
Apparatus configured for entering the spine of a body of a live human patient throughseparate first and second incisions, made in the patient adjacent to different vertebraein the spine, to remove material from the spine, the apparatus comprising: a handle(210), first (208) and second (200) elongate extensions, attached to said handle, long
]57[
![Page 315: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/315.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009315
enough to extend, simultaneously, from the handle respectively through the first andsecond incisions to separate first and second locations along the length of the spine;and a flexible rasp (202) configured to pass along the first extension into the bodythrough the first incision and up to the first location on the spine, through a spinalchannel from the first location to the second location, and from the second locationalong the second extension out of the body through the second incision.
__________
132251]21][11[
ืืขืื ืืืืคืืชNGFืืจืืื ืืื ืฉืื trkCโืืืืฆืืช ืืืื ื ืืืงื ืืช ืงืฉืืจ
NGF VARIANTS HAVING AMINOACID SUBSTITUTIONS THATIMPART TRKC BINDING
]54[
23.04.1998]22[US]33[25.04.1997]32[08/845541]31[US29.04.1997 08/841045
Int. Cl.(2009.01) A61K 38//18, C07K 14//48, C12N 15//12, 15//85]51[GENENTECH, INC., U.S.A.]71[WO/1998/049308]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
NGF variants which have trkC-binding activity and trkC-signal inducing activity areprovided. The variants optionally have trkA or trkB binding and signal induction activity.The NGF variants of the present invention are useful in the treatment of neuronaldisorders. Nucleic acids and expression vectors encoding the NGF variantneurotrophins are also provided.
]57[
__________
![Page 316: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/316.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 316
136219]21][11[
ืืขืจืืช ืืฉืืื ืื ืืืื ืืฉืืื ืืช ืืืืืืื ืืจืฉืช
NETWORK ACCOUNTING ANDBILLING SYSTEM AND METHOD
]54[
20.10.1998]22[US]33[20.11.1997]32[60/066898]31[US19.11.1998 60/109095
Int. Cl.(2008.04) G06F 13/00, H04L 12/24, H04M 15/00]51[XACCT TECHNOLOGIES, INC.,U.S.A.
]71[
WO/1999/027556]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
In some embodiments, network traffic information is captured at network informationsources. These sources provide detailed information about the networkcommunications transactions at a network device. Importantly, different types ofsources can provide different types of information. Gatherer devices gather the detailedinformation from the various information source devices and convert the informationinto standardized information. The gatherer devices can correlate the gatheredinformation with account information for network transaction accounting. Managerdevices manage the gatherer devices and store the gathered standardized information.The manager devices eliminate duplicate network information that may exist in thestandardized information. The manager devices also consolidate the information.Importantly, the information stored by the manager devices represents theconsolidated, account correlated, network transaction information that can be used forbilling or network accounting. The system thereby provides a distributed networkaccounting and billing system.
]57[
__________
137462]21][11[
AIR ืืื ืก ืืืืจ INTAKE]54[
24.07.2000]22[Int. Cl.(2009.01) F28F 03//12, 09//22, 13//08]51[
OREN ืืืจื ืืืืก ALOUCE]71[,ืืืจื ืืืืก
ืืืจืช ืืืจืื 5/2ืืืื' ืจืOREN ALOUCE,6/2 ELLA ST. TIRAT HACARMEL
]74[
ืฉื,ื ืืืืื ืื ืืงืืืช ืืืืืจืจืืื ืืืืืขื ืืงืืจืืจ ืฉื ืืืืื ืืืืชืง]57[ ืืืฉืจ ืืืื ืืขื ืืกืคืจ ืจืืื, ืืืจืื ืืืืฆืจืื ืืขืืื ืืืื ืฆืื ืืจืืช ืฉืืงืืืจ ืฉืืื ืืืื ืืงืื ืืคืชื ืืฆืื ืืจ ืืืฆืืืช ืืฆืื ืืจ ืืืฉืจ
ืฆืื ืืจ ืืืจืื ืืืกืคืจ ืฉืจืืืืื ืืืืืืจืื ืื ืืื ืื ืฉืืืืืืจ ืืืืจื ืืชืืื ืืฉื ื ืืช ืืกืืืื ืืืืืช ืฉื ืขื ืื ืช ืืืจืื ืืงืืจืืจ ืืืืืืจ ืืืืฆื ืืืฉืจืืื ืืขื ืืงืืืจ, ืืฉืจืืื ืืขืืืช ืืืขืืจ ืฉืืื ืื ืฉืจืืื 90
.ืืงืื ืืืืชืจ
![Page 317: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/317.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009317
ืืชืงื ืืช35ืคืืจืื ืื ื ืื) ืืืชื๏ฟฝ ืืชืงื ื 1968โื"ืชืฉื, ืืคืื ืื๏ฟฝ
This specification was examined inaccordance with regulation 35 of the PatentRegulations, 5728 - 1968
__________
138380]21][11[
ืืืขืจ ืืืืืืจ ืืจืืืืื ืืืืจืืื ืืขื ื ืฆืืืืช ืืืืื ืืืืืื ืกืืืืชื ื ืืื
HIGH EFFICIENCY LOWPOLLUTION HYBRID BRAYTONCYCLE COMBUSTOR
]54[
10.03.1999]22[US]33[13.03.1998]32[09/042231]31[
Int. Cl.(2008.04) F01K 21/04, F02C 3/30]51[VAST POWER PORTFOLIO, LLC,U.S.A.
]71[
WO/1999/046484]87[',ืื ืืื ืคืจืืืื ืืฉืืช
ืชื ืืืื,10ืืืช ืืื ืงืืื5ืืจืืืื ืืDANIEL FREIMANN & CO.,5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
]74[
A power generating system is described which operates at high pressure and utilizes aworking fluid consisting of a mixture of compressed non-flammable air components,fuel combustion products and steam. The working fluid exiting the power generatingsystem is substantially free of NOx and CO. Working fluid is provided at constantpressure and temperature. Combustion air is supplied by one or more stages ofcompression. Fuel is injected at pressure as needed. Substantially all of the oxygen inthe compressed air is consumed when the fuel is burned. Inert liquid is injected at highpressure to produce an inert mass of high specific heat diluent vapor for use for internalcooling of the combustion chamber. The use of non-flammable liquid injection inhibitsthe formation of pollutants, increases the efficiency and available horsepower from thesystem, and reduces specific fuel consumption. Control systems allow the independentcontrol of the quantity, temperature and pressure of the air, fuel and non-flammableliquid introduced in the combustion chamber allowing control of the maximumtemperature and average temperature within the combustion chamber as well as thetemperature of the exhaust from the combustion chamber. Substantially all of thetemperature control of the system is provided by the latent heat of vaporization of theinert liquid, which is preferably water, the latent heat of vaporization counteracting theheat generated by combustion of the fuel. If the injected water contains inorganic ororganic contaminants, they are collected as a molten or solid residue or, if flammable,ignited by the flame.
]57[
__________
![Page 318: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/318.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 318
138716]21][11[
GENES ืื ืื ืืืงืืืืื ืขืืืจ ืกืื ืชืื ืฉื ืคืืืื CODING FOR FLAVONESYNTHASES
]54[
28.01.2000]22[JP]33[29.01.1999]32[11-22427]31[JP19.07.1999 11-205229
Int. Cl.(2009.01) A01H 05//00, C12N 09//02, 15//53, 15//82]51[SUNTORY LIMITED, JAPAN]71[WO/2000/044907]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A DNA encoding an enzyme capable of converting flavanone directly into flavone whichis obtained from, for example, antirrhinum and torenia, and utilization thereof. Theamino acid sequences of this DNA and the enzyme encoded thereby are representedby, for example, SEQ ID NOS: 1, 2, 3 and 4. Transfer of this gene into a plant makes itpossible to, for example, change the flower color of the plant.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
195809,195808,The applications for divisionfrom this application havenot yet been published
__________
![Page 319: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/319.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009319
139674]21][11[
ืืืจืืช ืืืื ืฉืืืช ืืืืืฉืื ืฉื ืืกืคืจืืืฉืืืื ืืจืืื ืืืืคืจื ืืื ืืืื ื ืืกืืจืชืืช
ืขืืืื ืืฉื ืืื ืืืฉืืื ืืืืืืจื ืฉื ืืืืคืชื ืฆืืืืจื ืงืจืืคืืืืจืคื ืืืชืืื ื ืื
ืืโืืกโืืจโืืืืฉืื ืืกืื ืขืืงืื ืืืืคืืื )RSA(
EXTENDING THE RANGE OFCOMPUTATIONAL FIELDS OFINTEGERS AND WIDTH OFSERIAL INPUT OPERANDS INMODULAR ARITHMETICPUBLIC KEY CRYPTOGRAPHICCO-PROCESSORS DESIGNEDFOR ELLIPTIC CURVE AND RSATYPE COMPUTATIONS
]54[
14.11.2000]22[Int. Cl.(2008.04) G06F 7/60, 7/72, G09C 1/00, H04L 9/00]51[
SANDISK ืกืื- ืืคืจ,ื"ืกืื ืืืกืง ืืืืื ืืข IL LTD.]71[, ืืืืกื ืืืืฆื ืื, ืืืชื ืืจืืจ, ืืจืื ืืจืกื
ืืืืื ืืืกืืืืืCARMI GRESSEL, ITAYI DROR,ALEXEY MOLCHANOV,MICHAEL MOSTOVOY
]72[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจืืจืืืืืช, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A public key encryption system comprising: a processor for performing a modulararithmetic multiplication, A-B (mod N), of an integer multiplier, denoted A, with aninteger multiplicand, denoted B, modulo an integer modulus, denoted N, using base rinteger arithmetic and without performing an integer division operation, wherein at leastone of A, B and N is a large integer, comprising: memory registers storingrepresentations of each of A, B and N in base r as a sequence of at least one segment,wherein a segment is a k-character integer, and wherein a character is an integerbetween 0 and r-1, and wherein k is a pre-selected segment length; a multipliermultiplying two k-character integers in base r; an accumulator summing two k-characterintegers in base r; and a logical unit adjusting a k-character base r integer so as toforce its least significant character to be zero.
]57[
__________
![Page 320: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/320.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 320
140492]21][11[
POLYMORPH ืคืืืืืืจืฃ ืฉื ืืืืจ ืจืืงืื OF APHARMACEUTICAL
]54[
19.07.1999]22[US]33[20.07.1998]32[09/119345]31[US04.06.1999 09/326093
Int. Cl.(2009.01) A61K 31//426, A61P 31//18, C07D 417/00]51[ABBOTT LABORATORIES, U.S.A.]71[WO/2000/004016]87[
',ืจ ืฉืืื ืืื ืืฉืืช"ื ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืื
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A new crystalline polymorph of ritonavir and methods for its use andpreparation are disclosed.
]57[
__________
140625]21][11[
ืฉืืืืฉ ืืคืคืืืืื ืื ืืืืืจืืืื ืืืื ืืืคืจืืืืคืจืืืืืื ืืืื ืช ืชืจืืคื
ืืืืคืื ืืกืจืื ืืืืืืื ื ืืืคื
USE OF AN ANTIVIRAL ORANTIPROLIFERATIVE PEPTIDEIN THE PREPARATION OF AMEDICAMENT FOR TREATINGCANCER AND VIRAL INFECTION
]54[
30.06.1999]22[US]33[02.07.1998]32[60/091579]31[US09.02.1999 60/119264
Int. Cl.(2008.04) A61K 38/02, 38/08, C07K 7/06]51[ENVISION BIOMEDICALCONSULTING, U.S.A.
]71[
WO/2000/001402]87[,ืืืฆืืื ืืช ืืืฆืืื
ืฉื, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื ืขืืืจLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to peptides and proteins which may be used to inhibitinfection or cell proliferation. It is based, at least in part, on the discovery of peptidesand proteins isolated from embryonic tissue which have been found to exhibit anantiproliferative effect on a variety of cancer cells and/or to act as broad-spectrumantiviral agents.
]57[
__________
![Page 321: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/321.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009321
140793]21][11[
ืืขืจืืช ืืืืืืืช ืืืจืื ืืกืืืืืืฉืช ืืฉืจืชืื ืืฉืืืคืืื ืืืืืจืื ืืืฉืช
ืืขืื ืชืืืื ืืฉืืืฆืช
GLOBAL DOCUMENT HOSTINGSYSTEM UTILIZING EMBEDDEDCONTENT DISTRIBUTED GHOSTSERVERS
]54[
14.07.1999]22[US]33[14.07.1998]32[60/092710]31[US10.05.1999 09/314863
Int. Cl.(2008.04) G06F 12/00, 13/00, 17/30, H04L 29/06, 29/08, 29/12]51[MASSACHUSETTS INSTITUTE OFTECHNOLOGY, U.S.A.
]71[
WO/2000/004458]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A network architecture or framework that supports hosting and content distribution on atruly global scale. The framework allows a Content Provider to replicate and serve itsmost popular content at an unlimited number of points throughout the world. Theframework comprises a set of servers operating in a distributed manner. The actualcontent to be served is preferably supported on a set of hosting servers (36),sometimes referred to as ghost servers. This content comprises HTML page objectsthat, conventionally, are served from a Content Provider site. In accordance with theinvention, however, a base HTML document portion of a web page is served from theContent Provider's site (1), while one or more embedded objects for the page areserved from the hosting servers (3, 4), preferably those hosting servers (5) near theclient machine. By serving the base HTML document from the Content Provider's site,the Content Provider maintains control over the content.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198508,The applications for divisionfrom this application havenot yet been published
__________
![Page 322: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/322.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 322
141061]21][11[
ืืืืื ืืฉืืืืฉ ืืกืื ืืกืจืื ืืฉืืืืืืืืื ืกืจืื ืืขืจืืื ืืช ืื ืกืจืื
ื"ืฉืืคืืืืช ืืฉืชื ืืฉืืืืฉ ืืืืืื ืื
PROTEIN USEFUL AS A MARKERFOR CANCER AND METHOD FORDIAGNOSING PROSTATE ORBLADDER CANCER USING SAIDPROTEIN
]54[
10.08.1999]22[US]33[10.08.1998]32[60/095982]31[
Int. Cl.(2009.01) C07K 14//47, C12N 15//12, C12Q 01//68]51[AGENSYS, INC., U.S.A.]71[WO/2000/009691]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Described is a novel gene and its encoded secreted tumor antigen, termed BPC-1, andto diagnostic and therapeutic methods and compositions useful in the management ofvarious cancers which express BPC-1, particularly including prostate cancer andbladder cancer. In human normal tissues, BPC-1 is only expressed in certain tissues ofthe brain. However, BPC-1 is expressed at high levels in prostate cancer cells and isalso expressed in bladder cancer cells. The structure of BPC-1 includes a signalsequence and a CUB domain. BPC-1 protein is secreted. Preliminary experimentalevidence suggests that BPC-1 is directly involved in oncogenesis or maintenance ofthe transformed phenotype of cancer cells expressing BPC-1. BPC-1 also appears tobind specifically to a cellular protein expressed in prostate cancer cells and other cells.
]57[
__________
![Page 323: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/323.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009323
142025]21][11[
ืืืืื ืื/ืคืคืืืืื) ืคืืื(ืฉืืืืช ืืืฆืืชื ืืจื ืงืฉืจืื'ืขื ืืืงืืงื ืืืงืืจืืืคื
ืืืกืืืคืืืืื
METHODS FOR DISPLAYING(POLY) PEPTIDES/PROTEINS ONBACTERIOPHAGE PARTICLESVIA DISULFIDE BONDS
]54[
20.07.2000]22[EP]33[20.07.1999]32[99114072.4]31[EP18.02.2000 00103551.8
Int. Cl.(2008.04) C07K 14/01, C12N 15/10, 15/33, 7/01, C40B 40/02]51[MORPHOSYS AG, GERMANY]71[WO/2001/005950]87[
,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชื ืืจืฆืืื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจ
EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
The present invention relates to methods for displaying (poly)peptides/proteins on thesurface of bacteriophage particles by attaching the (poly)peptide/proteins via disulfidebonds.
]57[
__________
142905]21][11[
ืืืช ืื ืืืื ืืกืืื ืคืื ืงืฆืืื ืืืื ืฉื ืคืขืHEDGEHOG
FUNCTIONAL ANTAGONISTS OFHEDGEHOG ACTIVITY
]54[
02.11.1999]22[US]33[02.11.1998]32[60/106703]31[
Int. Cl.(2009.01) A61K 38//17, 48//00, C07K 14//435, C12N 15//12]51[CURIS INC., U.S.A.]71[WO/2000/025725]87[
,ืืฉืืชืคืื ืจืืื ืืืื ืืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Variants of hedgehog protein that contain N-terminal modifications are described thatcan block hedgehog function; thus allowing these variants to serve as functionalantagonists. These peptides have a primary amino acid sequence lacking the ability toelicit a hedgehog-dependent response in C3H 10T1/2 cells but having the ability to bindto the hedgehog receptor, patched-1. Methods for producing such functionalantagonists and methods of using the ๏ฟฝ unctional antagonists are also described.
]57[
__________
![Page 324: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/324.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 324
143015]21][11[
ืืืืงื ืืืืืื ืฉื ืืกืืจืืช ืืืฆืืืืืช ืืกืืจืืช ืฉื ืืืืื
SEGMENTATION ANDDETECTION OFREPRESENTATIVE FRAMES INVIDEO SEQUENCES
]54[
07.05.2001]22[US]33[09.05.2000]32[60/202794]31[US09.09.2000 09/677446
Int. Cl.(2009.01) H04N 05//76, 07//12]51[IBM CORPORATION, U.S.A.]71[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A computer-implemented method for organizing a sequence of video frames,comprising: generating a first portion of a segment of the sequence by: for each framebeginning from an initial frame in the sequence, computing a multi-dimensional vectorof parameters indicative of a characteristic of the frame; determining vector distancesbetween the frames in the sequence responsively to differences in the multi-dimensional vector of parameters among the frames; and finding, responsively to thedistances, a bounding subset comprising at least three of the frames in the sequence,chosen so as to maximize a sum of the distances between all of the at least threeframes in the subset, while each of the distances is no greater than a predeterminedmaximum, such that the first portion comprises the frames in the sequence that arebounded by the at least three of the frames in the bounding subset; selecting one of theframes in the first portion to be a representative frame for the segment; and generatinga second portion of the segment by adding to the segment further frames in thesequence subsequent to the first portion while determining that the respectivedistances between the added further frames and the representative frame are within apredefined bound.
]57[
__________
143351]21][11[
ืืจ ืื ืืฉื ืืืืืื ืชื ืืืจื ืืืืจืืื ืืืง ืื ืื ืฉื ืืื ืงืื
HUMAN HYBRID HOST CELLFOR MAMMALIAN GENEEXPRESSION
]54[
08.12.1999]22[US]33[10.12.1998]32[09/209920]31[
Int. Cl.(2008.04) C12N 15/08, 5/02, 5/22, 5/24]51[BAYER CORPORATION, U.S.A.]71[WO/2000/034462]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืืืืืจืืช ืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
![Page 325: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/325.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009325
Human/human hybrid cells were made via fusion of human embryonic kidney cells(293S) and modified Burkitt's lymphoma cells (2B8). The fusion cells are useful as hostcells for the recombinant expression of mammalian genes. The advantages of usingthese hybrid clones of human kidney- and B-cells, called HKBs, for mammalian geneexpression, include (i) the cells are negative for immunoglobulin expression, (ii) thecells grow easily in plasma protein-free medium (with or without the addition ofrecombinant insulin) as suspension cultures in a shake flask or in a fermenter (iii) thecells are very susceptible for transfection of DNA, and (iv) the cells secrete high levelsof heterologous recombinant proteins, such as recombinant monoclonal antibodies,soluble ICAM-1, rIL-4, and rFVIII.
]57[
__________
144043]21][11[
ืฉืืืืฉ ืืจืืืืืืจืืก ืืืื ืช ืชืืฉืืจ ืจืคืืื ืืืืคืื ืืืคืจืขืืช ืืชืจืืืช ืชืืืช
USE OF REOVIRUS FOR THEPREPARATION OF APHARMACEUTICALCOMPOSITION FOR THETREATMENT OF CELLULARPROLIFERATIVE DISORDERS
]54[
18.02.2000]22[US]33[24.02.1999]32[09/256824]31[
Int. Cl.(2008.04) A61K 35/76, A61P 35/00]51[ONCOLYTICS BIOTECH INC.,CANADA
]71[
WO/2000/050051]87[,ืืฉืืชืคืื ืจืืื ืืืื ืืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that itultimately directly contacts ras-mediated proliferating cells. Proliferative disordersinclude but are not limited to neoplasms. Human reovirus, non-human mammalianreovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, serotype1 (e.g., strain Lang), serotype 2 (e.g., strain Jones), serotype 3 (e.g., strain Dearing orstrain Abney), as well as other serotypes or strains of reovirus can be used.Combinations of more than one type and/or strain of reovirus can be used, as canreovirus from different species of animal. Either solid neoplasms or hematopoieticneoplasms can be treated.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
197903,The applications for divisionfrom this application havenot yet been published
__________
![Page 326: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/326.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 326
145145]21][11[
ืฆื ืชืจืื ืืืืืขืืื ืืืืืคื ืขื ืืื ืืคืขืื ืืืื ืืฉืืืืช ืืฉืืืืฉ ืืื
SINGLE OPERATOR EXCHANGECATHETERS AND METHODS OFUSE
]54[
14.12.2000]22[US]33[04.02.2000]32[09/498104]31[
Int. Cl.(2009.01) A61M 25//09, 29//00]51[BOSTON SCIENTIFIC LIMITED,BARBADOS
]71[
WO/2001/056645]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A single operator exchange biliary catheter having a tubular member extendingproximally from the proximal guidewire port. The tubular member defines a guidewirelumen extension adapted to permit the guidewire to be retracted from guidewire lumenand re-inserted therein. By retracting the guidewire from the guidewire lumen and intothe guidewire lumen extension, fluid may be readily injected via the guidewire lumenwithout encountering resistance to fluid flow from the guidewire. The guidewire lumenextension also maintains guidewire lumen access such that the guidewire may beeasily re-inserted into the guidewire lumen.
]57[
__________
145381]21][11[
ืชืืฉืืจืื ืจืคืืืืื ืืืืคืื ืืืืกืืจAืืืงืืืกืืืื ืืกืืโืืืืคื
MEDICAL PREPARATIONS FORTHE TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY
]54[
09.03.2000]22[US]33[11.03.1999]32[09/266014]31[
Int. Cl.(2008.04) A61K 38/46, C12N 15/52, 15/54, 15/56, 15/63, 9/40, C12P 21/02]51[SHIRE HUMAN GENETICTHERAPIES, INC., U.S.A.
]71[
WO/2000/053730]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
![Page 327: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/327.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009327
The invention provides highly purified $g(a)-Gal A, and various methods for purifying it;$g(a)-Gal A preparations with altered charge and methods for making thosepreparations; $g(a)-Gal A preparations that have an extended circulating half-life in amammalian host, and methods for making same; and methods and dosages foradministering an $g(a)-Gal A preparation to a subject.
]57[
__________
145688]21][11[
COATING ืืขืจืืช ืฆืืคืื SYSTEM]54[
29.03.2000]22[US]33[29.03.1999]32[60/126692]31[
Int. Cl.(2008.04) A61K 9/00, 9/28]51[WYETH, U.S.A.]71[WO/2000/057838]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A coating system for application to solid pharmaceutical dosage units, said systemcomprising:(a) a subcoat comprising (i) a water soluble cellulosic material and (ii) a sugarcomponent; and(b) a polish coat comprising polyethylene glycol, wherein the weight ratio of cellulosicmaterial to sugar component within the subcoat ranges from about 40:60 to about85:15 percent by weight.
]57[
__________
![Page 328: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/328.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 328
145759]21][11[
ืชืืืืืช ืืืื ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื
AMINE DERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
06.04.2000]22[JP]33[07.04.1999]32[11/99981]31[
Int. Cl.(2008.04) A61K 314/22, 314/27, 314/37, A61P 19/10, 29/00, 3/10, 35/00,37/02, 43/00, C07D 413/12, 417/12, 471/04
]51[
DAIICHI SANKYO COMPANYLIMITED, JAPAN
]71[
WO/2000/061581]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Amine derivatives represented by general formula (I) or pharmacologically acceptablesalts thereof, which are useful as therapeutic and/or preventive agents for diabetes,hyperlipemia, arteriosclerosis, cancers, and so on: wherein Rยฟ1? is optionallysubstituted carbamoyl or the like; Rยฟ2? is hydrogen or the like; Rยฟ3? is Cยฟ1?-Cยฟ10?alkyl or the like; Wยฟ1?, Wยฟ2? and Wยฟ3? are each independently a single bond orCยฟ1?-Cยฟ8? alkylene; X, Y and Q are each sulfur or the like; Z is =CH- or the like; Ar isa benzene ring or the like; and L is hydrogen or the like.
]57[
__________
145982]21][11[
VACCINE ืชืจืืืื ืืืกืื ADJUVANTS]54[
04.04.2000]22[GB]33[19.04.1999]32[9908885.8]31[US29.04.1999 09/301829
Int. Cl.(2008.04) A61K 39/00, 39/39]51[SMITHKLINE BEECHAMBIOLOGICALS S.A., BELGIUM
]71[
WO/2000/062800]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
![Page 329: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/329.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009329
The present invention relates to adjuvant compositions which are suitable to be used invaccines. In particular, the adjuvant compositions of the present invention comprises asaponin and an immunostimulatory oligonucleotide, optionally with a carrier. Alsoprovided by the present invention are vaccines comprising the adjuvants of the presentinvention and an antigen. Further provided are methods of manufacture of theadjuvants and vaccines of the present invention and their use as medicaments.Methods of treating an individual susceptible to or suffering from a disease by theadministration of the vaccines of the present invention are also provided.
]57[
ืื ืืงืฉืืช ืืืืงื ืืืงืฉื.ืฉืืจ๏ฟฝ ืคืืจืกืื
189736,The applications for divisionfrom this application havenot yet been published
__________
146679]21][11[
SIGNATURE ืืืืืช ืืชืืื ืืืืฆืขืืช ืฉืื ืืืฉืง CAPTURE VIAINTERFACE SURFACE
]54[
24.05.2000]22[AU]33[25.05.1999]32[PQ0559]31[AU30.06.1999 PQ1313AU25.10.1999PQ3632AU01.12.1999PQ4392
Int. Cl.(2009.01) G06K 09//62]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA
]71[
WO/2000/072246]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืืืจืืช ืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method of enabling user interaction with computer software running in a computersystem via an interface surface and a sensing device. The interface surface containsinformation relating to the computer software and coded data indicative of a signaturefield relating to the computer software. When the sensing device is placed in anoperative position relative to the interface surface, it senses indicating data indicative ofthe signature field. The sensing device also generates movement data indicative of thesensing device's movement. The indicating data and the movement data are receivedfrom the sensing device, and the signature field is identified. Once the signature hasbeen identified, the computer software is operated in reliance on the movement data,and in accordance with instructions associated with the signature field.
]57[
![Page 330: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/330.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 330
__________
146887]21][11[
ืคืจืืกืชืื ืกืงืืจืืืช ืืืืคืื ืืคืจืกืืืืคืื ืืืืืืช ืืืจืืช ืฉื ืืขืื
IMPROVED SCLERALPROSTHESIS FOR TREATMENTOF PRESBYOPIA AND OTHEREYE DISORDERS
]54[
07.06.2000]22[US]33[07.06.1999]32[60/138105]31[
Int. Cl.(2009.01) A61F 02//14]51[RAS HOLDING CORPORATION,U.S.A.
]71[
WO/2000/074600]87[,ืืจืืื ืืืื ืืื ืืฉืืชืคื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Presbyopia and other eye disorders are treated by implanting within a plurality ofelongated pockets formed in the tissue of the sclera of the eye transverse to a meridianof the eye, a prosthesis having an elongated base member having an inward surfaceadapted to be placed against the inward wall of the pocket and having a ridge on theinward surface of the base extending along at least a major portion of the majordimension of the base. The combined effect of the implanted prostheses is to exert aradially outward traction of the sclera in the region overlying the ciliary body whichexpands the sclera in the affected region together with the underlying ciliary body. Theexpansion of the ciliary body restores the effective working distance of the ciliarymuscle in the presbyopic eye and thereby increases the amplitude of accommodation.Introduced is an improved scleral prosthesis for the treatment of presbyopia and othereye disorders. An exemplary prosthesis is adapted for contact with the sclera of aneyeball, and comprises a body having a first end and a second end wherein the bodyhas (i) a planform adapted to expand the contacted sclera to increase the effectiveworking distance of the ciliary muscle of the eyeball, and (ii) means for stabilizing theprosthesis within the surgically formed pocket within the sclera of the eyeball.
]57[
![Page 331: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/331.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009331
__________
147214]21][11[
ืืชืื ืงืจืืืคืื ื ืืชืืฉืืจืโ1ืชืืืืืช ืืช ืืืืืืื ืืืชืืจืืงื
1-METHYLCARBAPENEMDERIVATIVES ANDPHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
06.07.2000]22[JP]33[06.07.1999]32[11/191368]31[
Int. Cl.(2008.04) A61K 314/07, C07D 477/20]51[DAIICHI SANKYO COMPANYLIMITED, JAPAN
]71[
WO/2001/002401]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Crystals of compound (I) or pharmacologically acceptable salts thereof, which exhibitan excellent antimicrobial activity and are so excellent in storage stability andhandleability as to be put into practical use as antimicrobial agents. Crystals ofcompound (I) or pharmacologically acceptable salts thereof, which exhibit an excellentantimicrobial activity and are so excellent in storage stability and handleability as to beput into practical use as antimicrobial agents.
]57[
__________
![Page 332: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/332.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 332
147963]21][11[
ืืขืจืืช ืฉืชื ืจืคืืืืช ืขื ืฉืืืืจ ืื ืจืืื ืืืืืื
MEDICAL IMPLANT APPARATUSWITH WIRELESS ENERGYTRANSMISSION
]54[
01.08.2000]22[US]33[12.08.1999]32[60/148345]31[US14.02.2000 60/182223
Int. Cl.(2008.04) A61F 2/48]51[POTENCIA MEDICAL AG,SWITZERLAND
]71[
WO/2001/012108]87[,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชื
ืืจืฆืืื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
A medical implant apparatus include or use an energy transmission means for wirelesstransmission of energy of a first form from outside a patient's body. An implantedmedical device is operable in response to energy of a second form different than theenergy of the first form. An implanted energy transforming means transforms energy ofthe first form wirelessly transmitted by the energy transmission means into energy ofthe second form for use in the control and operation of the medical device.
]57[
__________
148505]21][11[
PROGRESSIVE ืขืืฉืืช ืืืชืืืกืคืืช ืืืืคื ืืืจืืชื ADDITIONLENSES
]54[
25.08.2000]22[US]33[05.09.1999]32[391095]31[
Int. Cl.(2009.01) G02C 07//00, 07//06]51[ESSILOR INTERNATIONAL(COMPAGNIE GENERALED'OPTIQUE), FRANCE
]71[
WO/2001/018591]87[The present provides progressive addition lens designs and lenses in which unwantedlens astigmatism is reduced as compared to conventional progressive addition lenses.
]57[
![Page 333: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/333.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009333
__________
149108]21][11[
ืชืืืื, ืชืจืืืืืช ืืืงืกืืืืกืคืืืืืืจืืืื ืจืืงืืืื ืืืืืืื ืืืชื, ืืืื ืชื
ืืฉืืืืฉืืื ืืืื ืช ืชืจืืคื ืืืืคืื ืืืคืจืขื ืืงืฆื ืืื
OXABISPIDINE COMPOUNDS,PROCESS FOR THEIRPREPARATION,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM AND USE THEREOF INTHE PREPARATION OF AMEDICAMENT FOR THETREATMENT OF ARRHYTHMIA
]54[
13.10.2000]22[SE]33[18.10.1999]32[9903759-0 ]31[
Int. Cl.(2008.04) A61K 315/383, A61P 9/06, C07D 265/30, 303/36, 498/08]51[ASTRAZENECA AB, SWEDEN]71[PEDER SVENSSON, ANNIKABJORE, MAGNUS BJORSNE, DAVIDCALDINGBOEL, KURT-JURGENHOFFMAN, JOHN PAVEY, FRITIOFPONTEN, GERT STRANDLUND,COLIN THOMSON, JOHANMICHAEL WILSTERMANN
]72[
WO/2001/028992]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is provided compounds of formula (I), wherein R?1ยฟ, R?2ยฟ, R?3ยฟ, R?4ยฟ,R?41ยฟ to R?46ยฟ, A, B and G have meanings given in the description, which are usefulin the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventriculararrhythmias.
]57[
![Page 334: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/334.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 334
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
183854,183853,183852,The applications for divisionfrom this application havenot yet been published
__________
149249]21][11[
ืจืืฉืื ืืฉืืืืฉ ืืฉื ืืืืืื ืืฉืคื ืืงืืืืช
NATIVE LANGUAGE DOMAINNAME REGISTRATION ANDUSAGE
]54[
17.08.2001]22[US]33[21.08.2000]32[09/642471]31[
Int. Cl.(2008.04) G06F 17/28, H04L 29/06]51[KI SEOK KIM, U.S.A.JIYUL YOO, U.S.A.
]71[
WO/2002/017204]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A domain name system includes a native language domain name registrar (105), whichreceives a native language domain name, containing at least one non-alphanumericcharacter, registration request and converts the native language domain name into analphanumeric domain name. The alphanumeric domain name is used in the domainname/IP address entry in the domain name server (DMS) (103).
]57[
__________
![Page 335: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/335.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009335
149325]21][11[
ืื ืื ืคืืืืคืคืืืืื ืืืื ืืื ืกืื ืชืืืื ืืฉืืืืฉื ืืืืคืื ืืืืืืช ืืืืืืืืื ืืืช
SYNTHETIC HUMAN GENES ANDPOLYPEPTIDES AND THEIR USEIN THE TREATMENT OFAUTOIMMUNE DISEASES
]54[
26.10.2000]22[IL]33[27.10.1999]32[132611]31[
Int. Cl.(2008.04) A61K 38/17, C07K 14/47, C12N 15/62]51[AVRAHAM ืืื ื, ื ืื-ืืืจืื ืื BEN-NUN]71[
ืื, ื ืืงืื ืงืจืื ืื ืจืืกืื ืคืื, ื ืื-ืืืจืื ืืจืืืจ ืกืคืืจ
NICOLE KERLERO DE ROSBO,AVRAHAM BEN-NUN, PAULGREGOR SAPPLER
]72[
WO/2001/031037]87[',ืจ ืื ืืฉืืช"ื
ืจืืืืืช, 2189.ื.ืช,2ืคืงืจืืก' ืจืWEBB & ASSOCIATES,2 PEKERIS ST., P.O.B. 2189,
REHOVOT 76121
]74[
Synthetic human target autoantigen genes comprising sequences coding for at leasttwo immunogenic epitopic clusters (hereinafter IEC) of autoantigen(s) related to aspecific autoimmune disease, wherein said at least two IECs may be derived from asole autoantigen or from at least two different autoantigens related to said autoimmunedisease, and polypeptides encoded thereby, can be used for the treatment and thediagnosis of autoimmune diseases such as multiple sclerosis (MS), insulin-dependentdiabetes mellitus (IDDM), rheumatoid arthritis (RA), myasthenia gravis (MG) anduveitis.
]57[
__________
149496]21][11[
ืจืืงืืืื ืืฉืืืืฉื ืืืืคืื ืืจืืืื ืืืขืจืืช ืืขืืืื
PHARMACEUTICALCOMBINATIONS AND THEIR USEIN TREATINGGASTROINTESTINALDISORDERS
]54[
08.12.2000]22[US]33[10.12.1999]32[09/458388]31[
Int. Cl.(2008.04) A61K 45/00]51[NOVARTIS AG, SWITZERLAND]71[WO/2001/041748]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to a combination of a first agent including either a 5-HTยฟ4? receptor agonist or antagonist or a 5-HTยฟ3? receptor antagonist and a co-agentand pharmaceutical compositions and formulations containing the combination. The
]57[
![Page 336: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/336.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 336
pharmaceutical combination may be employed for the treatment of alteredgastrointestinal motility, sensitivity, secretion or abdominal disorders. The dosage ispreferably oral. The preferred first agent is tegaserod.
__________
150153]21][11[
ืชืืฉืืจืื ืืฉืืืืฉืื,GโCSFืชืฆืืืื ืฉืืื
G-CSF CONJUGATES,COMPOSITIONS AND USESTHEREOF
]54[
09.01.2001]22[DK]33[10.01.2000]32[PA200000024]31[DK02.03.2000 PA200000341DK16.06.2000PA200000943
Int. Cl.(2008.04) A61K 45/00, 47/48, C07K 145/35, 17/08, C12N 15/27]51[MAXYGEN HOLDINGS LTD., U.S.A.]71[WO/2001/051510]87[
,ืืฉืืชืคืืืจืืื ืืืื ืืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to polypeptide conjugates comprising a polypeptide exhibiting G-CSF activity and having an amino acid sequence that differs from the amino acidsequence of human G-CSF in at least one specified introduced and/or removed aminoacid residue comprising an attachment group for a non-polypeptide moiety, and havingat least one non-polypeptide moiety attached to an attachment group of thepolypeptide. The attachment group may e.g. be a lysine, cysteine, aspartic acid orglutamic acid residue or a glycosylation site, and the non-polypeptide moiety may e.g.be a polymer such as polyethylene glycol or an oligosaccharide. The conjugate hasone or more improved properties such as increased biological half-life and reducedside effects.
]57[
__________
![Page 337: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/337.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009337
150636]21][11[
ืฉืืื ืืืชืงื ืืืืฆืืจ ืืจืืืื ืืจืืืืืืืื ืชืคืืจืโืืกืืืื ืื ืจืงืืืื ืขื
ืืื ืืืชโืืืืจื
METHOD AND DEVICE FORPRODUCTION OF COMPOSITENON-WOVEN FIBRE FABRICS BYMEANS OF HYDRODYNAMICNEEDLING
]54[
13.01.2001]22[DE]33[17.01.2000]32[10001723.1]31[DE03.02.2000 10004448.4
Int. Cl.(2009.01) A61F 13//15, 13//511, D04H 01//46, 13//00]51[FLEISSNER GMBH & CO.MASCHINENFABRIK, GERMANY
]71[
WO/2001/053588]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A conventional method for the production of a composite non-woven fibre fromat least one spun non-woven fibre and subsequent application of a wood pulplayer to the above for production of a hygiene product is known. Accordingly,the spunbonded non-woven fibre is hydrodynamically needled, before theapplication of the pulp layer, in order to increase the fluid dispersionproperties. Consequently, the pulp layer can no longer be needled, as the pulpwould be washed out through the non-woven fibre. Due to the requiredabrasion resistance a bonding of the non-woven fibre is, however, necessary.According to the invention, the above problem is resolved, whereby a non-woven fibre is compressed or calendered with compressed air, as a pre-bonding treatment, before coating with the super-absorbent material, then thewoodpulp layer is applied and both are bonded with a hydrodynamic waterneedling, followed by drying. A further calandering can be added. A furtherpre-bonded, in other words, calendered spunbonded, or card non-woven fibrecan be applied to the spunbonded non-woven fibre as support layer, or thereverse.
]57[
__________
![Page 338: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/338.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 338
150972]21][11[
ืื ืืโืฉืืื ืืืชืงื ืืคืืงืื ืขื ืืืืจืชืืืงืืืืคืจืื ืฉื ืืื ืืชืืงืื ืืกืืืืื
ืืขืจื ืืืฃ
METHOD AND APPARATUS FORMONITORING THE ADVANCE OFSEAWATER INTO FRESH WATERAQUIFERS NEAR COASTALCITIES
]54[
30.01.2001]22[US]33[04.02.2000]32[60/180572]31[US08.02.2000 60/180981
Int. Cl.(2009.01) E03B 01//00, E21B 47//10]51[SCHLUMBERGER TECHNOLOGYCORPORATION, U.S.A.
]71[
WO/2001/057361]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Sensors are permanently placed in the ground near observation and injection wells inorder to passively and continuously monitor the status of seawater advance towardfresh water aquifers near coastal cities as well as the status of fresh water injected intothe injection wells. Such sensor devices are installed in the ground and electricallyconnected to surface acquisition equipment that would, without human intervention,transmit acquired data to a centralized facility for processing and interpretation. Varioustypes of sensors can be used: the sensors used for general reservoir monitoring and/orthe sensors used for leak detection, soil heating, and temperature mapping.Alternatively, a special type of sensor can be designed and provided for the purpose ofmonitoring the status of seawater advance toward fresh water aquifers.
]57[
__________
![Page 339: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/339.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009339
151139]21][11[
ืืจื, ืชืืืื ืืคืืจืืง ืชืืืืฆืช ืื ืงื ืืช ืงืชืืขืืืจื ืืชืืืื ืืืค
PROCESS FOR DECOMPOSINGN2O, CATALYST THEREFOR ANDPROCESS FOR ITS PRODUCTION
]54[
07.02.2001]22[DE]33[11.02.2000]32[10006103.6]31[
Int. Cl.(2008.04) B01D 53/86]51[UHDE GMBH, GERMANY]71[WO/2001/058570]87[
,ืคืจื ืืื ืฆืืง ืืฆืจ, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืื ืืจืื
ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a method for decomposing Nยฟ2?O during theproduction of nitric acid by bringing the waste gas, which containsNยฟ2?O and which is exiting the absorption column, into contact with acatalyst containing at least one oxidic cobalt compound and at least oneoxidic magnesium compound. The waste gas is brought into contactwith the catalyst under conditions that permit Nยฟ2?O to be convertedinto gaseous nitrogen and oxygen. The content of oxidic cobaltcompounds ranges from 0.1 to 50 wt. %, and the content of oxidicmagnesium compounds range from 50 to 99.9 wt. % each with regard tothe total mass of the catalyst. At least 30 % of the cobalt atoms in thecatalyst are provided in a trivalent state. The production of the catalystincludes a dry mixing of the oxidic cobalt compounds and the oxidicmagnesium compounds or corresponding precursors, which aretransformed into oxidic compounds by annealing, and involves acompacting of the mixture while eliminating water until the resultingcatalyst has the desired bulk density.
]57[
__________
![Page 340: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/340.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 340
151216]21][11[
ืคืืืจืคืืืื ืื ืื ืืืจืืช ืฉืืื ืชืืืื ืืืื ืชื ืืืฉืืืฉ ืืื
PLURAFLAVINS ANDDERIVATIVES THEREOF,PROCESS FOR THEIRPREPARATION AND USETHEREOF
]54[
15.02.2001]22[EP]33[18.02.2000]32[00103540.1]31[
Int. Cl.(2009.01) A61K 31//70, A61P 03//00, 31//00, 35//02, C07H 05//06, 17//04,C12P 19//26, 19//60, C12R 01//04
]51[
SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY
]71[
WO/2001/060832]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a compound of formula (I) wherein Rยฟ1? is a sugar; Rยฟ2? is -CHยฟ2?-O-(Rยฟ7?)m, Rยฟ7? representing a sugar, or Rยฟ2? is -COOH; Rยฟ3? is anepoxide-comprising group, Cยฟ1?-Cยฟ6?-alkyl or Cยฟ2?-Cยฟ6?-alkenyl, unsubstituted orsubstituted by at least one OH; Rยฟ5? is H, Cยฟ1?-Cยฟ6?-alkyl, Cยฟ2?-Cยฟ6?-alkenyl orCยฟ2?-Cยฟ6?-alkynyl; Rยฟ4?, Rยฟ6?, Rยฟ8? and Rยฟ10? independently of one another areH,Cยฟ1?-Cยฟ6?-alkyl, Cยฟ2?-Cยฟ6?-alkenyl, Cยฟ2?-Cยฟ6?-Alkynyl, -Xยฟ2?H, or -Xยฟ2?Rยฟ12?, or Rยฟ4? and Rยฟ6? together and/or Rยฟ8? and Rยฟ10? together are =Xยฟ2?;Xยฟ2? is O, NH, N-Cยฟ1?-Cยฟ6?-alkyl, N-Cยฟ2?-Cยฟ6?-alkenyl, N-Cยฟ2?-Cยฟ6?-alkynyl or S;Rยฟ12? is Cยฟ1?-Cยฟ6?-Alkenyl, Cยฟ2?-Cยฟ6?-alkynyl, Cยฟ2?-Cยฟ6?-alkynyl, aryl or acyl;and m and n are 1 or 2; and its physiologically acceptable salts. The compounds areobtainable from a culture of the microorganism Actinomycetales species HAG 003959,DSM 12931, by fermentation. Accordingly, the invention relates to a process for theirpreparation and to the use of the compounds as pharmaceuticals, for example as anti-tumor agents.
]57[
__________
![Page 341: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/341.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009341
151240]21][11[
POLYPROPYLENE ืกืืื ืคืืืืคืจืืคืืื FIBRES]54[
19.02.2001]22[EP]33[18.02.2000]32[00200552.8]31[
Int. Cl.(2008.04) D01F 6/06, 6/46, D04H 3/00]51[ATOFINA RESEARCH, BELGIUM]71[WO/2001/061084]87[
,ื"ืืข) 1995(ืืจืืื.ืื.ื'ืืจืืื ืื ืื ืืืื,15ืงืืื, ืืืื ืืืืื
ืื, 11 ืจืืช
G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,RAMAT GAN 52521
]74[
A polypropylene fibre including at least 80 % by weight of a first isotactic polypropyleneproduced by a metallocene catalyst, and from 5 to 20 by weight of a second isotacticpolypropylene produced by a Ziegler-Natta catalyst.
]57[
__________
151372]21][11[
ืชืืืืืช ืคืืจืืืืืื ืขื ืฆืืงืืืคืจืืคืื ืืืชื ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื
CYCLOPROPYL-FUSEDPYRROLIDINE DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
05.03.2001]22[US]33[10.03.2000]32[60/188555]31[
Int. Cl.(2008.04) A61K 314/03, A61P 3/04, 3/06, 3/10, C07D 209/52]51[BRISTOL-MYERS SQUIBBCOMPANY, U.S.A.
]71[
WO/2001/068603]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided having the formula (I)where x is 0 or 1 and y is 0 or 1 (provided that x = 1 when y = 0 and x = 0 when y = 1);n is 0 or 1; X is H or CN; and wherein R?1ยฟ, R?2ยฟ, R?3ยฟ and R?4ยฟ are as describedherein. A method is also provided for treating diabetes and related diseases, especiallyType II diabetes, and other diseases as set out herein, employing such DP 4 inhibitoror a combination of such DP 4 inhibitor and one or more of another antidiabetic agentsuch as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulinand/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or othertherapeutic agent.
]57[
![Page 342: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/342.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 342
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
177019,177018,The applications for divisionfrom this application havenot yet been published
__________
151705]21][11[
ืืื ืืืชืงื ืืืงืจืช ืฉืืืืจืื ืืืขืจืืชืฉ ืชืงืฉืืจืช
METHOD AND APPARATUS FORCONTROLLING TRANSMISSIONSOF A COMMUNICATIONSSYSTEM
]54[
20.03.2001]22[US]33[30.03.2000]32[09/539157]31[
Int. Cl.(2008.04) H04B 17/00, 17/07, 7/26, 70/05, H04J 1/00, 1/05, 11/00, 3/00,H04Q 7/28, 7/36, 7/38
]51[
QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2001/076098]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
In some aspects, each cell in the communications system can bedesigned to operate in accordance with a set of back-off factors thatidentify the reductions in peak transmit power levels for the channelsassociated with the back-off factors. The back-off factors are defined toprovide the required power to a large percentage of the users whilereducing the amount of interference. In some other aspects, the cellsoperate using an adaptive reuse scheme that allows the cells toefficiently allocate and reallocate the system resources to reflectchanges in the system. A reuse scheme is initially defined and resourcesare allocated to the cells. During operation, changes in the operatingconditions of the system are detected and the reuse scheme is redefinedas necessary based on the detected changes. For example, the loadingconditions of the cells can be detected, and the resources can be
]57[
![Page 343: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/343.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009343
reallocated and/or the reuse scheme can be redefined. In yet otheraspects, techniques are provided to efficiency schedule datatransmissions and to assign channels to users. Data transmissions can bescheduled based on user priorities, some fairness criteria, systemrequirements, and other factors. Users are assigned to available channelsbased on a number of channel assignment schemes. Channel metrics arealso provided, which can be used to prioritize users and for channelassignments.
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
197980,The applications for divisionfrom this application havenot yet been published
__________
151772]21][11[
ืงืคืกืืืจื ืกืืืจโืชืืืืืื ืืืื ืช ืจื ืคื ืืืืงืืงืื
METHODS FOR PRODUCINGPNEUMOCOCCAL CAPSULARPOLYSACCHARIDE
]54[
16.03.2001]22[US]33[16.03.2000]32[60/189847]31[
Int. Cl.(2009.01) A61K 39//09, C12N 01//20, C12P 19//00, C12Q 01//04]51[THE CHILDREN'S HOSPITAL OFPHILADELPHIA, U.S.A.
]71[
WO/2001/068903]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention relates to methods of modulating capsular polysaccharide production inpneumococci such as Streptococcus pneumoniae. The invention further relates tomethods of alleviating pneumococcal infections in animals, and to methods ofidentifying both agents capable of modulating pneumococcal infections in animals.Figure (1) comprising figures 1Ai-1Avi and 1Bi-1Bvi is a series of images indicating theeffect of environmental oxygen and carbon dioxide concentration on colony morphologyand capsule size, as assessed using the Quellung reaction.
]57[
![Page 344: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/344.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 344
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
191962,The applications for divisionfrom this application havenot yet been published
__________
151858]21][11[
ืืชืงื ืืฉืืื ืืืืคืื ืืื ืฉืืืื ืืืชื ืฉืชื ืื ืงืืืช
DEVICE AND METHOD FORTREATING URINARYINCONTINENCE IN FEMALES
]54[
21.03.2001]22[US]33[21.03.2000]32[09/531856]31[
Int. Cl.(2009.01) A61F 05//48]51[DURAMED PHARMACEUTICALS,INC., U.S.A.
]71[
WO/2001/070154]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
Provided herein is a novel and useful device and method for locallydelivering and controllably releasing oxybutynin in the cervical regionof a female. A device of the invention comprises a ring comprisingtrifluoropropylmethyl/dimethyl siloxane elastomer. A pharmaceuticalcomposition comprising oxybutynin and an excipient is placed within abore located in the ring, wherein the bore runs from the surface of thering into the ring. The ring has a sufficient size such that it can beinserted into the vaginal canal of a female. A cap comprising is placedover the bore at the surface of the ring in order to contain thepharmaceutical composition within the bore. When the ring is insertedinto the vaginal canal, the trifluoropropylmethyl/dimethyl siloxaneelastomer controllably releases and locally delivers a therapeuticallyeffective amount of oxybutynin to the detrusor muscle to treat thefemale's urinary incontinence.
]57[
__________
![Page 345: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/345.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009345
152328]21][11[
ืฉื ืชืืฉืืจืื ืืืืืืื ืฉืืืืื ืืชืจ ืคืงืืืจืื ืืคืืืจืืืื ืืืื ืื
ืืืืืคืืืืืื ืืฉืืืืฉื
FORMULATIONS CONTAINING ACOMBINATION OFDEFIBROTIDE AND ONE ORMORE HAEMATOPOIETICFACTORS AND USES THEREOF
]54[
10.04.2001]22[EP]33[18.04.2000]32[00830293.7]31[
Int. Cl.(2008.04) A61K 31/70, 38/19, A61P 7/00]51[GENTIUM SPA, ITALY]71[WO/2001/078761]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A description is given of a method of increasing the amount of stem cells andprogenitor cells in the peripheral blood of a mammal; the method is characterised bythe administration of defibrotide in combination or in temporal proximity with at leastone haematopoietic factor, (preferably G-CSF) having the capacity to mobilisehaematopoietic progenitors.
]57[
__________
152372]21][11[
ืืืฃ ืืืืื ืืฉืืื ืืืื ืืืื ืืื ืืืฉืืฉ ืื
ELECTRIC IMMERSIONELEMENT AND WATERHEATER USING SAME
]54[
20.10.2002]22[Int. Cl.(2008.04) F24H 1/20]51[
HAIM ืืจืืื, ืืืื ืืื HAZAN]71[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
![Page 346: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/346.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 346
152528]21][11[
,3ืืืื ืืกืืื ืืืจื ืจืืืื ืฉื ืืื ืชืืฉืืจื ืจืืงืืืช ืืืื ืชื
BETA3 ADRENERGIC AGONISTS,PHARMACEUTICALCOMPOSITIONS AND THEIRPREPARATION
]54[
09.07.2001]22[US]33[13.07.2000]32[60/217965]31[US19.10.2000 60/241614 US23.05.200160/292988
Int. Cl.(2009.01) A61K 31//14, A61P 03//04, C07D 20/7/333, 40/9/00]51[ELI LILLY & CO., U.S.A.]71[WO/2002/006276]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention relates to a $g(b)ยฟ3? adrenergic receptor agonist of formula (I)or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energyexpenditure in cells and, therefore, is useful for treating Type II diabetes and/or obesity.The compound can also be used to lower triglyceride levels and cholesterol levels orraise high density lipoprotein levels or to decrease gut motility. In addition, thecompound can be used to reduced neurogenic inflammation or as an antidepressantagent. Compositions and methods for the use of the compounds in the treatment ofdiabetes and obesity and for lowering triglyceride levels and cholesterol levels orraising high density lipoprotein levels or for decreasing gut motility are also disclosed.
]57[
__________
![Page 347: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/347.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009347
152561]21][11[
DISPOSABLE ืืชืงื ืงืืืข ืืืฆืื ื ืื ืคืขืื EXTERNALFIXATION DEVICE
]54[
02.03.2001]22[EP]33[26.05.2000]32[00830380.2]31[
Int. Cl.(2008.04) A61B 17/64]51[ORTHOFIX S.R.L., ITALY]71[DANIELE VENTURINI, SANDORBERKI, ANTAL INSPERGER
]72[
WO/2001/091655]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a novel disposable axial external fixation device for reducingbone fractures, of the type comprising an extendible rod-like middle body (2) andoppositely located bone screw clamps (5, 6) which are articulated to the respectiveends (3, 4) of the rod-like middle body (2) by means of ball joints. Advantageously, aball-and-socket joint (16) is mounted to each clamp (5, 6), within a main body (20) withwhich means (25, 26, 21, 22, 23) for clamping bone screws clamping is associated orco-operates. It is also provided an ancillary member (30) adapted for releasableassociation with one end of each clamp (5, 6) to better adapt each clamp for use indifferent conditions of installation of the fixation device.
]57[
__________
![Page 348: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/348.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 348
152625]21][11[
ืื ืคืคืืืืื ืืืืื ืื ืืื ืกืื ืชืืืื ืืbืืืืืืืืืื ืืื ืฉืืื ืขืจื ืืืืืืืืืื
ืืฉื ืืฆืืจืช ืชืืืื ืืืกืื ืืช ืืืืืืืืืืbืืืืฉืงืขืื ืืืืืืืืืืืื
SYNTHETIC IMMUNOGENIC BUTNON-AMYLOIDOGENICPEPTIDES HOMOLOGOUS TOAMYLOID B FOR INDUCTION OFAN IMMUNE RESPONSE TOAMYLOID B AND AMYLOIDDEPOSITS
]54[
22.05.2001]22[US]33[22.05.2000]32[60/205578]31[
Int. Cl.(2009.01) A61K 38//17, 39//00, A61P 03//00, 37//04, C07K 14//47, 19//00]51[NEW YORK UNIVERSITY, U.S.A.]71[WO/2001/090182]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The present invention relates to synthetic immunogenic but non-amyloidogenicpeptides homologous to amyloid $g(b) which can be used alone or conjugated to animmunostimulatory molecule in an immunizing composition for inducing an immuneresponse to amyloid $g(b) peptides and amyloid deposits.
]57[
__________
152645]21][11[
METHOD ืฉืืื ืขืืืจ ืืืื ื ืฉื ืฆืืืืืืคืจืื FOR THEPREPARATION OF CITALOPRAM
]54[
10.05.2001]22[DK]33[12.05.2000]32[PA200000783]31[
Int. Cl.(2009.01) C07D 30/7/00, 30/7/87]51[H. LUNDBECK A/S, DENMARK]71[WO/2001/085712]87[
',ืจ ืฉืืื ืืื ืืฉืืช"ื ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืื
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
![Page 349: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/349.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009349
A method for the preparation of citalopram comprising reaction of acompound of formula 5-aminomethyl-1-(3-dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran with an oxidising agent toprepare citalopram.
]57[
__________
152770]21][11[
ืฉืืืืฉ ืืื ืืืืื ืฉื ืืืืืคื ืืื ืืืื ืช ืชืืฉืืจืื ืืืืคืื ืืืคืจืขืืช ืฉืื ื
GABAPENTIN ANALOGUES FORUSE IN THE PREPARATION OFCOMPOSITIONS FOR TREATINGSLEEP DISORDERS
]54[
18.05.2001]22[US]33[26.06.2000]32[60/214171]31[
Int. Cl.(2008.04) A61K 311/97, A61P 25/00, C07C 229/28]51[WARNER-LAMBERT COMPANYLLC, U.S.A.
]71[
WO/2002/000209]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention provides a new use of compounds for formula (1) or (1A) or apharmaceutically acceptable salt thereof. The compounds are useful in the treatment ofinsomnia and related disorders.
]57[
__________
![Page 350: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/350.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 350
152786]21][11[
ืชืืืืฉืช ืขืืจืืช ืืืงืื ืขื ืืกืืืคืืืืื ืฆืื ืื ืืืืืฉ ืืืฃ, ืฉื ืฉืืขืื
SKIN PATCH FOR THE RELIEFOF THE SYMPTOMS OF COUGH,COLD AND NASALCONGESTION
]54[
12.05.2000]22[Int. Cl.(2009.01) A61K 09//00, 09//70]51[LECTEC CORPORATION, U.S.A.]71[WO/2001/089475]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A vaporizable decongestant is supported and stabilized on a flexible foraminous carriercomposed typically of open-cell plastic foam, cloth or other fibrous material such asnonwoven fabric. The term 'foraminous' herein is intended to refer to a substance ormedium containing minute openings or perforated by many minute apertures. Thedecongestant is placed on the surfaces within the interstices and minute apertures oron fibers from which the foraminous carrier is formed. Vaporization of the inhalabledecongestant is facilitated by providing the potential for greatly increasing its exposedsurface area. Distributing the decongestant composition over the large, expandedsurface within the foraminous carrier is beneficial in enhancing both the volatilizationand evaporation of the decongestant agent. It also prolongs the useful life of theproduct. Once vaporized, the aromatic decongestant is available for natural inhalationthrough the nose or mouth to help relieve one or more of the symptoms of cough,colds, nasal or chest congestion and related symptoms. The foraminous carrier ispreferably provided in the form of a patch or sheet that is bonded to the skin to serveas a supporting base for the active decongestant agent. The patch defining the carrieris typically adhesively bonded to the upper part of the body, e.g. on the face, neck orchest, in a location where the decongestant is liberated into the air and can be inhaledthrough the mouth or nose.
]57[
__________
![Page 351: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/351.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009351
153100]21][11[
ื PARTICULATE ืืงืืงืืืืงืกืื ืืชืืชื METAL OXIDE]54[
25.06.2001]22[GB]33[26.06.2000]32[0015381.7]31[
Int. Cl.(2008.04) C01B 13/14, C01G 230/53, C09C 1/36]51[CRODA INTERNATIONAL PLC,UNITED KINGDOM
]71[
WO/2002/000797]87[',ืืืจืืืืฅ ืืฉืืช.ืฉ
ืชื, 41-45ืืจืืช ืจืืืฉืืืืฉ, ืืืช ืฆืืื ืืืื
S. HOROWITZ & CO.,ZION HOUSE,
41-45 ROTHSCHILD BLVD.,TEL AVIV 65784
]74[
A particulate metal oxide having the mean length of the primaryparticles in the range from 50 to 90 nm, the mean width of the primaryparticles in the range from 5 to 20 nm, and the median volume particlediameter of the secondary particles is less than 45 nm. The metal oxidecan be used in a sunscreen product that exhibits both effective UVprotection and improved transparency.
]57[
__________
153257]21][11[
ืฉืืื ืืืงืืจืื ืืช ืืืขืืจื ืืืืืช ืฉื ืฉืืื ืขื ืืืืข ืืื
ELECTRONIC CHAT ANDINSTANT MESSAGING WITH INKDATA
]54[
01.06.2001]22[US]33[19.06.2000]32[09/596926]31[
Int. Cl.(2008.04) G06F 13/00, 3/00]51[INTEL CORPORATION, U.S.A.]71[WO/2001/098929]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A method and apparatus for implementing ink data communication between multipleparties using computing and/or communication devices on a network is disclosed. Anelectronic chat system comprising a hardware interface layer for receiving raw ink datafrom an input device, an ink management layer for processing the raw ink data into aform usable by a chat interface layer, and a network interface layer for transferring theprocessed ink data across a network to a chat interface layer on a remote computer.
]57[
![Page 352: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/352.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 352
__________
153719]21][11[
ืืืฉืืจ ืืฉืืื ืืืืคืื ืชืื ื ืจืชืืงื ืื, ืืืฅ ื ืจืชืืงื ืืืืงืืช ืคืืืจืืชืืืช
ืืืจืืืืืช ืื ืืคืืืืืช, ืืืืืงืืืช
DEVICE AND METHOD FORINTRAVAGINAL ORTRANSVAGINAL TREATMENTOF FUNGAL,BACTERIAL, VIRAL ORPARASITIC INFECTIONS
]54[
25.06.2001]22[US]33[11.07.2000]32[09/613441]31[
Int. Cl.(2008.04) A61F 6/06, A61K 9/00]51[UMD, INC., U.S.A.]71[WO/2002/003896]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
Devices, methods, and compositions for treating vaginal fungal,bacterial, viral and parasitic infections by intravaginal or transvaginaladministration of therapeutic and/or palliative antifungal, antibacterial,antiviral or parasiticidal drugs to the vagina or to the uterus.
]57[
__________
![Page 353: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/353.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009353
153804]21][11[
ื ืืืจืืช ืืืจืืืื ืืชืืฉืืจืื ืคืจืืฆืืืืื ืืืืื ืืืชืืื
TYROSINE DERIVATIVES ANDPHARMACEUTICALFORMULATIONS CONTAININGTHEM
]54[
05.07.2001]22[US]33[06.07.2000]32[60/216201]31[
Int. Cl.(2008.04) A61K 31/10, 31/18, A61P 3/10, 35/00, C07C 311/06, 311/13,311/19, 311/29, 317/28, 317/32, 323/24, 323/31
]51[
ARRAY BIOPHARMA INC., U.S.A.AMGEN INC., U.S.A.
]71[
WO/2002/004412]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Disclosed are compounds of the Formula (I), and pharmaceutically acceptable saltsand prodrugs thereof, wherein A, B, R?1ยฟ, R?2ยฟ, R?3ยฟ, R?4ยฟ and R?5ยฟ are asdefined in the specification. Such compounds are tyrosine phosphatase inhibitors anduseful in the treatment or prevention of Type II Diabetes Mellitus. Also encompassed bythe invention are formulations comprising the noted compounds, processes forpreparing such compounds, a method for treating or preventing Type II DiabetesMellitus.
]57[
__________
154130]21][11[
ISO-TRUSS ืงืืจืืชโืืื ื ืฉืืื STRUCTURE]54[
27.07.2001]22[US]33[28.07.2000]32[60/221445]31[
Int. Cl.(2008.04) B62K 19/02, E01D 6/00, E01F 90/11, E04C 3/08, E04H 12/00]51[BRIGHAM YOUNG UNIVERSITY,U.S.A.
]71[
WO/2002/010535]87[,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชื
ืืจืฆืืื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
![Page 354: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/354.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 354
An iso-truss structure (10) includes at least two helical components (30, 32) and atleast one reverse helical component (34) attached thereto with opposing angularorientations. Each helical and reverse helical component preferably includes at leastfour elongate, straight segments (22) rigidly connected end to end in a helicalconfiguration forming a single, substantially complete rotation about a common axis(14) forming a first square cross section. The structure may further include at least tworotated helical components (80, 92) and at least one rotated reverse helical component(98) which are rotated with respect to the helical and reverse helical componentsforming a second square cross section, rotated with respect to the first. The structuremay be straight, curved, flexible, or form angles.
]57[
__________
154334]21][11[
ืืขืจืืช ืืชืงืฉืืจืช ืืื ืืืืจ ืคื ืืื ืืืืืจ ืืืฆืื ื
SYSTEM FOR PROVIDINGCOMMUNICATION BETWEENTHE INTERIOR AND THEEXTERIOR OF ACOMPARTMENT
]54[
13.08.2001]22[GB]33[18.08.2000]32[0020272.1]31[
Int. Cl.(2009.01) G21F 07//005]51[ASEPTIC TECHNOLOGIES S.A.,BELGIUM
]71[
WO/2002/017332]87[,ืืจืืื ืืืื ืืื ืืฉืืชืคื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system for making a connection between the interior and exterior of a compartment,comprising a door opening through the compartment wall, a connector body which canengage with the wall, and having a connection port through it, and a removable coveron the connector body. The body is engaged with the door opening, and an inner doorwithin the compartment engages and removes the cover. A preferred constructioncreates a single line of confidence seal. The system is particularly suited for sterilecompartments.
]57[
![Page 355: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/355.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009355
__________
154495]21][11[
ErbB4ืฉืืืืฉ ืื ืืื ืกืคืฆืืคื ืืจืฆืคืืืจ ืืืขื ืืืฆืืจ ืชืจืืคื ืืืืคืื ืืกืื ืืืืก
USE OF AN ANTAGONISTSPECIFIC FOR A NATIVE ERBB4RECEPTOR IN THEMANUFACTURE OF AMEDICAMENT FOR THETREATMENT OF STENOSIS
]54[
29.08.2001]22[US]33[01.09.2000]32[60/229679]31[US31.01.2001 60/265516 US27.08.200109/940101
Int. Cl.(2009.01) A61K 39//395, C07K 16//28]51[GENENTECH, INC., U.S.A.]71[WO/2002/018444]87[
',ืืืจืืืืฅ ืืฉืืช.ืฉืชื, 41-45ืฉืืจืืช ืจืืืฉืืื, ืืืช ืฆืืื
ืืืื
S. HOROWITZ & CO.,ZION HOUSE,
41-45 ROTHSCHILD BLVD.,TEL AVIV 65784
]74[
The present invention concerns methods and means for controlling excessiveproliferation and/or migration of smooth muscle cells, and in particular for treatingstenosis, by using antagonists of a native ErbB4 receptor. The invention furtherconcerns a method for the identification of ErbB4 agonists and antagonists capable ofinhibiting or enhancing the proliferation or migration of smooth muscle cells.
]57[
__________
![Page 356: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/356.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 356
154538]21][11[
ืจืืืงืฆืืช ืืคืืื ืืฉืืืจ ืขื ืืืืืชืืฆืจื ืืคืืื ืืฉืืืจ ืื ืืฆืจืื, ืืืืืื ืืื
ืืื
REACTION OF CARBON BLACKWITH DIAZONIUM SALTS,RESULTANT CARBON BLACKPRODUCTS AND THEIR USES
]54[
13.12.1995]22[US]33[15.12.1994]32[356660]31[
Int. Cl.(2008.04) C01B 31/08, C08K 9/04, C09C 1/56, 3/08, D01F 11/14, D21H17/67
]51[
DIVISION FROM 116377]62[CABOT CORPORATION, U.S.A.]71[
',ืจืืืื ืืฉืืชืืืืืกืื ืื ืชื ืืืื, 1426.ื.ืช,31ืืื ื' ืจื
SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,
P.O.B. 1426,TEL AVIV 61013
]74[
A carbon black product having attached to the carbon black either an aliphatic group ora cyclic group selected from alicyclic hydrocarbon groups and heterocyclic hydrocarbongroups, said groups being substituted by a functional group selected from the consisting of OR, COR, COOR, OCOR, halogen, NR2, SO3H, sulfonate salts, OSO3H, OSO3 saltsNR(COR), CONR2, NO2 PO3H2, phosphonate salts, phosphate salts, NR3
+X-, PR3+X-,
SkR, SS03H, SS03 salts, S02NRR', S02SR, SNRR', SNQ, S02NQ, C02NQ, S-(1,4-piperazinediyl)-SR, 2-(1,3-dithianyl), 2(1,3-dithiolanyl), SOR, and S02R; when theattached group is an aliphatic group it may also be substituted by a functional groupselected COOLi, COONa, COO+NR4
+, and when the attached group is a cyclic group itmay also be substituted by a functional group selected from R, CN, N=NR or acarboxylate salt, wherein R and R' nay be the same or different, branched orunbranced C1-C20 unsubstituted or substituted alkyl, alkenyl or alkynyl; unsubstituted orsubstituted aryl; unsubstituted or substituted heteroaryl; unsubstituted or substitutedalkylaryl; or unsubstituted or substituted arylalkyl groups, and when the ๏ฟฝ roup attachedto the carbon black is a cyclic group R and R' may also be hydrogen, k is an integerfrom 1 to 8; X-is a halide or an anion derived from a mineral or organic acid; and Q is(CH2)w, (CH2)xO(CH2)z, (CH2)xNR(CH2)z or (CH2)xS(CH2)z where x is 1 to 6, z is 1 to 6,and w is 2 to 6.
]57[
__________
154581]21][11[
JOINT ืืคืจืง ืืืืืืจ ืฉื ื ืฉืืืื ืฉื ืืื FOR CONNECTING TWOADJACENT SECTIONS OF AROD
]54[
23.02.2003]22[Int. Cl.(2009.01) F16B 07//00]51[
REFAEL ืืืฉื ืื ื ืขืืจืืช, ืจืคืื ืคืื PELED]71[,ืจืคืื ืคืื
ืืืฉื ืื ื ืขืืจืืช,REFAEL PELED,MOSHAV BENE ATAROT
]74[
![Page 357: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/357.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009357
:ืืืคืจืง ืืืื,)10(ืืคืจืง ืืืืืืจ ืฉื ื ืฉืืื๏ฟฝ ืกืืืื๏ฟฝ ืฉื ืืื]57[;ืฉื ืืืื)1(ืืืงืืืข ืืฉืื ืจืืฉื), ืืขื ืืื ื ืืจืืื ืงืื ื ืืืจื, ื ืืื)3(, ืคืจืง ืจืืฉื)
ืฉื)5(ืืืข ืืฉืื ืฉื ื ืืืง, ืืขื ืืื ื ืืจืืื ืงืื ื ืืืจื ืื ืืื)4(, ืคืจืง ืฉื ื ืืกืื1 ืืฉืื ืืจืืฉื)ืืื ืื ืืืจืืื ืฉื ืืคืจืง ืืขื ืืืื ื ืืงืื ื ืืืืจื ืืชืื๏ฟฝ ืืืื ืื ืืืจืืื ืฉื ืืคืจืง ืืขื, ืืืื
ืืฉืืื ืืืืฉ ืืขืืืจ ืืืจืื ืืคืจืงื๏ฟฝ ืืืืืืจ ืืฆืืื ืืืื ืืฉืื)6(ืืื ืื ื); ืืืื ื ืืงืื ื ืื ืงืืื, ืืจืืฉื) ืืืฆืืื ืืฉื ื ืืฉืื ืืฉื ื .ืืืืฆืืจ1 ืืฆืืืช ืืฉืืื๏ฟฝ ืื
__________
154663]21][11[
ืฉืืื ืืงืืืขืช ืืจืืช ืืืชืืืฆืื ืฉืโ3'ืฆืืืืืื ืื ืืืืืจืื ืืื ื ืื ืืื ืืจืฆืฃ
CPG โ '5
METHOD FOR DETERMININGTHE DEGREE OFMETHYLATION OF DEFINEDCYTOSINES IN GENOMIC DNA INTHE SEQUENCE CONTEXT 5'-CPG-3'
]54[
01.09.2001]22[DE]33[01.09.2000]32[10043826.1]31[DE05.09.2000 10044543.8
Int. Cl.(2008.04) C12Q 1/68]51[EPIGENOMICS AG, GERMANY]71[WO/2002/018632]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a method for detecting the degree ofmethylation of a defined cytosine in the sequence context 5โฒ-CpG-3โฒ of agenomic DNA sample. The first stage involves chemically treating thegenomic DNA in such a way that the cytosine bases, but not the 5-methylcytosine bases, are converted into uracil. Parts of the genomicDNA containing the defined cytosine are then amplified. The amplifiedparts are given a detectable mark and the extent of the hybridisation ofthe amplified parts on the two classes of oligonucleotides is thendetermined by detecting the mark of the amplified parts. The degree ofmethylation of the defined cytosine in the genomic DNA sample can bededuced on the basis of the relationship between the marks detected onthe two classes of oligonucleotides following the hybridisation.
]57[
__________
![Page 358: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/358.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 358
154897]21][11[
HIGH ืกืืกืืืช ืืื ืืืื ืืืงื ืืื ืืฉืืืช ืืื ืชื STRENGTH MAGNESIUMALLOY AND ITS PREPARATIONMETHOD
]54[
26.09.2000]22[Int. Cl.(2008.04) C22C 23/04]51[KWANG SEON SHIN, REPUBLICOF KOREA
]71[
WO/2002/027053]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
ืจืืืืืช, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืืSANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The present invention provides high strength magnesium alloys consisting essentiallyof 3 $m(k) 10 wt.% Zn, 0.25 $m(k) 3.0 wt.% Mn, and the balance of Mg and inevitableimpurities, the high strength magnesium alloy further containing 1 $m(k) 6 wt.% Al, 0.1$m(k) 4.0 wt.% Si, and 0.1 $m(k) 2.0 wt.% Ca, in order to provide a high strengthmagnesium alloy having an improved hardness and strength, and an excellentelongation at an ambient temperature. In addition, the present invention provides amethod for preparing the high strength magnesium alloy characterized in that a Zn-Mnmother alloy is added to a magnesium melt by a fluxless melting method, and processconditions for working and heat-treating an obtained cast material.
]57[
__________
![Page 359: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/359.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009359
155183]21][11[
, ืงืกืืืืืชืืืืฆืืช ืงืจืืโ3โืืืงืกืืคื ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื ืืฉืืืืฉ
ืืื
OXAPENEM - 3 - CARBOXYLICACID, PHARMACEUTICALCOMPOSITIONS CONTAINING ITAND USES THEREOF
]54[
11.10.2001]22[EP]33[19.10.2000]32[00309207.9]31[GB08.03.2001 0105766.0 GB06.08.20010119165.9
Int. Cl.(2009.01) A61K 09//00, 31//424, 47//10, A61P 31//04, C07D 50/3/00]51[AMURA LIMITED, UNITEDKINGDOM
]71[
WO/2002/032423]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An oxapenem compound which is, or is capable of forming, a zwitterionof formula Ia or Ib: (Ia), (Ib) wherein R is a Cยฟ1?-Cยฟ8? branched orstraight chain alkyl group which includes a protonated basic substituent.The compounds find particular use as high bioavailability $g(b)-lactamase inhibitors.
]57[
__________
155507]21][11[
PESTICIDAL ืชืืฉืืจ ืงืืื ืืืืงืื COMPOSITION]54[
22.10.2001]22[JP]33[23.10.2000]32[2000-322558]31[
Int. Cl.(2008.04) A01N 43/40, C07D 213/82, 417/12]51[ISHIHARA SANGYO KAISHA LTD.,JAPAN
]71[
WO/2002/034050]87[ืขืืจืื ืืื ืืขืืจืื, ืงืืืฆืช ืืืชื ืืืืื
,ืคืื ืืื ืืจืฆืืื, 2081.ื.ืช,10ืฉืืจืืช ืืื ืืื
EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,
P.O. B. 2081,HERZLIYA 46120
]74[
A pesticidal composition comprisinig a pesticidally effective amount of at least one of apyridic compound of the formula (I) or it salt and at least one of otherpesticides:wherein Y is a haloalkyl group, m is 0 or 1, and Q is or a substituted orunsubstituted heterocyclic group, (wherein X is an oxygen atom or a sulfur atom, R?1ยฟand R?2ยฟ are respectively independently a hydrogen atom, a substituted orunsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or
]57[
![Page 360: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/360.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 360
unsubstituted alkynyl group, a substituted or unsubstituted cycloalkyl group, and thelike.
__________
155545]21][11[
SOLVATE ืฆืืจืช ืกืืืืื ืฉื ืงืืจืืืืื FORM OFCABERGOLINE
]54[
21.04.2003]22[Int. Cl.(2008.04) C07D 457/06]51[
FINETECH ื ืฉืจ,ื"ืคืืื ืืง ืคืืจืืฆืืืืงื ืืข PHARMACEUTICALLTD.
]71[
,ืคืจื ืืื ืฆืืง ืืฆืจ, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
Amorphous physical form of cabergoline substantially free of other physical forms,which is characterized by a halo x-ray powder diffraction pattern having a range ofsignals from between about 15 to about 23 degrees 2-theta.
]57[
__________
![Page 361: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/361.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009361
155801]21][11[
ืจืฆืฃ ืืืืฆืช ืืจืขืื ืืืงืืื ืงืื ืืื ืกืคืฆืืคืื ืืืฉื ืื ืืฉื
NUCLEIC ACID SEQUENCEENCODING HUMAN TESTISSPECIFIC KINASES
]54[
09.11.2001]22[US]33[09.11.2000]32[60/246939]31[US30.01.2001 60/264921
Int. Cl.(2008.04) A01K 670/27, A61K 38/45, A61P 15/16, C07K 16/40, C12N 15/52,15/54, 9/12
]51[
UNIVERSITY OF VIRGINIAPATENT FOUNDATION, U.S.A.GREGORY S. KOPF, U.S.A.
]71[
WO/2002/038732]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to a family of testis specific kinases (thetssk family), nucleic acid sequences encoding those kinases andantibodies against the kinases. The invention is further directed to theuse of thise kinases as targets for isolating specific inhibitors oranagonists of tssk kinase activity. Such inhibitors are anticipated to haveuse as contraceptive agents.
]57[
__________
155901]21][11[
โืชืืืื ืืคืจืื ืกืืคื ืืงืืืช ืคืืจื ืงืกืืื
ADSORPTIVE SEPARATIONPROCESS FOR RECOVERY OFPARA-XYLENE
]54[
15.11.2001]22[US]33[16.11.2000]32[713082]31[
Int. Cl.(2008.04) C07C 7/13]51[UOP LLC, U.S.A.]71[WO/2002/040432]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The performance of an adsorptive separation process recovering para-xylene from a Cยฟ8? aromatic hydrocarbon feed mixture is improved byoperating the process at higher desorbent purity. The improved
]57[
![Page 362: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/362.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 362
performance allows for tradeoffs in other operating parameters and ratesor improved product rates. The process preferably employs a bariumand potassium exchanged zeolitic molecular sieve as the adsorbent andtoluene as the desorbent.
__________
156049]21][11[
TAPPING ืืจื ROD]54[
21.11.2001]22[NL]33[23.11.2000]32[1016687]31[
Int. Cl.(2008.04) B67D 1/08]51[HEINEKEN TECHNICAL SERVICESB.V, THE NETHERLANDS
]71[
WO/2002/048019]87[,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชื
ืืจืฆืืื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
A tapping rod (2) with a beverage valve (16), a gas valve (14) cooperating therewith,and a collar (24), while in or on the collar a connecting device (26) is fitted, whichconnecting device comprises a pressure body (30) for opening the beverage valve (16)and the gas valve (14), wherein: the pressure body (30) comprise or defines at leastone first beverage channel (50) for bringing, with the beverage valve in open position,the inner space of a keg, in particular a riser of the taping rod, into fluid communicationwith a beverage dispensing line; the pressure body comprises or defines at least onegas channel (48) for bringing, with the gas valve in open position, the inner space of thekeg into fluid communication with a gas supply line.
]57[
__________
![Page 363: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/363.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009363
156115]21][11[
ืื STENT ืืขืจืืช ืืืืงืื ืชืืื ืืืื POSITIONING SYSTEM]54[
26.05.2003]22[Int. Cl.(2008.04) A61F 2/06, A61M 29/00]51[
,ื"ืืืกืืช ืฉืจืืชื ืืืงืจ ืจืคืืื ืืคืืชืื ืืข ืืจืืฉืืื
HADASIT MEDICAL RESEARCHSERVICES & DEVELOPMENTLTD.
]71[
, ืืก ืืจืฉืืฆืงืืืืจ, ื ืืื ืืืจืืืงืจ, ืืืื ืืืื ืืืจืืก ืืืกืจื
HAIM LOTAN, NACHUMBORIVKER, BORIS VARSHITSKY,MORRIS MOSSERI
]72[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A stent positioning system, comprising: a guide catheter 912); an inflatable balloon (22)connected to said catheter for expanding a stent, said balloon, in its collapsed state,fitting into and being adapted to carry said stent in its pre-expanded condition;characterized by a stent locator means (14) slidably coupled to said guide catheter andadapted to change its shape from a contracted shape extending along said guidecatheter to an expanded shape extending laterally from said guide catheter, andmechanical means for changing the shape of said stent locator means; wherein thechange of shape enables said locator means to about an interior wall surface of amajor blood vessel in the ostial region of a smaller blood vessel branching off from saidmajor blood vessel, therby ensuring correct position between the stent and an ostium ofsaid smaller blood vessel.
]57[
__________
156227]21][11[
MULTILAYER ืจืฆืืขื ืืงื ืจื ืฉืืืชืืช ืฉื ืืืจ ืืืื THIN FILMHYDROGEN GETTER
]54[
26.09.2002]22[US]33[28.09.2001]32[09/965759]31[
Int. Cl.(2008.04) H01L 23/26]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/028096]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
![Page 364: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/364.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 364
A thin film hydrogen getter is provided for protecting GaAs circuitry sealed in anhermetic package. The thin film getter which comprises a multilayer metal film which isdeposited by vacuum evaporation techniques onto a surface of the packaging. Themultilayer film comprises (1) a titanium film and (2) palladium film which is depositedonto the titanium film. Both the titanium and the palladium are deposited during thesame coating process run, thereby preventing the titanium from being oxidized. Thepalladium continues to prevent the titanium from being oxidized once the getter isexposed to the atmosphere. However, hydrogen is easily able to diffuse through thepalladium into the titanium where it is chemically bound up, since palladium is highlypermeable to hydrogen. If EMI shielding is desired, a conductive metal, such asaluminum or copper, can first be formed between the packaging and the titanium layer.
]57[
__________
156254]21][11[
ANALYTE ืืชืงื ืืืืื ืช ืืืืก TESTING DEVICE]54[
02.06.2003]22[GB]33[05.06.2002]32[0212920.3]31[
Int. Cl.(2008.04) G01N 334/87]51[DIABETES DIAGNOSTICS, INC.,U.S.A.
]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A testing device (100) for testing an analyte in a sample of bodily fluid, comprising:memory storing data, said data being analyte data related to analyte measurementscarried out by the testing device and lifestyle data, and the analyte data includes apointer to a bodily location from which an analyte sample was taken by an individualusing the testing device, wherein the testing device utilizes a plurality of data pointers,each of said data pointers indicating a separate bodily location; initiation means (102)for initiating immediate entry of data related to a specific category of lifestyle data;navigation means (104) for entry and navigation of said data; and transfer means fortransferring said data to said memory.
]57[
![Page 365: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/365.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009365
__________
156277]21][11[
ืชืจืืคืืช ืืืืืืืช, ื ืืืจืืช ืงืืืื ืืืืืืืฉืืืืฉ ืืื ืืฉืืื, ืชืจืืืืืช ืืื
ืืืื ืชื
QUINAZOLINE DERIVATIVES,MEDICAMENTS CONTAININGSAID COMPOUNDS, THEIRUTILIZATION AND METHODFOR THE PRODUCTIONTHEREOF
]54[
12.12.2001]22[DE]33[20.12.2000]32[10063435.4]31[
Int. Cl.(2008.04) A61K 314/95, C07D 239/94]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY
]71[
WO/2002/050043]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to quinazoline derivatives of general formula (I),wherein Rยฟa?, Rยฟb? and Rยฟc? have the meaning defined in claim 1, totheir tautomers, their stereoisomers and their salts, especially theirphysiologically acceptable salts with inorganic or organic acids. Saidcompounds have valuable pharmacological properties, especially aninhibiting effect upon signal transduction caused by tyrosine kinase.The invention further relates to their utilization in the treatment ofdiseases, especially of tumoral diseases, diseases of the lung and therespiratory tract and to the production of said compounds.
]57[
![Page 366: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/366.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 366
__________
156330]21][11[
ARTICLE ืืขืจืืช ืืืขืืจืช ืคืจืืื TRANSFER SYSTEM]54[
05.06.2003]22[Int. Cl.(2008.04) G05G 11/00]51[
NOVA ืจืืืืืช,ื"ื ืืื ืืืฉืืจื ืืืืื ืืข MEASURINGINSTRUMENTS LTD.
]71[
ื ,ืฉืืชืคืืืจืืื ืืืื ืืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system (100) for controlling a movement of an article, the system comprising: asupport stage assembly (112); a spring suspension arrangement (110) mounted onsaid support stage assembly and comprising first and second assemblies (114A, 114B)arranged in a coaxial relationship with respect to the axis of the article movement, andone inside the other, the first assembly being attached to said support stage assemblyand the second assembly serving for supporting an article-carrying member (118) andbeing driven for a movement along said axis of the article movement with respect to thefirst assembly, the outer one of the first and second assemblies being configured todefine two spaced-apart parallel planes perpendicular to said axis of the articlemovement, said first and second assemblies being attached to each other by first andsecond membrane members (M1 M2) arranged in a spaced-apart parallel relationshipalong said axis of the article movement; and a motor operable for rotating said supportstage assembly around said axis, said motor being located inside the inner one of saidfirst and second assemblies.
]57[
__________
![Page 367: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/367.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009367
156579]21][11[
INJECTION ืชืงื ืืืจืงืื DEVICE]54[
30.07.1998]22[GB]33[31.07.1997]32[9716065.9]31[
Int. Cl.(2009.01) A61M 05//178]51[DIVISION FROM 134284]62[ARES-TRADING S.A.,SWITZERLAND
]71[
WO/1999/006100]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืฉืืืืืจ, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
An injection device has a barrel (1) for housing and guiding a syringe (13) as it is urgedforward to project its needle (14), while the dose is ejected, and as a return spring (22)retracts it. A firing mechanism (6) is connectable to the rear end of the barrel and is re-usable, whereas the barrel (1) with its spent syringe (13) is disposable. The connection(4) has limited freedom of axial movement so that, once made, forward pressure on thefiring mechanism (6) moves the syringe (13) up to a ready position. A number of barrels(1) with syringes (13) can be housed in a common box (31) with a single firingmechanism (6), the forward end of each barrel (1) being screwed to a locator (32) onthe base of the box. The engagement of the firing mechanism (16) with the rear end ofeach barrel (1) is also screw-threaded, but of opposite hand, so that screwing the firingmechanism (6) on and continuing to turn releases the complete device; andcorrespondingly the barrel (1) can be returned and located in the box (31) while thefiring mechanism (6) is separated from it.
]57[
__________
![Page 368: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/368.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 368
156626]21][11[
SYSTEM ืืขืจืืช ืืืจืืกืช ืชืืื ืกืืงืืืืืช FOR SELECTIVE CELLDESTRUCTION
]54[
24.06.2003]22[Int. Cl.(2009.01) G01N 21//00]51[
YEDA ืจืืืืืช,ื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD.
]71[
YARON ืื ืืืจืื, ืืืืจ ืืืื, ืืจืื ืืืืืจืืจื SILBERBERG, DVIRYELIN, DAN ORON
]72[
,ื"ืืข) 1995(ืืจืืื.ืื.ื'ื,11ืื ืื ืืืื ืจืืื,15ืงืืื, ืืืื ืืืืื
ืจืืช ืื
G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,RAMAT GAN 52521
]74[
A system (10) for destroying living cells (12), the cells being characterized by anionization threshold, the system comprising: an optical device (14) for providing at leastone optical pulse having an optical field power which is smaller than the ionizationthreshold of the cells; and a mechanism (16) for locally increasing said optical fieldpower per unit area beyond the ionization threshold of the cells, thereby destroying thecells via ionization.
]57[
__________
![Page 369: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/369.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009369
156764]21][11[
ืฉืืื ืืืชืงื ืืืืฆืืข ืืกืืจื ืงืฉืืื ืืกืืืืขืช ื ืืืืืช ืืื ืืขืจืืืช ืชืงืฉืืจืช
METHOD AND APPARATUS FORPERFORMING MOBILEASSISTED HARD HANDOFFBETWEEN COMMUNICATIONSYSTEMS
]54[
19.12.1997]22[US]33[15.01.1997]32[08/784280]31[
Int. Cl.(2008.04) H04Q 7/38]51[DIVISION FROM 130734]62[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/1998/032262]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
In a wireless communication system wherein a mobile station (M1, M2, M3) is movingfrom the coverage area of an origination system (51) operating at a first frequency intothe coverage area of a destination system (52) operating at a second frequency, amethod for providing handoff from said origination system to said destination system,the method comprising: predicting at least one PN offset associated with thedestination system; transmitting, at the first frequency, from said origination system tosaid mobile station a set of search parameter data associated with the at least one PNoffset; determining at said mobile station the availability of said destination system inaccordance with said set of search parameter data; transmitting from said mobilestation to said origination system a message indicative of the received strength ofsignals associated with the at least one PN offset measured at the mobile station;generating at said origination system a set of acquisition parameters in accordancewith said message from said mobile station; and attempting at said mobile station toacquire said destination system in accordance with said set of acquisition parameters.
]57[
ืงื ืืืงืฉื ืื ืืงืฉืืช ืืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198051,The applications for divisionfrom this application havenot yet been published
__________
![Page 370: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/370.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 370
156858]21][11[
ืฉื ืืงืฆืืช ืงืืืฆืืช ืฉื ืืืื ืืืืืืขืจืืช) ืืกืจืช ืืืืกืืช(ืืืืืืืืืฆืื
ืืืื ื ืจืื
ASSIGNING CLUSTERS OFDEMODULATION ELEMENTS INA SPREAD SPECTRUM SYSTEM
]54[
10.01.2002]22[US]33[11.01.2001]32[60/261402]31[US28.09.2001 09/968344
Int. Cl.(2008.04) H04B 17/07, 7/06, H04J 13/02, H04K 1/00]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2002/056495]87[ืืกื ืค ',ืงืืื ืืฉืืช. ืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
An apparatus, such as a subscriber unit or a base station within a spread spectrumcommunication system, may add one or more additional 'virtual' paths to a list ofcandidate paths when assigning demodulation elements. These 'virtual' paths areadded as candidate paths even though a corresponding peak was not necessarilydetected within a received spread spectrum system. The list of paths may include a firstpath having a time offset approximately equal to a time offset for one of thedemodulation elements, and the virtual path having a short time separation from thefirst path. The time separation between the paths may be, for example, less than 2chips.
]57[
__________
![Page 371: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/371.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009371
156871]21][11[
ืขื ืื ืื ืืืจ ืืืืฆืขื ืชืฆืืื ืืืืจืื ืืจืืฉ ืื ืขื ืืืืง ืืขืื ืฉื ืืจืืฉ
LIGHT GUIDE FOR DISPLAYDEVICES OF THE HEAD-MOUNTEDOR HEAD-UP TYPE
]54[
10.07.2003]22[IT]33[17.07.2002]32[TO2002A000625]31[
Int. Cl.(2009.01) G02B 27//14]51[C.R.F. SOCIETA CONSORTILE PERAZIONI, ITALY
]71[
,ืืืฆืืื ืืช ืืืฆืืืืืืจ, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
ืฉืืข
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A light guide for display devices of the head-mounted or head-up type, comprising: abody of the light guide (22) at least in part transparent to visible light; a coupling device(24) associated to the body of the light guide and designed to couple the body to anoptical system designed to generate an image, the coupling device being obtained insuch a way the light beams coming from said optical system enter the ody of the lightguide and propagate in the body by total internal reflection; and an image-exteractiongrating (28) designed to extract the light beams which propagate in the body of the lightguide so as to enable an observer to visualize the extracted image on a backgroundvisible in transparency through the body of the light guide; wherein said extractiongrating is set in the proximity of one of the outer surfaces (22) of the guide; saidextraction grating has a saw-tooth profile; said extraction grating is coated with apartially reflecting coating deposited prevalently on the surfaces of the teeth (28) thatare least inclined with respect to the surfaces of the guide; and said coating is in turncoated with a layer of material having a refractive index that is substantially the sameas that of the body of the light guide and having a surface facing the extraction grating,which follows the saw-tooth profile, and another plane surface which is substantiallyparallel to the outer surface of the guide in an area corresponding to which the gratingis made.
]57[
__________
![Page 372: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/372.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 372
156999]21][11[
WEIGHT ืืืช ืืขืืช ืืฉืงื ืืืคืืชืช SAVING DOOR]54[
17.07.2003]22[Int. Cl.(2008.04) E06B 3/70]51[
RAV ืืื ื,ื"ืจื ืืจืื ืืืฆืจื ืืืืื ืืข BARIACH SECURITYPRODUCTS LTD.
]71[
EYAL ืืืคืจื ืืืืืืืจ, ืืืื ืืจืฆืืืื ARTSIELY, ALFREDGOLDOVER
]72[
,ื ืขืืจืื ืคืื ืืื"ืขื, ืืคืืคืื ืืจ ืคืืฉืจื2ืืื ืื ืืืจ ืื-ืจืืช,16ืงืืื.ืจ.ืก.ืืืื
APPELFELD ZER FISHER,B.S.R TOWER 1, FLOOR 16
2 BEN GURION ST.RAMAT GAN 52573
]74[
A door (10) comprising: a pair of first (12) and second (14) sheets which form front andrear faces of the door; and at least one filling element (20) placed between said firstand second sheets, wherein said at least one filling element has a non-straight shapecomprising at least one first surface (22) that abuts an inner surface of said first sheet,at least one second (24) surface that abuts an inner surface of said second sheet, andat least one intermediate portion (26) between and extending from said first and secondsurfaces, wherein said intermediate portion does not touch inner surfaces of said firstand second sheets.
]57[
__________
157015]21][11[
ABLATION ืฆื ืชืจ ืืืกืจืช ืจืงืื ืืขื ืืขืจื ืืขืฆื CATHETER HAVINGSTABILIZING ARRAY
]54[
18.07.2003]22[US]33[23.07.2002]32[10/201052]31[
Int. Cl.(2009.01) A61B 17//32]51[BIOSENSE WEBSTER, INC., U.S.A.]71[
ื"ื ',ืื ืืฉืืชืจ ืฉืืื ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืื
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A circumferential ablation catheter comprising: an elongated tubular catheter body (12)having an outer wall, proximal and distal ends, and at least one lumen extendingtherethrough; an ablation assembly (14) mounted at the distal end of the catheter body,the ablation assembly comprising a circumferential ablation element mounted on thedistal end of the catheter body; and an inflatable balloon (26) provided in surrounding
]57[
![Page 373: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/373.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009373
relation to the circumferential ablation element that is adjustable between a radiallycollapsed position and a radially expanded position; and a stabilization assembly (17)mounted on the catheter distal to the ablation assembly, the stabilization assemblybeing capable of contacting a plurality of points about an inner circurnference of agenerally tubular region of or near the heart.
__________
157048]21][11[
ืฉืืื ืืืขืจืืช ืืงืืืช ืืืืืช ืืืขืจืืช ืชืงืฉืืจืช
METHOD AND APPARATUS FORPROVIDING AUTHENTICATIONIN A COMMUNICATION SYSTEM
]54[
18.01.2002]22[US]33[16.02.2001]32[785722]31[
Int. Cl.(2008.04) H04L 9/32, H04Q 7/38]51[MOTOROLA, INC., U.S.A.]71[WO/2002/067495]87[
,ืคืืืจืืื ืืืื ืืื ืืฉืืช ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method includes receiving an authentication request from a mobile station (401) anddetermining whether to forward the request to an authentication agent. When it isdetermined to forward the request, the request is forwarded to the authentication agent(107). A random number and a random seed are received from the authenticationagent (107). The random number and the random seed are forwarded to the mobilestation (401). A response to the random number and the random seed from the mobilestation (401) is received and forwarded to the authentication agent (107). Theauthentication agent (107) compares the response with an expected response. Whenthe authentication agent (107) authenticates the mobile station (401), a derived cipherkey is received from the authentication agent (107).
]57[
__________
![Page 374: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/374.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 374
157097]21][11[
ืชืจืืืืื, ืชืจืืืฃ ืืืืื ืคืืืจืื ืืืืฉืืื ืืฆืืคืื, ืฉืืืืช ืืืื ืชื, ืืืืืืืื
ื ืฉืืื ืืืืืฉ,ืืื ืฉื ืขื ืชืจืืืฃ ืืฆืืคืื ืฉื ืื ืฉื ืืกืคืื ืงืืืื ืืฆืืคื
SUSPENSION COMPRISINGFIBRINOGEN,THROMBIN ANDALCOHOL, METHOD FORPREPARING SUCH ASUSPENSION, METHOD FORCOATING A CARRIER WITHSUCH A SUSPENSION, METHODOF DRYING A COATING OF ACARRIER AND COATEDCOLLAGEN SPONGE
]54[
25.01.2002]22[DK]33[25.01.2001]32[PA200100135]31[DK13.02.2001 PA200100235
Int. Cl.(2008.04) A61L 27/00]51[NYCOMED PHARMA AS, NORWAY]71[WO/2002/058750]87[
,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชืืืืืจืฆื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจ
EITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
A suspension of fibrinogen, thrombin, alcohol and optionally aprotinin is obtained bymixing fibrinogen in alcohol with thrombin in alcohol. The suspension containsfibrinogen and thrombin particles with a Folk Ward mean diameter of 25 โ 100 ยตm. Thethrombin may be human, bovine or recombinant. The fibrinogen may be human orrecombinant. A method for coating a carrier, such as a collagen sponge, with thesuspension, and a method for drying the coating is disclosed. The coated collagencarrier may be used as a ready-to-use absorbable composition for tissue gluing, tissuesealing and haemostasis wherein the carrier is coated with solidly fixed components offibrin glue, i.e. fibrinogen and thrombin.
]57[
__________
![Page 375: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/375.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009375
157106]21][11[
CAROTENOID ืืกืืจืื ืฉื ืงืจืืื ืืืื ESTERS]54[
22.02.2002]22[US]33[23.02.2001]32[60/270817]31[US11.01.2002 60/347443
Int. Cl.(2008.04) C07C 403/12]51[LUIS W. LEVY, ECUADORRICHARD BINNINGTON, UNITEDKINGDOMANTHONY TABATZNIK, UNITEDKINGDOM
]71[
WO/2002/068385]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters arecarotenoid compounds. The synthetic ester linkage between two ormore carotenoids provides new compounds in which the similar andcomplementary properties of the individual carotenoids are combined.The new all-carotenoid esters may be useful as antioxidants, therapeuticagents, pigmenting ingredients in poultry feed or as coloring agents forfats. The polyesters have the potential to act as molecular wires withunique electrical conductance characteristics. The all-carotenoid estersmay be prepared from the esterification of at least one hydroxycarotenoid with at least one carboxylic carotenoid, or via the reaction ofthe acid chloride of a carboxylic carotenoid with a hydroxy carotenoid.Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin,violaxanthin, carotene diol, hydroxy carotene, hydroxylcopene,alloxanthin and dehydrocryptoxanthin. Preferred caroxylic carotenoidsinclude bixin, norbixin, $g(b)-apo-8-carotenoic acid, crocetin,diapocarotenoic acid, carboxylcarotene and azafrin.
]57[
__________
![Page 376: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/376.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 376
157117]21][11[
DEVICE ืืชืงื ืืื ืืขืช ืืืืคืช ืฉืชื ืื ืฉืื FOR THE PREVENTIONOF URINARY INCONTINENCEIN FEMALES
]54[
27.07.2003]22[Int. Cl.(2008.04) A61F 50/48]51[
CONTIPI ืงืืกืจืื,ื"ืงืื ืืืคื ืืข LTD.]71[ELAN ืืืื ืืื ZIV]72[
,ื"ืืข) 1995(ืืจืืื.ืื.ื'ื,11ืจืืื ืื ืื ืืืื,15ืงืืื, ืืืื ืืืืื
ืจืืช ืื
G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,RAMAT GAN 52521
]74[
A disposable device (100) for minimizing involuntary urination in females adapted forbeing inserted into the vagina, comprising:(a) an internal support structure comprising:(i) a pressure providing member (101) capable of transition between a first collapsibleposition and a second expandable position, adapted for providing pressure, through thevaginal wall, on the mid-urethral region following insertion of the device into the vagina;(ii) an anchoring member (102), said anchoring member adapted for anchoring theinternal support structure following insertion of the device into the vagina, so as toprevent movement of the device into the apex of the vagina; the pressure providingmember and the anchoring member being spaced apart;(b) pulling means (107) for removal of the device from the vagina, so that when saidpressure providing member is in the collapsible position the internal device may beinserted or removed from the vagina; and when said pressure providing member is inthe second expanded position, the device is positioned in the vagina in such a mannerso at to provide pressure through the vaginal wall on the mid-urethra minimizinginvoluntary urination.
]57[
__________
![Page 377: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/377.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009377
157477]21][11[
ืชืจืืืืช ืืืืื ืจืืงืืืื ืืืืืืืืจืืงืืืช ืคืขืืื ืืชืืืืฃ ืกืืืจ ืืชืจืืคืืช
ืืืืืืืช ืืืชื
PHARMACEUTICAL SALTSCOMPRISING APHARMACEUTICALLY ACTIVESUBSTANCE AND A SUGARSUBSTITUTE ANDMEDICAMENTS COMPRISINGTHEM
]54[
28.02.2002]22[DE]33[28.02.2001]32[10109763.8]31[
Int. Cl.(2008.04) A61K 31/18, 31/39, 31/44, 31/54, 311/37, 312/16, 313/43, 313/57,313/81, 314/25, 315/375, 316/615, 45/08, A61P 13/02, 29/00, C07C 211/26, 215/30,215/46, 217/54, 219/22, 225/16, 271/40, 307/08, 323/32, C07D 213/62, 265/30,275/02, 275/06, 291/06, 307/79, 317/50, 333/16, C07F 9/40
]51[
GRUNENTHAL GMBH, GERMANY]71[WO/2002/067916]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to pharmaceutical salts comprised of apharmaceutical active substance, particularly N,N-dimethylaminopropylphenol compounds or tradamol, and of at least onesugar substitute such as saccharin, cyclamate or acesulfame, tomedicaments containing these salts, and to the use of these salts forproducing medicaments.
]57[
__________
![Page 378: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/378.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 378
157534]21][11[
, ืฆืืจื ืจืืงืืืช ืฉื ืกืืื ืืืืจืืกืืืืืชืจืืืืช ืฉืื ืืคืืจืืืืฆืื ืจืืงืืืช
ืืืืืื ืกืืื ืืืืจืืกืืืื
ATORVASTATIN CALCIUM IN APHARMACEUTICAL FORM,COMPOSITION THEREOF ANDPHARMACEUTICALFORMULATION COMPRISINGATORVASTATIN CALCIUM
]54[
13.03.2002]22[SI]33[14.03.2001]32[P-200100069]31[
Int. Cl.(2008.04) A61K 31/40, 9/16, 9/20, A61P 3/06, C07D 207/34]51[LEK PHARMACEUTICAL ANDCHEMICAL COMPANY D.D.,SLOVENIA
]71[
JANEZ KERC, SALOBIR MATEJA,SASA BAVEC
]72[
WO/2002/072073]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Atorvastatin calcium can exist in an amorphous form or in one of the atleast four known crystalline forms (Form I, Form II, Form III and FormIV). Atorvastatin calcium is the substance which is sparingly soluble inwater, with pKa 4,5, and it has been found that the crystalline forms areless soluble than the amorphous form, which may cause problems inbioavailability of atorvastatin in the body. The present invention solvesthe problem of providing therapeutic equivalence of atorvastatinpharmaceutical formulation regardless the form (crystalline, amorphous,mixture of both) of atorvastatin calcium used for its preparation.
]57[
__________
![Page 379: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/379.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009379
157588]21][11[
ืชืจืืืืืช ืงืจืืื ืืฉืืืืฉ ืืื ืืขื ืืืืืคืื ืืืคืจืขืืช ืคืกืืืืชืืืช
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING PSYCHOTICDISORDERS
]54[
21.02.2002]22[US]33[27.02.2001]32[60/271889]31[US21.02.2002 10/081761
Int. Cl.(2008.04) A61K 31/27, A61P 25/18, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.
]71[
WO/2002/067927]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating psychotic disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of formula (I) and formula (II)wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2?, Rยฟ3?,Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).
]57[
__________
![Page 380: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/380.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 380
157591]21][11[
ืชืจืืืืืช ืงืจืืื ืืฉืืืืฉ ืืื ืืขื ืืืืืคืื ืืืคืจืขืืช ื ืืืจืืืื ืจืืืืืืื
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATINGNEURODEGENERATIVEDISORDERS
]54[
21.02.2002]22[US]33[27.02.2001]32[60/271682]31[US21.02.2002 10/081764
Int. Cl.(2008.04) A61K 31/27, A61P 25/28, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.
]71[
WO/2002/067925]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating neurodegenerativedisorders comprising administering to a subject in need thereof a therapeuticallyeffective amount of a compound selected from the group consisting of Formula (I) andFormula (II), wherein phenyl is substituted at X with one to five halogen atoms selectedfrom the group consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2?,Rยฟ3?, Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).
]57[
__________
![Page 381: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/381.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009381
157592]21][11[
ืชืจืืืืืช ืงืจืืื ืืฉืืืืฉ ืืื ืืขืืืืืืืคืื ืฉื ืืคืจืขืืช ืืชื ืืข
CARBAMATE COMPOUNDS FORUSE IN PREVENTING ORTREATING MOVEMENTDISORDERS
]54[
21.02.2002]22[US]33[27.02.2001]32[60/271683]31[US21.02.2002 10/081501
Int. Cl.(2008.04) A61K 31/27, A61P 25/14, C07C 271/10]51[ORTHO-MCNEILPHARMACEUTICAL, INC., U.S.A.
]71[
WO/2002/067926]87[',ืจ ืฉืืื ืืื ืืฉืืช"ื
ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืืDR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
This invention is directed to a method for preventing or treating movement disorderscomprising administering to a subject in need thereof a therapeutically effective amountof a compound selected from the group consisting of Formula (I) and Formula (II):wherein phenyl is substituted at X with one to five halogen atoms selected from thegroup consisting of fluorine, chlorine, bromine and iodine; and, Rยฟ1?, Rยฟ2? Rยฟ3?,Rยฟ4?, Rยฟ5? and Rยฟ6? are independently selected from the group consisting ofhydrogen and Cยฟ1?-Cยฟ4? alkyl; wherein Cยฟ1?-Cยฟ4? alkyl is optionally substituted withphenyl (wherein phenyl is optionally substituted with substituents independentlyselected from the group consisting of halogen, Cยฟ1?-Cยฟ4? alkyl, Cยฟ1?-Cยฟ4? alkoxy,amino, nitro and cyano).
]57[
__________
![Page 382: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/382.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 382
157678]21][11[
ืชืื ืืืช ืืขืืืช ืืขืจืืช ืืฉืืื ืืืืืื ืจืขืฉ
SYSTEM AND METHOD FORDISCOVERING PATTERNS WITHNOISE
]54[
22.03.2002]22[US]33[22.03.2001]32[09/814512]31[
Int. Cl.(2008.04) G06F 19/00, G06K 9/00, 9/68]51[IBM CORPORATION, U.S.A.]71[WO/2002/077910]87[
,ืืืืงืช ืงื ืื ืจืืื ืืืขืืืืช ืืื ืืืคื, ืืื ืืืจืกืืืช ืืืคื ืืจ ืืืจืื
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A system and method for determining patterns in a data sequence (Fig. 1) constructs acompatibility matrix (100) which provides a probability between an actual occurrence ofan item and an observed occurrence of that or another item between each item in thedata sequence. Candidate patterns are generated (201). The candidate patternsinclude items in the data sequence. The candidate patterns are checked against thedata sequence to determine a match value (203) based on the compatibility matrix, andsignificant matches are determined based on candidate patterns having the matchvalue above a threshold (204).
]57[
__________
![Page 383: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/383.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009383
157721]21][11[
ืืชืงื ืืฉืืื ืืขืืืื ืืืืื ื ืฉื ืืืืื ืืืืืืืืช
APPARATUS AND METHOD FORPROCESSING AND TESTING ABIOLOGICAL SPECIMEN
]54[
06.03.2002]22[US]33[06.03.2001]32[799355]31[
Int. Cl.(2008.04) G01N 21/13]51[ื, ืืื ืืจืื 'ืืคืจ ืืืื
ืชืืจืืืช ืืื ืืื ืื ืืข-ืจืกืืืช ,ื"ืืืื ืืืื-ืชื
DAVID VARONRAMOT AT TEL-AVIVUNIVERSITY LTD.
]71[
WO/2002/071037]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An apparatus for analyzing liquid specimens, the device comprising at least onespecimen handling station for obtaining preparation on a specimen carrying device, andan imaging station fitted with an optical image capturing device for analyzing thepreparation. A carriage with a specimen carrying device receptacle rotatably retains thespecimen carrying device and is displaceable between a loading station and anunloading station with respective positions at the stations. An incremental displacementmechanism for displacing at least one of the specimen carrying device and an imagingdevice so as to obtain at least one consecutive image of the preparation.
]57[
__________
![Page 384: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/384.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 384
157818]21][11[
ืฉืืื ืื ืืืืจ ืชื ืืขืืช ืฉื ืืื ืืชืื ืืืจืื ืืืืืื, ืืืกืืื ืืื ืืื ืื
METHOD FOR MONITORINGTHE MOVEMENTS OFINDIVIDUALS IN AND AROUNDBUILDINGS, ROOMS AND THELIKE
]54[
04.03.2002]22[SE]33[20.03.2001]32[0100973-7 ]31[
Int. Cl.(2008.04) G01S 13/00, 13/75, 13/78, G07C 9/00]51[JAN BENGTSSON, SWEDENLEIF NYFELT, SWEDEN
]71[
WO/2002/075352]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to a method of monitoring the movements of an individualin and around buildings, rooms and other spaces, wherein each individual carries apassive transponder which has an individual-unique identity and which is intended forco-action with an active antenna that is connected, either directly or indirectly, to amonitoring centre (13) for transmitting signals received from transponders, and whereina plurality of antennas (12) are placed in and around the buildings, rooms or otherspaces to be monitored. The signals transmitted to the exercise centre (13) are used toshow movements of the individual in the form of a three-dimensional animated pictureon a picture screen.
]57[
__________
![Page 385: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/385.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009385
157878]21][11[
ืฉืืื ืืืื ืช ืชืจืืืคืื ืืฆืืืื ืืืืงืืช ืฉื ื ื ืืืืืืช ืืขืฉืืืืช ืืคืืื
METHOD FOR THEPREPARATION OF STABLESUSPENSIONS AND POWDERSOF SINGLE CARBONNANOTUBES
]54[
25.03.2002]22[IL]33[26.03.2001]32[142254]31[
Int. Cl.(2009.01) B01J 13//00, C01B 31//02]51[ืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืื ืืืจ ืฉืืข, ืืืืงืจ ืืคืืชืื
BEN GURION UNIVERSITY OF THENEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
]71[
WO/2002/076888]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method is provided for exfoliation of carbon nanotubes and for thepreparation of a stable aqueous suspension thereof containing dispersed,essentially single tubes, using a water-soluble polymeric material. Apowder of carbon nanotubes is further provided, that can be re-dispersedto form a stable suspension. Said nanotubes can be used in electronics,printing, coatings, thin layers, molecular machines, and for theproduction of composite materials.
]57[
__________
157895]21][11[
ืคืืจืืืืืืคืืจืืืืืื ืื ืืชืืืืืืืคืืจืืืืืื ืื ืืืชืืจืื
SUBSTITUTEDPYRAZOLOPYRIMIDINES ANDTHIAZOLOPYRIMIDINES
]54[
13.03.2002]22[DE]33[14.03.2001]32[10112197.0]31[DE29.10.2001 10153344.6
Int. Cl.(2009.01) A61K 31//505, A61P 25//00, 29//00, C07D 48/7/04, 51/3/04]51[GRUNENTHAL GMBH, GERMANY]71[WO/2002/072585]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
![Page 386: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/386.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 386
The invention relates to substituted pyrazolopyrimidines andthiazolopyrimidines with the general structures (I A), (I B) and (II), to amethod for their production, to substance libraries containing the same,to medicaments containing said compounds, to the use of saidcompounds in the production of medicaments for treating pain,epilepsy, schizophrenia, neurodegenerative diseases, in particularAlzheimer's disease, Huntington's disease and Parkinson's disease, fortreating cerebral ischaemia and infarcts, psychosis caused by increasedamino acid levels, cerebral oedema, conditions caused by an under-supply of the central nervous system, in particular in hypoxia, especiallynewborn hypoxia and anoxia, for treating AIDS-related dementia,encephalomyelitis, Tourette's syndrome, perinatal asphyxia, tinnitus,neuropathic pain, diseases of the respiratory tract, cancer, cardiacarrythmia, immune disorders and diseases, inflammatory conditions anddiseases, renal shutdown, dyssomnia, strokes, thromboses, urinaryincontinence, diabetes, psoriasis, septicaemic shock, cerebral traumas,glaucoma and/or congestive heart failure. The invention further relatesto pharmaceutical compositions containing said compounds.
]57[
__________
![Page 387: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/387.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009387
157902]21][11[
ืขื ืืืฆืขื ืืืืื ืื ืงืจื ืขื ืืื ืืืื ืืืืืืื ืงืคื ืืืื, ืืื ืืจืืืช ืื ื
ืืืืื ืืช ืืกืคืจืกื
MACHINE-READABLEIDENTIFIER ON A PORTIONPACKAGE WHICH CONTAINSGROUND COFFEE FORESPRESSO MACHINES
]54[
20.03.2002]22[DE]33[31.03.2001]32[10116239.1]31[
Int. Cl.(2008.04) A47J 31/40, B65D 81/00]51[EUGSTER/FRISMAG AG,SWITZERLANDGOTTHARD MAHLICH, GERMANY
]71[
WO/2002/078498]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืืืื ืฉืขืจ ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A machine-readable identifier on a portion package, which containsground coffee, for espresso machines is provided in a rotationallysymmetrical manner, whereby permitting it to be easily and reliablyread, on an essentially flat surface of the portion package. The portionpackage is preferably a portion capsule (1) with an essentially roundbottom (2) to which the identifier is coaxially applied.
]57[
__________
![Page 388: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/388.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 388
158060]21][11[
ืืฉืืืืฉ ืืื ืืขื25CDืืืืงืืืืช ืงืืฉืืจืื ืืืคืื ืืืืืืช ืืฆื ืืืืคืืื ืขื
ืชื ืืืืช ืืกืืจืืืืืื
CD25 BINDING MOLECULES FORUSE IN THE PREVENTION ORTREATMENT OF DISEASES INSTEROID-RESISTANT PATIENTS
]54[
05.04.2002]22[GB]33[06.04.2001]32[0108816.0]31[GB06.04.2001 0108821.0 GB06.04.20010108817.8
Int. Cl.(2009.01) A61K 39//395, A61P 01//04, 01//16, 09//14, 11//06, 13//12, 17//02,19//02, 25//28, 35//02, 37//06, C07K 16//28
]51[
UNIVERSITY OF BRISTOL, UNITEDKINGDOM
]71[
WO/2002/081508]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method for the treatment of a disease selected from the groupconsisting of autoimmune hepatitis, eczema, vasculitis, temporalarteritis, sarcoid and Crohn's disease, in a steroid-resistant or steroid-sensitive patient, comprising administering to the patient an effectiveamount of a CD25 binding molecule.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.๏ฟฝ ืคืืจืกืืืฉืืจ
198757,The applications for divisionfrom this application havenot yet been published
__________
158127]21][11[
ืืืืื ืงืืื ืืืืืกืก ืขื ืืืื ืืจื ื ืขืืค ืงืืืืช ืืืืฆืืข ืืืืืืืงืืื ืกืืจืช ืกืื ืืืื
WEB-BASED SPEECHRECOGNITION WITHSCRIPTING AND SEMANTICOBJECTS
]54[
14.03.2002]22[US]33[23.03.2001]32[815726]31[
Int. Cl.(2009.01) G10L 15//00]51[ELIZA CORPORATION, U.S.A.]71[WO/2002/077973]87[
',ืืืืืกืื ืืืจืืืื ืืฉืืช ืชื ืืืื, 1426.ื.ืช,31ืืื ื' ืจื
SELIGSOHN GABRIELI & CO.,31 YAVNE ST.,
P.O.B. 1426,TEL AVIV 61013
]74[
![Page 389: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/389.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009389
The present invention is a system and method for creating and implementingtransactional speech applications (SAs) using Web technologies, without reliance onserver-side standard or custom services. A transactional speech application may beany application that requires interpretation of speech in conjunction with a speechrecognition (SR) system (210), such as, for example, consumer survey systems. Aspeech application in accordance with the present invention is represented within aWeb page (220, 220'), as an application script (222, 222') that interprets semanticobjects (230) according to a context. Any commonly known scripting language can beused to write the application script, such as JavaScript (or ECMAScript), PerlScript, andVbscript. The present invention is 'Web-based' to the extent that it implements Webtechnologies, but it need not include or access the World Wide Web.
]57[
__________
158155]21][11[
ืฉืืืืฉ ืืืจืืชืจืืคืืืืื ืืืื ืช ืชืจืืคืืช ืื ืืืขืช ืืืืืืชืจืคืืืืืคืืชืช ืจืขืืื
USE OF ERYTHROPOIETIN FORTHE PREPARATION OF AMEDICAMENT TO AMELIORATECHEMOTHERAPY-INDUCEDTOXICITY
]54[
08.04.2002]22[US]33[09.04.2001]32[60/282621]31[
Int. Cl.(2008.04) A01N 37/18, A61K 38/18]51[EAST CAROLINA UNIVERSITY,U.S.A.
]71[
WO/2002/080676]87[,ืจ ืืฆืืง ืืก ืืฉืืชืคืื"ื
ืชื ืืืื, 6451.ื.ืช, 279ืจืืื ืืืจืงืืDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
A method of reducing organ toxicity in a subject being administered acytotoxic agent comprising concurrently administering with thecytotoxic agent erythropoietin (EPO), the EPO being administered in anamount effective to reduce pulmonary toxicity caused by the cytotoxicagent.
]57[
![Page 390: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/390.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 390
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198783,The applications for divisionfrom this application havenot yet been published
__________
158161]21][11[
ืฉืืื ืืืชืงื ืืฉืืจืืฉื ืฉืืืืจ ืืืขืจืืช ืชืงืฉืืจืช ืืืืืืืช
METHOD AND APPARATUS FORBROADCAST SERVICES IN AWIRELESS COMMUNICATIONSYSTEM
]54[
28.03.2002]22[US]33[28.03.2001]32[60/279970]31[US20.08.2001 09/933971
Int. Cl.(2008.04) H04B 7/26, H04H 1/00, H04L 12/00, 12/18, 12/56, 29/06, 29/08,9/08, 9/28, 9/30, H04Q 7/38
]51[
QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2002/080454]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Method and apparatus for providing a broadcast system parameter message in awireless communication system supporting a broadcast service. In one embodiment,the message identifies a service option number corresponding to a set of broadcastparameters. In an alternate embodiment, the message identifies a block of bytescorresponding to broadcast parameters. The message may be transmitted on achannel for transmitting overhead information. For a system supporting a broadcastservice, the message identifies a protocol stack for processing broadcast service, themessage identifies a protocol stack for processing broadcast content.
]57[
__________
![Page 391: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/391.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009391
158162]21][11[
ืืงืจืช ืื ืืฉืืจืืชื ื ืงืืื ืืืกืคืจ ื ืงืืืืช ืืืกืืคืงืื ืืืขืจืืช ืชืงืฉืืจืช
POWER CONTROL FOR POINT-TO-MULTIPOINT SERVICESPROVIDED IN COMMUNICATIONSYSTEMS
]54[
28.03.2002]22[US]33[28.03.2001]32[60/279970]31[
Int. Cl.(2008.04) H04B 7/00, 7/26, 70/05, H04L 12/18, 12/28, 9/08]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2002/080401]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
To enable point-to-multipoint communication services in an existing cellularcommunication system infrastructure, each member subscriber station (102), i.e., asubscriber station participating in such a service, is receiving a forward link sharedchannel (106), and in certain embodiments additionally a forward link dedicatedchannel. Because transmission on the forward link channels from neighboring sectorspresents interference to the transmission from the sector serving the subscriber station,it is desirable to control the forward link channel transmission power to the minimumacceptable power. Additionally, a transmission from each member subscriber station ona reverse link channel (108) presents interference to other subscriber stations.Therefore, it is desirable to control the reverse link channel transmission to theminimum signal level. Consequently, a method and apparatus for a power control thatenables point-to-multipoint services in an existing infrastructure of a wireless cellulartelephone system is disclosed.
]57[
__________
![Page 392: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/392.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 392
158228]21][11[
ืฉืืืืฉ ืืืกืืจืื ืฉื ืืืืฆืืช ืฉืืื ืืืชืืขืืืช ืฉืจืฉืจืช ืืจืืื ืืืื ืช ืชืจืืคืืช
ืืืืคืื ืืืืืืช ืืืืืืืืื ืืืช
USE OF ESTERS OF LONG-CHAINFATTY ACIDS FOR THEPREPARATION OFMEDICAMENTS FOR THETREATMENT OF AUTOIMMUNEDISEASES
]54[
11.04.2002]22[IL]33[11.04.2001]32[142537]31[
Int. Cl.(2008.04) A61K 31/23, 312/31, 312/32, 317/024, A61P 29/00, 31/02, C07C233/08, 233/09, 69/00, 69/22, 69/33, 69/52, 69/58
]51[
YEDA ืจืืืืืช,ื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข RESEARCH ANDDEVELOPMENT CO. LTD.
]71[
ืื, ืคื ืืก ืืืจืฉืืืื PINCHAS ื ืื- ืืืจืื BURSTEIN, AVRAHAMBEN-NUN
]72[
WO/2002/083059]87[',ืื ืขืื ืืฉืืช ืจืืืืืช,94.ื.ืช,8ืื ืื ืคืืืื
BEN-AMI & ASSOCIATES,8 PLAUT ST.,
PARK TAMAR,P.O.B. 94,REHOVOT 76100
]74[
Agents selected from: (i) a Cยฟ1? - Cยฟ24? alkyl ester of a saturated orcis-unsaturated Cยฟ10? - Cยฟ24? fatty acid; (ii) a monoester or polyesterof a polyol having at least four hydroxy groups with a saturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid or an anhydro derivative thereof;(iii) a monoester or polyester of a mono-, di- or poly-saccharide with asaturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid; (iv) an amide of asaturated or cis-unsaturated Cยฟ10? - Cยฟ24? fatty acid with an aliphaticor aromatic amine or with an amino acid, peptide, protein oraminosaccharide; and (v) combinations of any of (i) to (iv), can be usedfor treatment of autoimmune diseases and other immune-associatedinflammatory disorders. Preferred agents are ethyl oleate and mannidemonooleate or a combination thereof.
]57[
__________
![Page 393: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/393.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009393
158285]21][11[
ืคืคืืืืื ืืืื ืช ืชืืฉืืจืื ืืืืคืื ืืืกืื ืืืืจืฉืช ืขืืจืงืื ืืคืืชืื ืืืื ืืืืืกืก ืขื ืคืคืืืืื ืืงืืืขืช ืืชืืืื ืืืืกืื ืืช ื ืื
ืืืคืืคืจืืืืื ืื ืืืืืฆื ืื ืืขืื ืืฉืงื ืกืืืื ื ืืื
PEPTIDES FOR PREPARINGMEDICAMENT FOR IMMUNO-THERAPY OFATHEROSCLEROSIS ANDDEVELOPMENT OF PEPTIDE-BASE ASSAY FORDETERMINATION OF IMMUNERESPONSES AGAINST OXIDIZEDLOW DENSITY LIPOPROTEIN
]54[
05.04.2002]22[SE]33[05.04.2001]32[0101232-7 ]31[SE09.11.2001 0103754-8
Int. Cl.(2008.04) A61K 38/00, 38/17, 39/00, 393/95, A61P 9/10, C07K 147/75, G01N33/53
]51[
CEDARS-SINAI MEDICAL CENTER,U.S.A.FORSKARPATENT I SYD AB,SWEDEN
]71[
WO/2002/080954]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to fragments of apolipoprotein B, inparticular defined peptides thereof, for immunization or therapeutictreatment of mammals, including humans, against ischemiccardiovascular diseases, as well as diagnosing the presence or absenceof antibodies related to increased or decreased risk of developingischemic cardiovascular diseases, using one or more of said peptides inan ELISA (Enzyme Linked Immuno Sorbent Assay).
]57[
ืช ืืืืงื ืืืงืฉื ืื ืืงืฉื.ืฉืืจ๏ฟฝ ืคืืจืกืื
195356,188286,The applications for divisionfrom this application havenot yet been published
__________
![Page 394: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/394.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 394
158634]21][11[
ืชืืืื ืขืืืจ ืืื ืช ืชืืืืืชืคืจืืกืืืืืื ืืืื ืืืืืจ ืืื ื
ืกืืจืืืกืคืฆืืคืืื ืขืืืจื
PROCESS FOR PREPARINGPROSTAGLANDIN DERIVATIVESAND STEREOSPECIFICSTARTING MATERIALTHEREFOR
]54[
07.05.2002]22[KR]33[08.05.2001]32[2001/25011]31[
Int. Cl.(2009.01) C07C 40/5/00, 41//02, 43//02, 43//17, 43//174, C07F 07//00]51[YONSUNG FINE CHEMICAL CO.,REPUBLIC OF KOREA
]71[
WO/2002/090324]87[,ืจ ืืฆืืง ืืก ืืฉืืชืคืื"ื
ืชื ืืืื, 6451.ื.ืช, 279ืจืืื ืืืจืงืืDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
The present invention relates to a process for effectively preparingprostaglandin derivatives and to a stereospecific alkyl halide containing 15S-alcohol group as a starting material.
]57[
__________
158932]21][11[
METHOD ืฉืืื ืืืืื ืืืคืจืืื FOR PRODUCINGBIPERIDEN
]54[
17.05.2002]22[DE]33[18.05.2001]32[10124452.5]31[DE18.05.2001 10124450.9
Int. Cl.(2009.01) C07B 57//00, C07D 29/5/08, 29/5/10]51[ABBOTT GMBH & CO. KG,GERMANY
]71[
WO/2002/094801]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a method for producing biperiden which ischaracterised in that an exo/endo mixture of 1-(bicyclo[2.2.1]hept-5-en-2-yl)-3-piperidino-l-propanone is reacted with an isomer ratio of the exo form to theendo form of at least 2.5:1 with diphenyl magnesium, an isomer mixturecontaining biperiden is obtained therefrom and biperiden is producedtherefrom.
]57[
__________
![Page 395: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/395.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009395
158933]21][11[
METHOD ืฉืืื ืืืืื ืืืคืจืืื FOR THEPRODUCTION OF BIPERIDEN
]54[
17.05.2002]22[DE]33[18.05.2001]32[10124449.5]31[
Int. Cl.(2009.01) C07D 29/5/08, 29/5/10]51[ABBOTT GMBH & CO. KG,GERMANY
]71[
WO/2002/094781]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a method for the production of biperiden byreacting an exo/endo mixture of 1-(bicyclo[2.2.1.]hept-5-en-2-yl) 3-piperidino-1-propanone with a phenyl magnesium compound, whereinthe exo/endo ratio of 1-(bicyclo[2.2.1.]hept-5-en-2-yl)-3-piperidino-1-propanone is at least 4.5: 1.
]57[
__________
158935]21][11[
ืฆืืจืืื ืืืชืคืจืงืื ืืืืคืโืงืจืืืื ืื ืืืขื ืืขืื ืืชื ืืืืช ืืืืงืจืช ืืงืจืืขื
BIODEGRADABLE BIAXIALLYDRAWN FILM WITHCONTROLLED TEARRESISTANCE
]54[
31.05.2002]22[DE]33[06.06.2001]32[10127314.2]31[
Int. Cl.(2008.04) C08J 5/18, C08K 3/00, C08L 67/04]51[TRESPAPHAN GMBH, GERMANY]71[WO/2002/098982]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a film with controllable tear resistant properties,comprising at least one basic layer which contains at least one polymer Ifrom at least one hydroxycarboxylic acid, and >0.1 wt. %, in relation tothe weight of the layer, of a thermoplastic polymer II which is differentfrom polymer I, and/or inorganic additives.
]57[
__________
![Page 396: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/396.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 396
158968]21][11[
SOLAR ืืืื ืืื ืกืืืืจื WATER HEATER]54[
20.11.2003]22[Int. Cl.(2008.04) F24J 2/04]51[
OFER ืขืคืจ ืืื DAGAN]71[,ืขืคืจ ืืื
ืฉืขืจ ืืขืืงืืOFER DAGAN,SHA'AR HA'AMAKIM
]74[
An integral storage-collector solar water-heating system comprising: a tank (11) havingin inlet (13) for city water inlet โ located in the lower side of said tank, a first outlet (14a)for supplying hot water โ located in the upper side of said tank โ and a second outlet(20) for feeding water to a fin โ tube absorber (15) โ located in the lower side of saidtank: a thermally insulated layer (12), which is attached to the inside walls of said tank;and an upper solar tank-absorber (16) and said lower solar fin-tube absorber, each forthe purpose of enabling a flow of water there-through to which solar heat collected bythe absorbers can be transferred, wherein: said upper solar tank-absorber is built insidethe exposed wall of said tank, by a water-flow-grid made of tunnels (25) that aregrooved in said thermally insulated layer, having an inlet (17) and an outlet into saidtank; and said lower solar fin-tube absorber has an inlet and an outlet, wherein saidinlet is connected to said second outlet of said tank and said fin-tube absorber's outletis connected to said inlet of said upper solar tank-absorber.
]57[
__________
![Page 397: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/397.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009397
159017]21][11[
ืื ืื ื ืชืื ืื ืืืชืงื ื ืชืงืฉืืจืช ืืืืืืืช ืืฉืืื ืื ืืืื ื ืชืื ืื ืืืชืงื ืืืืืื
DATA MANAGER FOR WIRELESSCOMMUNICATION DEVICESAND METHOD OF MANAGINGDATA IN A WIRELESS DEVICE
]54[
31.05.2002]22[US]33[31.05.2001]32[09/871471]31[
Int. Cl.(2008.04) H04L 12/28, 12/56, 12/64, H04M 1/72, 12/53, 17/25, 34/93, 7/00]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2002/098078]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A data manager, and a method of managing data, for a wireless device. The datamanager includes a data receiver that receives voice data over the internet protocolconnection, a data sender that sends other voice data over the internet protocolconnection, a data recognizer that differentiates the voice data and the other voice datafrom non-voice data and non-data, and a controller that broadcasts the voice data andthe other voice data in an internet voice protocol format. The method includes the stepsof receiving voice data over the internet protocol connection at the wireless device,sending other voice data over the internet protocol connection from the wireless device,differentiating the voice data from non-voice data and non-data, differentiating the othervoice data from other non-voice data and non-data, and controlling the broadcast of thevoice data, and the other voice data.
]57[
__________
![Page 398: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/398.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 398
159218]21][11[
ื ืืืจืืช ืื ืืืคืืจืื ืืืชืืจืืช ื ืื ืืคืจืขืืช ืงืฆื ืื
SUBSTITUTED BENZOPYRANDERIVATIVES AGAINSTARRHYTHMIA
]54[
17.06.2002]22[JP]33[25.06.2001]32[2001-190594]31[
Int. Cl.(2008.04) A61K 31/42, 313/53, 313/81, 314/96, 315/06, A61P 9/06, C07D311/00, 311/68, 405/12, 407/12, 409/12, 413/12, 417/12, 513/12
]51[
NISSAN CHEMICAL INDUSTRIESLTD., JAPAN
]71[
WO/2003/000675]87[',ืืืจืืืืฅ ืืฉืืช.ืฉ
ืชื, 41-45ืฉืืจืืช ืจืืืฉืืื, ืืืช ืฆืืื ืืืื
S. HOROWITZ & CO.,ZION HOUSE,
41-45 ROTHSCHILD BLVD.,TEL AVIV 65784
]74[
This invention relates to benzopyran derivatives of the formula (1) or the formula (2)wherein R?1ยฟ and R?2ยฟ represent independently of each other hydrogen atom or Cยฟ1-6?alkyl group, R?3ยฟ represents hydroxyl group or Cยฟ1-6? alkylcarbonyloxy group,R?4ยฟ represents hydrogen atom or Cยฟ1-6? alkyl group, R?5ยฟ represents Cยฟ1-6? alkylgroup substituted with Cยฟ6-14? aryl group or heteroaryl group, R?6ยฟ represents Cยฟ1-6? alkyl group, Cยฟ1-6? alkoxy group, halogen atom, nitro group, C(O)NHยฟ2?,C(O)NHR?8ยฟ or C(O)NR?8ยฟR?9ยฟ, or pharmaceutically acceptable salts thereof. Thesecompounds are useful as an antiarrhythmic agent.
]57[
__________
![Page 399: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/399.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009399
159534]21][11[
ืฉืืื ืืืื ืช ืงืืจืืืื ืืืืชืืจืื ืืืืคื ืกืืงืืืื ืืงืืจืืืื ืืืชืืจืื ืืืฉืื
METHOD FOR THEPREPARATION OFSELECTIVELY-SUBSTITUTEDCORROLES AND NEWSUBSTITUTED CORROLES
]54[
01.07.2002]22[US]33[02.07.2001]32[60/301851]31[
Int. Cl.(2008.04) A61K 31/40, 31/55, C07D 487/22]51[TECHNION ืืืคื,ื"ืืืกื ืืืื ืืื ืืืืงืจ ืืคืืชืื ืืข RESEARCH AND
DEVELOPMENT FOUNDATIONLTD.
]71[
ZEEV ืืืจื ื ืืืฆืื, ืขืืืฃ ืืืืืื, ืืื ืืจืืก GROSS, ATIF MAHAMMED,IRENA SALTSMAN
]72[
WO/2003/004021]87[',ืื ืขืื ืืฉืืช ืจืืืืืช,94.ื.ืช,8ืื ืื ืคืืืื
BEN-AMI & ASSOCIATES,8 PLAUT ST.,
PARK TAMAR,P.O.B. 94,REHOVOT 76100
]74[
A corrole of the formula
wherein:Ar is aryl or heteroaryl;M is absent or is metal selected from the group consisting of Al, Ga, Co, Mn, Fe, Ru,Sn, Cr and Rh; E2, E3 and E17, the same or different, each is H, SO2Cl, SO3H,SO2NR1R2, CO2H, CO2R, COCl, CONR1R2, CHO or NO2 R is alkyl or aryl, and R1 andR2, the same or different, each is H, alkyl, aryl or together with the N atom to which theyare attached form a staturated 5-6 membered ring optionally containing a furtherheteroatom selected from the group consisting of O, S and N; and E18 is H or CHO; orE3 and E18 each is H and E2 and E17 each is SO2, both SO2 groups being linked by abridge R3N(R4)-phenyl-(R4)NR3, wherein R3 is H, alkyl, phenyl or aralkyl, and R4 isalkylene; and provided that at least one of E2, E3, E17 and E18 is not H.
]57[
__________
![Page 400: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/400.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 400
159859]21][11[
ANTINEOPLASTIC ืฆืืจืืคืื ื ืืืื ืกืจืืCOMBINATIONS
]54[
06.08.2002]22[US]33[07.08.2001]32[60/310646]31[
Int. Cl.(2008.04) A61K 313/95, 314/706, A61P 35/00]51[WYETH, U.S.A.]71[WO/2003/020266]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
This invention provides the use of a combination of CCI-779 and EKB-569 in thetreatment of neoplasms.
]57[
__________
159947]21][11[
ืฉืืืืช ืืชืืฉืืจืื ืืืื ื ืืืจืงืื ืืืืฆืขืืช ื ืืืจืืช ืื ืชืจืื ืืืืืื
METHODS AND COMPOSITIONSFOR PROTECTION FROMARTHROPODS USINGANTHRANILAMIDEDERIVATIVES
]54[
10.09.2002]22[US]33[21.09.2001]32[60/323941]31[
Int. Cl.(2009.01) A01N 43//56, 55//10, C07D 23/1/00, 40/1/04, 40/3/04, 40/5/04,40/5/12, 41/3/04, 41/3/14, 41/7/04, C07F 07//18
]51[
E.I. DUPONT DE NEMOURS ANDCOMPANY, U.S.A.
]71[
WO/2003/024222]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
This invention pertains to methods for protecting a propagule or a plant grown therefrom from invertebrate pests comprising contacting the propagule or the locus of the propagule with a biologically effective amount of a compound of Formula I: its N-oxide or an agriculturally suitable salt thereof wherein A and B and R?1? through R?8? are as defined in
]57[
![Page 401: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/401.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009401
the disclosure. This invention also relates to propagules treated with a compound of Formula I and compositions comprising a Formula I compound for coating propagules.
__________
159950]21][11[
ืืืื ืืืื ืช ืืืงืืช ื ื ืืืืจืืืช ืืืืงืืชืืขืืช ืืฆืจืคืื ืืืคืฉืืื ืฉื ืืืงืืงืื
ื ื ืืืืจืืื
PROCESS FOR PRODUCINGNANO-POWDERS AND NANO-PARTICLE LOOSE AGGREGATESPOWDER
]54[
26.07.2002]22[CN]33[27.07.2001]32[01127978.8]31[
Int. Cl.(2009.01) B01F 03//08, B01J 19//00, C01F 03//02]51[ANSHAN UNIVERSITY OFSCIENCE AND TECHNOLOGY,CHINA
]71[
WO/2003/011761]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention discloses a process for producing nano-powdersand powders of nano-particle loose aggregate, which comprises: (a)providing at least two reactant solutions A and B capable of rapidlyreacting to form deposits; (b) supplying the at least two solutions A andB at least at the reaction temperature into a mixing and reactionprecipitator respectively, in which mixing reaction and precipitation arecontinuously carried out in sequence, the said mixing and reactionprecipitator being selected from at least one of a tubular ejector mixingreactor, a tubular static mixing reactor and an atomizing mixing reactor;and (c) treating the deposit-containing slurry continuously dischargedfrom the mixing reaction precipitator. The process makes it possible tocontrol the size of the nano-particles, produces particles uniform in size,good in dispersibility and high in yield, while being simple and savingenergy. The process can be used to produce nano-powders of nano-particle aggregates of various kind of metals, oxides, hydroxides, salts,
]57[
![Page 402: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/402.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 402
phosphor compounds, sulphur compounds, organic compounds, andinorganic organic compounds.
__________
160049]21][11[
LACTOBACILLUSืื ื SALIVARIUSืคืืจืืืืฆืืืช ืฉืืื ืืฉืืืืฉ, ืคืจืืืืืืืื
ืืื ืืืืฆืืจ ืชืืฉืืจืื ืจืคืืืืื
ISOLATED PROBIOTICLACTOBACILLUS SALIVARIUSSTRAINS, FORMULATIONSTHEREOF AND USES THEREOFFOR THE MANUFACTURE OFMEDICAMENTS
]54[
26.07.2002]22[IE]33[26.07.2001]32[01/0707]31[IE26.07.2001 01/0702 IE26.07.200101/0701IE26.07.200101/0705IE26.07.200101/0708
Int. Cl.(2008.04) A61K 35/74, A61P 29/00, C12N 1/20, C12R 12/25]51[ALIMENTARY HEALTH LIMITED,IRELAND
]71[
WO/2003/010298]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A Loctabacillus salivarius strain,AHlO2, AHlO3, AHlO5, AHlO9 or AHllO or mutants orvariants thereof are useful in the prophylaxis and/or treatment of inflammatory activityespecially undesirable gastrointestinal inflammatory activity, such as inflammatorybowel disease or irritable bowel syndrome.
]57[
__________
![Page 403: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/403.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009403
160053]21][11[
ืฉืืื ืืืืืื ืืืคืืื ืฉื ืชืฆืืืืื ืืงืฉืืจืื ืืงืจืื ืืืืืืืืื ืืืืื ื
METHOD TO ISOLATE ANDCHARACTERIZE MEMBRANEBOUND LIGAND SPECIFICCOMPLEXES
]54[
29.07.2002]22[US]33[27.07.2001]32[60/308655]31[US17.08.2001 09/932166
Int. Cl.(2009.01) C07K 01//14, 01//22, 14//705, 16//28, G01N 33//48, 33//566,33//577
]51[
AGENSYS, INC., U.S.A.]71[WO/2003/012047]87[
,ืื ืืืืืจืืจื, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A method to recover or 'deracinate' receptors from intact membranes in their nativeconfiguration without removing microenvironmental components associated with themis described. The membranes containing the receptors are first associated with ligand-coupled solid supports to achieve association of the membranes through areceptor/ligand complex which includes the microenvironmental to the solid supportand then removing the membrane from the receptor and its microenvironment by shearforces. The thus isolated receptors and their microenvironments can then be analyzedfor their role in cellular differentiation, apoptosis, transformation and the like.
]57[
__________
![Page 404: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/404.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 404
160330]21][11[
ืืืฉืื ืคืขืืื ืฉื ืืงืฉืช ืฉืืืืจ ืืืืจืืืืืืืืช ืขื ืฉืืืช ืคืืกืืช ืขืืืจ ืืืืืช
ืื ืื
IMPLEMENTING A PHYSICALLAYER AUTOMATIC REPEATREQUEST FOR A SUBSCRIBERUNIT
]54[
23.08.2002]22[US]33[24.08.2001]32[939410]31[US27.02.2002 085203
Int. Cl.(2009.01) H04B 07//26, H04L 01//16]51[INTERDIGITAL TECHNOLOGYCORPORATION, U.S.A.
]71[
WO/2003/019844]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A subscriber unit implementing physical layer automatic repeat request includes atransmitter (12) and a receiver (16). The transmitter has a physical layer transmitter(12a); an acknowledge receiver (12b) for receiving the correspondingacknowledgment; and an adaptive modulation and coding controller (12c) forcollecting retransmission statistics and adjusting the particular dataencoding/modulation using the collected statistics. The receiver (16) has a physicallayer receiver (16a), and an acknowledgment generator (16c) for generating anacknowledgment for each packet if that packet has an acceptable error rate.
]57[
__________
![Page 405: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/405.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009405
160338]21][11[
ืืืื ืืืืฆืืจ ืืืืื ืื ืคืืืืคืคืืื ืฉืืฉืื ืขื ืืื ืืฆืื ืื ืืชืื ืฆืื ืืืฉืืืฉ
ืืืืืื ืืืืื ืืืืื ืคืคืืื ืืืชืืืจ ืืืืคื ืชื
PROCESS OF PRODUCING APROTEIN OR POLYPEPTIDE OFINTEREST IN A PLANT OR INPLANT CELLS USING FUSIONPROTEIN COMPRISING CELLWALL-BINDING PEPTIDE
]54[
28.08.2002]22[DE]33[04.09.2001]32[10143205.4]31[
Int. Cl.(2009.01) A01H 05//00, C12N 15//62, 15//82, C12P 21//00]51[ICON GENETICS GMBH,GERMANY
]71[
YURII DOROKHOV, EUGENESKURAT, VICTOR KLIMYUK, YURIGLEBA
]72[
WO/2003/020938]87[ืื'ื ืืข, ืื ืื ,ื"ืคืงืืืจ ืื ื ืงื
, 45087.ื.ืช, ืืจ ืืืฆืืื, ืจืืื ืืืจืคื ืืจืืฉืืื
JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,JERUSALEM 91450
]74[
A process of producing a protein or polypeptide of interest in a plant orin plant is provided, comprising: (i) transforming or transfecting a plantof plant cells with a nucleotide sequence having a coding regionencoding a fusion protein comprising the protein or polypeptide ofinterest, a signal peptide functional for targeting said fusion protein tothe apoplast, and a polypeptide capable of binding the fusion protein toa cell wall component, (ii) enriching cell wall components havingexpressed and bound fusion protein, and separating the protein orpolypeptide of interest or a protein comprising the protein orpolypeptide interest.
]57[
__________
![Page 406: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/406.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 406
160367]21][11[
ืคืืจืืื ืคืืจืืืืืื ืื ืืืืืจืื ืืื ืืขืช ืฆืืกืืืื ืคืจืืืืืื
PYRROLO PYRIMIDINES ASAGENTS FOR THE INHIBITIONOF CYSTEINE PROTEASES
]54[
29.08.2002]22[GB]33[30.08.2001]32[0121033.5]31[
Int. Cl.(2008.04) A61K 315/19, A61P 29/00, C07D 471/10, 487/04]51[NOVARTIS AG, SWITZERLAND]71[WO/2003/020721]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention provides compounds of Formula I or a pharmaceutically acceptable saltor ester thereof wherein the symbols have meaning as defined, which are inhibitors ofcathepsin K and find use pharmaceutically for treatment of diseases and medicalconditions in which cathepsin K is implicated, e.g. various disorders includinginflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198643,The applications for divisionfrom this application havenot yet been published
__________
![Page 407: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/407.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009407
160522]21][11[
ืืืืืืืื ืืขืืืช ืคืขืืืืชโH1ืชืืืืืช,CB1ืืืื ืืกืืืช ืืืื ืื ืืืงืืช ืืืคื
CB1ืื ืคืขืืืืช ืื ืืืื ืืกืืืช ืืืคื
1H - IMIDAZOLE DERIVATIVESHAVING CB1 AGONISTIC, CB1PARTIAL AGONISTIC OR CB1-ANTAGONISTIC ACTIVITY
]54[
17.09.2002]22[EP]33[21.09.2001]32[01203851.9]31[
Int. Cl.(2009.01) A61K 31//41, C07C 25/7/10, C07D 23/3/00, 23/3/54, 40/1/02,40/3/02, 40/3/12, 41/3/02
]51[
SOLVAY PHARMACEUTICALSB.V., THE NETHERLANDS
]71[
WO/2003/027076]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
AbstractThe present invention relates to a group of novel 1Hโimidazole derivatives, tomethods for the preparation of these compounds, and to pharmaceutical compositionscontaining one or more of these compounds as an active component.These1Hโimidazole derivatives are potent cannabinoidโCB1 receptor agonists, partialagonists or antagonists, useful for the treatment of psychiatric and neurologicaldisorders, as well as and other diseases involving cannabinoid neurotransmission.Thecompounds have the general formula (I) wherein R and R1โR4 have the meaningsgiven in the specification.
]57[
__________
![Page 408: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/408.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 408
160575]21][11[
ืช ืขืจืืฅ ืืขืืจืช ืืงืืืช ืืืืขืืช ืืืืฆืขื ืชืงืฉืืจืช ืืืชืื ืืืืื ืชืื ืืช
TRANSMITTING ANDRECEIVING MESSAGESTHROUGH A CUSTOMIZABLECOMMUNICATION CHANNELAND PROGRAMMING MODEL
]54[
25.02.2004]22[US]33[26.03.2003]32[400747]31[
Int. Cl.(2008.04) G06F 13/00, 15/00, 17/00, 9/46, H04L 29/06, 29/08, 29/10]51[MICROSOFT CORPORATION,U.S.A.
]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A computer system for implementing a messaging infrastructure which abstractsvarious processing layers within the infrastructure, wherein the infrastructure is adaptedto provide a base level of messaging functionality, and wherein the abstract processinglayers are extensible such that changes or enhancements can be made withoutnecessarily having to re-implement the base level of messaging functionality providedin other abstract processing layers, the computer system comprising: one or moremessaging layer modules adapted to provide endpoint-to-endpoint transmission of oneor more messages and to implement support for one or more message transportprotocols; one or more channel layer modules adapted to provide message exchangesemantics on top of the one or more message layer modules; and one or more servicelayer modules adapted to provide one or more programming modules on top of the oneor more channel layer modules adapted to interact with the messaging infrastructure byexposing one or more features of the messaging infrastructure to be accessed bysoftware designed to use the messaging infrastructure; wherein the one or morechannel layer modules comprise a channel manager adapted to gather and correlatemessages and present a higher-level channel abstraction to the one or more servicelayer modules.
]57[
__________
![Page 409: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/409.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009409
160580]21][11[
ืืขืจืืช ืกืื ืื ืืจืืืช ืฆืืืืช ืืฉืืชื ืืื ืืขืช ืกืชืืืืช ืืืืืจื ืืช
CROSSFLOW FILTRATIONSYSTEM AND METHOD FORMEMBRANE FOULINGPREVENTION
]54[
26.02.2004]22[Int. Cl.(2009.01) B01D 65//02]51[
BORIS ืืืคื, ืืืจืืก ืคืืืืืกืงื PODOLSKY]71[,ืืืจืืก ืคืืืืืกืงื
ืืืคื,,ื26ืืื'ืืืื' ืฉืBORIS PODOLSKY,26G WEDGWOOD AVE., HAIFA
]74[
A crossflow filtration system for membrane fouling prevention, comprising:(a) a pipe-line for feeding liquid to be cleaned;(b) a pressure pump associated via a hydraulic line with the pipe-line for feeding fluid tobe cleaned;(c) a membrane module, including a membrane enclosed in a body associated via apressure line with the pump and two exits, the first whereof serves for removingcleaned fluid, and the second โ for removing waste concentrate, this membranemodule serves for separating the feed into pure fluid and concentrate containingimpurities;(d) a pipe-line for cleaned fluid associated with the first exit of said membrane body;(e) a pipe-line for removing waste concentrate connected with the second exit of saidmembrane body;(f) means for applying an additional reciprocal fluid pulse to the fluid passing through(a) membrane located in a membrane module for applying an additional reciprocal fluidpulse to the fluid passing through the membrane module, whereby there are preventedmembrane fouling in said membrane module and formation thereof of a boundaryconcentrate layer.
]57[
__________
160640]21][11[
CRYSTALLINE ืืืืจืืื ืืืืฉืืื ืฉื ืชืืืืืช ืื ืืืื HYDRATES OFANILIDE DERIVATIVES
]54[
14.09.2002]22[DE]33[25.09.2001]32[10147034.7]31[
Int. Cl.(2008.04) A01N 43/40, C07C 233/64, C07D 213/82]51[BASF SE, GERMANY]71[WO/2003/029219]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืืืืจืืช ืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to crystalline hydrates of substituted nicotinic acid anilidederivatives and substituted benzoic acid anilide derivatives of formula (1), theproduction and use thereof to combat phytopathogenic fungi and undesirableinsect and accaride attacks and/or to regulate the growth of plants; wherein A
]57[
![Page 410: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/410.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 410
represents (A1) or (A2), R?1ยฟ represents phenyl substituted by halogen, R?2ยฟrepresents difluoromethyl, trifluorormethyl, chlorine, bromine or iodine andR?3ยฟ represents trifluoromethyl or chlorine.
__________
160660]21][11[
OPTICAL ืืืื ืืืคืื ืืืขืงื ืืืจ ืืืืืืช WINDOW FORMONITORING SAMPLES
]54[
13.09.2002]22[GB]33[20.09.2001]32[0122711.5]31[
Int. Cl.(2008.04) G01N 21/15]51[NDC INFRARED ENGINEERINGLTD., UNITED KINGDOM
]71[
WO/2003/025550]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
This invention is concerned with a material processing apparatus, e.g. a dryer such asa fluid bed dryer, for processing material, e.g. pharmaceuticals, in a compartment (12)having a wall (10). The wall has a window for transmitting radiation from an infraredspectrometer (30) into the dryer and for transmitting radiation from the material to thespectrometer. The spectrometer (30) can analyse the radiation transmitted from thematerial to measure a property of the material within the compartment, e.g. its moisturecontent. The radiation-transmitting element (28) is present in a moveable body (24),e.g. a sphere, that can be moved to bring the element (28) into a second position (31)in which the element is in contact with a duct (40) through which fluid can be passed toclean the element (28). In addition, a wiper member (34) may be provided that wipesthe element (28) as it passes over it as the moveable body (26) is moved into thesecond position.
]57[
__________
![Page 411: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/411.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009411
160680]21][11[
ืืฉืืืืช, ืื ืื ืช ืคืก ืืงืื ืืจืืฅ ืืืืืื ืชืฆืืจื ืฉืืืืืฆืืจ
DECADE BAND TAPERED SLOTANTENNA AND METHODS OFMAKING AND CONFIGURINGSAME
]54[
04.09.2002]22[US]33[04.09.2001]32[60/317410]31[US14.12.2001 10/023229 US14.12.200110/023800US14.12.200110/022753
Int. Cl.(2009.01) H01Q 09//04]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/021715]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An antenna apparatus (10) includes an antenna element (12, 412, 512) that hasconductive material with a recess therein. The recess includes a balun hole (36, 536),and a tapered slot (37, 537) communicating at its narrow end with the balun hole. Thebalun hole is approximately rectangular, has a peripheral edge defined by conductivematerial, and contains air. The tapered slot has a shape which is optimized as afunction of factors that include the balun hole design. Each slot edge follows apredetermined curve other than a first-order exponential curve.
]57[
__________
![Page 412: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/412.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 412
160769]21][11[
ืชืจืืืืืช ืืืจืืฆืืงืืืืช ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื
HETEROCYCLIC COMPOUNDSAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
04.10.2002]22[US]33[04.10.2001]32[60/327162]31[
Int. Cl.(2009.01) A61K 31//519, A61P 09//00, C07D 413/00]51[MORPHOCHEMAKTIENGESELLSCHAFT FURKOMBINATORISCHE CHEMIE,GERMANY
]71[
WO/2003/032962]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to compounds of the Formula (I) that are usefulantimicrobial agents and effective against a variety of multiโdrug resistant bacteria.
]57[
__________
160981]21][11[
SYSTEM ืืขืจืืช ืืฉืืื ืืฉืืืืจ ืืืชืืช ืืืืข AND METHOD FORCOMMUNICATING MEDIASIGNALS
]54[
26.09.2002]22[US]33[26.09.2001]32[60/325483]31[
Int. Cl.(2009.01) G06F 13//00, G06N 03//00, 03//08, H03M 07//30, H04L 29//06,H04N 07//26
]51[
INTERACT DEVICES, INC., U.S.A.]71[WO/2003/027876]87[
,ืืจืืื ืืืืืจ,ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A media streaming system for streaming media signals is provided. The mediastreaming system takes a library of separate and distinct CODECs (145) that areprovided as a searchable CODEC library and used in determining specificcharacteristics in the media signal to identify similar sections of the signal. The media
]57[
![Page 413: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/413.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009413
streaming system uses a computer implemented intelligence system, such as anintelligence mechanism to learn and capture the unique charateristics of a signal as thesignal is being streamed (150). The media streaming system also compresses anddecompresses the media signal as the signals are streamed from a source media (100)to a destination device (130, 135, 140).
__________
161165]21][11[
ืืื ื ืชืจื ืืืืฉื ืฉื ืืืืืกืจืืืืืฉืืืืฉ ืื ืืื ืืืื ืืกื ืืงืืืื
ืืื ืืืืื ืกืื
CRYSTALLINE SODIUM SALT OFTELMISARTAN AND THE USE OFTHE SAME AS AN ANGIOTENSINANTAGONIST
]54[
11.10.2002]22[DE]33[31.10.2001]32[10153737.9]31[
Int. Cl.(2009.01) A61K 31//4184, C07D 23/5/20]51[BOEHRINGER INGELHEIMPHARMA GMBH & CO. KG,GERMANY
]71[
WO/2003/037876]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a crystalline sodium salt of 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: Telmisartan), to a methodfor the production thereof, and to the use of the same for producing apharmaceutical having an angiotensin II antagonistic action.
]57[
__________
![Page 414: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/414.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 414
161401]21][11[
ORGANIC ืืืคืื ืืคืกืืืช ืืืจืื ืืช WASTE TREATMENT]54[
17.10.2002]22[AU]33[17.10.2001]32[PR8333]31[
Int. Cl.(2008.04) C02F 11/14, 3/00]51[ADVANCED ENVIRONMENTALTECHNOLOGIES PTY LTD.,AUSTRALIA
]71[
WO/2003/033418]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method of treatment of sewage comprising adding at least one cell signallingchemical (CSC) to a sewage substrate, wherein the at least one CSCregulates activity of a microbial population in the sewage substrate. Inparticular, methods of reducing odour in sewage treatment systems,preventing corrosion in sewage treatment systems, enhancing microbialdigestion of sewage, managing methane gas production in a sewagetreatment system, enhancing digestion of sewage sludge, resuscitatingdormant microbes or microbes that are in a starvation or stationary phase in asewage substrate and controlling the bacteria responsible for oxidation orreduction of nitrogenous compounds in a sewage substrate, are provided.
]57[
__________
161402]21][11[
POURING ืคืื ืืฉืคืืื SPOUT]54[
18.10.2002]22[GB]33[20.10.2001]32[0125296.4]31[
Int. Cl.(2009.01) B65D 05//74]51[SIG COMBIBLOC INTERNATIONALAG, SWITZERLAND
]71[
WO/2003/035491]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention describes a pouring spout device, comprising a spout fitment (4) and areclosable closure (2), said spout fitment (4) having a planar base (29) and a tubularside wall (24) defining a pouring zone therein and a flap (26) disposed at a lower end ofthe side wall (24), a cam follower (32) extending upward from said flap (26), whereinthe closure (2) retained on said fitment has an end wall (5) and a tubular side wall (3),
]57[
![Page 415: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/415.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009415
wherein the end wall (5) has a first cam (8) depending therefrom and engageable withsaid cam follower (32), and wherein the first cam (8) contacting the cam follower (32)during rotation of the closure (2). In order to avoid breakage of the cam follower (32),when the reclosable closure (2) is replaced on the spout fitment (4), a second cam (10)is formed on the reclosable closure (2) and disposed radially outermost of the first cam(8). When the cam follower (32) reaches the end region (12), the cam follower (32) willbe able to move radially inwardly and return to the surface (11) of the first cam (8). Thecam follower (32) will then be correctly positioned for future opening operations.
__________
161559]21][11[
ืชืืืืืช ืืืื ืืื ืืืื ืืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื
DIBENZYLAMINE DERIVATIVES ANDPHARMACEUTICAL COMPOSITIONSCONTAINING THE SAME
]54[
29.08.2003]22[JP]33[30.08.2002]32[2002-255604]31[JP10.04.2003 2003-107161
Int. Cl.(2008.04) A61K 31/41, 314/33, 315/05, C07C 229/28, 255/58, C07D 213/72,231/38, 233/44, 237/10, 239/42, 249/00, 257/04, 261/14, 263/00, 271/06, 277/38,405/12
]51[
JAPAN TOBACCO INC., JAPAN]71[WO/2004/020393]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A dibenzylamine compound represented by the general formula (1): (1)(wherein R1 and R2 each is optionally halogenated C1-6 alkyl, etc.; R3, R4, andR5 each is hydrogen, halogeno, etc., provided that R3 and R4 may form anoptionally substituted homocycle or heterocycle in cooperation with the carbonatoms bonded thereto; A is -N(R7)(R8), etc.; ring B is aryl or a heterocyclicresidue; R6 is hydrogen, halogeno, nitro, C1-6 alkyl, etc.; and n is an integer of 1to 3); a prodrug of the compound; or a pharmaceutically acceptable salt ofeither. They have selective and potent CETP inhibitory activity and are henceusable as, e.g., a therapeutic or preventive drug for hyperlipemia,arteriosclerosis, etc.
]57[
![Page 416: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/416.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 416
__________
161587]21][11[
โ3(โ3ืชืืฉืืจ ืจืืงืืืช ืืืืืโืืชืืโ2โืืชืืโ1โื ื ืืืืชืืืืื
ืคื ืื ืืืฉืจ ืืืคืฉืจ ืฉืืจืืจ) ืคืจืืคืื ืืืฉืื ืฉื ืืืจืืื ืืคืขืื
PHARMACEUTICALCOMPOSITION CONTAINING 3 -(3 - DIMETHYLAMINO - 1 -ETHYL - 2 - METHYL - PROPYL)PHENOL AND PROVIDINGDELAYED RELEASE OF THEACTIVE INGREDIENT
]54[
22.10.2002]22[DE]33[24.10.2001]32[10152469.2]31[DE16.10.2002 10248309.4
Int. Cl.(2009.01) A61K 09//22, C07C 21/5/00, 21/5/56]51[GRUNENTHAL GMBH, GERMANY]71[WO/2003/035053]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a pharmaceutical formulation which is characterised bydelayed release of the active ingredient. Said formulation contains 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol or one of its pharmaceutically acceptable salts in amatrix with delayed release of the active ingredient. Said matrix contains between 1and 80 wt. % of at least one hydrophilic or hydrophobic polymer as a pharmaceuticallyacceptable matrix forming agent and exhibits, in vitro, the following dissolution speed:between 3 and 35 wt. % (in relation to 100 wt. % of active ingredient) of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after half an hour, between 5and 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released afterone hour, between 10 and 75 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after two hours, between 15 and 82 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after three hours, between30 and 97 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released aftersix hours, more than 50 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol isreleased after twelve hours, more than 70 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after eighteen hours, and more than 80 wt. % of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol is released after twenty-four hours.
]57[
![Page 417: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/417.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009417
__________
161643]21][11[
ืืขื ืืืืCDMAืืขืจืื ืคืจืืืจื ืืืงืืื ืื ืืืงืื/ืืืคืืฉ ืขื ืืืื
PARAMETER ESTIMATOR FOR ACDMA RECEIVER WITH ASEARCH WINDOW OF VARIABLESIZE AND/OR PLACEMENT
]54[
25.10.2002]22[US]33[29.10.2001]32[60/336187]31[US24.01.2002 10/056877
Int. Cl.(2008.04) G01S 5/02, H04B 17/07]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2003/039020]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A parameter estimator for estimating one or more parameter(s) from a correlationfunction derived from a signal using a dynamically variable search window is described.The parameter estimator may be employed in a subscriber station to estimate the timeof arrival of one or more base station pilot signals in a wireless communication system.This information may be utilized in an overall advanced forward link trilateration (AFLT)process for estimating the location of the subscriber station.
]57[
__________
![Page 418: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/418.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 418
161654]21][11[
โืฉืืื ืืืืฆืืจ ื ืชืืื ืืืงืจืืื ืืืื ืืืืืกืกืื ืขื ืืืงืืจืื
CMOSืืฆืขืชืืื
METHOD OF FABRICATINGMICRO-ELECTROMECHANICALSWITCHES ON CMOSCOMPATIBLE SUBSTRATES
]54[
07.11.2002]22[US]33[07.11.2001]32[10/014660]31[
Int. Cl.(2008.04) B81C 1/00, H01L 21/00]51[IBM CORPORATION, U.S.A.]71[WO/2003/054938]87[
,ืืขืืืืช ืืื ืืืืงืช ืงื ืื ืจืืื ื ืืืคื, ืืื ืืืจืกืืืช ืืืคื ืืจ ืืืจืื
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A method of fabricating micro-electromechanical switches (MEMS) using a processstarting with a copper damascene interconnect layer, made of metal conductors inlaidin a dielectric (150). All, or portions, of the interconnects are recessed to a degreesufficient to provide a capacitive air gap when the switch is in the closed state, as wellas provide space for a protective layer of, for example, Ta/TaN. The metal structuresdefined within the area specified for the switch act as actuator electrodes to pull downthe movable beam (160) and provide one or more paths for the switched signal totraverse. The advantage of an air gap is that air is not subject to charge storage ortrapping that can cause reliability and voltage drift problems. Instead of recessing theelectrodes to provide a gap, one may just add dielectric on or around the electrode.The next layer is another dielectric layer which is deposited to the desired thickness ofthe gap formed between the moveable beam (160) that forms the switching device.Vias are fabricated through this dielectric to provide connections between the metalinterconnect layer and the next metal layer which will also contain the switchable beam.The via layer is then patterned and etched to provide a cavity area which contains thelower activation electrodes as well as the signal paths. The cavity is then back-filledwith a sacrificial release material.
]57[
__________
![Page 419: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/419.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009419
161872]21][11[
RA1ืืฆืืจ โILืืืืืจืฅ ืขื ืืื ื ืืืื ANTIBODY STIMULATING IL-1RA PRODUCTION
]54[
08.11.2002]22[FR]33[09.11.2001]32[01/14518]31[
Int. Cl.(2008.04) A61K 393/95, A61P 11/00, 17/00, 19/02, 19/10, 29/00, 35/00, C07K16/18
]51[
LABORATOIRE FRANCAIS DUFRACTIONNEMENT ET DESBIOTECHNOLOGIES, FRANCE
]71[
WO/2003/040188]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention concerns natural antibodies eventually monoclonalcapable of inducing a high production of IL-1Ra with monocytes ormacrophages and the use of said antibodies for treating inflammatory orautoimmune diseases.
]57[
__________
161876]21][11[
BLOCK ืืืฉ ืืื ืืื ื ืืืืจืื ืืฆืฃ ืขื ืคื ื ืืื OF RESIDENTIALBUILDINGS FLOATING ON THESEA SURFACE
]54[
09.05.2004]22[Int. Cl.(2009.01) B63B 35//44, E04H 03//02]51[
ื ืฆืจืช ืขืืืช, ืงืื'ืฉืืขืื ืกืืจืื ืืืคื, ืงืื'ืคืจื ืกืืจืื
SHIMON STRIZHAKOVFRED STRIZHAKOV
]71[
,ืงืื'ืฉืืขืื ืกืืจืื ื ืฆืจืช ืขืืืช, 15555.ื.ืช89ืืืืจืืื' ืจื
SHIMON STRIZHAKOV,89 HAVRADIM ST., P.O.B. 15555,
NAZERETH-ILLIT
]74[
A block of residential buildings floating on the sea surface; the residential buildings 6-11 are each interlinked only to the two nearest buildings around the periphery of theblock by rigid connections (16) to form a block; the rigid connection interlink both thelower and upper of the residential buildings; the residential buildings are connected asstraight hexahedron prisms; center gravity of each residential building is situated on itsaxis symmetry.
]57[
![Page 420: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/420.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 420
__________
161898]21][11[
ืืืฆืืจ ืืืืื ืืืื ืืื ืฉื ืืืืฆืืช ืงืจืืืืกืืืืืช ืืจืืืืืืช
PRODUCTION OF AMMONIUMSALTS OF AROMATICCARBOXYLIC ACIDS
]54[
03.12.2002]22[DE]33[04.12.2001]32[10159420.8]31[
Int. Cl.(2009.01) C07C 63//04, 63//08]51[BASF SE, GERMANY]71[WO/2003/048099]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method for the production of ammonium salts of aromatic carboxylic acidsby reaction of an aromatic carboxylic acid with ammonia in an aprotic solventis disclosed. Said reaction is carried out in a closed vessel and a solution ofthe aromatic carboxylic acid in an aprotic solvent and gaseous ammonia arecontinuously introduced into the vessel, such that a partial pressure ofammonia of 0.1 to 3 bars is maintained in the gas chamber of the vessel and asuspension of the ammonium salt separates out in the aprotic solvent. Themethod permits the production of ammonium salts with defined crystal sizeand a narrow size distribution.
]57[
__________
![Page 421: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/421.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009421
161984]21][11[
ืืขืจืืช ืืฉืืื ืืืคืกืงืช ืคืขืืืืช ืขืจืืฅ ืชื ืืขื ืืชืฆืืจืช ืฉืงืข ืชืงืฉืืจืช ืืืืืื
SYSTEM AND METHOD FORTRAFFIC CHANNEL DORMANCYIN WIRELESS COMMUNICATIONSOCKET MODE
]54[
22.11.2002]22[US]33[26.11.2001]32[10/994189]31[
Int. Cl.(2008.04) H04J 13/00, H04L 1/00, 29/02, 29/06, 29/08]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2003/047212]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
In a wireless communication system such as a CDMA system, a traffic channelsupporting two applications running in socket mode on a mobile station is allowed to godormant and is released when respective idle periods associated with each socketexpire, i.e., when there is no transmission over the traffic channel for the longer of twopotentially unequal idle periods.
]57[
__________
162035]21][11[
โNืชืืืืืชืืืจืืืจืืื ืืงืืืื ืืืืืืชืืฉืืจืื ืงืืืื
ืืืืงืื ืืืืืืื ืืืชื
N-HETEROARYLNICOTINAMIDEDERIVATIVES AND PESTICIDALCOMPOSITIONS CONTAININGTHE SAME
]54[
19.11.2002]22[JP]33[21.11.2001]32[2001-355561]31[JP11.03.2002 2002-65193
Int. Cl.(2009.01) A01N 43//80, C07D 41/3/12, C07D 413/00]51[SANKYO AGRO COMPANY,LIMITED, JAPAN
]71[
WO/2003/044013]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
![Page 422: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/422.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 422
NโHeteroarylโ4โ(trifluoromethyl)nicotinamide derivatives represented by the generalformula (‖) or salts thereof; pesticides containing the same as the activeingredient; a process for the production thereof; and intermediatestherefor: (‖) wherein R is C1โ6 haloalkyl; R1 is hydrogen, optionallysubstituted C1โ6 alkyl, C2โ6 alkenyl, or acyl; X is CโR2 or nitrogen; and R2
and R3 are each independently hydrogen, halogeno, optionally substituted C1โ6 alkyl,C3โ7 cycloalkyl, C2โ6 alkenyl, C3โ7 cycloalkenyl, formyl, CH=NOR4, cyano, optionallysubstituted phenyl, a heterocyclic group which may be substituted, optionallysubstituted C1โ6 alkoxy, C1โ6 alkylthio, or optionally substituted phenoxy.
]57[
__________
162092]21][11[
ืฉืืื ืืืชืงื ืืงืจืืื ืืืกืืฃ ืืืืืื ืืจืฉืช ืชืงืฉืืจืช ืืืืืื
METHOD OF AND APPARATUSFOR PAGING A WIRELESSTERMINAL IN A WIRELESSTELECOMMUNICATIONSSYSTEM
]54[
29.05.1998]22[US]33[30.05.1997]32[08/865650]31[US09.07.1997 08/890355
Int. Cl.(2008.04) H04J 13/00, H04Q 7/20]51[DIVISION FROM 133157]62[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/1998/054919]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A method of and apparatus for paging a wireless terminal in a wirelesstelecommunications system reduce standby mode power consumption. A minimallyencoded quick paging channel is established over which short, quick page messages(30) are transmitted during one of a set of quick paging slots. The quick page messageindicates that a communications request has been received, and that the receivingcommunication terminals should process a highly encoded full paging channel overwhich more detailed, full page messages (32) are transmitted during the next fullpaging slot. A terminal monitors full paging channel only after a quick page messagehas been received on the quick paging channel.
]57[
![Page 423: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/423.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009423
__________
162492]21][11[
ืฉืืืืฉ ืืืืงืืืคืืกืคืืืืืื ืื ืืืื ืชืืืืคืื ืื ืืขืชื ืืืืืืช ืื ืืจืืืช ืชืจืืคื
ืชืืืืโืืืฆืืจืื ืื
USE OFALKYLPHOSPHOCHOLINES FORPRODUCING A MEDICAMENTFOR THE PREVENTATIVETREATMENT OF PROTOZOANDISEASES
]54[
07.01.2003]22[DE]33[25.01.2002]32[10203195.9]31[
Int. Cl.(2008.04) A61K 316/85, A61P 1/12, 33/02, C07F 9/00]51[AETERNA ZENTARIS GMBH,GERMANY
]71[
WO/2003/061669]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to pharmaceutical compositions containingalkylphosphocholines, especially hexadecylphosphocholine oroctadecyl-(1, 1-dimethyl-piperidinio-4-yl)-phosphate for thepreventative treatment of protozoan diseases, especially leishmaniasis.The invention also relates to a dosing scheme of said compositions forthe preventative treatment of said illnesses.
]57[
__________
![Page 424: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/424.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 424
162513]21][11[
ืฉืืื ืืขืจืื ืืืืืื ืกืคืื ืืืืืืืื ื ืืืงืื
METHOD AND KIT FORDETECTING ALKALINESPHINGOMYELINASE
]54[
19.12.2002]22[IE]33[21.12.2001]32[011100]31[
Int. Cl.(2008.04) C12Q 1/44, G01N 33/48]51[ACTIAL FARMACEUTICA LDA,PORTUGAL
]71[
WO/2003/056031]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An analytical fluorometric method and a kit for use in such method aredisclosed for assessing the presence of alkaline sphingomyelinase(SMase) in the stools of a patient in need of such an assessment sincealkaline SMase is a marker of serious pathological states, such as coloncancer.
]57[
__________
162522]21][11[
ืฉืืื ืืฉืืืืจ ื ืชืื ืื ืขืืืจ ืืขืจืืชื ืงืืืืชโืฉืืืืจ ื ืชืื ืื ืืืืืืืืื ืจื
ืืฉืชืืฉืืโื ืงืืืืช ืืจืโืืจื
PROCESS FOR THETRANSMISSION OF DATA BY AMULTI-USER, POINT TO MULTI-POINT DIGITAL DATATRANSMISSION SYSTEM
]54[
14.01.2003]22[ES]33[18.01.2002]32[P200200101]31[
Int. Cl.(2009.01) H04B 03//54, H04J 03//16, 03//22, 11//00, H04L 05//14, 12//18,12//56
]51[
DISENO DE SISTEMAS EN SILICIO,S.A., SPAIN
]71[
WO/2003/061185]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The invention relates to a data transmission method for a multi-user, multipoint-to-multipoint digital data transmission system involving a plurality of pieces of userequipment (1) which are bidirectionally connected via a physical means (6). Theinventive method can be used to establish various communications from a piece ofuser equipment (1a) to different pieces of destination user equipment (1b-1d) at
]57[
![Page 425: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/425.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009425
different speeds, while maintaining the bandwidth and maximum latency valuesrequired by each of the pieces of destination user equipment (1b-1d). Said methodconsists in sending multiple information frames (4) from a piece of equipment (1a) to amultitude of pieces of destination user equipment (1b-1d) at different speeds.Moreover, using the percentage reserve of the frame, the invention provides a qualityof service based on that required by the piece of user equipment and supplies acriterion for dynamically assigning the packets which are sent to each piece of userequipment in the frame, grouping or dividing the packets to be sent.
__________
162562]21][11[
ืฉืืื, ืืืืืืืืืืืื ืื ืืืชืืจืืืื, ืืืื ืชื ืืืืจืช ืฉืืืืฉืืื ืืชืจืืคื
ืืืืื ืืชืจืืคื ืืืืืืช ืืืืืืืืืืืื ืื ืืืชืืจืื
SUBSTITUTED IMIDAZOLIDINES,METHOD FOR THEPRODUCTION THEREOF, USETHEREOF AS A DRUG OR FORDIAGNOSIS AND DRUGCONTAINING SUBSTITUTEDIMIDAZOLIDINES
]54[
09.12.2002]22[DE]33[21.12.2001]32[10163239.8]31[
Int. Cl.(2008.04) A61K 314/164, A61P 43/00, C07D 233/44, 235/02]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY
]71[
WO/2003/053434]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to new imidazolidine-type compounds of formula (I) in which R1to R7 have the meanings disclosed in the claims. Said compounds represent potentinhibitors of sodium/hydrogen exchanger (NHE), particularly NHE. These novelcompounds are used to produce a drug for the therapy or prophylaxis of the centralnervous system, lipometabolism, infestations by ectoparasites, dysfunctions of the galland for improving respiratory drive. The inventive compounds are therefore used for thetherapy of respiratory conditions in the following clinical states and diseases:malfunctioning central respiratory drive (e.g. sleep apnoea, sudden infant death,postoperative hypoxia), muscle-related breathing disturbances, breathing disturbancesfollowing long-term respiration, breathing disturbances when adapting to high mountainareas, obstructive sleep apnoea and a mixed type of sleep apnoea, acute and chronic
]57[
![Page 426: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/426.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 426
lung diseases with hypoxia and hypercapnia. Said compounds also increase themuscle tone in the upper respiratory tract so as to suppress snoring.
__________
162567]21][11[
ืืกืจืช ืืคืจืขื ืขืฆืืืช ืืืืฆืขืืช ืคืืฆืื ืืืืจ
ืืืขืจืืช ืชืงืฉืืจืช ืืืกืจืืช
SELF-INTERFERENCE REMOVALUSING CONVERTERCOMPENSATION IN A RELAYEDCOMMUNICATION SYSTEM
]54[
12.11.2002]22[US]33[15.01.2002]32[10/051887]31[
Int. Cl.(2008.04) H04B 1/50, 1/52, 71/85, H04L 27/34, 27/36, 5/12]51[VIASAT, INC., U.S.A.]71[WO/2003/061184]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Self-interference cancellation (10) in two-way relayed communication is improved bycreating models of upconverter and downconverter imperfections and thencompensating for those imperfections before self interference cancellation processing(36). The model includes compensation for phase offset, for amplitude imbalance andfor leakage in the mixers.
]57[
__________
![Page 427: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/427.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009427
162592]21][11[
CYSTINE-KNOT ืฆืืกืืืโืืืืื ืืงืืคื ืืฆืืจืช ืงืฉืจ FOLD PROTEIN]54[
20.12.2002]22[GB]33[21.12.2001]32[0130738.8]31[
Int. Cl.(2009.01) A01K 67//027, A61K 38//17, C07K 14//475, 14//52, 16//18, G01N33//53
]51[
ARES TRADING S.A.,SWITZERLAND
]71[
WO/2003/055911]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ,ืืื ืชืขืฉืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
This invention relates to a novel protein (INSP002), herein identified as a secretedprotein that is a member of the Dan family of the cystine-knot fold cytokine superfamilyand to the use of this protein and nucleic acid sequences from the encoding genes inthe diagnosis, prevention and treatment of disease.
]57[
__________
![Page 428: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/428.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 428
162676]21][11[
ืชืืืื ืืืืฆืืจ ืืืฆืจืื ืฉื ืืืจ ืงืจืืืื ืฆืคืืคืืช ืืืืื ืืขื
PROCESS FORMANUFACTURING HIGHDENSITY BORON CARBIDEARTICLES
]54[
22.06.2004]22[Int. Cl.(2008.04) C04B 355/63]51[
,ื"ืจืคืื ืืขืจืืืช ืืืืื ืืชืงืืืืช ืืข ืืืคื
RAFAEL ADVANCED DEFENSESYSTEMS LTD.
]71[
ืืืจ, ืืืืฉืข ืืืื, ืืื ืืืจื ื, ืืื-ืฉืืฉืื ืืจืฆืื, ืืืกืฃ ืคืจืื, ืืืชืืจ ืืืืื, ืืืคืืจ
ื ืืกื ืืืืฅ
SHIMSHON BAR-ZIV, DAVIDGORNI, YEHOSHUA HACHAMO,ZOHAR OPHIR, ITAMARGUTMAN, JOSEPH FREY, ZVINISENHOLZ
]72[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A process for manufacturing boron carbide objects comprising the steps of:(a) pre-washing a raw boron carbide powder;(b) mixing the washed boron carbide powder with a carbon precursor;(c) drying the mixture;(d) granulating the dried mixture;(e) compacting the granulated dried mixture to form a shaped object by applying apressure thereto;(f) carbonizing the shaped body in an inert atmosphere, by holding at a hightemperature for a predetermined period of time;(g) sintering the carbonized shaped body at a temperature between about 2,290oC andabout 2,350oC in an inert atmosphere for a time period of not less than about 30 min.
]57[
__________
![Page 429: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/429.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009429
162721]21][11[
[dโ2,3]ืคืืจืืืโ(ืืืืื ืโ2โืคืืจืืืื)โ2 ืืื ืืโ7โืจืืืืืืืคื
2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7-ONES
]54[
10.01.2003]22[US]33[22.01.2002]32[60/350877]31[
Int. Cl.(2008.04) A61K 315/19, C07D 471/04]51[WARNER-LAMBERT COMPANYLLC, U.S.A.
]71[
WO/2003/062236]87[,ืืช ืืืฆืืืืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The present invention provides substituted 2-aminopyridines useful in treating cellproliferative disorders. The novel compounds of the present invention are potentinhibitors of cyclin-dependent kinases 4 ( cdk4 ).
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198243,The applications for divisionfrom this application havenot yet been published
__________
162824]21][11[
APPARATUS ืืชืงื ืืืจืืืช ืืจืืืื FOR DONNINGSOCKS
]54[
01.07.2004]22[Int. Cl.(2008.04) A47G 25/90]51[
REUVEN ืืจืฆืืื, ืจืืืื ืืืืจืื BOARON]71[,ืจืืืื ืืืืจืื
ืืจืฆืืื,51ืจืื ืืื' ืจืREUVEN BOARON,51 REMEZ ST.
HERZLIYA 46288
]74[
An apparatus (100) for aiding in donning a sock comprising:(a) a base (101) having proximate and distal ends;(b) an elongated caddy (113) having a U-shaped cross-section, a first end of saidcaddy being connected to said base at a location close to said distal end and a second
]57[
![Page 430: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/430.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 430
end of said caddy over which a sock can be draped being displaceable with respect tosaid base;(c) a connecting pivot (110) for pivotally connecting said first end of the elongated U-shaped caddy with said base at a location close to the base distal end, allowing rotationof said elongated caddy about said pivot; and(d) counter weight means (103) by which said base is coupled to a fixed or heavyarticle, such as a furniture article, wherein said caddy is upwardly pivotable from aninitial substantially horizontal disposition, upon insertion of a foot within a sock drapedover the second end of said caddy, until a disposition at which said sock is releasedfrom said caddy after being fully donned on said foot and wherein said connectingmeans comprise a ribbon which is affixed to the base close to its proximate end.
__________
163048]21][11[
DISTORTION ืืืื ืืคืืชืช ืขืืืืช REDUCERCALIBRATION
]54[
03.02.2003]22[US]33[01.02.2002]32[10/066115]31[
Int. Cl.(2008.04) H04B 1/40]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2003/065602]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Techniques are disclosed for compensating for second-order distortion in a wirelesscommunication device. In a zero-intermediate frequency (IF) or low-IF architecture, IM2distortion generated by the mixer (20) results in undesirable distortion levels in thebaseband output signal. A compensation circuit (104) provides a measure of the IM2distortion current independent of the radio frequency (RF) pathway to generate an IM2calibration current. The IM2 calibration current is combined with the baseband outputsignal to thereby eliminate the IM2 currents generated within the RF pathway. In oneembodiment, the calibration is provided at the factory during final testing. In alternativeembodiment, additional circuitry (156, 158) may be added to the wirelesscommunication device to provide a pathway between the transmitter (150) and the
]57[
![Page 431: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/431.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009431
receiver (146). The transmitter signal is provided to the receiver to permit automaticcalibration of the unit. An internal signal source (162) may be used in place of thetransmitter (150). The auto-calibration may be performed to eliminate IM2 distortion orpermit optimization of the circuit to minimize other forms of distortion or interference.
__________
163287]21][11[
โ2ื ืืืจืืช ืืืชืืจืืช ืืืชืจืืืจืืื โ 6,7,8,9โืคืืจืืืืืืโ2ืคืืจืืืื ืื
โืคืืจืืืืืื]aโ2,1[ืืืจืืืืืจืืคืืจืืืืื ืืืโ4
HETEROARYL SUBSTITUTED 2 -PYRIDINYL AND 2 -PYRIMIDINYL - 6,7,8,9 -TETRAHYDROPYRIMIDO [1,2-A]PYRIMIDIN - 4 - ONEDERIVATIVES
]54[
26.02.2003]22[EP]33[28.02.2002]32[02290485.8]31[EP28.02.2002 02290486.6
Int. Cl.(2008.04) A61K 315/19, A61P 25/00, C07D 487/04]51[SANOFI AVENTIS, FRANCEMITSUBISHI TANABE PHARMACORPORATION, JAPAN
]71[
WO/2003/072579]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The invention relates to a pyrimidone derivative represented by formula (I) or a saltthereof wherein: (I) X represents two hydrogen atoms, a sulphur atom, an oxygen atomor a C1-2 alkyl group and a hydrogen atom; Y represents a bond, an ethenylene group,an ethynylene group or a methylene group optionally substituted; R1 represents a 2, 3or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring optionally substituted; R2 represents aheterocyclic bicyclic rings, having 1-4 heteroatoms selected from an oxygen atom, asulfur atom and a nitrogen atom and having 5-9 carbon atoms, of formula (II) R3represents a hydrogen atom, a C1-6 alkyl group, a hydroxy group, a C1-4 alkoxy group ora halogen atom; R4 represents a hydrogen atom, a C1-6 alkyl group, a C1-4 alkoxy groupor a halogen atom. The invention relates also to a medicament comprising the saidderivative or a salt thereof as an active ingredient which is used for preventive and/ortherapeutic treatment of a neurodegenerative disease caused by abnormal activity ofGSK3&bgr; or GSK3&bgr; and cdk5/p25, such as Alzheimer disease.
]57[
![Page 432: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/432.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 432
__________
163288]21][11[
) ืืืชืืจืืืจืื[(โ]ืืืงืื[โ1ื ืืืจืืช7โ] ืืืงืื) ืืจืื[(โ1ืื ืืืจืืช] ืืืงืื
]a1,2โ[ ืืืืืืโ)ืืโ4โืคืืจืืืืืื(โ ืืืโ)1H(โ5ืคืืจืืืืืื
1 - [ALKYL], 1 -(HETEROARYL)ALKYL] AND1 -[(ARYL) ALKYL] - 7 - (PYRIMIDIN- 4 - YL) - IMIDAZO [1,2-A]PYRIMIDIN - 5 (1H) - ONEDERIVATIVES
]54[
26.02.2003]22[EP]33[28.02.2002]32[02290487.4]31[
Int. Cl.(2008.04) A61K 314/37, A61P 25/28, C07D 487/04]51[SANOFI AVENTIS, FRANCEMITSUBISHI TANABE PHARMACORPORATION, JAPAN
]71[
WO/2003/072580]87[ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
The invention relates to a imidazo[1,2-a]pyrimidone derivative represented by formula(I) or a salt thereof: R1 wherein X represents a bond, an ethenylene group, anethenylene group, a methylene group optionally substituted; a carbonyl group, anoxygen atom, a sulfur atom, a sulfonyl group, a sulfoxide group or a nitrogen atombeing optionally substituted; R1 represents a 2, 4 or 5-pyrimidinyl optionally substituted;R2 represents a C1-6 alkyl group, a C1-2 perhalogenated alkyl group, a C1-3 halogenatedalkyl group, a benzyl group, a benzene ring, a naphthalene ring, 5,6,7,8-tetrahydronaphthalene ring, a pyridine ring, an indole ring, a pyrrole ring, a thiophenering, a furan ring or an imidazole ring, the benzyl group and the rings being optionallysubstituted; and n represents 0 to 3. The invention relates also to a medicamentcomprising the said derivative or a salt thereof as an active ingredient which is used forpreventive and/or therapeutic treatment of a neurodegenerative disease caused byabnormal activity of GSK3ร, such as Alzheimer disease.
]57[
__________
![Page 433: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/433.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009433
163376]21][11[
DECOPPERING ืืืจื ืืกืืจ ืืฉืงืข ื ืืืฉืช AGENT]54[
13.01.2003]22[SE]33[08.02.2002]32[0200366-3 ]31[
Int. Cl.(2009.01) C06B 23//00]51[EURENCO BOFORS AB, SWEDEN]71[SVEN-ERIC JOHANSSON]72[WO/2003/066544]87[
,ืฆืืง ืืฆืจ ืคืจื ืืื, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
There is provided a decoppering agent that is incorporated into thepropellant to remove copper from the rifling of the internal bore of agun barrel. The decoppering agent consists essentially of a lead-freepulverized additive mixed together with the other propellantcompounds. We have found that a mixture of tin and bismuth is a verygood decoppering agent. Especially in the ratio 42% Sn/58%Bi, themelting point for this combination is 138 degree C. Much lower thaneach of the components. It can be all kinds of suitable tin and bismuthcompounds. The bismuth and tin either vaporizes or liquefies when thepropellant is ignited and either embrittles or dissolves the copperdeposits facilitating removal.
]57[
__________
163450]21][11[
GUIDED ืืื ืืื ืื ืขื ืื ืื ืื ืื ืืื ืืืืืจ MISSILE WITHDISTRIBUTED GUIDANCEMECHANISM
]54[
10.08.2004]22[Int. Cl.(2009.01) F41G 07//20]51[
,ื"ืจืคืื ืืขืจืืืช ืืืืื ืืชืงืืืืช ืืข ืืืคื
RAFAEL ADVANCED DEFENSESYSTEMS LTD.
]71[
RONEN ืืกื ืคืืื, ืืืจืื- ืจืื ื ืื BEN- HORIN, ASSA FINE]72[ืืข"ื ,ื"ืจ ืืจืง ืคืจืืืื
ื,54.ืง, ืืืื ืืฉื ืืืื ,7ืืืืื ืกืงื'ืจืืื-ืจืืช
DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54TH
FLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520
]74[
![Page 434: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/434.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 434
A weapons system comprising:(a) a guided missile including:(i) a seeker for producing signals indicative of a position of a target, and(ii) a steering mechanism for steering said guided missile; and(b) a guidance mechanism, separate from said guided missile, for controlling saidsteering mechanism, based on said signals, so as to steer said guided missile tworadssaid target; wherein said guided missile is too small to carry an on-board guidancemechanism that activates said steering mechanism to guide said guided missileautonomously to said target in response to said signals.
]57[
__________
163734]21][11[
SHAPED ืืืคืื ืืขืืฆื TAMPON]54[
12.03.2003]22[US]33[18.03.2002]32[60/365672]31[US16.05.2002 150055
Int. Cl.(2008.04) A61F 13/20]51[THE PROCTER & GAMBLECOMPANY, U.S.A.
]71[
WO/2003/079949]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Shaped tampons having varying perimeters are provided. Tampons disclosed comprisea mass of absorbent material formed into a self-sustaining shape comprising aninsertion end, a withdrawal end, and a center region. The center region has at least oneperimeter which is less than a largest insertion end perimeter and is less than awithdrawal end perimeter. The shaped tampons may also have varying average fiberdensity regions. The shaped tampons may be wrapped in tightly conforming wrapperswhich optionally aid in maintaining the self-sustaining shape prior to use. Optionally, theshaped tampons may utilize tampon applicators which enable a user to visually see theshape of the tampon prior to use.
]57[
__________
![Page 435: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/435.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009435
163738]21][11[
ืื DISCืกืงืื ืขืื ืืืกืืื TUMBLER LOCK]54[
14.03.2003]22[FI]33[27.03.2002]32[20020587]31[
Int. Cl.(2008.04) E05B 21/00]51[BJORKBODA LAS OY AB,FINLAND
]71[
WO/2003/080969]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A disc tumbler lock, which comprises a lock case (1), which includes a bolt (3)displaceable with a key of the lock and a number of locking discs (13) provided withlocking channels (17) and which are displaceable with the key of the lock against theforce of a spring (14) to open the lock and for guiding the movements of which the lockcase is provided with stationary guiding members (8,9), and a locking pin (12)dependent on the movements of the bolt and which is arranged to cooperate with thelocking channels (17) of the locking discs. At least one of the locking discs (13) isequipped with gripping means (18), which, when the bolt (3) is pressed inwards to thelock case are arranged to cooperate with counter means (19) arranged in the lock casefor preventing the displacement of the said at least one locking disc (13). Further, thesaid at least one locking disc (13) is spring-loaded to turn the locking disc around a firstguiding member (8) against a second guiding members (9) so that the said secondguiding member (9) guides the said at least one locking disc (13) substantially towardsthe head of the bolt (3) to be protruded out from the lock case.
]57[
__________
![Page 436: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/436.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 436
163921]21][11[
ืื ืืืกืื ืชืื ืฉื ืชืจืืืืืช ืฉืืื ืืืื ืืืืืืช
METHOD FOR THEIDENTIFICATION ANDSYNTHESIS OF CHEMICALCOMPOUNDS
]54[
24.03.2003]22[US]33[22.03.2002]32[60/366548]31[
Int. Cl.(2008.04) B01J 19/00, G06F 19/00]51[ORIGENIS GMBH, GERMANY]71[WO/2003/080232]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A preferred embodiment of the present invention comprises method forplanning the synthesis of one or more chemical compounds withspecified chemical properties, comprising the steps of: (a) representinga space of synthesis plans, wherein each synthesis plan in the space ofsynthesis plans represents one or more vitual reaction schemas appliedto one or more classes of virtual input reactants; (b) representing a spaceof virtual compounds, wherein each compound in the space of virtualcompounds is a product of one or more of said synthesis plans; (c)constructing a first mapping from the space of virtual compounds torange space representing the desirability of a compound, wherein thefirst mapping is determined by one or more compound properties beingmeasured; and (d) searching the space of synthesis plans for desirablecompounds as represented in the range space.
]57[
__________
![Page 437: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/437.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009437
164037]21][11[
ืืขืจืืช ืกืื ืืืจืื ืืืฆืื ืืื ืจืฉืชืืชืืืขืชืืืช ืืื ืืฆืืืช ืืขืื ืืจืืฆืื
ืืืคืืืื
SYNCHRONIZATION SYSTEMFOR ALL OPTICAL SLOTTEDRING DYNAMIC NETWORKS
]54[
26.03.2003]22[US]33[26.03.2002]32[60/367275]31[US23.07.2002 10/200141
Int. Cl.(2008.04) H04J 14/08]51[MATISSE NETWORKS, U.S.A.]71[WO/2003/084109]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A method for communicating data over a network having a plurality of nodes (0-3)thereupon is discussed. A time slot clock signal is transmitted from one node (0-3) ofthe plurality of nodes (0-3) to other nodes of the plurality of nodes. After each of theother nodes of the plurality of nodes receives the time slot clock signal, the time slotclock signal is recalculated to achieve an integer number of slots on the network. Therecalculated time slot clock signal is transmitted from the one node of the plurality ofnodes (0-3) to the other nodes of the plurality of nodes.
]57[
__________
164066]21][11[
ืฉืื ืื ืื ืขื ืืกืืกโืืจื ืืืกืืืจ ืชืืฆืื ื ืืฆืื ืืจืืืช ืขื ืืืืืช ืืืชืืืฉืจ ืืฆืืจื
ืขืฆืืืช ืืฉืืืช ืืืฆืืจื
SELF-ALIGNED NANOTUBEFIELD EFFECT TRANSISTORAND METHOD OF FABRICATINGSAME
]54[
19.02.2003]22[US]33[20.03.2002]32[10/102365]31[
Int. Cl.(2009.01) H01L 29//76]51[IBM CORPORATION, U.S.A.]71[WO/2003/081687]87[
,ืืขืืืืช ืืื ืืืืงืช ืงื ืื ืจืืื ื ืืืคื, ืืื ืืืจืกืืืช ืืืคื ืืจ ืืืจืื
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
![Page 438: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/438.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 438
A self-aligned carbon-nanotube field effect transistor semiconductor device comprisesa carbon-nanotube [104] deposited on a substrate [102], a source and a drain [106-107] formed at a first end and a second end of the carbon-nanotube [104], respectively,and a gate [112] formed substantially over a portion of the carbon-nanotube [104],separated from 10 the carbon-nanotube by a dielectric film [111].
]57[
__________
164199]21][11[
ืืืจื ืขื ืืืกืืจืกืืกโืืงืจ ืืขืจืืช ืขืงืื ืืขื ืฉืืืช ืืงืจื ืชืืืืช
FOLLOW-UP SYSTEMCONTROLLER WITHHYSTERESIS ANDCORRESPONDING CONTROLMETHOD
]54[
07.05.2003]22[US]33[20.05.2002]32[10/152662]31[
Int. Cl.(2008.04) G05D 1/12]51[RAYTHEON COMPANY, U.S.A.]71[WO/2003/100539]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A control system (102) operates within a dynamic range, and a follow-up system (104)is commanded to reduce a positional error between the follow-up system and thecontrol system when the dynamic range is exceeded. A linear follow-up command maybe initially provided once a dead band value (208) is exceeded. The follow-up system(104) is driven relative to its base mount (103) in a direction to reduce the positionalerror to within a null value range (214). The follow-up command may also implement adecay function to control the follow-up system (104). A control variable transfer functionmay also be utilized to gradually subtract the dead band value from the follow-upsystem position error command as a function of time. The decaying function mayinclude linear as well as non-linear decaying functions. In one embodiment, a figureeight-type hysteresis control function may be implemented to control the inertialposition of an inertial element. The various embodiments of the present invention maybe suitable for space-based laser designating and targeting systems, space-basedcamera-positioning systems, space-based telescopes, and radar antenna positioningsystems.
]57[
![Page 439: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/439.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009439
__________
164271]21][11[
ืืืื ืืืืืืช ืฉื ืชืืื ืืงืืื ืฉืืื ืื ืืืืืืกื ืืจืฉื ืกืืคืจืชื ืืืฉื
METHOD FOR MANAGING THERIGHTS OF AN ENCRYPTEDCONTENT STORED ON APERSONAL DIGITAL RECORDER
]54[
15.04.2003]22[CH]33[19.04.2002]32[0664/02]31[
Int. Cl.(2008.04) H04N 1/00, 5/00, 71/67]51[NAGRAVISION S.A.,SWITZERLAND
]71[
WO/2003/090465]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The aim of the invention is to provide a method for storing an event which is encryptedby control words (CW) guaranteeing access to said event at any moment, even ifcertain modifications occur in the designation of the identifiers of said events betweenthe moment of storage and the moment of visualization.This is achieved by means of amethod for storing such an event in a receiving and decrypting unit (STB) connected toa security unit (SC), said control words (CW) and the required rights being contained incontrol messages (ECM). The inventive method is characterized in that it comprises thefollowing steps: the encrypted event is stored, along with the control messages (ECM),on the storage unit; the control messages (ECM) are transmitted to the security unit(SC); verification occurs as to whether the access rights to said event are contained inthe security unit (SC), if this is the case, a receipt (Q) is provided for all or part of thecontrol message (ECM) by means of a secret key (K) which is contained in the securityunit (SC) and is proper to each security unit; said receipt (Q) is stored on the storageunit.
]57[
__________
![Page 440: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/440.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 440
164696]21][11[
ืขื ืืืื ื ืืชืืืื ืขื ืืฉืฉ ืฆืฃ ืืืงืจื ืขืืืง ืืืืืจื
LANCING DEVICE WITH AFLOATING PROBE FORCONTROL OF PENETRATIONDEPTH
]54[
19.10.2004]22[US]33[20.10.2003]32[690083]31[
Int. Cl.(2008.04) A61B 05/151]51[LIFESCAN, INC., U.S.A.]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A lancing device comprising: a lancing mechanism having: a lancet carriage (614); alancet holder (676) slidably connected to the lancet carriage; a lancet (618) attached tothe lancet holder; and a lock-stop assembly; a floating probe (608); and a pressure tip(664) for engaging a target site and creating a target site bulge; wherein the floatingprobe is adapted to floatably rest upon said target site bulge as said target site bulge iscreated by the pressure tip and is configured to operatively interact with the lancetcarriage to control a penetration depth of the lancet into the target site bulge, andfurther configured to engage the lock-stop assembly to prevent movement of thefloating probe during penetration of the lancet into the target site bulge.
]57[
__________
![Page 441: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/441.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009441
164709]21][11[
ืืื ืืืชืื ืืจืงืื, ืืชืงื ืืืืืืื ืืืจืืช ืฉื ืฉืงืื
APPARATUS FORAUTMATICALY LIFTINGSLITTING, SITTING AND FULLYEPTYING BAGS
]54[
19.10.2004]22[Int. Cl.(2009.01) B65B 69/00]51[
AYAL ืืฉืื.ื .ื,ื"ืืื ืจืืืืืืงื ืืื ืืกื ืืข ROBOTICS ANDENGINEERING LTD.
]71[
RAZ ืจื ืืืื ืง JELINEK]72[, 3148.ื.ืช,2ืืืืื'ืจื, ืฆืืืื ืืืจื
38900ืงืืกืจืืYORAM TSIVION,2 HATOCHEN ST.P.O.B. 3148,CAESAREA 38900
]74[
An apparatus for emptying bags comprising a gripper having a plurality of pointedhooks for gripping at least one of said bags; a bag slitting and empting device, whereinsaid bag slitting and emptying device comprises at least two parallel blades for slittingsaid at least one bag, and at least two rods aligned in a row respectively with saidblades.
]57[
__________
164823]21][11[
ืค ืืืืืจ ืืืืื ืืคืจืขืืช ืืืื ืืืืืืืืืืจื ื ืืืงืืขืื ืืืืจื ืืืื
ืคืื ืงืฆืืื ืืืื
DETECTOR COMPRISING AMEMBRANE PERTURBATION -DETECTING POLYMER ANDFUNCTIONAL MEMBRANEFRAGMENTS
]54[
25.10.2004]22[Int. Cl.(2009.01) F01C 01//02, G01N 33//543]51[
ืืจืฉืืช ืืืืงืจ,ืืืืจืืื ืื ื-ืืื ืืืจืกืืืช ืื ืฉืืข-ืืืจ, ืืคืืชืื
BEN GURION UNIVERSITY OFTHE NEGEV RESEARCH ANDDEVELOPMENT AUTHORITY
]71[
RAZ ืจื ืืืื ืง JELINEK]72[,ืค"ืคืืืจื ืืง ืจืืืื ืขื
, 10012.ื.ืช,91ืืจืฆื'ืจื, ืืืช ืขืฆืืื ืืืจ ืฉืืข
PYERNIK RUTMAN,BEIT ETSION,
91 HERZL ST.,P.O.B. 10012,BEER SHEVA
]74[
A construct comprising functional membrane fragments and one or more perturbation-detecting polymers associated therewith, wherein said construct responds toperturbations of said membrane fragments by means of a detectable change in one ormore physical or chemical properties associated with said construct.
]57[
__________
![Page 442: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/442.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 442
164944]21][11[
ARTIFICIAL ืฉืจืืจ ืืืืืืชื MUSCLE]54[
04.05.2003]22[US]33[03.05.2002]32[10/137,387]31[
Int. Cl.(2008.04) F01B 19/00]51[ZALMAN ืืืืืืจ, ืืืื ืคืืก PELES]71[
WO/2003/093647]87[ืขื' ืืจ ,ืค"ืืืื ืืจืกืืจ
ืื-ืจืืช,11ืชืืืDR. EYAL BRESSLER,11 TUVAL ST.,
RAMAT GAN 52522
]74[
A hydraulic actuated artificial muscle is use with orthetic devices, prosthetic devices oras an actuator for other applications in medical or robotic devices. Working fluid ispumped between two expandable fluid-containing cells (2,10), which arecomplimentary active elements of the artificial muscle. This eliminates the need for astorage reservoir, thereby providing a self-contained, and force efficient device. Each ofthe preferred embodiments described has one or more expandable fluid-containingcells (2,10) that are defined by at least one flexible wall (4). The flexible walls (4,12) areconfigured so as to have elastic properties that are limited to predefined directions ofexpansion and contraction.
]57[
__________
![Page 443: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/443.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009443
164961]21][11[
ืชืขืจืืืืช ืฉื ืืกืืจืื ืืืจืืืืคืชืืืืืืืืืจืื ืืื ืขื ืืขืืจื ืืืืืืื ืืจืื
ืืฉืืืืฉ ืืืจืืื ืคืืืืืืจืชืื
BLENDS OFTETRAHALOPHTHALATEESTERS AND PHOSPHORUS-CONTAINING FLAMERETARDANTS FORPOLYURETHANECOMPOSITIONS
]54[
05.05.2003]22[US]33[06.05.2002]32[60/378299]31[
Int. Cl.(2008.04) C08K 3/00]51[GREAT LAKES CHEMICALCORPORATION, U.S.A.
]71[
WO/2003/095544]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Flame retardant flexible polyurethane foam compositions, methods of flame retardingflexible polyurethane foam compositions, articles made therefrom and flame retardantsthat comprise blends of tetrahalophthalate esters and phosphorus containing flameretardant having at least about 5 wt.% phosphorus additives. The combined weight ofthe tetrahalophthalate ester and the phosphorus-containing flame retardant comprisesabout 5 to about 20% by weight of the flexible polyurethane foam compositions orreaction mixtures. The ratio of the tetrahalophthalate ester to the phosphorus-containing flame retardant is from about 80:20 to about 20:80 percent by weight andpreferably from about 60:40 to about 40:60 percent by weight.
]57[
__________
164972]21][11[
EVENT ืชืืืื ืืืจืืขืื ืืืขืจืืืช ืืืืื SYNCHRONIZATION FORDETECTOR SYSTEMS
]54[
12.06.2003]22[US]33[12.06.2002]32[60/319310]31[US11.06.2003 10/250189
Int. Cl.(2008.04) H04N 52/25]51[LITTON SYSTEMS, INC., U.S.A.]71[WO/2003/107650]87[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An event synchronizing apparatus E for an image intensification camera system C forgathering image data includes an image intensifier (348) for amplifying received light(312). A relay optic assembly (316) is coupled between the image intensifier (348) and
]57[
![Page 444: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/444.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 444
a digital image sensor (350), such as a CMOS or CCD device. Digital logic (352) isused to process or output an image or related data (334). An event detector (340)digitizes an input signal (342) from an illumination source (338) and generates anelectrical output synchronization signal (346) in response to the input optical signal(342). The image intensifier camera C derives imaging and control information for thesynchronization signal.
__________
165027]21][11[
ืฆืืื ืขื ืืกืืก ืฉืื ืชืืฉืืจื ืจืืงืืืช ืืืืฉืื ืงืืง ืืืืืจ ืฉืขืืจ
ืคืืืืืืงืกืืืชืืืฆืื ืืฉืืื ืืืืฆืืจื
STABILIZED PHARMACEUTICALCOMPOSITIONS BASED ONPURIFIEDPOLYOXYETHYLATED CASTOROIL AND METHODS FORMANUFACTURING THE SAME
]54[
16.05.2003]22[CZ]33[10.06.2002]32[PV 2002-
2027]31[
Int. Cl.(2008.04) A61K 313/37, 47/00, 47/10, 47/44]51[PLIVA-LACHEMA, A.S., CZECHREPUBLIC
]71[
WO/2003/103714]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention relates to a stabilised pharmaceutical composition comprising apharmaceutically active substance poorly soluble in water, a solubilising agentwith a low content of both basic and acidic compounds and a polar organicsolvent, in particular a stabilised injection concentrate, methods for preparingsuch stabilised pharmaceutical compositions and the use of a solubilisingagent with a low content of both basic and acidic compounds to stabilisepharmaceutical compositions for pharmaceutically active substances.
]57[
__________
![Page 445: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/445.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009445
165162]21][11[
ืฉื ืืชืงื ืคืฉืื ืืืคืขืื ืืื ืืืช ืชืจืืกืื ืืชืื ืชื ืกืืืจ ืืืืืืืช
SIMPLIFIED DEVICE FORMAGNETICALLY OPERATINGBLINDS WITHIN A GLASS-ENCLOSED CHAMBER
]54[
08.07.2002]22[IT]33[19.06.2002]32[MI2002A001351]31[
Int. Cl.(2009.01) E06B 09//264]51[PELLINI S.R.L., ITALY]71[WO/2004/000011]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A system for operating a blind (18) in a glass-enclosed chamber (10), comprising twopanes of glass, (17, 18) and a frame (20) having an upper section (25) a lower section(86) and two lateral sections (27) joined together by four corner pieces (30) the systemcomprising an upper fixed box (40) which is fixed to the upper section of the frame andholds one end of the blind; a movable box (60) which holds another end of the blindand is elongated; a pulling device (85, 86) extending through a pane and operating saidmovable box; and a guiding device for translating said movable box parallel to adirection of elongation of said movable box when the blind is being opened or closed,wherein said device for pulling said movable box includes a first means (150) and asecond means for generating reciprocal magnetic attraction, said first means beingfixed to said movable box, said second means having a free knob (170) so that,through one pane of the glass-enclosed chamber, said knob cooperates with said firstmeans fixed to said movable box to open or close the blind, wherein said first meansfixed to said movable box include a parallelepiped box inserted in a center of saidmovable box, a small box housing, a cage (155) permanent magnets (152, 153) placedside-by-side between two sets of free rollers (160) longitudinal pins (161) passingthrough an external surface of said permanent magnets and from a fron of said box toassist said first means to slide over a glass pane.
]57[
__________
![Page 446: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/446.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 446
165439]21][11[
VOICE ืืชืงื ืืืขืจืืช ืืืขืืจืช ืงืื TRANSMISSION DEVICEAND VOICE TRANSMISSIONSYSTEM
]54[
04.04.2003]22[Int. Cl.(2009.01) H04M 03//00]51[MITSUBISHI DENKI KABUSHIKIKAISHA, JAPAN
]71[
WO/2004/091183]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A speech transmitter having a tandem pass through function in an STM, ATM and IPnetwork. A noise canceller (21) is provided at the succeeding stage of an echocanceller (12) in an encoding section. If not a tandem connection state, noise isremoved to carry out high-efficiency encoding; if the relay is in a tandem connectionstate, switching is carried out so that the operation of the noise canceller (21) isstopped so as to prevent degradation of speech quality due to excessive decoding andencoding. As a result, even if a portable telephone has no noise canceling function,high-quality speech transmission is realized in both normal and tandem pass throughmodes. By thus removing the noise component, the soundless portions in speech dataincrease, and the portions to be encoded decrease, thereby reducing the amount ofdata transmitted through the circuit.
]57[
__________
![Page 447: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/447.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009447
165520]21][11[
ืื โืืืืืจืโ2,3โืืืงืกืโ3((โื ืืืจืืช) ืืฆืืื,)ืืืโ1โืืืืืืื ืืืโืืืืจืืื
ืชืืฉืืจืืNHEโ1ืืืื ืืืื ืืืขืืืืชืชืืืื ืืืื ืชื, ืจืคืืืืื ืืืืืืื ืืืชื
ืืฉืืืืฉ ืฉืืื
N-((3-OXO-2, 3-DIHYDRO-1H-ISOINDOL-1-YL), ACETYL)GUANIDINE DERIVATIVES ASNHE - 1 - INHIBITORS,PHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM, PROCESS FOR THEIRPREPARATION AND USESTHEREOF
]54[
20.05.2003]22[FR]33[03.06.2002]32[02/06783]31[
Int. Cl.(2009.01) A61K 31//4035, A61P 03//10, 25//00, 35//00, C07D 20/9/46]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY
]71[
WO/2003/101450]87[,ืืฆืจ ืืืื ืฆืืง, ืคืจื, ืืืชื
ืืจืฆืืื, 12688.ื.ืช,7ืจืืื ืฉื ืงืจEITAN, PEARL, LATZER ANDCOHEN ZEDEK,P.O.B. 12688,
HERZLIYA 46733
]74[
Isoindolone derivatives, preparation process and intermediates of this process, theiruse as medicaments, and pharmaceutical compositions comprising them. The presentinvention relates to the novel isoindolone derivatives of the Formula (I), in which R1 toR6 have the meanings stated in the claims. The inventive compounds are suitable asantiarrhythmic medicaments with a cardioprotective component for infarctionprophylaxis and infarction treatment and for the treatment of angina pectoris. They alsoinhibit in a preventive manner the pathophysiological processes associated with thedevelopment of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure.
]57[
__________
![Page 448: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/448.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 448
165694]21][11[
]B,F[ ืืืืจืืื ืืืื ื5ืฉืืื ืืืื ืช ืงืจืืืงืกืืืืืโ5โืืืคืื
METHOD OF PREPARING A 5H-DIBENZ[B,F] AZEPINE-5-CARBOXAMIDE
]54[
13.06.2003]22[US]33[14.06.2002]32[60/388811]31[
Int. Cl.(2008.04) C07D 233/22]51[TARO PHARMACEUTICALS U.S.A.,INC., U.S.A.
]71[
WO/2003/106414]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The present invention provides a method of preparing a 5H-dibenz[b,f]azepine-5-carboxamide of formula (1) wherein R1, R2, R3, and R4 are independently selectedfrom the group consisting of hydrogen, halogen, nitro, cyano, carboxyl, A, -CO(A), -OCO(A), -O(A), -N(A)2, -CON(A)2, and -COO(A), wherein A is selected from the groupconsisting of C-1-C10 alkyl, C3-C10 cycloalkyl, C-2-C10 alkenyl, C-5-C10 cycloalkenyl,C-2-C10 alkynyl, and C-6-C20 aryl, wherein the two A groups of -N(A)2 and -CON(A)2can be the same or different, and wherein R2 and R3 can together form a bond;comprising reacting a 5H-dibenz[b,f]azepine of formula (2) with a) a cyanate saltselected from the group consisting of alkali metal cyanate salts and alkaline-earth metalcyanate salts, and b) a salt of an amino compound having no N-H bonds, wherein thesalt has a Ka (25ยฐ C) of at least about 10 x 10-11.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
198455,The applications for divisionfrom this application havenot yet been published
__________
![Page 449: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/449.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009449
165715]21][11[
3โืืืจืืืจืืโ6โืืืจืืืโ2ืชืืืืืช ืืืืฆืHโืงืจืืืงืกืืืืชโ4โืื ืืืืืืืืืื ,
ืชืืฉืืจื ืจืืงืืืช ืืืืืืื ืืืชื ืืชืืืืืื ืืืื ืชื
2-UREIDO-6-HETEROARYL-3H-BENZIMIDAZOLE-4-CARBOXYLIC ACIDDERIVATIVES,PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME AND METHODS FORTHE PREPARATION THEREOF
]54[
11.06.2003]22[US]33[13.06.2002]32[60/388665]31[US11.11.2002 60/429077
Int. Cl.(2008.04) A61K 314/184, A61P 11/00, 13/00, 17/00, 29/00, 31/00, 35/00,37/00, C07D 401/00, 401/10, 401/14, 403/10, 403/14
]51[
VERTEX PHARMACEUTICALSINCORPORATED, U.S.A.
]71[
WO/2003/105846]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The present invention relates to compounds of formula I, wherein X, Q, W, R1, R2 andR3 are as defined in the claims, which inhibit bacterial gyrase and/or Topo IV andpharmaceutically acceptable compositions comprising said compounds. Thesecompounds, and composition thereof, are useful in treating bacterial infection.Accordingly, the present invention also relates to methods for treating bacterialinfections in, mammals. The present invention also relates to a method for preparingthese compounds.
]57[
__________
![Page 450: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/450.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 450
165782]21][11[
ืช ืืืืืืช ืืืืืจ ืงืจืืื ืฉืืืช ืื ืคืืืืกื ืฉื ืงืืจื ืืืืื ืชืืจ ืจืืื
PULSED POWER METHOD FORINCREASED READ RANGE FOR ARADIO FREQUENCYIDENTIFICATION READER
]54[
11.08.2003]22[US]33[09.08.2002]32[216476]31[
Int. Cl.(2008.04) H04Q 5/22]51[SENSORMATIC ELECTRONICSCORPORATION, U.S.A.
]71[
WO/2004/015613]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method to power a radio frequency identification (RFID) reader to increase multitagreading capability and increase the reading range of a passive tag without maximizingthe continuous transmitted power level is provided. The RFID reader transmits a pulsedinterrogation signal until an RFID tag response is received, and then switches to acontinuous and pulsed power scheme. The continuous power emitted maintains thepower supplied to the RFID tags so the tags will not reset due to loss of power. Thepulsed signal permits reading the tags at longer ranges, especially when there is aplurality of tags in the area.
]57[
__________
![Page 451: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/451.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009451
165925]21][11[
, ืชืืืืืื ืืืื ืชื, ืคื ืื ืื ืืืืืืื ืชืืฉืืจืื ืืืืืืื ืืืชื ืืฉืืืืฉืืื
PHENYL BENZAMIDES,PROCESSES FOR THEIRPREPARATION, COMPOSITIONSCOMPRISING THEM AND USESTHEREOF
]54[
20.06.2003]22[DE]33[02.07.2002]32[10229595.6]31[
Int. Cl.(2009.01) A01N 37//22, C07C 21/1/44, 23/3/64]51[BAYER CROPSCIENCE AG,GERMANY
]71[
WO/2004/005242]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to novel phenyl benzamides of formula (I), in which R1 representstrifluoromethyl, chlorine, bromium or iodine and R2 represents hydrogen, methyl orethyl. The invention also relates to a method for producing said substances and to theiruse for controlling undesired micro-organisms, in addition to novel intermediateproducts and the production thereof.
]57[
__________
![Page 452: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/452.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 452
165965]21][11[
ืืืืจ ืืจืืื ืืืืงืืจืืื ืฉืืืืืช ืขืืืจ ืื ืืฉื ื ืืฉืืื ืืืืฆืืจืืืฆืืจ ืืืชื
LITHIUM SECONDARYBATTERY NEGATIVEELECTRODE COMPONENTMATERIAL AND METHOD OFITS MANUFACTURE
]54[
01.04.2004]22[Int. Cl.(2009.01) H01M 04//02, 04//40, 04//48]51[SUMITOMO ELECTRICINDUSTRIES, LTD., JAPAN
]71[
NOBUHIRO OTA, NOBUYUKIOKUDA, HIROYUKI UEKI,TOMOHIKO IHARA
]72[
WO/2005/101549]87[ืื'ื ืืข, ืื ืื ,ื"ืคืงืืืจ ืื ื ืงื
, 45087.ื.ืช, ืืจ ืืืฆืืื, ืจืืื ืืืจืคื ืืจืืฉืืื
JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,JERUSALEM 91450
]74[
It is intended to provide a secondary lithium battery in which short circuitcaused by the formation of dendrite from the metallic lithium negativeelectrode is regulated and which has a high energy density, a high stabilitywith excellent charge-discharge cycle properties and a high safety. A negativeelectrode member for a secondary lithium battery comprising a metallic lithiumfilm and an inorganic solid electrolyte film which are layered on a basematerial, characterized in that the inorganic solid electrolyte contains lithium,phosphorus, sulfur and oxygen, and is represented by the followingcompositional formula: aLiยทbPยทcSยทdO (Li: lithium, P: phosphorus, S: sulfur, O:oxygen) and the contents of the elements respectively fall within the followingranges: 0.20โคaโค0.45 0.10โคbโค0.20 0.35โคcโค0.60 0.03โคdโค0.13 (a+b+c+d=1).
]57[
__________
166014]21][11[
CULTURE ืืฆืข ืืืืืื ืืืขืจืืช ืฉื ืืืจ ืืืืืืื DISH ANDBIOREACTOR SYSTEM
]54[
26.06.2003]22[US]33[02.07.2002]32[189300]31[
Int. Cl.(2008.04) C12M 1/12, 1/34, 3/06]51[ORGANOGENESIS INC., U.S.A.]71[WO/2004/005453]87[A bioreactor has a base for defining a well, a dish with a membrane suspended in thebase, and a lid with gas permeable membranes and self-sealing ports.
]57[
![Page 453: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/453.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009453
__________
166354]21][11[
ASSEMBLY ืืืืื ืืฉืืื ืืืืื ืืกืืก ืชืฆืืื ืขืืืช AND METHOD FORHEAD-UP DISPLAY (HUD) TRAYHARMONIZATION
]54[
18.01.2005]22[Int. Cl.(2009.01) G02B 27//01]51[
ืืืคืืืงื ืืืืืค-ืืืืื ืืขืจืืืช ืืืงืืจื ืจืืืืืช,ื"ืืข
ELBIT SYSTEMS ELECTRO-OPTICAL ELOP LTD.
]71[
MICHAEL ืืขืงื ืืืฉืข, ืืืืื ืืจืืืกืงื BRODSKY, JACOBYOSHA
]72[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A head-up display (HUD) tray harmonization assembly, comprising: a mount alignmentjig (MAJ) (20) having a first end and a second end, said first end being connectable toan adjustable tray (18) affixed in an aircraft cabin (16) having a pilot's seat, located in afront end (6) of an aircraft, at a spaced-apart relationship to a front window (8) having alower edge (12) located adjacent the front end of said aircraft; a telescope (22)connected to the MAJ at, or adjacent, its second end oriented for viewing through saidwindow; an optical collimator holder (24) having a first portion (26) connectable to anoutside wall of said front end of the aircraft and a second portion (28) extendingtowards and terminating at least at least lower edge of said window, and an opticalcollimator (32) coupled to the second portion of said holder to form a line of sight withsaid telescope.
]57[
__________
![Page 454: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/454.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 454
166439]21][11[
ืื ืืืื ืืจืืช ืืืขืืืHื ืืืจืืช ืืืืฆืCโMAFืืื ืชื, ืืฉืืืืฉ ื ืื ืืกืชืื
ืืชืืฉืืจืื ืจืืงืืืื ืืืืืืื ืืืชื
ENDIANDRIC ACID HDERIVATIVES AS C-MAFINHIBITORS FOR USINGAGAINST ASTHMA, THEIRPREPARATION ANDPHARMACEUTICALCOMPOSITIONS COMPRISINGTHEM
]54[
18.07.2003]22[DE]33[02.08.2002]32[10235624.6]31[
Int. Cl.(2008.04) C07C 69/00]51[SANOFI-AVENTIS DEUTSCHLANDGMBH, GERMANY
]71[
WO/2004/001488]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
A compound of the formula
whereR1 and R2 are, independently of one another,1, 0 H or2.0 a โO-C1-C6-alkyl, -O-C2-C6-alkenyl, -O-C2-C6-alkynyl or โO-C6-C10-aryl group, inwhich alkyl, alkenyl and alkynyl are straight-chain or branched, and in which thealkyl, alkenyl and alkynyl groups are optionally mono- or disubstituted by:2.1 โOH,2.2 =O,2.3 โO-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 โO-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 C6-C10-aryl,2.6 โNH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 โNH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 โNH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or
]57[
![Page 455: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/455.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009455
2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted byโCN, -amide or โoxime functions, and 2.5 may be further substituted by โCN or amidefunctions, or R1 and R2 together form a group โO-[(C1-C6)-alkylene]-O-, R3 is 1.0 H or2.0 a C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl or C2-C10-aryl group, in which alkyl,alkenyl and alkynyl are straight-chain or branched, and in which the alkyl, alkenyl andalkynyl groups are optionally mono- or disubstituted by:2.1 โOH,2.2 =O,2.3 โO-C1-C6-alkyl in which alkyl is straight-chain or branched,2.4 โO-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.5 โC6-C10 aryl,2.6 โNH-C1-C6-alkyl in which alkyl is straight-chain or branched,2.7 โNH-C2-C6-alkenyl in which alkenyl is straight-chain or branched,2.8 โNH2 or2.9 halogen,and in which the aryl group is optionally mono-or disubstituted by substituent 2.1 or2.3 to 2.9, in which the substituents 2.3, 2.4, 2.6 and 2.7 may be further substituted byโCN, -amide or โoxime functions, and 2.5 may be further substituted by โCN or amidefunctions, and R4 is CO2R3, CO2NHR3, CHO, CH2OR3, CH2OSi(R3)3, CH2CN, whereR3 is as defined above, or a stereoisomeric form of the compound of the formula (l) ora physiologically tolerated salt of the formula (l) or a salt of a stereoisomeric form ofthe compound of the formula (l).
__________
166557]21][11[
ECHINACEA ืชืืฆืืืช ืืืื ืฆืื ืื ืืืกืืืคืืืื ANGUSTIFOLIAEXTRACTS
]54[
30.06.2003]22[IT]33[30.07.2002]32[MI2002A001691]31[
Int. Cl.(2008.04) A61K 35/00, 36/185, 36/28]51[INDENA S.P.A., ITALY]71[WO/2004/014404]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An Echinacea angustifolia extract and a process for the preparation thereofare herein described. The extract is characterized by an alkylamides contentlower than 0.1 %, an echinacoside content ranging from 1 to 10% andcontaining from 1 to 15% of a polysaccharide characteristic of Echinaceaangustifolia. The extract can be used for the treatment of pathologicalconditions in which it is desirable to strengthen the immune defenses.
__________
]57[
![Page 456: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/456.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 456
166746]21][11[
ืืขืจืืช ืืฉืืื ืืืืืื ืืคืจืขื ืืืืฉืื ืืืืืชโืืืงืื ืืฉืืืืฉ ืืืขืจืืช ืืืงืื ืื
SYSTEM AND METHOD FORINTERFERENCECANCELLATION IN ALOCATION CALCULATIONFOR USE IN A WIRELESSLOCATION SYSTEM
]54[
11.08.2003]22[Int. Cl.(2009.01) G01S 05//02, H04B 01//10]51[TRUEPOSITION, INC., U.S.A.]71[WO/2004/015878]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
In a Wireless Location System, reception and demodulation of signals is oftenperformed at many sites. A collision may occur, e.g., in a TDMA, AMPS, GSM, GPRS,EDGE, CDMA, CDMA 2000, or WCDMA system, when a signal of interest (atransmission from a mobile transmitter to be located) and an interfering signal arereceived at the same time and at the same site. In the event such a collision occurs,the interfering signal may have been demodulated by a receiver system, or SCS, atanother site, and the demodulated data be known by the TLP. This interferer can bereconstructed and subtracted from the raw data representing the combined signal ofinterest and interferer at the site where the collision occurred. This technique canprovide significant (e.g., approximately 10 - 15 dB) interference rejection, with littledegradation to the signal of interest.
]57[
__________
![Page 457: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/457.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009457
166769]21][11[
CATALYST ืืชืืืื ืืืกืืืืN2Oืืจืืื ืืคืืจืืง FOR THEDECOMPOSITION OF N2O IN THEOSTWALD PROCESS
]54[
09.02.2005]22[DE]33[11.03.2004]32[102004012333.0]31[DE13.05.2004 102004024026.4
Int. Cl.(2008.04) B01D 53/86, B01J 23/46, C01B 21/26]51[W.C. HERAEUS GMBH, GERMANY]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Use of a composition comprising:(A) a carrier material, wherein the carrier material is alpha-Al2O3 or ZrO2 or CeO2 ormixtures thereof,(B) a coating made of rhodium or rhodium oxide or a Pd-Rh alloy for the preparation ofa catalyst for the decomposition of N2O under the conditions of the Ostwald process at750oC to 1000oC and 0.9 to 15 bar.
]57[
__________
166897]21][11[
SINGLE ืืืืื ืืืืืฉ ืืืื CRYSTAL DIAMOND]54[
15.02.2005]22[Int. Cl.(2009.01) C30B 25//02, 28//04, 33//00]51[ELEMENT SIX LIMITED, UNITEDKINGDOM
]71[
WO/2004/027123]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method of producing a large area plate of single crystal diamond from CVD diamondgrown on a substrate substantially free of surface defects by chemical vapourdeposition (CVD). The homoepitaxial CVD grown diamond and the substrate aresevered transverse to the surface of the substrate on which diamond growth took placeto produce the large area plate of single crystal CVD diamond
]57[
![Page 458: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/458.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 458
__________
167005]21][11[
CLOSED ืกืืืจ-ืืขืื-ืืื ืื ืืจืืืืจืื ืขื ืื ืืฉืื LOOP-FEEDBACKARTILLERY FIRE CONTROL
]54[
21.02.2005]22[Int. Cl.(2009.01) F41G 05//06]51[
ืืขื ืืขืจืืืช ืืืืื ืืชืง"ืจืคื ,ื"ืืืืช ืืืคื
RAFAEL ADVANCED DEFENSESYSTEMS LTD.
]71[
MENACHEM ืื ืื ืืืืจ DVIR]72[ืืข"ื ,ื"ืจ ืืจืง ืคืจืืืื
ื,54.ืง, ืืืื ืืฉื ืืืื ,7ืืืืื ืกืงื'ืจืืื-ืจืืช
DR. MARK FRIEDMAN LTD.,MOSHE AVIV TOWER, 54TH
FLOOR,7 JABOTINSKY ST.,RAMAT GAN 52520
]74[
A method of directing fire of a gun at a target, comprising:(a) aiming the gun at the target in accordance with geographic coordinates of thetarget;(b) firing a shell at the target from the gun; and(c) if the shell misses the target:(i) acquiring an image of a region including an indication of an impact of the shell;(ii) inferring geographic coordinates of said indication from said image; and(iii)correcting an aim of the gun in accordance with said geographic coordinates of thetarget and said inferred geographic coordinates of said indication.
]57[
__________
![Page 459: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/459.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009459
167081]21][11[
ืงื โืืขืจืืช ืืฉืืื ืืืืฆืืข ืกืืืืช ืฉืืชืืกืืจืช ืืืืฆืขืืช ืืืืื ืืืช ืืืฉืืืื
ืฉืืื
SYSTEM AND METHOD FORTRANSMISSION-LINETERMINATION BY SIGNALCANCELLATION ANDAPPLICATIONS THEREOF
]54[
17.09.2000]22[Int. Cl.(2008.04) H04B 3/20, H04L 27/00, 5/14]51[DIVISION FROM 138517]62[MOSAID TECHNOLOGIESINCORPORATED, CANADA
]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method for signal termination with a device having terminating and transmittingstates, said method comprising: connecting the device to a connection point of a two-conductor transmission line; providing a termination circuit constructed for terminating asignal propagated over the two-conductor transmission line; providing a first driveroperative to conduct a signal over the two-conductor transmission line, the first driverhaving an input port selectively couplable to a signal source doe coupling the signalsource to the transmission line, and an output port; and placing the device in a selectedone of: a terminating state in which said termination circuit is coupled to the connectionpoint; and a transmitting state in which the first driver output port is coupled to theconnection point.
]57[
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
199120,The applications fordivision from thisapplication have not yetbeen published
__________
![Page 460: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/460.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 460
167337]21][11[
ื ืื ืฉืืืฆืจ ืืฉืืงืืข ืืจืงืข ืืืงืืจืืืจืื ืืฉืืื
ELECTROCHROMIC ORELECTRODEPOSITION DISPLAY
]54[
10.09.2003]22[AR]33[10.09.2002]32[60/409833]31[
Int. Cl.(2009.01) G02F 01//161]51[SIPIX IMAGING, INC., U.S.A.]71[WO/2004/025356]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืื ืืืจืื ืจื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
An electrochromic or electrodeposition display comprising a plurality of cells, each ofsaid cells comprises surrounding partition walls, an electrochromic or electrolytic fluidfilled therein, and a polymeric sealing layer which encloses said fluid within each celland sealingly adheres to the surface of the partition walls. Microcups are formed byembossing or imagewise exposure.
]57[
__________
167624]21][11[
CELL ืชืืฉืืจืื ืืฉืืืืช ืืืคืจืืช ืชืืื SEPARATIONCOMPOSITIONS AND METHODS
]54[
26.09.2003]22[US]33[27.09.2002]32[60/414692]31[
Int. Cl.(2008.04) A61K 317/21, 317/27, 393/95, C07K 16/28, G01N 33/53]51[BIOE, INC., U.S.A.]71[WO/2004/029208]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention provides compositions and methods for cell separation. Thesereagents and techniques specially agglutinate cells via surface recognition andcan be used to recover even rare cell types in high yield.
]57[
__________
![Page 461: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/461.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009461
167673]21][11[
HIGH ืืจืื ืืืืง ืืืื ืืฉืืื ืืขืฉืืชื PRECISION MIRROR ANDA METHOD OF MAKING IT
]54[
24.02.2003]22[US]33[24.02.2003]32[10/373448]31[
Int. Cl.(2009.01) G02B 01//10]51[RAYTHEON COMPANY, U.S.A.]71[WO/2004/077114]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A mirror includes: a substrate having a surface; and a thin-film finishlayer provided over the surface of the substrate and having aon a sidethereof opposite from the substrate a surface with a polished finish.According to a different aspect of the invention, a method of making amirror includes: providing a substrate having a surface thereon; forminga thin-film finish layer over the surface of the substrate using thin-filmtechniques, the finish layer having a surface on a side thereof oppositefrom the substrate; and polishing the surface of the finish layer.
]57[
__________
167935]21][11[
METHOD ืชืืืื ืืจืืื ืืคืืืื FOR PLASMAETCHING
]54[
06.10.2003]22[US]33[11.10.2002]32[60/417806]31[US14.11.2002 10/295601 US29.09.200310/674675
Int. Cl.(2008.04) H01L 213/065]51[LAM RESEARCH CORPORATION,U.S.A.
]71[
LUMIN LI, ZHISONG HUANG,REZA SADJADI
]72[
WO/2004/034445]87[ืื'ื ืืข, ืื ืื ,ื"ืคืงืืืจ ืื ื ืงื
, 45087.ื.ืช, ืืจ ืืืฆืืื, ืจืืื ืืืจืคื ืืจืืฉืืื
JMB, FACTOR & CO. LTD.,HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,JERUSALEM 91450
]74[
A method for etching a feature in a layer through an etching mask is provided. Aprotective layer is formed on exposed surfaces of the etching mask and verticalsidewalls of the feature with a passivation gas mixture. The feature is etched through
]57[
![Page 462: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/462.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 462
the etching mask with reactive etching mixtures containing at least one etchingchemical and at least one passivation chemical.
ืืงืฉืืช ืืืืงื ืืืงืฉื ืื.ืฉืืจ๏ฟฝ ืคืืจืกืื
190716,The applications for divisionfrom this application havenot yet been published
__________
168014]21][11[
ืฉืืื ืืืฆืืจ ืืืื ืืืืจ ืืจืื ืืืืื ืช ืืืืื ืืืืืฉืืช ืืช ืืฉืืื
METHOD FOR PRODUCING LOGSOF WEB MATERIAL ANDREWINDING MACHINEIMPLEMENTING SAID METHOD
]54[
14.10.2003]22[IT]33[16.10.2002]32[FI2002A000194]31[
Int. Cl.(2009.01) B65H 19//28]51[FABIO PERINI S.P.A., ITALY]71[WO/2004/035441]87[
,ืคืจื ืืื ืฆืืง ืืฆืจ.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื
ืืจืฆืืื, 12704
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
method for producing logs (Ll, L2) of web material (N) wound around tubular coreswherein the tubular core (Al-A4) is equipped with glue to secure the initial end of theweb material and allow winding. Part of the glue applied to the tubular core istransferred to the web material (N) before it is severed upon termination of winding thelog, to seal the final free end of the formed log.
]57[
__________
![Page 463: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/463.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009463
168041]21][11[
METHOD ืฉืืื ืืืืคืื ืืืืฆืช ืฉืคืืื ืืืืืืช OF TREATING RAWSEWAGE SLURRY
]54[
14.04.2005]22[Int. Cl.(2009.01) B01D 21//02, 61//04, E03F 09//00]51[
BAR-EDAN ืงืจืืช ืืืืื,ื"ืืจ ืขืืื ืืฆืืจ ืืคืืชืื ืืข MANUFACTURINGAND DEVELOPMENT LTD.
]71[
AHIAM ืืืืขื ืื ืืขืงื BEN YAACOV]72[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A method of treating a raw preconcentrated sewage slurry comprising(i) providing a preconcentrated sewage slurry having from about 10 to about 40% dryweight (%dw);(ii) irradiating said slurry with an electron dose of from 2.5 kGy to 20 kGy;(iii) mixing the irradiated slurry from the previous step with a base that is added in anamount of from about 20 to about 200 kg per 1 ton of dry weight of said irradiatedslurry, thereby obtaining an essentially homogeneous mixture; and(iv) allowing said base and said irradiated sludge to react in said mixture at a pH of atleast 11.5;thereby obtaining essentially disinfected and stabilized sludge.
]57[
__________
168245]21][11[
ASPERGILLUS ืคืจืืืืื ืืกืคืจืืืช ื ืืืืจ NIGER ASPARTICPROTEASE
]54[
01.11.1994]22[EP]33[03.11.1993]32[93810764.6]31[
Int. Cl.(2008.04) C12N 1/14, 15/57, 9/60]51[DIVISION FROM 111482]62[NOVARTIS AG, SWITZERLAND]71[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
A isolated DNA molecule comprising a DNA sequence encoding an Aspergillus nigeraspartic protease having the amino acid sequence shown in SEQ ID NO.2.
]57[
![Page 464: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/464.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 464
168608]21][11[
ืจืืฉ ืืืคืกืช ืชืจืื ืืืืจืงืช ืืื ืืขืืืขืืืืช ืืืืื ืืฉืืื ืืืืจืงืช ืืืคื ืฉื
ื ืืื ืืืืจืง ืืจืืฉ ืืืืคืกืช
HIGH EFFICIENCY THERMALINK JET PRINTHEAD AND AMETHOD FOR EJECTING ADROP OF AN EJECTABLELIQUID FROM THE PRINTHEAD
]54[
17.11.2003]22[US]33[23.11.2002]32[10/302669]31[
Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA
]71[
WO/2004/048108]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is configured such that anactuation energy of less than 500 nanojoules (nJ) is required to be applied to thatelement to heat it sufficiently to form such a bubble (12) in the bubble forming liquid(which liquid can also be the ink). This configuration thus provides for a high efficiencyprinthead.
]57[
__________
![Page 465: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/465.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009465
168700]21][11[
ืืขืจืืช, ืจืืฉ ืืืคืกืช ืืืืจืงืช ืืืืืืคืกืช ืืืืืื ืืืชื ืืฉืืื ืืืืจืงืช
ืืคื ืฉื ืืืขื ืืฆืืจืช ื ืืื ืืื ื
INK JET PRINTHEAD, PRINTERSYSTEM COMPRISING IT ANDMETHOD OF EJECTING A DROPOF A BUBBLE FORMING FLUIDFROM IT
]54[
17.11.2003]22[US]33[23.11.2002]32[10/302297]31[
Int. Cl.(2008.04) B41J 2/05]51[SILVERBROOK RESEARCH PTY.LTD., AUSTRALIA
]71[
WO/2004/048104]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
There is disclosed an ink jet printhead which comprises a plurality of nozzles (3) andone or more heater elements (10) corresponding to each nozzle (3). Each heaterelement is configured to heat a bubble forming liquid in the printhead to a temperatureabove its boiling point to form a gas bubble (12) therein. The generation of the bubblecauses the ejection of a drop of an ejectable liquid (such as ink) through the respectivecorresponding nozzle, to effect printing. Each heater element is substantially coveredby a conformal protective coating (77) which has been applied to all sides of the heaterelement (10) simultaneously so that the coating is seamless.
]57[
__________
![Page 466: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/466.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 466
168770]21][11[
ืฉืืืืช ืืืงืจืช ืืืืงืื ืชืื ืฉืืืืฉ ืืืืงืืงืื ืืชืืชืืื
METHODS FOR CONTROLLINGPESTS USING METALLICPARTICLES
]54[
05.12.2003]22[GB]33[05.12.2002]32[0228421.4]31[
Int. Cl.(2008.04) A01N 25/24, 59/16]51[EXOSECT LIMITED, UNITEDKINGDOM
]71[
WO/2004/049807]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
There is disclosed a method of controlling pests which comprises exposing asurface of the pest to a particulate composition containing particles of aninitially unmagnetized material, which is capable of becoming magneticallypolarized when subjected to an electric or magnetic field, the said particlesbeing associated with at least one pesticide or behaviour modifying chemical.
]57[
__________
168793]21][11[
STREPTOCOCCUS ืืืืงืืื ืืืืงื ืฉื ืืืืจืืก ืกืืจืคืืืงืืงืืก UBERISADHESION MOLECULE
]54[
22.10.2003]22[US]33[26.11.2002]32[60/429499]31[
Int. Cl.(2009.01) A61K 39//09, C07K 14//315]51[UNIVERSITY OF TENNESSEERESEARCH FOUNDATION, U.S.A.
]71[
WO/2004/048515]87[,ืจ ืืฆืืง ืืก ืืฉืืชืคืื"ื
ืชื ืืืื, 6451.ื.ืช, 279ืจืืื ืืืจืงืืDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
A polypeptide, designated as โStreptococcus uberis Adhesion Moleculeโ (SUAM), andfragments of SUAM, prevent internalization and adherence of Streptococcus uberis andother streptococcal pathogens to cells. The SUAN polypeptide and fragments may beused diagnostically and therapeutically. Nucleic acid sequences encoding the SUAMpolypeptide and fragments are included in the invention.
]57[
![Page 467: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/467.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009467
__________
168977]21][11[
CROSS ืฉืืชืืฃ ืืืฆื ืืืืฆืืช ืฉื ืืืืข ืขื ืืฆื PARTITION SHARING OFSTATE INFORMATION
]54[
14.11.2003]22[US]33[05.12.2002]32[10/313330]31[
Int. Cl.(2009.01) G06F 05//16]51[IBM CORPORATION, U.S.A.]71[WO/2004/051471]87[
,ืืขืืืืช ืืื ืืืืงืช ืงื ืื ืจืืื ื ืืืคื, ืืื ืืืจืกืืืช ืืืคื ืืจ ืืืจืื
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
A method and system are disclosed for managing saved process states in a memory ofa data processing system that has multiple partitions executing independent operatingsystems. A hypervisor manager affords access to any processor in the data processingsystem for the purpose of storing process states for that processor the memory,independent of the operating system running on the processor.
]57[
__________
![Page 468: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/468.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 468
169351]21][11[
URINARY ืฉืกืชืื ืืงืจืช ืืจืืื ืฉื ืฉืชื FLOW CONTROLVALVE
]54[
09.01.2003]22[Int. Cl.(2009.01) A61F 02//02]51[OPMI FUNDING CORP., U.S.A.]71[WO/2004/062532]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A flow control valve (22) such as for a catheter (10) allows discharge of urine from abladder (12) by manual actuation. The valve (22) may be a doubleโduckbill valve (22)with a single slit (62) at one apex (60a) thereof. An elastomeric band (66) is positionedin a groove (68) of the valve member (22). An isolation member such as a stem (72)spaces the valve (22) from the walls (34, 36) of the valve housing (32). Crush limitingstructure, such as a tube (76) or blade (82), is provided within valve member (22), orstop elements (86 or 92) are positioned external to valve member (22).
]57[
__________
169463]21][11[
ืคืืืจ ืจืืืฉ ืืืจ ืขื ืฆืืืืืช ืื ืืชื ืชืืืืกืืช ืขืืืจ ืืคืงืื ืฉื ืืชืืช ืขื ืืื
ืืฆืข ืืืื ืืืฉืืืืฉ ืื
PHOTOSENSITIVE DISPERSIONWITH ADJUSTABLE VISCOSITYFOR METAL DEPOSITION ON ANINSULATING SUBSTRATE ANDUSE OF SAME
]54[
24.12.2003]22[BE]33[03.01.2003]32[2003/0007]31[
Int. Cl.(2008.04) C23C 18/00, 18/30, C25D 5/56]51[SEMIKA S.A., LUXEMBOURG]71[WO/2004/061157]87[
,ืคืจื ืืื ืฆืืง ืืฆืจ, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
![Page 469: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/469.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009469
The invention relates to a photosensitive dispersion with adjustable viscosityfor metal deposition on an insulating substrate, which combines the following:a pigment providing oxidation-reduction properties under light irradiation, ametallic salt, a complex-forming agent for the metallic salt, a liquid film-formingpolymer formulation, a basic compound, an organic solvent and water. Theinvention also relates to the use of said dispersion.
]57[
__________
169515]21][11[
ืฉืืืืฉ ืืคืืจืืจืืื ืื ืคืืจืืจืื ืืืื ืขื ืืืื ืืกื ื ืืงืืืื ื ืืืืืื ืืจืืจืืคืืื
USE OF A PYRETHROID ORPYRETHRIN IN COMBINATIONWITH A NICOTINIC AGONISTFOR REPELLING ARTHROPODS
]54[
05.01.2004]22[DE]33[17.01.2003]32[10301906.5]31[
Int. Cl.(2008.04) A01N 37/34, 53/00]51[BAYER ANIMAL HEALTH GMBH,GERMANY
]71[
WO/2004/064522]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to the use of an arthropod-repelling constituent of thepyrethroid/pyrethrin class combined with an agonist of the nicotine-producingacetylcholine receptors of arthropods, for efficiently repelling arthropods,preferably on animals, for a long time.
]57[
__________
169612]21][11[
FREIGHT ืืขืจืืช ืืฉืืืช ืืืื ืืืขื CONTAINERMONITORING SYSTEM
]54[
10.07.2005]22[Int. Cl.(2009.01) G01S 13//04, 13//88]51[PHALANX GROUP, LLC, U.S.A.]71[
,ืืจืืื ืืืืืจ, ืืืืฃ ืฉืืืืืจื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A system for monitoring a freight container comprising: means for monitoring the freightcontainer including means for generating a resonant spectrum representative of aninitial condition of internal surfaces and contents of the freight container; and means forsaving said resonant spectrum representative of an initial condition of internal surfaces
]57[
![Page 470: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/470.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 470
and contents of the freight container; and means for saving said resonant spectrum forfuture comparison purposes.
__________
170010]21][11[
ืฉืืื ืืฉืืคืืจ ืืืจืืื ืืืืืจื ื ืืจืืืงืืืจ ืืืืืืื
METHOD FOR IMPROVING FLUXIN A MEMBRANE BIOREACTOR
]54[
01.08.2005]22[US]33[01.06.2005]32[11/142745]31[
Int. Cl.(2009.01) B01D 61//04, C02F 01//56, 03//12]51[NALCO COMPANY, U.S.A.]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A method for improving flux in a membrane bioreactor of which the influent has aconcentration of salts or inorganic oxides sufficient to cause scaling or inorganic foulingconditions comprising adding an effective amount of one or more cationic, amphoteric,or zwitterionic polymers, or a combination thereof to said membrane bioreactor,wherein a membrane bioreactor system comprises said membrane bioreactor, whereinsaid membrane bioreactor comprises an aerobic reactor wherein said membranebioreactor system further comprises a reactor selected from the group consisting ofanaerobic reactors and anoxic reactors and wherein said effective amount of cationicpolymer is about 10 to about 2,000 ppm as active based on the total membranebioreactor volume.
]57[
__________
170046]21][11[
SINGLE-BLOW ืืื ืืืื-ืืืฉืืจ ืืืืื ืื SHOCKWAVEGENERATION DEVICE
]54[
30.01.2004]22[FR]33[14.02.2003]32[03/01793]31[
Int. Cl.(2008.04) A61B 17/22]51[DULIVER INTERNATIONAL LTD.,BRITISH VIRGIN ISLANDS
]71[
WO/2004/078048]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืืืืจืฆ
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a single-blow mechanical shockwave generation device usedin urological surgery for disintegration of urinary duct stones (1), comprising strikingmeans (2) which strike shock wave generation means (3) at high speed. The shock
]57[
![Page 471: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/471.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009471
waves are transmitted by shock wave transfer means (4) to an object for destructionwith which said shock wave transfer means are in direct or indirect contact. The strikingmeans (2) are displaced by means of the expansion of a high-pressure gas introducedprior to each shock wave generation into accumulation means (5) supplied with highpressure gas from independent gas stores (7) and with supply and sealing meanswhereby the stored gas is released by the manual manipulation of control means (8)which connect the accumulation means (5) to the striking means (2).
__________
170190]21][11[
ืืขืจืืช ืฉื ืื ืืื ืจืื ืืืืืื ืืฉ ืืืืืกืชืช ืืืืคื ืขืฆืื
SELF-MODULATING INERT GASFIRE SUPPRESSION SYSTEM
]54[
19.12.2003]22[US]33[27.02.2003]32[10/377558]31[
Int. Cl.(2008.04) F16K 1/12, G05D 16/00, 16/16]51[FIKE CORPORATION, U.S.A.]71[WO/2004/079678]87[
ืขืืจืื ืืื ืืขืืจืื, ืงืืืฆืช ืืืชื ืืืืื,ืคืื ืืื
ืืจืฆืืื, 2081.ื.ืช,10ืฉืืจืืช ืืื ืืื
EITAN MEHULAL LAW GROUP,10 ABBA EBEN BLVD.,
P.O. B. 2081,HERZLIYA 46120
]74[
A valve unit (26) comprising: a valve body (48) presenting an inlet (58) adapted forcoupling with a source of pressurized gas (24) and an outlet (60) adapted for couplingwith a gas receiver (30); a shiftable valve member (56) located within said bodybetween said inlet and said outlet and shiftable between a closed, gas flow-blockingposition and an open position permitting flow of gas from said source to said receiver; aspring (186) operably coupled with said valve member and biasing the member towardthe open position thereof; first and second operating surfaces (S1, S2) forming a part ofsaid member, said first surface exposed to said pressurized gas from said source andsaid member being normally maintained in said closed position against the bias of saidspring, there being a modulation chamber (182) formed between at least a part of saidsecond operating surface and adjacent portions of said valve body, and a passageway(168) communicating said source with said modulation chamber; and an actuator (50)operable upon actuation thereof to cause flow of pressurized gas from said source intoand out of said modulation chamber, said passageway presenting a gas flow restriction(169) operable to limit the flow rate of gas between said source and said modulationchamber, said operating surface, modulation chamber, and spring being correlated sothat when said member is shifted to the open position thereof, gas from said source isdelivered to said receiver at a pressure of between 1MPa to 10MPa (10 to 100 bar)over a substantial part of the time gas flows from the source to the receiver by flow ofsaid gas into and out of said modulation chamber.
]57[
![Page 472: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/472.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 472
__________
170324]21][11[
ืืืจืง ืืื ืืื ืืืืื ืืื ืงืืืื ืืขืื ืืืืจืง
NEEDLELESS SYRINGECOMPRISING AN OPTIMIZEDINJECTOR-RECEPTACLE
]54[
09.04.2004]22[FR]33[16.04.2003]32[03/04761]31[
Int. Cl.(2008.04) A61M 5/00]51[CROSSJECT, FRANCE]71[WO/2004/093944]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN ANDPARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to the realm of needleless syringes used for injecting liquid activesubstances. Said syringe comprises a reservoir that is enclosed by means ofdisplaceable plugs which trap the liquid. The reservoir is initially isolated from aninjector-receptacle (37) which is provided with at least two peripheral injection conduits(38) that are arranged outside the receptacle (37). Said receptacle (37) encompasses apocket bore (31) which accommodates the plug located downstream such that theoptimized inlets (39) of the conduits are unobstructed. The face of the receptacle (37),which is located upstream, comprises a multilobed sealing joint (34) which is disposedparallel to and as close as possible to the edges of the bore (31) and the inlets (39).The aim of the invention is to create an injector-receptacle (37) that is optimizedregarding discharging and the resistance thereof to the injection pressure.
]57[
![Page 473: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/473.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009473
__________
170728]21][11[
OPTICALLY ืชืจืืืืช ืืืืจืื ื ืืืฉืช ืืืคืืืช ืคืขืืื ACTIVE COPPERCATALYST COMPOSITION
]54[
25.03.2004]22[JP]33[31.03.2003]32[2003-093750]31[
Int. Cl.(2008.04) B01J 31/18, 31/28]51[SUMITOMO CHEMICALCOMPANY, LIMITED., JAPAN
]71[
WO/2004/087317]87[,ืจ ืืฆืืง ืืก ืืฉืืชืคืื"ื
ืชื ืืืื, 6451.ื.ืช, 279ืจืืื ืืืจืงืืDR. YITZHAK HESS & PARTNERS,279 HAYARKON ST.,
P.O.B. 6451,TEL AVIV 61063
]74[
An optically active copper catalyst composition comprising (a) an optically activesalicylideneamino alcohol represented by the general formula (1): (1) [wherein R1 andR2 are each independently substituted or unsubstituted lower alkyl, substituted orunsubstituted aralkyl, or substituted or unsubstituted aryl; X1 and X2 are eachindependently hydrogen, lower alkoxy, nitro, lower alkoxy- carbonyl, cyano, orhalogeno; and * represents an asymmetric center, with the proviso that both of X1 andX2 are not hydrogen], (b) a mono- or di-valent copper compound, and (c-1) a lithiumcompound or (c-2) a compound selected from among aluminum compounds havingLewis acidity, titanium compounds having Lewis acidity, boron compounds havingLewis acidity, zirconium compounds having Lewis acidity, and hafnium compoundshaving Lewis acidity; and a process for the production of optically activecyclopropanecarboxylic acids with the composition.
]57[
__________
![Page 474: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/474.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 474
170901]21][11[
DEAD ืืื ืืืืืืช ืืืกืง ืืืฉืืืื ืืช ืชืืื ื ON DEMAND DISKTECHNOLOGY
]54[
18.03.2004]22[US]33[18.03.2003]32[60/455501]31[
Int. Cl.(2008.04) G06F 1/00, G11B 23/28]51[ENSCONCE DATA TECHNOLOGY,U.S.A.
]71[
WO/2004/084470]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system for rendering data stored on a data storage device (14) unrecoverable uponthe occurrence of a certain event, the system comprising: a reactant reservoir (18)including at least one chamber for holding a reactant chemical, the reactant reservoir influid communication with at least an area proximate at least one surface of said datastorage device; an activation device (44) coupled to said reactant reservoir andresponsive to at least one event, for causing at least a portion of the reactant chemicalto flow from the reactant reservoir into the at least an area proximate at least onesurface of said data storage device, thereby destroying the stored data, the at least oneevent being selected from the group consisting of removal of the data storage devicefrom a host computer, removal of data storage device from a primary power circuit (22),detected movement of the data storage device from its resting point, a certain numberof detected unsuccessful login attempts, an infrared signal sent from an infraredcontroller, a remote transmitter signal sent from a remote transmitter, a cellular signalsent from a cellular telephone, a wireless transmitter signal sent by a wirelesstransmitter, a keyboard signal sent from a wired controller, detected physical tamperingwith the data storage device, detected loss of power from the primary power circuit andbackup batteries, a command sent through an Internet, a key command sequenceentered from the keyboard, a voice command through a voice recognition system, abiometric signal, an incorrect biometric signal, and detected temperature outside arange of temperatures; and an event interface (42), coupled to said activation device,for establishing selected predetermined criteria for said at least one event, wherein theselected predetermined criteria include a countdown time before the reactant chemicalflows from the reactant reservoir.
]57[
__________
![Page 475: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/475.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009475
171104]21][11[
COMPACT ืืขืื ืืฉืืื OPTIC SENSOR]54[
23.02.1999]22[Int. Cl.(2008.04) G01B 9/00, G01N 21/01]51[DIVISION FROM 128659]62[CONMED CORPORATION, U.S.A.]71[
,ืืืฆืืื ืืช ืืืฆืืื ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ, ืื ืชืขืฉืืื
LUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
An integrated circuit (16) for the use in a compact optical sensor comprising a packageof at least two light sources (38, 40) concentrically surrounded by at least two waveguides (20, 22) being ring-like in cross-section, the integrated circuit comprises a pair ofsubstantially ring-like areas of photodiodes (26, 28) having different diameters andpositioned concentrically one inside the other; said integrated circuit being alsoprovided with a plurality of printed contact areas (30) and electric conductors (32),respectively intended for mounting thereon said light sources, controlling said lightsources, and for transmitting electric signals produced by said photodiodes areas tofurther processing.
]57[
__________
![Page 476: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/476.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 476
171165]21][11[
RELEASABLE ืืฆืื ืื ืืชื ืืฉืืจืืจ ืืืืื COUPLINGASSEMBLY
]54[
29.04.2004]22[US]33[30.04.2003]32[10/425934]31[US15.04.2004 10/824490
Int. Cl.(2009.01) E02F 09//28]51[ESCO CORPORATION, U.S.A.]71[WO/2004/099511]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A lock (10) that includes a wedge (12) and spool (14) are used to releasably secureseparable components of an assembly together. The wedge (12) and spool (14) arethreadedly coupled together to drive the wedge into and out of an opening in theassembly without hammering or prying. The direct coupling of the wedge (12) andspool eliminates the need for bolts, washers, nuts and other hardware so as tominimize the number of parts. As a result, the lock is inexpensive to make, easy to use,and unlikely to become inoperative because of lost or broken parts or due to fines orother difficulties encountered in harsh digging environments. Further, the wedge (12)can be driven into the assembly to provide the degree of tightness necessary for theintended operation and/or to re-tighten the assembly after incurring wear during use. Alatch assembly (56) is preferably provided to securely hold the wedge (12) in place andavoid and undesired loss of parts during use.
]57[
__________
171508]21][11[
DAMAGED ืืืื ืคืืื ืืืชืงื ืื ืืืกืจืช ืืืจื BOLT AND SCREWREMOVING DEVICES
]54[
23.04.2004]22[US]33[25.04.2003]32[60/465506]31[US23.04.2004 10/831391
Int. Cl.(2009.01) B25B 13//50]51[EAZYPOWER CORPORATION,U.S.A.
]71[
WO/2004/096471]87[,ืืจืืื ืืืืืจ, ืืืืฃ
ืืจืืฉืืื, 1352.ื.ืช,WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A bit for removing a broken fastener comprises a tip from which extend two or morenotches separated by scraping surfaces formed from two-sided frusto-conically-shapedregions. The scraping surfaces are bounded on one side by a cutting edge and on theother side by a non-cutting edge and are configured to cut into the fastener when thebit is rotated in a direction opposite to the fastener's direction of engagement. Specificembodiments include configurations where the cutting edges extend at different angles
]57[
![Page 477: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/477.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009477
with respect to the bit axis and where the scraping surfaces comprise a plurality ofserrations.
__________
171576]21][11[
PALLET ืืืื ืืืฉืื CONTAINER]54[
15.04.2004]22[DE]33[25.04.2003]32[20306550.6]31[
Int. Cl.(2008.04) B65D 77/06]51[MAUSER-WERKE GMBH & CO.KG,GERMANY
]71[
WO/2004/096660]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a pallet container (10) comprising: a thin-walled inner container(12) made of thermoplastic material for storing and transporting liquid or free-flowingproducts; a lattice tube frame (14), which closely surrounds the plastic container (12) inthe form of a supporting cage and which consists of vertical and horizontal tubular rods(20, 22) that are welded to one another, and; a base pallet (16) upon which the plasticcontainer (12) rests and to which the lattice tube frame (14) is joined in a fixed manner.Prior art pallet containers have shortcomings with regard to strength (tubular rod fatiguefailure) that are considerable in the event of longer lasting shaking during transport thatinvolves dynamic cyclic stresses. In order to improve the lattice tube frame durabilitywhile maintaining sufficient stacking load-bearing capacity, the invention achieves anadapted optimal elasticity for dynamic alternating loads. This is realized by virtue of thefact that the tubular rods (20, 22) with a closed tubular profile have a varying tubularprofile height, which is discontinuously higher in the intersection areas and continuouslylower between the intersection areas.
]57[
![Page 478: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/478.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 478
__________
171585]21][11[
ืืืฉืืจ ืืืืชืื ืืืืจ ืืืืฆืขืื ืฉื ืงืจื ืืืืืจ
DEVICE FOR CUTTINGMATERIAL BY MEANS OF ALASER BEAM
]54[
27.10.2005]22[EP]33[04.03.2005]32[05075533.9]31[
Int. Cl.(2009.01) B23K 26//38, B28D 01//22]51[BETTONVILLE INTEGRATEDSOLUTIONS, NAAMLOZEVENNOOTSCHAP, BELGIUM
]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
Device for cutting material by means of a laser beam, which device (1) comprises alaser source (2) for generating a laser beam (3) with an optical axis (10) and a focusinglens (8) for focusing said beam, characterized in that, between said laser source andsaid focusing lens are provided a first and a second retardation plate (4, 5) and arefraction element in between them, which is provided rotatable and tiltable withrespect to said optical axis of the incoming light beam.
]57[
__________
![Page 479: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/479.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009479
171598]21][11[
ืฉืืื ืืืชืงื ืืืงืืช ืงืฉืจ ืืืจ ืืืขืจืืช ืืืืืชโืื
WIDEBAND CONSTANT-GAINVOLTAGE AMPLIFIER
]54[
10.05.2004]22[US]33[09.05.2003]32[10/434675]31[
Int. Cl.(2008.04) H03F 3/45]51[QUALCOMM INCORPORATED,U.S.A.
]71[
WO/2004/102789]87[ืืกื ',ืงืืื ืืฉืืช. ืคืืจื
, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
A wideband, constant-gain voltage amplifier. An input transistor has atransconductance that is a function of temperature and fabrication process. Atransimpedance amplifier is connected to the input transistor. The transimpedanceamplifier has a transimpedance that is a function of temperature and process that issubstantially the inverse of the function of temperature and fabrication process of thetransconductance of the input transistor.
]57[
__________
171860]21][11[
FOOD ืืจืืืช ืืืื PACKAGING]54[
18.06.2004]22[GB]33[18.06.2003]32[0314189.2]31[
Int. Cl.(2009.01) B32B 27//32]51[TOMMEN GRAM HOLDING AS,NORWAYBOREALIS AG, AUSTRIA
]71[
WO/2004/113072]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
![Page 480: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/480.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 480
The use of a polyolefin film comprising a polypropylene polymer and apolyethylene polymer for the packaging of fresh produce.
]57[
__________
171947]21][11[
ืชืืชืืช ืืืจื ืืืกืืคืงืช ืขื ืืื ืืืืืืจ ืืชืื ืขืฆื ืืืจื
HIP PROSTHESIS PROVIDEDWITH A SHAFT INSERTED INTOTHE FEMUR
]54[
16.06.2004]22[EP]33[16.07.2003]32[03016157.4]31[
Int. Cl.(2008.04) A61F 2/36]51[WALDEMAR LINK GMBH & CO.KG, GERMANY
]71[
WO/2005/007039]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The invention relates to a hip prosthesis provided with a shaft (1) which can be insertedinto a hole in the femur without using cement. The proximal section of the shaft is madeup of a base body and the form thereof corresponds to the complementary form of thehole which is to be formed in the bone by means of a corresponding tool. A cuneus rib(12) is raised on the dorsal or ventral side of the base body and the width in the centrethereof is at least three times greater than the height thereof. The rear surface thereof(13) has rough and abrasive properties.
]57[
__________
![Page 481: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/481.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009481
171955]21][11[
ืฉืืืื ืฉื ืืืืง ืืืืื ืขืืืจ ืฉืชืื ืืืืืช
COMBINATION OF A DISPENSERAND CONTAINER FORCARBONATED DRINK
]54[
14.05.2004]22[NL]33[14.05.2003]32[1023429]31[
Int. Cl.(2008.04) B67D 1/04, 1/08]51[HEINEKEN TECHNICAL SERVICESB.V., THE NETHERLANDS
]71[
ENGBERT HERMANNES PAKKERT,QUINTIJN INNIKEL
]72[
WO/2004/101424]87[,ื"ืืข) 1995(ืืจืืื.ืื.ื'ื
ืจืืื ืื ืื ืืืื,15ืงืืื, ืืืื ืืืืืืื, 11 ืจืืช
G.E. EHRLICH (1995) LTD.,AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,RAMAT GAN 52521
]74[
Combination of a dispenser (1) and container (7) for carbonated drink, the containerbeing provided at the top with an outflow channel (10), extending in the directio of thecentral axis of the container, and a dispensing valve (11), closed under spring tension,for dispensing carbonated drink via a dispensing line (12, 13) connected to the outflowchannel (10), the dispenser (1) being provided with a chill chamber (4) foraccommodating the container (7) and with a dispensing head (15) with a handle (17)whereby the handle (17) is connected to an operating member (18, 20) that, duringuse, engages on the dispensing valve (11).
]57[
__________
![Page 482: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/482.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 482
172437]21][11[
ืื ืืืฆืืจ ืืกืืื ืืกืืื ืขื ืฆืืืืืช ืืฉื ืขื ืฆืืืืืช
PROFILED RAIL AND METHODFOR PRODUCING A PROFILEDRAIL
]54[
28.05.2004]22[DE]33[11.06.2003]32[10326333.0]31[
Int. Cl.(2009.01) E04B 09//06]51[PROTEKTORWERK FLORENZMAISCH GMBH & CO. KG,GERMANY
]71[
WO/2004/109030]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The invention relates to a profiled rail for supporting plate-shaped elements, particularlyfor inlay mounting of ceiling plates for louvered ceilings. The profiled rail comprises abase body, which is provided, at least in areas with a T-profile and which has alongitudinally extended web as well as a lower flange. The lower flange is placed alonga longitudinal edge of the web and comprises two lower flange sections each extendingfrom the web essentially in opposite directions. The lower flange is formed by bendingthe web, and the side of the lower flange, which is oriented away from the web, isprovided with a facing board. A multitude of openings are provided in the web, wherebyat least one of the lower flange sections is formed by material sections of the web thatare folded out from the openings, and the web is provided as a single layer essentiallyover its entire surface. The invention also relates to a method for producing a profiledrail of this type.
]57[
__________
![Page 483: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/483.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009483
172670]21][11[
ืืชืงื ืฉืืื ืืืขืจืืช ืืืืืื ืคืจืื ืืืืคื ืืคืืจืฉ
APPARATUS, METHOD ANDSYSTEM FOR POSITIVELYIDENTIFYING AN ITEM
]54[
24.06.2004]22[US]33[26.06.2003]32[10/608872]31[
Int. Cl.(2009.01) G01G 19//414, G06K 07//10, G07G 01//00]51[IBM CORPORATION, U.S.A.]71[WO/2005/001783]87[
,ืืขืืืืช ืืื ืืืืงืช ืงื ืื ืจืืื ื ืืืคื, ืืื ืืืจืกืืืช ืืืคื ืืจ ืืืจืื
IBM LABORATORIES,HAIFA UNIVERSITY,
HAIFA 31905
]74[
checkout station, for positively identifying items includes a reader that reads codedan item. The system further includes a capture module, such as a camera. The capture
sual characteristic of the item to be identified, such as the color, size, shape, or texture ofcharacteristic of the item is compared with visual characteristics of candidate items storedmultiple items within the database are associated with the item to be identified, theate items may be displayed to a user. The user may then select the candidate item thattem to be identified. The coded information of the item being identified is then compared
on of the selected item within the database. If the coded information of both itemsm is positively identified and is accepted for purchase by a consumer.
]57[
__________
172839]21][11[
ืขืฆืื ืชืจืืืฃ ืืืื ืฉื ืงืืื ืืืืืงืื ืืืืฉืื ืขื ืขืืื
AQUEOUS SUSPENSIONFORMULATION OF ABACTERICIDE FOR FOLIARAPPLICATION
]54[
07.07.2004]22[JP]33[18.07.2003]32[2003-199289]31[
Int. Cl.(2009.01) A01N 25//04, 43//56, 65//00]51[MITSUI CHEMICALS, INC., JAPAN]71[WO/2005/006863]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
![Page 484: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/484.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 484
It is intended to provide an aqueous suspension preparation of (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide showing stable residual effectiveness whilelittle affected by rainfall. An aqueous suspension preparation for foliageapplication, which is characterized by containing a bactericidalcomponent (RS)-N-[2-(1,3-dimethylbutyl)thiophen-3-yl]-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxamide together with apolyoxyalkyelne rosin acid ester or liquid paraffin, shows an improvedrain resistance on foliage and excellent residual effectiveness.
]57[
__________
173158]21][11[
ืคืืืืคืคืืืืื ืืขืื ืคืขืืืืช ืฆืืืืืื ืืืืื ืื ืืฉืืคืจืช
POLYPEPTIDE HAVING ANIMPROVED CYTOSINEDEAMINASE ACTIVITY
]54[
29.06.2004]22[EP]33[21.07.2003]32[03360087.5]31[US06.10.2003 60/508274
Int. Cl.(2009.01) A61K 38//43, C07K 14//195, C12N 15//62]51[TRANSGENE S.A., FRANCE]71[WO/2005/007857]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to a polypeptide possessing a CDase activity,characterized in that it is derived from a native CDase by addition of an amino acidsequence with the proviso that said polypeptide has no UPRtase or Thymidine Kinaseactivity.
]57[
ื ืื ืืงืฉืืช ืืืืงื ืืืงืฉ.ืฉืืจ๏ฟฝ ืคืืจืกืื
198433,The applications for divisionfrom this application havenot yet been published
__________
![Page 485: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/485.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009485
173505]21][11[
MACHINING ืืชืงื ืขืืืื ืืื ื APPARATUS]54[
02.02.2006]22[JP]33[04.02.2005]32[2005-28893]31[
Int. Cl.(2009.01) B24B 23//00, 27//08]51[DISCO CORPORATION, JAPAN]71[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
A machining apparatus, comprising: a mounting member (6) to be rotationally driven; atool support member (28) mounted on the mounting member; and a fixing member(30), fixed to the mounting member, for fixing the tool support member to the mountingmember, the mounting member having a mounting outer peripheral surface (24) of agenerally cylindrical shape, a cylindrical mounting hole (32) as a through-hole beingformed in the tool support member, and the tool support member being mounted on themounting member by fitting the mounting hole of the tool support member onto themounting outer peripheral surface of the mounting member, and wherein the mountingouter peripheral surface of the mounting member has a guide region, a support region,and a relief region arranged sequentially in a central axial direction, the support regionis of a cylindrical shape having an outer diameter D1, an outer diameter D2 of the guideregion increases up to D1 toward the support region, an outer diameter D3 of the reliefregion decreases from D1 with increasing distance from the support region, themounting hole of the tool support member has an inner diameter D4, D4 is larger thanD1 (D4>D1), a length in the central axial direction of the support region of the mountingouter peripheral surface is Wl, andWl is โ D42-Dl2 or smaller (Wl โค โ D42-D12).
]57[
__________
![Page 486: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/486.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 486
173681]21][11[
ืื OSCILLATOR ืฉืื ืืงืืกืืโืืชื ื ืืขื ืืืื WITH ACOUSTICSURFACE WAVE RESONATOR
]54[
24.08.2004]22[DE]33[25.08.2003]32[10339865.1]31[DE04.06.2004 102004028421.0
Int. Cl.(2008.04) H03B 5/32]51[TELE FILTER GMBH, GERMANY]71[WO/2005/041403]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
The invention relates to an oscillator or a sensor comprising a unit consisting of twofrequency determining elements each of which comprises at least one interdigitalconverter (24, 34) for acoustic surface waves and a back-coupling circuit comprising anamplifier, wherein the frequency determining elements (2, 3) are distinguished by atemperature dependence of a synchronous frequency. Said invention is characterisedin that a) the frequency determining elements are embodied in the form of acousticsurface wave resonators, b) the temperature coefficients of n-th order of thesynchronous frequency of the two acoustic surface wave resonators have differentsings if they are not equal to zero and the temperature coefficients of (n+1st) order ofthe synchronous frequency of the two acoustic surface wave resonators have the samesign and the temperature coefficients from the first order to (n-1st) order of thesynchronous frequency of the two acoustic surface wave resonators are equal to zero ifn is greater than 1, wherein n being equal to or greater than 1, c) the ratio between theconverter openings and the ratio between the lengths in the direction perpendicular tothe edge teeth of the converter and to strips of the object reflectors having differentfrequency determining elements which are assembled in one unit are selected in sucha way that the oscillator frequency variation is minimum within the range of giventemperatures.
]57[
__________
![Page 487: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/487.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009487
175109]21][11[
BEAK ืืืคืื ืืืงืืจ ืขื ืืื ื ืืืฉืื TREATMENT WITHTONGUE PROTECTION
]54[
04.11.2004]22[US]33[06.11.2003]32[10/702369]31[
Int. Cl.(2009.01) A01K 45//00]51[NOVA-TECH ENGINEERING, INC.,U.S.A.
]71[
WO/2005/046323]87[,ืคืจื ืืื ืฆืืง ืืฆืจ
, 12704.ื.ืช,5ืฉื ืงืจ'ืจื,1ืื-ืืจืื ืื ืืจืฆืืื
PEARL COHEN ZEDEK LATZER,5 SHENKAR ST.,
P.O.B. 12704,HERZLIYA 46733
]74[
The present invention provides apparatus and methods for treating the beaks of poultryto prevent further growth by non-contact heating while protecting the birds' tongues.The birds' tongues are protected by providing pressure on underside of the lower beakof the bird, proximate the base of the lower beak.
]57[
__________
175191]21][11[
ืืืฆืจ ืชืืื ื ืขืืืจ ืืืืื ืงืจืืืืืืชืืืืืืช ืืืฉืชืืฉืชโืชืืช
ืืจืงืื ืกืืจืืงืฆืืช ืืชืืจ ืืืืืจืกืื ืืช
SOFTWARE PRODUCT FORTHREE-DIMENSIONAL CARDIACIMAGING USING ULTRASOUNDCONTOUR RECONSTRUCTION
]54[
25.04.2006]22[US]33[26.04.2005]32[11/114800]31[
Int. Cl.(2009.01) A61B 08//00, G06T 17//40]51[BIOSENSE WEBSTER, INC., U.S.A.]71[
',ืจ ืฉืืื ืืื ืืฉืืช"ื ืชื ืืืื, 11490.ื.ืช, 124ืืื ืืืืจืื
DR. SHLOMO COHEN & CO.,124 IBN GABIROL ST.,
P.O.B. 11490,TEL AVIV 62038
]74[
A computer software product for modeling of an anatomical structure, the productcomprising a computer-readable medium, in which program instructions are stored,which instructions, when read by the computer, cause the computer to acquire aplurality of ultrasonic images of the anatomical structure using an ultrasonic sensor, ata respective plurality of spatial positions of the ultrasonic sensor, to measure location
]57[
![Page 488: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/488.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 488
and orientation coordinates of the ultrasonic sensor at each of the plurality of spatialpositions, to receive a manual input marking contours-of-interest that refer to featuresof the anatomical structure in one or more of the ultrasonic images and to construct a3-D model of the anatomical structure based on the contours-of-interest and on themeasured location and orientation coordinates.
__________
175454]21][11[
ืืขืจืืช ืืืคืงื ืืืืืจ ืืฉืืคืจ ืืชืขืืช ืืืื
SYSTEM FOR ENHANCED PURGEEFFECT IN GAS CONDUIT
]54[
04.05.2006]22[US]33[13.05.2005]32[11/128515]31[
Int. Cl.(2009.01) B08B 09//027, F17C 13//04, G05D 07//00]51[AIR PRODUCTS AND CHEMICALS,INC., U.S.A.
]71[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
A system for transferring gas from a gas supply vessel (2) to a delivery point of usewhich comprises: a vessel containing a gas source; a pigtail conduit (8) having an initialend and a terminal end adapted for delivery of gas to a point of use; a surge chamber(22) having a first end, a body section and a second end, said first end incommunication with the initial end of said pigtail conduit, said body section of saidsurge chamber having a cross-section larger than the cross-section of said pigtailconduit and a second end in communication with said vessel containing said gassource; a purge gas source for delivery of a purge gas in the direction from the terminalend toward the vessel containing a gas source within said pigtail conduit during analternating cycle of pressurization of said pigtail conduit with said purge gas; and adepressurization source within said pigtail conduit allowing for removal of impuritygases retained within said pigtail conduit.
]57[
__________
![Page 489: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/489.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009489
175846]21][11[
, ืคืื ืืืืงืช ืขืืจ ืืืืคืืชืชืืฉืืจืื ืืื ืชื ืืื ืืืืจืืื ืืขืืจ ืืคืฆืขื ืืืจืืช
COMPOSITIONS FOR THETREATMENT OF ATOPICDERMATITIS, SKIN ALLERGICCONDITIONS AND ACNE
]54[
08.11.2004]22[IT]33[24.11.2003]32[MI2003A002286]31[
Int. Cl.(2009.01) A61K 35//00, 36//00, A61P 17//00]51[INDENA S.P.A., ITALY]71[WO/2005/053720]87[
,ืจืืื ืืืื ืืื ืืฉืืชืคืื ืจืืช ืืืืื',ื26ืจืืื ืืืจืื
REINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention relates to topical compositions containing: a) Ginkgo bilobaterpenes; b) floroglucinols pure or in mixture thereof, extracted from Humulus lupulus,Hypericum sp and Mirtus sp; c) Zanthoxylum bungeanum or Echinacea angustifolialipophilic extract; for the treatment of atopic dermatitis, skin allergic conditions andacne.
]57[
__________
176518]21][11[
BALLISTIC-RESISTANT ืขืฆื ืขืืื ืืืืกืืืชARTICLE
]54[
01.01.2004]22[Int. Cl.(2008.04) F41H 5/04]51[DSM IP ASSETS B.V., THENETHERLANDS
]71[
WO/2005/066577]87[,ืืืฆืืื ืืช ืืืฆืืื
ืืืจ ืฉืืข, 5352.ื.ืช, ืขืืืจ,ืื ืชืขืฉืืืLUZZATTO & LUZZATTO,INDUSTRIAL PARK, OMER,
P.O.B. 5352,BEER-SHEVA 84152
]74[
The invention relates to a preformed sheet comprising at least two mono-layers, eachmono-layer containing unidirectionally oriented fibers having a tensile strength of atleast about 1.2 GPa and a tensile modulus of at least 40 GPa, and a binder, with a fibredirection in each mono-layer being rotated with respect to the fibre direction in anadjacent mono-layer, and a separating film on both outer surfaces, characterized in thatthe separating film has a porosity of between 40 and 90 %. With this preformed sheetassemblies and articles offering a substantially higher ballistic protection level at acertain weight can be obtained. The invention further relates to an assembly of at leasttwo such sheets and to a flexible ballistic-resistant article comprising said assembly.
]57[
![Page 490: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/490.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 490
__________
176731]21][11[
ืฉืืื ืืืฆืืจ ืงื ืชืืื ืกืืืื ื ืืฉืืคืืHCVืืงื ืชืืื ืืืืืฆืจ ืืฉืืื ืื
METHOD FOR PRODUCING ACELL LINE PERMISSIVE FORHCV REPLICATION AND A CELLLINE PRODUCED BY SAIDMETHOD
]54[
23.05.2001]22[US]33[23.05.2000]32[09/576989]31[
Int. Cl.(2008.04) A61K 39/29, C12Q 1/70]51[DIVISION FROM 152671]62[WASHINGTON UNIVERSITY,U.S.A.
]71[
WO/2001/089364]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
HCV variants are described. The variants include polynucleotides comprising non-naturally occurring HCV sequences and HCV variants that have a transfectionefficiency and ability to survive subpassage greater than HCV that have wild-typepolyprotein coding regions. Expression vectors comprising the above polynucleotidesand HCV variants are also described, as are the provision of cells and host cellscomprising the expression vectors. Methods for identifying a cell line that is permissivefor infection with HCV are also provided, as are vaccines comprising the abovepolynucleotides in a pharmaceutically acceptable carrier. Additionally, methods forinducing immunoprotection to HCV in a primate are described, as are methods fortesting a compound for inhibiting HCV replication.
]57[
__________
![Page 491: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/491.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009491
179865]21][11[
โ4โืืชืื3โ[4โ[[5โืชืืฉืืจ ืจืืงืืืช ืืืืืโ2โืืจื ืืืืโ4,3, ืืืงืกื
โืคื ืื]ืืชืืงืกื]ืงืื ืืืืื ืืืืืืื ืืฆืืจืโ4,2โืชืืืืืืืืืืืื]ืืชืื ืืืงื ืื ืืืืกื ืืชืืืื ืืืื ืชื, ืืืืืช
PHARMACEUTICALCOMPOSITION COMPRISING 5 -[[4-[3 - METHYL- 4- OXO - 3,4 -DIHYDRO - 2 -QUINAZOLINYL]METHOXY]PHENYL-METHYL]THIADIAZOLIDINE-2,4-DIONE IN THE FORM OF ATABLET, A POWDER OR ACAPSULE AND PROCESS FORITS PREPARATION
]54[
29.11.1999]22[DK]33[01.12.1998]32[PA19980158]31[
Int. Cl.(2008.04) A61K 314/25, A61P 3/10, C07D 417/00, 417/06]51[DIVISION FROM 143299]62[DR. REDDY'S LABORATORIESLIMITED, INDIADR. REDDY'S LABORATORIES,INC., U.S.A.
]71[
WO/2000/032191]87[,ืจืืื ืืืื ืืื ืืฉืืชืคืื
ืจืืช ืืืืื',ื26ืจืืื ืืืจืืREINHOLD COHN AND PARTNERS,26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]74[
The present invention provides a new stable pharmaceutical composition containing 5-[[4-[ 3-Methyl-4- oxo-3,4- dihydro-2- quinazolinyl] methoxy]phenyl -methyl]thiadiazolidine -2,4-dione as active ingredient.
]57[
__________
![Page 492: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/492.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 492
180304]21][11[
ืืชืืืช ืคืืื ืืกื ืขืืืจ ืงืืืขืช ืจืฆืคื ืืืืืืืจืืื
MASS DEFECT LABELING FORTHE DETERMINATION OFOLIGOMER SEQUENCES
]54[
19.10.2001]22[US]33[19.10.2000]32[60/242165]31[US19.10.2000 60/242398
Int. Cl.(2009.01) G01J 03//00, G01N 21//00, 27//62, 33//483]51[DIVISION FROM 155518]62[TARGET DISCOVERY, INC., U.S.A.]71[WO/2002/066952]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Mass tagging methods are provided that lead to mass spectrometer detectionsensitivities and molecular discriminations that are improved over other methods. Inparticular the methods are useful for discriminating tagged molecules and fragments ofmolecules from chemical noise in the mass spectrum. These mass tagging methodsare useful for oligomer sequencing, determining the relative abundances of moleculesfrom different samples, and identifying individual molecules or chemical processingsteps in combinatorial chemical libraries. The methods provided are useful for thesimultaneous analysis of multiple molecules and reaction mixtures by massspectrometric methods.
]57[
__________
184004]21][11[
ืืชืงื ืืืืืืช ืืืืืื ืื ืคืจืืืจืื ืจืืโืืืืืืืจืืื ืฉื ืชืืฉืืช ืืื
APPARATUS FOR MEASURINGAND ADJUSTING CHASSISGEOMETRY OF A MOTORVEHICLE
]54[
18.06.2007]22[Int. Cl.(2009.01) G01M 17//06]51[
MYKHAYLO ืืืคื, ืืืืืื ืืืงืฉืื LOKSHYN]71[,ืฉืืืขืื ืืืืื
ืืืคื, 13/3ืืืื' ืจืSHIMON GOYZMAN,13/3 AHAVA ST.,
HAIFA 35418
]74[
![Page 493: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/493.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009493
An apparatus for measuring and adjusting chassis geometry of a motor vehicle,comprising a pair of optically matched tools (1, 2), one of which includes device (7) witha laser emitter (20) and other tool (2) โ device (8) with a plane target (22) deflecting alaser beam, each tool having a mounting support (3) adapted to mount the tool on aninternal side of a circular element of a wheel and an X-direction orienting level (6) whichperpendicular to the laser beam and parallel to the plane target, wherein the devicesand the mounting supports are pivotally connected to each other through a pivot pin (9,10) disposed parallel to abscissa axis of the X-direction orienting level, wherein themounting supports are designed as a bracket having faces formed mostly by a pair ofright dihedral angles (internal and external), said bracket having edges parallel to theabscissa axis of the X-direction orienting level; wherein the internal bracket faces (B, C)are equipped with a fixing means (4, 5) intended for holding the bracket on the internalside of the circular element of the wheel, and a first external bracket face (D) comprisesthe rigidly fixed X-direction orienting level, and a second external bracket face (E) bearssaid device as well as a Y-direction orienting level (17) (18) disposed mainlyperpendicular to the abscissa axis of the X-direction orienting level on the plane parallelto the said abscissa axis.
]57[
ืืชืงื ืืช35ืคืืจืื ืื ื ืืื ืืืชืื ืืชืงื ื 1968โื"ืชืฉื, ืืคืื ืืื
This specification was examined in accordancewith regulation 35 of the Patent Regulations,5728 - 1968
__________
![Page 494: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/494.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 494
187551]21][11[
ืชืืฉืืจื, ืชืจืืืืืช ืื ืืืืืงืจืืืืืชืจืืงืืืช ืืืืืืื ืืืชื ืืชืืืืืื
ืืืื ืชื
ANTIMICROBIALCAPURAMYCIN DERIVATIVESAND PHARMACEUTICALCOMPOSITIONS CONTAININGTHE SAME
]54[
09.07.1999]22[JP]33[09.07.1998]32[10-194285]31[JP24.09.1998 10-269445
Int. Cl.(2008.04) A61K 31/70, A61P 31/04, C07H 190/67, C12P 19/38, C12R 15/45]51[DIVISION FROM 140731]62[SEQUELLA, INC., U.S.A.]71[WO/2000/002892]87[
,ืืจืืื ืืืืืจ, ืืืืฃ ืืจืืฉืืื, 1352.ื.ืช,
WOLFF, BREGMAN AND GOLLER,P.O.B. 1352,
JERUSALEM 91013
]74[
Pharmacologically acceptable esters, ethers and carbamoyl N-alkylates derived fromcompounds represented by general formula (Ia), and pharmacologically acceptablesalts of the same, which exhibit an excellent antibacterial activity and are useful in thetreatment or prevention of infectious diseases, wherein R?1ยฟ is hydrogen or methyl;R?2ยฟยฟa? is hydrogen, a hydroxyl-protecting group or methyl; R?3ยฟ is hydrogen or ahydroxyl-protecting group; R?4ยฟยฟa? is hydrogen or optionally protected hydroxyl; R?5ยฟis hydrogen or a hydroxyl-protecting group; and X is methylene or sulfur.
]57[
__________
![Page 495: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/495.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009495
188086]21][11[
ืฉืืืืช ืืฆืืื ืืขืฉืืช ืืืงืืงืื ืืฉืืืืฉืืืืืืฉ ืืชืจืกืืก ืืืืืื ืช ืกืืืื ืืชืื
ืืงื
METHOD AND APPARATUS FORMAKING PARTICLES USINGSPRAY DRYER AND IN-LINE JETMILL
]54[
20.11.2003]22[US]33[19.12.2002]32[10/324943]31[
Int. Cl.(2008.04) A61K 9/16, B01D 1/18, B01J 2/04]51[DIVISION FROM 168746]62[ACUSPHERE, INC., U.S.A.]71[WO/2004/060547]87[
ื ',ืงืืื ืืฉืืช. ืกื ืคืืจื, 2273.ื.ืช, ืืจืืืจืง,4ืฉืขืจ ืืืื
ืจืืืืืช
SANFORD T.COLB & CO.,P.O.B. 2273,
REHOVOT 76122
]74[
Methods and apparatus are provided for making particles comprising: (a) spraying anemulsion, solution, or suspension, which comprises a solvent and a bulk material (e.g.,a pharmaceutical agent), through an atomizer (14) and into a primary drying chamber(12), having a drying gas flowing therethrough, to form droplets comprising the solventand bulk material dispersed in the drying gas; (b) evaporating, in the primary dryingchamber (12), at least a portion of the solvent into the drying gas to solidify the dropletsand form particles dispersed in drying gas; and (c) flowing the particles and at least aportion of the drying gas through a jet mill (24) to deagglomerate or grind the particles.By coupling spray drying with 'in-line' jet milling, a single step process is created fromtwo separate unit operations, and an additional collection step is advantageouslyeliminated. The one-step, in-line process has further advantages in time and cost ofprocessing.
]57[
__________
![Page 496: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/496.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 496
PATENTS ืคืื ืืื
ืคืื ืืื ืฉื ืืชื ืPATENTS GRANTED
151733 133137 131282 130961 130766 130664 130349 115352 152390 152347 152118 152113 152077 151894 151757 151743 153339 153230 153137 152988 152800 152757 152432 152397 154187 154035 153876 153845 153793 153690 153648 153437 154600 154564 154543 154461 154418 154278 154275 154274 155380 155335 155334 155294 155206 154718 154645 154643 155970 155805 155794 155760 155732 155677 155515 155385 156650 156542 156304 156270 156251 156238 156231 156140 163537 163336 163311 163147 163097 162787 162503 162451 164575 164526 164418 164297 164213 163761 163703 163569 166077 166007 165794 165634 165202 165137 164881 164765 166991 166865 166808 166713 166547 166333 166251 166088 146780 126864 168849 168767 167956 167915 167610 167181 149856 149416 149132 148994 148896 148535 148469 148382 151382 151236 151213 150840 150575 150516 150080 150066 140834 140819 140593 138592 105855 169665 169558 169473 134842 133950 184402 142492 141933 141801 141481 141308 144975 144722 143691 143666 138212 138033 137845 135989 157186 157143 146555 146478 145927 145802 145168 145167 158352 158128 158125 158008 158002 157775 157635 157529 158797 158769 158724 158721 158656 158469 158389 158387 159611 159345 159217 159189 159155 159119 159080 158886 160311 160202 160167 160079 160039 159873 159861 159674 160832 160613 160523 160476 160400 160393 160360 160332 161565 161459 161304 161292 161249 161240 161177 160956
188445 162339 162253 162073
![Page 497: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/497.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009497
ืคืื ืืื ืฉืืืืฉืPATENTS RENEWED
98192 98161 98152 98137 98101 98077 98027 98014 98341 98273 98255 98254 98237 98217 98216 98204 98432 98431 98426 98408 98392 98386 98385 98365 98564 98515 98506 98463 98462 98456 98441 98438 98636 98614 98611 98604 98599 98598 98575 98572
113591 112141 111804 111254 110669 107309 107308 104253 113788 113786 113758 113756 113746 113682 113658 113595 113851 113832 113816 113812 113804 113803 113794 113789 113901 113898 113889 113879 113870 113865 113864 113852 113969 113966 113965 113957 113932 113930 113918 113908 114018 114015 114010 113994 113984 113983 113978 113970 114088 114082 114073 114050 114049 114039 114038 114037 114146 114131 114126 114123 114119 114118 114093 114091 114179 114176 114173 114171 114155 114153 114152 114151 114294 114274 114272 114246 114244 114238 114191 114190 114404 114399 114390 114387 114382 114375 114338 114337 126597 125881 125425 122359 122358 119396 115352 114690 129752 129738 129412 129379 128087 127723 127330 126598 130141 130039 130018 129953 129948 129947 129835 129827 130248 130224 130204 130191 130176 130171 130169 130151 130383 130371 130370 130368 130343 130332 130310 130262 130961 130513 130511 130477 130475 130462 130461 130405 134080 133950 133890 133841 133840 133519 132974 132601 135160 134842 134532 134496 134409 134305 134292 134229 138079 138033 137845 137743 137412 137004 136551 136290 138930 138876 138867 138776 138743 138684 138437 138129 139230 139201 139184 139133 139130 139109 139045 138931 139354 139353 139336 139283 139273 139240 139236 139231 139486 139472 139464 139430 139422 139396 139383 139355 139597 139592 139569 139546 139529 139528 139514 139509 139642 139640 139638 139612 139609 139607 139600 139598 139813 139786 139779 139775 139774 139773 139703 139653 139858 139852 139850 139847 139837 139831 139816 139814 139944 139940 139935 139929 139926 139921 139905 139861 139993 139991 139974 139964 139955 139952 139951 139946 140062 140061 140056 140032 140028 140004 140000 139996 140128 140109 140108 140089 140080 140078 140072 140068 140219 140218 140215 140199 140178 140155 140151 140149 140276 140273 140263 140260 140245 140238 140236 140234 140434 140431 140412 140391 140372 140353 140312 140277 140721 140720 140704 140649 140644 140619 140590 140564 141999 141982 141933 141606 141267 141105 140834 140819 144334 144188 144017 143666 143604 143232 142766 142699 146208 146029 145908 145904 145815 145518 145412 144675
![Page 498: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/498.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 498
147355 146819 146780 146716 146555 146544 146478 146255 148685 148638 148595 148469 148345 148014 147651 147579 149856 149531 149509 149416 149317 149291 148896 148891 150840 150678 150677 150575 150351 150080 150066 149974 151733 151644 151630 151399 151397 151236 151065 151035 152262 152261 152260 152259 152120 152077 151894 151757 153015 152778 152767 152592 152455 152432 152390 152347 153876 153758 153699 153654 153285 153163 153128 153049 154302 154231 154205 154187 154134 154044 153984 153883 154666 154652 154643 154575 154568 154564 154480 154450 155380 155337 155335 155334 155099 154905 154896 154696 155881 155831 155805 155760 155677 155659 155513 155385 156143 156140 156123 156080 156048 155973 155934 155923 156314 156310 156304 156226 156221 156189 156188 156178 156633 156560 156554 156537 156497 156446 156395 156350 157070 157064 157049 157020 156990 156948 156661 156650 158405 158389 158211 158150 157775 157529 157275 157073 158940 158921 158905 158886 158720 158409 158408 158406 159861 159753 159593 159552 159375 159345 159080 159072 160332 160223 160167 160079 159970 159918 159893 159873 161789 161444 161396 161249 161149 161141 160523 160334 162901 162587 162548 162525 162451 162253 161987 161904 164025 163761 163747 163703 163568 163537 163262 163173 164854 164765 164418 164348 164297 164213 164132 164034 165373 165345 165306 165219 165137 165135 165130 164959 166229 165908 165859 165746 165603 165601 165464 165463 166908 166738 166713 166697 166547 166480 166333 166251 169789 169636 169022 168225 167915 167798 167610 167203 175604 174098 173202 171479 171062 171061 171060 171015
188445 188300 184891 184402 182995 182994 180048
![Page 499: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/499.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009499
ืช ืืืืืฉืคืื ืืื ืฉืชืืงืคื ืคืงืขื ืืืื ืื ืชืฉืืื ืืืจPATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
110973 110971 110958 110954 110918 110915 110909 110897 111068 111066 111057 111050 111048 111045 111035 111025 111151 111128 111118 111114 111095 111087 111086 111084 111278 111268 111246 111238 111208 111194 111188 111173 111365 111355 111350 111334 111323 111319 111315 111279 129606 111446 111441 111419 111414 111409 111392 111377 132699 130592 130544 130305 130287 130229 130208 129791 126094 151624 151588 151477 150983 149218 148627 133251 126278 126252 126244 126218 126194 126172 126122 126103 126457 126448 126398 126373 126346 126284 126281 126279 126688 126639 126637 126592 126585 126549 126522 126466 126790 126776 126775 126773 126736 126706 126704 126694 163057 144481 144466 144139 142640 126816 126807 126805 165742 165741 165740 165739 164868 163567 163318 163159 95742 95739 95722 95720 95657 95598 166209 165743 95956 95949 95924 95871 95866 95832 95803 95764 96146 96112 96023 96021 96014 95986 95974 95972
134930 134927 134920 134871 134778 134777 134710 133851 135068 135066 135018 134986 134976 134957 134953 134937 135146 135145 135144 135143 135142 135109 135103 135094 135231 135228 135206 135204 135197 135196 135179 135174 135356 135354 135353 135330 135263 135237 135235 135233 135404 135400 135390 135380 135379 135370 135364 135360 135612 135609 135584 135583 135529 135503 135439 135426 135743 135733 135732 135668 135652 135648 135632 135631 136636 135856 135842 135841 135834 135833 135828 135782 153158 152571 152515 152465 151895 151821 151697 138251 123910 120073 156538 156424 155983 155512 153460 153386 160688 158649 157682 142209 141812 141810 141313 138566
177522 161567 161094
![Page 500: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/500.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 500
ืคืื ืืื ืฉืืืืฉื ืืขืฉืจืื ืฉื ืPATENTS RENEWED FOR 20 YEARS
113776
![Page 501: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/501.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009501
ืฆืืื ืืืจืื ืฉืืืืฉืEXTENSION ORDERS RENEWED
88363 84601 84497
![Page 502: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/502.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 502
NOTICEืืืืขืืืืืง60ืืคื ืกืขืืฃ 1967-ื"ืชืฉื, ืืคืื ืืื
Under section 60 of thePatent Law, 5727-1967
ืืืจ ืชืืงืคื ืืืืฉื ืืงืฉื ืื, ืฉื ืืคืื ื ืืืคืืจื ืืืืฉืชืืงืคื ืคืงืข ืืืืช ืื
ืชืฉืืื ืืืจืืช ืืืืืืฉ :ืืงืืืขืืช
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 137745 ืืคืื ื' ืืก of PatentAcceptance 3/2005:'ืงืืืื ืคืืจืกื ืืืืื ืืก published in
journal no::Proprietors:ืฉื ืืขื ืืคืื ื
MOTOROLA, INC.Title:ืฉื ืืืืฆืื of invention:
ืืืืืช-ืฉืืื ืืืขืจืืช ืืืขืจืืช ืืืงืื ืฉื ืื ืื ืืืืืจ ืฉืืจืืช ืืจืฉืช ืชืงืฉืืจืช ืืMETHOD AND SYSTEM FOR ESTIMATING A SUBSCRIBER'S LOCATION IN A
WIRELESSCOMMUNICATION SYSTEM SERVICE AREAืื ืืื ืจืฉืื ืืืชื ืืืืืงืฉื ืืืืืจื ืชืื
ืฉืืืฉื ืืืืฉืื ืืชืืจืื ืืคื ืฉื ืงืืข, ืืืื ืคืื ืืื ืื
92ืืืืง ืืืชืงื ื61ืืกืขืืฃ -ื"ืชืฉื, ืืชืงื ืืช ืืคืื ืืื
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
![Page 503: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/503.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009503
NOTICEืืืืขืืืืืง60ืืคื ืกืขืืฃ 1967-ื"ืชืฉื, ืืคืื ืืื
Under section 60 of thePatent Law, 5727-1967
ืืืืฉื ืืงืฉื ืืืืืจ ืชืืงืคื, ืฉื ืืคืื ื ืืืคืืจื ืืืืฉืชืืงืคื ืคืงืข ืืืืช ืื
ืชืฉืืื ืืืจืืช ืืืืืืฉ :ืืงืืืขืืช
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 138303 ืืคืื ื' ืืก of PatentAcceptance 6/2005:'ืงืืืื ืคืืจืกื ืืืืื ืืก published in
journal no::Proprietors:ืฉื ืืขื ืืคืื ื
TELEFONAKTIEBOLAGET LM ERICSSONTitle:ืฉื ืืืืฆืื of invention:
ืฉืืื ืืืชืงื ืืืงืจื ืขื ืืจืืืช ืืืืขMETHOD AND DEVICE FOR DATA FLOW CONTROL
ืืื ืจืฉืื ืืืชื ืื ืืืืืงืฉื ืืืืืจื ืชืื
ืฉืืืฉื ืืืืฉืื ืืชืืจืื ืืคื ืฉื ืงืืข, ืืืื ืคืื ืืื ืื
92ืืืืง ืืืชืงื ื61ืืกืขืืฃ -ื"ืชืฉื, ืืชืงื ืืช ืืคืื ืืื
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
![Page 504: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/504.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 504
NOTICEืืืืขืืืืืง60ืืคื ืกืขืืฃ 1967-ื"ืชืฉื, ืืคืื ืืื
Under section 60 of thePatent Law, 5727-1967
ืืืืฉื ืืงืฉื ืืืืืจ ืชืืงืคื, ืฉื ืืคืื ื ืืืคืืจื ืืืืฉืชืืงืคื ืคืงืข ืืืืช ืื
ืฉืืื ืืืจืืช ืืืืืืฉืช:ืืงืืืขืืช
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 138324 ืืคืื ื' ืืก of PatentAcceptance 5/2005:'ืงืืืื ืคืืจืกื ืืืืื ืืก published in
journal no::Proprietors:ืฉื ืืขื ืืคืื ื
ERICSSON, INC.Title:ืฉื ืืืืฆืื of invention:
ืืขืจืืช ืืฉืืื ืืืืข ืจืฉืช ืขื ืืืืืืช ืฉืืืช ืืืงืื ืืืืกืก ืืกืืฃSYSTEM AND METHOD FOR INFORMING NETWORK OF TERMINAL BASED
POSITIONING METHOD CAPABILITIESื ืืชื ืื ืื ืืื ืจืฉืื
ืืืงืฉื ืืืืืจื ืชืื ืฉืืืฉื ืืืืฉืื ืืชืืจืื
ืืคื ืฉื ืงืืข, ืืืื ืคืื ืืื ืื92ืืืืง ืืืชืงื ื61ืืกืขืืฃ
-ื"ืชืฉื, ืืชืงื ืืช ืืคืื ืืื1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
![Page 505: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/505.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009505
NOTICEืืืืขืืืืืง60ืืคื ืกืขืืฃ 1967-ื"ืชืฉื, ืืคืื ืืื
Under section 60 of thePatent Law, 5727-1967
ืืืืฉื ืืงืฉื ืืืืืจ ืชืืงืคื, ืฉื ืืคืื ื ืืืคืืจื ืืืืฉืชืืงืคื ืคืงืข ืืืืช ืื
ืชืฉืืื ืืืจืืช ืืืืืืฉ :ืชืืงืืืขื
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 165945 ืืคืื ื' ืืก of PatentAcceptance 11/2005:'ืงืืืื ืคืืจืกื ืืืืื ืืก published in
journal no::Proprietors:ื ืืคืื ืืฉื ืืข
ืฉืืื ืืืืืจืืSHLOMO ZILBERMAN
Title:ืฉื ืืืืฆืื of invention: ืืขืจืืช ืืืืืืช ืกืคืจื ืชืืจื
APPARATUS FOR ROLLING A SEFER TORAHืื ืืื ืจืฉืื ืืืชื ืืืืืงืฉื ืืืืืจื ืชืื
ืฉืืืฉื ืืืืฉืื ืืชืืจืื ืืคื ืฉื ืงืืข, ืืืื ืคืื ืืื ืื
92ืืืืง ืืืชืงื ื61ืืกืขืืฃ -ื"ืชืฉื, ืืชืงื ืืช ืืคืื ืืื
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
![Page 506: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/506.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 506
NOTICEืืืืขืืืืืง60 ืืคื ืกืขืืฃ 1967-ื"ืชืฉื, ืืคืื ืืื
Under section 60 of thePatent Law, 5727-1967
ืืืืฉื ืืงืฉื ืืืืืจ ืชืืงืคื, ืฉื ืืคืื ื ืืืคืืจื ืืืืฉืชืืงืคื ืคืงืข ืืืืช ืื
ืชืฉืืื ืืืจืืช ืืืืืืฉ :ืืงืืืขืืช
Application has been filedfor the restoration of thepatent recorded below,which has lapsed throughnon-payment of theprescribed renewal fees:
.No 169950 ืืคืื ื' ืืก of PatentAcceptance 3/2006:'ืงืืืื ืคืืจืกื ืืืืื ืืก published in
journal no::Proprietors:ืฉื ืืขื ืืคืื ื
ืฉืืขืื ืืืืืจืืSHLOMO ZILBERMAN
Title:ืฉื ืืืืฆืื of invention:ืจ ืชืืจื ืืขื ืืืกืืืืกืค
SEFER TORAH WITH BEARINGSืื ืืื ืจืฉืื ืืืชื ืืืืืงืฉื ืืืืืจื ืชืื
ืฉืืืฉื ืืืืฉืื ืืชืืจืื ืืคื ืฉื ืงืืข, ืืืื ืคืื ืืื ืื
92ืืืืง ืืืชืงื ื61ืืกืขืืฃ -ื"ืชืฉื, ืืชืงื ืืช ืืคืื ืืื
1968
Any person may oppose thesaid application within threemonths from the date of thisPatents Journal, asprescribed by section 61 ofthe law and by regulation 92of the Patent Regulations,5728-1968
![Page 507: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/507.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009507
ืชืืงืื ืืขืืชCORRIGENDUM
11/2008ืืืื
P. 4868 Patent application No 166919 166919'ืืงืฉืช ืคืื ื ืืก4868'ืขCorrect divisional application to- ื 153028-ืชืงื ืืงืฉืช ืืืืงื
3/2009ืืืื
P. 394 Patent application No 168609 168609'ืืงืฉืช ืคืื ื ืืก394'ืขCorrect date of priority to- ื 23.11.2002-ืชืงื ืชืืจืื ืืื ืงืืืื
![Page 508: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/508.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 508
ืงืืืื ืืืืื ืช ืืืืคืืขืื ืืืืืCOUNTRY CODES APPEARING IN THIS JOURNAL
Code Country or OrganizationAR ArgentinaAT AustriaAU AustraliaBA HerzegovinaBE BelgiumBR BrazilCA CanadaCH SwitzerlandCN ChinaCU CubaCZ Czech RepublicDE GermanyDK DenmarkEC EcuadorEP European Patent OfficeES SpainFI FinlandFR FranceGB United KingdomGE GeorgiaGR GreeceGT GuatemalaHR CroatiaHU HungaryIE IrelandIL IsraelIN IndiaIT ItalyJP JapanKR Republic of KoreaLK Sri LankaLU LuxembourgLV LatviaMX Mexico
MY Malaysia
![Page 509: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/509.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009509
NL The NetherlandsNO NorwayNZ New ZealandPL PolandPT PortugalRU Russian FederationSE SwedenSG SingaporeSI SloveniaSK SlovakiaTH ThailandTR TurkeyTW TaiwanUA UkraineUS United States of AmericaUY UruguayUZ UzbekistanWO World Intellectual Property Organization (W.I.P.O.)ZA South Africa
![Page 510: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/510.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 510
DESIGNS ืืืืืื ืืืืืื ืฉื ืจืฉืื
DESIGNS REGISTERED
44267, 44268, 44269, 44270Class 8(08) ืกืื
3. 6.2007XI MODULAR DESIGN LTD. ื"ืงืกืื ืขืืฆืื ืืืืืืืจื ืืขProfile ืคืจืืคืื
44371Class 13(03) ืกืื
18. 6.2007NISKO ELECTRICITY & ELECTRONICSPRODUCTS (1982) LTD.
ื ืืกืงื ืืืฆืจื ืืฉืื ืืืืงืืจืื ืืงืื"ืืข) 1982(
Socket ืฉืงืข
44512Class 11(02) ืกืื
18. 7.2007MEYTAL ZEMACH ืืืื ืฆืืCutlery decoration ื"ืงืืฉืื ืืกืื
44548Class 24(03) ืกืื
23. 7.2007
GARY PIERRE LAURYSSENMammary prosthesis ืชืืชืืช ืฉืConvention date (South Africa) 24.1.2007 )ืืจืื ืืคืจืืงื(ืชืืจืื ืืืื ื
44820, 47471, 47495Class 11(01) ืกืื
19. 9.2007
H. STERN COMERCIO E INDUSTRIAJewel ืชืืฉืื
![Page 511: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/511.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009511
45231Class 25(01) ืกืื
18. 12.2007
PRESS PLAST LTD. ื"ืคืจืก ืคืืกื ืืขProfile ืคืจืืคืื
45277Class 19(04) ืกืื
30. 12.2007
GIL FRIEDMAN ืืื ืคืจืืืืNotepad for hanging ืคื ืงืก ืืชืืื
45384, 45385Class 12(16) ืกืื
22. 1.2008HADAR ROSEN LTD. ื"ืืืจ ืจืืื ืืขVehicle seat cover ืืืกืื ืืืฉื ืืจืื
45455Class 24(04) ืกืื
12. 3.2007
GLAXO GROUP LIMITEDInhaler ืืฉืืฃConvention date (United Kingdom) 14.9.2006 ืืืืืื(ืชืืจืื ืืืื ื
)ืืืืืืืช
45489, 45490Class 8(08) ืกืื
7. 2.2008OZ GUM LTD. ื"ืขืืืืื ืืขRack ืืืืง
45656, 45657, 45658,45659, 45660, 45661,45662, 45663, 45664,
45665, 45666Class 26(05) ืกืื
9. 3.2008MARIELA BEN-SHACH ื"ืฉ-ืืจืืืื ืืWall lamp ืืฃ ืชืืืจื ืืงืืจ
![Page 512: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/512.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 512
45682Class 3(02) ืกืื
12. 3.2008WGI-WORLD GEMOLOGICALINSTITUTE
ืืขืืื ืืืืืืืืช ืืื ืืืืืืช. ืืื.ืื.ืืืื"ืืข
Document envelope ืขืืืคื ืืชืขืืืืช
45784Class 10(05) ืกืื
1. 4.2008WGI-WORLD GEMOLOGICALINSTITUTE
ืืขืืื ืืืืืืืืช ืืื ืืืืืืช. ืืื.ืื.ืืืื"ืืข
Loupe with internal lighting ืจื ืืืืืืช ืืืืืช ืืืื ื ืื ืขื ืชืืืคื ืืืืช
45910, 45911, 45912Class 11(01) ืกืื
1. 5.2008GERALDO LTD. ืืข'ื ื"ืจืืืืPrecious stone ืืื ืื
46006Class 8(08) ืกืื
26. 5.2008BARKAN MOUNTS LTD. ื"ืืจืืขืืช ืืจืงื ืืขLCD and plasma bracket ืืคืืืื LCD ืืจืืข ืืืกืื
46146Class 6(01) ืกืื
30. 6.2008GILI GLICKMAN ืืืื ืืืืงืืBaby cradle ืขืจืืกื ืืชืื ืืง
46185, 46202Class 2 (02) ืกืื
3. 7.2008
DIESEL S.P.A.Pants ืืื ืกืืื
![Page 513: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/513.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009513
46257Class 23(04) ืกืื
13. 7.2008TWITOPLAST LTD. ื"ืืืืืืืคืืกื ืืขAir conditioning system duct ืชืขืื ืืืขืจืืช ืืืืื ืืืืืจ
46360Class 12(16) ืกืื
31. 7.2008SHLOMO SHMUL ืฉืืื ืฉืืืCar cover ืืืกืื ืืจืื
46581Class 15(08) ืกืื
2. 9.2008
SOCIETE DES PRODUITS NESTLE S.A.Beverage dispenser ืืืชืืืื ืช ืืฉืงConvention date (Switzerland) 10.4.2008 )ืฉืืืืฅ(ืชืืจืื ืืืื ื
46584, 46585, 46586,46589, 46592, 46593,46598, 46600, 46601,46605, 46606, 46608
Class 2(04) ืกืื7. 9.2008
CAPLA LTD AND JHONY ELBAZ ืืขืงืค ืื"ืื ืื ื ืืื ื ืืื ืชื ืืืื'ืFootwear ื ืขื
46680Class 25(01) ืกืื
24. 9.2008EXTAL LTD. ื"ืืงืกืื ืืขProfile ืคืจืืคืื
46686Class 2(07) ืกืื
25. 9.2008YOSSEF YACOV COHEN ืืืกืฃ ืืขืงื ืืืSuspenders ืืชืคืืืช
![Page 514: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/514.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 514
46691Class 9(01) ืกืื
25. 9.2008
MARTELL & CO.Bottle ืืงืืืงConvention date (OHIM) 18.7.2008 )ืืืืืื(ืชืืจืื ืืืื ื
46822Class 9(01) ืกืื
6. 11.2008AMRAZ LTD. ื"ืืืจื ืืขBottle ืืงืืืง
46848Class 25(01) ืกืื
18. 11.2008AUREKA ALFA LTD. ื"ืืืืจืืงื ืืืคื ืืขProfile ืคืจืืคืื
46864, 46865, 46866,46867, 46868, 46871,46872, 46873, 46874,46875, 46876, 46877,
46878Class 25(01) ืกืื
23. 11.2008EXTAL LTD. ื"ืืงืกืื ืืขProfile ืคืจืืคืื
46962, 46963, 46964,46965, 46966, 46967,46968, 46969, 46970,46971, 46972, 46973,46974, 46975, 46976,46977, 46978, 46979,46980, 46981, 46982,
46983, 46984Class 2 (02) ืกืื
11. 12.2008
DIESEL S.P.A.Pants ืืื ืกืืื
![Page 515: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/515.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009515
47018, 47019, 47020,47021
Class 12(16) ืกืื23. 12.2008
HADAR ROSEN LTD. ื"ืืืจ ืจืืื ืืขCar seat cover ืืืกืื ืืืืฉื ืจืื
47025Class 13(03) ืกืื
23. 12.2008
MEIDENSHA CORPORATIONCapacitor ืงืืConvention date (Japan) 23.6.2008 )ืืคื(ืื ืืชืืจืื ืื
47045Class 2(07) ืกืื
30. 12.2008HAGIM NEHALIM MARKETING LTD. ื"ืืืื ื ืืืื ืฉืืืืง ืืขZipper ืจืืืกื
47048, 47049, 47050Class 13(03) ืกืื
31. 12.2008PHOTAX MOLDS LTD. ื"ืคืืืงืก ืชืื ืืืช ืืขDistribution box ืชืืืช ืืกืชืขืคืืช
47099Class 7(02) ืกืื
12. 1.2009
SANTOSElectric fruit squeezer ืืกืืืช ืคืืจืืช ืืฉืืืืชConvention date (OHIM) 17.7.2008 )ืืืืืื(ืชืืจืื ืืืื ื
47101Class 6(09) ืกืื
13. 1.2009NEZARIM MARKETING LTD. ื"ื ืฆืจืื ืฉืืืืง ืืขBeach mat ืืืจืื ืืืฆืืช
![Page 516: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/516.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 516
47106Class 12(16) ืกืื
13. 1.2009HADAR ROSEN LTD. ื"ืืืจ ืจืืื ืืขCar seat cover ืืืกืื ืืืืฉื ืจืื
47471, 47495Class 11(01) ืกืื
19. 9.2007
H. STERN COMERCIO E INDUSTRIA S.A.Jewel ืชืืฉืื
![Page 517: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/517.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009517
ืืืืืื ืฉืืืืฉืDESIGNS RENEWED
31796 31795 31728 31608 31607 31606 31548 31479 31804 31803 31802 31801 31800 31799 31798 31797 31821 31820 31819 31818 31817 31807 31806 31805 38988 36197 33548 32129 32063 31976 31974 31973 39364 39241 39184 39183 39182 39181 39180 39011
40962
![Page 518: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/518.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009 518
ืืืืืื ืฉืืืืืDESIGNS VOID
30696 30691 30646 30629 22669 2266822642 22577 38586 38582 38575 38574 38555 3073930738 30737
38628 38625 38620 3861938598 38587
Dr. Meir NoamCommissioner of Patents,Designs and Trade Marks
ืจ ืืืืจ ื ืืขื"ืืืืืืืื, ืจืฉื ืืคืื ืืื ืืกืืื ื ืืกืืจ
![Page 519: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/519.jpg)
Decemberโืข"ืืชืฉ ืืืืช'ื 24, 2009i
ืฉืื ืืืื ืืคืจืืื ืจืฉืืืื ืืคื ืงืกCHANGES IN PARTICULARS ENTERED IN REGISTER
ืืคืชืืืช ืืืงืฉืืช ืฉืงืืืืINDICES OF APPLICATIONS ACCEPTED
NAMEืืคืชื ืฉืื INDEX
149325ื ืื-ืืืจืื ืืืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืื 157878ืืืืงืจ ืืคืืชืื ืืจืฉืืช, ืืืจืืื ืื ืื-ืืื ืืืจืกืืืช ืื 164823ืืืืงืจ ืืคืืชืื
137462ืืืจื ืืืืกืืืคืืืงื-ืืืืื ืืขืจืืืช ืืืงืืจื
166354ื"ืืืืืค ืืข
160580ืืืจืืก ืคืืืืืกืงื 168041ื"ืืจ ืขืืื ืืฆืืจ ืืคืืชืื ืืข
157721ืืื ืืจืืื"ืืืกืงืืืง ืืื ืืืืืืืช ืจืคืืืืืช ืืข
131197
ื"ืืืกืืช ืฉืจืืชื ืืืงืจ ืจืคืืื ืืคืืชืื ืืข156115
164944ืืืื ืคืืก
152372ืืืื ืืื
, 149325ื"ืืืข ืืืจื ืืืืงืจ ืืคืืชืื ืืข156626 ,158228
ืืืฉืื ืืืจื ืืคืืชืื ืืืืงืจ ืฉืื"ืืืื ืืืจืกืืื ืืขืืจืืช ืืืจืืฉืืื ืืข
129966
160580ืืืื ืื ืืืืื ืงืื
ื"ืืืกื ืืืื ืืื ืืืืงืจ ืืคืืชืื ืืข129966 ,159534
184004ืืืืืื ืืืงืฉืื
156330ื"ื ืืื ืืืฉืืจื ืืืืื ืืข
139674ื"ืกืื ืืืกืง ืืืืื ืืข 171104ื"ืกืืืืจื ืืืืงื ืืข
167081ื"ืกืจืงืื ื ืืข
158968 ืขืคืจ ืืื
155545ื"ืคืืื ืืง ืืขืืืืช ืืข 155545ื"ืคืืื ืืง ืคืืจืืฆืืืืงื ืืข
161876ืงืื'ืคืจื ืกืืจืื
157117ื"ืงืื ืืืคื ืืข
162824ืจืืืื ืืืืจืื 156999ื"ืจื ืืจืื ืืืฆืจื ืืืืื ืืขืืข-ืจืืืช ืืื ืืื ืืืจืกืืืช ืชื ื"ืืืื
157721 ืืข"ืจืคื ื"ื ืืขืจืืืช ืืืืื ืืชืงืืืืช
167005 ืืขืจืคื ื"ื ืืขืจืืืช ืืืืื ืืชืงืืืืช
162676 ,163450 154581ืจืคืื ืคืื
![Page 520: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/520.jpg)
Decemberโืข"ืืชืฉ ืืืืช'ื 24, 2009 ii
161876ืงืื'ืฉืืขืื ืกืืจืืABBOTT GMBH & CO. KG 158932,
158933ABBOTT LABORATORIES 126626ABBOTT LABORATORIES 140492
ACTIAL FARMACEUTICA LDA162513
ACUSPHERE, INC. 188086ADVANCED ENVIRONMENTAL
TECHNOLOGIES PTY LTD. 161401AETERNA ZENTARIS GMBH 162492
AGENSYS, INC. 141061, 160053AIR PRODUCTS AND CHEMICALS,
INC. 175454ALIMENTARY HEALTH LIMITED
160049AMGEN INC. 153804
AMURA LIMITED 155183ANSHAN UNIVERSITY OF SCIENCE
AND TECHNOLOGY 159950ANTHONY TABATZNIK 157106
ARES TRADING S.A. 162592ARES-TRADING S.A. 156579
ARRAY BIOPHARMA INC. 153804ASEPTIC TECHNOLOGIES S.A.
154334ASTRAZENECA AB 149108
ATOFINA RESEARCH 151240AVRAHAM BEN-NUN 149325
BAR-EDAN MANUFACTURING ANDDEVELOPMENT LTD. 168041
BARLOVENTO INTERNATIONAL157106
BASF SE 160640, 161898BAYER ANIMAL HEALTH GMBH
169515BAYER CORPORATION 143351
BAYER CROPSCIENCE AG 165925BAYER HEALTHCARE AG 169515
BEN GURION UNIVERSITY OF THENEGEV RESEARCH AND
DEVELOPMENT AUTHORITY 157878BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH ANDDEVELOPMENT AUTHORITY 164823
BETTONVILLE INTEGRATEDSOLUTIONS, NAAMLOZE
VENNOOTSCHAP 171585BETTONVILLE, NAAMLOZEVENNOOTSCHAP OF 171585
BIOE, INC. 167624BIOGEN IDEC MA INC. 142905
BIOSENSE WEBSTER, INC. 157015,175191
BJORKBODA LAS OY AB 163738BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG 156277, 161165BOREALIS AG 171860BOREALIS AS 171860
BORIS PODOLSKY 160580BOSTON SCIENTIFIC LIMITED
145145BRIGHAM YOUNG UNIVERSITY
154130BRISTOL-MYERS SQUIBB
COMPANY 151372BURTON KOZAK 171508
C.R.F. SOCIETA CONSORTILE PERAZIONI 156871
CABOT CORPORATION 154538CEDARS-SINAI MEDICAL CENTER
158285CONMED CORPORATION 171104
CONTIPI LTD. 157117CRODA INTERNATIONAL PLC
153100CROSSJECT 170324CURIS INC. 142905
CYBRO MEDICAL LTD. 171104
DAIICHI SANKYO COMPANYLIMITED 145759, 147214, 187551
DAVID VARON 157721DIABETES DIAGNOSTICS, INC.
156254DISCO CORPORATION 173505
DISC-O-TECH MEDICALTECHNOLOGIES, LTD. 131197
DISENO DE SISTEMAS EN SILICIO,S.A. 162522
DR. REDDY'S LABORATORIESLIMITED 179865
DR. REDDY'S LABORATORIES, INC.179865
![Page 521: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/521.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009iii
DR. REDDY'S RESEARCHFOUNDATION 179865
DSM IP ASSETS B.V. 176518DULIVER INTERNATIONAL LTD.
170046DURAMED PHARMACEUTICALS,
INC. 151858
E.I. DUPONT DE NEMOURS ANDCOMPANY 159947
EAST CAROLINA UNIVERSITY158155
EAZYPOWER CORPORATION 171508ELBIT SYSTEMS ELECTRO-OPTICAL
ELOP LTD. 166354ELEMENT SIX LIMITED 166897
ELI LILLY & CO. 152528ELIZA CORPORATION 158127
ENSCONCE DATA TECHNOLOGY170901
ENVISION BIOMEDICALCONSULTING 140625
EPIGENOMICS AG 154663ESCO CORPORATION 171165
ESSILOR INTERNATIONAL(COMPAGNIE GENERALE
D'OPTIQUE) 148505EUGSTER/FRISMAG AG 157902EURENCO BOFORS AB 163376
EXOSECT LIMITED 168770
FABIO PERINI S.P.A. 168014FIKE CORPORATION 170190
FINETECH LABORATORIES LTD.155545
FINETECH PHARMACEUTICAL LTD.155545
FLEISSNER GMBH & CO.MASCHINENFABRIK 150636
FORSKARPATENT I SYD AB 158285FRED STRIZHAKOV 161876
GENENTECH, INC. 132251, 154495GENTIUM SPA 152328
GLAXOSMITHKLINE BIOLOGICALSS.A. 154334
GOTTHARD MAHLICH 157902GREAT LAKES CHEMICAL
CORPORATION 164961GREGORY S. KOPF 155801
GRUNENTHAL GMBH 157477,157895, 161587
H. LUNDBECK A/S 152645HADASIT MEDICAL RESEARCH
SERVICES & DEVELOPMENT LTD.156115
HAIM HAZAN 152372HEINEKEN TECHNICAL SERVICES
B.V 156049HEINEKEN TECHNICAL SERVICES
B.V. 171955
IBM CORPORATION 143015, 161654IBM CORPORATION 157678, 164066,
168977, 172670ICON GENETICS GMBH 160338
IMPERIAL CHEMICAL INDUSTRIESPLC 153100
INDENA S.P.A. 166557, 175846INTEL CORPORATION 153257
INTERACT DEVICES, INC. 160981INTERDIGITAL TECHNOLOGY
CORPORATION 160330ISHIHARA SANGYO KAISHA LTD.
155507
JAN BENGTSSON 157818JAPAN TOBACCO INC. 161559
JIYUL YOO 149249JOHNSON & JOHNSON VISION
CARE, INC. 148505
KI SEOK KIM 149249KWANG SEON SHIN 154897
KYPHON SARL 131197
LABORATOIRE FRANCAIS DUFRACTIONNEMENT ET DESBIOTECHNOLOGIES 161872
LAM RESEARCH CORPORATION167935
LEBET ALAIN 170046LECTEC CORPORATION 152786
LEIF NYFELT 157818LEK PHARMACEUTICAL AND
![Page 522: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/522.jpg)
Decemberโืข"ืืชืฉ ืืืืช'ื 24, 2009 iv
CHEMICAL COMPANY D.D. 157534LEONID BLYANKMAN 160580
LIFESCAN, INC. 164696LITTON SYSTEMS, INC. 164972
LUIS W. LEVY 157106
MASSACHUSETTS INSTITUTE OFTECHNOLOGY 140793
MATISSE NETWORKS 164037MAUSER-WERKE GMBH & CO.KG
171576MAXYGEN HOLDINGS LTD. 150153
MEDTRONIC SPINE LLC 131197MICROSOFT CORPORATION 160575
MITSUBISHI DENKI KABUSHIKIKAISHA 165439
MITSUBISHI TANABE PHARMACORPORATION 163287, 163288
MITSUI CHEMICALS, INC. 172839MORPHOCHEM
AKTIENGESELLSCHAFT FURKOMBINATORISCHE CHEMIE
160769, 163921MORPHOSYS AG 142025
MOSAID TECHNOLOGIESINCORPORATED 167081
MOTOROLA, INC. 157048MYKHAYLO LOKSHYN 184004
NAGRAVISION S.A. 164271NALCO COMPANY 170010
NDC INFRARED ENGINEERING LTD.160660
NEW YORK UNIVERSITY 152625NISSAN CHEMICAL INDUSTRIES
LTD. 126728, 159218NOVA MEASURING INSTRUMENTS
LTD. 156330NOVARTIS AG 149496, 160367, 168245
NOVA-TECH ENGINEERING, INC.175109
NOVO NORDISK A/S 179865NYCOMED PHARMA AS 157097
OFER DAGAN 158968ONCOLYTICS BIOTECH INC. 144043
OPMI FUNDING CORP. 169351OREN ALOUCE 137462
ORGANOGENESIS INC. 166014ORIGENIS GMBH 163921
ORTHOFIX INTERNATIONAL B.V152561
ORTHOFIX S.R.L. 152561ORTHOFIX S.R.L. 152561
ORTHO-MCNEILPHARMACEUTICAL, INC. 157588,
157591, 157592
PELLINI S.R.L. 165162PHALANX GROUP, LLC 169612PLIVA-LACHEMA, A.S. 165027
POTENCIA MEDICAL AG 147963PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG 172437
QUALCOMM INCORPORATED151705, 156764, 159017, 161643,
161984, 163048, 171598QUALCOMM INCORPORATED
156858QUALCOMM INCORPORATED
158161, 158162, 162092
RAFAEL ADVANCED DEFENSESYSTEMS LTD. 167005
RAFAEL ADVANCED DEFENSESYSTEMS LTD. 162676, 163450
RAMOT AT TEL-AVIV UNIVERSITYLTD. 157721
RAS HOLDING CORPORATION146887
RAV BARIACH SECURITYPRODUCTS LTD. 156999
RAYTHEON COMPANY 156227RAYTHEON COMPANY 160680RAYTHEON COMPANY 164199RAYTHEON COMPANY 167673
REFAEL PELED 154581REUVEN BOARON 162824
RICHARD BINNINGTON 157106
SANDISK IL LTD. 139674SANKYO AGRO COMPANY,
LIMITED 162035SANOFI AVENTIS 163287, 163288
SANOFI-AVENTIS DEUTSCHLAND
![Page 523: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/523.jpg)
Decemberโืข"ืืชืฉ ืืืกืื'ื 24, 2009v
GMBH 151216SANOFI-AVENTIS DEUTSCHLAND
GMBH 162562, 165520SANOFI-AVENTIS DEUTSCHLAND
GMBH 166439SCHLUMBERGER TECHNOLOGY
CORPORATION 150972SEMIKA S.A. 169463
SENSORMATIC ELECTRONICSCORPORATION 165782
SEQUELLA, INC. 187551SERCONET LTD. 167081
SHIMON STRIZHAKOV 161876SHIRE HUMAN GENETICTHERAPIES, INC. 145381
SIG COMBIBLOC INTERNATIONALAG 161402
SILVERBROOK RESEARCH PTY.LTD. 146679, 168608, 168700
SIPIX IMAGING, INC. 167337SMITHKLINE BEECHAM
BIOLOGICALS S.A. 145982SOLVAY PHARMACEUTICALS B.V.
160522SUMITOMO CHEMICAL COMPANY,
LIMITED. 170728SUMITOMO ELECTRIC INDUSTRIES,
LTD. 165965SUNTORY FLOWERS LIMITED
138716SUNTORY LIMITED 138716SUNTORY LIMITED 138716
TARGET DISCOVERY, INC. 180304TARO PHARMACEUTICALS U.S.A.,
INC. 165694TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.129966, 159534
TELE FILTER GMBH 173681THE CHILDREN'S HOSPITAL OF
PHILADELPHIA 151772THE CHILDREN'S MEDICAL CENTER
CORPORATION 126626THE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE 124636THE PROCTER & GAMBLE
COMPANY 163734
TOMMEN GRAM HOLDING AS171860
TRANSGENE S.A. 173158TRESPAPHAN GMBH 158935TRUEPOSITION, INC. 166746
UHDE GMBH 151139UMD, INC. 153719
UNIVERSITY OF BRISTOL 158060UNIVERSITY OF TENNESSEE
RESEARCH FOUNDATION 168793UNIVERSITY OF VIRGINIA PATENT
FOUNDATION 155801UOP LLC 155901
VAST POWER PORTFOLIO, LLC138380
VERTEX PHARMACEUTICALSINCORPORATED 165715
VIASAT, INC. 162567
W.C. HERAEUS GMBH 166769WALDEMAR LINK GMBH & CO. KG
171947WARNER-LAMBERT COMPANY LLC
152770, 162721WASHINGTON UNIVERSITY 176731
WYETH 145688, 159859
XACCT TECHNOLOGIES, INC. 136219
YEDA RESEARCH ANDDEVELOPMENT CO. LTD. 149325,
156626, 158228YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
129966YONSUNG FINE CHEMICAL CO.
158634
ZALMAN PELES 164944
![Page 524: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/524.jpg)
Decemberโืข"ืืชืฉ ืืืืช'ื 24, 2009 vi
ืืคืชื ืขื ืืื ืSUBJECT MATTER INDEX
A01K โ 155801, 175109
A01N โ 155507, 159947, 168770,169515, 172839
A47G โ 162824
A47J โ 157902
A61B โ 131197, 152561, 157015,164696, 170046
A61F โ 146887, 147963, 151858,153719, 156115, 157117,163734, 169351, 171947
A61K โ 140492, 140625, 144043,145381, 145688, 145982,149496, 151772, 152328,152528, 152786, 154495,157477, 158155, 158285,159859, 160769, 162492,165027, 166557, 168793,175846, 179865
A61L โ 157097
A61M โ 145145, 156579, 170324
B01D โ 151139, 160580
B01F โ 159950
B01J โ 157878, 163921, 166769,170728, 188086
B23K โ 171585
B24B โ 173505
B25B โ 171508
B32B โ 171860
B41J โ 168608, 168700
B62K โ 154130B63B โ 161876
B65D โ 161402, 171576
B65H โ 168014
B67D โ 156049, 171955
C01G โ 153100
C02F โ 161401, 170010
C04B โ 162676
C06B โ 163376
C07C โ 152770, 153804, 155901,157106, 157588, 157591,157592, 158228, 158634,161587, 161898, 165925,166439
C07D โ 126728, 145759, 147214,149108, 151372, 152645,155183, 155545, 156277,157534, 157895, 158932,158933, 159216,159534,160367, 160522, 160640,161165, 161559, 162035,162562, 162721, 163287,163288, 165520, 165694,165715
C07H โ 187551
C07K โ 132251, 150153, 152625,158060, 160053, 161872,162592
C08K โ 164961
![Page 525: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/525.jpg)
Decemberโืข"ืืชืฉ ืืืืช'ื 24, 2009vii
C08L โ 158935
C09C โ 154538
C12M โ 166014
C12N โ 124636, 126626, 129966,138716, 142905, 143351,149325, 160049, 160338,168245, 173158
C12P โ 151216
C12Q โ 144061, 154663, 176731
C22C โ 154897
C23C โ 169463
C30B โ 166897
C40B โ 142025
D01F โ 151240
D04H โ 150636
E02F โ 171165
E04B โ 172437
E06B โ 165162
E21B โ 150972
F01B โ 164944
F02C โ 138380
F16B โ 154581
F17C โ 175454
F24H โ 152372
F24J โ 158968
F28F โ 137462
F41G โ 163450, 167005F41H โ 176518
G01B โ 171104
G01M โ 184004
G01N โ 156254, 156626, 157721,160660, 162513, 164823,167624, 180304
G01S โ 157818, 161643, 166746,169612
G02B โ 156871, 166354, 167673
G02C โ 148505
G02F โ 167337
G05D โ 164196, 170046
G05G โ 156330
G06F โ 139674, 140793, 153257,168977, 170901
G06K โ 146679, 157678
G06T โ 175191
G07G โ 172670
G10L โ 158127
G21F โ 154334
H01L โ 156227, 161654, 164066,167935
H01M โ 165965
H01Q โ 160680
H03B โ 173681
H03F โ 171598
![Page 526: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/526.jpg)
Decemberโืข"ืืชืฉืืืืช'ื 24, 2009 viii
H04B โ 156858, 163048H04H โ 158161
H04J โ 164037
H04L โ 149249, 158162, 159017,160330, 160575, 161984,162522, 162567, 167081
H04M โ 136219, 165439
H04N โ 143015, 160981, 164271,164972
H04Q โ 151705, 156764, 157048,162092, 165782
![Page 527: PATENTS AND DESIGNS JOURNAL](https://reader030.fdocuments.net/reader030/viewer/2022012800/61b5b7d9712e8d79c472b431/html5/thumbnails/527.jpg)
ืข ืืจืืฉืืื, ืืฉืจื ืืืฉืคืืื,ื ืจืฉืืช ืืคืื ืืื"ื ืขืจื ืืจืืฉืืื, ืืืคืง ืืืืืคืก ืืืืคืืก ืืืืฉืืชื
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER